Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	json	split
In primary T lymphocytes we show that CD28 ligation leads to the rapid intracellular formation of reactive oxygen intermediates ( ROIs) which are required for CD28 - mediated activation of the NF - kappa B / CD28 - responsive complex and IL - 2 expression.	CD28,38,42,Gene/Protein	CD28,159,163,Gene/Protein	NF - kappa B,193,205,Gene/Protein	CD28 - responsive complex,208,233,Gene/Protein	IL - 2,238,244,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 193, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""CD28 - responsive complex"", ""start_span"": 208, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 238, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
In particular, two interleukins ( ILs), IL - 2 and IL - 12, have been shown to be potent inducers of IFN - gamma gene expression in both T cells and LGL.	interleukins,19,31,Gene/Protein	ILs,34,37,Gene/Protein	IL - 2,40,46,Gene/Protein	IL - 12,51,58,Gene/Protein	IFN - gamma,101,112,Gene/Protein	"[{""token"": ""interleukins"", ""start_span"": 19, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""ILs"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene/Protein""}]"	train
In this report we present evidence that the cell line NK3. 3 derived from human NK cells, responds to both IL - 2 and IL - 12, as measured by increases in IFN - gamma and granulocyte - macrophage colony - stimulating factor ( GM - CSF) cytoplasmic mRNA and protein expression.	IL - 2,107,113,Gene/Protein	IL - 12,118,125,Gene/Protein	IFN - gamma,155,166,Gene/Protein	granulocyte - macrophage colony - stimulating factor,171,223,Gene/Protein	GM - CSF,226,234,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 171, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 226, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
We further demonstrate that the p95vav - induced NFAT activation is not mimicked by Ras activation, though its function is dependent upon Ras and Raf.	p95vav,32,38,Gene/Protein	NFAT,49,53,Gene/Protein	Ras,84,87,Gene/Protein	Ras,138,141,Gene/Protein	Raf,146,149,Gene/Protein	"[{""token"": ""p95vav"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""Raf"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
PEBP2 alpha A1, alpha B1, and alpha B2 proteins bound the PEBP2 site within the mouse GM - CSF promoter.	PEBP2 alpha A1,0,14,Gene/Protein	alpha B1,16,24,Gene/Protein	alpha B2 proteins,30,47,Gene/Protein	PEBP2 site,58,68,Gene/Protein	mouse GM - CSF promoter,80,103,Gene/Protein	"[{""token"": ""PEBP2 alpha A1"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""alpha B1"", ""start_span"": 16, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""alpha B2 proteins"", ""start_span"": 30, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2 site"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""mouse GM - CSF promoter"", ""start_span"": 80, ""end_span"": 103, ""type"": ""Gene/Protein""}]"	train
The protein products of this gene contain the basic - helix - loop - helix motif characteristic of a large family of transcription factors that bind to the canonical DNA sequence CANNTG as protein heterodimers.	protein products,4,20,Gene/Protein	basic - helix - loop - helix motif,46,80,Gene/Protein	transcription factors,117,138,Gene/Protein	canonical DNA sequence CANNTG,156,185,Gene/Protein	protein heterodimers,189,209,Gene/Protein	"[{""token"": ""protein products"", ""start_span"": 4, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""basic - helix - loop - helix motif"", ""start_span"": 46, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 117, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""canonical DNA sequence CANNTG"", ""start_span"": 156, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""protein heterodimers"", ""start_span"": 189, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
Interleukin - 2 ( IL - 2) rapidly activated Stat5 in fresh PBL, and Stat3 and Stat5 in preactivated PBL.	Interleukin - 2,0,15,Gene/Protein	IL - 2,18,24,Gene/Protein	Stat5,44,49,Gene/Protein	Stat3,68,73,Gene/Protein	Stat5,78,83,Gene/Protein	"[{""token"": ""Interleukin - 2"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Gene/Protein""}]"	train
Rather, hEpoR transcription activity depends on coordination between Sp1 and GATA - 1 with other cell - specific factors, including possibly other Sp1 - like binding proteins, to provide high level, tissue - specific expression.	hEpoR,8,13,Gene/Protein	Sp1,69,72,Gene/Protein	GATA - 1,77,85,Gene/Protein	cell - specific factors,97,120,Gene/Protein	Sp1 - like binding proteins,147,174,Gene/Protein	"[{""token"": ""hEpoR"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 77, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""cell - specific factors"", ""start_span"": 97, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 - like binding proteins"", ""start_span"": 147, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
We have identified a cDNA clone, DR - nm23, differentially expressed in a blast - crisis cDNA library, which has approximately 70% sequence similarity to the putative metastatic suppressor genes, nm23 - H1 and nm23 - H2.	cDNA clone,21,31,Gene/Protein	DR - nm23,33,42,Gene/Protein	putative metastatic suppressor genes,158,194,Gene/Protein	nm23 - H1,196,205,Gene/Protein	nm23 - H2,210,219,Gene/Protein	"[{""token"": ""cDNA clone"", ""start_span"": 21, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""DR - nm23"", ""start_span"": 33, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""putative metastatic suppressor genes"", ""start_span"": 158, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""nm23 - H1"", ""start_span"": 196, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""nm23 - H2"", ""start_span"": 210, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Our results demonstrate that transcriptional regulation of the Fc gamma RIC gene by IFN - gamma involves the binding of STAT1 alpha to a 17 - bp GAS homology in the proximal promoter.	Fc gamma RIC gene,63,80,Gene/Protein	IFN - gamma,84,95,Gene/Protein	STAT1 alpha,120,131,Gene/Protein	17 - bp GAS homology,137,157,Gene/Protein	proximal promoter,165,182,Gene/Protein	"[{""token"": ""Fc gamma RIC gene"", ""start_span"": 63, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 alpha"", ""start_span"": 120, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""17 - bp GAS homology"", ""start_span"": 137, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""proximal promoter"", ""start_span"": 165, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
This inhibition was paralleled by reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar after stimulation by either IL - 1 alpha, IL - 1 beta, IL - 4, tumor necrosis factor ( TNF alpha), or bacterial lipopolysaccharide.	IL - 1 alpha,200,212,Gene/Protein	IL - 1 beta,214,225,Gene/Protein	IL - 4,227,233,Gene/Protein	tumor necrosis factor,235,256,Gene/Protein	TNF alpha,259,268,Gene/Protein	"[{""token"": ""IL - 1 alpha"", ""start_span"": 200, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 beta"", ""start_span"": 214, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 227, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 235, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""TNF alpha"", ""start_span"": 259, ""end_span"": 268, ""type"": ""Gene/Protein""}]"	train
The interleukin - 5 / receptor interaction activates Lyn and Jak2 tyrosine kinases and propagates signals via the Ras - Raf - 1 - MAP kinase and the Jak - STAT pathways in eosinophils.	interleukin - 5,4,19,Gene/Protein	Lyn and Jak2 tyrosine kinases,53,82,Gene/Protein	Ras - Raf - 1 - MAP kinase,114,140,Gene/Protein	Jak,149,152,Gene/Protein	- STAT,153,159,Gene/Protein	"[{""token"": ""interleukin - 5"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""Lyn and Jak2 tyrosine kinases"", ""start_span"": 53, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""Ras - Raf - 1 - MAP kinase"", ""start_span"": 114, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""Jak"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""- STAT"", ""start_span"": 153, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
RB and a novel E2F - 1 binding protein in MHC class II deficient B - cell lines and normal IFN - gamma induction of the class IL transactivator CIITA in class II non - inducible RB - defective tumor lines.	RB,0,2,Gene/Protein	E2F - 1 binding protein,15,38,Gene/Protein	IFN - gamma,91,102,Gene/Protein	class IL transactivator,120,143,Gene/Protein	CIITA,144,149,Gene/Protein	"[{""token"": ""RB"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 1 binding protein"", ""start_span"": 15, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""class IL transactivator"", ""start_span"": 120, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
In contrast, integrin ligation with antibodies induces tyrosine phosphorylation of Syk but not of FAK or paxillin.	integrin,13,21,Gene/Protein	antibodies,36,46,Gene/Protein	Syk,83,86,Gene/Protein	FAK,98,101,Gene/Protein	paxillin,105,113,Gene/Protein	"[{""token"": ""integrin"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""Syk"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""FAK"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""paxillin"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Gene/Protein""}]"	train
Transient transfection assays with EGR - 1 promoter fragments linked to the chloramphenicol acetyltransferase ( CAT) gene demonstrated that PWM induced EGR - 1 transcription is conferred by the CArG motif ( C C [ AT] 6GG) in the EGR - 1 promoter.	EGR - 1 promoter fragments,35,61,Gene/Protein	PWM,140,143,Gene/Protein	EGR - 1,152,159,Gene/Protein	CArG motif,194,204,Gene/Protein	EGR - 1 promoter,229,245,Gene/Protein	"[{""token"": ""EGR - 1 promoter fragments"", ""start_span"": 35, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""PWM"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""EGR - 1"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""CArG motif"", ""start_span"": 194, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""EGR - 1 promoter"", ""start_span"": 229, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
Induction of VCAM - 1 and E - selectin surface expression by TNF was dose - dependently reduced by aspirin over the same range, while induction of intercellular adhesion molecule - 1 ( ICAM - 1) was hardly affected.	VCAM - 1,13,21,Gene/Protein	E - selectin,26,38,Gene/Protein	TNF,61,64,Gene/Protein	intercellular adhesion molecule - 1,147,182,Gene/Protein	ICAM - 1,185,193,Gene/Protein	"[{""token"": ""VCAM - 1"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 26, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 147, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 185, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
rBPI21, a recombinant N - terminal fragment of human bactericidal / permeability - increasing protein ( BPI), inhibited LPS - induced E - selectin expression when added at the same time as, and up to 6 h after, LPS.	rBPI21,0,6,Gene/Protein	recombinant N - terminal fragment,10,43,Gene/Protein	human bactericidal / permeability - increasing protein,47,101,Gene/Protein	BPI,104,107,Gene/Protein	E - selectin,134,146,Gene/Protein	"[{""token"": ""rBPI21"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""recombinant N - terminal fragment"", ""start_span"": 10, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""human bactericidal / permeability - increasing protein"", ""start_span"": 47, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""BPI"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 134, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
By using recombinant proteins, we confirmed that AP - 1, NF - ATp, and a higher order NF - ATp / AP - 1 complex could all form with the hCLEO element, and we have also defined the sequence requirements for binding of each of these complexes.	recombinant proteins,9,29,Gene/Protein	AP - 1,49,55,Gene/Protein	NF - ATp,57,65,Gene/Protein	NF - ATp / AP - 1 complex,86,111,Gene/Protein	hCLEO element,136,149,Gene/Protein	"[{""token"": ""recombinant proteins"", ""start_span"": 9, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATp"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATp / AP - 1 complex"", ""start_span"": 86, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""hCLEO element"", ""start_span"": 136, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency.	MHC class II gene,6,23,Gene/Protein	carboxyl terminus,54,71,Gene/Protein	CIITA,75,80,Gene/Protein	defective genes,93,108,Gene/Protein	MHC,120,123,Gene/Protein	"[{""token"": ""MHC class II gene"", ""start_span"": 6, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""carboxyl terminus"", ""start_span"": 54, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""defective genes"", ""start_span"": 93, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""MHC"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}]"	train
The transactivation of multiple cis elements, especially S and X2, of the DR alpha proximal promoter in group II CID cells is CIITA dependent.	multiple cis elements,23,44,Gene/Protein	S,57,58,Gene/Protein	X2,63,65,Gene/Protein	DR alpha proximal promoter,74,100,Gene/Protein	CIITA,126,131,Gene/Protein	"[{""token"": ""multiple cis elements"", ""start_span"": 23, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""S"", ""start_span"": 57, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""X2"", ""start_span"": 63, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""DR alpha proximal promoter"", ""start_span"": 74, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}]"	train
Transcriptional regulation of the human alpha - like globin genes, embryonic zeta 2 and adult alpha, during erythroid development is mediated by a distal enhancer, HS - 40.	human alpha - like globin genes,34,65,Gene/Protein	embryonic zeta 2,67,83,Gene/Protein	adult alpha,88,99,Gene/Protein	distal enhancer,147,162,Gene/Protein	HS - 40,164,171,Gene/Protein	"[{""token"": ""human alpha - like globin genes"", ""start_span"": 34, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""embryonic zeta 2"", ""start_span"": 67, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""adult alpha"", ""start_span"": 88, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""distal enhancer"", ""start_span"": 147, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""HS - 40"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
Three of these HS - 40 enhancer motifs, 5 ' NF - E2 / AP1, GT II, and GATA - 1 ( c), positively regulate the zeta 2 - globin promoter activity in embryonic / fetal erythroid K562 cells and the adult alpha - globin promoter activity in adult erythroid MEL cells.	HS - 40 enhancer motifs,15,38,Gene/Protein	5 ' NF - E2 / AP1,40,57,Gene/Protein	GT II,59,64,Gene/Protein	zeta 2 - globin promoter,109,133,Gene/Protein	adult alpha - globin promoter,193,222,Gene/Protein	"[{""token"": ""HS - 40 enhancer motifs"", ""start_span"": 15, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""5 ' NF - E2 / AP1"", ""start_span"": 40, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""GT II"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""zeta 2 - globin promoter"", ""start_span"": 109, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""adult alpha - globin promoter"", ""start_span"": 193, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
Interaction between the stage selector element ( SSE) in the proximal gamma - globin promoter and hypersensitivity site 2 in the locus control region partly mediates the competitive silencing of the beta - globin promoter in the fetal developmental stage.	stage selector element,24,46,Gene/Protein	proximal gamma - globin promoter,61,93,Gene/Protein	hypersensitivity site 2,98,121,Gene/Protein	locus control region,129,149,Gene/Protein	beta - globin promoter,199,221,Gene/Protein	"[{""token"": ""stage selector element"", ""start_span"": 24, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""proximal gamma - globin promoter"", ""start_span"": 61, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""hypersensitivity site 2"", ""start_span"": 98, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""locus control region"", ""start_span"": 129, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin promoter"", ""start_span"": 199, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
Utilizing transient transfection assays in the fetal erythroid cell line, K562, we have shown that the core enhancer of hypersensitivity site 2 can preferentially interact with the proximal gamma - promoter in the absence of the SSE, completely silencing a linked beta - promoter.	core enhancer,103,116,Gene/Protein	hypersensitivity site 2,120,143,Gene/Protein	proximal gamma - promoter,181,206,Gene/Protein	SSE,229,232,Gene/Protein	linked beta - promoter,257,279,Gene/Protein	"[{""token"": ""core enhancer"", ""start_span"": 103, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""hypersensitivity site 2"", ""start_span"": 120, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""proximal gamma - promoter"", ""start_span"": 181, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""SSE"", ""start_span"": 229, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""linked beta - promoter"", ""start_span"": 257, ""end_span"": 279, ""type"": ""Gene/Protein""}]"	train
Insertion of oligonucleotides spanning the DQB X - box ( but not the DQB - W region or the DQB Y - box) upstream of - 141 in a DRA reporter plasmid rescued expression to nearly wild - type levels.	DQB X - box,43,54,Gene/Protein	DQB - W region,69,83,Gene/Protein	DQB Y - box,91,102,Gene/Protein	upstream of - 141,104,121,Gene/Protein	DRA reporter plasmid,127,147,Gene/Protein	"[{""token"": ""DQB X - box"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""DQB - W region"", ""start_span"": 69, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""DQB Y - box"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""upstream of - 141"", ""start_span"": 104, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""DRA reporter plasmid"", ""start_span"": 127, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	train
The ZEBRA activation region was replaced with the potent acid activation region from the herpes simplex virus VP16 protein or with the activation region of the EBV R protein.	ZEBRA activation region,4,27,Gene/Protein	acid activation region,57,79,Gene/Protein	herpes simplex virus VP16 protein,89,122,Gene/Protein	activation region,135,152,Gene/Protein	EBV R protein,160,173,Gene/Protein	"[{""token"": ""ZEBRA activation region"", ""start_span"": 4, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""acid activation region"", ""start_span"": 57, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""herpes simplex virus VP16 protein"", ""start_span"": 89, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""activation region"", ""start_span"": 135, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""EBV R protein"", ""start_span"": 160, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Thus, TAL1 activation in these patients may result from subtle alterations in cis - acting regulatory sequences ( affecting expression of a single TAL1 allele) or changes in trans - acting factors that control TAL1 transcription ( affecting expression of both TAL1 alleles).	TAL1,6,10,Gene/Protein	cis - acting regulatory sequences,78,111,Gene/Protein	single TAL1 allele,140,158,Gene/Protein	TAL1,210,214,Gene/Protein	TAL1 alleles,260,272,Gene/Protein	"[{""token"": ""TAL1"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""cis - acting regulatory sequences"", ""start_span"": 78, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""single TAL1 allele"", ""start_span"": 140, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""TAL1"", ""start_span"": 210, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""TAL1 alleles"", ""start_span"": 260, ""end_span"": 272, ""type"": ""Gene/Protein""}]"	train
Moreover, IL - 5 induced at least two DNA - binding complexes, using nuclear extracts from normal human eosinophils and the IL - 6 / interferon - gamma response element of the ICAM - 1 promoter ( ICAM - 1 pIRE) in an electromobility shift assay.	IL - 5,10,16,Gene/Protein	DNA - binding complexes,38,61,Gene/Protein	IL - 6 / interferon - gamma response element,124,168,Gene/Protein	ICAM - 1 promoter,176,193,Gene/Protein	ICAM - 1 pIRE,196,209,Gene/Protein	"[{""token"": ""IL - 5"", ""start_span"": 10, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding complexes"", ""start_span"": 38, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 / interferon - gamma response element"", ""start_span"": 124, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1 promoter"", ""start_span"": 176, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1 pIRE"", ""start_span"": 196, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
IL - 3 and granulocyte - macrophage colony - stimulating factor induced, similar to IL - 5, two DNA - binding complexes in human eosinophils, including Stat1 alpha.	IL - 3,0,6,Gene/Protein	granulocyte - macrophage colony - stimulating factor,11,63,Gene/Protein	IL - 5,84,90,Gene/Protein	DNA - binding complexes,96,119,Gene/Protein	Stat1 alpha,152,163,Gene/Protein	"[{""token"": ""IL - 3"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 11, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding complexes"", ""start_span"": 96, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""Stat1 alpha"", ""start_span"": 152, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
Several studies have established that Tat releases an elongation block to the transcription of HIV long terminal repeat ( LTR); however, it is not known whether this mechanism alone is sufficient to explain the block to HIV replication in human T cells when Tat is absent.	Tat,38,41,Gene/Protein	elongation block,54,70,Gene/Protein	HIV long terminal repeat,95,119,Gene/Protein	LTR,122,125,Gene/Protein	Tat,258,261,Gene/Protein	"[{""token"": ""Tat"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""elongation block"", ""start_span"": 54, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""HIV long terminal repeat"", ""start_span"": 95, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""Tat"", ""start_span"": 258, ""end_span"": 261, ""type"": ""Gene/Protein""}]"	train
CBF consists of two subunits, a DNA binding subunit, CBF alpha, and a second subunit, CBF beta, that stimulates the DNA binding activity of CBF alpha.	CBF,0,3,Gene/Protein	DNA binding subunit,32,51,Gene/Protein	CBF alpha,53,62,Gene/Protein	CBF beta,86,94,Gene/Protein	CBF alpha,140,149,Gene/Protein	"[{""token"": ""CBF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding subunit"", ""start_span"": 32, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""CBF alpha"", ""start_span"": 53, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CBF beta"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""CBF alpha"", ""start_span"": 140, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
A DNA response element ( TR2RE - SV40) for the TR2 orphan receptor, a member of the steroid - thyroid hormone receptor superfamily, has been identified in the simian virus 40 ( SV40) + 55 region ( nucleotide numbers 368 - 389, 5 ' - GTTAAGGTTCGTAGGTCATG - 3 ').	DNA response element,2,22,Gene/Protein	TR2RE - SV40,25,37,Gene/Protein	TR2 orphan receptor,47,66,Gene/Protein	steroid - thyroid hormone receptor superfamily,84,130,Gene/Protein	nucleotide numbers 368 - 389,197,225,Gene/Protein	"[{""token"": ""DNA response element"", ""start_span"": 2, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""TR2RE - SV40"", ""start_span"": 25, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""TR2 orphan receptor"", ""start_span"": 47, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""steroid - thyroid hormone receptor superfamily"", ""start_span"": 84, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""nucleotide numbers 368 - 389"", ""start_span"": 197, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	train
The previously characterized factors J kappa, PU. 1, and AML1 bind to the LMP - 1 E2RE, along with six other unidentified factors ( LBF2 to LBF7).	J kappa,37,44,Gene/Protein	AML1,57,61,Gene/Protein	LMP - 1 E2RE,74,86,Gene/Protein	LBF2,132,136,Gene/Protein	LBF7,140,144,Gene/Protein	"[{""token"": ""J kappa"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""AML1"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""LMP - 1 E2RE"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""LBF2"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""LBF7"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
LBF2 was found only in epithelial cell lines, whereas LBF3, LBF5, LBF6, and LBF7 were not cell type specific.	LBF2,0,4,Gene/Protein	LBF3,54,58,Gene/Protein	LBF5,60,64,Gene/Protein	LBF6,66,70,Gene/Protein	LBF7,76,80,Gene/Protein	"[{""token"": ""LBF2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""LBF3"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""LBF5"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""LBF6"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""LBF7"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}]"	train
LBF3, LBF5, LBF6, or LBF7 may also be involved, since their binding sites also contribute to EBNA - 2 responsiveness.	LBF3,0,4,Gene/Protein	LBF5,6,10,Gene/Protein	LBF6,12,16,Gene/Protein	LBF7,21,25,Gene/Protein	EBNA - 2,93,101,Gene/Protein	"[{""token"": ""LBF3"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""LBF5"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""LBF6"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""LBF7"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""EBNA - 2"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Gene/Protein""}]"	train
The PEBP2 alpha A and PEBP2 alpha B genes encode the DNA - binding subunit of a murine transcription factor, PEBP2, which is implicated as a T - cell - specific transcriptional regulator.	PEBP2 alpha A and PEBP2 alpha B genes,4,41,Gene/Protein	DNA - binding subunit,53,74,Gene/Protein	murine transcription factor,80,107,Gene/Protein	PEBP2,109,114,Gene/Protein	T - cell - specific transcriptional regulator,141,186,Gene/Protein	"[{""token"": ""PEBP2 alpha A and PEBP2 alpha B genes"", ""start_span"": 4, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding subunit"", ""start_span"": 53, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""murine transcription factor"", ""start_span"": 80, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""T - cell - specific transcriptional regulator"", ""start_span"": 141, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
The inducible factors NK - kappa B, beta E2, CD28RC, and AP - 1 are not expressed in resting cells and are twofold lower in anergized as compared with activated cells.	inducible factors,4,21,Gene/Protein	NK - kappa B,22,34,Gene/Protein	beta E2,36,43,Gene/Protein	CD28RC,45,51,Gene/Protein	AP - 1,57,63,Gene/Protein	"[{""token"": ""inducible factors"", ""start_span"": 4, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""NK - kappa B"", ""start_span"": 22, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""beta E2"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""CD28RC"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene/Protein""}]"	train
When the supplemented cytokine was switched from GM - CSF to EPO, hemoglobin synthesis in M - TAT / GM - CSF cells increased rapidly ( within 5 h), and the level of GATA - 1 mRNA increased.	cytokine,22,30,Gene/Protein	GM - CSF,49,57,Gene/Protein	EPO,61,64,Gene/Protein	hemoglobin,66,76,Gene/Protein	GATA - 1 mRNA,165,178,Gene/Protein	"[{""token"": ""cytokine"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""hemoglobin"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1 mRNA"", ""start_span"": 165, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
In order to investigate the mechanism of the regulation of cdc2 mRNA expression in hematopoietic cells, we isolated the 5 ' - flanking sequence of the cdc2 gene and found the putative E2F binding site at the position of nucleotides - 124 to - 117.	cdc2 mRNA,59,68,Gene/Protein	5 ' - flanking sequence,120,143,Gene/Protein	cdc2 gene,151,160,Gene/Protein	binding site,188,200,Gene/Protein	nucleotides - 124 to - 117,220,246,Gene/Protein	"[{""token"": ""cdc2 mRNA"", ""start_span"": 59, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - flanking sequence"", ""start_span"": 120, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""cdc2 gene"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""binding site"", ""start_span"": 188, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""nucleotides - 124 to - 117"", ""start_span"": 220, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
A predominance of p50 NF - kappa B moieties and possibly p50 homodimers or closely related species, rather than the p50 - p56 heterodimer of NF - kappa B that is the predominant NF - kappa B species in most T lymphocytic and monocytic cells, is demonstrated in the nuclei of U1 cells.	p50 NF - kappa B moieties,18,43,Gene/Protein	p50 homodimers,57,71,Gene/Protein	p50 - p56 heterodimer,116,137,Gene/Protein	NF - kappa B,141,153,Gene/Protein	NF - kappa B,178,190,Gene/Protein	"[{""token"": ""p50 NF - kappa B moieties"", ""start_span"": 18, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""p50 homodimers"", ""start_span"": 57, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""p50 - p56 heterodimer"", ""start_span"": 116, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 141, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 178, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
The demonstration that NF - kappa B can regulate I kappa B alpha / MAD - 3 gene transcription in other cell types suggested that the rapid increase in steady - state I kappa B alpha / MAD - 3 mRNA levels we observed within 30 min of monocyte adherence would result from NF - kappa B - dependent transcriptional stimulation of the I kappa B alpha / MAD - 3 gene.	NF - kappa B,23,35,Gene/Protein	I kappa B alpha / MAD - 3 gene,49,79,Gene/Protein	I kappa B alpha / MAD - 3 mRNA,166,196,Gene/Protein	NF - kappa B,270,282,Gene/Protein	I kappa B alpha / MAD - 3 gene,330,360,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha / MAD - 3 gene"", ""start_span"": 49, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha / MAD - 3 mRNA"", ""start_span"": 166, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 270, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha / MAD - 3 gene"", ""start_span"": 330, ""end_span"": 360, ""type"": ""Gene/Protein""}]"	train
To study this element and its role in class II gene regulation further, a cDNA library was screened with oligonucleotide probes containing both the S element and the nearby J element of the human DPA gene.	class II gene,38,51,Gene/Protein	cDNA library,74,86,Gene/Protein	S element,148,157,Gene/Protein	J element,173,182,Gene/Protein	human DPA gene,190,204,Gene/Protein	"[{""token"": ""class II gene"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""cDNA library"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""S element"", ""start_span"": 148, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""J element"", ""start_span"": 173, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""human DPA gene"", ""start_span"": 190, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	train
The 160 N - terminal amino acids in the nonfinger region of clone 18 are highly homologous with similar regions of several other human, mouse, and Drosophila sequences, defining a subfamily of Kruppel - like zinc finger proteins termed TAB ( tramtrack [ ttk] - associated box) here.	160 N - terminal amino acids,4,32,Gene/Protein	nonfinger region,40,56,Gene/Protein	clone 18,60,68,Gene/Protein	zinc finger proteins,208,228,Gene/Protein	TAB,236,239,Gene/Protein	"[{""token"": ""160 N - terminal amino acids"", ""start_span"": 4, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""nonfinger region"", ""start_span"": 40, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""clone 18"", ""start_span"": 60, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger proteins"", ""start_span"": 208, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""TAB"", ""start_span"": 236, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP - 1, Oct - 2, and retinoic acid receptor.	composite octamer motif,40,63,Gene/Protein	interleukin 2 enhancer,71,93,Gene/Protein	AP - 1,97,103,Gene/Protein	Oct - 2,105,112,Gene/Protein	retinoic acid receptor,118,140,Gene/Protein	"[{""token"": ""composite octamer motif"", ""start_span"": 40, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2 enhancer"", ""start_span"": 71, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""retinoic acid receptor"", ""start_span"": 118, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
The truncation resulted from limited proteolysis of p65 during cellular extraction which released particular lysosomal serine proteases, such as elastase, cathepsin G, and proteinase 3.	p65,52,55,Gene/Protein	lysosomal serine proteases,109,135,Gene/Protein	elastase,145,153,Gene/Protein	cathepsin G,155,166,Gene/Protein	proteinase 3,172,184,Gene/Protein	"[{""token"": ""p65"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""lysosomal serine proteases"", ""start_span"": 109, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""elastase"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""cathepsin G"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""proteinase 3"", ""start_span"": 172, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
Recent biochemical and genetic studies indicate that in addition to the octamer - binding proteins Oct - 1 and Oct - 2, other B cell components are required for lymphoid - restricted, octamer site - mediated immunoglobulin gene promoter activity.	octamer - binding proteins,72,98,Gene/Protein	Oct - 1,99,106,Gene/Protein	Oct - 2,111,118,Gene/Protein	B cell components,126,143,Gene/Protein	immunoglobulin gene promoter,208,236,Gene/Protein	"[{""token"": ""octamer - binding proteins"", ""start_span"": 72, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""B cell components"", ""start_span"": 126, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin gene promoter"", ""start_span"": 208, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
Using a genetic screen in yeast, we have isolated B cell - derived cDNAs encoding Oct - binding factor 1 ( OBF - 1), a novel protein that specifically associates with Oct - 1 and Oct - 2.	B cell - derived cDNAs,50,72,Gene/Protein	Oct - binding factor 1,82,104,Gene/Protein	OBF - 1,107,114,Gene/Protein	Oct - 1,167,174,Gene/Protein	Oct - 2,179,186,Gene/Protein	"[{""token"": ""B cell - derived cDNAs"", ""start_span"": 50, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""Oct - binding factor 1"", ""start_span"": 82, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""OBF - 1"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 167, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 179, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
Increased [ Ca2 +] i activates Ca2 + / calmodulin - dependent kinases including the multifunctional Ca2 + / calmodulin - dependent protein kinase II ( CaM - K II), as well as calcineurin, a type 2B protein phosphatase.	Ca2 + / calmodulin - dependent kinases,31,69,Gene/Protein	Ca2 + / calmodulin - dependent protein kinase II,100,148,Gene/Protein	CaM - K II,151,161,Gene/Protein	calcineurin,175,186,Gene/Protein	type 2B protein phosphatase,190,217,Gene/Protein	"[{""token"": ""Ca2 + / calmodulin - dependent kinases"", ""start_span"": 31, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Ca2 + / calmodulin - dependent protein kinase II"", ""start_span"": 100, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""CaM - K II"", ""start_span"": 151, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 175, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""type 2B protein phosphatase"", ""start_span"": 190, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	train
Induction of ICAM - 1 and LFA - 3 by Tax1 of human T - cell leukemia virus type 1 and mechanism of down - regulation of ICAM - 1 or LFA - 1 in adult - T - cell - leukemia cell lines.	ICAM - 1,13,21,Gene/Protein	LFA - 3,26,33,Gene/Protein	Tax1,37,41,Gene/Protein	ICAM - 1,120,128,Gene/Protein	LFA - 1,132,139,Gene/Protein	"[{""token"": ""ICAM - 1"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""LFA - 3"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""Tax1"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""LFA - 1"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
The present study was undertaken to determine the role of HTLV - I TaxI in the up - regulation of ICAM - I and LFA - 3 in human T cells transformed with HTLV - I and the mechanism of down - regulation of ICAM - I and LFA - I in ATL - derived cell lines.	HTLV - I TaxI,58,71,Gene/Protein	ICAM - I,98,106,Gene/Protein	LFA - 3,111,118,Gene/Protein	ICAM - I,204,212,Gene/Protein	LFA - I,217,224,Gene/Protein	"[{""token"": ""HTLV - I TaxI"", ""start_span"": 58, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - I"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""LFA - 3"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - I"", ""start_span"": 204, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""LFA - I"", ""start_span"": 217, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
Western blot and phosphorylation analyses demonstrate that the synergistic effect on NF - kappa B functional activity is independent of I kappa B alpha ( MAD3) - NF - kappa B dissociation in the cytosol and is not associated with I kappa B nuclear translocation.	NF - kappa B,85,97,Gene/Protein	I kappa B alpha,136,151,Gene/Protein	MAD3,154,158,Gene/Protein	NF - kappa B,162,174,Gene/Protein	I kappa B,230,239,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 136, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""MAD3"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 162, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 230, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Antigen receptor signals prolong NF - kappa B - DNA interaction, probably by functionally antagonizing the IL - 1 - induced synthesis of a protein ( s) responsible for the transient NF - kappa B - DNA interaction and consequently synergistically enhance IL - 1 - induced NF - kappa B - dependent gene transcription.	NF - kappa B,33,45,Gene/Protein	IL - 1,107,113,Gene/Protein	NF - kappa B,182,194,Gene/Protein	IL - 1,254,260,Gene/Protein	NF - kappa B,271,283,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 33, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 182, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 254, ""end_span"": 260, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 271, ""end_span"": 283, ""type"": ""Gene/Protein""}]"	train
The human platelet - activating factor receptor ( PAFR) gene is transcribed by two distinct promoters ( promoter 1 and promoter 2) to generate two transcripts ( designated as PAFR transcript 1 and PAFR transcript 2), though their open reading frames are identical.	promoters,92,101,Gene/Protein	promoter 1,104,114,Gene/Protein	promoter 2,119,129,Gene/Protein	PAFR transcript 1,175,192,Gene/Protein	PAFR transcript 2,197,214,Gene/Protein	"[{""token"": ""promoters"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""promoter 1"", ""start_span"": 104, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""promoter 2"", ""start_span"": 119, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""PAFR transcript 1"", ""start_span"": 175, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""PAFR transcript 2"", ""start_span"": 197, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
By primer extension analysis to discriminate two transcripts, we found that the levels of PAFR transcript 1 ( leukocyte - type), but not PAFR transcript 2 ( tissue - type), are upregulated by PAF as well as by 12 - O - tetradecanoylphorbol - 13 - acetate ( TPA) in the human stomach cancer cell line ( JR - St cells) which expresses both functional PAFR transcript 1 and PAFR transcript 2 endogenously.	PAFR transcript 1,90,107,Gene/Protein	PAFR transcript 2,137,154,Gene/Protein	PAF,192,195,Gene/Protein	PAFR transcript 1,349,366,Gene/Protein	PAFR transcript 2,371,388,Gene/Protein	"[{""token"": ""PAFR transcript 1"", ""start_span"": 90, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""PAFR transcript 2"", ""start_span"": 137, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""PAFR transcript 1"", ""start_span"": 349, ""end_span"": 366, ""type"": ""Gene/Protein""}, {""token"": ""PAFR transcript 2"", ""start_span"": 371, ""end_span"": 388, ""type"": ""Gene/Protein""}]"	train
Functional analysis of the promoter 1 with a transient expression assay using chloramphenicol acetyltransferase ( CAT) gene as a reporter showed that both PAF and TPA activated the promoter 1 but not the deleted promoter lacking the three consensus binding sites for NF - kappa B located from - 571 bp to - 459 bp.	promoter 1,27,37,Gene/Protein	PAF,155,158,Gene/Protein	promoter 1,181,191,Gene/Protein	consensus binding sites,239,262,Gene/Protein	NF - kappa B,267,279,Gene/Protein	"[{""token"": ""promoter 1"", ""start_span"": 27, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""promoter 1"", ""start_span"": 181, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""consensus binding sites"", ""start_span"": 239, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 267, ""end_span"": 279, ""type"": ""Gene/Protein""}]"	train
Our results define the NF - kappa B system as an intermediate event in CD40 signaling and suggest that the CD40 pathway can influence the expression of B cell - associated genes with NF - kappa B consensus sites.	NF - kappa B,23,35,Gene/Protein	CD40,71,75,Gene/Protein	CD40,107,111,Gene/Protein	B cell - associated genes,152,177,Gene/Protein	NF - kappa B consensus sites,183,211,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""B cell - associated genes"", ""start_span"": 152, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B consensus sites"", ""start_span"": 183, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Co - stimulation of T - lymphocytes by T - cell receptor ( TcR) occupancy and activation of the CD28 surface molecule results in enhanced proliferation and interleukin 2 ( IL - 2) production.	T - cell receptor,39,56,Gene/Protein	TcR,59,62,Gene/Protein	CD28 surface molecule,96,117,Gene/Protein	interleukin 2,156,169,Gene/Protein	IL - 2,172,178,Gene/Protein	"[{""token"": ""T - cell receptor"", ""start_span"": 39, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""TcR"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CD28 surface molecule"", ""start_span"": 96, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2"", ""start_span"": 156, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Calcineurin activates transcription from the GM - CSF promoter in synergy with either protein kinase C or NF - kappa B / AP - 1 in T cells.	Calcineurin,0,11,Gene/Protein	GM - CSF promoter,45,62,Gene/Protein	protein kinase C,86,102,Gene/Protein	NF - kappa B,106,118,Gene/Protein	/ AP - 1,119,127,Gene/Protein	"[{""token"": ""Calcineurin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF promoter"", ""start_span"": 45, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 86, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 106, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""/ AP - 1"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Gene/Protein""}]"	train
Expression of a constitutively active calcineurin ( CN), a Ca2 + / calmodulin - dependent protein phosphatase, potentiated by two fold the transcriptional activation by NF - kappa B / AP - 1.	calcineurin,38,49,Gene/Protein	CN,52,54,Gene/Protein	Ca2 + / calmodulin - dependent protein phosphatase,59,109,Gene/Protein	NF - kappa B,169,181,Gene/Protein	/ AP - 1,182,190,Gene/Protein	"[{""token"": ""calcineurin"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""CN"", ""start_span"": 52, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Ca2 + / calmodulin - dependent protein phosphatase"", ""start_span"": 59, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 169, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""/ AP - 1"", ""start_span"": 182, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
Based on sequence homology we identified two binding motifs for Pit - 1 and seven half - sites for glucocorticoid receptor / progesterone receptor ( PR) binding.	binding motifs,45,59,Gene/Protein	Pit - 1,64,71,Gene/Protein	half - sites,82,94,Gene/Protein	glucocorticoid receptor / progesterone receptor,99,146,Gene/Protein	PR,149,151,Gene/Protein	"[{""token"": ""binding motifs"", ""start_span"": 45, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""Pit - 1"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""half - sites"", ""start_span"": 82, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""glucocorticoid receptor / progesterone receptor"", ""start_span"": 99, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""PR"", ""start_span"": 149, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	train
Mouse thymoma line EL - 4 cells produce cytokines such as interleukin ( IL) - 2, IL - 3, IL - 4, IL - 10, and granulocyte - macrophage colony - stimulating factor in response to phorbol 12 - myristate 13 - acetate ( PMA).	cytokines,40,49,Gene/Protein	IL - 3,81,87,Gene/Protein	IL - 4,89,95,Gene/Protein	IL - 10,97,104,Gene/Protein	granulocyte - macrophage colony - stimulating factor,110,162,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 40, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 110, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
In electromobility shift assays both NF - kappa B ( P65 or P65 / P50 heterodimer) and NF - AT bound to the P sequence.	NF - kappa B,37,49,Gene/Protein	P65,52,55,Gene/Protein	P65 / P50 heterodimer,59,80,Gene/Protein	NF - AT,86,93,Gene/Protein	P sequence,107,117,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""P65"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""P65 / P50 heterodimer"", ""start_span"": 59, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""P sequence"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
Similar to its effect on IL - 2 induction, cyclosporin A ( CsA) inhibited the synergistic activation of JNK, and a competitive inhibitor of Jun phosphorylation by JNK inhibited IL - 2 promoter activation.	IL - 2,25,31,Gene/Protein	JNK,104,107,Gene/Protein	Jun,140,143,Gene/Protein	JNK,163,166,Gene/Protein	IL - 2 promoter,177,192,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 177, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
RESULTS: BZLF1 ( ZEBRA) or early gene products ( EA - R and EA - D / BHLF1 / NotI) were detected in a small proportion ( < 0. 01 - 5%) of tumour cells in eight of these 17 cases by immunohistochemistry and in situ hybridization.	BZLF1,9,14,Gene/Protein	ZEBRA,17,22,Gene/Protein	early gene products,27,46,Gene/Protein	EA - R,49,55,Gene/Protein	EA - D / BHLF1 / NotI,60,81,Gene/Protein	"[{""token"": ""BZLF1"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""ZEBRA"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""early gene products"", ""start_span"": 27, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""EA - R"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""EA - D / BHLF1 / NotI"", ""start_span"": 60, ""end_span"": 81, ""type"": ""Gene/Protein""}]"	train
When cells were stimulated with anti - CD3 mAb or PMA / A23187, a complex formation of NF - kappa B ( p50 / p65) heterodimer with the kappa B sequence was induced.	anti - CD3 mAb,32,46,Gene/Protein	NF - kappa B,87,99,Gene/Protein	p50,102,105,Gene/Protein	/ p65,106,111,Gene/Protein	kappa B sequence,134,150,Gene/Protein	"[{""token"": ""anti - CD3 mAb"", ""start_span"": 32, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""/ p65"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""kappa B sequence"", ""start_span"": 134, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
Characterization of NF ( P), the nuclear factor that interacts with the regulatory P sequence ( 5 ' - CGAAAATTTCC - 3 ') of the human interleukin - 4 gene: relationship to NF - kappa B and NF - AT.	nuclear factor,33,47,Gene/Protein	P sequence,83,93,Gene/Protein	human interleukin - 4 gene,128,154,Gene/Protein	NF - kappa B,172,184,Gene/Protein	NF - AT,189,196,Gene/Protein	"[{""token"": ""nuclear factor"", ""start_span"": 33, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""P sequence"", ""start_span"": 83, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""human interleukin - 4 gene"", ""start_span"": 128, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 172, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
Cell adhesion to endothelial cells stimulated by tumor necrosis factor - alpha ( TNF) is due to induction of surface receptors, such as vascular cell adhesion molecule - 1 ( VCAM - 1).	stimulated by tumor necrosis factor - alpha,35,78,Gene/Protein	TNF,81,84,Gene/Protein	surface receptors,109,126,Gene/Protein	vascular cell adhesion molecule - 1,136,171,Gene/Protein	VCAM - 1,174,182,Gene/Protein	"[{""token"": ""stimulated by tumor necrosis factor - alpha"", ""start_span"": 35, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""surface receptors"", ""start_span"": 109, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 136, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 174, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
Activation of the enhancer in non - B cells upon overexpression of the basic helix - loop - helix ( bHLH) protein E2A appears to be mediated not only by the binding of E2A to its cognate E box but also by the resulting displacement of a repressor from that same site.	enhancer,18,26,Gene/Protein	E2A,114,117,Gene/Protein	E2A,168,171,Gene/Protein	E box,187,192,Gene/Protein	repressor,237,246,Gene/Protein	"[{""token"": ""enhancer"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 168, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""E box"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""repressor"", ""start_span"": 237, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
It is suggested that constitutive expression of c - myb mRNA is necessary for Hm - induced differentiation, and that a decrease in the amount of c - myb mRNA induced by antisense myb RNA expression suppresses Hm - induced differentiation.	c - myb mRNA,48,60,Gene/Protein	Hm,78,80,Gene/Protein	c - myb mRNA,145,157,Gene/Protein	antisense myb RNA,169,186,Gene/Protein	Hm,209,211,Gene/Protein	"[{""token"": ""c - myb mRNA"", ""start_span"": 48, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""Hm"", ""start_span"": 78, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""c - myb mRNA"", ""start_span"": 145, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""antisense myb RNA"", ""start_span"": 169, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""Hm"", ""start_span"": 209, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Both LAM - and LPS - inducible IL - 6 promoter activity was localized to a DNA fragment, positions - 158 to - 49, by deletion analysis and chloramphenicol acetyltransferase assay.	LAM,5,8,Gene/Protein	LPS - inducible IL - 6 promoter,15,46,Gene/Protein	DNA fragment,75,87,Gene/Protein	- 158 to - 49,99,112,Gene/Protein	chloramphenicol acetyltransferase,139,172,Gene/Protein	"[{""token"": ""LAM"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""LPS - inducible IL - 6 promoter"", ""start_span"": 15, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""DNA fragment"", ""start_span"": 75, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""- 158 to - 49"", ""start_span"": 99, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase"", ""start_span"": 139, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
Both wild - type and chimeric HLF proteins displayed transcriptional activator properties in lymphoid and nonlymphoid cells on reporter genes containing HLF or C / EBP consensus binding sites.	wild - type,5,16,Gene/Protein	chimeric HLF proteins,21,42,Gene/Protein	transcriptional activator,53,78,Gene/Protein	reporter genes,127,141,Gene/Protein	HLF or C / EBP consensus binding sites,153,191,Gene/Protein	"[{""token"": ""wild - type"", ""start_span"": 5, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""chimeric HLF proteins"", ""start_span"": 21, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activator"", ""start_span"": 53, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""reporter genes"", ""start_span"": 127, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""HLF or C / EBP consensus binding sites"", ""start_span"": 153, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
Here we report the characterization of a nuclear complex from human monocytic cells that bound to a kappa B - like site, 5 ' - CGGAGTTTCC - 3 ', in the 5 ' - flanking region of the human TF gene.	nuclear complex,41,56,Gene/Protein	kappa B - like site,100,119,Gene/Protein	5 ' - CGGAGTTTCC - 3 ',121,143,Gene/Protein	5 ' - flanking region,152,173,Gene/Protein	human TF gene,181,194,Gene/Protein	"[{""token"": ""nuclear complex"", ""start_span"": 41, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - like site"", ""start_span"": 100, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - CGGAGTTTCC - 3 '"", ""start_span"": 121, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - flanking region"", ""start_span"": 152, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""human TF gene"", ""start_span"": 181, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
We show here that soluble TN inhibits proliferation of human T cells in response to alpha CD3 Ab co - immobilized with the extracellular matrix protein fibronectin ( FN).	TN,26,28,Gene/Protein	alpha CD3 Ab,84,96,Gene/Protein	extracellular matrix protein,123,151,Gene/Protein	fibronectin,152,163,Gene/Protein	FN,166,168,Gene/Protein	"[{""token"": ""TN"", ""start_span"": 26, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""alpha CD3 Ab"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""extracellular matrix protein"", ""start_span"": 123, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 152, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 166, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
Human immunodeficiency virus type 1 ( HIV - 1) negative factor ( Nef) has been shown to down - regulate the transcription factors NF - kappa B and AP - 1 in vitro.	negative factor,47,62,Gene/Protein	Nef,65,68,Gene/Protein	transcription factors,108,129,Gene/Protein	NF - kappa B,130,142,Gene/Protein	AP - 1,147,153,Gene/Protein	"[{""token"": ""negative factor"", ""start_span"": 47, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""Nef"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 108, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 130, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
Because the Nef protein does not affect the surface expression of the CD3 - TCR complex, we conclude that the Nef protein down - regulates the transcriptional factors NF - kappa B and AP - 1 in T cells in vitro through an effect on the TCR - dependent signal transduction pathway.	Nef,12,15,Gene/Protein	CD3,70,73,Gene/Protein	Nef,110,113,Gene/Protein	NF - kappa B,167,179,Gene/Protein	AP - 1,184,190,Gene/Protein	"[{""token"": ""Nef"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Nef"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 167, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
The AP - 1 complex consists of distinct protein heterodimers encoded by the proto - oncogene c - fos and c - jun mRNA whose gene expression can be induced by TPA, cyclic AMP and growth factors.	AP - 1,4,10,Gene/Protein	protein heterodimers,40,60,Gene/Protein	proto - oncogene c - fos,76,100,Gene/Protein	c - jun mRNA,105,117,Gene/Protein	growth factors,178,192,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""protein heterodimers"", ""start_span"": 40, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""proto - oncogene c - fos"", ""start_span"": 76, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""c - jun mRNA"", ""start_span"": 105, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""growth factors"", ""start_span"": 178, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
The regulation of interleukin - 2 receptor alpha chain ( IL - 2R alpha) expression and nuclear factor ( NF) activation by protein kinase C ( PKC) in resting T cells, has been studied.	interleukin - 2 receptor alpha chain,18,54,Gene/Protein	IL - 2R alpha,57,70,Gene/Protein	nuclear factor,87,101,Gene/Protein	protein kinase C,122,138,Gene/Protein	PKC,141,144,Gene/Protein	"[{""token"": ""interleukin - 2 receptor alpha chain"", ""start_span"": 18, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 57, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor"", ""start_span"": 87, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 122, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
Human interleukin - 13 activates the interleukin - 4 - dependent transcription factor NF - IL4 sharing a DNA binding motif with an interferon - gamma - induced nuclear binding factor.	Human interleukin - 13,0,22,Gene/Protein	interleukin - 4 - dependent transcription factor,37,85,Gene/Protein	NF - IL4,86,94,Gene/Protein	DNA binding motif,105,122,Gene/Protein	interferon - gamma - induced nuclear binding factor,131,182,Gene/Protein	"[{""token"": ""Human interleukin - 13"", ""start_span"": 0, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 4 - dependent transcription factor"", ""start_span"": 37, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL4"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding motif"", ""start_span"": 105, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""interferon - gamma - induced nuclear binding factor"", ""start_span"": 131, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
We provide evidence that in monocytes as well as in T lymphocytes both IL - 4 and IL - 13 activate the same recently identified transcription factor NF - IL4 which binds to the specific responsive element IL - 4RE.	IL - 4,71,77,Gene/Protein	IL - 13,82,89,Gene/Protein	transcription factor,128,148,Gene/Protein	NF - IL4,149,157,Gene/Protein	specific responsive element IL - 4RE,177,213,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 128, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL4"", ""start_span"": 149, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""specific responsive element IL - 4RE"", ""start_span"": 177, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
Although these heterodimers do not recognize a classical thyroid hormone response element ( TRE) characterized by direct repeat separated by four nucleotides ( DR + 4), PPAR behaves as a dominant negative regulator of thyroid hormone ( TH) action.	heterodimers,15,27,Gene/Protein	thyroid hormone response element,57,89,Gene/Protein	TRE,92,95,Gene/Protein	DR + 4,160,166,Gene/Protein	PPAR,169,173,Gene/Protein	"[{""token"": ""heterodimers"", ""start_span"": 15, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""thyroid hormone response element"", ""start_span"": 57, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""TRE"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""DR + 4"", ""start_span"": 160, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""PPAR"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
A 55 - kDa isoform, I kappa B gamma - 2, lacks the 190 C - terminal amino acids of p70 I kappa B gamma.	55 - kDa isoform,2,18,Gene/Protein	I kappa B gamma - 2,20,39,Gene/Protein	190 C - terminal amino acids,51,79,Gene/Protein	p70,83,86,Gene/Protein	I kappa B gamma,87,102,Gene/Protein	"[{""token"": ""55 - kDa isoform"", ""start_span"": 2, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma - 2"", ""start_span"": 20, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""190 C - terminal amino acids"", ""start_span"": 51, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""p70"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma"", ""start_span"": 87, ""end_span"": 102, ""type"": ""Gene/Protein""}]"	train
In contrast to p70 I kappa B gamma, which is a cytoplasmic protein, I kappa B gamma - 1 is found in both the cytoplasm and nucleus, whereas I kappa B gamma - 2 is predominantly nuclear.	p70,15,18,Gene/Protein	I kappa B gamma,19,34,Gene/Protein	cytoplasmic protein,47,66,Gene/Protein	I kappa B gamma - 1,68,87,Gene/Protein	I kappa B gamma - 2,140,159,Gene/Protein	"[{""token"": ""p70"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma"", ""start_span"": 19, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic protein"", ""start_span"": 47, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma - 1"", ""start_span"": 68, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma - 2"", ""start_span"": 140, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
While p70 I kappa B gamma inhibits p50 -, p65 -, and c - Rel - mediated transactivation and / or DNA binding, both I kappa B gamma - 1 and I kappa B gamma - 2 are specific for p50 and have different affinities for this subunit.	p70,6,9,Gene/Protein	I kappa B gamma,10,25,Gene/Protein	I kappa B gamma - 1,115,134,Gene/Protein	I kappa B gamma - 2,139,158,Gene/Protein	p50,176,179,Gene/Protein	"[{""token"": ""p70"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma"", ""start_span"": 10, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma - 1"", ""start_span"": 115, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma - 2"", ""start_span"": 139, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
Two anti - MHC class II Ab, L227 and 2. 06, inhibited the growth of B104 cells, although 2. 06, but not L227, needed to be further cross - linked with a goat anti - mouse IgG Ab ( GAM) to show the effect.	anti - MHC class II Ab,4,26,Gene/Protein	L227,28,32,Gene/Protein	L227,104,108,Gene/Protein	goat anti - mouse IgG Ab,153,177,Gene/Protein	GAM,180,183,Gene/Protein	"[{""token"": ""anti - MHC class II Ab"", ""start_span"": 4, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""L227"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""L227"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""goat anti - mouse IgG Ab"", ""start_span"": 153, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""GAM"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
Elements necessary for the steroid hormone 1 alpha, 25 - dihydroxyvitamin D3 ( 1 alpha, 25 - ( OH) 2D3) to induce a biological response include the presence of specific intracellular receptors ( vitamin D3 receptors ( VDR)) and modulation of gene expression via hormone - activated receptor binding to regulatory regions of target genes.	intracellular receptors,169,192,Gene/Protein	vitamin D3 receptors,195,215,Gene/Protein	VDR,218,221,Gene/Protein	regulatory regions,302,320,Gene/Protein	target genes,324,336,Gene/Protein	"[{""token"": ""intracellular receptors"", ""start_span"": 169, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""vitamin D3 receptors"", ""start_span"": 195, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""VDR"", ""start_span"": 218, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""regulatory regions"", ""start_span"": 302, ""end_span"": 320, ""type"": ""Gene/Protein""}, {""token"": ""target genes"", ""start_span"": 324, ""end_span"": 336, ""type"": ""Gene/Protein""}]"	train
Two other sites display disparate effects on IL - 2 gene expression in different T leukemia cell lines: the distal purine box ( - 291 to - 277) and the proximal purine box sites ( - 145 to - 128).	IL - 2 gene,45,56,Gene/Protein	distal purine box,108,125,Gene/Protein	- 291 to - 277,128,142,Gene/Protein	proximal purine box sites,152,177,Gene/Protein	- 145 to - 128,180,194,Gene/Protein	"[{""token"": ""IL - 2 gene"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""distal purine box"", ""start_span"": 108, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""- 291 to - 277"", ""start_span"": 128, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""proximal purine box sites"", ""start_span"": 152, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""- 145 to - 128"", ""start_span"": 180, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
CD14 Sp1 site oligonucleotides bound preferentially to a 105 - kDa Sp1 species, which is present in higher relative levels in monocytic than non - monocytic cells, suggesting that modification of Sp1, such as phosphorylation, may explain how the Sp1 site mediates monocytic specific promoter activity.	CD14,0,4,Gene/Protein	Sp1,5,8,Gene/Protein	105 - kDa Sp1 species,57,78,Gene/Protein	Sp1,196,199,Gene/Protein	Sp1,246,249,Gene/Protein	"[{""token"": ""CD14"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""105 - kDa Sp1 species"", ""start_span"": 57, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 246, ""end_span"": 249, ""type"": ""Gene/Protein""}]"	train
Furthermore, we confirmed the previous report that FK506 suppressed the PMA / ionomycin - induced activation through authentic kappa B site of immunoglobulin ( Ig) gene, to which NF - kappa B binding was also decreased by FK506, indicating that both IL - 8 kappa B - like site and Ig kappa B site are FK506 - sensitive in spite of the difference of binding factors.	kappa B site,127,139,Gene/Protein	NF - kappa B,179,191,Gene/Protein	IL - 8 kappa B - like site,250,276,Gene/Protein	kappa B site,284,296,Gene/Protein	binding factors,349,364,Gene/Protein	"[{""token"": ""kappa B site"", ""start_span"": 127, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 179, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8 kappa B - like site"", ""start_span"": 250, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""kappa B site"", ""start_span"": 284, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""binding factors"", ""start_span"": 349, ""end_span"": 364, ""type"": ""Gene/Protein""}]"	train
Our results indicate that not only the reported IL - 2 NF - AT and NFIL - 2A sites and Ig kappa B site, but also the IL - 8 AP - 1 and kappa B - like sites are terminals of FK506 - sensitive pathway involving Ca2 + mobilization.	IL - 2 NF - AT and NFIL - 2A sites,48,82,Gene/Protein	kappa B site,90,102,Gene/Protein	IL - 8,117,123,Gene/Protein	AP - 1,124,130,Gene/Protein	kappa B - like sites,135,155,Gene/Protein	"[{""token"": ""IL - 2 NF - AT and NFIL - 2A sites"", ""start_span"": 48, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""kappa B site"", ""start_span"": 90, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - like sites"", ""start_span"": 135, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	train
The binding sites fulfil the required criteria for specific steroid binding sites however differ somewhat from the classic androgen receptors from genital skin fibroblast: in fertile adult males ( n = 20) the binding sites showed ( 1) a high affinity for testosterone ( 1. 32 + / - 0. 49 nM; mean + / - SD), ( 2) a saturable capacity ( 184 + / - 52 binding sites per cell; mean + / - SD), and ( 3) a characteristic competitive binding profile for other steroid hormones ( relative binding affinities: testosterone = dihydrotestosterone > 17 beta - estradiol > progesterone, whereas aldosterone, 17 - hydroxy - progesterone and cortisol did not compete appreciably).	binding sites,4,17,Gene/Protein	steroid binding sites,60,81,Gene/Protein	androgen receptors,123,141,Gene/Protein	binding sites,209,222,Gene/Protein	binding sites,349,362,Gene/Protein	"[{""token"": ""binding sites"", ""start_span"": 4, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""steroid binding sites"", ""start_span"": 60, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""androgen receptors"", ""start_span"": 123, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 209, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 349, ""end_span"": 362, ""type"": ""Gene/Protein""}]"	train
Sequence homology, single nucleotide mutations, and anti - CD28 Ab stimulation studies established that the NF - kappa B - like sequence in the promoter of the IL - 8 gene functioned as a CD28 response element.	anti - CD28 Ab,52,66,Gene/Protein	NF - kappa B - like sequence,108,136,Gene/Protein	promoter,144,152,Gene/Protein	IL - 8 gene,160,171,Gene/Protein	CD28 response element,188,209,Gene/Protein	"[{""token"": ""anti - CD28 Ab"", ""start_span"": 52, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B - like sequence"", ""start_span"": 108, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8 gene"", ""start_span"": 160, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""CD28 response element"", ""start_span"": 188, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
We have examined the possibility that stimulation of phospholipase D ( PLD) may regulate activation of transcription factor AP - 1 in human T cells by transfecting human T lymphocyte Jurkat cells with a plasmid containing an AP - 1 enhancer element and a chloramphenicol acetyltransferase reporter gene.	phospholipase D,53,68,Gene/Protein	PLD,71,74,Gene/Protein	transcription factor AP - 1,103,130,Gene/Protein	AP - 1 enhancer element,225,248,Gene/Protein	chloramphenicol acetyltransferase reporter gene,255,302,Gene/Protein	"[{""token"": ""phospholipase D"", ""start_span"": 53, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""PLD"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor AP - 1"", ""start_span"": 103, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 enhancer element"", ""start_span"": 225, ""end_span"": 248, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase reporter gene"", ""start_span"": 255, ""end_span"": 302, ""type"": ""Gene/Protein""}]"	train
The increases in AP - 1 enhancer activity induced by PA or anti - CD3 mAb were efficiently abrogated by the presence of propranolol, an inhibitor of PA phosphohydrolase and protein kinase C ( PKC).	AP - 1 enhancer,17,32,Gene/Protein	anti - CD3 mAb,59,73,Gene/Protein	phosphohydrolase,152,168,Gene/Protein	protein kinase C,173,189,Gene/Protein	PKC,192,195,Gene/Protein	"[{""token"": ""AP - 1 enhancer"", ""start_span"": 17, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3 mAb"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""phosphohydrolase"", ""start_span"": 152, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 173, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Upregulation of bcl - 2 by the Epstein - Barr virus latent membrane protein LMP1: a B - cell - specific response that is delayed relative to NF - kappa B activation and to induction of cell surface markers.	bcl - 2,16,23,Gene/Protein	Epstein - Barr virus latent membrane protein,31,75,Gene/Protein	LMP1,76,80,Gene/Protein	NF - kappa B,141,153,Gene/Protein	cell surface markers,185,205,Gene/Protein	"[{""token"": ""bcl - 2"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""Epstein - Barr virus latent membrane protein"", ""start_span"": 31, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 141, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""cell surface markers"", ""start_span"": 185, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
Although two cases expressed CD4, no case expressed CD2, CD3, or CD8 and no case showed clonal rearrangement of genes encoding the T - cell receptor ( TCR beta, gamma, delta).	CD4,29,32,Gene/Protein	CD2,52,55,Gene/Protein	CD3,57,60,Gene/Protein	CD8,65,68,Gene/Protein	T - cell receptor,131,148,Gene/Protein	"[{""token"": ""CD4"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""CD8"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""T - cell receptor"", ""start_span"": 131, ""end_span"": 148, ""type"": ""Gene/Protein""}]"	train
IL - 1 beta and IL - 6 genes contain AP - 1 binding sites as regulatory elements, the AP - 1 protein being composed of c - jun and c - fos gene products.	IL - 1 beta and IL - 6 genes,0,28,Gene/Protein	AP - 1 binding sites,37,57,Gene/Protein	regulatory elements,61,80,Gene/Protein	AP - 1,86,92,Gene/Protein	c - jun and c - fos gene products,119,152,Gene/Protein	"[{""token"": ""IL - 1 beta and IL - 6 genes"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 binding sites"", ""start_span"": 37, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""regulatory elements"", ""start_span"": 61, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""c - jun and c - fos gene products"", ""start_span"": 119, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
Deletion analyses of the pCD41 ORF - A and the use of promoter constructs further mapped an internal functional promoter within the pCD41 sequence that can direct the synthesis of the trans - activating protein.	pCD41,25,30,Gene/Protein	ORF - A,31,38,Gene/Protein	promoter constructs,54,73,Gene/Protein	pCD41,132,137,Gene/Protein	trans - activating protein,184,210,Gene/Protein	"[{""token"": ""pCD41"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""ORF - A"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""promoter constructs"", ""start_span"": 54, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""pCD41"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""trans - activating protein"", ""start_span"": 184, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
Analysis of truncated LTRs confirmed that inhibition of LTR activation was not mediated through NF - kappa B - binding activity but through the region containing the negative responding elements ( NREs).	LTRs,22,26,Gene/Protein	LTR,56,59,Gene/Protein	NF - kappa B,96,108,Gene/Protein	negative responding elements,166,194,Gene/Protein	NREs,197,201,Gene/Protein	"[{""token"": ""LTRs"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 96, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""negative responding elements"", ""start_span"": 166, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""NREs"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
Overproduction of NFKB2 ( lyt - 10) and c - Rel: a mechanism for HTLV - I Tax - mediated trans - activation via the NF - kappa B signalling pathway.	NFKB2,18,23,Gene/Protein	lyt - 10,26,34,Gene/Protein	c - Rel,40,47,Gene/Protein	HTLV - I Tax,65,77,Gene/Protein	NF - kappa B,116,128,Gene/Protein	"[{""token"": ""NFKB2"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""lyt - 10"", ""start_span"": 26, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""HTLV - I Tax"", ""start_span"": 65, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 116, ""end_span"": 128, ""type"": ""Gene/Protein""}]"	train
We propose that NFKB2 synthesis and processing allows continuous nuclear expression of an otherwise cytoplasmic protein and, in conjunction with overexpression of c - Rel, NFKB2 alters the NF - kappa B signalling pathway and contributes to leukemic transformation of T cells by HTLV - I.	NFKB2,16,21,Gene/Protein	cytoplasmic protein,100,119,Gene/Protein	c - Rel,163,170,Gene/Protein	NFKB2,172,177,Gene/Protein	NF - kappa B,189,201,Gene/Protein	"[{""token"": ""NFKB2"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic protein"", ""start_span"": 100, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""NFKB2"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 189, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
The last 13 amino acids containing a PXQXT / S sequence are highly conserved in human and simian EBV LMP1 but do not bind TRAF3, suggesting a distinct role for this conserved region of LMP1.	last 13 amino acids,4,23,Gene/Protein	PXQXT / S sequence,37,55,Gene/Protein	LMP1,101,105,Gene/Protein	TRAF3,122,127,Gene/Protein	LMP1,185,189,Gene/Protein	"[{""token"": ""last 13 amino acids"", ""start_span"": 4, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""PXQXT / S sequence"", ""start_span"": 37, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""TRAF3"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
The NF - kappa B inhibitor, tepoxalin, suppresses surface expression of the cell adhesion molecules CD62E, CD11b / CD18 and CD106.	NF - kappa B,4,16,Gene/Protein	cell adhesion molecules,76,99,Gene/Protein	CD62E,100,105,Gene/Protein	CD11b / CD18,107,119,Gene/Protein	CD106,124,129,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""cell adhesion molecules"", ""start_span"": 76, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""CD62E"", ""start_span"": 100, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""CD11b / CD18"", ""start_span"": 107, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""CD106"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	train
The BZLF1 gene promoter ( Zp) was activated by crosslinking of cell surface immunoglobulin ( Ig) with anti - Ig antibody in B cells, even in the absence of other viral genes.	BZLF1 gene promoter,4,23,Gene/Protein	Zp,26,28,Gene/Protein	cell surface immunoglobulin,63,90,Gene/Protein	Ig,93,95,Gene/Protein	anti - Ig antibody,102,120,Gene/Protein	"[{""token"": ""BZLF1 gene promoter"", ""start_span"": 4, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""Zp"", ""start_span"": 26, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""cell surface immunoglobulin"", ""start_span"": 63, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""Ig"", ""start_span"": 93, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""anti - Ig antibody"", ""start_span"": 102, ""end_span"": 120, ""type"": ""Gene/Protein""}]"	train
Pervanadate induced activation of the tyrosine kinases lck and fyn ( 4 - and 3 - fold respectively) and a dramatic increase in tyrosine phosphorylation of cellular proteins, notably phospholipase C gamma 1.	tyrosine kinases,38,54,Gene/Protein	lck,55,58,Gene/Protein	fyn,63,66,Gene/Protein	cellular proteins,155,172,Gene/Protein	phospholipase C gamma 1,182,205,Gene/Protein	"[{""token"": ""tyrosine kinases"", ""start_span"": 38, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""lck"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""fyn"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""cellular proteins"", ""start_span"": 155, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""phospholipase C gamma 1"", ""start_span"": 182, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
TCR signaling was triggered by treating Jurkat T cells with PHA or anti - CD3 Abs, and NF - kappaB activation was monitored by electrophoretic mobility shift assays and / or by kappaB - dependent reporter assays.	TCR,0,3,Gene/Protein	PHA,60,63,Gene/Protein	anti - CD3 Abs,67,81,Gene/Protein	NF - kappaB,87,98,Gene/Protein	kappaB,177,183,Gene/Protein	"[{""token"": ""TCR"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3 Abs"", ""start_span"": 67, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 87, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""kappaB"", ""start_span"": 177, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
Contrary to the idea that protein kinase C is involved in TCR - mediated activation of NF - kappaB, high doses of staurosporine did not interfere with activation of NF - kappaB by PHA, while the same dose of staurosporine completely blocked activation by PMA.	protein kinase C,26,42,Gene/Protein	TCR,58,61,Gene/Protein	NF - kappaB,87,98,Gene/Protein	NF - kappaB,165,176,Gene/Protein	PHA,180,183,Gene/Protein	"[{""token"": ""protein kinase C"", ""start_span"": 26, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 87, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 165, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
Consistent with these observations, coexpression of constitutively active forms of Raf - 1 and calcineurin synergistically induced kappaB - dependent reporter activity, suggesting a physiologically relevant functional interaction between the kinase and the phosphatase.	Raf - 1,83,90,Gene/Protein	calcineurin,95,106,Gene/Protein	kappaB,131,137,Gene/Protein	kinase,242,248,Gene/Protein	phosphatase,257,268,Gene/Protein	"[{""token"": ""Raf - 1"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""kappaB"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""kinase"", ""start_span"": 242, ""end_span"": 248, ""type"": ""Gene/Protein""}, {""token"": ""phosphatase"", ""start_span"": 257, ""end_span"": 268, ""type"": ""Gene/Protein""}]"	train
These results demonstrate that CD40, like sIg, may employ PKC in producing select outcomes, that individual B cell receptors may signal downstream events via both PKC - dependent and PKC - independent pathways, and that multiple signal transduction pathways may be used to activate the expression of closely related genes.	CD40,31,35,Gene/Protein	sIg,42,45,Gene/Protein	PKC,58,61,Gene/Protein	B cell receptors,108,124,Gene/Protein	genes,316,321,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""sIg"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""B cell receptors"", ""start_span"": 108, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""genes"", ""start_span"": 316, ""end_span"": 321, ""type"": ""Gene/Protein""}]"	train
Sequence analysis revealed that PB1 is composed of adjacent binding sites for Ets and AP - 1 transcription factors.	PB1,32,35,Gene/Protein	adjacent binding sites,51,73,Gene/Protein	Ets,78,81,Gene/Protein	AP - 1,86,92,Gene/Protein	transcription factors,93,114,Gene/Protein	"[{""token"": ""PB1"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""adjacent binding sites"", ""start_span"": 51, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Ets"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 93, ""end_span"": 114, ""type"": ""Gene/Protein""}]"	train
High doses of sodium salicylate suppressed NF - kappa B p65 mRNA accumulation, resulting in suppression of total NF - kappa B, p50 on tissue oligonucleotide had no effects on lipopolysaccharide - induced NF - kappa B activation.	NF - kappa B,43,55,Gene/Protein	p65 mRNA,56,64,Gene/Protein	NF - kappa B,113,125,Gene/Protein	p50,127,130,Gene/Protein	NF - kappa B,204,216,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 43, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""p65 mRNA"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 113, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 204, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
Interferon regulatory factor 2 ( IRF - 2) is a transcriptional regulatory protein that terminates interferon beta expression initiated by interferon regulatory factor 1.	Interferon regulatory factor 2,0,30,Gene/Protein	IRF - 2,33,40,Gene/Protein	transcriptional regulatory protein,47,81,Gene/Protein	interferon beta,98,113,Gene/Protein	interferon regulatory factor 1,138,168,Gene/Protein	"[{""token"": ""Interferon regulatory factor 2"", ""start_span"": 0, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 2"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulatory protein"", ""start_span"": 47, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""interferon beta"", ""start_span"": 98, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""interferon regulatory factor 1"", ""start_span"": 138, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
The MNDA mRNA level in primary granulocytes was unaffected by addition of interferon alpha and other agents including interferon gamma, endotoxin, poly ( I). poly ( C), and FMLP.	MNDA mRNA,4,13,Gene/Protein	interferon alpha,74,90,Gene/Protein	interferon gamma,118,134,Gene/Protein	endotoxin,136,145,Gene/Protein	FMLP,173,177,Gene/Protein	"[{""token"": ""MNDA mRNA"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""interferon alpha"", ""start_span"": 74, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""interferon gamma"", ""start_span"": 118, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""endotoxin"", ""start_span"": 136, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""FMLP"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
In addition, electrophoretic mobility shift and supershift assays revealed that important NF - kappaB binding activity composed of at least p50, p65, and c - Rel NF - kappaB subunits was present in nuclei of CD40 - stimulated B cells.	NF - kappaB,90,101,Gene/Protein	p50,140,143,Gene/Protein	p65,145,148,Gene/Protein	c - Rel,154,161,Gene/Protein	NF - kappaB subunits,162,182,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 90, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB subunits"", ""start_span"": 162, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
G0S3 is a member of a set of putative G0 / G1 switch regulatory genes ( G0S genes) selected by screening cDNA libraries prepared from human blood mononuclear cells cultured for 2 hr with lectin and cycloheximide.	G0S3,0,4,Gene/Protein	putative G0 / G1 switch regulatory genes,29,69,Gene/Protein	G0S genes,72,81,Gene/Protein	cDNA libraries,105,119,Gene/Protein	lectin,187,193,Gene/Protein	"[{""token"": ""G0S3"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""putative G0 / G1 switch regulatory genes"", ""start_span"": 29, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""G0S genes"", ""start_span"": 72, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""cDNA libraries"", ""start_span"": 105, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""lectin"", ""start_span"": 187, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
The Pan gene encodes at least two distinct transcripts, Pan - 1 and Pan - 2 ( also known as E47 and E12, respectively), by the mechanism of alternative RNA splicing.	Pan gene,4,12,Gene/Protein	Pan - 1,56,63,Gene/Protein	Pan - 2,68,75,Gene/Protein	E47,92,95,Gene/Protein	E12,100,103,Gene/Protein	"[{""token"": ""Pan gene"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""Pan - 1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Pan - 2"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""E47"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""E12"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}]"	train
We have developed a monoclonal antibody, Yae, which is specific for Pan / E2A proteins, and have used the Yae antibody to examine a variety of endocrine and nonendocrine cell lineages for differences in Pan / E2A protein expression, subcellular localization, and heteromeric complex formation.	monoclonal antibody,20,39,Gene/Protein	Yae,41,44,Gene/Protein	Pan / E2A proteins,68,86,Gene/Protein	Yae antibody,106,118,Gene/Protein	E2A protein,209,220,Gene/Protein	"[{""token"": ""monoclonal antibody"", ""start_span"": 20, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""Yae"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Pan / E2A proteins"", ""start_span"": 68, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""Yae antibody"", ""start_span"": 106, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""E2A protein"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Gene/Protein""}]"	train
Nuclear factor - kappa B ( NF - kappa B) is a transcription factor that binds to the consensus DNA sequence in the cis - acting elements of various genes.	Nuclear factor - kappa B,0,24,Gene/Protein	NF - kappa B,27,39,Gene/Protein	consensus DNA sequence,85,107,Gene/Protein	cis - acting elements,115,136,Gene/Protein	various genes,140,153,Gene/Protein	"[{""token"": ""Nuclear factor - kappa B"", ""start_span"": 0, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 27, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""consensus DNA sequence"", ""start_span"": 85, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""cis - acting elements"", ""start_span"": 115, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""various genes"", ""start_span"": 140, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
Stimulation of DND39 cells with IL - 4 or anti - CD40 monoclonal antibody ( mAb) activated phosphatidylinositol 3 - kinase and subsequently induced nuclear expression of NF - kappa B, which was identified by electrophoretic mobility shift assays.	IL - 4,32,38,Gene/Protein	anti - CD40 monoclonal antibody,42,73,Gene/Protein	mAb,76,79,Gene/Protein	phosphatidylinositol 3 - kinase,91,122,Gene/Protein	NF - kappa B,170,182,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD40 monoclonal antibody"", ""start_span"": 42, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""mAb"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 91, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 170, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
These results indicate that NF - kappa B activity is commonly inducible in DND39 cells by IL - 4 and anti - CD40 mAb and suggest that NF - kappa B sensitive to NAC may play a role in regulating IgE synthesis in B cells.	NF - kappa B,28,40,Gene/Protein	IL - 4,90,96,Gene/Protein	anti - CD40 mAb,101,116,Gene/Protein	NF - kappa B,134,146,Gene/Protein	IgE,194,197,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 28, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 90, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD40 mAb"", ""start_span"": 101, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 134, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
RT - PCR demonstrated that NL of both subtypes expressed EBNAI of the QUK splice pattern, the latent membrane proteins, LMP1 and 2 and the BamHI A rightward transcripts in the absence of EBNA2 mRNAs, compatible with the latency type II pattern.	EBNAI,57,62,Gene/Protein	latent membrane proteins,94,118,Gene/Protein	LMP1 and 2,120,130,Gene/Protein	BamHI A rightward transcripts,139,168,Gene/Protein	EBNA2 mRNAs,187,198,Gene/Protein	"[{""token"": ""EBNAI"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""latent membrane proteins"", ""start_span"": 94, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""LMP1 and 2"", ""start_span"": 120, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""BamHI A rightward transcripts"", ""start_span"": 139, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""EBNA2 mRNAs"", ""start_span"": 187, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
Autoregulation of the NF - kappa B transactivator RelA ( p65) by multiple cytoplasmic inhibitors containing ankyrin motifs.	NF - kappa B transactivator,22,49,Gene/Protein	RelA,50,54,Gene/Protein	p65,57,60,Gene/Protein	cytoplasmic inhibitors,74,96,Gene/Protein	ankyrin motifs,108,122,Gene/Protein	"[{""token"": ""NF - kappa B transactivator"", ""start_span"": 22, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic inhibitors"", ""start_span"": 74, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""ankyrin motifs"", ""start_span"": 108, ""end_span"": 122, ""type"": ""Gene/Protein""}]"	train
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not Stat1 and blocked IL - 10 - induced Stat3 phosphorylation in a cell - free system.	phosphorylated form,81,100,Gene/Protein	Stat3,116,121,Gene/Protein	Stat1,130,135,Gene/Protein	IL - 10,148,155,Gene/Protein	Stat3,166,171,Gene/Protein	"[{""token"": ""phosphorylated form"", ""start_span"": 81, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
These data demonstrate that Stat3 but not Stat1 or Stat5 is directly recruited to the ligand - activated IL - 10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.	Stat3,28,33,Gene/Protein	Stat1,42,47,Gene/Protein	Stat5,51,56,Gene/Protein	ligand - activated IL - 10 receptor,86,121,Gene/Protein	receptor intracellular domain sequences,159,198,Gene/Protein	"[{""token"": ""Stat3"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""ligand - activated IL - 10 receptor"", ""start_span"": 86, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""receptor intracellular domain sequences"", ""start_span"": 159, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
Impaired silencing of gamma - globin expression identifies EKLF as the first transcription factor participating quantitatively in the gamma - globin to beta - globin switch.	gamma - globin,22,36,Gene/Protein	EKLF,59,63,Gene/Protein	transcription factor,77,97,Gene/Protein	gamma - globin,134,148,Gene/Protein	beta - globin,152,165,Gene/Protein	"[{""token"": ""gamma - globin"", ""start_span"": 22, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 77, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""gamma - globin"", ""start_span"": 134, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin"", ""start_span"": 152, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
Here, we show that zinc addition in a serum - and lipopolysaccharide - free cell culture system leads to significantly enhanced levels of interleukin 1 beta ( IL - 1 beta) and tumour necrosis factor alpha ( TNF - alpha) and to expression of the corresponding mRNA in human peripheral blood mononuclear cells ( PBMC).	interleukin 1 beta,138,156,Gene/Protein	IL - 1 beta,159,170,Gene/Protein	tumour necrosis factor alpha,176,204,Gene/Protein	TNF - alpha,207,218,Gene/Protein	mRNA,259,263,Gene/Protein	"[{""token"": ""interleukin 1 beta"", ""start_span"": 138, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 beta"", ""start_span"": 159, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""tumour necrosis factor alpha"", ""start_span"": 176, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 207, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 259, ""end_span"": 263, ""type"": ""Gene/Protein""}]"	train
Addition of the - 176 to - 96 sequence to the 4X NF - AT - Oct construct did not impart the ability to be affected by anergy, but addition of the - 236 to - 96 sequence did, demonstrating that anergy is an active inhibitory process and that more than the presence of the - 150 AP - 1 binding site ( - 152 to - 147) is required to mediate the effect.	- 176 to - 96 sequence,16,38,Gene/Protein	4X NF - AT - Oct construct,46,72,Gene/Protein	- 236 to - 96 sequence,146,168,Gene/Protein	- 150 AP - 1 binding site,271,296,Gene/Protein	- 152 to - 147,299,313,Gene/Protein	"[{""token"": ""- 176 to - 96 sequence"", ""start_span"": 16, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""4X NF - AT - Oct construct"", ""start_span"": 46, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""- 236 to - 96 sequence"", ""start_span"": 146, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""- 150 AP - 1 binding site"", ""start_span"": 271, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""- 152 to - 147"", ""start_span"": 299, ""end_span"": 313, ""type"": ""Gene/Protein""}]"	train
Site - directed mutagenesis of these cis elements demonstrated that Cp activity is highly dependent on the presence of a properly positioned CCAAT box, with the dependence on the distal CCAAT box apparent only when the proximal CCAAT box was deleted or mutated.	cis elements,37,49,Gene/Protein	Cp,68,70,Gene/Protein	CCAAT box,141,150,Gene/Protein	distal CCAAT box,179,195,Gene/Protein	proximal CCAAT box,219,237,Gene/Protein	"[{""token"": ""cis elements"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Cp"", ""start_span"": 68, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CCAAT box"", ""start_span"": 141, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""distal CCAAT box"", ""start_span"": 179, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""proximal CCAAT box"", ""start_span"": 219, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	train
To examine the molecular basis of constitutive NF - kappaB DNA - binding activity in HIV1 - infected cells, we analyzed the phosphorylation and turnover of IkappaBalpha protein, the activity of the double - stranded RNA - dependent protein kinase ( PKR) and the intracellular levels of NF - kappaB subunits in the PLB - 985 and U937 myeloid cell models.	NF - kappaB,47,58,Gene/Protein	IkappaBalpha,156,168,Gene/Protein	double - stranded RNA - dependent protein kinase,198,246,Gene/Protein	PKR,249,252,Gene/Protein	NF - kappaB subunits,286,306,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 156, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""double - stranded RNA - dependent protein kinase"", ""start_span"": 198, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""PKR"", ""start_span"": 249, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB subunits"", ""start_span"": 286, ""end_span"": 306, ""type"": ""Gene/Protein""}]"	train
A dramatic increase in the intracellular levels of NF - kappaB subunits c - Rel and NF - kappaB2 p100 and a moderate increase in NF - kappaB2 p52 and RelA ( p65) were detected in HIV - 1 - infected cells, whereas NF - kappaB1 p105 / p50 levels were not altered relative to the levels in uninfected cells.	NF - kappaB,51,62,Gene/Protein	c - Rel,72,79,Gene/Protein	NF - kappaB2 p100,84,101,Gene/Protein	NF - kappaB2 p52,129,145,Gene/Protein	NF - kappaB1 p105 / p50,213,236,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB2 p100"", ""start_span"": 84, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB2 p52"", ""start_span"": 129, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB1 p105 / p50"", ""start_span"": 213, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
Moreover, alteration of any one of these features ( e. g., cis - element, trans - factor, or cell - specific background) switched c - Jun to a transcriptional activator of the rPRL promoter.	cis - element,59,72,Gene/Protein	trans - factor,74,88,Gene/Protein	c - Jun,130,137,Gene/Protein	transcriptional activator,143,168,Gene/Protein	rPRL promoter,176,189,Gene/Protein	"[{""token"": ""cis - element"", ""start_span"": 59, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""trans - factor"", ""start_span"": 74, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activator"", ""start_span"": 143, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""rPRL promoter"", ""start_span"": 176, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
In HeLa nonpituitary cells, c - Jun alone activated the rPRL promoter via the most proximal GHF - 1 / Pit - 1 binding site, footprint I, and synergized with GHF - 1.	c - Jun,28,35,Gene/Protein	rPRL promoter,56,69,Gene/Protein	GHF - 1 / Pit - 1 binding site,92,122,Gene/Protein	footprint I,124,135,Gene/Protein	GHF - 1,157,164,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""rPRL promoter"", ""start_span"": 56, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""GHF - 1 / Pit - 1 binding site"", ""start_span"": 92, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""footprint I"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""GHF - 1"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
NGFI - B / nur77 and its related genes constitute a family and the NGFI - B / nur77 family consists of three subtypes, named nur77 alpha, nur77 beta, nur77 gamma.	NGFI - B / nur77,0,16,Gene/Protein	NGFI - B / nur77 family,67,90,Gene/Protein	nur77 alpha,125,136,Gene/Protein	nur77 beta,138,148,Gene/Protein	nur77 gamma,150,161,Gene/Protein	"[{""token"": ""NGFI - B / nur77"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""NGFI - B / nur77 family"", ""start_span"": 67, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""nur77 alpha"", ""start_span"": 125, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""nur77 beta"", ""start_span"": 138, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""nur77 gamma"", ""start_span"": 150, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
As glucocorticoids regulate interferon - alpha ( IFN alpha) production, we hypothesized that IFN alpha, a cytokine produced predominantly by monocytes in AIDS, should be increased in cortisol - resistant AIDS, attributing the lack of cortisol inhibition to IFN alpha production.	interferon - alpha,28,46,Gene/Protein	IFN alpha,49,58,Gene/Protein	IFN alpha,93,102,Gene/Protein	cytokine,106,114,Gene/Protein	IFN alpha,257,266,Gene/Protein	"[{""token"": ""interferon - alpha"", ""start_span"": 28, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""IFN alpha"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""IFN alpha"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""IFN alpha"", ""start_span"": 257, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
Although the CRE site is necessary, optimal induction of bcl - 2 expression requires participation of the upstream regulatory element, suggesting that phosphorylation of CREB alters its interaction with the upstream regulatory element.	CRE site,13,21,Gene/Protein	bcl - 2,57,64,Gene/Protein	upstream regulatory element,106,133,Gene/Protein	CREB,170,174,Gene/Protein	upstream regulatory element,207,234,Gene/Protein	"[{""token"": ""CRE site"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""bcl - 2"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""upstream regulatory element"", ""start_span"": 106, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""upstream regulatory element"", ""start_span"": 207, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
Other DNA elements present include a cluster of Myb sites, several Ets, an Ets related PU. 1 site and an Sp1 site located within 600 bp of the transcription start sites.	DNA elements,6,18,Gene/Protein	Myb sites,48,57,Gene/Protein	Ets,67,70,Gene/Protein	Sp1 site,105,113,Gene/Protein	transcription start sites,143,168,Gene/Protein	"[{""token"": ""DNA elements"", ""start_span"": 6, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""Myb sites"", ""start_span"": 48, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Ets"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 site"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""transcription start sites"", ""start_span"": 143, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
The SH3 domains of Grb2 form a stable complex with SOS1 and two proteins of 75 kD and 120 kD, which undergo tyrosine phosphorylation in Fc gamma RIIA stimulated cells.	SH3 domains,4,15,Gene/Protein	Grb2,19,23,Gene/Protein	SOS1,51,55,Gene/Protein	75 kD,76,81,Gene/Protein	120 kD,86,92,Gene/Protein	"[{""token"": ""SH3 domains"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""Grb2"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""SOS1"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""75 kD"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""120 kD"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}]"	train
The variant Id - 3L protein is functionally distinguishable from conventional Id - 3 since in in vitro DNA mobility shift assays, it was greatly impaired in its ability to abrogate binding of the basic helix - loop - helix protein, E47, to an E box recognition sequence.	Id - 3L protein,12,27,Gene/Protein	Id - 3,78,84,Gene/Protein	helix - loop - helix protein,202,230,Gene/Protein	E47,232,235,Gene/Protein	E box recognition sequence,243,269,Gene/Protein	"[{""token"": ""Id - 3L protein"", ""start_span"": 12, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""Id - 3"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""helix - loop - helix protein"", ""start_span"": 202, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""E47"", ""start_span"": 232, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""E box recognition sequence"", ""start_span"": 243, ""end_span"": 269, ""type"": ""Gene/Protein""}]"	train
Elevated cAMP did not prevent nuclear translocation of p50 / p65 and c - Rel / p65 heterodimers, decrease nuclear translocation of p65, or significantly modify TNFalpha - induced phosphorylation of p65.	p50 / p65,55,64,Gene/Protein	c - Rel / p65 heterodimers,69,95,Gene/Protein	p65,131,134,Gene/Protein	TNFalpha,160,168,Gene/Protein	p65,198,201,Gene/Protein	"[{""token"": ""p50 / p65"", ""start_span"": 55, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel / p65 heterodimers"", ""start_span"": 69, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 160, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
Functional studies demonstrated that transcriptional activation of a plasmid containing multimerized kappaB sites by p65 was inhibited by agents that elevate cAMP and by overexpression of the catalytic subunit of PKA.	plasmid,69,76,Gene/Protein	multimerized kappaB sites,88,113,Gene/Protein	p65,117,120,Gene/Protein	catalytic subunit,192,209,Gene/Protein	PKA,213,216,Gene/Protein	"[{""token"": ""plasmid"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""multimerized kappaB sites"", ""start_span"": 88, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""catalytic subunit"", ""start_span"": 192, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""PKA"", ""start_span"": 213, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
The BCL6 gene encodes a 95 - kDa protein containing six C - terminal zinc - finger motifs and an N - terminal POZ domain, suggesting that it may function as a transcription factor.	BCL6 gene,4,13,Gene/Protein	95 - kDa protein,24,40,Gene/Protein	C - terminal zinc - finger motifs,56,89,Gene/Protein	N - terminal POZ domain,97,120,Gene/Protein	transcription factor,159,179,Gene/Protein	"[{""token"": ""BCL6 gene"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""95 - kDa protein"", ""start_span"": 24, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal zinc - finger motifs"", ""start_span"": 56, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal POZ domain"", ""start_span"": 97, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 159, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
We find that OCA - B binds DNA directly in the major groove between the two subdomains of the POU domain, requiring both an A at the fifth position of the octamer element and contact with the POU domain.	OCA - B,13,20,Gene/Protein	POU domain,94,104,Gene/Protein	fifth position,133,147,Gene/Protein	octamer element,155,170,Gene/Protein	POU domain,192,202,Gene/Protein	"[{""token"": ""OCA - B"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""POU domain"", ""start_span"": 94, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""fifth position"", ""start_span"": 133, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""octamer element"", ""start_span"": 155, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""POU domain"", ""start_span"": 192, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
A 4 - or 10 - bp insertion between muE3 and muB inactivated the mu enhancer in S194 plasma cells but did not affect in vitro binding of Ets - 1, PU. 1, or the muE3 - binding protein TFE3, alone or in pairwise combinations.	muE3,35,39,Gene/Protein	muB,44,47,Gene/Protein	mu enhancer,64,75,Gene/Protein	muE3 - binding protein,159,181,Gene/Protein	TFE3,182,186,Gene/Protein	"[{""token"": ""muE3"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""muB"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""mu enhancer"", ""start_span"": 64, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""muE3 - binding protein"", ""start_span"": 159, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""TFE3"", ""start_span"": 182, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
NFAT1 possesses two transactivation domains whose sequences are not conserved in the other NFAT - family proteins, and a conserved DNA - binding domain that mediates the recruitment of cooperating nuclear transcription factors even when it is expressed in the absence of other regions of the protein.	NFAT1,0,5,Gene/Protein	transactivation domains,20,43,Gene/Protein	NFAT - family proteins,91,113,Gene/Protein	DNA - binding domain,131,151,Gene/Protein	nuclear transcription factors,197,226,Gene/Protein	"[{""token"": ""NFAT1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""transactivation domains"", ""start_span"": 20, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""NFAT - family proteins"", ""start_span"": 91, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding domain"", ""start_span"": 131, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""nuclear transcription factors"", ""start_span"": 197, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	train
Comparison of the different combinations of GC and cytokines / LPS revealed differences in the level of GC - dependent enhancement of sialoadhesin expression, with IFN - beta and IL - 4 being more potent than IFN - gamma and LPS.	cytokines,51,60,Gene/Protein	sialoadhesin,134,146,Gene/Protein	IFN - beta,164,174,Gene/Protein	IL - 4,179,185,Gene/Protein	IFN - gamma,209,220,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""sialoadhesin"", ""start_span"": 134, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""IFN - beta"", ""start_span"": 164, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 179, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Gene/Protein""}]"	train
We found that the adenylate cyclase activator, forskolin, inhibits anti - CD3 - induced shift in Lck electrophoretic mobility, suggesting an intervention at the TCR - coupled phosphoinositide turnover that precedes the activation of PKC.	adenylate cyclase,18,35,Gene/Protein	anti - CD3,67,77,Gene/Protein	Lck,97,100,Gene/Protein	TCR,161,164,Gene/Protein	PKC,233,236,Gene/Protein	"[{""token"": ""adenylate cyclase"", ""start_span"": 18, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""Lck"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 233, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
To further analyze potential cross points between positively and negatively regulating signaling pathways in T cells, we tested the effects of activators of the adenylate cyclase or PKA on two parallel mitogen - activated protein kinase signaling pathways mediated by extracellular signal - regulated kinase ( ERK) and c - Jun N - terminal kinase.	adenylate cyclase,161,178,Gene/Protein	PKA,182,185,Gene/Protein	extracellular signal - regulated kinase,268,307,Gene/Protein	ERK,310,313,Gene/Protein	c - Jun N - terminal kinase,319,346,Gene/Protein	"[{""token"": ""adenylate cyclase"", ""start_span"": 161, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""PKA"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""extracellular signal - regulated kinase"", ""start_span"": 268, ""end_span"": 307, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 310, ""end_span"": 313, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun N - terminal kinase"", ""start_span"": 319, ""end_span"": 346, ""type"": ""Gene/Protein""}]"	train
Major STAT complexes activated by G - CSF - R / IL - 7R alpha contained STAT1 or STAT5, while some formation of STAT3 - containing complexes was also seen.	STAT complexes,6,20,Gene/Protein	G - CSF - R / IL - 7R alpha,34,61,Gene/Protein	STAT1,72,77,Gene/Protein	STAT5,81,86,Gene/Protein	STAT3 - containing complexes,112,140,Gene/Protein	"[{""token"": ""STAT complexes"", ""start_span"": 6, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF - R / IL - 7R alpha"", ""start_span"": 34, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""STAT3 - containing complexes"", ""start_span"": 112, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
Here we show that CaMKIV / Gr induces the transcription factor activation protein 1 ( AP - 1) alone or in synergy with T cell mitogens and with the p21ras oncoprotein.	CaMKIV / Gr,18,29,Gene/Protein	transcription factor activation protein 1,42,83,Gene/Protein	AP - 1,86,92,Gene/Protein	T cell mitogens,119,134,Gene/Protein	p21ras oncoprotein,148,166,Gene/Protein	"[{""token"": ""CaMKIV / Gr"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor activation protein 1"", ""start_span"": 42, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""T cell mitogens"", ""start_span"": 119, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""p21ras oncoprotein"", ""start_span"": 148, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
Treatment of B lymphocytes with the cytokine IL - 4 ( IL - 4), in the absence of prior activation, induces a weak up - regulation of VDR expression but fails to generate vitamin D - responsive element ( VDRE) - reactive nuclear protein complexes or to initiate the genomic transcription of 25 - hydroxyvitamin D3 24 - hydroxylase.	cytokine,36,44,Gene/Protein	IL - 4,45,51,Gene/Protein	IL - 4,54,60,Gene/Protein	VDR,133,136,Gene/Protein	25 - hydroxyvitamin D3 24 - hydroxylase,290,329,Gene/Protein	"[{""token"": ""cytokine"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""VDR"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""25 - hydroxyvitamin D3 24 - hydroxylase"", ""start_span"": 290, ""end_span"": 329, ""type"": ""Gene/Protein""}]"	train
Tax is localized to the DNA through its interaction with the site - specific activators cyclic AMP - responsive element - binding protein, NF - kappaB, and serum response factor.	Tax,0,3,Gene/Protein	site - specific activators,61,87,Gene/Protein	cyclic AMP - responsive element - binding protein,88,137,Gene/Protein	NF - kappaB,139,150,Gene/Protein	serum response factor,156,177,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""site - specific activators"", ""start_span"": 61, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""cyclic AMP - responsive element - binding protein"", ""start_span"": 88, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""serum response factor"", ""start_span"": 156, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
Downregulation of LPS - induced AP - 1 was accompanied, and thus possibly explained, by a reduced expression at mRNA level of the two major components of the AP - 1 complex, namely c - fos and c - jun as determined by Northern experiments.	LPS - induced AP - 1,18,38,Gene/Protein	mRNA,112,116,Gene/Protein	AP - 1 complex,158,172,Gene/Protein	c - fos,181,188,Gene/Protein	c - jun,193,200,Gene/Protein	"[{""token"": ""LPS - induced AP - 1"", ""start_span"": 18, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 complex"", ""start_span"": 158, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 181, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 193, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
NF - IL6 mRNA levels were not affected by IL - 10 or IL - 4, suggesting that IL - 4 affects binding activity of preexisting NF - IL6.	NF - IL6 mRNA,0,13,Gene/Protein	IL - 10,42,49,Gene/Protein	IL - 4,53,59,Gene/Protein	IL - 4,77,83,Gene/Protein	NF - IL6,124,132,Gene/Protein	"[{""token"": ""NF - IL6 mRNA"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Gene/Protein""}]"	train
Similarly, the complexes binding the consensus AP - 1 TRE and jun TRE - like motifs in cells exposed to oxidative signals or PHA / PMA were indistinguishable, being composed of c - Fos, c - Jun, and JunD.	consensus AP - 1 TRE,37,57,Gene/Protein	jun TRE - like motifs,62,83,Gene/Protein	c - Fos,177,184,Gene/Protein	c - Jun,186,193,Gene/Protein	JunD,199,203,Gene/Protein	"[{""token"": ""consensus AP - 1 TRE"", ""start_span"": 37, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""jun TRE - like motifs"", ""start_span"": 62, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 186, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
Electrophoretic mobility shift assay ( EMSA) and supershift assay using an NF - kappa B binding sequence from the kappa light chain as a probe, revealed that both p65 ( RelA) and c - Rel were present in CD40 - stimulated B cells.	NF - kappa B binding sequence,75,104,Gene/Protein	kappa light chain,114,131,Gene/Protein	p65,163,166,Gene/Protein	RelA,169,173,Gene/Protein	c - Rel,179,186,Gene/Protein	"[{""token"": ""NF - kappa B binding sequence"", ""start_span"": 75, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""kappa light chain"", ""start_span"": 114, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 179, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
Like LPS, purified native B. burgdorferi OspA and synthetic analogs of OspA, OspB, and two T. pallidum lipoproteins ( Tpp47 and Tpp17) all induced NF - kappa B translocation in THP - 1 human monocytoid cells.	OspA,41,45,Gene/Protein	OspB,77,81,Gene/Protein	Tpp47,118,123,Gene/Protein	Tpp17,128,133,Gene/Protein	NF - kappa B,147,159,Gene/Protein	"[{""token"": ""OspA"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""OspB"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""Tpp47"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""Tpp17"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 147, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
In addition to SP100 homology regions, one LYSP100 cDNA isoform contains a bromodomain and a PHD / TTC domain, which are present in a variety of transcriptional regulatory proteins.	SP100 homology regions,15,37,Gene/Protein	LYSP100 cDNA isoform,43,63,Gene/Protein	bromodomain,75,86,Gene/Protein	PHD / TTC domain,93,109,Gene/Protein	transcriptional regulatory proteins,145,180,Gene/Protein	"[{""token"": ""SP100 homology regions"", ""start_span"": 15, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""LYSP100 cDNA isoform"", ""start_span"": 43, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""bromodomain"", ""start_span"": 75, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""PHD / TTC domain"", ""start_span"": 93, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulatory proteins"", ""start_span"": 145, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
We found that GIG18 was rapidly induced to comparable levels by both AR and GR, demonstrating that AR can indeed function as a transcriptional activator in S49 cells and, moreover, that GIG18 induction may be a marker of early apoptotic events in steroid - treated cells.	GIG18,14,19,Gene/Protein	AR,69,71,Gene/Protein	GR,76,78,Gene/Protein	AR,99,101,Gene/Protein	GIG18,186,191,Gene/Protein	"[{""token"": ""GIG18"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""AR"", ""start_span"": 69, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""AR"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""GIG18"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
Expression of dominant negative N17Rac also prevents TCR and p21ras activation of NFAT, but without interfering with the ERK - 2 pathway.	dominant negative N17Rac,14,38,Gene/Protein	TCR,53,56,Gene/Protein	p21ras,61,67,Gene/Protein	NFAT,82,86,Gene/Protein	ERK - 2,121,128,Gene/Protein	"[{""token"": ""dominant negative N17Rac"", ""start_span"": 14, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""p21ras"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""ERK - 2"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}]"	train
Thus, p21ras regulation of NFAT in T cells requires the activity of multiple effector pathways including those regulated by MAPKK - 1 / ERK - 2 and Rac - 1.	p21ras,6,12,Gene/Protein	NFAT,27,31,Gene/Protein	MAPKK - 1,124,133,Gene/Protein	/ ERK - 2,134,143,Gene/Protein	Rac - 1,148,155,Gene/Protein	"[{""token"": ""p21ras"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""MAPKK - 1"", ""start_span"": 124, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""/ ERK - 2"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""Rac - 1"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	train
In contrast to IL - 2 and IFN - alpha, IL - 12 induced strong tyrosine phosphorylation of STAT4 and variable weak phosphorylation of STAT3.	IL - 2,15,21,Gene/Protein	IFN - alpha,26,37,Gene/Protein	IL - 12,39,46,Gene/Protein	STAT4,90,95,Gene/Protein	STAT3,133,138,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 15, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""STAT4"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}]"	train
Differential phosphorylation and consequent differential activation of both separate and overlapping STAT proteins by IL - 2, IL - 12, and IFN - alpha may provide a molecular basis for the similarities and differences in the actions of these cytokines on NK cells.	STAT proteins,101,114,Gene/Protein	IL - 2,118,124,Gene/Protein	IL - 12,126,133,Gene/Protein	IFN - alpha,139,150,Gene/Protein	cytokines,242,251,Gene/Protein	"[{""token"": ""STAT proteins"", ""start_span"": 101, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 242, ""end_span"": 251, ""type"": ""Gene/Protein""}]"	train
In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL - 2 are unresponsive to IFN - gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1 ( alpha), a signal transducer and activator of transcription.	TCR,90,93,Gene/Protein	IL - 2,112,118,Gene/Protein	IFN - gamma,139,150,Gene/Protein	jak kinases,193,204,Gene/Protein	transcription factor,213,233,Gene/Protein	"[{""token"": ""TCR"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""jak kinases"", ""start_span"": 193, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 213, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
Our data suggest that IL - 13 utilizes IL - 4R and its signaling pathway, and JAK2 may play an important role in the function of IL - 4R and IL - 13R in colon cancer cells.	IL - 13,22,29,Gene/Protein	IL - 4R,39,46,Gene/Protein	JAK2,78,82,Gene/Protein	IL - 4R,129,136,Gene/Protein	IL - 13R,141,149,Gene/Protein	"[{""token"": ""IL - 13"", ""start_span"": 22, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R"", ""start_span"": 129, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13R"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
Incubation of B - chronic lymphocytic leukemia ( B - CLL) cells with phorbol esters resulted in the phosphorylation of two major PKC substrates, MARCKS ( myristoylated, alanine - rich C kinase substrate) and MRP ( MARCKS - related protein), and of a third protein, with an apparent m. w. of 60, 000 that was the most prominent protein kinase C substrate in these cells.	PKC substrates,129,143,Gene/Protein	MARCKS,145,151,Gene/Protein	MRP,208,211,Gene/Protein	MARCKS - related protein,214,238,Gene/Protein	protein kinase C substrate,327,353,Gene/Protein	"[{""token"": ""PKC substrates"", ""start_span"": 129, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""MARCKS"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""MRP"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""MARCKS - related protein"", ""start_span"": 214, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C substrate"", ""start_span"": 327, ""end_span"": 353, ""type"": ""Gene/Protein""}]"	train
COS - 1 cells, co - expressing the human IL - 10R and individual STAT proteins, confirmed a preference of the IL - 10R for STAT3 and STAT1.	IL - 10R,41,49,Gene/Protein	STAT proteins,65,78,Gene/Protein	IL - 10R,110,118,Gene/Protein	STAT3,123,128,Gene/Protein	STAT1,133,138,Gene/Protein	"[{""token"": ""IL - 10R"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""STAT proteins"", ""start_span"": 65, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10R"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}]"	train
A gel retardation experiment with synthetic double - stranded oligonucleotides showed that activated NF - kappa B consisting of p50 / p65 heterodimer bound to all four putative NF - kappa B DNA probes, suggesting that all four putative NF - kappa B recognition sites play an important role in inducible TNF - alpha expression.	NF - kappa B,101,113,Gene/Protein	p50 / p65 heterodimer,128,149,Gene/Protein	NF - kappa B DNA probes,177,200,Gene/Protein	NF - kappa B recognition sites,236,266,Gene/Protein	TNF - alpha,303,314,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""p50 / p65 heterodimer"", ""start_span"": 128, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B DNA probes"", ""start_span"": 177, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B recognition sites"", ""start_span"": 236, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 303, ""end_span"": 314, ""type"": ""Gene/Protein""}]"	train
C - terminal activating and inhibitory domains determine the transactivation potential of BSAP ( Pax - 5), Pax - 2 and Pax - 8.	C - terminal activating and inhibitory domains,0,46,Gene/Protein	BSAP,90,94,Gene/Protein	Pax - 5,97,104,Gene/Protein	Pax - 2,107,114,Gene/Protein	Pax - 8,119,126,Gene/Protein	"[{""token"": ""C - terminal activating and inhibitory domains"", ""start_span"": 0, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 2"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 8"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	train
The same arrangement of positively and negatively acting sequences has been conserved in the mammalian Pax - 2 and Pax - 8, the zebrafish Pax - b as well as the sea urchin Pax - 258 proteins.	positively and negatively acting sequences,24,66,Gene/Protein	mammalian Pax - 2,93,110,Gene/Protein	Pax - 8,115,122,Gene/Protein	zebrafish Pax - b,128,145,Gene/Protein	sea urchin Pax - 258 proteins,161,190,Gene/Protein	"[{""token"": ""positively and negatively acting sequences"", ""start_span"": 24, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""mammalian Pax - 2"", ""start_span"": 93, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 8"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""zebrafish Pax - b"", ""start_span"": 128, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""sea urchin Pax - 258 proteins"", ""start_span"": 161, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
CD36 is a cell surface glycoprotein composed of a single polypeptide chain, which interacts with thrombospondin, collagens type I and IV, oxidized low density lipoprotein, fatty acids, anionic phospholipids, and erythrocytes parasitized with Plasmodium falciparum.	CD36,0,4,Gene/Protein	glycoprotein,23,35,Gene/Protein	thrombospondin,97,111,Gene/Protein	collagens type I and IV,113,136,Gene/Protein	low density lipoprotein,147,170,Gene/Protein	"[{""token"": ""CD36"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""glycoprotein"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""thrombospondin"", ""start_span"": 97, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""collagens type I and IV"", ""start_span"": 113, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""low density lipoprotein"", ""start_span"": 147, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
In this study, we examined the expression of two T - cell - specific transcription factors ( TCF - 1 and GATA - 3) and one B - cell - specific transcription factor ( BSAP) in cultured H - RS cells by using a gel mobility shift assay.	T - cell - specific transcription factors,49,90,Gene/Protein	TCF - 1,93,100,Gene/Protein	GATA - 3,105,113,Gene/Protein	B - cell - specific transcription factor,123,163,Gene/Protein	BSAP,166,170,Gene/Protein	"[{""token"": ""T - cell - specific transcription factors"", ""start_span"": 49, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 3"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific transcription factor"", ""start_span"": 123, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
Active Raf - 1 phosphorylates and activates the mitogen - activated protein ( MAP) kinase / extracellular signal - regulated kinase kinase 1 ( MEK1), which in turn phosphorylates and activates the MAP kinases / extracellular signal regulated kinases, ERK1 and ERK2.	Raf - 1,7,14,Gene/Protein	MEK1,143,147,Gene/Protein	MAP kinases / extracellular signal regulated kinases,197,249,Gene/Protein	ERK1,251,255,Gene/Protein	ERK2,260,264,Gene/Protein	"[{""token"": ""Raf - 1"", ""start_span"": 7, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""MEK1"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""MAP kinases / extracellular signal regulated kinases"", ""start_span"": 197, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 251, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""ERK2"", ""start_span"": 260, ""end_span"": 264, ""type"": ""Gene/Protein""}]"	train
Expression of MEK1 - interfering mutants inhibited the stimulation of IL - 2 promoter - driven transcription and blocked the ability of constitutively active Ras and Raf - 1 to costimulate NF - AT activity with a calcium ionophore.	MEK1 - interfering mutants,14,40,Gene/Protein	IL - 2 promoter,70,85,Gene/Protein	Ras,158,161,Gene/Protein	Raf - 1,166,173,Gene/Protein	NF - AT,189,196,Gene/Protein	"[{""token"": ""MEK1 - interfering mutants"", ""start_span"": 14, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 70, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""Raf - 1"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
Transient expression of the luciferase reporter gene linked to serially deleted sequences of the 5 ' - flanking region of the IL - 9 gene has revealed several positive and negative regulatory elements involved in the basal and inducible expression of the IL - 9 gene in C5MJ2 cells.	luciferase reporter gene,28,52,Gene/Protein	5 ' - flanking region,97,118,Gene/Protein	IL - 9 gene,126,137,Gene/Protein	negative regulatory elements,172,200,Gene/Protein	IL - 9 gene,255,266,Gene/Protein	"[{""token"": ""luciferase reporter gene"", ""start_span"": 28, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - flanking region"", ""start_span"": 97, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9 gene"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""negative regulatory elements"", ""start_span"": 172, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9 gene"", ""start_span"": 255, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
This paper reports the expression of IL - 12R on a human gamma delta T cell line that responds to IL - 12 with enhanced cytolytic activity and increased expression of cytolytic effector molecules granzyme B and perforin.	IL - 12R,37,45,Gene/Protein	IL - 12,98,105,Gene/Protein	cytolytic effector molecules,167,195,Gene/Protein	granzyme B,196,206,Gene/Protein	perforin,211,219,Gene/Protein	"[{""token"": ""IL - 12R"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""cytolytic effector molecules"", ""start_span"": 167, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""granzyme B"", ""start_span"": 196, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""perforin"", ""start_span"": 211, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
hLH - 2 was mapped to chromosome 9Q33 - 34. 1, in the same region as the reciprocal translocation that creates the BCR - ABL chimera of the Philadelphia chromosome ( Ph '), the hallmark of CML; hLH - 2 was retained on the derivative 9 chromosome and is therefore centromeric of c - ABL.	hLH - 2,0,7,Gene/Protein	BCR - ABL chimera,115,132,Gene/Protein	hLH - 2,194,201,Gene/Protein	derivative 9 chromosome,222,245,Gene/Protein	c - ABL,278,285,Gene/Protein	"[{""token"": ""hLH - 2"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""BCR - ABL chimera"", ""start_span"": 115, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""hLH - 2"", ""start_span"": 194, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""derivative 9 chromosome"", ""start_span"": 222, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""c - ABL"", ""start_span"": 278, ""end_span"": 285, ""type"": ""Gene/Protein""}]"	train
p45 subunit of NF - E2 contains a basic - leucine zipper domain and dimerizes with the small Maf family protein to form functional NF - E2 complex.	p45 subunit,0,11,Gene/Protein	NF - E2,15,22,Gene/Protein	basic - leucine zipper domain,34,63,Gene/Protein	small Maf family protein,87,111,Gene/Protein	NF - E2 complex,131,146,Gene/Protein	"[{""token"": ""p45 subunit"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""NF - E2"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""basic - leucine zipper domain"", ""start_span"": 34, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""small Maf family protein"", ""start_span"": 87, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""NF - E2 complex"", ""start_span"": 131, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
Although p45 mRNA is transcribed from two different promoters, aNF - E2 promoter and fNF - E2 promoter, in erythroid and megakaryocytic lineage cells, p45 mRNA is transcribed only from aNF - E2 promoter.	p45 mRNA,9,17,Gene/Protein	aNF - E2 promoter,63,80,Gene/Protein	fNF - E2 promoter,85,102,Gene/Protein	p45 mRNA,151,159,Gene/Protein	aNF - E2 promoter,185,202,Gene/Protein	"[{""token"": ""p45 mRNA"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""aNF - E2 promoter"", ""start_span"": 63, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""fNF - E2 promoter"", ""start_span"": 85, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""p45 mRNA"", ""start_span"": 151, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""aNF - E2 promoter"", ""start_span"": 185, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
The protein products of the c - fos ( p62c - fos) and c - jun ( p39c - jun) genes are members of the AP - 1 transcription factor family and are thought to play important roles in the regulation of gene expression during the cell cycle.	c - fos,28,35,Gene/Protein	p62c - fos,38,48,Gene/Protein	c - jun,54,61,Gene/Protein	p39c - jun,64,74,Gene/Protein	AP - 1 transcription factor family,101,135,Gene/Protein	"[{""token"": ""c - fos"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""p62c - fos"", ""start_span"": 38, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""p39c - jun"", ""start_span"": 64, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 transcription factor family"", ""start_span"": 101, ""end_span"": 135, ""type"": ""Gene/Protein""}]"	train
We demonstrated an uncoupling of AP - 1 binding activity from p62c - fos, and p39c - jun AP - 1 activity was expressed more strongly in the G1 - and G2 / M - phase enriched samples than in the S - phase enriched samples of HL60 cells, while levels of nuclear p62c - fos and p39c - jun were constant.	AP - 1,33,39,Gene/Protein	p62c - fos,62,72,Gene/Protein	p39c - jun,78,88,Gene/Protein	AP - 1,89,95,Gene/Protein	nuclear p62c - fos and p39c - jun,251,284,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""p62c - fos"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""p39c - jun"", ""start_span"": 78, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""nuclear p62c - fos and p39c - jun"", ""start_span"": 251, ""end_span"": 284, ""type"": ""Gene/Protein""}]"	train
Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation.	STAT1,18,23,Gene/Protein	STAT2,29,34,Gene/Protein	STAT3,39,44,Gene/Protein	signalling complexes,57,77,Gene/Protein	cytokine,87,95,Gene/Protein	"[{""token"": ""STAT1"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""STAT2"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""signalling complexes"", ""start_span"": 57, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	train
LPS - stimulated monocytes showed an increased expression of p105 mRNA, the precursor of the p50 subunit of the transcription factor nuclear factor - kappa B ( NF - kappa B), while no effect was noticed on the expression of p65 mRNA.	p105 mRNA,61,70,Gene/Protein	p50 subunit,93,104,Gene/Protein	transcription factor nuclear factor - kappa B,112,157,Gene/Protein	NF - kappa B,160,172,Gene/Protein	p65 mRNA,224,232,Gene/Protein	"[{""token"": ""p105 mRNA"", ""start_span"": 61, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""p50 subunit"", ""start_span"": 93, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor nuclear factor - kappa B"", ""start_span"": 112, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 160, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""p65 mRNA"", ""start_span"": 224, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	train
Stimulation with LPS or IFN - gamma resulted in the expression of p50 and p65 subunits, while the combination of IFN - gamma plus LPS caused a further increase in the expression of NF - kappa B.	IFN - gamma,24,35,Gene/Protein	p50,66,69,Gene/Protein	p65 subunits,74,86,Gene/Protein	IFN - gamma,113,124,Gene/Protein	NF - kappa B,181,193,Gene/Protein	"[{""token"": ""IFN - gamma"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""p65 subunits"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 113, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 181, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
We propose that HIV - 1 tat may inhibit MIP - 1 alpha expression by inducing MNP - 1 expression in T - cells, probably by either competing with MNP - 2 for binding to the MIP - 1 alpha promoter or by sequestering it into inactive forms.	HIV - 1 tat,16,27,Gene/Protein	MIP - 1 alpha,40,53,Gene/Protein	MNP - 1,77,84,Gene/Protein	MNP - 2,144,151,Gene/Protein	MIP - 1 alpha promoter,171,193,Gene/Protein	"[{""token"": ""HIV - 1 tat"", ""start_span"": 16, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 1 alpha"", ""start_span"": 40, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""MNP - 1"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""MNP - 2"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 1 alpha promoter"", ""start_span"": 171, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
Moreover, deletion of either 5 ' or 3 ' NF - kappaB sites reduced IL - 1alpha promoter activity in MT - 2 cells and transactivation of the IL - 1alpha promoter by exogenous NF - kappaB and Tax in Jurkat cells.	5 ' or 3 ' NF - kappaB sites,29,57,Gene/Protein	IL - 1alpha promoter,66,86,Gene/Protein	IL - 1alpha promoter,139,159,Gene/Protein	NF - kappaB,173,184,Gene/Protein	Tax,189,192,Gene/Protein	"[{""token"": ""5 ' or 3 ' NF - kappaB sites"", ""start_span"": 29, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1alpha promoter"", ""start_span"": 66, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1alpha promoter"", ""start_span"": 139, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 173, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
DNase I footprinting assays revealed four distinct sites that bind myeloid nuclear proteins ( - 408 to - 386, - 293 to - 254, - 76 to - 65, and - 34 to + 3).	myeloid nuclear proteins,67,91,Gene/Protein	- 408 to - 386,94,108,Gene/Protein	- 293 to - 254,110,124,Gene/Protein	- 76 to - 65,126,138,Gene/Protein	- 34 to + 3,144,155,Gene/Protein	"[{""token"": ""myeloid nuclear proteins"", ""start_span"": 67, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""- 408 to - 386"", ""start_span"": 94, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""- 293 to - 254"", ""start_span"": 110, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""- 76 to - 65"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""- 34 to + 3"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	train
Granulocyte - macrophage colony - stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93fes, STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes.	Granulocyte - macrophage colony - stimulating factor,0,52,Gene/Protein	JAK2,64,68,Gene/Protein	p93fes,109,115,Gene/Protein	STAT1 p91,117,126,Gene/Protein	STAT3 p92,132,141,Gene/Protein	"[{""token"": ""Granulocyte - macrophage colony - stimulating factor"", ""start_span"": 0, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""p93fes"", ""start_span"": 109, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 p91"", ""start_span"": 117, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""STAT3 p92"", ""start_span"": 132, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	train
In order to better characterize the human gammac promoter and define the minimal tissue - specific promoter region, progressive 5 ' - deletion constructs of a segment extending 1053 base pairs upstream of the major transcription start site were generated and tested for promoter activity in various hematopoietic and nonhematopoietic cell types.	human gammac promoter,36,57,Gene/Protein	minimal tissue - specific promoter region,73,114,Gene/Protein	5 ' - deletion constructs,128,153,Gene/Protein	1053 base pairs upstream,177,201,Gene/Protein	major transcription start site,209,239,Gene/Protein	"[{""token"": ""human gammac promoter"", ""start_span"": 36, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""minimal tissue - specific promoter region"", ""start_span"": 73, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - deletion constructs"", ""start_span"": 128, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""1053 base pairs upstream"", ""start_span"": 177, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""major transcription start site"", ""start_span"": 209, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Genetic characterization of transactivation of the human T - cell leukemia virus type 1 promoter: Binding of Tax to Tax - responsive element 1 is mediated by the cyclic AMP - responsive members of the CREB / ATF family of transcription factors.	human T - cell leukemia virus type 1 promoter,51,96,Gene/Protein	Tax,109,112,Gene/Protein	Tax - responsive element 1,116,142,Gene/Protein	cyclic AMP - responsive members,162,193,Gene/Protein	CREB / ATF family,201,218,Gene/Protein	"[{""token"": ""human T - cell leukemia virus type 1 promoter"", ""start_span"": 51, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Tax - responsive element 1"", ""start_span"": 116, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""cyclic AMP - responsive members"", ""start_span"": 162, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""CREB / ATF family"", ""start_span"": 201, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
Analysis of different CREB mutants with this genetic system indicated that the C - terminal 92 amino acid residues, which include the basic domain and the leucine zipper, are necessary and sufficient to mediate transactivation by Tax.	CREB mutants,22,34,Gene/Protein	C - terminal 92 amino acid residues,79,114,Gene/Protein	basic domain,134,146,Gene/Protein	leucine zipper,155,169,Gene/Protein	Tax,230,233,Gene/Protein	"[{""token"": ""CREB mutants"", ""start_span"": 22, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal 92 amino acid residues"", ""start_span"": 79, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""basic domain"", ""start_span"": 134, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""leucine zipper"", ""start_span"": 155, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 230, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
To identify cellular proteins binding to TRE - 1 in a Tax - dependent manner, this strain was also used to screen a library of human cDNAs fused to GAD.	cellular proteins,12,29,Gene/Protein	TRE - 1,41,48,Gene/Protein	Tax,54,57,Gene/Protein	human cDNAs,127,138,Gene/Protein	GAD,148,151,Gene/Protein	"[{""token"": ""cellular proteins"", ""start_span"": 12, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""TRE - 1"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""human cDNAs"", ""start_span"": 127, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""GAD"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	train
When fused to GAD, the C - terminal region of Ku was able to activate transcription via TRE - 1 but this activation was not dependent on Tax.	GAD,14,17,Gene/Protein	C - terminal region,23,42,Gene/Protein	Ku,46,48,Gene/Protein	TRE - 1,88,95,Gene/Protein	Tax,137,140,Gene/Protein	"[{""token"": ""GAD"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal region"", ""start_span"": 23, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Ku"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""TRE - 1"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
Oligonucleotides containing the IL - 13 or IL - 4 P element sites specifically bound the transcriptional activator protein, nuclear factor - activated T cells, preformed ( NF - ATp), when incubated with nuclear protein extracts from activated T cells.	IL - 13,32,39,Gene/Protein	IL - 4 P element sites,43,65,Gene/Protein	transcriptional activator protein,89,122,Gene/Protein	nuclear factor - activated T cells,124,158,Gene/Protein	NF - ATp,172,180,Gene/Protein	"[{""token"": ""IL - 13"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 P element sites"", ""start_span"": 43, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activator protein"", ""start_span"": 89, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - activated T cells"", ""start_span"": 124, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATp"", ""start_span"": 172, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
Because the primed T cells contain higher levels of nuclear NF - ATp, capable of binding to P elements of the IL - 4 and IL - 13 promoters, than do freshly - isolated T cells, the NF - AT - binding P elements are attractive candidates to mediate the coordinate expression of these two cytokine genes.	nuclear NF - ATp,52,68,Gene/Protein	P elements,92,102,Gene/Protein	IL - 4 and IL - 13 promoters,110,138,Gene/Protein	NF - AT - binding P elements,180,208,Gene/Protein	cytokine genes,285,299,Gene/Protein	"[{""token"": ""nuclear NF - ATp"", ""start_span"": 52, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""P elements"", ""start_span"": 92, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 and IL - 13 promoters"", ""start_span"": 110, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT - binding P elements"", ""start_span"": 180, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 285, ""end_span"": 299, ""type"": ""Gene/Protein""}]"	train
In resting T lymphocytes, the transcription factor NF - kappaB is sequestered in the cytoplasm via interactions with members of the I kappa B family of inhibitors, including IkappaBalpha and IkappaBbeta.	transcription factor,30,50,Gene/Protein	NF - kappaB,51,62,Gene/Protein	I kappa B family,132,148,Gene/Protein	IkappaBalpha,174,186,Gene/Protein	IkappaBbeta,191,202,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 30, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B family"", ""start_span"": 132, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 174, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBbeta"", ""start_span"": 191, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
Nevertheless, in the two leukemia cell lines transient overexpression of p16 reestablished the normal regulation of thymidine kinase, paralleled by an increase of the underphosphorylated form of retinoblastoma protein and decrease of free E2F bound to its motif in the thymidine kinase promoter.	p16,73,76,Gene/Protein	thymidine kinase,116,132,Gene/Protein	retinoblastoma protein,195,217,Gene/Protein	E2F,239,242,Gene/Protein	thymidine kinase promoter,269,294,Gene/Protein	"[{""token"": ""p16"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""thymidine kinase"", ""start_span"": 116, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""retinoblastoma protein"", ""start_span"": 195, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 239, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""thymidine kinase promoter"", ""start_span"": 269, ""end_span"": 294, ""type"": ""Gene/Protein""}]"	train
DNase I footprinting indicated that nuclear factors from activated T lymphocytes bound a promoter - proximal site, META ( P), and a promoter - distal site, META ( D +), within the 400 - base pair META region.	DNase I,0,7,Gene/Protein	nuclear factors,36,51,Gene/Protein	promoter - proximal site,89,113,Gene/Protein	promoter - distal site,132,154,Gene/Protein	400 - base pair META region,180,207,Gene/Protein	"[{""token"": ""DNase I"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factors"", ""start_span"": 36, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""promoter - proximal site"", ""start_span"": 89, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""promoter - distal site"", ""start_span"": 132, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""400 - base pair META region"", ""start_span"": 180, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
ICSAT is structurally most closely related to the previously cloned ICSBP, a member of the IFN regulatory factor ( IRF) family of proteins that binds to interferon consensus sequences ( ICSs) found in many promoters of the IFN - regulated genes.	ICSAT,0,5,Gene/Protein	ICSBP,68,73,Gene/Protein	interferon consensus sequences,153,183,Gene/Protein	ICSs,186,190,Gene/Protein	IFN - regulated genes,223,244,Gene/Protein	"[{""token"": ""ICSAT"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""ICSBP"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""interferon consensus sequences"", ""start_span"": 153, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""ICSs"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""IFN - regulated genes"", ""start_span"": 223, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
The class II transactivator ( CIITA) and B cell octamer - binding protein 1 / octamer - binding factor 1 / Oct coactivator from B cells ( Bob1 / OBF - 1 / OCA - B) represent two B cell - specific transcriptional coactivators.	class II transactivator,4,27,Gene/Protein	CIITA,30,35,Gene/Protein	B cell octamer - binding protein 1 / octamer - binding factor 1 / Oct coactivator,41,122,Gene/Protein	Bob1 / OBF - 1 / OCA - B,138,162,Gene/Protein	B cell - specific transcriptional coactivators,178,224,Gene/Protein	"[{""token"": ""class II transactivator"", ""start_span"": 4, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""B cell octamer - binding protein 1 / octamer - binding factor 1 / Oct coactivator"", ""start_span"": 41, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Bob1 / OBF - 1 / OCA - B"", ""start_span"": 138, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""B cell - specific transcriptional coactivators"", ""start_span"": 178, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
Here we show that HHV - 6 upregulates Zebra gene transcription through a cyclic AMP - responsive element ( CRE) located within the Zebra promoter ( Zp).	Zebra gene,38,48,Gene/Protein	cyclic AMP - responsive element,73,104,Gene/Protein	CRE,107,110,Gene/Protein	Zebra promoter,131,145,Gene/Protein	Zp,148,150,Gene/Protein	"[{""token"": ""Zebra gene"", ""start_span"": 38, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""cyclic AMP - responsive element"", ""start_span"": 73, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""CRE"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""Zebra promoter"", ""start_span"": 131, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""Zp"", ""start_span"": 148, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
The expression of cell surface markers including the interleukin 2 receptor alpha ( IL - 2R alpha) chain ( CD25), CD69 and L - selectin ( CD62) is normal in mitogen - activated Rel - / - T cells, but cytokine production is impaired.	CD25,107,111,Gene/Protein	CD69,114,118,Gene/Protein	L - selectin,123,135,Gene/Protein	CD62,138,142,Gene/Protein	cytokine,200,208,Gene/Protein	"[{""token"": ""CD25"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""CD69"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""L - selectin"", ""start_span"": 123, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""CD62"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 200, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	train
We analyzed expression of AP - 1, NF - kappa B, NF - AT, and octamer binding transcription factors, which are known to be involved in the regulation of IL - 2 gene promoter activity.	AP - 1,26,32,Gene/Protein	NF - kappa B,34,46,Gene/Protein	NF - AT,48,55,Gene/Protein	octamer binding transcription factors,61,98,Gene/Protein	IL - 2,152,158,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 34, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""octamer binding transcription factors"", ""start_span"": 61, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 152, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
In contrast, anergic CD4 + T cells contained severely reduced levels of AP - 1 and Fos / Jun - containing NF - AT complexes but expressed significant amounts of NF - kappa B and Oct binding proteins after SEA stimulation.	AP - 1,72,78,Gene/Protein	Fos / Jun - containing NF - AT complexes,83,123,Gene/Protein	NF - kappa B,161,173,Gene/Protein	Oct binding proteins,178,198,Gene/Protein	SEA,205,208,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 72, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""Fos / Jun - containing NF - AT complexes"", ""start_span"": 83, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 161, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""Oct binding proteins"", ""start_span"": 178, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""SEA"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	train
It has been shown that TCR stimulation requires both the membrane tyrosine phosphatase, CD45, and the Src - family kinase, Lck, to result in cellular activation.	TCR,23,26,Gene/Protein	membrane tyrosine phosphatase,57,86,Gene/Protein	CD45,88,92,Gene/Protein	Src - family kinase,102,121,Gene/Protein	Lck,123,126,Gene/Protein	"[{""token"": ""TCR"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""membrane tyrosine phosphatase"", ""start_span"": 57, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""CD45"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""Src - family kinase"", ""start_span"": 102, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Lck"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	train
Our data suggest that although CD45 and Lck are not required for Fas signaling, JNK activation may play an important role transducing distal signals that lead to apoptosis after Fas ligation.	CD45,31,35,Gene/Protein	Lck,40,43,Gene/Protein	Fas,65,68,Gene/Protein	JNK,80,83,Gene/Protein	Fas,178,181,Gene/Protein	"[{""token"": ""CD45"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""Lck"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""Fas"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""Fas"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
Analysis of various Tax mutants suggested that galectin - 3 promoter induction is dependent on activation of the cyclic - AMP - responsive element binding protein / activation transcription factor family of transcription factors and, to a lesser extent, nuclear factor - kappa B / Rel induction.	Tax mutants,20,31,Gene/Protein	galectin - 3 promoter,47,68,Gene/Protein	cyclic - AMP - responsive element binding protein / activation transcription factor family,113,203,Gene/Protein	transcription factors,207,228,Gene/Protein	nuclear factor - kappa B / Rel,254,284,Gene/Protein	"[{""token"": ""Tax mutants"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""galectin - 3 promoter"", ""start_span"": 47, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""cyclic - AMP - responsive element binding protein / activation transcription factor family"", ""start_span"": 113, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 207, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappa B / Rel"", ""start_span"": 254, ""end_span"": 284, ""type"": ""Gene/Protein""}]"	train
Polyubiquitinylated c - Jun, wbFos, and wbJun, but not E220K - ubiquitinylated c - Jun, were readily degraded by the ATP - dependent 26 S multicatalytic proteases.	c - Jun,20,27,Gene/Protein	wbFos,29,34,Gene/Protein	wbJun,40,45,Gene/Protein	E220K - ubiquitinylated c - Jun,55,86,Gene/Protein	ATP - dependent 26 S multicatalytic proteases,117,162,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""wbFos"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""wbJun"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""E220K - ubiquitinylated c - Jun"", ""start_span"": 55, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""ATP - dependent 26 S multicatalytic proteases"", ""start_span"": 117, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
These results suggest that the temporal control of c - Jun and c - Fos may be regulated through the ubiquitinylation pathways, and the ubiquitinylation of c - Jun and c - Fos may in turn be regulated in response to the heterodimerization between them and the cooperation between E220K and E3 mediated polyubiquitinylation.	c - Jun,51,58,Gene/Protein	c - Fos,63,70,Gene/Protein	c - Jun,155,162,Gene/Protein	c - Fos,167,174,Gene/Protein	E220K,279,284,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 167, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""E220K"", ""start_span"": 279, ""end_span"": 284, ""type"": ""Gene/Protein""}]"	train
Signal transducers and activators of transcription ( STATs) are rapidly phosphorylated on tyrosine residues in response to cytokine and growth factor stimulation of cell surface receptors.	Signal transducers and activators of transcription,0,50,Gene/Protein	STATs,53,58,Gene/Protein	cytokine,123,131,Gene/Protein	growth factor,136,149,Gene/Protein	cell surface receptors,165,187,Gene/Protein	"[{""token"": ""Signal transducers and activators of transcription"", ""start_span"": 0, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""STATs"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""growth factor"", ""start_span"": 136, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""cell surface receptors"", ""start_span"": 165, ""end_span"": 187, ""type"": ""Gene/Protein""}]"	train
Tyrosine kinase - dependent, and not protein kinase C - dependent, pathways mediate CD23 - triggered NF - kappaB activation but do not participate in the direct phosphorylation of IkappaBalpha.	Tyrosine kinase,0,15,Gene/Protein	protein kinase C,37,53,Gene/Protein	CD23,84,88,Gene/Protein	NF - kappaB,101,112,Gene/Protein	IkappaBalpha,180,192,Gene/Protein	"[{""token"": ""Tyrosine kinase"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 37, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 180, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
Phosphorylated Bcl - 2 can not bind calcineurin, and NFAT activation, FasL expression, and apoptosis can occur after Bcl - 2 phosphorylation.	Bcl - 2,15,22,Gene/Protein	calcineurin,36,47,Gene/Protein	NFAT,53,57,Gene/Protein	FasL,70,74,Gene/Protein	Bcl - 2,117,124,Gene/Protein	"[{""token"": ""Bcl - 2"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 36, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""FasL"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Gene/Protein""}]"	train
These in vivo anti - inflammatory effects of IL - 11 were associated with reduced NF - kappaB activation in lung, reduced levels of tumor necrosis factor alpha ( TNF - alpha) in bronchoalveolar lavage ( BAL) fluids, and diminished up - regulation of lung vascular ICAM - 1.	IL - 11,45,52,Gene/Protein	NF - kappaB,82,93,Gene/Protein	tumor necrosis factor alpha,132,159,Gene/Protein	TNF - alpha,162,173,Gene/Protein	lung vascular ICAM - 1,250,272,Gene/Protein	"[{""token"": ""IL - 11"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 132, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 162, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""lung vascular ICAM - 1"", ""start_span"": 250, ""end_span"": 272, ""type"": ""Gene/Protein""}]"	train
These data indicate that IL - 11 is a regulatory cytokine in the lung and that, like other members of this family, its anti - inflammatory properties appear to be linked to its suppression of NF - kappaB activation, diminished production of TNF - alpha, and reduced up - regulation of lung vascular ICAM - 1.	IL - 11,25,32,Gene/Protein	regulatory cytokine,38,57,Gene/Protein	NF - kappaB,192,203,Gene/Protein	TNF - alpha,241,252,Gene/Protein	lung vascular ICAM - 1,285,307,Gene/Protein	"[{""token"": ""IL - 11"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""regulatory cytokine"", ""start_span"": 38, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 192, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 241, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""lung vascular ICAM - 1"", ""start_span"": 285, ""end_span"": 307, ""type"": ""Gene/Protein""}]"	train
The Jak family of tyrosine kinases are known to mediate some of the effects of cytokines or hematopoietic growth factors by recruitment and tyrosine phosphorylation of a variety of Stat ( signal transducers and activators of transcription) proteins.	tyrosine kinases,18,34,Gene/Protein	cytokines,79,88,Gene/Protein	hematopoietic growth factors,92,120,Gene/Protein	Stat,181,185,Gene/Protein	signal transducers and activators of transcription,188,238,Gene/Protein	"[{""token"": ""tyrosine kinases"", ""start_span"": 18, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""hematopoietic growth factors"", ""start_span"": 92, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""Stat"", ""start_span"": 181, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers and activators of transcription"", ""start_span"": 188, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	train
Cytotoxicity markers assessed include tumor cell killing, IL - 1 secretion, reactive oxygen intermediate release, nitric oxide synthetase activity as measured by the release of reactive nitrogen intermediates, complement receptor - 1 cell surface protein, and TNF - alpha protein presence.	Cytotoxicity markers,0,20,Gene/Protein	IL - 1,58,64,Gene/Protein	nitric oxide synthetase,114,137,Gene/Protein	complement receptor - 1 cell surface protein,210,254,Gene/Protein	TNF - alpha protein,260,279,Gene/Protein	"[{""token"": ""Cytotoxicity markers"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""nitric oxide synthetase"", ""start_span"": 114, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""complement receptor - 1 cell surface protein"", ""start_span"": 210, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha protein"", ""start_span"": 260, ""end_span"": 279, ""type"": ""Gene/Protein""}]"	train
These findings demonstrate that IFNs inhibit IL - 4 - induced activation of STAT6 and STAT6 - dependent gene expression, at least in part, by inducing expression of SOCS - 1.	IFNs,32,36,Gene/Protein	IL - 4,45,51,Gene/Protein	STAT6,76,81,Gene/Protein	STAT6,86,91,Gene/Protein	SOCS - 1,165,173,Gene/Protein	"[{""token"": ""IFNs"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""SOCS - 1"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Body weight, body mass index, body fat, lean body mass, blood - glucose, cholesterol, HDL - cholesterol, triglyceride, beta - lipoproteins, insulin, gonadotropin, estradiol, testosterone, SHBG, T3, T4 and TSH levels as well as estradiol and progesterone receptor levels in excised tumor were studied in 40 patients with breast cancer prior to conservative treatment.	HDL - cholesterol,86,103,Gene/Protein	beta - lipoproteins,119,138,Gene/Protein	SHBG,188,192,Gene/Protein	T3,194,196,Gene/Protein	T4,198,200,Gene/Protein	"[{""token"": ""HDL - cholesterol"", ""start_span"": 86, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""beta - lipoproteins"", ""start_span"": 119, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""SHBG"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""T3"", ""start_span"": 194, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""T4"", ""start_span"": 198, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
Taken together, these results suggest that IL - 10 - activated STAT1 has a specificity in binding to the GAS - motif sequences, whereas IFN - gamma - activated STAT1 and STAT5 have a broader spectrum in binding to the GAS - motif sequences.	IL - 10 - activated STAT1,43,68,Gene/Protein	GAS - motif sequences,105,126,Gene/Protein	IFN - gamma - activated STAT1,136,165,Gene/Protein	STAT5,170,175,Gene/Protein	GAS - motif sequences,218,239,Gene/Protein	"[{""token"": ""IL - 10 - activated STAT1"", ""start_span"": 43, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""GAS - motif sequences"", ""start_span"": 105, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma - activated STAT1"", ""start_span"": 136, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""GAS - motif sequences"", ""start_span"": 218, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Transcription factor NF kappa B ( nuclear factor kappa B) is induced in T lymphocytes from young individuals following activation with a variety of stimuli including anti - CD3, phorbol myristate acetate ( PMA), and tumor necrosis factor - alpha ( TNF - alpha).	NF kappa B,21,31,Gene/Protein	nuclear factor kappa B,34,56,Gene/Protein	anti - CD3,166,176,Gene/Protein	tumor necrosis factor - alpha,216,245,Gene/Protein	TNF - alpha,248,259,Gene/Protein	"[{""token"": ""NF kappa B"", ""start_span"": 21, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappa B"", ""start_span"": 34, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 166, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 216, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 248, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	train
Promoter assays revealed CD28 - dependent effects on both NF - kappaB and AP - 1, but not on NF - AT or the intact IL - 2 promoter.	CD28,25,29,Gene/Protein	NF - kappaB,58,69,Gene/Protein	AP - 1,74,80,Gene/Protein	NF - AT,93,100,Gene/Protein	IL - 2 promoter,115,130,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 58, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Gene/Protein""}]"	train
Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL - 2 and the IL - 2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL - 2.	Abs,73,76,Gene/Protein	IL - 2,85,91,Gene/Protein	IL - 2 receptor,100,115,Gene/Protein	CD28,166,170,Gene/Protein	IL - 2,190,196,Gene/Protein	"[{""token"": ""Abs"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor"", ""start_span"": 100, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 190, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
We have recently shown that the expression of Tax protected the mouse T - cell line CTLL - 2 against apoptosis induced by interleukin - 2 ( IL - 2) deprivation and converted its growth from being IL - 2 dependent to being IL - 2 independent.	Tax,46,49,Gene/Protein	interleukin - 2,122,137,Gene/Protein	IL - 2,140,146,Gene/Protein	IL - 2,196,202,Gene/Protein	IL - 2,222,228,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 122, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 196, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 222, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	train
Compared with IL - 2, CD3 ligation induces a delayed Stat3 binding to oligonucleotide probes from the ICAM - 1 and IL - 2R alpha promoter.	IL - 2,14,20,Gene/Protein	CD3,22,25,Gene/Protein	Stat3,53,58,Gene/Protein	ICAM - 1,102,110,Gene/Protein	IL - 2R alpha promoter,115,137,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha promoter"", ""start_span"": 115, ""end_span"": 137, ""type"": ""Gene/Protein""}]"	train
Consistent with these data, CD40 signals up - regulate c - jun but not c - fos mRNA and alter the transcription factor ATF2 but not the Raf - 1 protein.	CD40,28,32,Gene/Protein	c - jun but not c - fos mRNA,55,83,Gene/Protein	transcription factor,98,118,Gene/Protein	ATF2,119,123,Gene/Protein	Raf - 1 protein,136,151,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""c - jun but not c - fos mRNA"", ""start_span"": 55, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 98, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""ATF2"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""Raf - 1 protein"", ""start_span"": 136, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	train
TNF is the major inducer of NF - kappaB and particularly of the p50 - p65 complex, whereas IL - 7 acts as a cofactor by sustaining the expression of the p75 TNF receptor.	TNF,0,3,Gene/Protein	NF - kappaB,28,39,Gene/Protein	p50 - p65 complex,64,81,Gene/Protein	IL - 7,91,97,Gene/Protein	p75 TNF receptor,153,169,Gene/Protein	"[{""token"": ""TNF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""p50 - p65 complex"", ""start_span"": 64, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""p75 TNF receptor"", ""start_span"": 153, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
In addition to Bcl - x, a known CD40 - regulated antiapoptotic molecule, we identified a related antiapoptotic molecule, A1 / Bfl - 1, as a CD40 - inducible gene.	Bcl - x,15,22,Gene/Protein	CD40 - regulated antiapoptotic molecule,32,71,Gene/Protein	antiapoptotic molecule,97,119,Gene/Protein	A1 / Bfl - 1,121,133,Gene/Protein	CD40 - inducible gene,140,161,Gene/Protein	"[{""token"": ""Bcl - x"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CD40 - regulated antiapoptotic molecule"", ""start_span"": 32, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""antiapoptotic molecule"", ""start_span"": 97, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""A1 / Bfl - 1"", ""start_span"": 121, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""CD40 - inducible gene"", ""start_span"": 140, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
These findings indicate that MBP is selective among the eosinophil granule proteins as a stimulus for neutrophil IL - 8 release and, further, that stimulation of neutrophil IL - 8 release by MBP involves both transcriptional and posttranscriptional regulation.	MBP,29,32,Gene/Protein	eosinophil granule proteins,56,83,Gene/Protein	IL - 8,113,119,Gene/Protein	IL - 8,173,179,Gene/Protein	MBP,191,194,Gene/Protein	"[{""token"": ""MBP"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""eosinophil granule proteins"", ""start_span"": 56, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
The flow of information from calcium - mobilizing receptors to nuclear factor of activated T cells ( NFAT) - dependent genes is critically dependent on interaction between the phosphatase calcineurin and the transcription factor NFAT.	calcium - mobilizing receptors,29,59,Gene/Protein	phosphatase,176,187,Gene/Protein	calcineurin,188,199,Gene/Protein	transcription factor,208,228,Gene/Protein	NFAT,229,233,Gene/Protein	"[{""token"": ""calcium - mobilizing receptors"", ""start_span"": 29, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""phosphatase"", ""start_span"": 176, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 188, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 208, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 229, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
In the current study, we show 9 - cis retinoic acid ( RA), a ligand for the nuclear hormone receptor retinoid X receptor ( RXR) and retinoic acid receptor ( RAR), markedly induces the expression of MCP - 1.	nuclear hormone receptor retinoid X receptor,76,120,Gene/Protein	RXR,123,126,Gene/Protein	retinoic acid receptor,132,154,Gene/Protein	RAR,157,160,Gene/Protein	MCP - 1,198,205,Gene/Protein	"[{""token"": ""nuclear hormone receptor retinoid X receptor"", ""start_span"": 76, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""RXR"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""retinoic acid receptor"", ""start_span"": 132, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""RAR"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
Reporter gene experiments finally showed that transcription from promoters of STAT5 target genes can be specifically induced by challenging cells with IL - 4, and that both STAT5a and STAT5b can contribute to IL - 4 - triggered transcriptional control.	STAT5,78,83,Gene/Protein	IL - 4,151,157,Gene/Protein	STAT5a,173,179,Gene/Protein	STAT5b,184,190,Gene/Protein	IL - 4,209,215,Gene/Protein	"[{""token"": ""STAT5"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""STAT5a"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""STAT5b"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 209, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
Adenoviruses encode proteins that block responses to interferons, intrinsic cellular apoptosis, killing by CD8 ( +) cytotoxic T lymphocytes and killing by the death ligands TNF, Fas ligand and TRAIL.	interferons,53,64,Gene/Protein	death ligands,159,172,Gene/Protein	TNF,173,176,Gene/Protein	Fas ligand,178,188,Gene/Protein	TRAIL,193,198,Gene/Protein	"[{""token"": ""interferons"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""death ligands"", ""start_span"": 159, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""Fas ligand"", ""start_span"": 178, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""TRAIL"", ""start_span"": 193, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
Our results provide the first evidence that both GATA - 1 and C / EBPbeta synergistically transactivate the promoter of an eosinophil - specific granule protein gene and that FOG may act as a negative cofactor for the eosinophil lineage, unlike its positively regulatory function for the erythroid and megakaryocyte lineages.	GATA - 1,49,57,Gene/Protein	C / EBPbeta,62,73,Gene/Protein	promoter,108,116,Gene/Protein	eosinophil - specific granule protein gene,123,165,Gene/Protein	FOG,175,178,Gene/Protein	"[{""token"": ""GATA - 1"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""C / EBPbeta"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""eosinophil - specific granule protein gene"", ""start_span"": 123, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""FOG"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
These analyses demonstrated that the [ 3H] aldosterone - MBP - HBD complex is at least associated with hsp90 in reticulocyte lysate and that the HBD of hMR is sufficient to bind hsp90.	MBP - HBD complex,57,74,Gene/Protein	hsp90,103,108,Gene/Protein	HBD,145,148,Gene/Protein	hMR,152,155,Gene/Protein	hsp90,178,183,Gene/Protein	"[{""token"": ""MBP - HBD complex"", ""start_span"": 57, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""hsp90"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""HBD"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""hMR"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""hsp90"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
By using Jurkat and primary human T lymphocytes, we demonstrate that the simultaneous activation of two second messengers of the TCR - initiated signal transduction, protein kinase C ( PKC) and calcineurin, results in the synergistic activation of the IkappaBalpha kinase ( IKK) complex but not of another putative IkappaBalpha kinase, p90 ( rsk).	TCR,129,132,Gene/Protein	protein kinase C,166,182,Gene/Protein	PKC,185,188,Gene/Protein	calcineurin,194,205,Gene/Protein	putative IkappaBalpha kinase,306,334,Gene/Protein	"[{""token"": ""TCR"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 166, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 194, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""putative IkappaBalpha kinase"", ""start_span"": 306, ""end_span"": 334, ""type"": ""Gene/Protein""}]"	train
mRNA levels for IL - 13R alpha1, but not IL - 4R alpha, were markedly decreased in in vitro monocyte - derived macrophages ( MDMac), and with increasing time of monocytes in culture correlated with the loss of IL - 13 regulation of lipopolysaccharide - induced TNF - alpha production.	mRNA,0,4,Gene/Protein	IL - 13R alpha1,16,31,Gene/Protein	IL - 4R alpha,41,54,Gene/Protein	IL - 13,210,217,Gene/Protein	TNF - alpha,261,272,Gene/Protein	"[{""token"": ""mRNA"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13R alpha1"", ""start_span"": 16, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R alpha"", ""start_span"": 41, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 210, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 261, ""end_span"": 272, ""type"": ""Gene/Protein""}]"	train
IL - 13 activation of STAT6 was reduced in MDMac which was associated with diminished IL - 13 - induced expression of CD23 and MHC class II.	IL - 13,0,7,Gene/Protein	STAT6,22,27,Gene/Protein	IL - 13,86,93,Gene/Protein	CD23,118,122,Gene/Protein	MHC class II,127,139,Gene/Protein	"[{""token"": ""IL - 13"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""MHC class II"", ""start_span"": 127, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
In addition, it has been established that tumor necrosis factor - alpha ( TNF - alpha) can activate the expression of wild type p53 in concert with the nuclear transcription factor, NF - kappa B.	tumor necrosis factor - alpha,42,71,Gene/Protein	TNF - alpha,74,85,Gene/Protein	wild type p53,118,131,Gene/Protein	nuclear transcription factor,152,180,Gene/Protein	NF - kappa B,182,194,Gene/Protein	"[{""token"": ""tumor necrosis factor - alpha"", ""start_span"": 42, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""wild type p53"", ""start_span"": 118, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""nuclear transcription factor"", ""start_span"": 152, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 182, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
To understand the function of AML1 during B cell differentiation, we analyzed regulatory regions of B cell - specific genes for potential AML1 - binding sites and have identified a putative AML1 - binding site in the promoter of the B cell - specific tyrosine kinase gene, blk.	AML1,30,34,Gene/Protein	regulatory regions,78,96,Gene/Protein	B cell - specific genes,100,123,Gene/Protein	AML1 - binding sites,138,158,Gene/Protein	AML1 - binding site,190,209,Gene/Protein	"[{""token"": ""AML1"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""regulatory regions"", ""start_span"": 78, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""B cell - specific genes"", ""start_span"": 100, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""AML1 - binding sites"", ""start_span"": 138, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""AML1 - binding site"", ""start_span"": 190, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
Physical interaction of AML1 with BSAP correlates with functional cooperativity in transfection studies where AML1 and BSAP synergistically activate blk promoter transcription by more than 50 - fold.	AML1,24,28,Gene/Protein	BSAP,34,38,Gene/Protein	AML1,110,114,Gene/Protein	BSAP,119,123,Gene/Protein	blk,149,152,Gene/Protein	"[{""token"": ""AML1"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""AML1"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""blk"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
These results demonstrate physical and functional interactions between AML1 and BSAP and suggest that AML1 is an important factor for regulating a critical B cell - specific gene, blk.	AML1,71,75,Gene/Protein	BSAP,80,84,Gene/Protein	AML1,102,106,Gene/Protein	B cell - specific gene,156,178,Gene/Protein	blk,180,183,Gene/Protein	"[{""token"": ""AML1"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""AML1"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""B cell - specific gene"", ""start_span"": 156, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""blk"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
Tumor cell lines with a defective retinoblastoma gene are unable to transcribe the HLA class II genes in response to IFN - gamma treatment, and reconstitution of functional Rb rescues IFN - gamma - induced class II gene expression.	retinoblastoma gene,34,53,Gene/Protein	HLA class II genes,83,101,Gene/Protein	IFN - gamma,117,128,Gene/Protein	Rb,173,175,Gene/Protein	class II gene,206,219,Gene/Protein	"[{""token"": ""retinoblastoma gene"", ""start_span"": 34, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""HLA class II genes"", ""start_span"": 83, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 117, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 173, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""class II gene"", ""start_span"": 206, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
In addition, BLPs stimulated nuclear factor - kappaB, a transcriptional activator of multiple host defense genes, and activated the respiratory burst through hTLR2.	BLPs,13,17,Gene/Protein	nuclear factor - kappaB,29,52,Gene/Protein	transcriptional activator,56,81,Gene/Protein	multiple host defense genes,85,112,Gene/Protein	hTLR2,158,163,Gene/Protein	"[{""token"": ""BLPs"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappaB"", ""start_span"": 29, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activator"", ""start_span"": 56, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""multiple host defense genes"", ""start_span"": 85, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""hTLR2"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
We show that TLR2 associates with the high - affinity LPS binding protein membrane CD14 to serve as an LPS receptor complex, and that LPS treatment enhances the oligomerization of TLR2.	TLR2,13,17,Gene/Protein	high - affinity LPS binding protein,38,73,Gene/Protein	CD14,83,87,Gene/Protein	LPS receptor complex,103,123,Gene/Protein	TLR2,180,184,Gene/Protein	"[{""token"": ""TLR2"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""high - affinity LPS binding protein"", ""start_span"": 38, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""LPS receptor complex"", ""start_span"": 103, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""TLR2"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
Furthermore, IL - 2 and IL - 12 synergistically induced IRF - 1, whereas IFN - alpha and IL - 12 did not.	IL - 2,13,19,Gene/Protein	IL - 12,24,31,Gene/Protein	IRF - 1,56,63,Gene/Protein	IFN - alpha,73,84,Gene/Protein	IL - 12,89,96,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 73, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Gene/Protein""}]"	train
First, STAT4 was required for the IL - 12 - dependent transactivation of an IRF - 1 reporter construct, and second, STAT4 binding to the IRF - 1 promoter was shown using EMSA.	STAT4,7,12,Gene/Protein	IL - 12,34,41,Gene/Protein	IRF - 1 reporter construct,76,102,Gene/Protein	STAT4,116,121,Gene/Protein	IRF - 1 promoter,137,153,Gene/Protein	"[{""token"": ""STAT4"", ""start_span"": 7, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1 reporter construct"", ""start_span"": 76, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""STAT4"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1 promoter"", ""start_span"": 137, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
In contrast to IL - 12, no up - regulation of IRF - 1 was found in IL - 4 - stimulated cells, and IL - 4 did not block IL - 12 - dependent up - regulation of IRF - 1.	IL - 12,15,22,Gene/Protein	IRF - 1,46,53,Gene/Protein	IL - 4,67,73,Gene/Protein	IL - 12,119,126,Gene/Protein	IRF - 1,158,165,Gene/Protein	"[{""token"": ""IL - 12"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 158, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
The correlation between C5a - induced kappaB binding activity and IL - 8 gene expression was examined in the RAW264. 7 macrophage cells using reporter genes directed by the kappaB sequence from IkappaBalpha and IL - 8 promoter regions.	kappaB,38,44,Gene/Protein	IL - 8,66,72,Gene/Protein	kappaB sequence,173,188,Gene/Protein	IkappaBalpha,194,206,Gene/Protein	IL - 8 promoter regions,211,234,Gene/Protein	"[{""token"": ""kappaB"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""kappaB sequence"", ""start_span"": 173, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 194, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8 promoter regions"", ""start_span"": 211, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
We have constructed an HIV - 1 genome carrying the cDNA of a proteolysis - resistant nuclear factor - kappaB inhibitor ( IkappaB - alphaS32 / 36A) in the nef region.	HIV - 1 genome,23,37,Gene/Protein	cDNA,51,55,Gene/Protein	proteolysis - resistant nuclear factor - kappaB inhibitor,61,118,Gene/Protein	IkappaB - alphaS32 / 36A,121,145,Gene/Protein	nef region,154,164,Gene/Protein	"[{""token"": ""HIV - 1 genome"", ""start_span"": 23, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""cDNA"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""proteolysis - resistant nuclear factor - kappaB inhibitor"", ""start_span"": 61, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB - alphaS32 / 36A"", ""start_span"": 121, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""nef region"", ""start_span"": 154, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
We developed retroviral vectors in which the constitutive viral enhancer in the U3 region of the 3 ' LTR is replaced by an autoregulatory enhancer of the erythroid - specific GATA - 1 transcription factor gene.	constitutive viral enhancer,45,72,Gene/Protein	U3 region,80,89,Gene/Protein	3 ' LTR,97,104,Gene/Protein	autoregulatory enhancer,123,146,Gene/Protein	erythroid - specific GATA - 1 transcription factor gene,154,209,Gene/Protein	"[{""token"": ""constitutive viral enhancer"", ""start_span"": 45, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""U3 region"", ""start_span"": 80, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""3 ' LTR"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""autoregulatory enhancer"", ""start_span"": 123, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""erythroid - specific GATA - 1 transcription factor gene"", ""start_span"": 154, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
LMP1 needs only 11 amino acids to activate NF - kappaB or synergize with TRADD in NF - kappaB activation, while TNFR1 requires approximately 70 residues.	LMP1,0,4,Gene/Protein	NF - kappaB,43,54,Gene/Protein	TRADD,73,78,Gene/Protein	NF - kappaB,82,93,Gene/Protein	TNFR1,112,117,Gene/Protein	"[{""token"": ""LMP1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""TRADD"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""TNFR1"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
Further, LMP1 does not require TRADD residues 294 to 312 for NF - kappaB activation, while TNFR1 requires TRADD residues 296 to 302.	LMP1,9,13,Gene/Protein	TRADD,31,36,Gene/Protein	NF - kappaB,61,72,Gene/Protein	TNFR1,91,96,Gene/Protein	TRADD,106,111,Gene/Protein	"[{""token"": ""LMP1"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""TRADD"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""TNFR1"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""TRADD"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Gene/Protein""}]"	train
Unlike TNFR1, LMP1 can interact directly with receptor - interacting protein ( RIP) and stably associates with RIP in EBV - transformed lymphoblastoid cell lines.	TNFR1,7,12,Gene/Protein	LMP1,14,18,Gene/Protein	receptor - interacting protein,46,76,Gene/Protein	RIP,79,82,Gene/Protein	RIP,111,114,Gene/Protein	"[{""token"": ""TNFR1"", ""start_span"": 7, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""receptor - interacting protein"", ""start_span"": 46, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""RIP"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""RIP"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}]"	train
We identified this 92 - kDa protein as STAT5, but not as STATs1, 3, and 6 nor c - fes and vav protooncogene products, and demonstrated its translocation to the nucleus, enhancement of specific DNA binding capacity, and potentiation of trancriptional activity by GM - CSF.	92 - kDa protein,19,35,Gene/Protein	STAT5,39,44,Gene/Protein	c - fes,78,85,Gene/Protein	vav protooncogene products,90,116,Gene/Protein	GM - CSF,262,270,Gene/Protein	"[{""token"": ""92 - kDa protein"", ""start_span"": 19, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""c - fes"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""vav protooncogene products"", ""start_span"": 90, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 262, ""end_span"": 270, ""type"": ""Gene/Protein""}]"	train
Mutation of Aiolos - binding sites within the Bcl - 2 promoter inhibits transactivation of the reporter gene luciferase, suggesting direct control of Bcl - 2 expression by Aiolos.	Aiolos - binding sites,12,34,Gene/Protein	Bcl - 2 promoter,46,62,Gene/Protein	reporter gene luciferase,95,119,Gene/Protein	Bcl - 2,150,157,Gene/Protein	Aiolos,172,178,Gene/Protein	"[{""token"": ""Aiolos - binding sites"", ""start_span"": 12, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2 promoter"", ""start_span"": 46, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene luciferase"", ""start_span"": 95, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""Aiolos"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Our results suggest that the induction of STAT1 and STAT5 by Tax enhances cytokine - induced functions of virus - infected T - cells, hence the induction may play a role in IL - 2 - dependent transformation steps of T - cells by HTLV - 1.	STAT1,42,47,Gene/Protein	STAT5,52,57,Gene/Protein	Tax,61,64,Gene/Protein	cytokine,74,82,Gene/Protein	IL - 2,173,179,Gene/Protein	"[{""token"": ""STAT1"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
IL - 4R are thought to be composed of the IL - 4R alpha chain ( IL - 4R alpha) and either the IL - 2R gamma chain or the IL - 13R alpha chain.	IL - 4R,0,7,Gene/Protein	IL - 4R alpha chain,42,61,Gene/Protein	IL - 4R alpha,64,77,Gene/Protein	IL - 2R gamma chain,94,113,Gene/Protein	IL - 13R alpha chain,121,141,Gene/Protein	"[{""token"": ""IL - 4R"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R alpha chain"", ""start_span"": 42, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R alpha"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R gamma chain"", ""start_span"": 94, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13R alpha chain"", ""start_span"": 121, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	train
We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP - 1, and DRIP205, a subunit of the DRIP coactivator complex.	VDR,52,55,Gene/Protein	RXR,78,81,Gene/Protein	GRIP - 1,83,91,Gene/Protein	DRIP205,97,104,Gene/Protein	DRIP coactivator complex,123,147,Gene/Protein	"[{""token"": ""VDR"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""RXR"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""GRIP - 1"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""DRIP205"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""DRIP coactivator complex"", ""start_span"": 123, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	train
Compared with the interaction of VDR with RXR or GRIP - 1, the differentiation dose - response most closely correlated to the ligand - dependent recruitment of the DRIP coactivator complex to VDR and to the ability of the receptor to activate transcription in a cell - free system.	VDR,33,36,Gene/Protein	RXR,42,45,Gene/Protein	GRIP - 1,49,57,Gene/Protein	DRIP coactivator complex,164,188,Gene/Protein	VDR,192,195,Gene/Protein	"[{""token"": ""VDR"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""RXR"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""GRIP - 1"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""DRIP coactivator complex"", ""start_span"": 164, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""VDR"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Following T cell antigen receptor stimulation, SLP - 76 and Vav both undergo tyrosine phosphorylation and associate with each other via the SH2 domain of Vav and phosphorylated tyrosines of SLP - 76.	T cell antigen receptor,10,33,Gene/Protein	SLP - 76,47,55,Gene/Protein	Vav,60,63,Gene/Protein	Vav,154,157,Gene/Protein	SLP - 76,190,198,Gene/Protein	"[{""token"": ""T cell antigen receptor"", ""start_span"": 10, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""SLP - 76"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""Vav"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Vav"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""SLP - 76"", ""start_span"": 190, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
Consequently, inhibition of NF - kappaB nuclear translocation and the expression of dominant negative mutant forms of components of the NF - kappaB activation pathway, such as IkappaBalpha or p65, prompt rapid apoptosis of T. parva - transformed T cells.	NF - kappaB,28,39,Gene/Protein	dominant negative mutant,84,108,Gene/Protein	NF - kappaB,136,147,Gene/Protein	IkappaBalpha,176,188,Gene/Protein	p65,192,195,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""dominant negative mutant"", ""start_span"": 84, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 176, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Based on these and our recent findings of associations between Ikaros and Mi - 2 - HDAC, we propose that Ikaros family members modulate gene expression during lymphocyte development by recruiting distinct histone deacetylase complexes to specific promoters.	Ikaros,63,69,Gene/Protein	Mi - 2 - HDAC,74,87,Gene/Protein	Ikaros family members,105,126,Gene/Protein	histone deacetylase complexes,205,234,Gene/Protein	specific promoters,238,256,Gene/Protein	"[{""token"": ""Ikaros"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Mi - 2 - HDAC"", ""start_span"": 74, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""Ikaros family members"", ""start_span"": 105, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""histone deacetylase complexes"", ""start_span"": 205, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""specific promoters"", ""start_span"": 238, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
PI3 - kinase activity was an upstream activator of PKB / Akt because the PI3 - kinase inhibitor LY294002 blocked both constitutive PKB / Akt and factor - dependent PKB / Akt activity.	PI3 - kinase,0,12,Gene/Protein	PKB / Akt,51,60,Gene/Protein	PI3 - kinase,73,85,Gene/Protein	PKB / Akt,131,140,Gene/Protein	PKB / Akt,164,173,Gene/Protein	"[{""token"": ""PI3 - kinase"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""PKB / Akt"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""PI3 - kinase"", ""start_span"": 73, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""PKB / Akt"", ""start_span"": 131, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""PKB / Akt"", ""start_span"": 164, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Constitutive STAT5 activity, activated through an unknown pathway not including JAK2 or EPOR, may act in concert with the constitutive PI3 - kinase / PKB / Akt pathway to protect the EPO - independent HCD57 - SREI cells from apoptosis and promote limited proliferation.	STAT5,13,18,Gene/Protein	JAK2,80,84,Gene/Protein	EPOR,88,92,Gene/Protein	PI3 - kinase,135,147,Gene/Protein	/ PKB / Akt,148,159,Gene/Protein	"[{""token"": ""STAT5"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""EPOR"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""PI3 - kinase"", ""start_span"": 135, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""/ PKB / Akt"", ""start_span"": 148, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
Likewise, NF - AT1 mRNA and NF - AT4 mRNA have been detected in resting eosinophils, and their levels can be significantly up - regulated by the Th2 - associated cytokines IL - 4 and IL - 5.	NF - AT1 mRNA,10,23,Gene/Protein	NF - AT4 mRNA,28,41,Gene/Protein	Th2 - associated cytokines,145,171,Gene/Protein	IL - 4,172,178,Gene/Protein	IL - 5,183,189,Gene/Protein	"[{""token"": ""NF - AT1 mRNA"", ""start_span"": 10, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT4 mRNA"", ""start_span"": 28, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""Th2 - associated cytokines"", ""start_span"": 145, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 183, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
We show here that the transcriptional co - activators CBP / p300 bind to and control the activity of the inducible N - terminal transactivation domain of NF - ATc, TAD - A.	transcriptional co - activators,22,53,Gene/Protein	CBP / p300,54,64,Gene/Protein	inducible N - terminal transactivation domain,105,150,Gene/Protein	NF - ATc,154,162,Gene/Protein	TAD - A,164,171,Gene/Protein	"[{""token"": ""transcriptional co - activators"", ""start_span"": 22, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""CBP / p300"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""inducible N - terminal transactivation domain"", ""start_span"": 105, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATc"", ""start_span"": 154, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""TAD - A"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
Constitutive active versions of c - Raf and Rac synergistically enhance the CBP / p300 - mediated increase of TAD - A activity, indicating the important role CBP / p300 plays in the integration of T cell activation signals.	c - Raf,32,39,Gene/Protein	Rac,44,47,Gene/Protein	CBP / p300,76,86,Gene/Protein	TAD - A,110,117,Gene/Protein	CBP / p300,158,168,Gene/Protein	"[{""token"": ""c - Raf"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""Rac"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""CBP / p300"", ""start_span"": 76, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""TAD - A"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""CBP / p300"", ""start_span"": 158, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
We demonstrate here that a third region encompassing a proline rich sequence within the 33 bp repetitive stretch of LMP1 ' s C - terminus is required for the activation of Janus kinase 3 ( JAK3).	proline rich sequence,55,76,Gene/Protein	LMP1,116,120,Gene/Protein	C - terminus,125,137,Gene/Protein	Janus kinase 3,172,186,Gene/Protein	JAK3,189,193,Gene/Protein	"[{""token"": ""proline rich sequence"", ""start_span"": 55, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""C - terminus"", ""start_span"": 125, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase 3"", ""start_span"": 172, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
These results reveal a novel activating region in the LMP1 C - terminus and identify the JAK / STAT pathway as a target of this viral integral membrane protein in B cells.	LMP1,54,58,Gene/Protein	C - terminus,59,71,Gene/Protein	JAK,89,92,Gene/Protein	/ STAT,93,99,Gene/Protein	viral integral membrane protein,128,159,Gene/Protein	"[{""token"": ""LMP1"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""C - terminus"", ""start_span"": 59, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""/ STAT"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""viral integral membrane protein"", ""start_span"": 128, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
Composite elements are regulatory modules of promoters or enhancers that consist of binding sites of two different but synergizing transcription factors.	Composite elements,0,18,Gene/Protein	regulatory modules,23,41,Gene/Protein	promoters,45,54,Gene/Protein	enhancers,58,67,Gene/Protein	transcription factors,131,152,Gene/Protein	"[{""token"": ""Composite elements"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""regulatory modules"", ""start_span"": 23, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 45, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""enhancers"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 131, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
Mutation of the E box abolished USF / c - Myc - mediated up - regulation of CXCR4 promoter activity, and mutation of the YY1 binding site was associated with unresponsiveness to YY1 - mediated inhibition.	E box,16,21,Gene/Protein	USF / c - Myc,32,45,Gene/Protein	CXCR4,76,81,Gene/Protein	YY1 binding site,121,137,Gene/Protein	YY1,178,181,Gene/Protein	"[{""token"": ""E box"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""USF / c - Myc"", ""start_span"": 32, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""CXCR4"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""YY1 binding site"", ""start_span"": 121, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""YY1"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
Taken together these results indicate that STAT1 plays a pivotal role in the differentiation / maturation process of monocytes as an early transcription factor initially activated by adherence and then able to modulate the expression of functional genes, such as ICAM - 1 and FcgammaRI.	STAT1,43,48,Gene/Protein	transcription factor,139,159,Gene/Protein	functional genes,237,253,Gene/Protein	ICAM - 1,263,271,Gene/Protein	FcgammaRI,276,285,Gene/Protein	"[{""token"": ""STAT1"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 139, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""functional genes"", ""start_span"": 237, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 263, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""FcgammaRI"", ""start_span"": 276, ""end_span"": 285, ""type"": ""Gene/Protein""}]"	train
Strict dependence of HS I activity on a GATA site implies that assembly of a protein complex containing a GATA - factor, presumably GATA - 1 or GATA - 2, is critical to activating or maintaining its function.	HS I,21,25,Gene/Protein	GATA site,40,49,Gene/Protein	GATA - factor,106,119,Gene/Protein	GATA - 1,132,140,Gene/Protein	GATA - 2,144,152,Gene/Protein	"[{""token"": ""HS I"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""GATA site"", ""start_span"": 40, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""GATA - factor"", ""start_span"": 106, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 2"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
At least in the case of the IL1B promoter, repression did not seem to involve another factor whose activity is affected by the NSAIDs, NFkappaB as the IL1B promoter fragment used in our studies is not NFkappaB responsive and binds specifically to HSF1.	IL1B promoter,28,41,Gene/Protein	NFkappaB,135,143,Gene/Protein	IL1B promoter fragment,151,173,Gene/Protein	NFkappaB,201,209,Gene/Protein	HSF1,247,251,Gene/Protein	"[{""token"": ""IL1B promoter"", ""start_span"": 28, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 135, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""IL1B promoter fragment"", ""start_span"": 151, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 201, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""HSF1"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Gene/Protein""}]"	train
Analogous to costimulation via CD28, this activity is mediated through activation of Rel / kappaB, a family of transcription factors known to regulate IL - 2 and other activation - inducible proteins.	CD28,31,35,Gene/Protein	Rel / kappaB,85,97,Gene/Protein	transcription factors,111,132,Gene/Protein	IL - 2,151,157,Gene/Protein	activation - inducible proteins,168,199,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""Rel / kappaB"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 111, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""activation - inducible proteins"", ""start_span"": 168, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
In contrast to transcriptional activation in PBMC, EMSA revealed that CD28 coligation of CD2 - activated LPMC does not result in increased binding of trans - factors to the CD28RE, nor did Western blots detect changes in I - kappaBalpha or I - kappaBbeta levels following CD28 coligation.	CD28,70,74,Gene/Protein	CD28RE,173,179,Gene/Protein	I - kappaBalpha,221,236,Gene/Protein	I - kappaBbeta,240,254,Gene/Protein	CD28,272,276,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""CD28RE"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""I - kappaBalpha"", ""start_span"": 221, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""I - kappaBbeta"", ""start_span"": 240, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 272, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	train
Upon HBsAg stimulation, expression of IFN - gamma, IL - 2, IL - 4, and IL - 10 was detected in 41%, 8%, 41%, and 50% of the patients, respectively.	HBsAg,5,10,Gene/Protein	IFN - gamma,38,49,Gene/Protein	IL - 2,51,57,Gene/Protein	IL - 4,59,65,Gene/Protein	IL - 10,71,78,Gene/Protein	"[{""token"": ""HBsAg"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene/Protein""}]"	train
In these experiments, SOCS - 3 associated with Jak1 and inhibited Jak1 phosphorylation, and this inhibition was markedly enhanced by the presence of IL - 2 receptor beta chain ( IL - 2Rbeta).	SOCS - 3,22,30,Gene/Protein	Jak1,47,51,Gene/Protein	Jak1,66,70,Gene/Protein	IL - 2 receptor beta chain,149,175,Gene/Protein	IL - 2Rbeta,178,189,Gene/Protein	"[{""token"": ""SOCS - 3"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor beta chain"", ""start_span"": 149, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2Rbeta"", ""start_span"": 178, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
Moreover, following IL - 2 stimulation of T cells, SOCS - 3 was able to interact with the IL - 2 receptor complex, and in particular tyrosine phosphorylated Jak1 and IL - 2Rbeta.	IL - 2,20,26,Gene/Protein	SOCS - 3,51,59,Gene/Protein	IL - 2 receptor complex,90,113,Gene/Protein	tyrosine phosphorylated Jak1,133,161,Gene/Protein	IL - 2Rbeta,166,177,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""SOCS - 3"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor complex"", ""start_span"": 90, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine phosphorylated Jak1"", ""start_span"": 133, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2Rbeta"", ""start_span"": 166, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
Additionally, in lymphocytes expressing SOCS - 3 but not CIS, IL - 2 - induced tyrosine phosphorylation of STAT5b was markedly reduced, while there was only a weak effect on IL - 3 - mediated STAT5b tyrosine phosphorylation.	SOCS - 3,40,48,Gene/Protein	CIS,57,60,Gene/Protein	IL - 2,62,68,Gene/Protein	STAT5b,107,113,Gene/Protein	IL - 3 - mediated STAT5b,174,198,Gene/Protein	"[{""token"": ""SOCS - 3"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""CIS"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""STAT5b"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3 - mediated STAT5b"", ""start_span"": 174, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
We recently developed an assay in which nuclear export of the shuttling transcription factor NFAT ( nuclear factor of activated T cells) can be reconstituted in permeabilized cells with the GTPase Ran and the nuclear export receptor CRM1.	transcription factor NFAT,72,97,Gene/Protein	nuclear factor of activated T cells,100,135,Gene/Protein	GTPase,190,196,Gene/Protein	Ran,197,200,Gene/Protein	CRM1,233,237,Gene/Protein	"[{""token"": ""transcription factor NFAT"", ""start_span"": 72, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 100, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""GTPase"", ""start_span"": 190, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""Ran"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""CRM1"", ""start_span"": 233, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	train
After preincubation of permeabilized cells with a Ran mutant that can not hydrolyze GTP ( RanQ69L), cytosol supports NFAT export, but CRM1 and Ran alone do not.	Ran mutant,50,60,Gene/Protein	RanQ69L,90,97,Gene/Protein	NFAT,117,121,Gene/Protein	CRM1,134,138,Gene/Protein	Ran,143,146,Gene/Protein	"[{""token"": ""Ran mutant"", ""start_span"": 50, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""RanQ69L"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""CRM1"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""Ran"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
The RanQ69L preincubation leads to accumulation of CRM1 at the cytoplasmic periphery of the nuclear pore complex ( NPC) in association with the p62 complex and Can / Nup214.	RanQ69L,4,11,Gene/Protein	CRM1,51,55,Gene/Protein	nuclear pore complex,92,112,Gene/Protein	NPC,115,118,Gene/Protein	p62 complex,144,155,Gene/Protein	"[{""token"": ""RanQ69L"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""CRM1"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""nuclear pore complex"", ""start_span"": 92, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""NPC"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""p62 complex"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	train
To determine activation status of the IL - 2R - associated ( Jak / STAT) pathway in the HTLV - I infected cells, we examined tyrosine phosphorylation of Jak3, STAT3, and STAT5 in several HTLV - I ( +) T - cell lines and in uncultured leukemic T cells isolated from patients with adult T - cell lymphoma / leukemia ( ATLL).	IL - 2R,38,45,Gene/Protein	Jak / STAT,61,71,Gene/Protein	Jak3,153,157,Gene/Protein	STAT3,159,164,Gene/Protein	STAT5,170,175,Gene/Protein	"[{""token"": ""IL - 2R"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""Jak / STAT"", ""start_span"": 61, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 159, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
We provide evidence here that virtually all human CD34 ( +) bone marrow cells express NF - kappaB that can be activated by exposure to phorbol 12 - myristate 13 - acetate and a variety of cytokines, eg, tumor necrosis factor alpha, interleukin - 3, and granulocyte - macrophage colony - stimulating factor.	NF - kappaB,86,97,Gene/Protein	cytokines,188,197,Gene/Protein	tumor necrosis factor alpha,203,230,Gene/Protein	interleukin - 3,232,247,Gene/Protein	granulocyte - macrophage colony - stimulating factor,253,305,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 188, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 203, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 3"", ""start_span"": 232, ""end_span"": 247, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 253, ""end_span"": 305, ""type"": ""Gene/Protein""}]"	train
Cloning of the 5 ' and 3 ' untranslated region ( UTR) of human keratinocyte PCD / DCoH revealed that it has 53 bp more of GC - rich 5 ' untranslated sequence than the published liver PCD / DCoH.	5 ' and 3 ' untranslated region,15,46,Gene/Protein	UTR,49,52,Gene/Protein	human keratinocyte PCD / DCoH,57,86,Gene/Protein	GC - rich 5 ' untranslated sequence,122,157,Gene/Protein	liver PCD / DCoH,177,193,Gene/Protein	"[{""token"": ""5 ' and 3 ' untranslated region"", ""start_span"": 15, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""UTR"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""human keratinocyte PCD / DCoH"", ""start_span"": 57, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""GC - rich 5 ' untranslated sequence"", ""start_span"": 122, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""liver PCD / DCoH"", ""start_span"": 177, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
It is perhaps possible that all of Stat4 actions on Th1 development may be exert directly by Stat4 at the IFN - gamma gene, however we suggest that, more likely, Stat4 may act to induce Th1 development through the induction of other non - cytokine genes, whose stable expression maintains the transcriptional state of a Th1 cell.	Stat4,35,40,Gene/Protein	Stat4,93,98,Gene/Protein	IFN - gamma gene,106,122,Gene/Protein	Stat4,162,167,Gene/Protein	non - cytokine genes,233,253,Gene/Protein	"[{""token"": ""Stat4"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Stat4"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma gene"", ""start_span"": 106, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Stat4"", ""start_span"": 162, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""non - cytokine genes"", ""start_span"": 233, ""end_span"": 253, ""type"": ""Gene/Protein""}]"	train
In contrast to that reported for human Jurkat T cells, we found that p38 MAPK, but not Jun NH2 - terminal kinase ( JNK), is weakly activated upon stimulation with either anti - CD3 or anti - CD28 in murine thymocytes and splenic T cells.	p38 MAPK,69,77,Gene/Protein	Jun NH2 - terminal kinase,87,112,Gene/Protein	JNK,115,118,Gene/Protein	anti - CD3,170,180,Gene/Protein	anti - CD28,184,195,Gene/Protein	"[{""token"": ""p38 MAPK"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""Jun NH2 - terminal kinase"", ""start_span"": 87, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 170, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD28"", ""start_span"": 184, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
In parallel, NAC was shown to down - regulate the production of cytokines by DC as well as their surface expression of HLA - DR, CD86 ( B7 - 2), and CD40 molecules both at the basal state and upon LPS activation.	cytokines,64,73,Gene/Protein	HLA - DR,119,127,Gene/Protein	CD86,129,133,Gene/Protein	B7 - 2,136,142,Gene/Protein	CD40 molecules,149,163,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DR"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""B7 - 2"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""CD40 molecules"", ""start_span"": 149, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
To examine the activation status of the transcription factors nuclear factor kappaB ( NF - kappaB) and heat shock factor - 1 ( HSF - 1), electrophoretic mobility shift assays were performed.	transcription factors,40,61,Gene/Protein	nuclear factor kappaB,62,83,Gene/Protein	NF - kappaB,86,97,Gene/Protein	heat shock factor - 1,103,124,Gene/Protein	HSF - 1,127,134,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 40, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappaB"", ""start_span"": 62, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""heat shock factor - 1"", ""start_span"": 103, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""HSF - 1"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
The ability of type I and type II IFNs to inhibit IL - 4 / IL - 13 - induced STAT6 activity is dose - and time - dependent, and is not unique to monocytes because IFNs induce the same effects in fibroblasts.	type I and type II IFNs,15,38,Gene/Protein	IL - 4,50,56,Gene/Protein	IL - 13,59,66,Gene/Protein	STAT6,77,82,Gene/Protein	IFNs,163,167,Gene/Protein	"[{""token"": ""type I and type II IFNs"", ""start_span"": 15, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IFNs"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
Furthermore, there was no increase in cyclin D - associated kinase activity upon HLA class I ligation, suggesting that cyclin E - dependent kinase activity mediates Rb inactivation, leading to E2F activation and cell proliferation.	cyclin D - associated kinase,38,66,Gene/Protein	HLA class I,81,92,Gene/Protein	cyclin E - dependent kinase,119,146,Gene/Protein	Rb,165,167,Gene/Protein	E2F,193,196,Gene/Protein	"[{""token"": ""cyclin D - associated kinase"", ""start_span"": 38, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""HLA class I"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""cyclin E - dependent kinase"", ""start_span"": 119, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 165, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
Switching the cells to the nonpermissive temperature led to a marked increase in globin gene expression and concomitant decrease in expression of Spi - 1, Fli - 1, and megakaryocytic genes in an erythropoietin - dependent manner.	globin gene,81,92,Gene/Protein	Spi - 1,146,153,Gene/Protein	Fli - 1,155,162,Gene/Protein	megakaryocytic genes,168,188,Gene/Protein	erythropoietin,195,209,Gene/Protein	"[{""token"": ""globin gene"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""Spi - 1"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""Fli - 1"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""megakaryocytic genes"", ""start_span"": 168, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""erythropoietin"", ""start_span"": 195, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
However, Spi - C may represent a novel subgroup within the Ets protein family, as it differed significantly from Spi - B and PU. 1 within helix 1 of the Ets domain.	Spi - C,9,16,Gene/Protein	Ets protein family,59,77,Gene/Protein	Spi - B,113,120,Gene/Protein	helix 1,138,145,Gene/Protein	Ets domain,153,163,Gene/Protein	"[{""token"": ""Spi - C"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""Ets protein family"", ""start_span"": 59, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""Spi - B"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""helix 1"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""Ets domain"", ""start_span"": 153, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
Lipopolysaccharide ( LPS) stimulation of human neutrophils is known to result in activation of p38 mitogen - activated protein kinase ( MAPk); however, the upstream activator ( s) of p38 MAPk is unknown, and consequences of p38 MAPk activation remain largely undefined.	p38 mitogen - activated protein kinase,95,133,Gene/Protein	MAPk,136,140,Gene/Protein	upstream activator,156,174,Gene/Protein	p38 MAPk,183,191,Gene/Protein	p38 MAPk,224,232,Gene/Protein	"[{""token"": ""p38 mitogen - activated protein kinase"", ""start_span"": 95, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""MAPk"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""upstream activator"", ""start_span"": 156, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPk"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPk"", ""start_span"": 224, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	train
These findings support a pathway by which LPS stimulation of neutrophils results in activation of MKK3, which in turn activates p38alpha MAPk, ultimately regulating adhesion, NF - kappaB activation, enhanced gene expression of TNF - alpha, and regulation of TNF - alpha synthesis.	MKK3,98,102,Gene/Protein	p38alpha MAPk,128,141,Gene/Protein	NF - kappaB,175,186,Gene/Protein	TNF - alpha,227,238,Gene/Protein	TNF - alpha,258,269,Gene/Protein	"[{""token"": ""MKK3"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""p38alpha MAPk"", ""start_span"": 128, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 175, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 227, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 258, ""end_span"": 269, ""type"": ""Gene/Protein""}]"	train
We took advantage of our monoclonal model of germinal center B cell differentiation, IgM + IgD + CL - 01 cells, to define the role of the I gamma 3 evolutionarily conserved sequence ( ECS) in the germline transcriptional activation of the human C gamma 3 gene.	I gamma 3,138,147,Gene/Protein	evolutionarily conserved sequence,148,181,Gene/Protein	ECS,184,187,Gene/Protein	germline,196,204,Gene/Protein	human C gamma 3 gene,239,259,Gene/Protein	"[{""token"": ""I gamma 3"", ""start_span"": 138, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""evolutionarily conserved sequence"", ""start_span"": 148, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""ECS"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""germline"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""human C gamma 3 gene"", ""start_span"": 239, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	train
Thus, the gamma 3 ECS is an inducible promoter containing cis elements that critically mediate CD40L and IL - 4 - triggered transcriptional activation of the human C gamma 3 gene.	gamma 3 ECS,10,21,Gene/Protein	cis elements,58,70,Gene/Protein	CD40L,95,100,Gene/Protein	IL - 4,105,111,Gene/Protein	human C gamma 3 gene,158,178,Gene/Protein	"[{""token"": ""gamma 3 ECS"", ""start_span"": 10, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""cis elements"", ""start_span"": 58, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CD40L"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""human C gamma 3 gene"", ""start_span"": 158, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
GrpL, a Grb2 - related adaptor protein, interacts with SLP - 76 to regulate nuclear factor of activated T cell activation.	GrpL,0,4,Gene/Protein	Grb2,8,12,Gene/Protein	adaptor protein,23,38,Gene/Protein	SLP - 76,55,63,Gene/Protein	nuclear factor of activated T cell,76,110,Gene/Protein	"[{""token"": ""GrpL"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""Grb2"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""adaptor protein"", ""start_span"": 23, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""SLP - 76"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cell"", ""start_span"": 76, ""end_span"": 110, ""type"": ""Gene/Protein""}]"	train
In - vitro cleavage of recombinant SP1 by recombinant caspase 3 ( CPP32) or caspase 7 ( Mch 3) results in similar cleavage products as those observed in vivo.	recombinant SP1,23,38,Gene/Protein	recombinant caspase 3,42,63,Gene/Protein	CPP32,66,71,Gene/Protein	caspase 7,76,85,Gene/Protein	Mch 3,88,93,Gene/Protein	"[{""token"": ""recombinant SP1"", ""start_span"": 23, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""recombinant caspase 3"", ""start_span"": 42, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""CPP32"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""caspase 7"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""Mch 3"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Gene/Protein""}]"	train
CD40 expression could be enhanced in CD40 - positive MM by stimulation with IFN - gamma and tumor necrosis factor - alpha but not by interleukin ( IL) - 1beta or CD40 triggering.	CD40,0,4,Gene/Protein	CD40,37,41,Gene/Protein	IFN - gamma,76,87,Gene/Protein	tumor necrosis factor - alpha,92,121,Gene/Protein	CD40,162,166,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 92, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
MDS1 / EVI1 enhances TGF - beta1 signaling and strengthens its growth - inhibitory effect but the leukemia - associated fusion protein AML1 / MDS1 / EVI1, product of the t ( 3; 21), abrogates growth - inhibition in response to TGF - beta1.	MDS1 / EVI1,0,11,Gene/Protein	TGF - beta1,21,32,Gene/Protein	leukemia - associated fusion protein,98,134,Gene/Protein	AML1 / MDS1 / EVI1,135,153,Gene/Protein	TGF - beta1,227,238,Gene/Protein	"[{""token"": ""MDS1 / EVI1"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 21, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""leukemia - associated fusion protein"", ""start_span"": 98, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""AML1 / MDS1 / EVI1"", ""start_span"": 135, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 227, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	train
However, although Wnt signals are known to inhibit the activity of the negative regulatory protein kinase glycogen synthase kinase - 3beta ( GSK - 3beta), resulting in increased levels of beta - catenin, we find no evidence for involvement of GSK - 3beta in Tcf - mediated transcription in T cells.	negative regulatory protein kinase,71,105,Gene/Protein	glycogen synthase kinase - 3beta,106,138,Gene/Protein	GSK - 3beta,141,152,Gene/Protein	beta - catenin,188,202,Gene/Protein	GSK - 3beta,243,254,Gene/Protein	"[{""token"": ""negative regulatory protein kinase"", ""start_span"": 71, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""glycogen synthase kinase - 3beta"", ""start_span"": 106, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""GSK - 3beta"", ""start_span"": 141, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""beta - catenin"", ""start_span"": 188, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""GSK - 3beta"", ""start_span"": 243, ""end_span"": 254, ""type"": ""Gene/Protein""}]"	train
Extracellular - regulated kinase 1 / 2, Jun N - terminal kinase, and c - Jun are involved in NF - kappa B - dependent IL - 6 expression in human monocytes.	Extracellular - regulated kinase 1 / 2,0,38,Gene/Protein	Jun N - terminal kinase,40,63,Gene/Protein	c - Jun,69,76,Gene/Protein	NF - kappa B,93,105,Gene/Protein	IL - 6,118,124,Gene/Protein	"[{""token"": ""Extracellular - regulated kinase 1 / 2"", ""start_span"": 0, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Jun N - terminal kinase"", ""start_span"": 40, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 93, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Gene/Protein""}]"	train
The biologic effects of RA are mediated by two distinct families of transcriptional factors: RA receptors ( RARs) and retinoid X receptors ( RXRs).	transcriptional factors,68,91,Gene/Protein	RA receptors,93,105,Gene/Protein	RARs,108,112,Gene/Protein	retinoid X receptors,118,138,Gene/Protein	RXRs,141,145,Gene/Protein	"[{""token"": ""transcriptional factors"", ""start_span"": 68, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""RA receptors"", ""start_span"": 93, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""RARs"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""retinoid X receptors"", ""start_span"": 118, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""RXRs"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	train
Cytokine effects on immunity and inflammation often depend on the transcription factors termed signal transducers and activators of transcription ( STATs), so STAT signaling pathways are candidates for influencing inflammatory disease.	Cytokine,0,8,Gene/Protein	transcription factors,66,87,Gene/Protein	signal transducers and activators of transcription,95,145,Gene/Protein	STATs,148,153,Gene/Protein	STAT,159,163,Gene/Protein	"[{""token"": ""Cytokine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 66, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers and activators of transcription"", ""start_span"": 95, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""STATs"", ""start_span"": 148, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""STAT"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
Furthermore, epithelial levels of activated Stat1 correlated with levels of expression for epithelial ICAM - 1, IRF - 1, and Stat1, and in turn, ICAM - 1 levels correlated with T - cell accumulation in tissue.	Stat1,44,49,Gene/Protein	epithelial ICAM - 1,91,110,Gene/Protein	IRF - 1,112,119,Gene/Protein	Stat1,125,130,Gene/Protein	ICAM - 1,145,153,Gene/Protein	"[{""token"": ""Stat1"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""epithelial ICAM - 1"", ""start_span"": 91, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
In this study, transient cotransfection of several GPIX promoter / reporter constructs into 293T kidney fibroblasts with a Fli - 1 expression vector shows that the oncogenic protein Fli - 1 can transactivate the GPIX promoter when an intact GPIX Ets site is present.	GPIX promoter / reporter constructs,51,86,Gene/Protein	Fli - 1 expression vector,123,148,Gene/Protein	Fli - 1,182,189,Gene/Protein	GPIX promoter,212,225,Gene/Protein	GPIX Ets site,241,254,Gene/Protein	"[{""token"": ""GPIX promoter / reporter constructs"", ""start_span"": 51, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""Fli - 1 expression vector"", ""start_span"": 123, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""Fli - 1"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""GPIX promoter"", ""start_span"": 212, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""GPIX Ets site"", ""start_span"": 241, ""end_span"": 254, ""type"": ""Gene/Protein""}]"	train
Furthermore, CoCl2 also caused time - dependent tyrosine phosphorylation of mitogen - activated protein ( MAP) kinase isoform ERK2 without significantly affecting ERK1, indicating ERK2 is the preferred substrate for upstream kinase of the MAPK pathway.	ERK2,126,130,Gene/Protein	ERK1,163,167,Gene/Protein	ERK2,180,184,Gene/Protein	upstream kinase,216,231,Gene/Protein	MAPK,239,243,Gene/Protein	"[{""token"": ""ERK2"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""ERK2"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""upstream kinase"", ""start_span"": 216, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 239, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
Our data suggests that CoCl2 - induced cellular signals directing increased expression of VCAM - 1 in HUVEC involve downstream activation of MAP kinase and NF - kappaB, while the phosphorylation of PECAM - 1 occurs as a result of activation of PKC.	VCAM - 1,90,98,Gene/Protein	MAP kinase,141,151,Gene/Protein	NF - kappaB,156,167,Gene/Protein	PECAM - 1,198,207,Gene/Protein	PKC,244,247,Gene/Protein	"[{""token"": ""VCAM - 1"", ""start_span"": 90, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""MAP kinase"", ""start_span"": 141, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""PECAM - 1"", ""start_span"": 198, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 244, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	train
Here we investigated the role and involvement of interleukin - 1 ( IL - 1) and tumor necrosis factor ( TNF - alpha) signal transducer molecules in LPS signaling in human dermal microvessel endothelial cells ( HDMEC) and THP - 1 monocytic cells.	interleukin - 1,49,64,Gene/Protein	IL - 1,67,73,Gene/Protein	tumor necrosis factor,79,100,Gene/Protein	TNF - alpha,103,114,Gene/Protein	signal transducer molecules,116,143,Gene/Protein	"[{""token"": ""interleukin - 1"", ""start_span"": 49, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 79, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 103, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer molecules"", ""start_span"": 116, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	train
RESULTS: We show that binding of IFN - gamma to human eosinophils initiated a series of events that resulted in the rapid tyrosine phosphorylation of not only the IFN - gammaRalpha chain but also Jak1, Jak2, and Stat1alpha.	IFN - gamma,33,44,Gene/Protein	IFN - gammaRalpha chain,163,186,Gene/Protein	Jak1,196,200,Gene/Protein	Jak2,202,206,Gene/Protein	Stat1alpha,212,222,Gene/Protein	"[{""token"": ""IFN - gamma"", ""start_span"": 33, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gammaRalpha chain"", ""start_span"": 163, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 196, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""Jak2"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""Stat1alpha"", ""start_span"": 212, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
Unexpectedly, we observed that an RXR - specific, rather than an RAR - specific, agonist induces terminal granulocytic differentiation of MPRO promyelocytes, and this differentiation is associated with activation of DNA response elements corresponding to RAR - RXR heterodimers rather than RXR - RXR homodimers.	RXR,34,37,Gene/Protein	RAR,65,68,Gene/Protein	DNA response elements,216,237,Gene/Protein	RAR - RXR heterodimers,255,277,Gene/Protein	RXR - RXR homodimers,290,310,Gene/Protein	"[{""token"": ""RXR"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""RAR"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""DNA response elements"", ""start_span"": 216, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""RAR - RXR heterodimers"", ""start_span"": 255, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""RXR - RXR homodimers"", ""start_span"": 290, ""end_span"": 310, ""type"": ""Gene/Protein""}]"	train
Using antibodies against the p50 and p65 subunits of NF - kappaB in EMSAs, the involvement of both p50 and p65 proteins was further demonstrated.	p50,29,32,Gene/Protein	p65 subunits,37,49,Gene/Protein	NF - kappaB,53,64,Gene/Protein	p50,99,102,Gene/Protein	p65 proteins,107,119,Gene/Protein	"[{""token"": ""p50"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""p65 subunits"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""p65 proteins"", ""start_span"": 107, ""end_span"": 119, ""type"": ""Gene/Protein""}]"	train
A loss - of - function mutation in Cbl - b disrupted the interaction between Cbl - b and Zap - 70 and nearly completely abrogated the Cbl - b - mediated activation of NFAT.	Cbl - b,35,42,Gene/Protein	Cbl - b,77,84,Gene/Protein	Zap - 70,89,97,Gene/Protein	Cbl - b,134,141,Gene/Protein	NFAT,167,171,Gene/Protein	"[{""token"": ""Cbl - b"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Cbl - b"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""Zap - 70"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""Cbl - b"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
Several new functions of Ras, such as downregulation of major histocompatibility complex molecules, upregulation of certain cytokines, growth factors and degradative enzymes have been uncovered in the last decade.	Ras,25,28,Gene/Protein	major histocompatibility complex molecules,56,98,Gene/Protein	cytokines,124,133,Gene/Protein	growth factors,135,149,Gene/Protein	degradative enzymes,154,173,Gene/Protein	"[{""token"": ""Ras"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""major histocompatibility complex molecules"", ""start_span"": 56, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 124, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""growth factors"", ""start_span"": 135, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""degradative enzymes"", ""start_span"": 154, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
This modulation of DNA binding activity mediated through the dephosphorylation of DP1 and E2F4 could help to explain the lack of in vivo DNA footprinting in late G1 and S phases of gene promoters negatively regulated through E2F sites and suggests a novel mechanism for controlling E2F transcriptional activity during the transition from quiescence to proliferation.	DP1,82,85,Gene/Protein	E2F4,90,94,Gene/Protein	gene promoters,181,195,Gene/Protein	E2F sites,225,234,Gene/Protein	E2F,282,285,Gene/Protein	"[{""token"": ""DP1"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""E2F4"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""gene promoters"", ""start_span"": 181, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""E2F sites"", ""start_span"": 225, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 282, ""end_span"": 285, ""type"": ""Gene/Protein""}]"	train
Ligation of either CD80 ( B7 - 1) or CD86 ( B7 - 2), two principal ligands for CD28, is thought to skew the immune response toward Th1 or Th2 differentiation.	CD80,19,23,Gene/Protein	B7 - 1,26,32,Gene/Protein	CD86,37,41,Gene/Protein	B7 - 2,44,50,Gene/Protein	CD28,79,83,Gene/Protein	"[{""token"": ""CD80"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""B7 - 1"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""B7 - 2"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}]"	train
Purified human peripheral T cells or Jurkat T cells were stimulated with Chinese hamster ovary ( CHO) cells expressing either human CD80 ( CHO - CD80) or human CD86 ( CHO - CD86) or with anti - CD28 monoclonal antibody ( mAb).	human CD80,126,136,Gene/Protein	CHO - CD80,139,149,Gene/Protein	human CD86,154,164,Gene/Protein	CHO - CD86,167,177,Gene/Protein	anti - CD28 monoclonal antibody,187,218,Gene/Protein	"[{""token"": ""human CD80"", ""start_span"": 126, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""CHO - CD80"", ""start_span"": 139, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""human CD86"", ""start_span"": 154, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""CHO - CD86"", ""start_span"": 167, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD28 monoclonal antibody"", ""start_span"": 187, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
Surprisingly, although stimulation of Jurkat T cells with either CHO - CD80 or anti - CD28 mAb resulted in robust tyrosine phosphorylation of CD28 itself, ligation with CHO - CD86 was unable to induce detectable CD28 tyrosyl phosphorylation over a range of stimulation conditions.	CHO - CD80,65,75,Gene/Protein	anti - CD28 mAb,79,94,Gene/Protein	CD28,142,146,Gene/Protein	CHO - CD86,169,179,Gene/Protein	CD28,212,216,Gene/Protein	"[{""token"": ""CHO - CD80"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD28 mAb"", ""start_span"": 79, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""CHO - CD86"", ""start_span"": 169, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
We hypothesized that activation of the protein kinase A signaling pathway may inhibit NF - kappaB - mediated transcription by phosphorylating proteins, such as cAMP response element - binding protein ( CREB), which compete for limiting amounts of the coactivator CBP.	protein kinase A,39,55,Gene/Protein	NF - kappaB,86,97,Gene/Protein	cAMP response element - binding protein,160,199,Gene/Protein	CREB,202,206,Gene/Protein	CBP,263,266,Gene/Protein	"[{""token"": ""protein kinase A"", ""start_span"": 39, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""cAMP response element - binding protein"", ""start_span"": 160, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""CBP"", ""start_span"": 263, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
These results suggest that activation of the protein kinase A pathway inhibits NF - kappaB transcription by phosphorylating CREB, which competes with p65 for limiting amounts of CBP.	protein kinase A,45,61,Gene/Protein	NF - kappaB,79,90,Gene/Protein	CREB,124,128,Gene/Protein	p65,150,153,Gene/Protein	CBP,178,181,Gene/Protein	"[{""token"": ""protein kinase A"", ""start_span"": 45, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""CBP"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
Thus, Egr - 2, in addition to Egr - 3, regulates FasL expression in activated normal T cells, and Egr - 2 is likely to play a direct role in aberrant fasL up - regulation in lpr / lpr and gld / gld CD4 ( -) CD8 ( -) T cells.	Egr - 2,6,13,Gene/Protein	Egr - 3,30,37,Gene/Protein	FasL,49,53,Gene/Protein	Egr - 2,98,105,Gene/Protein	fasL,150,154,Gene/Protein	"[{""token"": ""Egr - 2"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 3"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""FasL"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 2"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""fasL"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
Biochemically we show that the stimulated tyrosine phosphorylation of Vav, Shc, and ZAP - 70 itself is diminished, whereas that of Slp - 76 is increased in cells reconstituted with Delta.	Vav,70,73,Gene/Protein	Shc,75,78,Gene/Protein	ZAP - 70,84,92,Gene/Protein	Slp - 76,131,139,Gene/Protein	Delta,181,186,Gene/Protein	"[{""token"": ""Vav"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Shc"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""ZAP - 70"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""Slp - 76"", ""start_span"": 131, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""Delta"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
Cross - linking CD19 on early human B lineage cells induces the formation of a CD19 / Vav / phosphatidylinositol - 3 kinase complex, tyrosine phosphorylation of CD19 and Vav, and activation of the Ras pathway.	CD19,16,20,Gene/Protein	CD19 / Vav / phosphatidylinositol - 3 kinase complex,79,131,Gene/Protein	CD19,161,165,Gene/Protein	Vav,170,173,Gene/Protein	Ras,197,200,Gene/Protein	"[{""token"": ""CD19"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CD19 / Vav / phosphatidylinositol - 3 kinase complex"", ""start_span"": 79, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""Vav"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
Sequence analysis revealed the presence of a previously unrecognized composite binding site for both the Sp1 and NF - kappaB transcription factors at positions - 295 to - 286.	unrecognized composite binding site,56,91,Gene/Protein	Sp1,105,108,Gene/Protein	NF - kappaB,113,124,Gene/Protein	transcription factors,125,146,Gene/Protein	positions - 295 to - 286,150,174,Gene/Protein	"[{""token"": ""unrecognized composite binding site"", ""start_span"": 56, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 113, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 125, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""positions - 295 to - 286"", ""start_span"": 150, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
The study of NF - kappaB showed that oxLDLs led to a decrease of activation - induced p65 / p50 NF - kappaB heterodimer binding to DNA, whereas the presence of the constitutive nuclear form of p50 dimer was unchanged.	NF - kappaB,13,24,Gene/Protein	oxLDLs,37,43,Gene/Protein	activation - induced p65 / p50,65,95,Gene/Protein	NF - kappaB,96,107,Gene/Protein	p50 dimer,193,202,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""oxLDLs"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""activation - induced p65 / p50"", ""start_span"": 65, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""p50 dimer"", ""start_span"": 193, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
DOR1 ligation by a specific DOR1 agonist, deltorphin, augmented IL - 2 secretion by synergizing with signals from TCR - CD3 and CD28.	DOR1,0,4,Gene/Protein	DOR1,28,32,Gene/Protein	IL - 2,64,70,Gene/Protein	TCR - CD3,114,123,Gene/Protein	CD28,128,132,Gene/Protein	"[{""token"": ""DOR1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""DOR1"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""TCR - CD3"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}]"	train
Deltorphin also increased accumulation of AP - 1 transcription factor complexes, suggesting that DOR1 augments IL - 2 secretion by increasing the AP - 1 component of the NF - AT / AP - 1 transcription factor.	AP - 1 transcription factor complexes,42,79,Gene/Protein	DOR1,97,101,Gene/Protein	IL - 2,111,117,Gene/Protein	AP - 1 component,146,162,Gene/Protein	NF - AT / AP - 1 transcription factor,170,207,Gene/Protein	"[{""token"": ""AP - 1 transcription factor complexes"", ""start_span"": 42, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""DOR1"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 component"", ""start_span"": 146, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT / AP - 1 transcription factor"", ""start_span"": 170, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
This pathway involves the Rac1 and Cdc42 GTPases, two enzymes which are not required for NF - kappaB activation by IL - 1beta in epithelial cells.	Rac1,26,30,Gene/Protein	Cdc42,35,40,Gene/Protein	GTPases,41,48,Gene/Protein	NF - kappaB,89,100,Gene/Protein	IL - 1beta,115,125,Gene/Protein	"[{""token"": ""Rac1"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""Cdc42"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""GTPases"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 89, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 115, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	train
In conclusion, three different cell - specific pathways lead to NF - kappaB activation by IL - 1beta: a pathway dependent on ROI production by 5 - LOX in lymphoid cells, an ROI - and 5 - LOX - independent pathway in epithelial cells, and a pathway requiring ROI production by NADPH oxidase in monocytic cells.	NF - kappaB,64,75,Gene/Protein	IL - 1beta,90,100,Gene/Protein	5 - LOX,143,150,Gene/Protein	5 - LOX,183,190,Gene/Protein	NADPH oxidase,276,289,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 64, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""5 - LOX"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""5 - LOX"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""NADPH oxidase"", ""start_span"": 276, ""end_span"": 289, ""type"": ""Gene/Protein""}]"	train
These transcription factors are either not produced due to block of transcription of their respective genes ( Oct - 2, OBF - 1, PU. 1), or are rendered inactive posttranslationally ( NF - kappa B, E47).	transcription factors,6,27,Gene/Protein	Oct - 2,110,117,Gene/Protein	OBF - 1,119,126,Gene/Protein	NF - kappa B,183,195,Gene/Protein	E47,197,200,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 6, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""OBF - 1"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 183, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""E47"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
We demonstrate that a fusion protein composed of a C - terminal Hsp70 peptide and the p50 subunit of NF - kappaB was directed into the nucleus of cells, could bind DNA specifically, and activated Igkappa expression and TNFalpha production.	Hsp70,64,69,Gene/Protein	p50 subunit,86,97,Gene/Protein	NF - kappaB,101,112,Gene/Protein	Igkappa,196,203,Gene/Protein	TNFalpha,219,227,Gene/Protein	"[{""token"": ""Hsp70"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""p50 subunit"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Igkappa"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 219, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
These include ( 5 ' - 3 ') a composite NF - AT / ` ` AP - 1 ' ' element, a CD28 response element, an AP - 1 element, an NF - AT element, and the AP - 1 part of an AP - 1 / octamer composite element.	NF - AT / ` ` AP - 1 ' ' element,39,71,Gene/Protein	CD28 response element,75,96,Gene/Protein	AP - 1 element,101,115,Gene/Protein	NF - AT element,120,135,Gene/Protein	AP - 1 part of an AP - 1 / octamer composite element,145,197,Gene/Protein	"[{""token"": ""NF - AT / ` ` AP - 1 ' ' element"", ""start_span"": 39, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD28 response element"", ""start_span"": 75, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 element"", ""start_span"": 101, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT element"", ""start_span"": 120, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 part of an AP - 1 / octamer composite element"", ""start_span"": 145, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
IFN - alpha enhanced tyrosine phosphorylation of STAT1, STAT3, STAT4, STAT5a, and STAT5b.	IFN - alpha,0,11,Gene/Protein	STAT3,56,61,Gene/Protein	STAT4,63,68,Gene/Protein	STAT5a,70,76,Gene/Protein	STAT5b,82,88,Gene/Protein	"[{""token"": ""IFN - alpha"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""STAT4"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""STAT5a"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""STAT5b"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene/Protein""}]"	train
Functional association of Nmi with Stat5 and Stat1 in IL - 2 - and IFNgamma - mediated signaling.	Nmi,26,29,Gene/Protein	Stat5,35,40,Gene/Protein	Stat1,45,50,Gene/Protein	IL - 2,54,60,Gene/Protein	IFNgamma,67,75,Gene/Protein	"[{""token"": ""Nmi"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Gene/Protein""}]"	train
We evaluated two cytokine systems, IL - 2 and IFNgamma, and demonstrate that Nmi augments STAT - mediated transcription in response to these cytokines.	IL - 2,35,41,Gene/Protein	IFNgamma,46,54,Gene/Protein	Nmi,77,80,Gene/Protein	STAT,90,94,Gene/Protein	cytokines,141,150,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Nmi"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""STAT"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 141, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
Lactobacilli also increased tumor necrosis factor - alphaand interleukin - 1betaproduction and activated NF - kappaB in THP - 1 cells and increased tumor necrosis factor - alphaproduction by human monocytes.	tumor necrosis factor,28,49,Gene/Protein	interleukin,61,72,Gene/Protein	NF - kappaB,105,116,Gene/Protein	THP - 1 cells,120,133,Gene/Protein	tumor necrosis factor,148,169,Gene/Protein	"[{""token"": ""tumor necrosis factor"", ""start_span"": 28, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""interleukin"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""THP - 1 cells"", ""start_span"": 120, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 148, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
In addition, AR are not detectable on the surface of intact T cells when using anti - AR antibodies directed against the amino and carboxy terminus of the AR, although T cells contain AR, as revealed by reverse transcription - polymerase chain reactions and Western blotting.	AR,13,15,Gene/Protein	anti - AR antibodies,79,99,Gene/Protein	amino and carboxy terminus,121,147,Gene/Protein	AR,155,157,Gene/Protein	AR,184,186,Gene/Protein	"[{""token"": ""AR"", ""start_span"": 13, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""anti - AR antibodies"", ""start_span"": 79, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""amino and carboxy terminus"", ""start_span"": 121, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""AR"", ""start_span"": 155, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""AR"", ""start_span"": 184, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
Therefore, IL - 10 can directly inhibit STAT - dependent early response gene expression induced by both IFNalpha and IFNgamma in monocytes by suppressing the tyrosine phosphorylation of STAT1.	IL - 10,11,18,Gene/Protein	STAT - dependent early response gene,40,76,Gene/Protein	IFNalpha,104,112,Gene/Protein	IFNgamma,117,125,Gene/Protein	STAT1,186,191,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 11, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""STAT - dependent early response gene"", ""start_span"": 40, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""IFNalpha"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
We have analyzed the effects of interleukin - 10 ( IL - 10) on the entry of quiescent CD4 ( +) T cells into the cell cycle upon stimulation with the superantigen staphylococcal enterotoxin B ( SEB).	interleukin - 10,32,48,Gene/Protein	IL - 10,51,58,Gene/Protein	superantigen,149,161,Gene/Protein	staphylococcal enterotoxin B,162,190,Gene/Protein	SEB,193,196,Gene/Protein	"[{""token"": ""interleukin - 10"", ""start_span"": 32, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""superantigen"", ""start_span"": 149, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""staphylococcal enterotoxin B"", ""start_span"": 162, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""SEB"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
Inhibition of IL - 1R gene expression by IFN - gamma and IL - 10 was not due to down - regulation of surface IL - 4R because pretreatment with these cytokines did not decrease the number of IL - 4 binding sites per cell.	IL - 1R gene,14,26,Gene/Protein	IFN - gamma,41,52,Gene/Protein	IL - 10,57,64,Gene/Protein	surface IL - 4R,101,116,Gene/Protein	IL - 4,190,196,Gene/Protein	"[{""token"": ""IL - 1R gene"", ""start_span"": 14, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""surface IL - 4R"", ""start_span"": 101, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 190, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
These findings demonstrate that certain cytokines, including IFN - gamma and IL - 10, antagonize the ability of IL - 4 and IL - 13 to induce increased expression of the IL - 1RI and IL - 1RII genes in monocytes.	IFN - gamma,61,72,Gene/Protein	IL - 10,77,84,Gene/Protein	IL - 4,112,118,Gene/Protein	IL - 13,123,130,Gene/Protein	IL - 1RII genes,182,197,Gene/Protein	"[{""token"": ""IFN - gamma"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1RII genes"", ""start_span"": 182, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
Activation of NF - kappa B seems to play an important role in the regulation of many proinflammatory cytokine genes, but can not be the only mechanism, since several cytokine genes lack respective binding sites in their promoter regions.	NF - kappa B,14,26,Gene/Protein	proinflammatory cytokine genes,85,115,Gene/Protein	cytokine genes,166,180,Gene/Protein	binding sites,197,210,Gene/Protein	promoter regions,220,236,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 14, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""proinflammatory cytokine genes"", ""start_span"": 85, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 166, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 197, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""promoter regions"", ""start_span"": 220, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
Therefore, we additionally investigated other transcription factors of possible importance such as CREB, CTF, OTF - 1, and OTF - 2.	transcription factors,46,67,Gene/Protein	CREB,99,103,Gene/Protein	CTF,105,108,Gene/Protein	OTF - 1,110,117,Gene/Protein	OTF - 2,123,130,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 46, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""CTF"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 1"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 2"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}]"	train
Transcripts for osteoprotegerin ligand ( OPGL), an osteoclast differentiation factor ( also known as RANKL and TRANCE) are expressed, likely by adherent cells.	osteoprotegerin ligand,16,38,Gene/Protein	OPGL,41,45,Gene/Protein	osteoclast differentiation factor,51,84,Gene/Protein	RANKL,101,106,Gene/Protein	TRANCE,111,117,Gene/Protein	"[{""token"": ""osteoprotegerin ligand"", ""start_span"": 16, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""OPGL"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""osteoclast differentiation factor"", ""start_span"": 51, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""RANKL"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""TRANCE"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
By using PD - 98059 and SB203580, two potent and selective inhibitors of MEK1 ( a kinase upstream of ERK1 / 2) and p38, respectively, we have demonstrated that both ERK1 / 2 and p38 cascades play a key role in the production of IL - 8 by monocytes and PMN stimulated with bacterial fractions.	MEK1,73,77,Gene/Protein	kinase,82,88,Gene/Protein	ERK1 / 2,101,109,Gene/Protein	p38,115,118,Gene/Protein	IL - 8,228,234,Gene/Protein	"[{""token"": ""MEK1"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""kinase"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""ERK1 / 2"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""p38"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 228, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
The OCA - B and VP16 interactions with the Oct - 1 POU domain are sufficiently different to permit OCA - B and VP16 to bind the Oct - 1 POU domain simultaneously.	VP16,16,20,Gene/Protein	Oct - 1 POU domain,43,61,Gene/Protein	OCA - B,99,106,Gene/Protein	VP16,111,115,Gene/Protein	Oct - 1 POU domain,128,146,Gene/Protein	"[{""token"": ""VP16"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1 POU domain"", ""start_span"": 43, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""OCA - B"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""VP16"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1 POU domain"", ""start_span"": 128, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
TRADD associated with wild - type LMP1 but not with isoleucine - mutated LMP1 in mammalian cells, and TRADD constitutively associated with LMP1 in EBV - transformed cells.	TRADD,0,5,Gene/Protein	wild - type LMP1,22,38,Gene/Protein	LMP1,73,77,Gene/Protein	TRADD,102,107,Gene/Protein	LMP1,139,143,Gene/Protein	"[{""token"": ""TRADD"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""wild - type LMP1"", ""start_span"": 22, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""TRADD"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	train
O - side chain - specific mAb concurrently enhanced complement - dependent LPS uptake by monocytes through complement receptor - 1 ( CR1) and uptake by CHO - CD14 cells involving another heat - labile serum factor ( s) and cell - associated recognition molecule ( s).	O - side chain - specific mAb,0,29,Gene/Protein	complement receptor - 1,107,130,Gene/Protein	CR1,133,136,Gene/Protein	heat - labile serum factor,187,213,Gene/Protein	cell - associated recognition molecule,223,261,Gene/Protein	"[{""token"": ""O - side chain - specific mAb"", ""start_span"": 0, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""complement receptor - 1"", ""start_span"": 107, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""CR1"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""heat - labile serum factor"", ""start_span"": 187, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""cell - associated recognition molecule"", ""start_span"": 223, ""end_span"": 261, ""type"": ""Gene/Protein""}]"	train
EMSA showed that both constitutive and inducible complexes bound to CLE0, P, P2 and P4, whereas only a constitutive complex bound to P3.	CLE0,68,72,Gene/Protein	P,74,75,Gene/Protein	P2,77,79,Gene/Protein	P4,84,86,Gene/Protein	P3,133,135,Gene/Protein	"[{""token"": ""CLE0"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""P"", ""start_span"": 74, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""P2"", ""start_span"": 77, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""P4"", ""start_span"": 84, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""P3"", ""start_span"": 133, ""end_span"": 135, ""type"": ""Gene/Protein""}]"	train
This inhibition, which occurred with a parallel activation of c - Jun transactivating functions and expression, was reflected by transfection experiments at the IL - 2 promoter level, and involved not only the inhibition of NF - kappaB - driven reporter activation but also that of nuclear factor of activated T cells ( NFAT).	c - Jun,62,69,Gene/Protein	IL - 2 promoter,161,176,Gene/Protein	NF - kappaB,224,235,Gene/Protein	nuclear factor of activated T cells,282,317,Gene/Protein	NFAT,320,324,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 161, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 224, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 282, ""end_span"": 317, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 320, ""end_span"": 324, ""type"": ""Gene/Protein""}]"	train
We propose that the activation of an NFAT kinase by PDTC could be responsible for the rapid shuttling of the NFAT, therefore transiently converting the sustained transactivation of this transcription factor that occurs during lymphocyte activation, and show that c - Jun NH2 - terminal kinase ( JNK) can act by directly phosphorylating NFATp.	NFAT,37,41,Gene/Protein	transcription factor,186,206,Gene/Protein	c - Jun NH2 - terminal kinase,263,292,Gene/Protein	JNK,295,298,Gene/Protein	NFATp,336,341,Gene/Protein	"[{""token"": ""NFAT"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 186, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun NH2 - terminal kinase"", ""start_span"": 263, ""end_span"": 292, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 295, ""end_span"": 298, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 336, ""end_span"": 341, ""type"": ""Gene/Protein""}]"	train
Two other members of the family have been cloned more recently, A - myb and B - myb, which show sequence homology with c - myb in several domains, of which the DNA binding domain as well as other regulatory domains.	A - myb,64,71,Gene/Protein	B - myb,76,83,Gene/Protein	c - myb,119,126,Gene/Protein	DNA binding domain,160,178,Gene/Protein	regulatory domains,196,214,Gene/Protein	"[{""token"": ""A - myb"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""B - myb"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""c - myb"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding domain"", ""start_span"": 160, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""regulatory domains"", ""start_span"": 196, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
Sp3 mediates transcriptional activation of the leukocyte integrin genes CD11C and CD11B and cooperates with c - Jun to activate CD11C.	Sp3,0,3,Gene/Protein	leukocyte integrin genes,47,71,Gene/Protein	CD11C,72,77,Gene/Protein	CD11B,82,87,Gene/Protein	CD11C,128,133,Gene/Protein	"[{""token"": ""Sp3"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""leukocyte integrin genes"", ""start_span"": 47, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD11C"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""CD11B"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""CD11C"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Gene/Protein""}]"	train
In previous experiments, the - 70 to - 65 and - 121 to - 103 regions of the CD11c promoter and the - 66 to - 59 region of the CD11b promoter were shown to be essential for Sp1 - mediated activation of these genes.	- 70 to - 65 and - 121 to - 103 regions,29,68,Gene/Protein	CD11c promoter,76,90,Gene/Protein	- 66 to - 59 region,99,118,Gene/Protein	CD11b promoter,126,140,Gene/Protein	Sp1 -,172,177,Gene/Protein	"[{""token"": ""- 70 to - 65 and - 121 to - 103 regions"", ""start_span"": 29, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""CD11c promoter"", ""start_span"": 76, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""- 66 to - 59 region"", ""start_span"": 99, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""CD11b promoter"", ""start_span"": 126, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 -"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
In this study, we investigated the effect of ER alpha ( referred to throughout as ER) on DNA - binding activities of transcription factors involved in regulating the expression of erythroid - specific genes, and, in particular, the histone H5 gene.	ER alpha,45,53,Gene/Protein	ER,82,84,Gene/Protein	transcription factors,117,138,Gene/Protein	erythroid - specific genes,180,206,Gene/Protein	histone H5 gene,232,247,Gene/Protein	"[{""token"": ""ER alpha"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""ER"", ""start_span"": 82, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 117, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""erythroid - specific genes"", ""start_span"": 180, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""histone H5 gene"", ""start_span"": 232, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	train
These downstream sequence elements, termed DSE, can bind both AP - 1 and CREB / ATF transcription factors.	downstream sequence elements,6,34,Gene/Protein	DSE,43,46,Gene/Protein	AP - 1,62,68,Gene/Protein	CREB / ATF,73,83,Gene/Protein	transcription factors,84,105,Gene/Protein	"[{""token"": ""downstream sequence elements"", ""start_span"": 6, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""DSE"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""CREB / ATF"", ""start_span"": 73, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 84, ""end_span"": 105, ""type"": ""Gene/Protein""}]"	train
Repression of Cp activity required amino acids 207 to 368, which encompasses a region resembling a basic DBD adjacent to a leucine zipper DNA binding motif and a site which binds to the cellular factor CBF1 / RBP - Jkappa.	Cp,14,16,Gene/Protein	amino acids 207 to 368,35,57,Gene/Protein	basic DBD,99,108,Gene/Protein	leucine zipper DNA binding motif,123,155,Gene/Protein	cellular factor CBF1 / RBP - Jkappa,186,221,Gene/Protein	"[{""token"": ""Cp"", ""start_span"": 14, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""amino acids 207 to 368"", ""start_span"": 35, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""basic DBD"", ""start_span"": 99, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""leucine zipper DNA binding motif"", ""start_span"": 123, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""cellular factor CBF1 / RBP - Jkappa"", ""start_span"": 186, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
Finally, although it has been reported that EBNA3C can upregulate CD21 in some B cells, we were unable to demonstrate any effect of EBNA3C on reporter plasmids which contain the CD21 promoter.	EBNA3C,44,50,Gene/Protein	CD21,66,70,Gene/Protein	EBNA3C,132,138,Gene/Protein	reporter plasmids,142,159,Gene/Protein	CD21 promoter,178,191,Gene/Protein	"[{""token"": ""EBNA3C"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""CD21"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""EBNA3C"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""reporter plasmids"", ""start_span"": 142, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""CD21 promoter"", ""start_span"": 178, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
Considering that nuclear regulatory factor - kappa beta ( NF - kappa B) / Rel is a common regulatory element of the promoter region of the inflammatory cytokine genes, herein, we tested the hypothesis that acute ethanol affects NF - kappa B activation in human monocytes.	nuclear regulatory factor - kappa beta,17,55,Gene/Protein	regulatory element,90,108,Gene/Protein	promoter region,116,131,Gene/Protein	inflammatory cytokine genes,139,166,Gene/Protein	NF - kappa B,228,240,Gene/Protein	"[{""token"": ""nuclear regulatory factor - kappa beta"", ""start_span"": 17, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""regulatory element"", ""start_span"": 90, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""promoter region"", ""start_span"": 116, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""inflammatory cytokine genes"", ""start_span"": 139, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 228, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	train
Consequently, these results suggest that physiologically relevant concentrations of ethanol may affect production of inflammatory cytokines, such as tumor necrosis factor - alpha, interleukin - 1 beta, and interleukin - 6 by disrupting NF - kappa B signaling in monocytes.	inflammatory cytokines,117,139,Gene/Protein	tumor necrosis factor - alpha,149,178,Gene/Protein	interleukin - 1 beta,180,200,Gene/Protein	interleukin - 6,206,221,Gene/Protein	NF - kappa B,236,248,Gene/Protein	"[{""token"": ""inflammatory cytokines"", ""start_span"": 117, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 149, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1 beta"", ""start_span"": 180, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 6"", ""start_span"": 206, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 236, ""end_span"": 248, ""type"": ""Gene/Protein""}]"	train
The human G0 / G1 switch gene, G0S2, has potential NFAT - binding sites in the 5 ' flank and encodes a small basic potential phosphoprotein of unknown function.	human G0 / G1 switch gene,4,29,Gene/Protein	G0S2,31,35,Gene/Protein	NFAT - binding sites,51,71,Gene/Protein	5 ' flank,79,88,Gene/Protein	small basic potential phosphoprotein,103,139,Gene/Protein	"[{""token"": ""human G0 / G1 switch gene"", ""start_span"": 4, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""G0S2"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""NFAT - binding sites"", ""start_span"": 51, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""5 ' flank"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""small basic potential phosphoprotein"", ""start_span"": 103, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
For this purpose, human GATA - 3, either recombinant or in nuclear extracts, and three natural GATA elements of the HIV - 1 long terminal repeat ( sites 1, 2, and 3) were chosen, in which only site 2 is a noncanonical GATA site.	human GATA - 3,18,32,Gene/Protein	natural GATA elements,87,108,Gene/Protein	HIV - 1 long terminal repeat,116,144,Gene/Protein	site 2,193,199,Gene/Protein	GATA site,218,227,Gene/Protein	"[{""token"": ""human GATA - 3"", ""start_span"": 18, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""natural GATA elements"", ""start_span"": 87, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat"", ""start_span"": 116, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""site 2"", ""start_span"": 193, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""GATA site"", ""start_span"": 218, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
Flow cytometry analysis indicated that these cells were expressing high levels of vascular cell adhesion molecule 1 ( VCAM - 1 [ CD106]), a 110 - kDa member of the immunoglobulin gene superfamily, first identified on endothelial cells stimulated with inflammatory cytokines.	vascular cell adhesion molecule 1,82,115,Gene/Protein	VCAM - 1,118,126,Gene/Protein	CD106,129,134,Gene/Protein	immunoglobulin gene superfamily,164,195,Gene/Protein	inflammatory cytokines,251,273,Gene/Protein	"[{""token"": ""vascular cell adhesion molecule 1"", ""start_span"": 82, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""CD106"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin gene superfamily"", ""start_span"": 164, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""inflammatory cytokines"", ""start_span"": 251, ""end_span"": 273, ""type"": ""Gene/Protein""}]"	train
We now show that IL - 2 regulation of STAT3 proteins in T cells is a complex response involving activation of two forms of STAT3: 90 - kDa STAT3alpha and an 83 - kDa carboxyl - terminal truncated STAT3beta.	IL - 2,17,23,Gene/Protein	STAT3 proteins,38,52,Gene/Protein	STAT3,123,128,Gene/Protein	STAT3alpha,139,149,Gene/Protein	83 - kDa carboxyl - terminal truncated STAT3beta,157,205,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""STAT3 proteins"", ""start_span"": 38, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""STAT3alpha"", ""start_span"": 139, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""83 - kDa carboxyl - terminal truncated STAT3beta"", ""start_span"": 157, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
In vitro, the ICAM - 1 kappa B site appeared to bind RelA and c - Rel homodimers as well as heterodimers with NF - kappa B1, but weakly NF - kappa B1 homodimers.	ICAM - 1 kappa B site,14,35,Gene/Protein	RelA,53,57,Gene/Protein	c - Rel homodimers,62,80,Gene/Protein	NF - kappa B1,110,123,Gene/Protein	NF - kappa B1 homodimers,136,160,Gene/Protein	"[{""token"": ""ICAM - 1 kappa B site"", ""start_span"": 14, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel homodimers"", ""start_span"": 62, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B1"", ""start_span"": 110, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B1 homodimers"", ""start_span"": 136, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
Here we show that in E29. 1 T cell hybridoma I kappa B alpha and I kappa B beta are equally associated with p65 and that I kappa B beta is degraded in response to TNF alpha in contrast to what has been originally published.	I kappa B alpha,45,60,Gene/Protein	I kappa B beta,65,79,Gene/Protein	p65,108,111,Gene/Protein	I kappa B beta,121,135,Gene/Protein	TNF alpha,163,172,Gene/Protein	"[{""token"": ""I kappa B alpha"", ""start_span"": 45, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B beta"", ""start_span"": 65, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B beta"", ""start_span"": 121, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""TNF alpha"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
G28 - 5 IgG partially blocked, whereas G28 - 5 sFv augmented CD40 responses during stimulation with natural ligand ( gp39 - CD8 fusion protein).	G28 - 5 IgG,0,11,Gene/Protein	G28 - 5 sFv,39,50,Gene/Protein	CD40,61,65,Gene/Protein	natural ligand,100,114,Gene/Protein	gp39 - CD8 fusion protein,117,142,Gene/Protein	"[{""token"": ""G28 - 5 IgG"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""G28 - 5 sFv"", ""start_span"": 39, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""natural ligand"", ""start_span"": 100, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""gp39 - CD8 fusion protein"", ""start_span"": 117, ""end_span"": 142, ""type"": ""Gene/Protein""}]"	train
Promoter activity was increased by the transcription factors C / EBPbeta ( NF - IL6) and more strongly, by C / EBPdelta ( NF - IL6beta).	transcription factors,39,60,Gene/Protein	C / EBPbeta,61,72,Gene/Protein	NF - IL6,75,83,Gene/Protein	C / EBPdelta,107,119,Gene/Protein	NF - IL6beta,122,134,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 39, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""C / EBPbeta"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""C / EBPdelta"", ""start_span"": 107, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6beta"", ""start_span"": 122, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
The molecular mechanisms underlying the IL - 7 effect involve the upregulation of the DNA binding activity of NFAT ( 60%) and AP - 1 ( 120%), without affecting the activities of NFkappaB and CD28RC, which was confirmed by transfection assays.	IL - 7,40,46,Gene/Protein	NFAT,110,114,Gene/Protein	AP - 1,126,132,Gene/Protein	NFkappaB,178,186,Gene/Protein	CD28RC,191,197,Gene/Protein	"[{""token"": ""IL - 7"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""CD28RC"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
Since AP - 1 is part of the NFAT complex, we conclude that the IL - 7 - signaling pathway is involved in the activation of the fos and jun proteins of which AP - 1 consists.	AP - 1,6,12,Gene/Protein	NFAT complex,28,40,Gene/Protein	IL - 7,63,69,Gene/Protein	fos and jun proteins,127,147,Gene/Protein	AP - 1,157,163,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""NFAT complex"", ""start_span"": 28, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""fos and jun proteins"", ""start_span"": 127, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
Proteasome - dependent inhibitory kappa B alpha ( I kappa B alpha) and I kappa B beta degradation occurred downstream of CD40 ligation and preceded CD40 - mediated NF - kappa B nuclear translocation.	I kappa B alpha,50,65,Gene/Protein	I kappa B beta,71,85,Gene/Protein	CD40,121,125,Gene/Protein	CD40,148,152,Gene/Protein	NF - kappa B,164,176,Gene/Protein	"[{""token"": ""I kappa B alpha"", ""start_span"": 50, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B beta"", ""start_span"": 71, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 164, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
However, NF - kappa B activation was insufficient for CD40 - mediated up - regulation of B7 - 1, Fas, and CD23.	NF - kappa B,9,21,Gene/Protein	CD40,54,58,Gene/Protein	B7 - 1,89,95,Gene/Protein	Fas,97,100,Gene/Protein	CD23,106,110,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 9, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""B7 - 1"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""Fas"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene/Protein""}]"	train
One of the proteins that binds to these sites is TRAF2, a signal transduction molecule that is also utilized by TNFR1 to mediate the activation of several downstream kinases and transcription factors.	TRAF2,49,54,Gene/Protein	signal transduction molecule,58,86,Gene/Protein	TNFR1,112,117,Gene/Protein	kinases,166,173,Gene/Protein	transcription factors,178,199,Gene/Protein	"[{""token"": ""TRAF2"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""signal transduction molecule"", ""start_span"": 58, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""TNFR1"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""kinases"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 178, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
Low proliferative capacity was observed after 1 week in culture in the presence of stem cell factor ( SCF) + Flt - 3 ligand ( FL) + G - CSF.	stem cell factor,83,99,Gene/Protein	SCF,102,105,Gene/Protein	Flt - 3 ligand,109,123,Gene/Protein	FL,126,128,Gene/Protein	G - CSF,132,139,Gene/Protein	"[{""token"": ""stem cell factor"", ""start_span"": 83, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Flt - 3 ligand"", ""start_span"": 109, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""FL"", ""start_span"": 126, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
Recent studies from our laboratory have indicated that protein tyrosine phosphatase ( PTPase) inhibitors can down - modulate the tumor necrosis factor ( TNF) - mediated activation of the nuclear transcription factor NF - kappa B in ML - 1a, a monocytic cell line ( Singh and Aggarwal, J. Biol. Chem. 1995: 270: 10631).	protein tyrosine phosphatase,55,83,Gene/Protein	PTPase,86,92,Gene/Protein	tumor necrosis factor,129,150,Gene/Protein	TNF,153,156,Gene/Protein	nuclear transcription factor NF - kappa B,187,228,Gene/Protein	"[{""token"": ""protein tyrosine phosphatase"", ""start_span"": 55, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""PTPase"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 129, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""nuclear transcription factor NF - kappa B"", ""start_span"": 187, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	train
Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF - kappa B, we examined the effect of PTPase inhibitors on the TNF - mediated induction of intracellular adhesion molecule ( ICAM) - 1, vascular cell adhesion molecule ( VCAM) - 1 and endothelial leukocyte adhesion molecule ( ELAM) - 1.	TNF,6,9,Gene/Protein	adhesion molecules,50,68,Gene/Protein	NF - kappa B,155,167,Gene/Protein	PTPase,195,201,Gene/Protein	TNF,220,223,Gene/Protein	"[{""token"": ""TNF"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""adhesion molecules"", ""start_span"": 50, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 155, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""PTPase"", ""start_span"": 195, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 220, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
This inhibition is selective, as the activity of four other transcription factors, Oct - 1, TBP, Sp1 and STAT 5 was not affected.	transcription factors,60,81,Gene/Protein	Oct - 1,83,90,Gene/Protein	TBP,92,95,Gene/Protein	Sp1,97,100,Gene/Protein	STAT 5,105,111,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 60, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""TBP"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""STAT 5"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Gene/Protein""}]"	train
We also identified Sp1, Sp3, and NGFI - A / Egr - 1 as the primary nuclear transcription factors binding to TRE1 which mediate Tax responsiveness.	Sp1,19,22,Gene/Protein	NGFI - A / Egr - 1,33,51,Gene/Protein	primary nuclear transcription factors,59,96,Gene/Protein	TRE1,108,112,Gene/Protein	Tax,127,130,Gene/Protein	"[{""token"": ""Sp1"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""NGFI - A / Egr - 1"", ""start_span"": 33, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""primary nuclear transcription factors"", ""start_span"": 59, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""TRE1"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}]"	train
In summary, our data reveal a novel effector of LMP - 1, the SEK / JNK / c - Jun / AP - 1 pathway, which contributes to our understanding of the immortalizing and transforming potential of LMP - 1.	LMP - 1,48,55,Gene/Protein	JNK,67,70,Gene/Protein	c - Jun,73,80,Gene/Protein	AP - 1,83,89,Gene/Protein	LMP - 1,189,196,Gene/Protein	"[{""token"": ""LMP - 1"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 83, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""LMP - 1"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
Cloning of the cDNA encoding human SR - BP shows an open reading frame for a 223 - amino acid protein, which is homologous to the recently cloned sigma 1 receptor.	cDNA,15,19,Gene/Protein	human SR - BP,29,42,Gene/Protein	open reading frame,52,70,Gene/Protein	223 - amino acid protein,77,101,Gene/Protein	sigma 1 receptor,146,162,Gene/Protein	"[{""token"": ""cDNA"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""human SR - BP"", ""start_span"": 29, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""open reading frame"", ""start_span"": 52, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""223 - amino acid protein"", ""start_span"": 77, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""sigma 1 receptor"", ""start_span"": 146, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
The JAK ( Janus kinase) family of protein tyrosine kinases and the STATs ( signal transducers and activators of transcription) have been shown to be activated in response to a number of cytokines and growth factors.	protein tyrosine kinases,34,58,Gene/Protein	STATs,67,72,Gene/Protein	signal transducers and activators of transcription,75,125,Gene/Protein	cytokines,186,195,Gene/Protein	growth factors,200,214,Gene/Protein	"[{""token"": ""protein tyrosine kinases"", ""start_span"": 34, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""STATs"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers and activators of transcription"", ""start_span"": 75, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 186, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""growth factors"", ""start_span"": 200, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
METHODS AND RESULTS: Incubation of human whole blood with platelet - activating factor ( PAF, 1 mumol / L) evoked downregulation of L - selectin and upregulation of CD11 / CD18 adhesion receptors on neutrophils as measured by flow cytometry.	platelet - activating factor,58,86,Gene/Protein	PAF,89,92,Gene/Protein	L - selectin,132,144,Gene/Protein	CD11 / CD18,165,176,Gene/Protein	adhesion receptors,177,195,Gene/Protein	"[{""token"": ""platelet - activating factor"", ""start_span"": 58, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""L - selectin"", ""start_span"": 132, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""CD11 / CD18"", ""start_span"": 165, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""adhesion receptors"", ""start_span"": 177, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
In this paper, we demonstrate that PIF is Egr - 1 based on its recognition by anti - Egr - 1 antisera in gel mobility shift assays, even though the IL - 2Rbeta DNA binding motif differed substantially from the canonical Egr - 1 binding site.	PIF,35,38,Gene/Protein	Egr - 1,42,49,Gene/Protein	Egr - 1,85,92,Gene/Protein	IL - 2Rbeta DNA binding motif,148,177,Gene/Protein	Egr - 1 binding site,220,240,Gene/Protein	"[{""token"": ""PIF"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2Rbeta DNA binding motif"", ""start_span"": 148, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1 binding site"", ""start_span"": 220, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	train
In contrast, when HSF2 - beta is expressed at levels exceeding those of endogenous HSF2 - alpha, the hemin - induced DNA binding activity and transcription of heat shock genes are repressed, whereas overexpression of HSF2 - alpha results in an enhanced hemin response.	HSF2 - beta,18,29,Gene/Protein	endogenous HSF2 - alpha,72,95,Gene/Protein	heat shock genes,159,175,Gene/Protein	HSF2 - alpha,217,229,Gene/Protein	hemin,253,258,Gene/Protein	"[{""token"": ""HSF2 - beta"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""endogenous HSF2 - alpha"", ""start_span"": 72, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""heat shock genes"", ""start_span"": 159, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""HSF2 - alpha"", ""start_span"": 217, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""hemin"", ""start_span"": 253, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	train
A membrane - proximal region that contains the BOX1 consensus sequence is required for IL - 9 - induced cell proliferation and tyrosine phosphorylation of Janus kinases ( JAKs).	membrane - proximal region,2,28,Gene/Protein	BOX1 consensus sequence,47,70,Gene/Protein	IL - 9,87,93,Gene/Protein	Janus kinases,155,168,Gene/Protein	JAKs,171,175,Gene/Protein	"[{""token"": ""membrane - proximal region"", ""start_span"": 2, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""BOX1 consensus sequence"", ""start_span"": 47, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinases"", ""start_span"": 155, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""JAKs"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
Deletion of this region significantly impaired IL - 9 - induced cell growth, activation of JAK kinases, insulin receptor substrate - 2, and STAT3 and expression of early response genes.	IL - 9,47,53,Gene/Protein	JAK kinases,91,102,Gene/Protein	insulin receptor substrate - 2,104,134,Gene/Protein	STAT3,140,145,Gene/Protein	early response genes,164,184,Gene/Protein	"[{""token"": ""IL - 9"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""JAK kinases"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""insulin receptor substrate - 2"", ""start_span"": 104, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""early response genes"", ""start_span"": 164, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
A point mutation changing YLPQ into YLPA greatly reduced IL - 9 - induced activation of STAT3 and expression of c - myc but did not affect cell proliferation.	YLPQ,26,30,Gene/Protein	YLPA,36,40,Gene/Protein	IL - 9,57,63,Gene/Protein	STAT3,88,93,Gene/Protein	c - myc,112,119,Gene/Protein	"[{""token"": ""YLPQ"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""YLPA"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene/Protein""}]"	train
By using several HBD subfragments, the mAb 18C7 epitope was located in the N - terminal region of the HBD from Thr729 to Leu765.	HBD subfragments,17,33,Gene/Protein	mAb 18C7 epitope,39,55,Gene/Protein	N - terminal region,75,94,Gene/Protein	HBD,102,105,Gene/Protein	Thr729 to Leu765,111,127,Gene/Protein	"[{""token"": ""HBD subfragments"", ""start_span"": 17, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""mAb 18C7 epitope"", ""start_span"": 39, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal region"", ""start_span"": 75, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""HBD"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Thr729 to Leu765"", ""start_span"": 111, ""end_span"": 127, ""type"": ""Gene/Protein""}]"	train
Here we show that ETS1 can transactivate a GM - CSF reporter construct in unstimulated Jurkat cells, providing that either NFkappaB or AP1 transcription factors are supplied by co - transfection.	ETS1,18,22,Gene/Protein	GM - CSF reporter construct,43,70,Gene/Protein	NFkappaB,123,131,Gene/Protein	AP1,135,138,Gene/Protein	transcription factors,139,160,Gene/Protein	"[{""token"": ""ETS1"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF reporter construct"", ""start_span"": 43, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""AP1"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 139, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
Fine mapping by in vivo footprinting demonstrated five transcription factor binding sites that are occupied in both resting and activated peripheral blood T lymphocytes; these are tandem CRE motifs, a Sp1 site, an overlapping Egr - 1 / Sp1 site, and a novel palindromic octamer sequence ( POS).	tandem CRE motifs,180,197,Gene/Protein	Sp1 site,201,209,Gene/Protein	Egr - 1 / Sp1 site,226,244,Gene/Protein	palindromic octamer sequence,258,286,Gene/Protein	POS,289,292,Gene/Protein	"[{""token"": ""tandem CRE motifs"", ""start_span"": 180, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 site"", ""start_span"": 201, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1 / Sp1 site"", ""start_span"": 226, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""palindromic octamer sequence"", ""start_span"": 258, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""POS"", ""start_span"": 289, ""end_span"": 292, ""type"": ""Gene/Protein""}]"	train
Unlike published studies with pyrrolidinedithiocar, which specifically inhibited vascular cell adhesion molecule 1 ( VCAM - 1), NAC inhibited IL - 1 beta - induced mRNA and cell surface expression of both E - selectin and VCAM - 1.	vascular cell adhesion molecule 1,81,114,Gene/Protein	VCAM - 1,117,125,Gene/Protein	IL - 1 beta - induced mRNA,142,168,Gene/Protein	E - selectin,205,217,Gene/Protein	VCAM - 1,222,230,Gene/Protein	"[{""token"": ""vascular cell adhesion molecule 1"", ""start_span"": 81, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 beta - induced mRNA"", ""start_span"": 142, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 205, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 222, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
Therefore, we have constructed a single cDNA that encodes a single - chain protein, called Flexi - 12, which retains all of the biological characteristics of recombinant IL - 12 ( rIL - 12).	cDNA,40,44,Gene/Protein	single - chain protein,60,82,Gene/Protein	Flexi - 12,91,101,Gene/Protein	IL - 12,170,177,Gene/Protein	rIL - 12,180,188,Gene/Protein	"[{""token"": ""cDNA"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""single - chain protein"", ""start_span"": 60, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""Flexi - 12"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 170, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""rIL - 12"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
Next, in an effort to determine critical transcription factors that regulate CD95 ligand expression, we demonstrate a cyclosporin A - sensitive nuclear factor - AT response element in the promoter region of this gene that is critical for optimal CD95 ligand reporter activity in stimulated T cells.	transcription factors,41,62,Gene/Protein	CD95 ligand,77,88,Gene/Protein	cyclosporin A - sensitive nuclear factor - AT response element,118,180,Gene/Protein	promoter region,188,203,Gene/Protein	CD95 ligand,246,257,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 41, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CD95 ligand"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""cyclosporin A - sensitive nuclear factor - AT response element"", ""start_span"": 118, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""promoter region"", ""start_span"": 188, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""CD95 ligand"", ""start_span"": 246, ""end_span"": 257, ""type"": ""Gene/Protein""}]"	train
Stimulation of cells with IFN - alpha leads to the assembly of IFN - stimulated gene factor 3 transcription factor complex formed by STAT1, STAT2, and p48 protein.	IFN - alpha,26,37,Gene/Protein	IFN - stimulated gene factor 3 transcription factor complex,63,122,Gene/Protein	STAT1,133,138,Gene/Protein	STAT2,140,145,Gene/Protein	p48 protein,151,162,Gene/Protein	"[{""token"": ""IFN - alpha"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""IFN - stimulated gene factor 3 transcription factor complex"", ""start_span"": 63, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""STAT2"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""p48 protein"", ""start_span"": 151, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
This suggests that higher intracellular levels of STAT1, STAT2, and p48 protein may result in enhanced signal transduction for cytokines utilizing these transcription factors.	STAT1,50,55,Gene/Protein	STAT2,57,62,Gene/Protein	p48 protein,68,79,Gene/Protein	cytokines,127,136,Gene/Protein	transcription factors,153,174,Gene/Protein	"[{""token"": ""STAT1"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""STAT2"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""p48 protein"", ""start_span"": 68, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 127, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 153, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
Effects of TPA, bryostatin 1, and retinoic acid on PO - B, AP - 1, and AP - 2 DNA binding during HL - 60 differentiation.	TPA,11,14,Gene/Protein	bryostatin 1,16,28,Gene/Protein	PO - B,51,57,Gene/Protein	AP - 1,59,65,Gene/Protein	AP - 2,71,77,Gene/Protein	"[{""token"": ""TPA"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""bryostatin 1"", ""start_span"": 16, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""PO - B"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene/Protein""}]"	train
Aggregation was likely caused by the up - regulated surface expression of adhesion molecules including integrin alpha, L - selectin, ICAM - 3, and H - CAM.	adhesion molecules,74,92,Gene/Protein	integrin alpha,103,117,Gene/Protein	L - selectin,119,131,Gene/Protein	ICAM - 3,133,141,Gene/Protein	H - CAM,147,154,Gene/Protein	"[{""token"": ""adhesion molecules"", ""start_span"": 74, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""integrin alpha"", ""start_span"": 103, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""L - selectin"", ""start_span"": 119, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 3"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""H - CAM"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
We show here that c - Raf, which is at the helm of the classic MAP - Erk cascade, contributes to IL - 2 induction through a distal enhancer element spanning the nucleotides from positions - 502 to - 413 in front of the transcriptional start site of the IL - 2 gene.	c - Raf,18,25,Gene/Protein	Erk,69,72,Gene/Protein	IL - 2,97,103,Gene/Protein	distal enhancer element,124,147,Gene/Protein	IL - 2 gene,253,264,Gene/Protein	"[{""token"": ""c - Raf"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""Erk"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""distal enhancer element"", ""start_span"": 124, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 gene"", ""start_span"": 253, ""end_span"": 264, ""type"": ""Gene/Protein""}]"	train
Introduction of point mutations suppressing GABP binding to the DSE interfered with the induction of the distal enhancer and the entire IL - 2 promoter - enhancer, while overexpression of both GABP factors enhanced the IL - 2 promoter - enhancer induction.	DSE,64,67,Gene/Protein	distal enhancer,105,120,Gene/Protein	IL - 2 promoter - enhancer,136,162,Gene/Protein	GABP factors,193,205,Gene/Protein	IL - 2 promoter - enhancer,219,245,Gene/Protein	"[{""token"": ""DSE"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""distal enhancer"", ""start_span"": 105, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter - enhancer"", ""start_span"": 136, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""GABP factors"", ""start_span"": 193, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter - enhancer"", ""start_span"": 219, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
In conjunction with previously published data on c - Raf - induced phosphorylation of GABP factors ( E. Flory, A. Hoffmeyer, U. Smola, U. R. Rapp, and J. T. Bruder, J. Virol. 70: 2260 - 2268, 1996), these results indicate a contribution of GABP factors to the Raf - mediated enhancement of IL - 2 induction during T - cell activation.	c - Raf,49,56,Gene/Protein	GABP factors,86,98,Gene/Protein	GABP factors,240,252,Gene/Protein	Raf,260,263,Gene/Protein	IL - 2,290,296,Gene/Protein	"[{""token"": ""c - Raf"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""GABP factors"", ""start_span"": 86, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""GABP factors"", ""start_span"": 240, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""Raf"", ""start_span"": 260, ""end_span"": 263, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 290, ""end_span"": 296, ""type"": ""Gene/Protein""}]"	train
We found that IL - 2, interferon - alpha ( IFN - alpha), and IFN - beta inhibited IL - 2 deprivation apoptosis in Th0, Th1, and Th2 clones.	IL - 2,14,20,Gene/Protein	interferon - alpha,22,40,Gene/Protein	IFN - alpha,43,54,Gene/Protein	IFN - beta,61,71,Gene/Protein	IL - 2,82,88,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""interferon - alpha"", ""start_span"": 22, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IFN - beta"", ""start_span"": 61, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene/Protein""}]"	train
We also found that IL - 2 protects T cell clones from IL - 2 deprivation apoptosis accompanying active proliferation and enhanced expression of P53, Rb and Bcl - xL proteins.	IL - 2,19,25,Gene/Protein	IL - 2,54,60,Gene/Protein	P53,144,147,Gene/Protein	Rb,149,151,Gene/Protein	Bcl - xL proteins,156,173,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""P53"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 149, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - xL proteins"", ""start_span"": 156, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
In this study, we investigated the mechanism by which IL - 10 downregulates expression of intercellular adhesion molecule - 1 ( ICAM - 1) on the cell surface of normal human monocytes activated with interferon - gamma ( IFN - gamma).	IL - 10,54,61,Gene/Protein	intercellular adhesion molecule - 1,90,125,Gene/Protein	ICAM - 1,128,136,Gene/Protein	interferon - gamma,199,217,Gene/Protein	IFN - gamma,220,231,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 90, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""interferon - gamma"", ""start_span"": 199, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 220, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
Nuclear run - on transcription assays showed that IL - 10 inhibited the rate of IFN - gamma - induced transcription of the ICAM - 1 gene, and mRNA stability studies showed that IL - 10 did not alter the half - life of IFN - gamma - induced ICAM - 1 message.	IL - 10,50,57,Gene/Protein	IFN - gamma,80,91,Gene/Protein	ICAM - 1 gene,123,136,Gene/Protein	IL - 10,177,184,Gene/Protein	IFN - gamma - induced ICAM - 1 message,218,256,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1 gene"", ""start_span"": 123, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma - induced ICAM - 1 message"", ""start_span"": 218, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
We have previously shown that in T cells the PI3 - K inhibitor, wortmannin, interferes with activation of the mitogen - activated kinase, Erk2, after T cell receptor ( TcR) stimulation.	PI3 - K,45,52,Gene/Protein	mitogen - activated kinase,110,136,Gene/Protein	Erk2,138,142,Gene/Protein	T cell receptor,150,165,Gene/Protein	TcR,168,171,Gene/Protein	"[{""token"": ""PI3 - K"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated kinase"", ""start_span"": 110, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""Erk2"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""T cell receptor"", ""start_span"": 150, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""TcR"", ""start_span"": 168, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
Following TcR stimulation, activation of Erk2 was only inhibited by a previously described truncated form of p85 that can not bind the catalytic subunit, but not by other constructs of p85.	TcR,10,13,Gene/Protein	Erk2,41,45,Gene/Protein	truncated form of p85,91,112,Gene/Protein	catalytic subunit,135,152,Gene/Protein	p85,185,188,Gene/Protein	"[{""token"": ""TcR"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""Erk2"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""truncated form of p85"", ""start_span"": 91, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""catalytic subunit"", ""start_span"": 135, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""p85"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
Most interestingly, the N - terminal SH2 domain had an inhibitory effect, whereas a mutant p85 containing only the two SH2 domains enhanced basal NFAT activity in a Ras - dependent manner.	N - terminal SH2 domain,24,47,Gene/Protein	mutant p85,84,94,Gene/Protein	two SH2 domains,115,130,Gene/Protein	NFAT,146,150,Gene/Protein	Ras,165,168,Gene/Protein	"[{""token"": ""N - terminal SH2 domain"", ""start_span"": 24, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""mutant p85"", ""start_span"": 84, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""two SH2 domains"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
Nonetheless, CREB, Ets - 1, and AML1 bind and activate cooperatively and very efficiently through the nonconsensus binding sites at the core promoter region.	CREB,13,17,Gene/Protein	Ets - 1,19,26,Gene/Protein	AML1,32,36,Gene/Protein	nonconsensus binding sites,102,128,Gene/Protein	core promoter region,136,156,Gene/Protein	"[{""token"": ""CREB"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""Ets - 1"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""AML1"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""nonconsensus binding sites"", ""start_span"": 102, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""core promoter region"", ""start_span"": 136, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
Binding assays using 125I - labeled C - C chemokines in mammalian cells indicated that CHEMR1 did not bind MIP - 1alpha, RANTES, or MIP - 1beta, whereas CCR - 1 binds MIP - 1alpha and RANTES.	125I - labeled C - C chemokines,21,52,Gene/Protein	CHEMR1,87,93,Gene/Protein	CCR - 1,153,160,Gene/Protein	MIP - 1alpha,167,179,Gene/Protein	RANTES,184,190,Gene/Protein	"[{""token"": ""125I - labeled C - C chemokines"", ""start_span"": 21, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""CHEMR1"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""CCR - 1"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 1alpha"", ""start_span"": 167, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""RANTES"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
Cyclin A was observed after 4 days of costimulation with anti CD2 + CD28 whereas stimulation by anti CD2 or anti CD28 alone was not effective.	Cyclin A,0,8,Gene/Protein	anti CD2,57,65,Gene/Protein	CD28,68,72,Gene/Protein	anti CD2,96,104,Gene/Protein	anti CD28,108,117,Gene/Protein	"[{""token"": ""Cyclin A"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""anti CD2"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""anti CD2"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""anti CD28"", ""start_span"": 108, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
An enhancer - blocking element ( BEAD - 1, for blocking element alpha / delta 1) was localized to a 2. 0 - kb region 3 ' of TCR delta gene segments and 5 ' of TCR alpha joining gene segments within this locus.	enhancer - blocking element,3,30,Gene/Protein	BEAD - 1,33,41,Gene/Protein	element alpha / delta 1,56,79,Gene/Protein	TCR delta gene segments,124,147,Gene/Protein	TCR alpha joining gene segments,159,190,Gene/Protein	"[{""token"": ""enhancer - blocking element"", ""start_span"": 3, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""BEAD - 1"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""element alpha / delta 1"", ""start_span"": 56, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""TCR delta gene segments"", ""start_span"": 124, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""TCR alpha joining gene segments"", ""start_span"": 159, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
In vivo footprinting identified protected regions over the known high affinity B cell lineage - specific activator protein ( BSAP) site, the low affinity BSAP site, a SP1 / Egr - 1 site termed the CD19 GC box, and two novel sites named the AT box and PyG box.	low affinity BSAP site,141,163,Gene/Protein	SP1 / Egr - 1 site,167,185,Gene/Protein	CD19 GC box,197,208,Gene/Protein	AT box,240,246,Gene/Protein	PyG box,251,258,Gene/Protein	"[{""token"": ""low affinity BSAP site"", ""start_span"": 141, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""SP1 / Egr - 1 site"", ""start_span"": 167, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""CD19 GC box"", ""start_span"": 197, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""AT box"", ""start_span"": 240, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""PyG box"", ""start_span"": 251, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	train
To test this latter possibility, a chimeric receptor containing the extracellular domain of c - kit ( the stem cell factor ( SCF) receptor) and the cytoplasmic and transmembrane domains of the IL - 4R alpha chain was generated.	chimeric receptor,35,52,Gene/Protein	extracellular domain,68,88,Gene/Protein	c - kit,92,99,Gene/Protein	cytoplasmic and transmembrane domains,148,185,Gene/Protein	IL - 4R alpha chain,193,212,Gene/Protein	"[{""token"": ""chimeric receptor"", ""start_span"": 35, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""extracellular domain"", ""start_span"": 68, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""c - kit"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic and transmembrane domains"", ""start_span"": 148, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R alpha chain"", ""start_span"": 193, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	train
SCF - mediated ligation of kit / IL - 4R alpha is sufficient to elicit IL - 4 - specific gene expression, including up - regulation of CD23 and synthesis of germ - line epsilon transcripts.	SCF,0,3,Gene/Protein	kit / IL - 4R alpha,27,46,Gene/Protein	IL - 4,71,77,Gene/Protein	CD23,135,139,Gene/Protein	germ - line epsilon transcripts,157,188,Gene/Protein	"[{""token"": ""SCF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""kit / IL - 4R alpha"", ""start_span"": 27, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""germ - line epsilon transcripts"", ""start_span"": 157, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP - Jkappa or nuclear localization sequences retain the ability to associate with RBP - Jkappa and activate transcription.	NOTCH1,19,25,Gene/Protein	primary binding site,45,65,Gene/Protein	RBP - Jkappa,70,82,Gene/Protein	nuclear localization sequences,86,116,Gene/Protein	RBP - Jkappa,154,166,Gene/Protein	"[{""token"": ""NOTCH1"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""primary binding site"", ""start_span"": 45, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""RBP - Jkappa"", ""start_span"": 70, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""nuclear localization sequences"", ""start_span"": 86, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""RBP - Jkappa"", ""start_span"": 154, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
EMS analyses performed with nuclear extracts from Tax - expressing Jurkat cells and HTLV - I - transformed peripheral blood mononuclear cells demonstrate that Tax prevents the formation of U1 ( U1A / U1B) and U2 DNA - protein complexes.	Tax,50,53,Gene/Protein	U1,189,191,Gene/Protein	U1A / U1B,194,203,Gene/Protein	U2,209,211,Gene/Protein	DNA - protein complexes,212,235,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""U1"", ""start_span"": 189, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""U1A / U1B"", ""start_span"": 194, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""U2"", ""start_span"": 209, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""DNA - protein complexes"", ""start_span"": 212, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
The nuclear factor kappaB ( NF - kappaB) is thought to be crucially involved in the gene activation of several cytokines, including tumor necrosis factor alpha ( TNF).	nuclear factor kappaB,4,25,Gene/Protein	NF - kappaB,28,39,Gene/Protein	cytokines,111,120,Gene/Protein	tumor necrosis factor alpha,132,159,Gene/Protein	TNF,162,165,Gene/Protein	"[{""token"": ""nuclear factor kappaB"", ""start_span"": 4, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 111, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 132, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
Human neutrophil elastase proteolytically activates the platelet integrin alphaIIbbeta3 through cleavage of the carboxyl terminus of the alphaIIb subunit heavy chain.	Human neutrophil elastase,0,25,Gene/Protein	platelet integrin,56,73,Gene/Protein	alphaIIbbeta3,74,87,Gene/Protein	carboxyl terminus,112,129,Gene/Protein	alphaIIb subunit heavy chain,137,165,Gene/Protein	"[{""token"": ""Human neutrophil elastase"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""platelet integrin"", ""start_span"": 56, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""alphaIIbbeta3"", ""start_span"": 74, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""carboxyl terminus"", ""start_span"": 112, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""alphaIIb subunit heavy chain"", ""start_span"": 137, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
Using flow cytometry analysis, NE was shown to trigger a time - dependent binding of PAC - 1 and AP - 5, two monoclonal antibodies specific for the activated and ligand - occupied conformers of alphaIIbbeta3.	NE,31,33,Gene/Protein	PAC - 1,85,92,Gene/Protein	AP - 5,97,103,Gene/Protein	monoclonal antibodies,109,130,Gene/Protein	alphaIIbbeta3,194,207,Gene/Protein	"[{""token"": ""NE"", ""start_span"": 31, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""PAC - 1"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""AP - 5"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""monoclonal antibodies"", ""start_span"": 109, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""alphaIIbbeta3"", ""start_span"": 194, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
By contrast, phosphatidic acid accumulation, pleckstrin phosphorylation, and calcium mobilization produced by the combination of NE and threshold of cathepsin G were not significantly different from those measured with threshold of cathepsin G alone ( p > 0. 05), indicating that the phospholipase C / protein kinase C pathway is not involved in the potentiation of aggregation.	NE,129,131,Gene/Protein	cathepsin G,149,160,Gene/Protein	cathepsin G,232,243,Gene/Protein	phospholipase C,284,299,Gene/Protein	/ protein kinase C,300,318,Gene/Protein	"[{""token"": ""NE"", ""start_span"": 129, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""cathepsin G"", ""start_span"": 149, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""cathepsin G"", ""start_span"": 232, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""phospholipase C"", ""start_span"": 284, ""end_span"": 299, ""type"": ""Gene/Protein""}, {""token"": ""/ protein kinase C"", ""start_span"": 300, ""end_span"": 318, ""type"": ""Gene/Protein""}]"	train
The foregoing data, as well as the requirement of catalytically active NE to trigger alphaIIbbeta3 activation and potentiate threshold of cathepsin G - initiated platelet aggregation, led us to examine whether the structure of this integrin was affected by NE.	NE,71,73,Gene/Protein	alphaIIbbeta3,85,98,Gene/Protein	cathepsin G,138,149,Gene/Protein	integrin,232,240,Gene/Protein	NE,257,259,Gene/Protein	"[{""token"": ""NE"", ""start_span"": 71, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""alphaIIbbeta3"", ""start_span"": 85, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""cathepsin G"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""integrin"", ""start_span"": 232, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""NE"", ""start_span"": 257, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	train
Using electrophoretic mobility shift assays, the levels of nuclear regulatory proteins recognizing the AP - 1 consensus TRE motif, the proximal c - jun TRE - like promoter element, and the c - fos serum response element ( SRE) were determined in resting and stimulated T cells.	nuclear regulatory proteins,59,86,Gene/Protein	AP - 1 consensus TRE motif,103,129,Gene/Protein	proximal c - jun TRE - like promoter element,135,179,Gene/Protein	c - fos serum response element,189,219,Gene/Protein	SRE,222,225,Gene/Protein	"[{""token"": ""nuclear regulatory proteins"", ""start_span"": 59, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 consensus TRE motif"", ""start_span"": 103, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""proximal c - jun TRE - like promoter element"", ""start_span"": 135, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""c - fos serum response element"", ""start_span"": 189, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""SRE"", ""start_span"": 222, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	train
In the present study we have examined the immune modulating effects of RA on IL - 2 mRNA, another important cytokine for B cell immunoglobulin production, the expression of IL - 2 receptors on T cells, and the RA nuclear receptors.	IL - 2 mRNA,77,88,Gene/Protein	cytokine,108,116,Gene/Protein	immunoglobulin,128,142,Gene/Protein	IL - 2 receptors,173,189,Gene/Protein	RA nuclear receptors,210,230,Gene/Protein	"[{""token"": ""IL - 2 mRNA"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin"", ""start_span"": 128, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptors"", ""start_span"": 173, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""RA nuclear receptors"", ""start_span"": 210, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
The increase in IL - 6 luciferase activity occurs in the absence of the multiple response region, the area of the IL - 6 promoter responsive to IL - 1, TNF alpha, cyclic amp, and phorbol 12 - myristate 13 - acetate.	IL - 6,16,22,Gene/Protein	luciferase,23,33,Gene/Protein	IL - 6 promoter,114,129,Gene/Protein	IL - 1,144,150,Gene/Protein	TNF alpha,152,161,Gene/Protein	"[{""token"": ""IL - 6"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""luciferase"", ""start_span"": 23, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 promoter"", ""start_span"": 114, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""TNF alpha"", ""start_span"": 152, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
ALY, a context - dependent coactivator of LEF - 1 and AML - 1, is required for TCRalpha enhancer function.	ALY,0,3,Gene/Protein	context - dependent coactivator,7,38,Gene/Protein	LEF - 1,42,49,Gene/Protein	AML - 1,54,61,Gene/Protein	TCRalpha enhancer,79,96,Gene/Protein	"[{""token"": ""ALY"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""context - dependent coactivator"", ""start_span"": 7, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""AML - 1"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""TCRalpha enhancer"", ""start_span"": 79, ""end_span"": 96, ""type"": ""Gene/Protein""}]"	train
In the mouse Th2 D10 cells and in the human Th2 clones, POS - 1 ( designated POS - 1b) contains NF - IL6beta, Jun, and NF - ATc / p.	POS - 1,56,63,Gene/Protein	POS - 1b,77,85,Gene/Protein	NF - IL6beta,96,108,Gene/Protein	Jun,110,113,Gene/Protein	NF - ATc / p,119,131,Gene/Protein	"[{""token"": ""POS - 1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""POS - 1b"", ""start_span"": 77, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6beta"", ""start_span"": 96, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATc / p"", ""start_span"": 119, ""end_span"": 131, ""type"": ""Gene/Protein""}]"	train
Jak3 is constitutively associated with CD40, and this interaction requires a proline - rich sequence in the membrane - proximal region of CD40.	Jak3,0,4,Gene/Protein	CD40,39,43,Gene/Protein	proline - rich sequence,77,100,Gene/Protein	membrane - proximal region,108,134,Gene/Protein	CD40,138,142,Gene/Protein	"[{""token"": ""Jak3"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""proline - rich sequence"", ""start_span"": 77, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""membrane - proximal region"", ""start_span"": 108, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}]"	train
Using various constructs expressing a lacZ reporter gene under the control of the intact or three deleted forms of HIV - 1 LTR, we obtained evidence that the kappaB regulatory elements located in the U3 region are involved in cell - to - cell activation of HIV - 1 LTR.	lacZ reporter gene,38,56,Gene/Protein	HIV - 1 LTR,115,126,Gene/Protein	kappaB regulatory elements,158,184,Gene/Protein	U3 region,200,209,Gene/Protein	HIV - 1 LTR,257,268,Gene/Protein	"[{""token"": ""lacZ reporter gene"", ""start_span"": 38, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 115, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""kappaB regulatory elements"", ""start_span"": 158, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""U3 region"", ""start_span"": 200, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 257, ""end_span"": 268, ""type"": ""Gene/Protein""}]"	train
We now report that dimers consisting of p50 NFkappaB1, p65 RelA, and / or c - Rel are present in neutrophils and that the greater part of these protein complexes is physically associated with cytoplasmic IkappaB - alpha in resting cells.	p50 NFkappaB1,40,53,Gene/Protein	p65 RelA,55,63,Gene/Protein	c - Rel,74,81,Gene/Protein	protein complexes,144,161,Gene/Protein	cytoplasmic IkappaB - alpha,192,219,Gene/Protein	"[{""token"": ""p50 NFkappaB1"", ""start_span"": 40, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""p65 RelA"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""protein complexes"", ""start_span"": 144, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic IkappaB - alpha"", ""start_span"": 192, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Mutational analysis showed that optimal transcriptional activity required the GATA sequence at position - 24, and gel - shift assays further showed that the GATA - 2 transcription factor, but not GATA - 1, bound to this region of the PECAM - 1 promoter.	GATA sequence,78,91,Gene/Protein	- 24,104,108,Gene/Protein	GATA - 2 transcription factor,157,186,Gene/Protein	GATA - 1,196,204,Gene/Protein	PECAM - 1 promoter,234,252,Gene/Protein	"[{""token"": ""GATA sequence"", ""start_span"": 78, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""- 24"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 2 transcription factor"", ""start_span"": 157, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""PECAM - 1 promoter"", ""start_span"": 234, ""end_span"": 252, ""type"": ""Gene/Protein""}]"	train
Dexamethasone ( 10 ( - 8) M) repressed chloramphenicol acetyltransferase ( CAT) production by 75% in the wild - type fragment but not in a deletion mutant lacking the 19 - bp site.	chloramphenicol acetyltransferase,39,72,Gene/Protein	CAT,75,78,Gene/Protein	wild - type fragment,105,125,Gene/Protein	deletion mutant,139,154,Gene/Protein	19 - bp site,167,179,Gene/Protein	"[{""token"": ""chloramphenicol acetyltransferase"", ""start_span"": 39, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""wild - type fragment"", ""start_span"": 105, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""deletion mutant"", ""start_span"": 139, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""19 - bp site"", ""start_span"": 167, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
Expression of the HIV - 1 transactivator Tat recapitulated this phenotype and was associated with increased IL - 2 secretion in response to costimulation with CD3 plus CD28.	HIV - 1 transactivator,18,40,Gene/Protein	Tat,41,44,Gene/Protein	IL - 2,108,114,Gene/Protein	CD3,159,162,Gene/Protein	CD28,168,172,Gene/Protein	"[{""token"": ""HIV - 1 transactivator"", ""start_span"": 18, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Tat"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
When cells were exposed to C5b - 9, GTP - bound Ras in anti - C5b - 9 immunoprecipitates was increased 3. 2 - fold at 2 min, while GTP - bound Ras in anti - Ras immunoprecipitates was increased 2 - fold at 10 min.	C5b - 9,27,34,Gene/Protein	GTP - bound Ras,36,51,Gene/Protein	anti - C5b - 9 immunoprecipitates,55,88,Gene/Protein	GTP - bound Ras,131,146,Gene/Protein	anti - Ras immunoprecipitates,150,179,Gene/Protein	"[{""token"": ""C5b - 9"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""GTP - bound Ras"", ""start_span"": 36, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""anti - C5b - 9 immunoprecipitates"", ""start_span"": 55, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""GTP - bound Ras"", ""start_span"": 131, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""anti - Ras immunoprecipitates"", ""start_span"": 150, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
The role of mitogen - activated protein kinase ( MAPK) pathway on TCC - inducible mitotic signaling was evaluated by assessing DNA synthesis and activator protein 1 ( AP - 1) DNA - binding activity.	mitogen - activated protein kinase,12,46,Gene/Protein	MAPK,49,53,Gene/Protein	TCC,66,69,Gene/Protein	activator protein 1,145,164,Gene/Protein	AP - 1,167,173,Gene/Protein	"[{""token"": ""mitogen - activated protein kinase"", ""start_span"": 12, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""TCC"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""activator protein 1"", ""start_span"": 145, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 167, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
In addition to the existing isoform ( Pax - 5, which we have named Pax - 5a), we have isolated three new isoforms, Pax - 5b, Pax - 5d, and Pax - 5e, from murine spleen and B - lymphoid cell lines using library screenings and polymerase chain reaction amplification.	Pax - 5,38,45,Gene/Protein	Pax - 5a,67,75,Gene/Protein	Pax - 5b,115,123,Gene/Protein	Pax - 5d,125,133,Gene/Protein	Pax - 5e,139,147,Gene/Protein	"[{""token"": ""Pax - 5"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5a"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5b"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5d"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5e"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	train
Here we report that overexpression of Syk in the Lck - negative JCaM1 cells enabled the T cell antigen receptor / CD3 complex to induce a normal activation of the mitogen - activated protein kinase ( MAPK) pathway and expression of a nuclear factor of activated T cells reporter construct.	Syk,38,41,Gene/Protein	T cell antigen receptor / CD3 complex,88,125,Gene/Protein	mitogen - activated protein kinase,163,197,Gene/Protein	MAPK,200,204,Gene/Protein	nuclear factor of activated T cells,234,269,Gene/Protein	"[{""token"": ""Syk"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""T cell antigen receptor / CD3 complex"", ""start_span"": 88, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 163, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 234, ""end_span"": 269, ""type"": ""Gene/Protein""}]"	train
A Y341 - - > F mutant of Syk, which is deficient in its interaction with phospholipase Cy1 and Vav, was less efficient than wild - type Syk.	F mutant,13,21,Gene/Protein	Syk,25,28,Gene/Protein	phospholipase Cy1,73,90,Gene/Protein	Vav,95,98,Gene/Protein	wild - type Syk,124,139,Gene/Protein	"[{""token"": ""F mutant"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""Syk"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""phospholipase Cy1"", ""start_span"": 73, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""Vav"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""wild - type Syk"", ""start_span"": 124, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
Characterization of the NF - kappa B1 promoter identified an Egr - 1 site which was found to be essential for both the PMA / PHA - mediated induction as well as the synergistic activation observed after the expression of the RelA subunit of NF - kappa B and Egr - 1.	NF - kappa B1 promoter,24,46,Gene/Protein	Egr - 1 site,61,73,Gene/Protein	PHA,125,128,Gene/Protein	NF - kappa B,241,253,Gene/Protein	Egr - 1,258,265,Gene/Protein	"[{""token"": ""NF - kappa B1 promoter"", ""start_span"": 24, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1 site"", ""start_span"": 61, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 241, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1"", ""start_span"": 258, ""end_span"": 265, ""type"": ""Gene/Protein""}]"	train
In this report, we describe the cloning of human GATA - 4 ( hGATA - 4) and show that hGATA - 4 selectively interacts with the - 70 GATA site within the IL - 5 proximal promoter region.	human GATA - 4,43,57,Gene/Protein	hGATA - 4,60,69,Gene/Protein	hGATA - 4,85,94,Gene/Protein	- 70 GATA site,126,140,Gene/Protein	IL - 5 proximal promoter region,152,183,Gene/Protein	"[{""token"": ""human GATA - 4"", ""start_span"": 43, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""hGATA - 4"", ""start_span"": 60, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""hGATA - 4"", ""start_span"": 85, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""- 70 GATA site"", ""start_span"": 126, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5 proximal promoter region"", ""start_span"": 152, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
ATL - 16T cells express mRNA of three GATA - binding proteins, hGATA - 2, hGATA - 3 and hGATA - 4, and each of them has a potential to bind to the consensus ( A / T) GATA ( G / A) motif.	mRNA,24,28,Gene/Protein	GATA - binding proteins,38,61,Gene/Protein	hGATA - 2,63,72,Gene/Protein	hGATA - 3,74,83,Gene/Protein	hGATA - 4,88,97,Gene/Protein	"[{""token"": ""mRNA"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""GATA - binding proteins"", ""start_span"": 38, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""hGATA - 2"", ""start_span"": 63, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""hGATA - 3"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""hGATA - 4"", ""start_span"": 88, ""end_span"": 97, ""type"": ""Gene/Protein""}]"	train
We also show that calcineurin associated with the N - terminal domain of NFATx1 at multiple docking sites and caused a reduction of size, indicative of dephosphorylation, in NFATx1.	calcineurin,18,29,Gene/Protein	N - terminal domain,50,69,Gene/Protein	NFATx1,73,79,Gene/Protein	multiple docking sites,83,105,Gene/Protein	NFATx1,174,180,Gene/Protein	"[{""token"": ""calcineurin"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal domain"", ""start_span"": 50, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""NFATx1"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""multiple docking sites"", ""start_span"": 83, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""NFATx1"", ""start_span"": 174, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
NO derived from nNOS in glia inhibits the transcription factor nuclear factor kappaB ( NF kappaB) as NOS inhibitors enhance basal NF kappaB activation.	nNOS,16,20,Gene/Protein	transcription factor,42,62,Gene/Protein	nuclear factor kappaB,63,84,Gene/Protein	NF kappaB,87,96,Gene/Protein	NF kappaB,130,139,Gene/Protein	"[{""token"": ""nNOS"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 42, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappaB"", ""start_span"": 63, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""NF kappaB"", ""start_span"": 87, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""NF kappaB"", ""start_span"": 130, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
Our data suggest that nNOS in astrocytes regulates NF kappaB activity and iNOS expression, and indicate a novel regulatory role for nNOS in tonically suppressing central nervous system, NF kappaB - regulated genes.	nNOS,22,26,Gene/Protein	NF kappaB,51,60,Gene/Protein	iNOS,74,78,Gene/Protein	nNOS,132,136,Gene/Protein	NF kappaB - regulated genes,186,213,Gene/Protein	"[{""token"": ""nNOS"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""NF kappaB"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""iNOS"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""nNOS"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""NF kappaB - regulated genes"", ""start_span"": 186, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
A chimeric IL - 6 receptor, comprised of the intracellular tail of the IL - 6 receptor subunit gp130 fused to the extracellular domain of the epidermal growth factor ( EGF) receptor, was stably transfected into SKW6. 4 cells.	IL - 6 receptor,11,26,Gene/Protein	intracellular tail,45,63,Gene/Protein	IL - 6 receptor subunit,71,94,Gene/Protein	gp130,95,100,Gene/Protein	extracellular domain,114,134,Gene/Protein	"[{""token"": ""IL - 6 receptor"", ""start_span"": 11, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""intracellular tail"", ""start_span"": 45, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 receptor subunit"", ""start_span"": 71, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""gp130"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""extracellular domain"", ""start_span"": 114, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
To define further the relation between Stat3 activation and enhanced IgM production, we determined the effect of chimeric gp130 on the transcriptional activation of a genetic element linked to immunoglobulin production, namely the immunoglobulin heavy chain enhancer ( IgH - enhancer).	Stat3,39,44,Gene/Protein	IgM,69,72,Gene/Protein	immunoglobulin,193,207,Gene/Protein	immunoglobulin heavy chain enhancer,231,266,Gene/Protein	IgH - enhancer,269,283,Gene/Protein	"[{""token"": ""Stat3"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IgM"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin"", ""start_span"": 193, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin heavy chain enhancer"", ""start_span"": 231, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""IgH - enhancer"", ""start_span"": 269, ""end_span"": 283, ""type"": ""Gene/Protein""}]"	train
NF - Y is formed by three subunits, A, B, and C, all of which are necessary for DNA binding.	NF - Y,0,6,Gene/Protein	subunits,26,34,Gene/Protein	A,36,37,Gene/Protein	B,39,40,Gene/Protein	C,46,47,Gene/Protein	"[{""token"": ""NF - Y"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""subunits"", ""start_span"": 26, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""A"", ""start_span"": 36, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""B"", ""start_span"": 39, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""C"", ""start_span"": 46, ""end_span"": 47, ""type"": ""Gene/Protein""}]"	train
Furthermore a dominant negative form of AML1, AML1a, totally suppressed granulocytic differentiation otherwise induced by granulocyte colony - stimulating factor when AML1a was overexpressed in 32Dc13 murine myeloid cells.	dominant negative form,14,36,Gene/Protein	AML1,40,44,Gene/Protein	AML1a,46,51,Gene/Protein	granulocyte colony - stimulating factor,122,161,Gene/Protein	AML1a,167,172,Gene/Protein	"[{""token"": ""dominant negative form"", ""start_span"": 14, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""AML1"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""AML1a"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte colony - stimulating factor"", ""start_span"": 122, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""AML1a"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
Both MAP ERK kinase kinase - 1 ( MEKK1) and Raf are activated strongly by FMLP, but minimally by PAF.	MAP ERK kinase kinase - 1,5,30,Gene/Protein	MEKK1,33,38,Gene/Protein	Raf,44,47,Gene/Protein	FMLP,74,78,Gene/Protein	PAF,97,100,Gene/Protein	"[{""token"": ""MAP ERK kinase kinase - 1"", ""start_span"": 5, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""MEKK1"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Raf"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""FMLP"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}]"	train
These TRAF binding domains were shown to be functionally important for the RANK - dependent induction of NF - kappaB and c - Jun NH2 - terminal kinase activities.	TRAF binding domains,6,26,Gene/Protein	RANK,75,79,Gene/Protein	NF - kappaB,105,116,Gene/Protein	c - Jun,121,128,Gene/Protein	NH2 - terminal kinase,129,150,Gene/Protein	"[{""token"": ""TRAF binding domains"", ""start_span"": 6, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""RANK"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""NH2 - terminal kinase"", ""start_span"": 129, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
An NH2 - terminal truncation mutant of TRAF6 inhibited RANKL - mediated NF - kappaB activation, but failed to affect constitutive signaling induced by receptor overexpression, revealing a selective role for TRAF6 in ligand - induced activation events.	NH2 - terminal truncation mutant,3,35,Gene/Protein	TRAF6,39,44,Gene/Protein	RANKL,55,60,Gene/Protein	NF - kappaB,72,83,Gene/Protein	TRAF6,207,212,Gene/Protein	"[{""token"": ""NH2 - terminal truncation mutant"", ""start_span"": 3, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""TRAF6"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""RANKL"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""TRAF6"", ""start_span"": 207, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	train
Bone marrow samples from 33 patients affected by MM and MGUS, and 8 patients not affected by lymphoproliferative diseases were studied for expression of c - Jun ( a component of the transcription factor AP - 1) and glutathione - S - transferase pi ( GST - pi) using immunocytochemical methods.	c - Jun,153,160,Gene/Protein	transcription factor,182,202,Gene/Protein	AP - 1,203,209,Gene/Protein	glutathione - S - transferase pi,215,247,Gene/Protein	GST - pi,250,258,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 182, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 203, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""glutathione - S - transferase pi"", ""start_span"": 215, ""end_span"": 247, ""type"": ""Gene/Protein""}, {""token"": ""GST - pi"", ""start_span"": 250, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	train
The IL - 3, IL - 5 and GM - CSF receptors share a common signal transducer that possesses no intrinsic kinase domain.	IL - 3,4,10,Gene/Protein	IL - 5,12,18,Gene/Protein	GM - CSF receptors,23,41,Gene/Protein	common signal transducer,50,74,Gene/Protein	intrinsic kinase domain,93,116,Gene/Protein	"[{""token"": ""IL - 3"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF receptors"", ""start_span"": 23, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""common signal transducer"", ""start_span"": 50, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""intrinsic kinase domain"", ""start_span"": 93, ""end_span"": 116, ""type"": ""Gene/Protein""}]"	train
Using Wp reporter constructs in in vitro transfection assays, we found that Wp was 11 - to 190 - fold more active in B cell than in non - B cell lines and that three regions of the promoter ( termed UAS1, UAS2, and UAS3) contributed to transcriptional activation.	Wp reporter constructs,6,28,Gene/Protein	promoter,181,189,Gene/Protein	UAS1,199,203,Gene/Protein	UAS2,205,209,Gene/Protein	UAS3,215,219,Gene/Protein	"[{""token"": ""Wp reporter constructs"", ""start_span"": 6, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""UAS1"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""UAS2"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""UAS3"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
T cell receptor ( TCR) stimulation induces rapid tyrosine phosphorylation of cellular proteins, including Cbl, a protooncogene product whose function remains unclear.	T cell receptor,0,15,Gene/Protein	TCR,18,21,Gene/Protein	cellular proteins,77,94,Gene/Protein	Cbl,106,109,Gene/Protein	protooncogene product,113,134,Gene/Protein	"[{""token"": ""T cell receptor"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""cellular proteins"", ""start_span"": 77, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""Cbl"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""protooncogene product"", ""start_span"": 113, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
Addition of an anti - TNF alpha antibody decreased by 40% E - selectin and ICAM - 1 induction and suppressed PAI - 1 overproduction with a weak effect on vWf.	anti - TNF alpha antibody,15,40,Gene/Protein	E - selectin,58,70,Gene/Protein	ICAM - 1,75,83,Gene/Protein	PAI - 1,109,116,Gene/Protein	vWf,154,157,Gene/Protein	"[{""token"": ""anti - TNF alpha antibody"", ""start_span"": 15, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 58, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""PAI - 1"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""vWf"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
Phosphorylation of CREB occurred through a herbimycin A and Rp - cAMP - sensitive pathway, suggesting phosphorylation required antecedent activation of both protein tyrosine kinases ( PTK) and protein kinase A ( PKA).	CREB,19,23,Gene/Protein	protein tyrosine kinases,157,181,Gene/Protein	PTK,184,187,Gene/Protein	protein kinase A,193,209,Gene/Protein	PKA,212,215,Gene/Protein	"[{""token"": ""CREB"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""protein tyrosine kinases"", ""start_span"": 157, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""PTK"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase A"", ""start_span"": 193, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""PKA"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
IFN regulatory factor 1 ( IRF - 1) is a transcription factor activated by either CD40 or cytokines.	IFN regulatory factor 1,0,23,Gene/Protein	IRF - 1,26,33,Gene/Protein	transcription factor,40,60,Gene/Protein	CD40,81,85,Gene/Protein	cytokines,89,98,Gene/Protein	"[{""token"": ""IFN regulatory factor 1"", ""start_span"": 0, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 40, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 89, ""end_span"": 98, ""type"": ""Gene/Protein""}]"	train
Human monocytic cells express interleukin - 1beta ( IL - 1beta) when stimulated with the extracellular matrix glycoprotein, fibronectin ( FN).	interleukin - 1beta,30,49,Gene/Protein	IL - 1beta,52,62,Gene/Protein	extracellular matrix glycoprotein,89,122,Gene/Protein	fibronectin,124,135,Gene/Protein	FN,138,140,Gene/Protein	"[{""token"": ""interleukin - 1beta"", ""start_span"": 30, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 52, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""extracellular matrix glycoprotein"", ""start_span"": 89, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 138, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
Protein kinase C ( PKC) activation is considered important for this process; however, the metabolic steps at which PKC acts upon to mediate the FN - induced IL - 1beta response remain unclear.	Protein kinase C,0,16,Gene/Protein	PKC,19,22,Gene/Protein	PKC,115,118,Gene/Protein	FN,144,146,Gene/Protein	IL - 1beta,157,167,Gene/Protein	"[{""token"": ""Protein kinase C"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 144, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 157, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
These studies revealed that Calphostin C inhibited the nuclear translocation of the transcription factor activator protein - 1 ( AP - 1) which is considered necessary for FN induction of IL - 1beta gene transcription, and prevented the transcription of the IL - 1beta gene.	transcription factor activator protein - 1,84,126,Gene/Protein	AP - 1,129,135,Gene/Protein	FN,171,173,Gene/Protein	IL - 1beta,187,197,Gene/Protein	IL - 1beta gene,257,272,Gene/Protein	"[{""token"": ""transcription factor activator protein - 1"", ""start_span"": 84, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 171, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 187, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta gene"", ""start_span"": 257, ""end_span"": 272, ""type"": ""Gene/Protein""}]"	train
TRAMP, a novel apoptosis - mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas ( Apo - 1 / CD95).	TRAMP,0,5,Gene/Protein	apoptosis - mediating receptor,15,45,Gene/Protein	tumor necrosis factor receptor 1,72,104,Gene/Protein	Fas,109,112,Gene/Protein	Apo - 1 / CD95,115,129,Gene/Protein	"[{""token"": ""TRAMP"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""apoptosis - mediating receptor"", ""start_span"": 15, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor receptor 1"", ""start_span"": 72, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""Fas"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Apo - 1 / CD95"", ""start_span"": 115, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	train
First, a substantial number of cells can express class II molecules in the absence of CIITA, albeit at 5 - fold reduced levels, most notably dendritic cells in s. c. lymph nodes; therefore, the CIITA gene can not be an absolute ' master gene ' controlling the expression of class II molecules, as had been thought.	class II molecules,49,67,Gene/Protein	CIITA,86,91,Gene/Protein	CIITA gene,194,204,Gene/Protein	master gene,230,241,Gene/Protein	class II molecules,274,292,Gene/Protein	"[{""token"": ""class II molecules"", ""start_span"": 49, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""CIITA gene"", ""start_span"": 194, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""master gene"", ""start_span"": 230, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""class II molecules"", ""start_span"": 274, ""end_span"": 292, ""type"": ""Gene/Protein""}]"	train
Granzyme B gene transcription is induced in activated lymphocytes upon antigenic stimulation, and several regulatory regions including CBF, AP - 1, and Ikaros binding sites have been shown to be essential in the control of granzyme B promoter activation.	regulatory regions,106,124,Gene/Protein	CBF,135,138,Gene/Protein	AP - 1,140,146,Gene/Protein	Ikaros binding sites,152,172,Gene/Protein	granzyme B promoter,223,242,Gene/Protein	"[{""token"": ""regulatory regions"", ""start_span"": 106, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""CBF"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""Ikaros binding sites"", ""start_span"": 152, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""granzyme B promoter"", ""start_span"": 223, ""end_span"": 242, ""type"": ""Gene/Protein""}]"	train
We demonstrated the presence of a polymorphism in the promoter region of the IL - 10 gene and four in the TGF - beta gene promoters ( 3 in TGF - beta1 and 1 in TGF - beta2).	promoter region,54,69,Gene/Protein	IL - 10 gene,77,89,Gene/Protein	TGF - beta gene promoters,106,131,Gene/Protein	TGF - beta1,139,150,Gene/Protein	TGF - beta2,160,171,Gene/Protein	"[{""token"": ""promoter region"", ""start_span"": 54, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10 gene"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta gene promoters"", ""start_span"": 106, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta2"", ""start_span"": 160, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
We, therefore, conclude that signals generated by the convergence of the MAPK and the calcineurin / NFAT pathway are necessary and sufficient for the activation of the IL - 2 promoter by Tpl - 2.	MAPK,73,77,Gene/Protein	calcineurin,86,97,Gene/Protein	/ NFAT,98,104,Gene/Protein	IL - 2 promoter,168,183,Gene/Protein	Tpl - 2,187,194,Gene/Protein	"[{""token"": ""MAPK"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""/ NFAT"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 168, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""Tpl - 2"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
Interleukin - 5 ( IL - 5) and granulocyte macrophage - colony stimulating factor ( GM - CSF) are important cytokines for the proliferation, differentiation, and activation of myeloid lineages.	Interleukin - 5,0,15,Gene/Protein	IL - 5,18,24,Gene/Protein	granulocyte macrophage - colony stimulating factor,30,80,Gene/Protein	GM - CSF,83,91,Gene/Protein	cytokines,107,116,Gene/Protein	"[{""token"": ""Interleukin - 5"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte macrophage - colony stimulating factor"", ""start_span"": 30, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 107, ""end_span"": 116, ""type"": ""Gene/Protein""}]"	train
The gene encoding the retinoic acid - synthesizing enzyme aldehyde dehydrogenase 1 ( Aldh1), initially called Hdg - 1, was found to be ectopically activated by HOX11 in this system.	retinoic acid - synthesizing enzyme,22,57,Gene/Protein	aldehyde dehydrogenase 1,58,82,Gene/Protein	Aldh1,85,90,Gene/Protein	Hdg - 1,110,117,Gene/Protein	HOX11,160,165,Gene/Protein	"[{""token"": ""retinoic acid - synthesizing enzyme"", ""start_span"": 22, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""aldehyde dehydrogenase 1"", ""start_span"": 58, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""Aldh1"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""Hdg - 1"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""HOX11"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
NF - X2, which contains members of the AP - 1 / ATF / CREB families of transcription factors, interacts with the X2 box ( 5 ' - TGCGTCA - 3 ') from positions - 97 to - 91 in the DRA promoter.	NF - X2,0,7,Gene/Protein	AP - 1 / ATF / CREB families,39,67,Gene/Protein	transcription factors,71,92,Gene/Protein	X2 box,113,119,Gene/Protein	DRA promoter,178,190,Gene/Protein	"[{""token"": ""NF - X2"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 / ATF / CREB families"", ""start_span"": 39, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 71, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""X2 box"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""DRA promoter"", ""start_span"": 178, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
Since the co - expression with a dominant negative c - Fos abolished the responsiveness to TPA, we conclude that activated transcription of the DRA gene depends on interactions between the X2 box and NF - X2, which contains c - Fos.	c - Fos,51,58,Gene/Protein	DRA gene,144,152,Gene/Protein	X2 box,189,195,Gene/Protein	NF - X2,200,207,Gene/Protein	c - Fos,224,231,Gene/Protein	"[{""token"": ""c - Fos"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""DRA gene"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""X2 box"", ""start_span"": 189, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""NF - X2"", ""start_span"": 200, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 224, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
The 5 ' - positive regulatory unit, consisting of the promoter and the 5 ' enhancer, is already active at the CD4 - CD8 - double - negative ( DN) stage of development.	5 ' - positive regulatory unit,4,34,Gene/Protein	promoter,54,62,Gene/Protein	5 ' enhancer,71,83,Gene/Protein	CD4,110,113,Gene/Protein	CD8,116,119,Gene/Protein	"[{""token"": ""5 ' - positive regulatory unit"", ""start_span"": 4, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""5 ' enhancer"", ""start_span"": 71, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""CD8"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Gene/Protein""}]"	train
However, we show that mutant forms of E1A that no longer bind p300 / CBP can still interact directly with Stat1 ( via E1A N - terminal and Stat1 C - terminal residues) and block IFNgamma - driven, Stat1 - dependent gene activation and consequent function during early - phase infection in the natural host cell.	E1A,38,41,Gene/Protein	p300 / CBP,62,72,Gene/Protein	Stat1,106,111,Gene/Protein	E1A N - terminal and Stat1 C - terminal residues,118,166,Gene/Protein	Stat1,197,202,Gene/Protein	"[{""token"": ""E1A"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""p300 / CBP"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""E1A N - terminal and Stat1 C - terminal residues"", ""start_span"": 118, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 197, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
The results provide a distinct and more specific mechanism for E1A - mediated immune suppression and an alternative model of IFNgamma - driven enhanceosome formation that may allow for other adaptors ( in addition to p300 / CBP) to link Stat1 to the basal transcription complex.	E1A,63,66,Gene/Protein	IFNgamma,125,133,Gene/Protein	p300 / CBP,217,227,Gene/Protein	Stat1,237,242,Gene/Protein	basal transcription complex,250,277,Gene/Protein	"[{""token"": ""E1A"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""p300 / CBP"", ""start_span"": 217, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 237, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""basal transcription complex"", ""start_span"": 250, ""end_span"": 277, ""type"": ""Gene/Protein""}]"	train
To understand the molecular mechanisms of functional synergy between TAL1 and LMO in tumorigenesis and transcriptional regulation, we tried to identify downstream target genes regulated by TAL1 and LMO by a subtractive PCR method.	TAL1,69,73,Gene/Protein	LMO,78,81,Gene/Protein	downstream target genes,152,175,Gene/Protein	TAL1,189,193,Gene/Protein	LMO,198,201,Gene/Protein	"[{""token"": ""TAL1"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""LMO"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""downstream target genes"", ""start_span"": 152, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""TAL1"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""LMO"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
Exogenously transfected TAL1 and LMO, but not either alone, induced RALDH2 expression in a T - ALL cell line, HPB - ALL, not expressing endogeneous TAL1 or LMO.	TAL1,24,28,Gene/Protein	LMO,33,36,Gene/Protein	RALDH2,68,74,Gene/Protein	TAL1,148,152,Gene/Protein	LMO,156,159,Gene/Protein	"[{""token"": ""TAL1"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""LMO"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""RALDH2"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""TAL1"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""LMO"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
Taken together, our findings indicate that signaling via CD27 on B cells induces IgE synthesis, in cooperation with IL - 4 and CD40 signaling, by promoting the generation of plasma cells through up - regulation of positive regulatory domain I - binding factor - 1.	CD27,57,61,Gene/Protein	IgE,81,84,Gene/Protein	IL - 4,116,122,Gene/Protein	CD40,127,131,Gene/Protein	positive regulatory domain I - binding factor - 1,214,263,Gene/Protein	"[{""token"": ""CD27"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""positive regulatory domain I - binding factor - 1"", ""start_span"": 214, ""end_span"": 263, ""type"": ""Gene/Protein""}]"	train
To study the regulatory mechanism of gp91phox gene expression in eosinophils, we transiently transfected eosinophil - committed HL - 60 - C15 cells with gp91phox promoter constructs, and identified a negative element from bp - 267 to - 246 of the gp91phox gene, the deletion of which caused an 83% increase in promoter activity.	gp91phox gene,37,50,Gene/Protein	gp91phox promoter constructs,153,181,Gene/Protein	negative element,200,216,Gene/Protein	- 267 to - 246,225,239,Gene/Protein	gp91phox gene,247,260,Gene/Protein	"[{""token"": ""gp91phox gene"", ""start_span"": 37, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""gp91phox promoter constructs"", ""start_span"": 153, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""negative element"", ""start_span"": 200, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""- 267 to - 246"", ""start_span"": 225, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""gp91phox gene"", ""start_span"": 247, ""end_span"": 260, ""type"": ""Gene/Protein""}]"	train
Uncoupling activation - dependent HS1 phosphorylation from nuclear factor of activated T cells transcriptional activation in Jurkat T cells: differential signaling through CD3 and the costimulatory receptors CD2 and CD28.	HS1,34,37,Gene/Protein	nuclear factor of activated T cells,59,94,Gene/Protein	CD3,172,175,Gene/Protein	CD2,208,211,Gene/Protein	CD28,216,220,Gene/Protein	"[{""token"": ""HS1"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 59, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 216, ""end_span"": 220, ""type"": ""Gene/Protein""}]"	train
Using the specific MAPK / extracellular signal - regulated kinase kinase ( MAPK kinase) inhibitor PD98059, we found that MAPK activation is necessary for FcR - dependent activation of the nuclear factor NF - kappaB.	MAPK,19,23,Gene/Protein	MAPK,75,79,Gene/Protein	FcR,154,157,Gene/Protein	nuclear factor,188,202,Gene/Protein	NF - kappaB,203,214,Gene/Protein	"[{""token"": ""MAPK"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""FcR"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor"", ""start_span"": 188, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 203, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A - HLF.	AD1,4,7,Gene/Protein	AD2,12,15,Gene/Protein	E2A,43,46,Gene/Protein	chimeric oncoprotein,99,119,Gene/Protein	E2A - HLF,120,129,Gene/Protein	"[{""token"": ""AD1"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""AD2"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""chimeric oncoprotein"", ""start_span"": 99, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""E2A - HLF"", ""start_span"": 120, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	train
In addition, IL - 6 and IL - 2 synergistically induce homo - and heterodimerized STAT1 alpha and STAT3 in both NK and T cells, consistent with their reported synergism in modulating perforin gene expression.	IL - 6,13,19,Gene/Protein	IL - 2,24,30,Gene/Protein	STAT1 alpha,81,92,Gene/Protein	STAT3,97,102,Gene/Protein	perforin gene,182,195,Gene/Protein	"[{""token"": ""IL - 6"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 alpha"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""perforin gene"", ""start_span"": 182, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
In vitro studies identify three essential elements of the TATA - less blr1 core promoter that confer cell type - and differentiation - specific expression in the B cells of both humans and mice, a functional promoter region ( - 36 with respect to the transcription start site), a NF - kappaB motif ( + 44), and a noncanonical octamer motif ( + 157).	TATA - less blr1 core promoter,58,88,Gene/Protein	functional promoter region,197,223,Gene/Protein	transcription start site,251,275,Gene/Protein	NF - kappaB motif,280,297,Gene/Protein	noncanonical octamer motif,313,339,Gene/Protein	"[{""token"": ""TATA - less blr1 core promoter"", ""start_span"": 58, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""functional promoter region"", ""start_span"": 197, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""transcription start site"", ""start_span"": 251, ""end_span"": 275, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB motif"", ""start_span"": 280, ""end_span"": 297, ""type"": ""Gene/Protein""}, {""token"": ""noncanonical octamer motif"", ""start_span"": 313, ""end_span"": 339, ""type"": ""Gene/Protein""}]"	train
Last, we have identified two open reading frames ( ORFs) of HHV - 6, U86 and U89 from the immediate - early locus A, that can transactivate the CD4 promoter in HeLa cells.	open reading frames,29,48,Gene/Protein	ORFs,51,55,Gene/Protein	U86,69,72,Gene/Protein	U89,77,80,Gene/Protein	CD4 promoter,144,156,Gene/Protein	"[{""token"": ""open reading frames"", ""start_span"": 29, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""ORFs"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""U86"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""U89"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""CD4 promoter"", ""start_span"": 144, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
Inv ( 16) ( p13; q22) fuses the gene encoding the beta subunit of Pebp2 to the MYH11 gene encoding a smooth muscle myosin heavy chain ( Smmhc).	beta subunit,50,62,Gene/Protein	Pebp2,66,71,Gene/Protein	MYH11 gene,79,89,Gene/Protein	smooth muscle myosin heavy chain,101,133,Gene/Protein	Smmhc,136,141,Gene/Protein	"[{""token"": ""beta subunit"", ""start_span"": 50, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""Pebp2"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""MYH11 gene"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""smooth muscle myosin heavy chain"", ""start_span"": 101, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""Smmhc"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	train
In 1G5, a Jurkat - derived T cell line stably transfected with a luciferase gene driven by HIV - 1 long terminal repeat ( LTR), we found that PGE2 markedly enhanced HIV - 1 LTR - mediated reporter gene activity.	luciferase gene,65,80,Gene/Protein	HIV - 1 long terminal repeat,91,119,Gene/Protein	LTR,122,125,Gene/Protein	HIV - 1 LTR,165,176,Gene/Protein	reporter gene,188,201,Gene/Protein	"[{""token"": ""luciferase gene"", ""start_span"": 65, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat"", ""start_span"": 91, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 165, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene"", ""start_span"": 188, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
Human neutrophils can be induced to actively transcribe a number of early - response genes, in particular those encoding cytokines, chemokines, and the high - affinity surface receptor for IgG, FcgammaRI.	early - response genes,68,90,Gene/Protein	cytokines,121,130,Gene/Protein	chemokines,132,142,Gene/Protein	IgG,189,192,Gene/Protein	FcgammaRI,194,203,Gene/Protein	"[{""token"": ""early - response genes"", ""start_span"": 68, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 121, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""chemokines"", ""start_span"": 132, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""FcgammaRI"", ""start_span"": 194, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
Co - transfections with expression plasmids for Sp1 and AP - 2 further emphasized the important role of these transcription factors in both basal and PMA - enhanced LAL expression.	expression plasmids,24,43,Gene/Protein	Sp1,48,51,Gene/Protein	AP - 2,56,62,Gene/Protein	transcription factors,110,131,Gene/Protein	LAL,165,168,Gene/Protein	"[{""token"": ""expression plasmids"", ""start_span"": 24, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 110, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""LAL"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
LMP1 contains two domains that activate the transcription factor NF - kappaB, one through interactions with TRAF proteins and the other with the TRADD protein.	LMP1,0,4,Gene/Protein	transcription factor,44,64,Gene/Protein	NF - kappaB,65,76,Gene/Protein	TRAF proteins,108,121,Gene/Protein	TRADD protein,145,158,Gene/Protein	"[{""token"": ""LMP1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 44, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 65, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""TRAF proteins"", ""start_span"": 108, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""TRADD protein"", ""start_span"": 145, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
Cell surface markers in the YJ cells were positive for CD33 and were negative for CD34, CD16 and CD23.	Cell surface markers,0,20,Gene/Protein	CD33,55,59,Gene/Protein	CD34,82,86,Gene/Protein	CD16,88,92,Gene/Protein	CD23,97,101,Gene/Protein	"[{""token"": ""Cell surface markers"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CD33"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""CD34"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}]"	train
Although IFN - gamma alone did not induce CD23 mRNA transcription, Northern blot analysis revealed a transient up - regulation of the IL - 4 - induced CD23 mRNA by IFN - gamma within 2 h of IFN - gamma treatment in these tonsillar cells.	IFN - gamma,9,20,Gene/Protein	CD23 mRNA,42,51,Gene/Protein	IL - 4 - induced CD23 mRNA,134,160,Gene/Protein	IFN - gamma,164,175,Gene/Protein	IFN - gamma,190,201,Gene/Protein	"[{""token"": ""IFN - gamma"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CD23 mRNA"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 - induced CD23 mRNA"", ""start_span"": 134, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 164, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 190, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
Indeed, when Tax is coexpressed with the E2F - 1 transcription factor in CEM T - cells, which lack expression of p16 ( INK4A), it strongly potentiates the E2F - dependent activation of a reporter construct driven by a promoter containing E2F binding sites.	Tax,13,16,Gene/Protein	E2F - 1,41,48,Gene/Protein	transcription factor,49,69,Gene/Protein	E2F,155,158,Gene/Protein	E2F binding sites,238,255,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 1"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 49, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""E2F binding sites"", ""start_span"": 238, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
Inhibition of iNO synthase ( iNOS) activity with N omega - monomethyl - L - arginine in endothelial - RAW264. 7 cocultures, stimulated with murine - specific IFN - gamma and LPS, decreased iNO production by 86%, augmented VCAM - 1 and iNOS expression in endothelial and RAW264. 7 cells, respectively, and increased monocyte adhesion to the endothelial cell surface.	iNO synthase,14,26,Gene/Protein	iNOS,29,33,Gene/Protein	murine - specific IFN - gamma,140,169,Gene/Protein	VCAM - 1,222,230,Gene/Protein	iNOS,235,239,Gene/Protein	"[{""token"": ""iNO synthase"", ""start_span"": 14, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""iNOS"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""murine - specific IFN - gamma"", ""start_span"": 140, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 222, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""iNOS"", ""start_span"": 235, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Effector pathways for this guanine nucleotide binding protein in T cells are mediated by the serine / threonine kinase Raf - 1 and the Ras - related GTPase Rac - 1.	guanine nucleotide binding protein,27,61,Gene/Protein	serine / threonine kinase,93,118,Gene/Protein	Raf - 1,119,126,Gene/Protein	Ras - related GTPase,135,155,Gene/Protein	Rac - 1,156,163,Gene/Protein	"[{""token"": ""guanine nucleotide binding protein"", ""start_span"": 27, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""serine / threonine kinase"", ""start_span"": 93, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""Raf - 1"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""Ras - related GTPase"", ""start_span"": 135, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""Rac - 1"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
In contrast, p21ras signals are unable to induce Akt / PKB activity in T cell nor is Ras function required for Akt / PKB activation in response to the TCR.	p21ras,13,19,Gene/Protein	Akt / PKB,49,58,Gene/Protein	Ras,85,88,Gene/Protein	Akt / PKB,111,120,Gene/Protein	TCR,151,154,Gene/Protein	"[{""token"": ""p21ras"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""Akt / PKB"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""Akt / PKB"", ""start_span"": 111, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
The induction of IL - 5 gene expression by GATA - 3 involves high affinity binding of GATA - 3 to an inverted GATA repeat in the IL - 5 promoter.	IL - 5 gene,17,28,Gene/Protein	GATA - 3,43,51,Gene/Protein	GATA - 3,86,94,Gene/Protein	GATA repeat,110,121,Gene/Protein	IL - 5 promoter,129,144,Gene/Protein	"[{""token"": ""IL - 5 gene"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 3"", ""start_span"": 43, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 3"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""GATA repeat"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5 promoter"", ""start_span"": 129, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
In T lymphocytes from NF - ATp - deficient mice, the expression of CD25 is severely impaired, leading to a delayed IL - 2 receptor expression after T cell receptor ( TCR) / CD3 stimulation.	NF - ATp,22,30,Gene/Protein	CD25,67,71,Gene/Protein	IL - 2 receptor,115,130,Gene/Protein	TCR,166,169,Gene/Protein	CD3,173,176,Gene/Protein	"[{""token"": ""NF - ATp"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""CD25"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
The two Duffy polymorphic antigens, Fya and Fyb ( coded by the FY * A and FY * B alleles), are present on erythrocyte membranes.	Duffy polymorphic antigens,8,34,Gene/Protein	Fya,36,39,Gene/Protein	Fyb,44,47,Gene/Protein	FY * A and FY * B alleles,63,88,Gene/Protein	erythrocyte membranes,106,127,Gene/Protein	"[{""token"": ""Duffy polymorphic antigens"", ""start_span"": 8, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""Fya"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""Fyb"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""FY * A and FY * B alleles"", ""start_span"": 63, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""erythrocyte membranes"", ""start_span"": 106, ""end_span"": 127, ""type"": ""Gene/Protein""}]"	train
FK506. FKBP12 drug - immunophilin complexes inhibited the interaction of NFAT with activated calcineurin much more effectively than they inhibited the interaction with inactive calcineurin, suggesting that part of the interaction with activated calcineurin involved the enzyme active site.	NFAT,73,77,Gene/Protein	calcineurin,93,104,Gene/Protein	calcineurin,177,188,Gene/Protein	calcineurin,245,256,Gene/Protein	enzyme active site,270,288,Gene/Protein	"[{""token"": ""NFAT"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 93, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 177, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 245, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""enzyme active site"", ""start_span"": 270, ""end_span"": 288, ""type"": ""Gene/Protein""}]"	train
Upon cell activation, displacement of the autoinhibitory domain by calmodulin binding allows NFAT to bind additionally to the calcineurin active site, thus positioning NFAT for immediate dephosphorylation at functional phosphoserine residues.	autoinhibitory domain,42,63,Gene/Protein	calmodulin,67,77,Gene/Protein	NFAT,93,97,Gene/Protein	calcineurin active site,126,149,Gene/Protein	NFAT,168,172,Gene/Protein	"[{""token"": ""autoinhibitory domain"", ""start_span"": 42, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""calmodulin"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin active site"", ""start_span"": 126, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
Specific families of receptors, kinases, transcription factors, and cysteine proteases, termed caspases, are involved in the apoptotic cascade leading to proteolysis of specific substrates and to morphological changes associated with programmed cell death.	receptors,21,30,Gene/Protein	kinases,32,39,Gene/Protein	transcription factors,41,62,Gene/Protein	cysteine proteases,68,86,Gene/Protein	termed caspases,88,103,Gene/Protein	"[{""token"": ""receptors"", ""start_span"": 21, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""kinases"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 41, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""cysteine proteases"", ""start_span"": 68, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""termed caspases"", ""start_span"": 88, ""end_span"": 103, ""type"": ""Gene/Protein""}]"	train
We conclude that although cell cycle arrest induced by alpha - IFN may be mediated in part by formation of a complex containing p130 and E2F - 4, alpha - IFN does not induce hyperphosphorylation of E2F - 4, which characterizes primary hemopoietic cells in G0.	alpha - IFN,55,66,Gene/Protein	p130,128,132,Gene/Protein	E2F - 4,137,144,Gene/Protein	alpha - IFN,146,157,Gene/Protein	E2F - 4,198,205,Gene/Protein	"[{""token"": ""alpha - IFN"", ""start_span"": 55, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""p130"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 4"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""alpha - IFN"", ""start_span"": 146, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 4"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
The transcription factors c - myb and C / EBP alpha regulate the monocytic / myeloic gene MRP14.	transcription factors,4,25,Gene/Protein	c - myb,26,33,Gene/Protein	C / EBP alpha,38,51,Gene/Protein	monocytic / myeloic gene,65,89,Gene/Protein	MRP14,90,95,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 4, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""c - myb"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP alpha"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""monocytic / myeloic gene"", ""start_span"": 65, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""MRP14"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	train
To investigate the transcriptional regulation of these genes we cotransfected constructs expressing CAT under control of the MRP14 promoter and expression constructs of C / EBP alpha and v - myb, two transcription factors involved in myeloid / monocytic differentiation.	CAT,100,103,Gene/Protein	MRP14 promoter,125,139,Gene/Protein	C / EBP alpha,169,182,Gene/Protein	v - myb,187,194,Gene/Protein	transcription factors,200,221,Gene/Protein	"[{""token"": ""CAT"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""MRP14 promoter"", ""start_span"": 125, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP alpha"", ""start_span"": 169, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""v - myb"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 200, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
Analysis of the regulation of the p40 gene promoter revealed that ASA inhibited NF - kappaB activation and binding to the p40 - kappaB site in the p40 promoter, leading to transcriptional repression of the p40 gene.	p40 gene promoter,34,51,Gene/Protein	NF - kappaB,80,91,Gene/Protein	p40 - kappaB site,122,139,Gene/Protein	p40 promoter,147,159,Gene/Protein	p40 gene,206,214,Gene/Protein	"[{""token"": ""p40 gene promoter"", ""start_span"": 34, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""p40 - kappaB site"", ""start_span"": 122, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""p40 promoter"", ""start_span"": 147, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""p40 gene"", ""start_span"": 206, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
We have isolated NFATx, which is one of four members of the NFAT family of transcription factors and is preferentially expressed in the thymus and peripheral blood leukocytes, and an isoform of NFATx, NFATx1.	NFATx,17,22,Gene/Protein	NFAT family,60,71,Gene/Protein	transcription factors,75,96,Gene/Protein	NFATx,194,199,Gene/Protein	NFATx1,201,207,Gene/Protein	"[{""token"": ""NFATx"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""NFAT family"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 75, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""NFATx"", ""start_span"": 194, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""NFATx1"", ""start_span"": 201, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
These data demonstrate that the 15 - amino acid sequence of NFATx1 is a major transactivation sequence required for induction of genes by NFATx1 in T cells and possibly regulates NFAT activity through tissue - specific alternative splicing.	15 - amino acid sequence,32,56,Gene/Protein	NFATx1,60,66,Gene/Protein	major transactivation sequence,72,102,Gene/Protein	NFATx1,138,144,Gene/Protein	NFAT,179,183,Gene/Protein	"[{""token"": ""15 - amino acid sequence"", ""start_span"": 32, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""NFATx1"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""major transactivation sequence"", ""start_span"": 72, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""NFATx1"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
Upregulation of interleukin 6 and granulocyte colony - stimulating factor receptors by transcription factor CCAAT enhancer binding protein alpha ( C / EBP alpha) is critical for granulopoiesis.	interleukin 6,16,29,Gene/Protein	granulocyte colony - stimulating factor receptors,34,83,Gene/Protein	transcription factor,87,107,Gene/Protein	CCAAT enhancer binding protein alpha,108,144,Gene/Protein	C / EBP alpha,147,160,Gene/Protein	"[{""token"": ""interleukin 6"", ""start_span"": 16, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte colony - stimulating factor receptors"", ""start_span"": 34, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 87, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""CCAAT enhancer binding protein alpha"", ""start_span"": 108, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP alpha"", ""start_span"": 147, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
To elucidate the role of retinoic acid ( RA) in anti - CD40 + interleukin - 4 ( IL - 4) - mediated B - cell activation, the effect of 10 ( - 12) to 10 ( - 6) mol / L RA was studied in anti - CD40 ( 1 microgram / mL) + IL - 4 ( 5 ng / mL) - mediated proliferation and Ig synthesis by human peripheral blood mononuclear cells ( PBMC) and B cells in healthy donors.	anti - CD40,48,59,Gene/Protein	interleukin - 4,62,77,Gene/Protein	IL - 4,80,86,Gene/Protein	anti - CD40,184,195,Gene/Protein	IL - 4,218,224,Gene/Protein	"[{""token"": ""anti - CD40"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 4"", ""start_span"": 62, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD40"", ""start_span"": 184, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 218, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
Transfection of kinase - deficient mutants of IKKalpha and IKKbeta into either human Jurkat T or 293 cells also inhibits NF - kappaB - dependent reporter gene expression induced by Tax.	IKKalpha,46,54,Gene/Protein	IKKbeta,59,66,Gene/Protein	NF - kappaB,121,132,Gene/Protein	reporter gene,145,158,Gene/Protein	Tax,181,184,Gene/Protein	"[{""token"": ""IKKalpha"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene"", ""start_span"": 145, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
Phosphorylation of the IkappaB cytoplasmic inhibitors, IkappaBalpha, IkappaBbeta, and IkappaBepsilon, by these kinases triggers proteolytic degradation and the release of NF - kappaB / Rel proteins into the nucleus.	IkappaB cytoplasmic inhibitors,23,53,Gene/Protein	IkappaBalpha,55,67,Gene/Protein	IkappaBbeta,69,80,Gene/Protein	IkappaBepsilon,86,100,Gene/Protein	NF - kappaB / Rel proteins,171,197,Gene/Protein	"[{""token"": ""IkappaB cytoplasmic inhibitors"", ""start_span"": 23, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 55, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBbeta"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBepsilon"", ""start_span"": 86, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB / Rel proteins"", ""start_span"": 171, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
In transfection experiments, overexpression of wild type IKK1, a dominant negative mutant IKK1 ( K44M), or wild type IKK2 did not affect LPS - induced kappaB - dependent transcription in monocytic cells.	IKK1,57,61,Gene/Protein	dominant negative mutant IKK1,65,94,Gene/Protein	K44M,97,101,Gene/Protein	wild type IKK2,107,121,Gene/Protein	kappaB,151,157,Gene/Protein	"[{""token"": ""IKK1"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""dominant negative mutant IKK1"", ""start_span"": 65, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""K44M"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""wild type IKK2"", ""start_span"": 107, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""kappaB"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
IL - 7 also delayed the decreases in the levels of c - Myc, Bcl - 2, and Bcl - xL that occur upon loss of v - Abl kinase activity.	IL - 7,0,6,Gene/Protein	c - Myc,51,58,Gene/Protein	Bcl - 2,60,67,Gene/Protein	Bcl - xL,73,81,Gene/Protein	v - Abl,106,113,Gene/Protein	"[{""token"": ""IL - 7"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""c - Myc"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - xL"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""v - Abl"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Gene/Protein""}]"	train
These results identify a potential role for IL - 7 signaling pathways in transformation by v - Abl while demonstrating that a combination of IL - 4 and IL - 7 signaling can not substitute for an active v - Abl kinase in transformed pre - B cells.	IL - 7,44,50,Gene/Protein	v - Abl,91,98,Gene/Protein	IL - 4,141,147,Gene/Protein	IL - 7,152,158,Gene/Protein	v - Abl,202,209,Gene/Protein	"[{""token"": ""IL - 7"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""v - Abl"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 152, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""v - Abl"", ""start_span"": 202, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
The ML - 1 human myeloblastic leukemia cells used in this study proliferate when treated with insulin - like growth factor I and transferrin but differentiate to monocytes when exposed to tumor necrosis factor alpha or transforming growth factor beta1, or to macrophage - like cells when treated with both these cytokines.	insulin - like growth factor I,94,124,Gene/Protein	transferrin,129,140,Gene/Protein	tumor necrosis factor alpha,188,215,Gene/Protein	transforming growth factor beta1,219,251,Gene/Protein	cytokines,312,321,Gene/Protein	"[{""token"": ""insulin - like growth factor I"", ""start_span"": 94, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""transferrin"", ""start_span"": 129, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 188, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""transforming growth factor beta1"", ""start_span"": 219, ""end_span"": 251, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 312, ""end_span"": 321, ""type"": ""Gene/Protein""}]"	train
In contrast, induction of differentiation but not of proliferation was followed by a 25 - to 30 - fold increase in the nuclear level of the tumor suppressor proteins p53 ( wild type), pRb, and p130 / Rb2 and of the p53 - dependent cyclin kinase inhibitor p21 / Cip1.	tumor suppressor proteins p53,140,169,Gene/Protein	pRb,184,187,Gene/Protein	p130 / Rb2,193,203,Gene/Protein	p53 - dependent cyclin kinase inhibitor,215,254,Gene/Protein	p21 / Cip1,255,265,Gene/Protein	"[{""token"": ""tumor suppressor proteins p53"", ""start_span"": 140, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""pRb"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""p130 / Rb2"", ""start_span"": 193, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""p53 - dependent cyclin kinase inhibitor"", ""start_span"": 215, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""p21 / Cip1"", ""start_span"": 255, ""end_span"": 265, ""type"": ""Gene/Protein""}]"	train
Over a 3 - week course of IL - 2 therapy, in most patients the binding patterns of AP - 1, Sp1, and NF - kappaB proteins changed to resemble those seen in PBMC activated by IL - 2 in vitro.	IL - 2,26,32,Gene/Protein	AP - 1,83,89,Gene/Protein	Sp1,91,94,Gene/Protein	NF - kappaB,100,111,Gene/Protein	IL - 2,173,179,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 83, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 100, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
V14Rho binds strongly to protein kinase Calpha ( PKCalpha) in vivo; however, deletion of the CAAX site on V14Rho severely diminished this association.	V14Rho,0,6,Gene/Protein	protein kinase Calpha,25,46,Gene/Protein	PKCalpha,49,57,Gene/Protein	CAAX site,93,102,Gene/Protein	V14Rho,106,112,Gene/Protein	"[{""token"": ""V14Rho"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase Calpha"", ""start_span"": 25, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""PKCalpha"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""CAAX site"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""V14Rho"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Gene/Protein""}]"	train
Activation of nonreceptor protein tyrosine kinases ( PTKs) is essential for T cell receptor ( TCR) responsiveness; however, the function of individual PTK substrates is often uncertain.	nonreceptor protein tyrosine kinases,14,50,Gene/Protein	PTKs,53,57,Gene/Protein	T cell receptor,76,91,Gene/Protein	TCR,94,97,Gene/Protein	PTK substrates,151,165,Gene/Protein	"[{""token"": ""nonreceptor protein tyrosine kinases"", ""start_span"": 14, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""PTKs"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""T cell receptor"", ""start_span"": 76, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""PTK substrates"", ""start_span"": 151, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
We recently determined that erythropoietin ( EPO) activates 3 members of the signal transducer and activator of transcription ( STAT) family, Stat1alpha, Stat3, and Stat5, in the human EPO - dependent cell lines, UT - 7 and UT - 7 / EPO ( Kirito et al, J Biol Chem 272: 16507, 1997).	erythropoietin,28,42,Gene/Protein	EPO,45,48,Gene/Protein	Stat1alpha,142,152,Gene/Protein	Stat3,154,159,Gene/Protein	Stat5,165,170,Gene/Protein	"[{""token"": ""erythropoietin"", ""start_span"": 28, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""Stat1alpha"", ""start_span"": 142, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
Full activity can be restored by the combined action of recombinant PC4 and the PC4 - depleted USA fraction, thus suggesting a joint requirement for PC4 and another, USA - derived component ( s) for optimal function of Oct - 1 / OCA - B in the reconstituted system.	PC4,68,71,Gene/Protein	PC4,80,83,Gene/Protein	PC4,149,152,Gene/Protein	Oct - 1,219,226,Gene/Protein	/ OCA - B,227,236,Gene/Protein	"[{""token"": ""PC4"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""PC4"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""PC4"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 219, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""/ OCA - B"", ""start_span"": 227, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
Cross - linking of MHC - I mediated tyrosine phosphorylation of Tyk2, but not Jak1, Jak2, and Jak3.	MHC - I,19,26,Gene/Protein	Tyk2,64,68,Gene/Protein	Jak1,78,82,Gene/Protein	Jak2,84,88,Gene/Protein	Jak3,94,98,Gene/Protein	"[{""token"": ""MHC - I"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""Tyk2"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""Jak2"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}]"	train
The biological effects of RA are mediated by two distinct families of transcription factors: retinoic acid receptors ( RARs) and retinoid X receptors ( RXRs).	transcription factors,70,91,Gene/Protein	retinoic acid receptors,93,116,Gene/Protein	RARs,119,123,Gene/Protein	retinoid X receptors,129,149,Gene/Protein	RXRs,152,156,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 70, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""retinoic acid receptors"", ""start_span"": 93, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""RARs"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""retinoid X receptors"", ""start_span"": 129, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""RXRs"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
The human toll signaling pathway: divergence of nuclear factor kappaB and JNK / SAPK activation upstream of tumor necrosis factor receptor - associated factor 6 ( TRAF6).	nuclear factor kappaB,48,69,Gene/Protein	JNK,74,77,Gene/Protein	/ SAPK,78,84,Gene/Protein	tumor necrosis factor receptor - associated factor 6,108,160,Gene/Protein	TRAF6,163,168,Gene/Protein	"[{""token"": ""nuclear factor kappaB"", ""start_span"": 48, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""/ SAPK"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor receptor - associated factor 6"", ""start_span"": 108, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""TRAF6"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
We demonstrate here that TRAIL ( TNF - related apoptosis - inducing ligand), a recently identified DIL, also activates NFkappaB in lymphoid cell lines in a kinetic similar to TNFalpha.	TRAIL,25,30,Gene/Protein	TNF - related apoptosis - inducing ligand,33,74,Gene/Protein	DIL,99,102,Gene/Protein	NFkappaB,119,127,Gene/Protein	TNFalpha,175,183,Gene/Protein	"[{""token"": ""TRAIL"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""TNF - related apoptosis - inducing ligand"", ""start_span"": 33, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""DIL"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 175, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
The characterization of Pax - 5 - deficient pro - B cells demonstrated an important role of BSAP in the regulation of the CD19, mb - 1 ( Ig alpha) and N - myc genes as well as in the developmental pathway controlling VH - to - DHJH recombination at the immunoglobulin heavy - chain ( IgH) locus.	BSAP,92,96,Gene/Protein	CD19,122,126,Gene/Protein	mb - 1,128,134,Gene/Protein	Ig alpha,137,145,Gene/Protein	N - myc genes,151,164,Gene/Protein	"[{""token"": ""BSAP"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""mb - 1"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""Ig alpha"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""N - myc genes"", ""start_span"": 151, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P / CAF.	EKLF,13,17,Gene/Protein	acetylated transcription factor,24,55,Gene/Protein	CBP,92,95,Gene/Protein	p300,97,101,Gene/Protein	P / CAF,107,114,Gene/Protein	"[{""token"": ""EKLF"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""acetylated transcription factor"", ""start_span"": 24, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""CBP"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""p300"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""P / CAF"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene/Protein""}]"	train
The functional effects of these interactions are that CBP and p300, but not P / CAF, enhance EKLF ' s transcriptional activation of the beta - globin promoter in erythroid cells.	CBP,54,57,Gene/Protein	p300,62,66,Gene/Protein	P / CAF,76,83,Gene/Protein	EKLF,93,97,Gene/Protein	beta - globin promoter,136,158,Gene/Protein	"[{""token"": ""CBP"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""p300"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""P / CAF"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin promoter"", ""start_span"": 136, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
Expression cloning with this region of DNA now shows that tegument protein VP22 and the viral dUTPase, encoded by genes UL49 and UL50, respectively, are T - cell antigens.	tegument protein,58,74,Gene/Protein	VP22,75,79,Gene/Protein	viral dUTPase,88,101,Gene/Protein	genes UL49 and UL50,114,133,Gene/Protein	T - cell antigens,153,170,Gene/Protein	"[{""token"": ""tegument protein"", ""start_span"": 58, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""VP22"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""viral dUTPase"", ""start_span"": 88, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""genes UL49 and UL50"", ""start_span"": 114, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""T - cell antigens"", ""start_span"": 153, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
Blocking mAbs against CD18 and CD11b abrogated fibrinogen - induced NF - kappa B activation.	mAbs,9,13,Gene/Protein	CD18,22,26,Gene/Protein	CD11b,31,36,Gene/Protein	fibrinogen,47,57,Gene/Protein	NF - kappa B,68,80,Gene/Protein	"[{""token"": ""mAbs"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""CD18"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""fibrinogen"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Gene/Protein""}]"	train
Cells were subsequently stimulated with 1) PMA for 24 h, inducing CAT activity by 2. 6 - fold, 2) fibrinogen / Mn2 + for 2 h, inducing CAT activity by 3. 2 - fold, or 3) costimulation with fibrinogen and PMA, inducing 5. 7 - fold the CAT activity induced by PMA alone.	CAT,66,69,Gene/Protein	fibrinogen,98,108,Gene/Protein	CAT,135,138,Gene/Protein	fibrinogen,189,199,Gene/Protein	CAT,234,237,Gene/Protein	"[{""token"": ""CAT"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""fibrinogen"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""fibrinogen"", ""start_span"": 189, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	train
To gain a better understanding of the impact of long terminal repeat ( LTR) sequence diversity on LTR - directed gene expression in cells of the central nervous system ( CNS) and immune system, we amplified and cloned LTRs from proviral DNA in HIV - 1 - infected peripheral blood.	long terminal repeat,48,68,Gene/Protein	LTR,71,74,Gene/Protein	LTR - directed gene,98,117,Gene/Protein	LTRs,218,222,Gene/Protein	proviral DNA,228,240,Gene/Protein	"[{""token"": ""long terminal repeat"", ""start_span"": 48, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""LTR - directed gene"", ""start_span"": 98, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""LTRs"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""proviral DNA"", ""start_span"": 228, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	train
Both Dex and CsA inhibited the binding of transcription factors AP - 1 and NF - AT, but not of NF - kB and OCT - 1 / OAF, to their corresponding sites on the IL - 2 gene promoter.	AP - 1,64,70,Gene/Protein	NF - AT,75,82,Gene/Protein	NF - kB,95,102,Gene/Protein	OCT - 1 / OAF,107,120,Gene/Protein	IL - 2 gene promoter,158,178,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""OCT - 1 / OAF"", ""start_span"": 107, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 gene promoter"", ""start_span"": 158, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Most of the target genes for NF - kappa B are of relevance for the immune response and can be grouped into those encoding cytokines, cell surface receptors, acute phase proteins and viral genomes, such as that of human immunodeficiency virus type 1 ( HIV - 1).	NF - kappa B,29,41,Gene/Protein	cytokines,122,131,Gene/Protein	cell surface receptors,133,155,Gene/Protein	acute phase proteins,157,177,Gene/Protein	viral genomes,182,195,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 29, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 122, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""cell surface receptors"", ""start_span"": 133, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""acute phase proteins"", ""start_span"": 157, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""viral genomes"", ""start_span"": 182, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Overexpression of cJun or JunD, but not JunB, also eliminates the requirement for PMA, indicating that many but not all Jun - and Fos - related proteins functionally activate NF - AT - dependent transcription in the presence of the cytoplasmic component.	cJun,18,22,Gene/Protein	JunD,26,30,Gene/Protein	JunB,40,44,Gene/Protein	Jun - and Fos - related proteins,120,152,Gene/Protein	NF - AT,175,182,Gene/Protein	"[{""token"": ""cJun"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""JunB"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Jun - and Fos - related proteins"", ""start_span"": 120, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
Here we report that binding of human IL - 2 to its binding site leads to transcriptional activation of the macrophage CSF ( M - CSF) gene in Mo resulting in accumulation of M - CSF mRNA and subsequent release of bioactive M - CSF protein as demonstrated by ELISA and inhibition of IL - 2 induced release of an activity - stimulating growth of monocyte - type colonies by a neutralizing anti - M - CSF antibody.	human IL - 2,31,43,Gene/Protein	M - CSF mRNA,173,185,Gene/Protein	M - CSF protein,222,237,Gene/Protein	IL - 2,281,287,Gene/Protein	anti - M - CSF antibody,386,409,Gene/Protein	"[{""token"": ""human IL - 2"", ""start_span"": 31, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF mRNA"", ""start_span"": 173, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF protein"", ""start_span"": 222, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 281, ""end_span"": 287, ""type"": ""Gene/Protein""}, {""token"": ""anti - M - CSF antibody"", ""start_span"": 386, ""end_span"": 409, ""type"": ""Gene/Protein""}]"	train
They are part of the high affinity IgE receptor in mast cells, basophils, Langerhans cells, and possibly other cells; a component of the low affinity receptor for IgG ( Fc gamma RIIIA or CD16) in natural killer cells and macrophages; and part of the T cell antigen receptor in subsets of T cells.	high affinity IgE receptor,21,47,Gene/Protein	IgG,163,166,Gene/Protein	Fc gamma RIIIA,169,183,Gene/Protein	CD16,187,191,Gene/Protein	T cell antigen receptor,250,273,Gene/Protein	"[{""token"": ""high affinity IgE receptor"", ""start_span"": 21, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""Fc gamma RIIIA"", ""start_span"": 169, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 187, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""T cell antigen receptor"", ""start_span"": 250, ""end_span"": 273, ""type"": ""Gene/Protein""}]"	train
In the present study, analysis of the interleukin - 2 ( IL - 2) gene activation shows that naive human helper T cells ( cord blood CD4 + T cells, adult CD4 + CD45RO - T cells) regulate IL - 2 transcription by a mechanism involving both a silencer and an activator acting on the purine - rich IL - 2 promoter elements ( NF - AT binding sites).	IL - 2,56,62,Gene/Protein	silencer,238,246,Gene/Protein	activator,254,263,Gene/Protein	purine - rich IL - 2 promoter elements,278,316,Gene/Protein	NF - AT binding sites,319,340,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""silencer"", ""start_span"": 238, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""activator"", ""start_span"": 254, ""end_span"": 263, ""type"": ""Gene/Protein""}, {""token"": ""purine - rich IL - 2 promoter elements"", ""start_span"": 278, ""end_span"": 316, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT binding sites"", ""start_span"": 319, ""end_span"": 340, ""type"": ""Gene/Protein""}]"	train
We demonstrate evidence suggesting that redox regulation of NF kappa B by Trx might be exerted at a step after dissociation of the inhibitory molecule I kappa B, a cytosolic - anchoring protein for NF kappa B.	NF kappa B,60,70,Gene/Protein	Trx,74,77,Gene/Protein	I kappa B,151,160,Gene/Protein	cytosolic - anchoring protein,164,193,Gene/Protein	NF kappa B,198,208,Gene/Protein	"[{""token"": ""NF kappa B"", ""start_span"": 60, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""Trx"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""cytosolic - anchoring protein"", ""start_span"": 164, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 198, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	train
Our studies demonstrate for the first time that CD3 antigen - derived signals and CD2 antigen - derived signals are synergistic in inducing the emergence of transcription factors that bind to the NF - AT1, AP - 1, and NF - kB sites located in the promoter / enhancer region of the IL - 2 gene.	CD3,48,51,Gene/Protein	CD2 antigen,82,93,Gene/Protein	transcription factors,157,178,Gene/Protein	promoter / enhancer region,247,273,Gene/Protein	IL - 2,281,287,Gene/Protein	"[{""token"": ""CD3"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""CD2 antigen"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 157, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""promoter / enhancer region"", ""start_span"": 247, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 281, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
Increase of IL - 2R alpha gene transcription involves the enhanced binding of the transcription factor NF - kappa B to its consensus sequence in the 5 ' - regulatory region of the IL - 2R alpha gene.	IL - 2R alpha gene,12,30,Gene/Protein	NF - kappa B,103,115,Gene/Protein	consensus sequence,123,141,Gene/Protein	5 ' - regulatory region,149,172,Gene/Protein	IL - 2R alpha gene,180,198,Gene/Protein	"[{""token"": ""IL - 2R alpha gene"", ""start_span"": 12, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""consensus sequence"", ""start_span"": 123, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - regulatory region"", ""start_span"": 149, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha gene"", ""start_span"": 180, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
To dissect the molecular basis for the unusually persistent transcription of the IL - 2R alpha gene, we analyzed nuclear NF - kappa B binding to a radiolabeled IL - 2R alpha kappa B - specific oligonucleotide probe during the time course of CD2 + CD28 activation.	IL - 2R alpha gene,81,99,Gene/Protein	NF - kappa B,121,133,Gene/Protein	IL - 2R alpha,160,173,Gene/Protein	CD2,241,244,Gene/Protein	CD28,247,251,Gene/Protein	"[{""token"": ""IL - 2R alpha gene"", ""start_span"": 81, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 121, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 160, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 241, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Gene/Protein""}]"	train
After stimulation, two new kappa B - specific complexes were identified as NF - kappa B p50 - p65 heterodimer and putative c - Rel homodimer or c - Rel - p65 heterodimer.	kappa B - specific complexes,27,55,Gene/Protein	NF - kappa B,75,87,Gene/Protein	p50 - p65 heterodimer,88,109,Gene/Protein	c - Rel homodimer,123,140,Gene/Protein	c - Rel - p65 heterodimer,144,169,Gene/Protein	"[{""token"": ""kappa B - specific complexes"", ""start_span"": 27, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 75, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""p50 - p65 heterodimer"", ""start_span"": 88, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel homodimer"", ""start_span"": 123, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel - p65 heterodimer"", ""start_span"": 144, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
NF - AT is thought to consist of two components: a ubiquitous, inducible nuclear component that we have identified as Fos and Jun proteins, and a preexisting, T cell - specific component ( NF - ATp) which is the target for the immunosuppressive agents cyclosporin A ( CsA) and FK506.	NF - AT,0,7,Gene/Protein	Fos,118,121,Gene/Protein	Jun proteins,126,138,Gene/Protein	T cell - specific component,159,186,Gene/Protein	NF - ATp,189,197,Gene/Protein	"[{""token"": ""NF - AT"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""Fos"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Jun proteins"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""T cell - specific component"", ""start_span"": 159, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATp"", ""start_span"": 189, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
The transcription factor E2F activates the expression of multiple genes involved in cell proliferation, such as c - myc and the dihydrofolate reductase gene.	transcription factor,4,24,Gene/Protein	E2F,25,28,Gene/Protein	genes,66,71,Gene/Protein	c - myc,112,119,Gene/Protein	dihydrofolate reductase gene,128,156,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 4, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""genes"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""dihydrofolate reductase gene"", ""start_span"": 128, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
Nuclear factor NF - kB, activation protein 1 ( AP - 1), OCT - 1, and NF - IL - 2B binding activity were normal.	Nuclear factor NF - kB,0,22,Gene/Protein	activation protein 1,24,44,Gene/Protein	AP - 1,47,53,Gene/Protein	OCT - 1,56,63,Gene/Protein	NF - IL - 2B,69,81,Gene/Protein	"[{""token"": ""Nuclear factor NF - kB"", ""start_span"": 0, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""activation protein 1"", ""start_span"": 24, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""OCT - 1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL - 2B"", ""start_span"": 69, ""end_span"": 81, ""type"": ""Gene/Protein""}]"	train
To ascertain whether the abnormal NF - AT binding activity was related to an impaired function, we transfected patient and control T lymphocytes with constructs containing the reporter gene encoding chloramphenicol acetyl transferase ( CAT) under the control of the entire IL2 regulatory region or of multimers of individual enhancer sequences.	NF - AT,34,41,Gene/Protein	chloramphenicol acetyl transferase,199,233,Gene/Protein	CAT,236,239,Gene/Protein	IL2 regulatory region,273,294,Gene/Protein	enhancer sequences,325,343,Gene/Protein	"[{""token"": ""NF - AT"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyl transferase"", ""start_span"": 199, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 236, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""IL2 regulatory region"", ""start_span"": 273, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""enhancer sequences"", ""start_span"": 325, ""end_span"": 343, ""type"": ""Gene/Protein""}]"	train
Using these drugs as probes, chemists and biologists have uncovered several intracellular signalling molecules bridging the generation of second - messenger Ca2 + ions and the transcriptional activation of IL - 2, among which are calmodulin, calcineurin and the nuclear factor of activated T cells ( NF - AT).	IL - 2,206,212,Gene/Protein	calmodulin,230,240,Gene/Protein	calcineurin,242,253,Gene/Protein	nuclear factor of activated T cells,262,297,Gene/Protein	NF - AT,300,307,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 206, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""calmodulin"", ""start_span"": 230, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 242, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 262, ""end_span"": 297, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 300, ""end_span"": 307, ""type"": ""Gene/Protein""}]"	train
Both p105 and p98 were found to form stable complexes with other Rel / NF - kappa B family members, including p65 and c - Rel.	p105,5,9,Gene/Protein	p98,14,17,Gene/Protein	Rel / NF - kappa B family members,65,98,Gene/Protein	p65,110,113,Gene/Protein	c - Rel,118,125,Gene/Protein	"[{""token"": ""p105"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""p98"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""Rel / NF - kappa B family members"", ""start_span"": 65, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	train
One of the essential proteins which bound to the enhancer was similar or identical to members of the C / EBP family of transcription factors required for both IL - 1 - and LPS - specific induction of the IL - 6 gene ( i. e., the NF - IL6 proteins).	C / EBP family,101,115,Gene/Protein	transcription factors,119,140,Gene/Protein	IL - 1,159,165,Gene/Protein	IL - 6 gene,204,215,Gene/Protein	NF - IL6 proteins,229,246,Gene/Protein	"[{""token"": ""C / EBP family"", ""start_span"": 101, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 119, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 159, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 gene"", ""start_span"": 204, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6 proteins"", ""start_span"": 229, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
This function has been attributed to the coordinated binding of subunits of NF - kappa B to distinct regions of the promoter elements of numerous genes, including cytokines, growth factor receptors, and adhesion molecules.	NF - kappa B,76,88,Gene/Protein	promoter elements,116,133,Gene/Protein	cytokines,163,172,Gene/Protein	growth factor receptors,174,197,Gene/Protein	adhesion molecules,203,221,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 76, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""promoter elements"", ""start_span"": 116, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""growth factor receptors"", ""start_span"": 174, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""adhesion molecules"", ""start_span"": 203, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
In contrast to the type I receptor, the type II IL - 1R has a small cytoplasmic tail, and it is not clear whether this receptor is a signal - transducing or a regulatory molecule.	type I receptor,19,34,Gene/Protein	type II IL - 1R,40,55,Gene/Protein	cytoplasmic tail,68,84,Gene/Protein	signal - transducing,133,153,Gene/Protein	regulatory molecule,159,178,Gene/Protein	"[{""token"": ""type I receptor"", ""start_span"": 19, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""type II IL - 1R"", ""start_span"": 40, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic tail"", ""start_span"": 68, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""signal - transducing"", ""start_span"": 133, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""regulatory molecule"", ""start_span"": 159, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
However, a hybrid receptor composed of the extracellular and transmembrane regions of the human type II interleukin - 1 fused to the cytoplasmic domain of the human type I IL - 1R was capable of transducing a signal across the membrane resulting in a pattern of gene activation identical to that mediated by the type I IL - 1R.	extracellular and transmembrane regions,43,82,Gene/Protein	human type II interleukin - 1,90,119,Gene/Protein	cytoplasmic domain,133,151,Gene/Protein	human type I IL - 1R,159,179,Gene/Protein	type I IL - 1R,312,326,Gene/Protein	"[{""token"": ""extracellular and transmembrane regions"", ""start_span"": 43, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""human type II interleukin - 1"", ""start_span"": 90, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic domain"", ""start_span"": 133, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""human type I IL - 1R"", ""start_span"": 159, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""type I IL - 1R"", ""start_span"": 312, ""end_span"": 326, ""type"": ""Gene/Protein""}]"	train
When the wild - type hGR and hGR - Ile 729 were expressed in CV - 1 cells that were cotransfected with the mouse mammary tumor virus long terminal repeat fused to the chloramphenicol acetyl transferase ( CAT) gene, the hGR - Ile 729 conferred a fourfold decrease in apparent potency on dexamethasone stimulation of CAT activity.	wild - type hGR,9,24,Gene/Protein	hGR - Ile 729,29,42,Gene/Protein	mouse mammary tumor virus long terminal repeat,107,153,Gene/Protein	hGR - Ile 729,219,232,Gene/Protein	CAT,315,318,Gene/Protein	"[{""token"": ""wild - type hGR"", ""start_span"": 9, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""hGR - Ile 729"", ""start_span"": 29, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""mouse mammary tumor virus long terminal repeat"", ""start_span"": 107, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""hGR - Ile 729"", ""start_span"": 219, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 315, ""end_span"": 318, ""type"": ""Gene/Protein""}]"	train
Using transfection and reporter gene assays specifically designed for primary T lymphocytes in conjunction with gel retardation assays, Western blot analyses and UV cross - linking studies, we found that c - Jun, c - Fos, and octamer - binding proteins play a major role in transcriptional activation of the IL3 gene via their interaction with two specific regions contained within the IL3 5 ' - flanking sequence.	c - Jun,204,211,Gene/Protein	c - Fos,213,220,Gene/Protein	octamer - binding proteins,226,252,Gene/Protein	IL3 gene,308,316,Gene/Protein	IL3 5 ' - flanking sequence,386,413,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 204, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 213, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""octamer - binding proteins"", ""start_span"": 226, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""IL3 gene"", ""start_span"": 308, ""end_span"": 316, ""type"": ""Gene/Protein""}, {""token"": ""IL3 5 ' - flanking sequence"", ""start_span"": 386, ""end_span"": 413, ""type"": ""Gene/Protein""}]"	train
These kappa B enhancer elements are recognized by a structurally related family of interactive proteins that includes p50, p65, and the product of the c - rel protooncogene ( c - Rel).	kappa B enhancer elements,6,31,Gene/Protein	p50,118,121,Gene/Protein	p65,123,126,Gene/Protein	c - rel protooncogene,151,172,Gene/Protein	c - Rel,175,182,Gene/Protein	"[{""token"": ""kappa B enhancer elements"", ""start_span"": 6, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""c - rel protooncogene"", ""start_span"": 151, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
We therefore propose a model whereby a core NFAT complex consisting of Jun, Fos, and a constitutive nuclear factor is formed in both T and B cells, but an additional factor and / or post - translational modification of a factor, missing in B cells, might be required for transactivation by NFAT.	NFAT complex,44,56,Gene/Protein	Jun,71,74,Gene/Protein	Fos,76,79,Gene/Protein	constitutive nuclear factor,87,114,Gene/Protein	NFAT,290,294,Gene/Protein	"[{""token"": ""NFAT complex"", ""start_span"": 44, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""Fos"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""constitutive nuclear factor"", ""start_span"": 87, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 290, ""end_span"": 294, ""type"": ""Gene/Protein""}]"	train
The reactivity of murine monoclonal antibodies, anti - CD4 - FITC, anti - CD8 - FITC, anti - CD2 - FITC and anti - calla - FITC, were analyzed using flow cytometry.	murine monoclonal antibodies,18,46,Gene/Protein	anti - CD4 - FITC,48,65,Gene/Protein	anti - CD8 - FITC,67,84,Gene/Protein	anti - CD2 - FITC,86,103,Gene/Protein	anti - calla - FITC,108,127,Gene/Protein	"[{""token"": ""murine monoclonal antibodies"", ""start_span"": 18, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD4 - FITC"", ""start_span"": 48, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD8 - FITC"", ""start_span"": 67, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD2 - FITC"", ""start_span"": 86, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""anti - calla - FITC"", ""start_span"": 108, ""end_span"": 127, ""type"": ""Gene/Protein""}]"	train
Group 1 contains G0S24 and the rat and mouse TIS11 genes ( also known as TTP, Nup475, and Zfp36).	G0S24,17,22,Gene/Protein	rat and mouse TIS11 genes,31,56,Gene/Protein	TTP,73,76,Gene/Protein	Nup475,78,84,Gene/Protein	Zfp36,90,95,Gene/Protein	"[{""token"": ""G0S24"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""rat and mouse TIS11 genes"", ""start_span"": 31, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""TTP"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""Nup475"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""Zfp36"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	train
G0S24 has potential sites for transcription factors in the 5 ' flank and intron; these include a serum response element.	G0S24,0,5,Gene/Protein	transcription factors,30,51,Gene/Protein	5 ' flank,59,68,Gene/Protein	intron,73,79,Gene/Protein	serum response element,97,119,Gene/Protein	"[{""token"": ""G0S24"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 30, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""5 ' flank"", ""start_span"": 59, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""intron"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""serum response element"", ""start_span"": 97, ""end_span"": 119, ""type"": ""Gene/Protein""}]"	train
We studied the functional interaction between human embryonic zeta 2 globin promoter and the alpha globin regulatory element ( HS - 40) located 40 kb upstream of the zeta 2 globin gene.	human embryonic zeta 2 globin promoter,46,84,Gene/Protein	alpha globin regulatory element,93,124,Gene/Protein	HS - 40,127,134,Gene/Protein	40 kb upstream,144,158,Gene/Protein	zeta 2 globin gene,166,184,Gene/Protein	"[{""token"": ""human embryonic zeta 2 globin promoter"", ""start_span"": 46, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""alpha globin regulatory element"", ""start_span"": 93, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""HS - 40"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""40 kb upstream"", ""start_span"": 144, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""zeta 2 globin gene"", ""start_span"": 166, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
The interleukin 2 CD28 - responsive complex contains at least three members of the NF kappa B family: c - Rel, p50, and p65.	interleukin 2 CD28 - responsive complex,4,43,Gene/Protein	NF kappa B family,83,100,Gene/Protein	c - Rel,102,109,Gene/Protein	p50,111,114,Gene/Protein	p65,120,123,Gene/Protein	"[{""token"": ""interleukin 2 CD28 - responsive complex"", ""start_span"": 4, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B family"", ""start_span"": 83, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}]"	train
In this report, we show that in human peripheral blood T cells, CD28 - mediated signal transduction involves the rel family proteins - - c - Rel, p50, and p65.	CD28,64,68,Gene/Protein	rel family proteins,113,132,Gene/Protein	c - Rel,137,144,Gene/Protein	p50,146,149,Gene/Protein	p65,155,158,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""rel family proteins"", ""start_span"": 113, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
Treatment of peripheral blood T cells with phorbol 12 - myristate 13 - acetate ( PMA) and anti - CD28 monoclonal antibody ( mAb) results in augmentation of nuclear c - Rel, p50, and p65, and this augmentation can occur in the presence of the immunosuppressant cyclosporin A.	anti - CD28 monoclonal antibody,90,121,Gene/Protein	mAb,124,127,Gene/Protein	nuclear c - Rel,156,171,Gene/Protein	p50,173,176,Gene/Protein	p65,182,185,Gene/Protein	"[{""token"": ""anti - CD28 monoclonal antibody"", ""start_span"": 90, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""mAb"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""nuclear c - Rel"", ""start_span"": 156, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Gene/Protein""}]"	train
The functional significance of c - Rel involvement in the CD28 - responsive complex is demonstrated by transient transfection analysis, where cotransfection of c - Rel augments the level of expression of a chloramphenicol acetyltransferase reporter gene linked to the CD28 - responsive element.	c - Rel,31,38,Gene/Protein	CD28 - responsive complex,58,83,Gene/Protein	c - Rel,160,167,Gene/Protein	chloramphenicol acetyltransferase reporter gene,206,253,Gene/Protein	CD28 - responsive element,268,293,Gene/Protein	"[{""token"": ""c - Rel"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""CD28 - responsive complex"", ""start_span"": 58, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 160, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase reporter gene"", ""start_span"": 206, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""CD28 - responsive element"", ""start_span"": 268, ""end_span"": 293, ""type"": ""Gene/Protein""}]"	train
Tax co - transfected with reporter constructs into Jurkat cells maximally activated HTLV - I - LTR - CAT and kappa B - fos - CAT and also activated LT - 293 to a lesser extent.	Tax,0,3,Gene/Protein	reporter constructs,26,45,Gene/Protein	HTLV - I - LTR - CAT,84,104,Gene/Protein	kappa B - fos - CAT,109,128,Gene/Protein	LT - 293,148,156,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""reporter constructs"", ""start_span"": 26, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""HTLV - I - LTR - CAT"", ""start_span"": 84, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - fos - CAT"", ""start_span"": 109, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""LT - 293"", ""start_span"": 148, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
These studies, the first to demonstrate induction of LT promoter activity over basal levels, indicate that HTLV - I tax causes low - level activation of both endogenous LT and the LT promoter, at least in part through activation of NF - kappa B.	LT promoter,53,64,Gene/Protein	HTLV - I tax,107,119,Gene/Protein	LT,169,171,Gene/Protein	LT promoter,180,191,Gene/Protein	NF - kappa B,232,244,Gene/Protein	"[{""token"": ""LT promoter"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""HTLV - I tax"", ""start_span"": 107, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""LT"", ""start_span"": 169, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""LT promoter"", ""start_span"": 180, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 232, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
TSH - R expression levels were variable, but displayed a close correlation to the expression of thyroid peroxidase ( r = 0. 703; P < 0. 05), thyroglobulin ( r = 0. 817; P < 0. 01), and the nuclear oncogene c - fos ( r = 0. 935; P < 0. 001), but not c - myc.	TSH - R,0,7,Gene/Protein	thyroid peroxidase,96,114,Gene/Protein	thyroglobulin,141,154,Gene/Protein	nuclear oncogene c - fos,189,213,Gene/Protein	c - myc,249,256,Gene/Protein	"[{""token"": ""TSH - R"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""thyroid peroxidase"", ""start_span"": 96, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""thyroglobulin"", ""start_span"": 141, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""nuclear oncogene c - fos"", ""start_span"": 189, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 249, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
Overall, TSH - R transcript levels were low or absent in those thyroids in which expression of the major histocompatibility complex class I or II ( MHC I or II) was high, thus establishing an inverse relation ( MHC I, r = - 0. 791; P < 0. 01; MHC II, r = - 0. 784; P < 0. 01).	TSH - R,9,16,Gene/Protein	major histocompatibility complex class I or II,99,145,Gene/Protein	MHC I or II,148,159,Gene/Protein	MHC I,211,216,Gene/Protein	MHC II,243,249,Gene/Protein	"[{""token"": ""TSH - R"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""major histocompatibility complex class I or II"", ""start_span"": 99, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""MHC I or II"", ""start_span"": 148, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""MHC I"", ""start_span"": 211, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""MHC II"", ""start_span"": 243, ""end_span"": 249, ""type"": ""Gene/Protein""}]"	train
TPA - GR synergism was determined to have occurred at the GR - responsive element ( GRE) level by functional analysis of deletion mutants or synthetic GRE oligonucleotides driving chloramphenicol acetyl - transferase expression.	GR - responsive element,58,81,Gene/Protein	GRE,84,87,Gene/Protein	deletion mutants,121,137,Gene/Protein	synthetic GRE oligonucleotides,141,171,Gene/Protein	chloramphenicol acetyl - transferase,180,216,Gene/Protein	"[{""token"": ""GR - responsive element"", ""start_span"": 58, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""GRE"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""deletion mutants"", ""start_span"": 121, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""synthetic GRE oligonucleotides"", ""start_span"": 141, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyl - transferase"", ""start_span"": 180, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
The ability of Jun proteins to cooperate with GR in T cells has been investigated after transfection of c - jun, jun - B, or jun - D expression vectors, which augmented GR - dependent transcription from either MMTV LTR or GRE.	Jun proteins,15,27,Gene/Protein	GR,46,48,Gene/Protein	GR,169,171,Gene/Protein	MMTV LTR,210,218,Gene/Protein	GRE,222,225,Gene/Protein	"[{""token"": ""Jun proteins"", ""start_span"": 15, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 169, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""MMTV LTR"", ""start_span"": 210, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""GRE"", ""start_span"": 222, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	train
We have shown previously that EBNA2 transactivates the promoters of the latent membrane antigens LMP, TP1 and TP2.	EBNA2,30,35,Gene/Protein	latent membrane antigens,72,96,Gene/Protein	LMP,97,100,Gene/Protein	TP1,102,105,Gene/Protein	TP2,110,113,Gene/Protein	"[{""token"": ""EBNA2"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""latent membrane antigens"", ""start_span"": 72, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""LMP"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""TP1"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""TP2"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene/Protein""}]"	train
In vitro DNase I footprinting analysis revealed six hGATA - 3 binding sites in the U3 region ( the transcriptional regulatory domain) of the HIV - 1 LTR.	DNase I,9,16,Gene/Protein	hGATA - 3 binding sites,52,75,Gene/Protein	U3 region,83,92,Gene/Protein	transcriptional regulatory domain,99,132,Gene/Protein	HIV - 1 LTR,141,152,Gene/Protein	"[{""token"": ""DNase I"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""hGATA - 3 binding sites"", ""start_span"": 52, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""U3 region"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulatory domain"", ""start_span"": 99, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 141, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
The E2A gene encodes transcription factors of the helix - loop - helix family that are implicated in cell - specific gene expression as part of dimeric complexes that interact with E box enhancer elements.	E2A gene,4,12,Gene/Protein	transcription factors,21,42,Gene/Protein	helix - loop - helix family,50,77,Gene/Protein	dimeric complexes,144,161,Gene/Protein	E box enhancer elements,181,204,Gene/Protein	"[{""token"": ""E2A gene"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 21, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""helix - loop - helix family"", ""start_span"": 50, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""dimeric complexes"", ""start_span"": 144, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""E box enhancer elements"", ""start_span"": 181, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	train
In light of the evidence showing physical and functional interactions between Oct factors and OCA - B, we propose a mechanism of action for OCA - B and discuss the implications of OCA - B for the transcriptional regulation of other tissue - specific promoters.	Oct factors,78,89,Gene/Protein	OCA - B,94,101,Gene/Protein	OCA - B,140,147,Gene/Protein	OCA - B,180,187,Gene/Protein	tissue - specific promoters,232,259,Gene/Protein	"[{""token"": ""Oct factors"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""OCA - B"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""OCA - B"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""OCA - B"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""tissue - specific promoters"", ""start_span"": 232, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	train
Five members of this family ( MYC, SCL, TAL - 2, LYL - 1 and E2A) are implicated in oncogenic events in human lymphoid tumors because of their consistent involvement in chromosomal translocations.	MYC,30,33,Gene/Protein	SCL,35,38,Gene/Protein	TAL - 2,40,47,Gene/Protein	LYL - 1,49,56,Gene/Protein	E2A,61,64,Gene/Protein	"[{""token"": ""MYC"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""SCL"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""TAL - 2"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""LYL - 1"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}]"	train
Oct - 2 is a transcription factor that binds specifically to octamer DNA motifs in the promoters of immunoglobulin and interleukin - 2 genes.	Oct - 2,0,7,Gene/Protein	transcription factor,13,33,Gene/Protein	octamer DNA motifs,61,79,Gene/Protein	promoters,87,96,Gene/Protein	immunoglobulin and interleukin - 2 genes,100,140,Gene/Protein	"[{""token"": ""Oct - 2"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 13, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""octamer DNA motifs"", ""start_span"": 61, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 87, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin and interleukin - 2 genes"", ""start_span"": 100, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
We have shown that the Z gene product, which binds to AP - 1 sites as a homodimer and has sequence similarity to c - Fos, can efficiently activate the EBV early promoter, BMRF1, in certain cell types ( i. e., HeLa cells) but not others ( i. e., Jurkat cells).	Z gene product,23,37,Gene/Protein	AP - 1 sites,54,66,Gene/Protein	c - Fos,113,120,Gene/Protein	EBV early promoter,151,169,Gene/Protein	BMRF1,171,176,Gene/Protein	"[{""token"": ""Z gene product"", ""start_span"": 23, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 sites"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""EBV early promoter"", ""start_span"": 151, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""BMRF1"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
That the c - myb oncogene product can interact synergistically with an EBV - encoded member of the leucine zipper protein family suggests c - myb is likely to engage in similar interactions with cellularly encoded transcription factors.	c - myb oncogene product,9,33,Gene/Protein	EBV - encoded member,71,91,Gene/Protein	leucine zipper protein family,99,128,Gene/Protein	c - myb,138,145,Gene/Protein	cellularly encoded transcription factors,195,235,Gene/Protein	"[{""token"": ""c - myb oncogene product"", ""start_span"": 9, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""EBV - encoded member"", ""start_span"": 71, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""leucine zipper protein family"", ""start_span"": 99, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""c - myb"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""cellularly encoded transcription factors"", ""start_span"": 195, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
In this study multiple NF - kappa B related polypeptides ranging from 85 to 45 kDa were examined for their capacity to interact with the PRDII regulatory element of interferon beta and were shown to possess distinct intrinsic DNA binding affinities for this NF - kappa B site and form multiple DNA binding homo - and heterodimer complexes in co - renaturation experiments.	NF - kappa B related polypeptides,23,56,Gene/Protein	PRDII regulatory element,137,161,Gene/Protein	interferon beta,165,180,Gene/Protein	NF - kappa B site,258,275,Gene/Protein	multiple DNA binding homo - and heterodimer complexes,285,338,Gene/Protein	"[{""token"": ""NF - kappa B related polypeptides"", ""start_span"": 23, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""PRDII regulatory element"", ""start_span"": 137, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""interferon beta"", ""start_span"": 165, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 258, ""end_span"": 275, ""type"": ""Gene/Protein""}, {""token"": ""multiple DNA binding homo - and heterodimer complexes"", ""start_span"": 285, ""end_span"": 338, ""type"": ""Gene/Protein""}]"	train
Furthermore, using DNA templates containing two copies of the PRDII domain linked to the rabbit beta globin gene, the purified polypeptides specifically stimulated NF - kappa B dependent transcription in an in vitro reconstitution assay as heterodimers but not as p50 homodimers.	DNA templates,19,32,Gene/Protein	PRDII domain,62,74,Gene/Protein	rabbit beta globin gene,89,112,Gene/Protein	NF - kappa B,164,176,Gene/Protein	p50 homodimers,264,278,Gene/Protein	"[{""token"": ""DNA templates"", ""start_span"": 19, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""PRDII domain"", ""start_span"": 62, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""rabbit beta globin gene"", ""start_span"": 89, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 164, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""p50 homodimers"", ""start_span"": 264, ""end_span"": 278, ""type"": ""Gene/Protein""}]"	train
We report here that interleukin 2 ( IL - 2) acts on human blood monocytes by enhancing binding activity of the transcription factor NF - kappa B to its consensus sequence in the 5 ' regulatory enhancer region of the IL - 2 receptor alpha chain ( p55).	interleukin 2,20,33,Gene/Protein	IL - 2,36,42,Gene/Protein	transcription factor NF - kappa B,111,144,Gene/Protein	IL - 2 receptor alpha chain,216,243,Gene/Protein	p55,246,249,Gene/Protein	"[{""token"": ""interleukin 2"", ""start_span"": 20, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor NF - kappa B"", ""start_span"": 111, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor alpha chain"", ""start_span"": 216, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""p55"", ""start_span"": 246, ""end_span"": 249, ""type"": ""Gene/Protein""}]"	train
Transient - transfection experiments in embryonal carcinoma cells demonstrate a functional cooperation between p50B and RelB or p65 in transactivation of a reporter plasmid dependent on a kappa B site.	p50B,111,115,Gene/Protein	RelB,120,124,Gene/Protein	p65,128,131,Gene/Protein	reporter plasmid,156,172,Gene/Protein	kappa B site,188,200,Gene/Protein	"[{""token"": ""p50B"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""reporter plasmid"", ""start_span"": 156, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""kappa B site"", ""start_span"": 188, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
We have investigated whether a palmitate conjugate of a human monoclonal antibody specific for thyroglobulin ( TG) could function as a surrogate TG receptor on blood mononuclear cells separated into fractions enriched for T cells or depleted of T cells ( non - T cells).	palmitate conjugate,31,50,Gene/Protein	human monoclonal antibody,56,81,Gene/Protein	thyroglobulin,95,108,Gene/Protein	TG,111,113,Gene/Protein	surrogate TG receptor,135,156,Gene/Protein	"[{""token"": ""palmitate conjugate"", ""start_span"": 31, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""human monoclonal antibody"", ""start_span"": 56, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""thyroglobulin"", ""start_span"": 95, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""TG"", ""start_span"": 111, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""surrogate TG receptor"", ""start_span"": 135, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
The proto - oncogene products c - Fos and c - Jun heterodimerize through their leucine zippers to form the AP - 1 transcription factor.	proto - oncogene products,4,29,Gene/Protein	c - Fos,30,37,Gene/Protein	c - Jun,42,49,Gene/Protein	leucine zippers,79,94,Gene/Protein	AP - 1 transcription factor,107,134,Gene/Protein	"[{""token"": ""proto - oncogene products"", ""start_span"": 4, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""leucine zippers"", ""start_span"": 79, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 transcription factor"", ""start_span"": 107, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
A cis - acting element ( P sequence) resides in the 5 ' upstream region; no additional DNA segments with enhancer activity were identified in the human IL - 4 gene.	cis - acting element,2,22,Gene/Protein	P sequence,25,35,Gene/Protein	5 ' upstream region,52,71,Gene/Protein	DNA segments,87,99,Gene/Protein	human IL - 4 gene,146,163,Gene/Protein	"[{""token"": ""cis - acting element"", ""start_span"": 2, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""P sequence"", ""start_span"": 25, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""5 ' upstream region"", ""start_span"": 52, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""DNA segments"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""human IL - 4 gene"", ""start_span"": 146, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
The P sequence does not share homology with the 5 ' upstream sequence of the IL - 2 gene, even though surrounding sequences of the IL - 4 gene share high homology with the IL - 2 gene.	P sequence,4,14,Gene/Protein	5 ' upstream sequence,48,69,Gene/Protein	IL - 2 gene,77,88,Gene/Protein	IL - 4 gene,131,142,Gene/Protein	IL - 2 gene,172,183,Gene/Protein	"[{""token"": ""P sequence"", ""start_span"": 4, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""5 ' upstream sequence"", ""start_span"": 48, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 gene"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 gene"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 gene"", ""start_span"": 172, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
The v - erbA oncogene, a mutated version of the thyroid hormone receptor alpha ( c - erbA / TR - alpha), inhibits erythroid differentiation and constitutively represses transcription of certain erythrocyte genes, suggesting a normal function of the proto - oncogene c - erbA in erythropoiesis.	v - erbA oncogene,4,21,Gene/Protein	thyroid hormone receptor alpha,48,78,Gene/Protein	c - erbA / TR - alpha,81,102,Gene/Protein	erythrocyte genes,194,211,Gene/Protein	proto - oncogene c - erbA,249,274,Gene/Protein	"[{""token"": ""v - erbA oncogene"", ""start_span"": 4, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""thyroid hormone receptor alpha"", ""start_span"": 48, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""c - erbA / TR - alpha"", ""start_span"": 81, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""erythrocyte genes"", ""start_span"": 194, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""proto - oncogene c - erbA"", ""start_span"": 249, ""end_span"": 274, ""type"": ""Gene/Protein""}]"	train
The AP - 1 site at - 150 bp, but not the NF - kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter.	AP - 1 site,4,15,Gene/Protein	- 150 bp,19,27,Gene/Protein	NF - kappa B site,41,58,Gene/Protein	protein kinase C,103,119,Gene/Protein	interleukin 2 promoter,127,149,Gene/Protein	"[{""token"": ""AP - 1 site"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""- 150 bp"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 41, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 103, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2 promoter"", ""start_span"": 127, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
In contrast, mutations in the AP - 1 site located at - 150 bp almost completely abrogate induction of the IL - 2 promoter, and appearance of an inducible nuclear factor binding to this site is sensitive to PKC depletion.	AP - 1 site,30,41,Gene/Protein	- 150 bp,53,61,Gene/Protein	IL - 2 promoter,106,121,Gene/Protein	inducible nuclear factor,144,168,Gene/Protein	PKC,206,209,Gene/Protein	"[{""token"": ""AP - 1 site"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""- 150 bp"", ""start_span"": 53, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 106, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""inducible nuclear factor"", ""start_span"": 144, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
The active nuclear form of the NF - kappa B transcription factor complex is composed of two DNA binding subunits, NF - kappa B p65 and NF - kappa B p50, both of which share extensive N - terminal sequence homology with the v - rel oncogene product.	NF - kappa B transcription factor complex,31,72,Gene/Protein	DNA binding subunits,92,112,Gene/Protein	NF - kappa B p65,114,130,Gene/Protein	NF - kappa B p50,135,151,Gene/Protein	v - rel oncogene product,223,247,Gene/Protein	"[{""token"": ""NF - kappa B transcription factor complex"", ""start_span"": 31, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding subunits"", ""start_span"": 92, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B p65"", ""start_span"": 114, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B p50"", ""start_span"": 135, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""v - rel oncogene product"", ""start_span"": 223, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	train
On the basis of binding, reconstitution and cotransfection experiments, we propose that activation of NF - AT occurs in at least two stages: a CsA - sensitive stage involving modification and / or translocation of the pre - existing NF - AT complex, and a CsA - insensitive stage involving the addition of newly synthesized Fos or Fos / Jun proteins to the pre - existing complex.	NF - AT,102,109,Gene/Protein	NF - AT complex,233,248,Gene/Protein	Fos,324,327,Gene/Protein	Fos / Jun proteins,331,349,Gene/Protein	pre - existing complex,357,379,Gene/Protein	"[{""token"": ""NF - AT"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT complex"", ""start_span"": 233, ""end_span"": 248, ""type"": ""Gene/Protein""}, {""token"": ""Fos"", ""start_span"": 324, ""end_span"": 327, ""type"": ""Gene/Protein""}, {""token"": ""Fos / Jun proteins"", ""start_span"": 331, ""end_span"": 349, ""type"": ""Gene/Protein""}, {""token"": ""pre - existing complex"", ""start_span"": 357, ""end_span"": 379, ""type"": ""Gene/Protein""}]"	train
The proto - oncoprotein c - Rel is a member of the nuclear factor kappa B transcription factor family, which includes the p50 and p65 subunits of nuclear factor kappa B.	proto - oncoprotein c - Rel,4,31,Gene/Protein	nuclear factor kappa B transcription factor family,51,101,Gene/Protein	p50,122,125,Gene/Protein	p65 subunits,130,142,Gene/Protein	nuclear factor kappa B,146,168,Gene/Protein	"[{""token"": ""proto - oncoprotein c - Rel"", ""start_span"": 4, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappa B transcription factor family"", ""start_span"": 51, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""p65 subunits"", ""start_span"": 130, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappa B"", ""start_span"": 146, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
We show here that c - Rel binds to kappa B sites as homodimers as well as heterodimers with p50.	c - Rel,18,25,Gene/Protein	kappa B sites,35,48,Gene/Protein	homodimers,52,62,Gene/Protein	heterodimers,74,86,Gene/Protein	p50,92,95,Gene/Protein	"[{""token"": ""c - Rel"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""kappa B sites"", ""start_span"": 35, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""homodimers"", ""start_span"": 52, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""heterodimers"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	train
We therefore screened a T - cell cDNA library under low - stringency conditions with a probe from the DNA binding domain of Ets - 1 and isolated a novel Ets family member, Elf - 1.	T - cell cDNA,24,37,Gene/Protein	DNA binding domain,102,120,Gene/Protein	Ets - 1,124,131,Gene/Protein	novel Ets family member,147,170,Gene/Protein	Elf - 1,172,179,Gene/Protein	"[{""token"": ""T - cell cDNA"", ""start_span"": 24, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding domain"", ""start_span"": 102, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""Ets - 1"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""novel Ets family member"", ""start_span"": 147, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""Elf - 1"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
We have previously reported the presence of a transcriptional control element with the properties of a silencer extending from - 392 to - 177 bp relative to the cap site of the human epsilon - globin - encoding gene [ Cao et al., Proc. Natl. Acad. Sci. USA 86 ( 1989) 5306 - 5309].	transcriptional control element,46,77,Gene/Protein	silencer,103,111,Gene/Protein	- 392 to - 177 bp,127,144,Gene/Protein	cap site,161,169,Gene/Protein	human epsilon - globin - encoding gene,177,215,Gene/Protein	"[{""token"": ""transcriptional control element"", ""start_span"": 46, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""silencer"", ""start_span"": 103, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""- 392 to - 177 bp"", ""start_span"": 127, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""cap site"", ""start_span"": 161, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""human epsilon - globin - encoding gene"", ""start_span"": 177, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
Much attention has been focused on the interaction of Tat with a specific RNA target termed TAR ( transactivation responsive) which is present in the leader sequence of all HIV - 1 mRNAs.	Tat,54,57,Gene/Protein	RNA target,74,84,Gene/Protein	TAR,92,95,Gene/Protein	transactivation responsive,98,124,Gene/Protein	HIV - 1 mRNAs,173,186,Gene/Protein	"[{""token"": ""Tat"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""RNA target"", ""start_span"": 74, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""TAR"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""transactivation responsive"", ""start_span"": 98, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 mRNAs"", ""start_span"": 173, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
The HTLV - I LTR contains three conserved regulatory elements known as 21 base pair repeats which are required for stimulation of gene expression by the transactivator protein tax.	HTLV - I LTR,4,16,Gene/Protein	regulatory elements,42,61,Gene/Protein	21 base pair repeats,71,91,Gene/Protein	transactivator protein,153,175,Gene/Protein	tax,176,179,Gene/Protein	"[{""token"": ""HTLV - I LTR"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""regulatory elements"", ""start_span"": 42, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""21 base pair repeats"", ""start_span"": 71, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""transactivator protein"", ""start_span"": 153, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""tax"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
This factor is composed of a DNA - binding protein ( ISGF3 gamma), which normally is present in the cytoplasm, and other IFN - alpha - activated proteins which preexist as latent cytoplasmic precursors ( ISGF3 alpha).	DNA - binding protein,29,50,Gene/Protein	ISGF3 gamma,53,64,Gene/Protein	IFN - alpha - activated proteins,121,153,Gene/Protein	latent cytoplasmic precursors,172,201,Gene/Protein	ISGF3 alpha,204,215,Gene/Protein	"[{""token"": ""DNA - binding protein"", ""start_span"": 29, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""ISGF3 gamma"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha - activated proteins"", ""start_span"": 121, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""latent cytoplasmic precursors"", ""start_span"": 172, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""ISGF3 alpha"", ""start_span"": 204, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
Activation of expression of genes encoding transcription factors: c - fos and c - jun and formation of AP1 transcriptional complex in human monocytes was investigated.	genes,28,33,Gene/Protein	transcription factors,43,64,Gene/Protein	c - fos,66,73,Gene/Protein	c - jun,78,85,Gene/Protein	AP1 transcriptional complex,103,130,Gene/Protein	"[{""token"": ""genes"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 43, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""AP1 transcriptional complex"", ""start_span"": 103, ""end_span"": 130, ""type"": ""Gene/Protein""}]"	train
The sites and their corresponding nuclear binding factors include: NF - kappa B, AP - 1, AP - 3, OCT - 1, and NF - AT.	NF - kappa B,67,79,Gene/Protein	AP - 1,81,87,Gene/Protein	AP - 3,89,95,Gene/Protein	OCT - 1,97,104,Gene/Protein	NF - AT,110,117,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 67, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""AP - 3"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""OCT - 1"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
Only the activities for NF - AT and AP - 1 sites require two signals for optimal induction, i. e., PMA plus either lectin or antibody to the CD3 or CD28 surface molecules.	NF - AT and AP - 1 sites,24,48,Gene/Protein	lectin,115,121,Gene/Protein	antibody,125,133,Gene/Protein	CD3,141,144,Gene/Protein	CD28 surface molecules,148,170,Gene/Protein	"[{""token"": ""NF - AT and AP - 1 sites"", ""start_span"": 24, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""lectin"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""CD28 surface molecules"", ""start_span"": 148, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
The effect of constitutive Tax expression on the interaction of NF - kappa B with its recognition sequence and on NF - kappa B - dependent gene expression was examined in T lymphoid Jurkat cell lines ( 19D and 9J) stably transformed with a Tax expression vector.	Tax,27,30,Gene/Protein	NF - kappa B,64,76,Gene/Protein	recognition sequence,86,106,Gene/Protein	NF - kappa B,114,126,Gene/Protein	Tax expression vector,240,261,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 64, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""recognition sequence"", ""start_span"": 86, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 114, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""Tax expression vector"", ""start_span"": 240, ""end_span"": 261, ""type"": ""Gene/Protein""}]"	train
A nuclear factor NF - GM2 that interacts with a regulatory region of the GM - CSF gene essential for its induction in responses to T - cell activation: purification from human T - cell leukemia line Jurkat cells and similarity to NF - kappa B.	nuclear factor,2,16,Gene/Protein	NF - GM2,17,25,Gene/Protein	regulatory region,48,65,Gene/Protein	GM - CSF gene,73,86,Gene/Protein	NF - kappa B,230,242,Gene/Protein	"[{""token"": ""nuclear factor"", ""start_span"": 2, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""NF - GM2"", ""start_span"": 17, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""regulatory region"", ""start_span"": 48, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF gene"", ""start_span"": 73, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 230, ""end_span"": 242, ""type"": ""Gene/Protein""}]"	train
Electrophoretically purified p50 alone can form a protein - DNA complex, but in the mixture, p50 associates preferentially with p65 to form the NF - GM2 complex.	p50,29,32,Gene/Protein	protein - DNA complex,50,71,Gene/Protein	p50,93,96,Gene/Protein	p65,128,131,Gene/Protein	NF - GM2 complex,144,160,Gene/Protein	"[{""token"": ""p50"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""protein - DNA complex"", ""start_span"": 50, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""NF - GM2 complex"", ""start_span"": 144, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
One of the induced transcripts ( MAD - 3) encodes a protein of 317 amino acids with one domain containing five tandem repeats of the cdc10 / ankyrin motif, which is 60% similar ( 46% identical) to the ankyrin repeat region of the precursor of NF - kappa B / KBF1 p50.	MAD - 3,33,40,Gene/Protein	five tandem repeats,106,125,Gene/Protein	cdc10 / ankyrin motif,133,154,Gene/Protein	ankyrin repeat region,201,222,Gene/Protein	NF - kappa B / KBF1 p50,243,266,Gene/Protein	"[{""token"": ""MAD - 3"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""five tandem repeats"", ""start_span"": 106, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""cdc10 / ankyrin motif"", ""start_span"": 133, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""ankyrin repeat region"", ""start_span"": 201, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B / KBF1 p50"", ""start_span"": 243, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
In addition, the 65 - kD protein associated with the p50 subunit of NF - kappa B and the kappa B probe to form a complex with the same electrophoretic mobility as the NF - kappa B - DNA complex.	65 - kD protein,17,32,Gene/Protein	p50 subunit,53,64,Gene/Protein	NF - kappa B,68,80,Gene/Protein	kappa B probe,89,102,Gene/Protein	NF - kappa B - DNA complex,167,193,Gene/Protein	"[{""token"": ""65 - kD protein"", ""start_span"": 17, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""p50 subunit"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""kappa B probe"", ""start_span"": 89, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B - DNA complex"", ""start_span"": 167, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
Macrophage - colony - stimulating factor ( M - CSF), also referred to as CSF - 1, regulates the survival, growth, differentiation and functional activity of monocytes by binding to a single class of high - affinity cell surface receptors, known to be the product of the c - fms protooncogene.	Macrophage - colony - stimulating factor,0,40,Gene/Protein	M - CSF,43,50,Gene/Protein	CSF - 1,73,80,Gene/Protein	high - affinity cell surface receptors,199,237,Gene/Protein	c - fms protooncogene,270,291,Gene/Protein	"[{""token"": ""Macrophage - colony - stimulating factor"", ""start_span"": 0, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""CSF - 1"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""high - affinity cell surface receptors"", ""start_span"": 199, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""c - fms protooncogene"", ""start_span"": 270, ""end_span"": 291, ""type"": ""Gene/Protein""}]"	train
The results suggest that M - CSF induction of M - CSF involves G proteins, PKC and NF kappa B.	M - CSF,25,32,Gene/Protein	M - CSF,46,53,Gene/Protein	G proteins,63,73,Gene/Protein	PKC,75,78,Gene/Protein	NF kappa B,83,93,Gene/Protein	"[{""token"": ""M - CSF"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""G proteins"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 83, ""end_span"": 93, ""type"": ""Gene/Protein""}]"	train
NAC and other thiol compounds also blocked the activation of NF - kappa B by cycloheximide, double - stranded RNA, calcium ionophore, TNF - alpha, active phorbol ester, interleukin - 1, lipopolysaccharide and lectin.	NF - kappa B,61,73,Gene/Protein	double - stranded RNA,92,113,Gene/Protein	TNF - alpha,134,145,Gene/Protein	interleukin - 1,169,184,Gene/Protein	lectin,209,215,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 61, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""double - stranded RNA"", ""start_span"": 92, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 134, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1"", ""start_span"": 169, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""lectin"", ""start_span"": 209, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
The most likely interpretation of our results is that both the ubiquitous transcription factor, OTF - 1, and the B - cell - specific transcription factor, OTF - 2, can activate U2 snRNA transcription.	transcription factor,74,94,Gene/Protein	OTF - 1,96,103,Gene/Protein	B - cell - specific transcription factor,113,153,Gene/Protein	OTF - 2,155,162,Gene/Protein	U2 snRNA,177,185,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 74, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 1"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific transcription factor"", ""start_span"": 113, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 2"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""U2 snRNA"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene/Protein""}]"	train
Purified NF - kB is also able to bind to the TCEd, but TCF - 1 binds stronger than NF - kB to TCEd DNA.	Purified NF - kB,0,16,Gene/Protein	TCEd,45,49,Gene/Protein	TCF - 1,55,62,Gene/Protein	NF - kB,83,90,Gene/Protein	TCEd,94,98,Gene/Protein	"[{""token"": ""Purified NF - kB"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""TCEd"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""TCEd"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}]"	train
Moreover, Tax1 activated expression of two other transcription factors having zinc finger motifs, Egr - 1 and Egr - 2, in the same cells.	Tax1,10,14,Gene/Protein	transcription factors,49,70,Gene/Protein	zinc finger motifs,78,96,Gene/Protein	Egr - 1,98,105,Gene/Protein	Egr - 2,110,117,Gene/Protein	"[{""token"": ""Tax1"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 49, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger motifs"", ""start_span"": 78, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 2"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
The PMA induction of c - fos mRNA correlated well with TNF gene induction; expression of genes encoding other proteins in the AP - 1 complex ( junB and junD) were also induced by PMA.	c - fos mRNA,21,33,Gene/Protein	TNF,55,58,Gene/Protein	AP - 1 complex,126,140,Gene/Protein	junB,143,147,Gene/Protein	junD,152,156,Gene/Protein	"[{""token"": ""c - fos mRNA"", ""start_span"": 21, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 complex"", ""start_span"": 126, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""junB"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""junD"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
Internal labeling with [ 35S] methionine and immunoprecipitation with anti - IgM, anti - kappa, and anti - lambda antibodies revealed a striking reduction in kappa L chain in the presence of TGF - beta.	anti - IgM,70,80,Gene/Protein	anti - kappa,82,94,Gene/Protein	anti - lambda antibodies,100,124,Gene/Protein	kappa L chain,158,171,Gene/Protein	TGF - beta,191,201,Gene/Protein	"[{""token"": ""anti - IgM"", ""start_span"": 70, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""anti - kappa"", ""start_span"": 82, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""anti - lambda antibodies"", ""start_span"": 100, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""kappa L chain"", ""start_span"": 158, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta"", ""start_span"": 191, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
Furthermore, a significant decrease in the switch from the membrane forms of mu and gamma to their respective secreted forms was noted in the presence of TGF - beta.	membrane forms,59,73,Gene/Protein	mu,77,79,Gene/Protein	gamma,84,89,Gene/Protein	secreted forms,110,124,Gene/Protein	TGF - beta,154,164,Gene/Protein	"[{""token"": ""membrane forms"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""mu"", ""start_span"": 77, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""gamma"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""secreted forms"", ""start_span"": 110, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta"", ""start_span"": 154, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
A family of transcriptional activators has recently been identified in chickens; these transcriptional activators recognize a common consensus motif ( WGATAR) through a conserved C4 zinc finger DNA - binding domain.	transcriptional activators,12,38,Gene/Protein	transcriptional activators,87,113,Gene/Protein	consensus motif,133,148,Gene/Protein	WGATAR,151,157,Gene/Protein	C4 zinc finger DNA - binding domain,179,214,Gene/Protein	"[{""token"": ""transcriptional activators"", ""start_span"": 12, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activators"", ""start_span"": 87, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""consensus motif"", ""start_span"": 133, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""WGATAR"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""C4 zinc finger DNA - binding domain"", ""start_span"": 179, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
Isolation of a candidate repressor / activator, NF - E1 ( YY - 1, delta), that binds to the immunoglobulin kappa 3 ' enhancer and the immunoglobulin heavy - chain mu E1 site.	NF - E1,48,55,Gene/Protein	YY - 1,58,64,Gene/Protein	delta,66,71,Gene/Protein	immunoglobulin kappa 3 ' enhancer,92,125,Gene/Protein	immunoglobulin heavy - chain mu E1 site,134,173,Gene/Protein	"[{""token"": ""NF - E1"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""YY - 1"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""delta"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin kappa 3 ' enhancer"", ""start_span"": 92, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin heavy - chain mu E1 site"", ""start_span"": 134, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
The HIV - TF1 - binding site in HIV LTR was similar to the site recognized by upstream stimulatory factor ( USF) in the adenovirus major late promoter.	HIV - TF1 - binding site,4,28,Gene/Protein	HIV LTR,32,39,Gene/Protein	upstream stimulatory factor,78,105,Gene/Protein	USF,108,111,Gene/Protein	adenovirus major late promoter,120,150,Gene/Protein	"[{""token"": ""HIV - TF1 - binding site"", ""start_span"": 4, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""HIV LTR"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""upstream stimulatory factor"", ""start_span"": 78, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""USF"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""adenovirus major late promoter"", ""start_span"": 120, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
Cysteine and NAC also inhibit NF - kappa B activity as determined by electrophoretic mobility shift assays and chloramphenicol acetyl - transferase ( CAT) gene expression under control of NF - kappa B binding sites in uninfected cells.	NF - kappa B,30,42,Gene/Protein	chloramphenicol acetyl - transferase,111,147,Gene/Protein	CAT,150,153,Gene/Protein	NF - kappa B,188,200,Gene/Protein	binding sites,201,214,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 30, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyl - transferase"", ""start_span"": 111, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 188, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 201, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
The TCF - 1 alpha cDNA contains a single 68 - amino - acid domain that is homologous to a region conserved among high - mobility group ( HMG) and nonhistone chromosomal proteins.	TCF - 1 alpha cDNA,4,22,Gene/Protein	68 - amino - acid domain,41,65,Gene/Protein	high - mobility group,113,134,Gene/Protein	HMG,137,140,Gene/Protein	nonhistone chromosomal proteins,146,177,Gene/Protein	"[{""token"": ""TCF - 1 alpha cDNA"", ""start_span"": 4, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""68 - amino - acid domain"", ""start_span"": 41, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""high - mobility group"", ""start_span"": 113, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""HMG"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""nonhistone chromosomal proteins"", ""start_span"": 146, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
Expression of full - length and mutant cDNA clones in bacteria reveal that the single HMG motif, which is predicted to contain two extended alpha - helical segments, is sufficient to direct the sequence - specific binding of TCF - 1 alpha to DNA.	full - length,14,27,Gene/Protein	mutant cDNA clones,32,50,Gene/Protein	single HMG motif,79,95,Gene/Protein	alpha - helical segments,140,164,Gene/Protein	TCF - 1 alpha,225,238,Gene/Protein	"[{""token"": ""full - length"", ""start_span"": 14, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""mutant cDNA clones"", ""start_span"": 32, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""single HMG motif"", ""start_span"": 79, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""alpha - helical segments"", ""start_span"": 140, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1 alpha"", ""start_span"": 225, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	train
These findings therefore suggest that the HTLV - I enhancer contains multiple functional elements, including binding sites for at least CREB - and NF - kappa B - like factors, which synergistically cooperate in activation of the HTLV - I enhancer in response to p40tax.	HTLV - I enhancer,42,59,Gene/Protein	multiple functional elements,69,97,Gene/Protein	CREB - and NF - kappa B - like factors,136,174,Gene/Protein	HTLV - I enhancer,229,246,Gene/Protein	p40tax,262,268,Gene/Protein	"[{""token"": ""HTLV - I enhancer"", ""start_span"": 42, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""multiple functional elements"", ""start_span"": 69, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""CREB - and NF - kappa B - like factors"", ""start_span"": 136, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""HTLV - I enhancer"", ""start_span"": 229, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""p40tax"", ""start_span"": 262, ""end_span"": 268, ""type"": ""Gene/Protein""}]"	train
Although three sites in the TNF - alpha promoter ( kappa 1, kappa 2, and kappa 3) specifically bind the transcription factor NF - kappa B in lymphoid nuclear extracts, TNF - alpha mRNA induction by PMA does not correlate with NF - kappa B binding activities displayed by different T and B cell lines.	TNF - alpha promoter,28,48,Gene/Protein	transcription factor,104,124,Gene/Protein	NF - kappa B,125,137,Gene/Protein	TNF - alpha mRNA,168,184,Gene/Protein	NF - kappa B,226,238,Gene/Protein	"[{""token"": ""TNF - alpha promoter"", ""start_span"": 28, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 104, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 125, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha mRNA"", ""start_span"": 168, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 226, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	train
TCF - 1, a T cell - specific transcription factor of the HMG box family, interacts with sequence motifs in the TCR beta and TCR delta enhancers.	TCF - 1,0,7,Gene/Protein	T cell - specific transcription factor,11,49,Gene/Protein	HMG box family,57,71,Gene/Protein	sequence motifs,88,103,Gene/Protein	TCR beta and TCR delta enhancers,111,143,Gene/Protein	"[{""token"": ""TCF - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""T cell - specific transcription factor"", ""start_span"": 11, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""HMG box family"", ""start_span"": 57, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""sequence motifs"", ""start_span"": 88, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""TCR beta and TCR delta enhancers"", ""start_span"": 111, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	train
Here, we show by gel retardation analysis that TCF - 1 specifically recognizes the T beta 5 element of the TCR beta enhancer and the T delta 7 element of the TCR delta enhancer.	TCF - 1,47,54,Gene/Protein	T beta 5 element,83,99,Gene/Protein	TCR beta enhancer,107,124,Gene/Protein	T delta 7 element,133,150,Gene/Protein	TCR delta enhancer,158,176,Gene/Protein	"[{""token"": ""TCF - 1"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""T beta 5 element"", ""start_span"": 83, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""TCR beta enhancer"", ""start_span"": 107, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""T delta 7 element"", ""start_span"": 133, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""TCR delta enhancer"", ""start_span"": 158, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
The regulatory effect of insulin on the specific binding power of glucocorticoid receptor ( GR) of human leukocytes was assessed by the unoccupied receptor sites capable of combining with [ 3H] labelled dexamethasone measured at 3 and 24 h after incubation with various concentrations of insulin added to the medium.	insulin,25,32,Gene/Protein	glucocorticoid receptor,66,89,Gene/Protein	GR,92,94,Gene/Protein	unoccupied receptor sites,136,161,Gene/Protein	insulin,288,295,Gene/Protein	"[{""token"": ""insulin"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""glucocorticoid receptor"", ""start_span"": 66, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 92, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""unoccupied receptor sites"", ""start_span"": 136, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""insulin"", ""start_span"": 288, ""end_span"": 295, ""type"": ""Gene/Protein""}]"	train
An analysis of the immediate promoter of the human erythroid ALAS gene revealed several putative erythroid - specific cis - acting elements including both a GATA - 1 and an NF - E2 binding site.	immediate promoter,19,37,Gene/Protein	human erythroid ALAS gene,45,70,Gene/Protein	erythroid - specific cis - acting elements,97,139,Gene/Protein	GATA - 1,157,165,Gene/Protein	NF - E2 binding site,173,193,Gene/Protein	"[{""token"": ""immediate promoter"", ""start_span"": 19, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""human erythroid ALAS gene"", ""start_span"": 45, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""erythroid - specific cis - acting elements"", ""start_span"": 97, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 157, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""NF - E2 binding site"", ""start_span"": 173, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
To dissect the molecular basis for the unusual persistent expression of the IL - 2 and IL - 2 - R alpha genes in these IARC 301 T cells, we have analyzed the interactions of constitutively expressed nuclear proteins with the 5 ' flanking regions of the IL - 2 and IL - 2 - R alpha genes using both DNase I footprinting and gel retardation techniques.	IL - 2 and IL - 2 - R alpha genes,76,109,Gene/Protein	constitutively expressed nuclear proteins,174,215,Gene/Protein	5 ' flanking regions,225,245,Gene/Protein	IL - 2 and IL - 2 - R alpha genes,253,286,Gene/Protein	DNase I,298,305,Gene/Protein	"[{""token"": ""IL - 2 and IL - 2 - R alpha genes"", ""start_span"": 76, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""constitutively expressed nuclear proteins"", ""start_span"": 174, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""5 ' flanking regions"", ""start_span"": 225, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 and IL - 2 - R alpha genes"", ""start_span"": 253, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""DNase I"", ""start_span"": 298, ""end_span"": 305, ""type"": ""Gene/Protein""}]"	train
TCF - 1 contained a single DNA - binding HMG box most closely related to similar boxes in the putative mammalian sex - determining gene SRY and in the Schizosaccharomyces pombe Mc mating type gene.	TCF - 1,0,7,Gene/Protein	DNA - binding HMG box,27,48,Gene/Protein	putative mammalian sex - determining gene,94,135,Gene/Protein	SRY,136,139,Gene/Protein	Schizosaccharomyces pombe Mc mating type gene,151,196,Gene/Protein	"[{""token"": ""TCF - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding HMG box"", ""start_span"": 27, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""putative mammalian sex - determining gene"", ""start_span"": 94, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""SRY"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""Schizosaccharomyces pombe Mc mating type gene"", ""start_span"": 151, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
During latent Epstein - Barr virus ( EBV) infection of human B lymphocytes, six viral nuclear antigen ( EBNAs) are expressed from long primary transcripts by means of alternative splicing and alternative polyadenylylation sites.	six viral nuclear antigen,76,101,Gene/Protein	EBNAs,104,109,Gene/Protein	long primary transcripts,130,154,Gene/Protein	alternative splicing,167,187,Gene/Protein	alternative polyadenylylation sites,192,227,Gene/Protein	"[{""token"": ""six viral nuclear antigen"", ""start_span"": 76, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""EBNAs"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""long primary transcripts"", ""start_span"": 130, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""alternative splicing"", ""start_span"": 167, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""alternative polyadenylylation sites"", ""start_span"": 192, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
We demonstrate that JunD, a component of the AP - 1 transcription factor complex, activates transcription of the human proenkephalin gene in a fashion that is completely dependent upon the cAMP - dependent protein kinase, protein kinase A.	JunD,20,24,Gene/Protein	AP - 1 transcription factor complex,45,80,Gene/Protein	human proenkephalin gene,113,137,Gene/Protein	cAMP - dependent protein kinase,189,220,Gene/Protein	protein kinase A,222,238,Gene/Protein	"[{""token"": ""JunD"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 transcription factor complex"", ""start_span"": 45, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""human proenkephalin gene"", ""start_span"": 113, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""cAMP - dependent protein kinase"", ""start_span"": 189, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase A"", ""start_span"": 222, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	train
Binding of the drug inhibits isomerase activity, but studies with other prolyl isomerase inhibitors and analysis of cyclosporin - resistant mutants in yeast suggest that the effects of the drug result from the formation of an inhibitory complex between the drug and isomerase, and not from inhibition of isomerase activity.	isomerase,29,38,Gene/Protein	isomerase,79,88,Gene/Protein	inhibitory complex,226,244,Gene/Protein	isomerase,266,275,Gene/Protein	isomerase,304,313,Gene/Protein	"[{""token"": ""isomerase"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""isomerase"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""inhibitory complex"", ""start_span"": 226, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""isomerase"", ""start_span"": 266, ""end_span"": 275, ""type"": ""Gene/Protein""}, {""token"": ""isomerase"", ""start_span"": 304, ""end_span"": 313, ""type"": ""Gene/Protein""}]"	train
We report on a computer algorithm capable of predicting the location of T - helper - cell epitopes in protein antigen ( Ag) by analysing the Ag amino acid sequence.	T - helper - cell epitopes,72,98,Gene/Protein	protein antigen,102,117,Gene/Protein	Ag,120,122,Gene/Protein	Ag,141,143,Gene/Protein	amino acid sequence,144,163,Gene/Protein	"[{""token"": ""T - helper - cell epitopes"", ""start_span"": 72, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""protein antigen"", ""start_span"": 102, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Ag"", ""start_span"": 120, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Ag"", ""start_span"": 141, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""amino acid sequence"", ""start_span"": 144, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
This gene encodes a protein with duplicated cysteine - rich regions called LIM domains, which show homology to zinc - binding proteins and to iron - sulfur centers of ferredoxins.	cysteine - rich regions,44,67,Gene/Protein	LIM domains,75,86,Gene/Protein	zinc - binding proteins,111,134,Gene/Protein	iron - sulfur centers,142,163,Gene/Protein	ferredoxins,167,178,Gene/Protein	"[{""token"": ""cysteine - rich regions"", ""start_span"": 44, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""LIM domains"", ""start_span"": 75, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""zinc - binding proteins"", ""start_span"": 111, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""iron - sulfur centers"", ""start_span"": 142, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""ferredoxins"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Therefore, chromosome bands 11p15 ( rhombotin) and 11p13 ( Rhom - 2) are consistent sites of chromosome translocation in T - cell leukemia, with the 11p15 target more rarely involved.	chromosome bands 11p15,11,33,Gene/Protein	rhombotin,36,45,Gene/Protein	11p13,51,56,Gene/Protein	Rhom - 2,59,67,Gene/Protein	11p15 target,149,161,Gene/Protein	"[{""token"": ""chromosome bands 11p15"", ""start_span"": 11, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""rhombotin"", ""start_span"": 36, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""11p13"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""Rhom - 2"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""11p15 target"", ""start_span"": 149, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
Our results show that the structure of this promoter only permits productive interactions of the two transcription factors Sp1 and CP1 with the basal transcription machinery in the presence of enhancer sequences.	promoter,44,52,Gene/Protein	transcription factors,101,122,Gene/Protein	Sp1,123,126,Gene/Protein	CP1,131,134,Gene/Protein	enhancer sequences,193,211,Gene/Protein	"[{""token"": ""promoter"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 101, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""CP1"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""enhancer sequences"", ""start_span"": 193, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
We have examined the binding of nuclear proteins and recombinant thyroid hormone receptors ( TRs) to the palindromic thyroid hormone responsive element AGGTCATGACCT ( TREp) using a gel electrophoretic mobility shift assay.	nuclear proteins,32,48,Gene/Protein	recombinant thyroid hormone receptors,53,90,Gene/Protein	TRs,93,96,Gene/Protein	palindromic thyroid hormone responsive element,105,151,Gene/Protein	TREp,167,171,Gene/Protein	"[{""token"": ""nuclear proteins"", ""start_span"": 32, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""recombinant thyroid hormone receptors"", ""start_span"": 53, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""TRs"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""palindromic thyroid hormone responsive element"", ""start_span"": 105, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""TREp"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
TR alpha 1 and TR beta 2 each formed a single major TR: TREp complex which comigrated with the least retarded complex formed by GH3 NE, while TR beta 1 formed multiple complexes suggesting that it can bind to TREp as an oligomer.	TR alpha 1,0,10,Gene/Protein	TR beta 2,15,24,Gene/Protein	TR beta 1,142,151,Gene/Protein	TREp,209,213,Gene/Protein	oligomer,220,228,Gene/Protein	"[{""token"": ""TR alpha 1"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""TR beta 2"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""TR beta 1"", ""start_span"": 142, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""TREp"", ""start_span"": 209, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""oligomer"", ""start_span"": 220, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	train
Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding, suggesting that the carboxyl - terminus of the TRs is essential for interaction with nuclear proteins.	TR alpha 1,14,24,Gene/Protein	amino acid 210,28,42,Gene/Protein	carboxyl - terminus,155,174,Gene/Protein	TRs,182,185,Gene/Protein	nuclear proteins,220,236,Gene/Protein	"[{""token"": ""TR alpha 1"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""amino acid 210"", ""start_span"": 28, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""carboxyl - terminus"", ""start_span"": 155, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""TRs"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""nuclear proteins"", ""start_span"": 220, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
This ` ` octamer ` ` in the context of DRA appears capable of binding both the ubiquitous ( OTF - 1) and lymphoid - specific ( OTF - 2) ` ` octamer ' ' binding proteins, but at least one other distinct ` ` octamer ' ' complex was found.	octamer,9,16,Gene/Protein	DRA,39,42,Gene/Protein	ubiquitous,79,89,Gene/Protein	OTF - 1,92,99,Gene/Protein	` ` octamer ' ' complex,202,225,Gene/Protein	"[{""token"": ""octamer"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""DRA"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitous"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 1"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""` ` octamer ' ' complex"", ""start_span"": 202, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	train
Demonstration of the complete dependence on the Y box in this system suggests that, despite its demonstrated importance in the DRA promoter, the DRA ` ` octamer ' ' does not utilize OTF - 2 in a manner analogous to immunoglobulin promoters in B cells.	Y box,48,53,Gene/Protein	DRA promoter,127,139,Gene/Protein	DRA ` ` octamer ' ',145,164,Gene/Protein	OTF - 2,182,189,Gene/Protein	immunoglobulin promoters,215,239,Gene/Protein	"[{""token"": ""Y box"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""DRA promoter"", ""start_span"": 127, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""DRA ` ` octamer ' '"", ""start_span"": 145, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 2"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin promoters"", ""start_span"": 215, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Erythroid - specific genes contain binding sites for NF - E1 ( also called GF - 1 and Eryf - 1; refs 1 - 3 respectively), the principal DNA - binding protein of the erythrocytic lineage.	Erythroid - specific genes,0,26,Gene/Protein	NF - E1,53,60,Gene/Protein	GF - 1,75,81,Gene/Protein	Eryf - 1,86,94,Gene/Protein	DNA - binding protein,136,157,Gene/Protein	"[{""token"": ""Erythroid - specific genes"", ""start_span"": 0, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""NF - E1"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""GF - 1"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""Eryf - 1"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding protein"", ""start_span"": 136, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
Because insertion mutations in phoP are polar on phoQ, we constructed strains that expressed the PhoQ protein in the absence of PhoP to test whether resistance to defensin requires only the phoQ gene product.	phoP,31,35,Gene/Protein	phoQ,49,53,Gene/Protein	PhoQ protein,97,109,Gene/Protein	PhoP,128,132,Gene/Protein	phoQ gene product,190,207,Gene/Protein	"[{""token"": ""phoP"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""phoQ"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""PhoQ protein"", ""start_span"": 97, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""PhoP"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""phoQ gene product"", ""start_span"": 190, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
We also tested for the ability of defensins NP - 1, NP - 5, and HNP - 1 to activate pag expression and found that these peptides have no effect.	defensins,34,43,Gene/Protein	NP - 1,44,50,Gene/Protein	NP - 5,52,58,Gene/Protein	HNP - 1,64,71,Gene/Protein	pag,84,87,Gene/Protein	"[{""token"": ""defensins"", ""start_span"": 34, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""NP - 1"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""NP - 5"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""HNP - 1"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""pag"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene/Protein""}]"	train
Our finding that induction of NF - kappa B by tumor necrosis factor or antibody to CD3 is not sufficient to induce HIV enhancer - dependent transcription in cloned T cells contrasts with results obtained in most lymphoblastoid T - cell lines and indicates that normal T lymphocytes differ from tumoral T cells in terms of requirements for HIV LTR activation.	NF - kappa B,30,42,Gene/Protein	tumor necrosis factor,46,67,Gene/Protein	antibody to CD3,71,86,Gene/Protein	HIV enhancer,115,127,Gene/Protein	HIV LTR,339,346,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 30, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 46, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""antibody to CD3"", ""start_span"": 71, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""HIV enhancer"", ""start_span"": 115, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""HIV LTR"", ""start_span"": 339, ""end_span"": 346, ""type"": ""Gene/Protein""}]"	train
Moreover, BSAP is clearly a B - cell - specific transcription factor, as a wild - type but not a mutant TSAP - binding site of the sea urchin functions only in transfected B cells as an upstream promoter element.	BSAP,10,14,Gene/Protein	B - cell - specific transcription factor,28,68,Gene/Protein	wild - type,75,86,Gene/Protein	mutant TSAP - binding site,97,123,Gene/Protein	upstream promoter element,186,211,Gene/Protein	"[{""token"": ""BSAP"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific transcription factor"", ""start_span"": 28, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""wild - type"", ""start_span"": 75, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""mutant TSAP - binding site"", ""start_span"": 97, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""upstream promoter element"", ""start_span"": 186, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
This sequence motif is a binding site for nuclear proteins, the so - called octamer transcription factors ( Oct or OTF factors).	sequence motif,5,19,Gene/Protein	nuclear proteins,42,58,Gene/Protein	octamer transcription factors,76,105,Gene/Protein	Oct,108,111,Gene/Protein	OTF factors,115,126,Gene/Protein	"[{""token"": ""sequence motif"", ""start_span"": 5, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""nuclear proteins"", ""start_span"": 42, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""octamer transcription factors"", ""start_span"": 76, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Oct"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""OTF factors"", ""start_span"": 115, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	train
Here we report that the formation of two distinct mitogen - inducible DNA - binding complexes, the kappa B complex within the HIV enhancer and the NFAT - 1 complex within the interleukin - 2 enhancer, is inhibited in the presence of CsA.	mitogen - inducible DNA - binding complexes,50,93,Gene/Protein	kappa B complex,99,114,Gene/Protein	HIV enhancer,126,138,Gene/Protein	NFAT - 1 complex,147,163,Gene/Protein	interleukin - 2 enhancer,175,199,Gene/Protein	"[{""token"": ""mitogen - inducible DNA - binding complexes"", ""start_span"": 50, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""kappa B complex"", ""start_span"": 99, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""HIV enhancer"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""NFAT - 1 complex"", ""start_span"": 147, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 enhancer"", ""start_span"": 175, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
B - cell - specific transcription of this gene was dependent on the octamer element 5 ' - ATGCAAAG - 3 ', located in the upstream region of this promoter and in the promoters of all other immunoglobulin heavy - and light - chain genes.	octamer element,68,83,Gene/Protein	upstream region,121,136,Gene/Protein	promoter,145,153,Gene/Protein	promoters,165,174,Gene/Protein	immunoglobulin heavy - and light - chain genes,188,234,Gene/Protein	"[{""token"": ""octamer element"", ""start_span"": 68, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""upstream region"", ""start_span"": 121, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 165, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin heavy - and light - chain genes"", ""start_span"": 188, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
The interaction of purified octamer transcription factors 1 and 2 ( OTF1 and OTF2) with the MOPC 141 promoter was studied by using electrophoretic mobility shift assays and DNase I footprinting.	octamer transcription factors,28,57,Gene/Protein	OTF1,68,72,Gene/Protein	OTF2,77,81,Gene/Protein	MOPC 141 promoter,92,109,Gene/Protein	DNase I,173,180,Gene/Protein	"[{""token"": ""octamer transcription factors"", ""start_span"": 28, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""OTF1"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""OTF2"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""MOPC 141 promoter"", ""start_span"": 92, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""DNase I"", ""start_span"": 173, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
The N element bound a transcription factor, NTF, that is ubiquitous in cell - type distribution, and NTF was distinct from any of the previously described proteins that bind to similar sequences.	N element,4,13,Gene/Protein	transcription factor,22,42,Gene/Protein	NTF,44,47,Gene/Protein	NTF,101,104,Gene/Protein	previously described proteins,134,163,Gene/Protein	"[{""token"": ""N element"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 22, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""NTF"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""NTF"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""previously described proteins"", ""start_span"": 134, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
The expression of the gene encoding the granulocyte - macrophage colony - stimulating factor ( GM - CSF) is induced upon activation of T cells with phytohemagglutinin and active phorbolester and upon expression of tax1, a transactivating protein of the human T - cell leukemia virus type I.	granulocyte - macrophage colony - stimulating factor,40,92,Gene/Protein	GM - CSF,95,103,Gene/Protein	phytohemagglutinin,148,166,Gene/Protein	tax1,214,218,Gene/Protein	transactivating protein,222,245,Gene/Protein	"[{""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 40, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 95, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""phytohemagglutinin"", ""start_span"": 148, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""tax1"", ""start_span"": 214, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""transactivating protein"", ""start_span"": 222, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
As shown by a methylation interference analysis and oligonucleotide competition experiments, purified NF - kappa B binds at positions - 82 to - 91 ( GGGAACTACC) of the GM - CSF promoter sequence with an affinity similar to that with which it binds to the biologically functional kappa B motif in the beta interferon promoter ( GGGAAATTCC).	NF - kappa B,102,114,Gene/Protein	positions - 82 to - 91,124,146,Gene/Protein	GM - CSF promoter,168,185,Gene/Protein	biologically functional kappa B motif,255,292,Gene/Protein	beta interferon promoter,300,324,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 102, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""positions - 82 to - 91"", ""start_span"": 124, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF promoter"", ""start_span"": 168, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""biologically functional kappa B motif"", ""start_span"": 255, ""end_span"": 292, ""type"": ""Gene/Protein""}, {""token"": ""beta interferon promoter"", ""start_span"": 300, ""end_span"": 324, ""type"": ""Gene/Protein""}]"	train
We hypothesized that adherence itself might be an important trigger for a sequence of gene activation culminating in cells with increased mRNA encoding profibrotic growth factors such as platelet - derived growth factor B subunit ( PDGF [ B]) and transforming growth factor - beta ( TGF - beta).	mRNA,138,142,Gene/Protein	growth factors,164,178,Gene/Protein	platelet - derived growth factor B subunit,187,229,Gene/Protein	transforming growth factor - beta,247,280,Gene/Protein	TGF - beta,283,293,Gene/Protein	"[{""token"": ""mRNA"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""growth factors"", ""start_span"": 164, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""platelet - derived growth factor B subunit"", ""start_span"": 187, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""transforming growth factor - beta"", ""start_span"": 247, ""end_span"": 280, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta"", ""start_span"": 283, ""end_span"": 293, ""type"": ""Gene/Protein""}]"	train
The Epstein - Barr virus ( EBV) BMRF1 promoter for early antigen ( EA - D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell - specific manner.	early antigen,51,64,Gene/Protein	EA - D,67,73,Gene/Protein	EBV transactivators,95,114,Gene/Protein	BRLF1,116,121,Gene/Protein	BZLF1,126,131,Gene/Protein	"[{""token"": ""early antigen"", ""start_span"": 51, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""EA - D"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""EBV transactivators"", ""start_span"": 95, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""BRLF1"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""BZLF1"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}]"	train
In epithelial cells, the Z transactivator alone produced maximal stimulation of the EA - D promoter; the effect of R and Z together was no greater than that of Z alone.	Z transactivator,25,41,Gene/Protein	EA - D promoter,84,99,Gene/Protein	R,115,116,Gene/Protein	Z,121,122,Gene/Protein	Z,160,161,Gene/Protein	"[{""token"": ""Z transactivator"", ""start_span"": 25, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""EA - D promoter"", ""start_span"": 84, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""R"", ""start_span"": 115, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""Z"", ""start_span"": 121, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Z"", ""start_span"": 160, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
After the recent discovery that the cyclosporin A - binding protein cyclophilin is identical to peptidylprolyl cis - trans isomerase, a cellular binding protein for FK506 was found to be distinct from cyclophilin but to have the same enzymatic activity.	cyclosporin A - binding protein,36,67,Gene/Protein	cyclophilin,68,79,Gene/Protein	peptidylprolyl cis - trans isomerase,96,132,Gene/Protein	cellular binding protein,136,160,Gene/Protein	cyclophilin,201,212,Gene/Protein	"[{""token"": ""cyclosporin A - binding protein"", ""start_span"": 36, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""cyclophilin"", ""start_span"": 68, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""peptidylprolyl cis - trans isomerase"", ""start_span"": 96, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""cellular binding protein"", ""start_span"": 136, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""cyclophilin"", ""start_span"": 201, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	train
To determine whether enhancer elements in addition to the highly conserved octamer ( OCTA) - nucleotide motif are important for lymphoid - specific expression of the immunoglobulin heavy - chain ( IgH) gene, we have investigated the effect of mutating the binding site for a putative additional lymphoid - specific transcription factor, designated NF - microB, in the murine IgH enhancer.	enhancer elements,21,38,Gene/Protein	binding site,256,268,Gene/Protein	putative additional lymphoid - specific transcription factor,275,335,Gene/Protein	NF - microB,348,359,Gene/Protein	murine IgH enhancer,368,387,Gene/Protein	"[{""token"": ""enhancer elements"", ""start_span"": 21, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""binding site"", ""start_span"": 256, ""end_span"": 268, ""type"": ""Gene/Protein""}, {""token"": ""putative additional lymphoid - specific transcription factor"", ""start_span"": 275, ""end_span"": 335, ""type"": ""Gene/Protein""}, {""token"": ""NF - microB"", ""start_span"": 348, ""end_span"": 359, ""type"": ""Gene/Protein""}, {""token"": ""murine IgH enhancer"", ""start_span"": 368, ""end_span"": 387, ""type"": ""Gene/Protein""}]"	train
While the HIV - 2 and HIV - 1 tat genes and T - cell activators apparently employ independent modes of action, the CMV transactivator in combination with the HIV - 2 tat or T - cell activators may employ a gene activation pathway with some common and some distinct components.	HIV - 1 tat genes,22,39,Gene/Protein	T - cell activators,44,63,Gene/Protein	CMV transactivator,115,133,Gene/Protein	HIV - 2 tat,158,169,Gene/Protein	T - cell activators,173,192,Gene/Protein	"[{""token"": ""HIV - 1 tat genes"", ""start_span"": 22, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""T - cell activators"", ""start_span"": 44, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""CMV transactivator"", ""start_span"": 115, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 2 tat"", ""start_span"": 158, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""T - cell activators"", ""start_span"": 173, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
Fibronectin synergized with anti - CD3 antibody to promote CD4 cell proliferation in a serum - free culture system whereas no proliferation was observed when CD4 cells were cultured with anti - CD3 alone or fibronectin alone.	Fibronectin,0,11,Gene/Protein	anti - CD3 antibody,28,47,Gene/Protein	CD4,59,62,Gene/Protein	anti - CD3,187,197,Gene/Protein	fibronectin,207,218,Gene/Protein	"[{""token"": ""Fibronectin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3 antibody"", ""start_span"": 28, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 187, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 207, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
In an analysis of the molecular mechanism by which IL - 2 message was generated, we showed that a fibronectin - VLA - 5 fibronectin receptor interaction may contribute an independent signal distinct from the CD3 pathway of activation by the induction of an AP - 1 transcriptional factor.	IL - 2,51,57,Gene/Protein	fibronectin,98,109,Gene/Protein	fibronectin receptor,120,140,Gene/Protein	CD3,208,211,Gene/Protein	AP - 1 transcriptional factor,257,286,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin receptor"", ""start_span"": 120, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 transcriptional factor"", ""start_span"": 257, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	train
Two complementary DNAs were isolated that encode proteins, denoted ITF - 1 and ITF - 2, that are expressed in a variety of cell types and bind the microE5 / kappa 2 motif found in both heavy and kappa light chain enhancers.	complementary DNAs,4,22,Gene/Protein	ITF - 1,67,74,Gene/Protein	ITF - 2,79,86,Gene/Protein	microE5 / kappa 2 motif,147,170,Gene/Protein	heavy and kappa light chain enhancers,185,222,Gene/Protein	"[{""token"": ""complementary DNAs"", ""start_span"": 4, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""ITF - 1"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""ITF - 2"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""microE5 / kappa 2 motif"", ""start_span"": 147, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""heavy and kappa light chain enhancers"", ""start_span"": 185, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
The relationship of the N - Oct proteins to Oct - 1 and Oct - 2A was analyzed by proteolytic clipping bandshift assays and by their reactivity towards antisera raised against recombinant Oct - 1 and Oct - 2A proteins.	N - Oct proteins,24,40,Gene/Protein	Oct - 1,44,51,Gene/Protein	Oct - 2A,56,64,Gene/Protein	Oct - 1,187,194,Gene/Protein	Oct - 2A,199,207,Gene/Protein	"[{""token"": ""N - Oct proteins"", ""start_span"": 24, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2A"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2A"", ""start_span"": 199, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
These results suggest that OTF - 1, without OTF - 2, is sufficient for transcription of immunoglobulin genes and that OTF - 2 alone is not responsible for the B - cell - specific regulation of immunoglobulin gene expression.	OTF - 1,27,34,Gene/Protein	OTF - 2,44,51,Gene/Protein	immunoglobulin genes,88,108,Gene/Protein	OTF - 2,118,125,Gene/Protein	immunoglobulin gene,193,212,Gene/Protein	"[{""token"": ""OTF - 1"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 2"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin genes"", ""start_span"": 88, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 2"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin gene"", ""start_span"": 193, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	train
Addition of phosphorothioate oligonucleotides that contained the octamer consensus to Jurkat T leukemia cells inhibited interleukin - 2 ( IL - 2) secretion to a degree similar to that observed with a mutated octamer site in the IL - 2 enhancer.	octamer consensus,65,82,Gene/Protein	interleukin - 2,120,135,Gene/Protein	IL - 2,138,144,Gene/Protein	mutated octamer site,200,220,Gene/Protein	IL - 2 enhancer,228,243,Gene/Protein	"[{""token"": ""octamer consensus"", ""start_span"": 65, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 120, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""mutated octamer site"", ""start_span"": 200, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 enhancer"", ""start_span"": 228, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
Several lines of evidence are compatible with the hypothesis that Epstein - Barr virus ( EBV) nuclear antigen 2 ( EBNA - 2) or leader protein ( EBNA - LP) affects expression of the EBV latent infection membrane protein LMP1.	EBNA - 2,114,122,Gene/Protein	leader protein,127,141,Gene/Protein	EBNA - LP,144,153,Gene/Protein	EBV latent infection membrane protein,181,218,Gene/Protein	LMP1,219,223,Gene/Protein	"[{""token"": ""EBNA - 2"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""leader protein"", ""start_span"": 127, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""EBNA - LP"", ""start_span"": 144, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""EBV latent infection membrane protein"", ""start_span"": 181, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 219, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
The carboxy - terminal half of the HBx protein was preferentially recognized by antibodies from patients with chronic hepatitis and contained a short immunodominant antigenic region with at least two major nonoverlapping epitopes.	carboxy - terminal half,4,27,Gene/Protein	HBx protein,35,46,Gene/Protein	antibodies,80,90,Gene/Protein	immunodominant antigenic region,150,181,Gene/Protein	nonoverlapping epitopes,206,229,Gene/Protein	"[{""token"": ""carboxy - terminal half"", ""start_span"": 4, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""HBx protein"", ""start_span"": 35, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 80, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""immunodominant antigenic region"", ""start_span"": 150, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""nonoverlapping epitopes"", ""start_span"": 206, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
In the DRA promoter, one of these cis - acting regulatory motifs is the X2 - box to which nuclear factor X2 ( NF - X2) binds.	DRA promoter,7,19,Gene/Protein	cis - acting regulatory motifs,34,64,Gene/Protein	X2 - box,72,80,Gene/Protein	nuclear factor X2,90,107,Gene/Protein	NF - X2,110,117,Gene/Protein	"[{""token"": ""DRA promoter"", ""start_span"": 7, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""cis - acting regulatory motifs"", ""start_span"": 34, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""X2 - box"", ""start_span"": 72, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor X2"", ""start_span"": 90, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""NF - X2"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
This cDNA clone was isolated by expression cDNA cloning, and encodes the human c - Jun protein, which together with c - Fos forms the heterodimeric activator protein - 1 transcription complex.	cDNA clone,5,15,Gene/Protein	cDNA,43,47,Gene/Protein	human c - Jun protein,73,94,Gene/Protein	c - Fos,116,123,Gene/Protein	heterodimeric activator protein - 1 transcription complex,134,191,Gene/Protein	"[{""token"": ""cDNA clone"", ""start_span"": 5, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""cDNA"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""human c - Jun protein"", ""start_span"": 73, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""heterodimeric activator protein - 1 transcription complex"", ""start_span"": 134, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
In this work we show that the monoclonal antibody KN 382 / EC1 raised against the rabbit 59 - kDa protein reacts with 9S, untransformed glucocorticoid receptor complexes in cytosol prepared from human IM - 9 lymphocytes but not with 4S salt - transformed receptors.	monoclonal antibody KN 382 / EC1,30,62,Gene/Protein	rabbit 59 - kDa protein,82,105,Gene/Protein	9S,118,120,Gene/Protein	untransformed glucocorticoid receptor complexes,122,169,Gene/Protein	4S salt - transformed receptors,233,264,Gene/Protein	"[{""token"": ""monoclonal antibody KN 382 / EC1"", ""start_span"": 30, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""rabbit 59 - kDa protein"", ""start_span"": 82, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""9S"", ""start_span"": 118, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""untransformed glucocorticoid receptor complexes"", ""start_span"": 122, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""4S salt - transformed receptors"", ""start_span"": 233, ""end_span"": 264, ""type"": ""Gene/Protein""}]"	train
The cDNA sequence has an 813 - bp open reading frame ( ORF) whose predicted amino acid sequence is 97. 6% identical to the 272 carboxy - terminal amino acids of the human ets - 1 protein.	cDNA sequence,4,17,Gene/Protein	813 - bp open reading frame,25,52,Gene/Protein	ORF,55,58,Gene/Protein	272 carboxy - terminal amino acids,123,157,Gene/Protein	human ets - 1 protein,165,186,Gene/Protein	"[{""token"": ""cDNA sequence"", ""start_span"": 4, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""813 - bp open reading frame"", ""start_span"": 25, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""ORF"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""272 carboxy - terminal amino acids"", ""start_span"": 123, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""human ets - 1 protein"", ""start_span"": 165, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
B - cell - specific activator protein ( BSAP) is a recently identified member of the Pax - gene family of transcription factors; in the lymphoid system, BSAP is produced only in B cells.	B - cell - specific activator protein,0,37,Gene/Protein	BSAP,40,44,Gene/Protein	Pax - gene family,85,102,Gene/Protein	transcription factors,106,127,Gene/Protein	BSAP,153,157,Gene/Protein	"[{""token"": ""B - cell - specific activator protein"", ""start_span"": 0, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Pax - gene family"", ""start_span"": 85, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 106, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
The MZF - 1 protein contains 13 C2H2 zinc fingers arranged in bipartite DNA binding domains containing zinc fingers through 4 and, in the carboxy - terminus, 5 through 13.	MZF - 1,4,11,Gene/Protein	C2H2 zinc fingers,32,49,Gene/Protein	DNA binding domains,72,91,Gene/Protein	zinc fingers,103,115,Gene/Protein	carboxy - terminus,138,156,Gene/Protein	"[{""token"": ""MZF - 1"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""C2H2 zinc fingers"", ""start_span"": 32, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding domains"", ""start_span"": 72, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""zinc fingers"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""carboxy - terminus"", ""start_span"": 138, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
HSF exhibits the properties of a transcriptional activator, as judged from the stimulatory activity of transiently overexpressed HSF3 measured by using a heat shock element - containing reporter construct and as independently assayed by the activity of a chimeric GAL4 - HSF3 protein on a GAL4 reporter construct.	transcriptional activator,33,58,Gene/Protein	transiently overexpressed HSF3,103,133,Gene/Protein	heat shock element - containing reporter construct,154,204,Gene/Protein	chimeric GAL4 - HSF3 protein,255,283,Gene/Protein	GAL4 reporter construct,289,312,Gene/Protein	"[{""token"": ""transcriptional activator"", ""start_span"": 33, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""transiently overexpressed HSF3"", ""start_span"": 103, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""heat shock element - containing reporter construct"", ""start_span"": 154, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""chimeric GAL4 - HSF3 protein"", ""start_span"": 255, ""end_span"": 283, ""type"": ""Gene/Protein""}, {""token"": ""GAL4 reporter construct"", ""start_span"": 289, ""end_span"": 312, ""type"": ""Gene/Protein""}]"	train
We report here that the nuclear factor of activated T cells ( NFATp), a cyclosporin A ( CsA) - sensitive factor that regulates the transcription of several cytokines, mediates CD16 - induced activation of cytokine genes in human NK cells.	nuclear factor,24,38,Gene/Protein	NFATp,62,67,Gene/Protein	cytokines,156,165,Gene/Protein	CD16,176,180,Gene/Protein	cytokine genes,205,219,Gene/Protein	"[{""token"": ""nuclear factor"", ""start_span"": 24, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 156, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 205, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
These results provide the first direct evidence that both CsA - sensitive transcription factors, NFATp and NFATc, are expressed in human NK cells, and that their activation and / or expression can be regulated in primary cells by a single stimulus, that, in the case of CD16 in NK cells, results in early activation of NFATp and subsequently induced expression of NFATc mRNA.	CsA - sensitive transcription factors,58,95,Gene/Protein	NFATp,97,102,Gene/Protein	NFATc,107,112,Gene/Protein	NFATp,319,324,Gene/Protein	NFATc mRNA,364,374,Gene/Protein	"[{""token"": ""CsA - sensitive transcription factors"", ""start_span"": 58, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""NFATc"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 319, ""end_span"": 324, ""type"": ""Gene/Protein""}, {""token"": ""NFATc mRNA"", ""start_span"": 364, ""end_span"": 374, ""type"": ""Gene/Protein""}]"	train
p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 ( SH2) domain, but otherwise are immunologically distinct from Stat1.	p94,0,3,Gene/Protein	p95,8,11,Gene/Protein	Stat1,32,37,Gene/Protein	phosphorylation site,45,65,Gene/Protein	Stat1,155,160,Gene/Protein	"[{""token"": ""p94"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""p95"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""phosphorylation site"", ""start_span"": 45, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
Thus, after 4 hr of exposure to SEA and SEB, the expression of IL - 2R beta was down - regulated, IL - 2R gamma was slightly up - regulated, while IL - 2R alpha remained largely unaffected.	SEA,32,35,Gene/Protein	SEB,40,43,Gene/Protein	IL - 2R beta,63,75,Gene/Protein	IL - 2R gamma,98,111,Gene/Protein	IL - 2R alpha,147,160,Gene/Protein	"[{""token"": ""SEA"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""SEB"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 63, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R gamma"", ""start_span"": 98, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 147, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
Transcription factors belonging to the NF - kappa B family are controlled by inhibitory I kappa B proteins, mainly I kappa B alpha and I kappa B beta.	Transcription factors,0,21,Gene/Protein	NF - kappa B family,39,58,Gene/Protein	inhibitory I kappa B proteins,77,106,Gene/Protein	I kappa B alpha,115,130,Gene/Protein	I kappa B beta,135,149,Gene/Protein	"[{""token"": ""Transcription factors"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B family"", ""start_span"": 39, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""inhibitory I kappa B proteins"", ""start_span"": 77, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B beta"", ""start_span"": 135, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
Additionally, it inhibited the production of LTB4 ( IC50 = 0. 5 microM) and the cytokines IL - 2, IL - 6 and TNF alpha ( IC50 = 10 - 12 microM).	LTB4,45,49,Gene/Protein	cytokines,80,89,Gene/Protein	IL - 2,90,96,Gene/Protein	IL - 6,98,104,Gene/Protein	TNF alpha,109,118,Gene/Protein	"[{""token"": ""LTB4"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 80, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 90, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""TNF alpha"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Gene/Protein""}]"	train
This requirement has been attributed to the activation of the transcription factor NF - kappa B, which synergizes with the constitutive transcription factor Sp1 to drive the HIV - 1 promoter.	transcription factor,62,82,Gene/Protein	NF - kappa B,83,95,Gene/Protein	constitutive transcription factor,123,156,Gene/Protein	Sp1,157,160,Gene/Protein	HIV - 1 promoter,174,190,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 62, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 83, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""constitutive transcription factor"", ""start_span"": 123, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 promoter"", ""start_span"": 174, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
DCs express high levels of all known NF - kappa B and Rel proteins, with activity residing primarily within RelB, p50, and p65.	NF - kappa B,37,49,Gene/Protein	Rel proteins,54,66,Gene/Protein	RelB,108,112,Gene/Protein	p50,114,117,Gene/Protein	p65,123,126,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Rel proteins"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	train
The sequence of one of these elements, OSE2, is identical to the DNA - binding site of the PEBP2 alpha / AML - 1 transcription factors, the mammalian homologues of the Drosophila Runt protein.	elements,29,37,Gene/Protein	DNA - binding site,65,83,Gene/Protein	PEBP2 alpha / AML - 1 transcription factors,91,134,Gene/Protein	mammalian homologues,140,160,Gene/Protein	Drosophila Runt protein,168,191,Gene/Protein	"[{""token"": ""elements"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding site"", ""start_span"": 65, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2 alpha / AML - 1 transcription factors"", ""start_span"": 91, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""mammalian homologues"", ""start_span"": 140, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""Drosophila Runt protein"", ""start_span"": 168, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
Initiation binding repressor, a factor that binds to the transcription initiation site of the histone h5 gene, is a glycosylated member of a family of cell growth regulators [ corrected] [ published erratum appears in Mol Cell Biol 1996 Feb; 16 ( 2): 735]	Initiation binding repressor,0,28,Gene/Protein	transcription initiation site,57,86,Gene/Protein	histone h5 gene,94,109,Gene/Protein	glycosylated member,116,135,Gene/Protein	cell growth regulators,151,173,Gene/Protein	"[{""token"": ""Initiation binding repressor"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""transcription initiation site"", ""start_span"": 57, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""histone h5 gene"", ""start_span"": 94, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""glycosylated member"", ""start_span"": 116, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""cell growth regulators"", ""start_span"": 151, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Initiation binding repressor [ corrected] ( IBR) is a chicken erythrocyte factor ( apparent molecular mass, 70 to 73 kDa) that binds to the sequences spanning the transcription initiation site of the histone h5 gene, repressing its transcription.	Initiation binding repressor,0,28,Gene/Protein	IBR,44,47,Gene/Protein	chicken erythrocyte factor,54,80,Gene/Protein	transcription initiation site,163,192,Gene/Protein	histone h5 gene,200,215,Gene/Protein	"[{""token"": ""Initiation binding repressor"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""IBR"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""chicken erythrocyte factor"", ""start_span"": 54, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""transcription initiation site"", ""start_span"": 163, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""histone h5 gene"", ""start_span"": 200, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
The evolutionarily conserved N - terminal half of IBR / F harbors the DNA - binding / dimerization domain ( outer limits, 127 to 283), one or several casein kinase II sites ( 37 to 67), and a bipartite nuclear localization signal ( 89 to 106) which appears to be necessary for nuclear targeting.	N - terminal half,29,46,Gene/Protein	IBR / F,50,57,Gene/Protein	DNA - binding / dimerization domain,70,105,Gene/Protein	casein kinase II sites,150,172,Gene/Protein	bipartite nuclear localization signal,192,229,Gene/Protein	"[{""token"": ""N - terminal half"", ""start_span"": 29, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""IBR / F"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding / dimerization domain"", ""start_span"": 70, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""casein kinase II sites"", ""start_span"": 150, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""bipartite nuclear localization signal"", ""start_span"": 192, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
We also found that tumor necrosis factor - alpha ( TNF - alpha) is capable of inducing the surface expression of the CD69 molecule as well as the promoter activity of fusion plasmids that contain 5 ' - flanking sequences of the CD69 gene, suggesting that this cytokine may regulate in vivo the expression of CD69.	tumor necrosis factor - alpha,19,48,Gene/Protein	TNF - alpha,51,62,Gene/Protein	CD69,117,121,Gene/Protein	CD69,228,232,Gene/Protein	CD69,308,312,Gene/Protein	"[{""token"": ""tumor necrosis factor - alpha"", ""start_span"": 19, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CD69"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""CD69"", ""start_span"": 228, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""CD69"", ""start_span"": 308, ""end_span"": 312, ""type"": ""Gene/Protein""}]"	train
A major transcription initiation site was located in three human tissues approximately 560 bp upstream from the translation initiation codon and 380 bp upstream from any previously identified transcription initiation site.	transcription initiation site,8,37,Gene/Protein	560 bp upstream,87,102,Gene/Protein	translation initiation codon,112,140,Gene/Protein	380 bp upstream,145,160,Gene/Protein	transcription initiation site,192,221,Gene/Protein	"[{""token"": ""transcription initiation site"", ""start_span"": 8, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""560 bp upstream"", ""start_span"": 87, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""translation initiation codon"", ""start_span"": 112, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""380 bp upstream"", ""start_span"": 145, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""transcription initiation site"", ""start_span"": 192, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
Mutational analyses of I kappa B alpha and competition experiments with the synthetic peptides identified major phosphorylation sites by the bound kinase as Ser and Thr residues in the C - terminal acidic domain of I kappa B alpha.	I kappa B,23,32,Gene/Protein	phosphorylation sites,112,133,Gene/Protein	kinase,147,153,Gene/Protein	C - terminal acidic domain,185,211,Gene/Protein	I kappa B alpha,215,230,Gene/Protein	"[{""token"": ""I kappa B"", ""start_span"": 23, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""phosphorylation sites"", ""start_span"": 112, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""kinase"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal acidic domain"", ""start_span"": 185, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 215, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
These results suggested that the bound kinase is involved in the signaling pathway of LPS by inducing the phosphorylation of the C - terminal region of I kappa B alpha and subsequent dissociation of the NF - kappa B. I kappa B alpha complex.	bound kinase,33,45,Gene/Protein	C - terminal region,129,148,Gene/Protein	I kappa B alpha,152,167,Gene/Protein	NF - kappa B,203,215,Gene/Protein	I kappa B alpha complex,217,240,Gene/Protein	"[{""token"": ""bound kinase"", ""start_span"": 33, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal region"", ""start_span"": 129, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 152, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 203, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha complex"", ""start_span"": 217, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	train
In transient transfection assays, Bik promotes cell death in a manner similar to the death - promoting members of the Bcl - 2 family, Bax and Bak.	Bik,34,37,Gene/Protein	death - promoting members,85,110,Gene/Protein	Bcl - 2 family,118,132,Gene/Protein	Bax,134,137,Gene/Protein	Bak,142,145,Gene/Protein	"[{""token"": ""Bik"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""death - promoting members"", ""start_span"": 85, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2 family"", ""start_span"": 118, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""Bax"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Bak"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	train
Here we report that cross - linking of Fc gamma RI or Fc gamma RII by adherent human IgG or by specific anti - Fc gamma R mAb activates HIV - 1 gene expression in the human monocytic cell line BF24 and increased HIV RNA expression in monocytes from HIV infected patients as assayed by reverse transcription - PCR.	Fc gamma RI,39,50,Gene/Protein	Fc gamma RII,54,66,Gene/Protein	adherent human IgG,70,88,Gene/Protein	anti - Fc gamma R mAb,104,125,Gene/Protein	HIV RNA,212,219,Gene/Protein	"[{""token"": ""Fc gamma RI"", ""start_span"": 39, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""Fc gamma RII"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""adherent human IgG"", ""start_span"": 70, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""anti - Fc gamma R mAb"", ""start_span"": 104, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""HIV RNA"", ""start_span"": 212, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Cis - acting elements with NF kappa B, AP - 1 and ETS - like motifs have been identified in the promoter region of the GM - CSF gene, which are important for transcriptional activity following PMA and ionomycin stimulation.	Cis - acting elements,0,21,Gene/Protein	NF kappa B,27,37,Gene/Protein	AP - 1,39,45,Gene/Protein	ETS - like motifs,50,67,Gene/Protein	GM - CSF gene,119,132,Gene/Protein	"[{""token"": ""Cis - acting elements"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 27, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""ETS - like motifs"", ""start_span"": 50, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF gene"", ""start_span"": 119, ""end_span"": 132, ""type"": ""Gene/Protein""}]"	train
A strong repressor element, termed nuclear inhibitory protein ( NIP), was previously mapped to a segment of the IL - 3 promoter between nucleotides - 271 and - 250.	repressor element,9,26,Gene/Protein	nuclear inhibitory protein,35,61,Gene/Protein	NIP,64,67,Gene/Protein	IL - 3 promoter,112,127,Gene/Protein	nucleotides - 271 and - 250,136,163,Gene/Protein	"[{""token"": ""repressor element"", ""start_span"": 9, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""nuclear inhibitory protein"", ""start_span"": 35, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""NIP"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3 promoter"", ""start_span"": 112, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""nucleotides - 271 and - 250"", ""start_span"": 136, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
Nuclear factor of activated T cells ( NFAT) was originally described as a T - cell - specific transcription factor athat supported the activation of cytokine gene expression and mediated the immunoregulatory effects of cyclosporin A ( CsA).	Nuclear factor of activated T cells,0,35,Gene/Protein	NFAT,38,42,Gene/Protein	T - cell - specific transcription factor,74,114,Gene/Protein	cytokine,149,157,Gene/Protein	immunoregulatory,191,207,Gene/Protein	"[{""token"": ""Nuclear factor of activated T cells"", ""start_span"": 0, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""T - cell - specific transcription factor"", ""start_span"": 74, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 149, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""immunoregulatory"", ""start_span"": 191, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
The lymphoid - specific transcription factor Oct - 2a contains two transcriptional activation domains which are located within the N - terminal and C - terminal regions.	lymphoid - specific transcription factor,4,44,Gene/Protein	Oct - 2a,45,53,Gene/Protein	transcriptional activation domains,67,101,Gene/Protein	N - terminal,131,143,Gene/Protein	C - terminal regions,148,168,Gene/Protein	"[{""token"": ""lymphoid - specific transcription factor"", ""start_span"": 4, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2a"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activation domains"", ""start_span"": 67, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal"", ""start_span"": 131, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal regions"", ""start_span"": 148, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
A pair of restriction fragment length polymorphisms ( RFLPs), one of which hybridizes to the TCR constant region C beta 1 and the other to the C beta 2 gene, has been identified, suggesting these may be genotypic markers for an extended region of the TCR beta locus.	restriction fragment length polymorphisms,10,51,Gene/Protein	RFLPs,54,59,Gene/Protein	TCR constant region C beta 1,93,121,Gene/Protein	C beta 2 gene,143,156,Gene/Protein	TCR beta locus,251,265,Gene/Protein	"[{""token"": ""restriction fragment length polymorphisms"", ""start_span"": 10, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""RFLPs"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""TCR constant region C beta 1"", ""start_span"": 93, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""C beta 2 gene"", ""start_span"": 143, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""TCR beta locus"", ""start_span"": 251, ""end_span"": 265, ""type"": ""Gene/Protein""}]"	train
This phenomenon is due to mutually exclusive binding of NF - ATp and NF - kappa B to the P sequence, an element located 69 bp upstream of the IL4 transcription initiation site.	NF - ATp,56,64,Gene/Protein	NF - kappa B,69,81,Gene/Protein	P sequence,89,99,Gene/Protein	69 bp upstream,120,134,Gene/Protein	IL4 transcription initiation site,142,175,Gene/Protein	"[{""token"": ""NF - ATp"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 69, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""P sequence"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""69 bp upstream"", ""start_span"": 120, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""IL4 transcription initiation site"", ""start_span"": 142, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
Thus, competition between two general transcriptional activators, RelA and NF - ATp, mediates the inhibitory effect of protein kinase C stimulation on IL4 expression and may contribute to differential gene expression in TH cells.	transcriptional activators,38,64,Gene/Protein	RelA,66,70,Gene/Protein	NF - ATp,75,83,Gene/Protein	protein kinase C,119,135,Gene/Protein	IL4,151,154,Gene/Protein	"[{""token"": ""transcriptional activators"", ""start_span"": 38, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATp"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 119, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""IL4"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
SFs blocked the sustained activity of transcription factor Stat1, but not Stat3, during the priming period, and Stat1 activity was differentially regulated by cytokines in parallel with their positive or negative regulation of IFN - gamma production.	transcription factor Stat1,38,64,Gene/Protein	Stat3,74,79,Gene/Protein	Stat1,112,117,Gene/Protein	cytokines,159,168,Gene/Protein	IFN - gamma,227,238,Gene/Protein	"[{""token"": ""transcription factor Stat1"", ""start_span"": 38, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 159, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 227, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	train
The effect of LPS and TNF - alpha is mediated by their ability to induce nuclear translocation of the DNA - binding heterodimer NF - kappa B ( p50 / p65), which binds to a specific sequence in the HIV - long terminal repeat.	TNF - alpha,22,33,Gene/Protein	DNA - binding heterodimer,102,127,Gene/Protein	NF - kappa B,128,140,Gene/Protein	p50 / p65,143,152,Gene/Protein	HIV - long terminal repeat,197,223,Gene/Protein	"[{""token"": ""TNF - alpha"", ""start_span"": 22, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding heterodimer"", ""start_span"": 102, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""p50 / p65"", ""start_span"": 143, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""HIV - long terminal repeat"", ""start_span"": 197, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
A naturally occurring mutation ( - 175 T - C) in the area bound by HMG - I results in overexpression of gamma - globin in adult red blood cells ( HPFH) and up - regulation of the gamma - globin promoter in in vitro expression assays; HMG - I does not bind to this mutant sequence.	HMG - I,67,74,Gene/Protein	gamma - globin,104,118,Gene/Protein	gamma - globin promoter,179,202,Gene/Protein	HMG - I,234,241,Gene/Protein	mutant sequence,264,279,Gene/Protein	"[{""token"": ""HMG - I"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""gamma - globin"", ""start_span"": 104, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""gamma - globin promoter"", ""start_span"": 179, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""HMG - I"", ""start_span"": 234, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""mutant sequence"", ""start_span"": 264, ""end_span"": 279, ""type"": ""Gene/Protein""}]"	train
Treatment of T cells with the selective PKC inhibitor GF109203X abrogates the PMA - induced IkB alpha phosphorylation / degradation irrespective of activation of Ca ( 2 +) - dependent pathways, but not the phosphorylation and degradation of IkB alpha induced by TNF - alpha, a PKC - independent stimulus.	PKC,40,43,Gene/Protein	IkB alpha,92,101,Gene/Protein	IkB alpha,241,250,Gene/Protein	TNF - alpha,262,273,Gene/Protein	PKC,277,280,Gene/Protein	"[{""token"": ""PKC"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""IkB alpha"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IkB alpha"", ""start_span"": 241, ""end_span"": 250, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 262, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 277, ""end_span"": 280, ""type"": ""Gene/Protein""}]"	train
These results indicate that Ca ( 2 +) - dependent pathways, including the phosphatase calcineurin, participate in the regulation of NF - kappa B in a cell specific fashion and synergize with PKC - dependent and - independent pathways at the level of IkB alpha phosphorylation and degradation.	phosphatase,74,85,Gene/Protein	calcineurin,86,97,Gene/Protein	NF - kappa B,132,144,Gene/Protein	PKC,191,194,Gene/Protein	IkB alpha,250,259,Gene/Protein	"[{""token"": ""phosphatase"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 132, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""IkB alpha"", ""start_span"": 250, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	train
We show that the expression of four cell genes, cdc - 2, cyclin E, CD23, and cyclin D2, are up - regulated approximately 100 - fold as a result of EBV - mediated immortalization.	cell genes,36,46,Gene/Protein	cdc - 2,48,55,Gene/Protein	cyclin E,57,65,Gene/Protein	CD23,67,71,Gene/Protein	cyclin D2,77,86,Gene/Protein	"[{""token"": ""cell genes"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""cdc - 2"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""cyclin E"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""cyclin D2"", ""start_span"": 77, ""end_span"": 86, ""type"": ""Gene/Protein""}]"	train
In our attempt to identify chemokine receptors that are related to Burkitt ' s lymphoma receptor 1 ( BLR1) and are expressed in activated lymphocytes we used RT - PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2.	chemokine receptors,27,46,Gene/Protein	Burkitt ' s lymphoma receptor 1,67,98,Gene/Protein	BLR1,101,105,Gene/Protein	seven transmembrane receptor,215,243,Gene/Protein	BLR2,251,255,Gene/Protein	"[{""token"": ""chemokine receptors"", ""start_span"": 27, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""Burkitt ' s lymphoma receptor 1"", ""start_span"": 67, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""BLR1"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""seven transmembrane receptor"", ""start_span"": 215, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""BLR2"", ""start_span"": 251, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
In Jurkat T cells, the ZIP site serves as an activator for IL - 2 gene expression, and a combination of ZIP and NFAT binding sites is required for maximal IL - 2 promoter activity.	ZIP site,23,31,Gene/Protein	IL - 2,59,65,Gene/Protein	ZIP,104,107,Gene/Protein	NFAT binding sites,112,130,Gene/Protein	IL - 2 promoter,155,170,Gene/Protein	"[{""token"": ""ZIP site"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""ZIP"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""NFAT binding sites"", ""start_span"": 112, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 155, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
First, we show that mutations in the LEF - 1 - binding site inhibit the activity of multimerized copies of the HIV - 1 enhancer in Jurkat T cells, and that LEF - 1 / GAL4 can activate a GAL4 - substituted HIV - 1 enhancer 80 - to 100 - fold in vivo.	LEF - 1 - binding site,37,59,Gene/Protein	multimerized copies,84,103,Gene/Protein	HIV - 1 enhancer,111,127,Gene/Protein	LEF - 1 / GAL4,156,170,Gene/Protein	GAL4 - substituted HIV - 1 enhancer,186,221,Gene/Protein	"[{""token"": ""LEF - 1 - binding site"", ""start_span"": 37, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""multimerized copies"", ""start_span"": 84, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 enhancer"", ""start_span"": 111, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1 / GAL4"", ""start_span"": 156, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""GAL4 - substituted HIV - 1 enhancer"", ""start_span"": 186, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
Individually or collectively, none of the three enhancer - binding proteins ( LEF - 1, Ets - 1, and TFE - 3) could activate transcription in the absence of Sp1.	enhancer - binding proteins,48,75,Gene/Protein	LEF - 1,78,85,Gene/Protein	Ets - 1,87,94,Gene/Protein	TFE - 3,100,107,Gene/Protein	Sp1,156,159,Gene/Protein	"[{""token"": ""enhancer - binding proteins"", ""start_span"": 48, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""Ets - 1"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""TFE - 3"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
The stimulatory effects of gp160 are mediated through the CD4 molecule, since treatment of gp160 with soluble CD4 - IgG abrogates its activity, and CD4 negative T cell lines fail to be stimulated with gp160.	gp160,27,32,Gene/Protein	CD4 molecule,58,70,Gene/Protein	gp160,91,96,Gene/Protein	CD4 - IgG,110,119,Gene/Protein	gp160,201,206,Gene/Protein	"[{""token"": ""gp160"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""CD4 molecule"", ""start_span"": 58, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""gp160"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""CD4 - IgG"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""gp160"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
Transient transfection experiments show that several elements in the promoter - proximal region of the IL - 2R alpha gene contribute to IL - 1 responsiveness, most importantly an NF - kappa B site conserved in the human and mouse gene.	promoter - proximal region,69,95,Gene/Protein	IL - 2R alpha gene,103,121,Gene/Protein	IL - 1,136,142,Gene/Protein	NF - kappa B site,179,196,Gene/Protein	human and mouse gene,214,234,Gene/Protein	"[{""token"": ""promoter - proximal region"", ""start_span"": 69, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha gene"", ""start_span"": 103, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 179, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""human and mouse gene"", ""start_span"": 214, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	valid
In addition, when used together IL - 2 and IL - 12 synergized in the induction of IFN - gamma and GM - CSF and this synergy was attributed to an increased accumulation and stability of the IFN - gamma and GM - CSF mRNAs.	IL - 2,32,38,Gene/Protein	IL - 12,43,50,Gene/Protein	IFN - gamma,82,93,Gene/Protein	GM - CSF,98,106,Gene/Protein	IFN - gamma and GM - CSF mRNAs,189,219,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma and GM - CSF mRNAs"", ""start_span"": 189, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	valid
Since the terminal events of erythropoiesis are controlled by the glycoprotein hormone erythropoietin ( Epo), we investigated whether the expression or activity of the TAL1 gene and its protein products were affected by Epo in splenic erythroblasts from mice infected with an anemia - inducing strain of Friend virus ( FVA cells).	glycoprotein hormone erythropoietin,66,101,Gene/Protein	Epo,104,107,Gene/Protein	TAL1 gene,168,177,Gene/Protein	protein products,186,202,Gene/Protein	Epo,220,223,Gene/Protein	"[{""token"": ""glycoprotein hormone erythropoietin"", ""start_span"": 66, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Epo"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""TAL1 gene"", ""start_span"": 168, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""protein products"", ""start_span"": 186, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""Epo"", ""start_span"": 220, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	valid
The deduced amino acid sequence similarity to the proteins encoded by these two latter genes is approximately 65% and includes domains and amino acid residues ( the leucine zipper - like and the RGD domain, a serine and a histidine residue in the NH2 - and in the COOH - terminal portion of the protein, respectively) postulated to be important for nm23 function.	leucine zipper - like,165,186,Gene/Protein	RGD domain,195,205,Gene/Protein	NH2 -,247,252,Gene/Protein	COOH - terminal portion,264,287,Gene/Protein	nm23,349,353,Gene/Protein	"[{""token"": ""leucine zipper - like"", ""start_span"": 165, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""RGD domain"", ""start_span"": 195, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""NH2 -"", ""start_span"": 247, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""COOH - terminal portion"", ""start_span"": 264, ""end_span"": 287, ""type"": ""Gene/Protein""}, {""token"": ""nm23"", ""start_span"": 349, ""end_span"": 353, ""type"": ""Gene/Protein""}]"	valid
We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ human interleukin - 2, - 4, - 5 and - 13 and human and mouse granulocyte / macrophage - colony stimulating factor ( GM - CSF)].	conserved motif,31,46,Gene/Protein	promoters,54,63,Gene/Protein	T - cell - expressed cytokines,75,105,Gene/Protein	human and mouse granulocyte / macrophage - colony stimulating factor,153,221,Gene/Protein	GM - CSF,224,232,Gene/Protein	"[{""token"": ""conserved motif"", ""start_span"": 31, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""T - cell - expressed cytokines"", ""start_span"": 75, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""human and mouse granulocyte / macrophage - colony stimulating factor"", ""start_span"": 153, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 224, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	valid
Together, these results suggest that phosphorylation of I kappa B alpha, mediated through both the TNF - alpha - inducible and the PP - 2A - opposing kinases, may serve to target I kappa B alpha for proteasome - mediated degradation.	I kappa B alpha,56,71,Gene/Protein	TNF - alpha,99,110,Gene/Protein	PP - 2A - opposing kinases,131,157,Gene/Protein	I kappa B alpha,179,194,Gene/Protein	proteasome,199,209,Gene/Protein	"[{""token"": ""I kappa B alpha"", ""start_span"": 56, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""PP - 2A - opposing kinases"", ""start_span"": 131, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 179, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""proteasome"", ""start_span"": 199, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	valid
The Ah receptor recognizes DNA binding sites for the B cell transcription factor, BSAP: a possible mechanism for dioxin - mediated alteration of CD19 gene expression in human B lymphocytes.	Ah receptor,4,15,Gene/Protein	DNA binding sites,27,44,Gene/Protein	B cell transcription factor,53,80,Gene/Protein	BSAP,82,86,Gene/Protein	CD19 gene,145,154,Gene/Protein	"[{""token"": ""Ah receptor"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding sites"", ""start_span"": 27, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""B cell transcription factor"", ""start_span"": 53, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""CD19 gene"", ""start_span"": 145, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	valid
This observation, together with the fact that both GM - CSF and IL - 2 respond to TCR signals via NFAT, implies a high degree of conservation in the regulation of cytokine gene expression in T cells.	GM - CSF,51,59,Gene/Protein	IL - 2,64,70,Gene/Protein	TCR,82,85,Gene/Protein	NFAT,98,102,Gene/Protein	cytokine,163,171,Gene/Protein	"[{""token"": ""GM - CSF"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	valid
IL - 10 treatment of both T cells and monocytes results in the ligand - induced tyrosine phosphorylation of tyk2 and Jak1, but not Jak2 or Jak3.	IL - 10,0,7,Gene/Protein	tyk2,108,112,Gene/Protein	Jak1,117,121,Gene/Protein	Jak2,131,135,Gene/Protein	Jak3,139,143,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""tyk2"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Jak2"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	valid
Alanine substitutions introduced at two serine residues positioned within this N - terminal regulatory region of I kappa B alpha also yielded constitutive repressors that escaped from Tax - induced turnover and that potently inhibited immune activation pathways for NF - kappa B induction, including those initiated from antigen and cytokine receptors.	N - terminal regulatory region,79,109,Gene/Protein	I kappa B alpha,113,128,Gene/Protein	Tax,184,187,Gene/Protein	NF - kappa B,266,278,Gene/Protein	antigen and cytokine receptors,321,351,Gene/Protein	"[{""token"": ""N - terminal regulatory region"", ""start_span"": 79, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 113, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 266, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""antigen and cytokine receptors"", ""start_span"": 321, ""end_span"": 351, ""type"": ""Gene/Protein""}]"	valid
Human peripheral blood monocytes responded to stimulation of platelet - activating factor ( PAF) with up - regulation of the transcript for heparin - binding epidermal growth factor - like growth factor ( HB - EGF), a potent mitogen for vascular smooth muscle cells.	platelet - activating factor,61,89,Gene/Protein	PAF,92,95,Gene/Protein	heparin - binding epidermal growth factor - like growth factor,140,202,Gene/Protein	HB - EGF,205,213,Gene/Protein	potent mitogen,218,232,Gene/Protein	"[{""token"": ""platelet - activating factor"", ""start_span"": 61, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""heparin - binding epidermal growth factor - like growth factor"", ""start_span"": 140, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""HB - EGF"", ""start_span"": 205, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""potent mitogen"", ""start_span"": 218, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	valid
These functions of PAF appeared to be mediated through the cell surface PAF receptors, as two PAF receptor antagonists, WEB 2086 and L - 659, 989, blocked both the up - regulation of HB - EGF mRNA and kappa B binding activity induced by PAF.	PAF,19,22,Gene/Protein	cell surface PAF receptors,59,85,Gene/Protein	PAF,94,97,Gene/Protein	HB - EGF mRNA,183,196,Gene/Protein	PAF,237,240,Gene/Protein	"[{""token"": ""PAF"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""cell surface PAF receptors"", ""start_span"": 59, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""HB - EGF mRNA"", ""start_span"": 183, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 237, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	valid
ZEBRA is a bZIP transcriptional activator which binds as a dimer to 7 - bp response elements within EBV promoters and is directly involved in the stimulation of virus replication at the EBV lytic origin.	ZEBRA,0,5,Gene/Protein	bZIP transcriptional activator,11,41,Gene/Protein	7 - bp response elements,68,92,Gene/Protein	EBV promoters,100,113,Gene/Protein	EBV lytic origin,186,202,Gene/Protein	"[{""token"": ""ZEBRA"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""bZIP transcriptional activator"", ""start_span"": 11, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""7 - bp response elements"", ""start_span"": 68, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""EBV promoters"", ""start_span"": 100, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""EBV lytic origin"", ""start_span"": 186, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	valid
The promoters were used without enhancers, or with enhancers derived from the beta - globin locus control region and the alpha - globin HS - 40 enhancer.	promoters,4,13,Gene/Protein	enhancers,32,41,Gene/Protein	enhancers,51,60,Gene/Protein	beta - globin locus control region,78,112,Gene/Protein	alpha - globin HS - 40 enhancer,121,152,Gene/Protein	"[{""token"": ""promoters"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""enhancers"", ""start_span"": 32, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""enhancers"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin locus control region"", ""start_span"": 78, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""alpha - globin HS - 40 enhancer"", ""start_span"": 121, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	valid
When transfected into K562 cells, which express zeta - globin, comparable amounts of activity were obtained from the - 557 and - 417 zeta - luciferase constructs and the alpha - luciferase constructs when no enhancers or the alpha - globin locus enhancers were used.	zeta - globin,48,61,Gene/Protein	- 557 and - 417 zeta - luciferase constructs,117,161,Gene/Protein	alpha - luciferase constructs,170,199,Gene/Protein	enhancers,208,217,Gene/Protein	alpha - globin locus enhancers,225,255,Gene/Protein	"[{""token"": ""zeta - globin"", ""start_span"": 48, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""- 557 and - 417 zeta - luciferase constructs"", ""start_span"": 117, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""alpha - luciferase constructs"", ""start_span"": 170, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""enhancers"", ""start_span"": 208, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""alpha - globin locus enhancers"", ""start_span"": 225, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	valid
Moreover, the data comparing the effects of activated Ras and PKC mutants suggest that PKC - alpha, p21ras, and PKC - epsilon are not positioned linearly on a single signal transduction pathway.	activated Ras,44,57,Gene/Protein	PKC mutants,62,73,Gene/Protein	PKC - alpha,87,98,Gene/Protein	p21ras,100,106,Gene/Protein	PKC - epsilon,112,125,Gene/Protein	"[{""token"": ""activated Ras"", ""start_span"": 44, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""PKC mutants"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""PKC - alpha"", ""start_span"": 87, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""p21ras"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""PKC - epsilon"", ""start_span"": 112, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	valid
Signaling by a wide variety of cytokines, including interferons, interleukins, and growth factors, involves activation of JAK kinases and Stat ( Signal transducers and activators of transcription) proteins.	cytokines,31,40,Gene/Protein	interferons,52,63,Gene/Protein	interleukins,65,77,Gene/Protein	growth factors,83,97,Gene/Protein	JAK kinases,122,133,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""interferons"", ""start_span"": 52, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""interleukins"", ""start_span"": 65, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""growth factors"", ""start_span"": 83, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""JAK kinases"", ""start_span"": 122, ""end_span"": 133, ""type"": ""Gene/Protein""}]"	valid
In EBV - positive cases of Hodgkin ' s disease, the EBERs, EBNA1, and the LMPs are expressed ( latency II), whereas in Burkitt ' s lymphoma ( BL) only the EBERs and EBNA1 have been detected ( latency I).	EBERs,52,57,Gene/Protein	EBNA1,59,64,Gene/Protein	LMPs,74,78,Gene/Protein	EBERs,155,160,Gene/Protein	EBNA1,165,170,Gene/Protein	"[{""token"": ""EBERs"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""EBNA1"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""LMPs"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""EBERs"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""EBNA1"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	valid
In HeLa cells stably transfected with the HIV - 1 tat gene ( HeLa - tat cells), expression of the Tat protein enhanced both TNF - induced activation of NF - kappa B and TNF - mediated cytotoxicity.	HIV - 1 tat gene,42,58,Gene/Protein	Tat protein,98,109,Gene/Protein	TNF,124,127,Gene/Protein	NF - kappa B,152,164,Gene/Protein	TNF,169,172,Gene/Protein	"[{""token"": ""HIV - 1 tat gene"", ""start_span"": 42, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""Tat protein"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 152, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	valid
EBNA - 2 is known to interact with the cellular DNA - binding protein J kappa and is recruited to promoters containing the GTGGGAA J kappa recognition sequence.	EBNA - 2,0,8,Gene/Protein	cellular DNA - binding protein,39,69,Gene/Protein	J kappa,70,77,Gene/Protein	promoters,98,107,Gene/Protein	J kappa recognition sequence,131,159,Gene/Protein	"[{""token"": ""EBNA - 2"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""cellular DNA - binding protein"", ""start_span"": 39, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""J kappa"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 98, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""J kappa recognition sequence"", ""start_span"": 131, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	valid
In this study, we show that an activation - deficient glucocorticoid receptor mutant is as effective as the wild - type receptor in repression of AP - 1 activity, inhibition of interleukin - 2 production, inhibition of c - myc expression and induction of apoptosis.	activation - deficient glucocorticoid receptor mutant,31,84,Gene/Protein	wild - type receptor,108,128,Gene/Protein	AP - 1,146,152,Gene/Protein	interleukin - 2,177,192,Gene/Protein	c - myc,219,226,Gene/Protein	"[{""token"": ""activation - deficient glucocorticoid receptor mutant"", ""start_span"": 31, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""wild - type receptor"", ""start_span"": 108, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 146, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 177, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 219, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	valid
Insertion of this chimeric promoter ( ISG15 LTR) upstream of the human IFNA2 gene directed high levels of IFN synthesis in Tat - expressing cells, while this promoter was not responsive to tumor necrosis factor alpha - mediated activation.	chimeric promoter,18,35,Gene/Protein	ISG15 LTR,38,47,Gene/Protein	human IFNA2 gene,65,81,Gene/Protein	IFN,106,109,Gene/Protein	tumor necrosis factor alpha,189,216,Gene/Protein	"[{""token"": ""chimeric promoter"", ""start_span"": 18, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""ISG15 LTR"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""human IFNA2 gene"", ""start_span"": 65, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 189, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	valid
Selected transfected clones produced low levels of IFN A ( IFNA) constitutively, and their abilities to express interleukin - 2 and interleukin - 2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.	IFN A,51,56,Gene/Protein	IFNA,59,63,Gene/Protein	interleukin - 2,112,127,Gene/Protein	interleukin - 2 receptor,132,156,Gene/Protein	phytohemagglutinin,179,197,Gene/Protein	"[{""token"": ""IFN A"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""IFNA"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 112, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 receptor"", ""start_span"": 132, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""phytohemagglutinin"", ""start_span"": 179, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	valid
Flow cytometric analysis also showed that at 72 h of virus exposure fewer T cells from the elderly produced interferon - gamma ( IFN - gamma), suggesting a link between the magnitude of the Fos and Jun and IFN - gamma responses.	interferon - gamma,108,126,Gene/Protein	IFN - gamma,129,140,Gene/Protein	Fos,190,193,Gene/Protein	Jun,198,201,Gene/Protein	IFN - gamma,206,217,Gene/Protein	"[{""token"": ""interferon - gamma"", ""start_span"": 108, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 129, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""Fos"", ""start_span"": 190, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 206, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	valid
The cis - acting region, GM - kappa B / GC - box ( positions - 95 and - 73), within the murine GM - CSF gene promoter is required for maximal induction by stimulation with phorbol - 12 - myristate acetate ( PMA) and calcium ionophore ( A23187) in T cells.	cis - acting region,4,23,Gene/Protein	GM - kappa B / GC - box,25,48,Gene/Protein	positions - 95,51,65,Gene/Protein	- 73,70,74,Gene/Protein	murine GM - CSF gene promoter,88,117,Gene/Protein	"[{""token"": ""cis - acting region"", ""start_span"": 4, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""GM - kappa B / GC - box"", ""start_span"": 25, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""positions - 95"", ""start_span"": 51, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""- 73"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""murine GM - CSF gene promoter"", ""start_span"": 88, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	valid
Therefore, we propose that the TPA / calcium - activated AP - 1 / OAP element is the main target of positive or negative regulatory signals influencing the IL - 2 octamer motif, through synergism with Oct - 2 and antagonism by RAR.	AP - 1,57,63,Gene/Protein	/ OAP,64,69,Gene/Protein	IL - 2 octamer motif,156,176,Gene/Protein	Oct - 2,201,208,Gene/Protein	RAR,227,230,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""/ OAP"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 octamer motif"", ""start_span"": 156, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 201, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""RAR"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	valid
Induction of TaxI in a human T - cell line Jurkat carrying the TaxI gene under the metallothionein promoter led to increases in mRNA and surface expression of ICAM - I.	TaxI,13,17,Gene/Protein	TaxI gene,63,72,Gene/Protein	metallothionein promoter,83,107,Gene/Protein	mRNA,128,132,Gene/Protein	ICAM - I,159,167,Gene/Protein	"[{""token"": ""TaxI"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""TaxI gene"", ""start_span"": 63, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""metallothionein promoter"", ""start_span"": 83, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - I"", ""start_span"": 159, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	valid
These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF - kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.	PAFR,71,75,Gene/Protein	PAF,95,98,Gene/Protein	NF - kappa B,107,119,Gene/Protein	protein kinase C,170,186,Gene/Protein	PAF,190,193,Gene/Protein	"[{""token"": ""PAFR"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 107, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 170, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 190, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	valid
T lymphocyte activation and interleukin - 2 ( IL - 2) production require at least two signals, generated by phorbol ester ( TPA) and Ca2 + ionophore or costimulation of the T cell receptor ( TCR) and the CD28 auxiliary receptor.	interleukin - 2,28,43,Gene/Protein	IL - 2,46,52,Gene/Protein	T cell receptor,173,188,Gene/Protein	TCR,191,194,Gene/Protein	CD28 auxiliary receptor,204,227,Gene/Protein	"[{""token"": ""interleukin - 2"", ""start_span"": 28, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""T cell receptor"", ""start_span"": 173, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""CD28 auxiliary receptor"", ""start_span"": 204, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	valid
It seems therefore that PGE2, by elevating cAMP levels, interferes with the activation pathway for NF - kappa B but not for NF - AT, AP - 1 or CLE0 binding protein.	PGE2,24,28,Gene/Protein	NF - kappa B,99,111,Gene/Protein	NF - AT,124,131,Gene/Protein	AP - 1,133,139,Gene/Protein	CLE0 binding protein,143,163,Gene/Protein	"[{""token"": ""PGE2"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 99, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 133, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""CLE0 binding protein"", ""start_span"": 143, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	valid
Stimulation of the CD28 cell surface molecule delivers costimulatory signals essential for lymphokine production in activated T cells via a conserved sequence element found in the promoter of several lymphokine genes.	CD28 cell surface molecule,19,45,Gene/Protein	lymphokine,91,101,Gene/Protein	conserved sequence element,140,166,Gene/Protein	promoter,180,188,Gene/Protein	lymphokine genes,200,216,Gene/Protein	"[{""token"": ""CD28 cell surface molecule"", ""start_span"": 19, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""lymphokine"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""conserved sequence element"", ""start_span"": 140, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""lymphokine genes"", ""start_span"": 200, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	valid
In addition, a new combination isoform containing Oct2a ' s amino terminal insert ( exon 7a) and Oct2b ' s carboxy terminal insert ( exon 13) was found that created a novel large isoform, Oct2ab.	Oct2a ' s amino terminal insert,50,81,Gene/Protein	exon 7a,84,91,Gene/Protein	Oct2b ' s carboxy terminal insert,97,130,Gene/Protein	exon 13,133,140,Gene/Protein	Oct2ab,188,194,Gene/Protein	"[{""token"": ""Oct2a ' s amino terminal insert"", ""start_span"": 50, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""exon 7a"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""Oct2b ' s carboxy terminal insert"", ""start_span"": 97, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""exon 13"", ""start_span"": 133, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""Oct2ab"", ""start_span"": 188, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	valid
Acetylsalicylic acid and sodium salicylate inhibit LPS - induced NF - kappa B / c - Rel nuclear translocation, and synthesis of tissue factor ( TF) and tumor necrosis factor alfa ( TNF - alpha) in human monocytes.	NF - kappa B / c - Rel,65,87,Gene/Protein	tissue factor,128,141,Gene/Protein	TF,144,146,Gene/Protein	tumor necrosis factor alfa,152,178,Gene/Protein	TNF - alpha,181,192,Gene/Protein	"[{""token"": ""NF - kappa B / c - Rel"", ""start_span"": 65, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""tissue factor"", ""start_span"": 128, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""TF"", ""start_span"": 144, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alfa"", ""start_span"": 152, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 181, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	valid
In the present study, we showed that CD14 + adherent human monocytes can differentiate into CD1 + relB + dendritic cells ( DC) by the combination of GM - CSF plus interleukin - 4 ( IL - 4) and that they differentiate into tartrate - resistant acid phosphatase ( TRAP) - positive osteoclast - like multinucleated giant cells ( MGC) by the combination of M - CSF plus IL - 4.	GM - CSF,149,157,Gene/Protein	interleukin - 4,163,178,Gene/Protein	IL - 4,181,187,Gene/Protein	M - CSF,353,360,Gene/Protein	IL - 4,366,372,Gene/Protein	"[{""token"": ""GM - CSF"", ""start_span"": 149, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 4"", ""start_span"": 163, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 181, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF"", ""start_span"": 353, ""end_span"": 360, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 366, ""end_span"": 372, ""type"": ""Gene/Protein""}]"	valid
NH2 - terminal amino acid sequence analysis identified the 140 - kDa surface antigen for mAb J393 as CD43 / leukosialin, the major sialoglycoprotein of leukocytes.	NH2,0,3,Gene/Protein	140 - kDa surface antigen,59,84,Gene/Protein	mAb J393,89,97,Gene/Protein	CD43 / leukosialin,101,119,Gene/Protein	sialoglycoprotein,131,148,Gene/Protein	"[{""token"": ""NH2"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""140 - kDa surface antigen"", ""start_span"": 59, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""mAb J393"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""CD43 / leukosialin"", ""start_span"": 101, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""sialoglycoprotein"", ""start_span"": 131, ""end_span"": 148, ""type"": ""Gene/Protein""}]"	valid
While Jurkat cells co - expressed two discrete cell - surface isoforms of CD43, recognized by mAb J393 and mAb G10 - 2, respectively, only J393 / CD43 signaled apoptosis.	cell - surface isoforms,47,70,Gene/Protein	CD43,74,78,Gene/Protein	mAb J393,94,102,Gene/Protein	mAb G10 - 2,107,118,Gene/Protein	J393 / CD43,139,150,Gene/Protein	"[{""token"": ""cell - surface isoforms"", ""start_span"": 47, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CD43"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""mAb J393"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""mAb G10 - 2"", ""start_span"": 107, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""J393 / CD43"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	valid
Induction of fra - 1 following engagement of CD40 did not require protein synthesis, suggesting that the PKC - dependent linkage between CD40 and fra - 1 is direct.	fra - 1,13,20,Gene/Protein	CD40,45,49,Gene/Protein	PKC,105,108,Gene/Protein	CD40,137,141,Gene/Protein	fra - 1,146,153,Gene/Protein	"[{""token"": ""fra - 1"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""fra - 1"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	valid
Association of TRAF1, TRAF2, and TRAF3 with an Epstein - Barr virus LMP1 domain important for B - lymphocyte transformation: role in NF - kappaB activation.	TRAF1,15,20,Gene/Protein	TRAF2,22,27,Gene/Protein	TRAF3,33,38,Gene/Protein	Epstein - Barr virus LMP1 domain,47,79,Gene/Protein	NF - kappaB,133,144,Gene/Protein	"[{""token"": ""TRAF1"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""TRAF3"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Epstein - Barr virus LMP1 domain"", ""start_span"": 47, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	valid
Calcineurin stimulates the NF - kappa B element by enhancing inactivation of I kappa B / MAD3, an inhibitor of NF - kappa B, thereby increasing the amount of nuclear NF - kappa B DNA binding activity.	Calcineurin,0,11,Gene/Protein	NF - kappa B element,27,47,Gene/Protein	I kappa B / MAD3,77,93,Gene/Protein	NF - kappa B,111,123,Gene/Protein	NF - kappa B,166,178,Gene/Protein	"[{""token"": ""Calcineurin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B element"", ""start_span"": 27, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B / MAD3"", ""start_span"": 77, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 111, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 166, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	valid
In all cells tested, IL - 10 activated Stat1 and Stat3 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.	IL - 10,21,28,Gene/Protein	Stat1,39,44,Gene/Protein	Stat3,49,54,Gene/Protein	DNA binding complexes,99,120,Gene/Protein	transcription factors,172,193,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding complexes"", ""start_span"": 99, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 172, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	valid
Using a structure - function mutagenesis approach, two tyrosine residues ( Tyr427 and Tyr477) in the intracellular domain of the murine IL - 10 receptor were found to be redundantly required for receptor function and for activation of Stat3 but not for Stat1 or Stat5.	intracellular domain,101,121,Gene/Protein	IL - 10,136,143,Gene/Protein	Stat3,235,240,Gene/Protein	Stat1,253,258,Gene/Protein	Stat5,262,267,Gene/Protein	"[{""token"": ""intracellular domain"", ""start_span"": 101, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 235, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 253, ""end_span"": 258, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 262, ""end_span"": 267, ""type"": ""Gene/Protein""}]"	valid
To examine whether an active negative regulatory process occurs, we created a reporter construct containing as an enhancer four copies of the NF - AT site and one copy of the octamer site ( 4X NF - AT - Oct).	reporter construct,78,96,Gene/Protein	enhancer,114,122,Gene/Protein	NF - AT site,142,154,Gene/Protein	octamer site,175,187,Gene/Protein	4X NF - AT - Oct,190,206,Gene/Protein	"[{""token"": ""reporter construct"", ""start_span"": 78, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""enhancer"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT site"", ""start_span"": 142, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""octamer site"", ""start_span"": 175, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""4X NF - AT - Oct"", ""start_span"": 190, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	valid
During Epstein - Barr virus latent infection of B lymphocytes in vitro, six viral nuclear antigens ( EBNAs) are expressed from one of two promoters, Cp or Wp, whose activities are mutually exclusive.	viral nuclear antigens,76,98,Gene/Protein	EBNAs,101,106,Gene/Protein	promoters,138,147,Gene/Protein	Cp,149,151,Gene/Protein	Wp,155,157,Gene/Protein	"[{""token"": ""viral nuclear antigens"", ""start_span"": 76, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""EBNAs"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 138, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""Cp"", ""start_span"": 149, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""Wp"", ""start_span"": 155, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	valid
Constitutive expression of IFN - alpha5 and IFN - beta was detected in different lymphoid cells including peripheral blood mononuclear cells from normal individuals following amplification of IFN mRNA by reverse transcriptase - polymerase chain reaction and direct sequencing of the amplified product.	IFN - alpha5,27,39,Gene/Protein	IFN - beta,44,54,Gene/Protein	IFN mRNA,192,200,Gene/Protein	reverse transcriptase,204,225,Gene/Protein	amplified product,283,300,Gene/Protein	"[{""token"": ""IFN - alpha5"", ""start_span"": 27, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""IFN - beta"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IFN mRNA"", ""start_span"": 192, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""reverse transcriptase"", ""start_span"": 204, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""amplified product"", ""start_span"": 283, ""end_span"": 300, ""type"": ""Gene/Protein""}]"	valid
Thus, IL - 2 - induced IL - 2R alpha promoter activity requires a complex upstream element, which appears to contain binding sites for both positive and negative regulatory factors.	IL - 2,6,12,Gene/Protein	IL - 2R alpha promoter,23,45,Gene/Protein	complex upstream element,66,90,Gene/Protein	binding sites,117,130,Gene/Protein	positive and negative regulatory factors,140,180,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha promoter"", ""start_span"": 23, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""complex upstream element"", ""start_span"": 66, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 117, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""positive and negative regulatory factors"", ""start_span"": 140, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	valid
We report here on the identification of a 17 kDa variant of the 14 kDa Id - 3 protein termed Id - 3L ( long version) which possesses a unique 60 amino acid carboxy - terminus generated by read through of a ' coding intron ' and alternative splicing.	17 kDa variant,42,56,Gene/Protein	14 kDa Id - 3,64,77,Gene/Protein	Id - 3L,93,100,Gene/Protein	60 amino acid carboxy - terminus,142,174,Gene/Protein	coding intron,208,221,Gene/Protein	"[{""token"": ""17 kDa variant"", ""start_span"": 42, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""14 kDa Id - 3"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""Id - 3L"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""60 amino acid carboxy - terminus"", ""start_span"": 142, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""coding intron"", ""start_span"": 208, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	valid
In this study, we examined the molecular mechanism by which agents that elevate intracellular cAMP inhibit the expression of the tumor necrosis factor alpha ( TNFalpha), tissue factor, endothelial leukocyte adhesion molecule - 1, and vascular cell adhesion molecule - 1 genes.	tumor necrosis factor alpha,129,156,Gene/Protein	TNFalpha,159,167,Gene/Protein	tissue factor,170,183,Gene/Protein	endothelial leukocyte adhesion molecule - 1,185,228,Gene/Protein	vascular cell adhesion molecule - 1 genes,234,275,Gene/Protein	"[{""token"": ""tumor necrosis factor alpha"", ""start_span"": 129, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 159, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""tissue factor"", ""start_span"": 170, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""endothelial leukocyte adhesion molecule - 1"", ""start_span"": 185, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""vascular cell adhesion molecule - 1 genes"", ""start_span"": 234, ""end_span"": 275, ""type"": ""Gene/Protein""}]"	valid
Three subtypes of retinoic acid receptors ( RAR), termed RAR alpha, RAR beta, and RAR gamma, have been described.	retinoic acid receptors,18,41,Gene/Protein	RAR,44,47,Gene/Protein	RAR alpha,57,66,Gene/Protein	RAR beta,68,76,Gene/Protein	RAR gamma,82,91,Gene/Protein	"[{""token"": ""retinoic acid receptors"", ""start_span"": 18, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""RAR"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""RAR alpha"", ""start_span"": 57, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""RAR beta"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""RAR gamma"", ""start_span"": 82, ""end_span"": 91, ""type"": ""Gene/Protein""}]"	valid
When single - point mutation was introduced to each GC box, EBS, and GT box in PFP9a20, at least 3 - fold less CAT activity was observed in CTLL - R8 cells.	GC box,52,58,Gene/Protein	EBS,60,63,Gene/Protein	GT box,69,75,Gene/Protein	PFP9a20,79,86,Gene/Protein	CAT,111,114,Gene/Protein	"[{""token"": ""GC box"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""EBS"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""GT box"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""PFP9a20"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}]"	valid
A major obstacle in understanding the signaling events that follow CD28 receptor ligation arises from the fact that CD28 acts as a costimulus to TCR engagement, making it difficult to assess the relative contribution of CD28 signals as distinct from those of the TCR.	CD28,67,71,Gene/Protein	CD28,116,120,Gene/Protein	TCR,145,148,Gene/Protein	CD28,220,224,Gene/Protein	TCR,263,266,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 220, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 263, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	valid
This was identified as the mRNA encoding the transcription factor egr - 1, which is expressed with fast kinetics in T and NK cells upon IL - 2, but not IL - 12, stimulation.	mRNA,27,31,Gene/Protein	transcription factor,45,65,Gene/Protein	egr - 1,66,73,Gene/Protein	IL - 2,136,142,Gene/Protein	IL - 12,152,159,Gene/Protein	"[{""token"": ""mRNA"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 45, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""egr - 1"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	valid
GM - CSF gene activation in T cells is known to involve the transcription factors nuclear factor - kappa B, AP - 1, NFAT, and Sp1.	GM - CSF gene,0,13,Gene/Protein	transcription factors,60,81,Gene/Protein	nuclear factor - kappa B,82,106,Gene/Protein	AP - 1,108,114,Gene/Protein	NFAT,116,120,Gene/Protein	"[{""token"": ""GM - CSF gene"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 60, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappa B"", ""start_span"": 82, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}]"	valid
To better understand the contribution of the GR N - terminal transactivation domain in mediating murine thymocyte apoptosis, we stably transfected GR, GR variants, and the androgen receptor ( AR) into receptor - negative S49 murine thymoma cells.	GR N - terminal transactivation domain,45,83,Gene/Protein	GR,147,149,Gene/Protein	GR variants,151,162,Gene/Protein	androgen receptor,172,189,Gene/Protein	AR,192,194,Gene/Protein	"[{""token"": ""GR N - terminal transactivation domain"", ""start_span"": 45, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 147, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""GR variants"", ""start_span"": 151, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""androgen receptor"", ""start_span"": 172, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""AR"", ""start_span"": 192, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	valid
Latent membrane protein 1 and, to a lesser extent, EBV nuclear antigen 2 mediated the increase in p53 levels via activation of the NF - kappaB transcription factor.	Latent membrane protein 1,0,25,Gene/Protein	EBV nuclear antigen 2,51,72,Gene/Protein	p53,98,101,Gene/Protein	NF - kappaB,131,142,Gene/Protein	transcription factor,143,163,Gene/Protein	"[{""token"": ""Latent membrane protein 1"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""EBV nuclear antigen 2"", ""start_span"": 51, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 143, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	valid
In chloramphenicol acetyltransferase assays, utilizing the transient transfection of a chloramphenicol acetyltransferase reporter plasmid containing the IL - 6 gene promoter, IL - 4, but not IL - 10, suppressed the transcriptional activity of the IL - 6 gene promoter stimulated by PMA and LPS.	chloramphenicol acetyltransferase,3,36,Gene/Protein	chloramphenicol acetyltransferase reporter plasmid,87,137,Gene/Protein	IL - 6 gene promoter,153,173,Gene/Protein	IL - 4,175,181,Gene/Protein	IL - 10,191,198,Gene/Protein	"[{""token"": ""chloramphenicol acetyltransferase"", ""start_span"": 3, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase reporter plasmid"", ""start_span"": 87, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 gene promoter"", ""start_span"": 153, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 175, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 191, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	valid
These results suggest that IL - 4 may inhibit the transcription of the IL - 6 gene by affecting NF - kappaB binding activity, while IL - 10 may inhibit the IL - 6 mRNA levels post - transcriptionally, without suppressing promoter activity.	IL - 4,27,33,Gene/Protein	IL - 6 gene,71,82,Gene/Protein	NF - kappaB,96,107,Gene/Protein	IL - 10,132,139,Gene/Protein	IL - 6 mRNA,156,167,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 gene"", ""start_span"": 71, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 mRNA"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	valid
Costimulation of U1 cells with LPS plus GM - CSF resulted in the accumulation of steady - state levels of HIV RNA; however, only a weak induction of HIV long terminal repeat - driven transcription, which was not associated with the activation of the cellular transcription factor nuclear factor - kappa B, was noted.	GM - CSF,40,48,Gene/Protein	HIV RNA,106,113,Gene/Protein	HIV long terminal repeat,149,173,Gene/Protein	cellular transcription factor,250,279,Gene/Protein	nuclear factor - kappa B,280,304,Gene/Protein	"[{""token"": ""GM - CSF"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""HIV RNA"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""HIV long terminal repeat"", ""start_span"": 149, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""cellular transcription factor"", ""start_span"": 250, ""end_span"": 279, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappa B"", ""start_span"": 280, ""end_span"": 304, ""type"": ""Gene/Protein""}]"	valid
r - hTBP - 1 and rhu TNFR: Fc also decreased p24 antigen synthesized by U1 cells in response to other stimuli, including phytohemagglutinin ( PHA) - induced supernatant, granulocyte - macrophage colony - stimulating factor, interleukin - 6, and TNF.	r - hTBP - 1,0,12,Gene/Protein	p24 antigen,45,56,Gene/Protein	granulocyte - macrophage colony - stimulating factor,170,222,Gene/Protein	interleukin - 6,224,239,Gene/Protein	TNF,245,248,Gene/Protein	"[{""token"": ""r - hTBP - 1"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""p24 antigen"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 170, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 6"", ""start_span"": 224, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 245, ""end_span"": 248, ""type"": ""Gene/Protein""}]"	valid
The effects of IFN - gamma on the transcription factors were specific, since no change was observed in the expression of NF - IL - 6 or I kappa B alpha, the inhibitor of NF - kappa B.	IFN - gamma,15,26,Gene/Protein	transcription factors,34,55,Gene/Protein	NF - IL - 6,121,132,Gene/Protein	I kappa B alpha,136,151,Gene/Protein	NF - kappa B,170,182,Gene/Protein	"[{""token"": ""IFN - gamma"", ""start_span"": 15, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 34, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL - 6"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 136, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 170, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	valid
Electrophoretic mobility shift analyses demonstrated that the 151 - bp region contains nuclear protein binding sites for Sp1, PU. 1, and / or Elf - 1, and a novel factor.	151 - bp region,62,77,Gene/Protein	nuclear protein binding sites,87,116,Gene/Protein	Sp1,121,124,Gene/Protein	Elf - 1,142,149,Gene/Protein	novel factor,157,169,Gene/Protein	"[{""token"": ""151 - bp region"", ""start_span"": 62, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""nuclear protein binding sites"", ""start_span"": 87, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""Elf - 1"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""novel factor"", ""start_span"": 157, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	valid
This shows that in a eukaryotic nucleus, Tax specifically interacts with the basic domain - leucine zipper region of ATF - 1, CREB, and CREM.	Tax,41,44,Gene/Protein	basic domain - leucine zipper region,77,113,Gene/Protein	ATF - 1,117,124,Gene/Protein	CREB,126,130,Gene/Protein	CREM,136,140,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""basic domain - leucine zipper region"", ""start_span"": 77, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""ATF - 1"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""CREM"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	valid
Like IkappaBalpha, Tax - mediated breakdown of IkappaBbeta in transfected T lymphocytes is blocked either by cell - permeable proteasome inhibitors or by mutation Of IkappaBbeta at two serine residues present within its N - terminal region.	IkappaBalpha,5,17,Gene/Protein	Tax,19,22,Gene/Protein	IkappaBbeta,47,58,Gene/Protein	IkappaBbeta,166,177,Gene/Protein	N - terminal region,220,239,Gene/Protein	"[{""token"": ""IkappaBalpha"", ""start_span"": 5, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBbeta"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBbeta"", ""start_span"": 166, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal region"", ""start_span"": 220, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	valid
Mutation of the consensus AP - 1 / CRE site within ZII abolished the inducibility of Zp by HHV - 6, whereas positioning of the ZII domain upstream of the beta - globin minimal promoter conferred responsiveness following HHV - 6 infection.	consensus AP - 1 / CRE site,16,43,Gene/Protein	ZII,51,54,Gene/Protein	Zp,85,87,Gene/Protein	ZII domain,127,137,Gene/Protein	beta - globin minimal promoter,154,184,Gene/Protein	"[{""token"": ""consensus AP - 1 / CRE site"", ""start_span"": 16, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""ZII"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Zp"", ""start_span"": 85, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""ZII domain"", ""start_span"": 127, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin minimal promoter"", ""start_span"": 154, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	valid
Structure / function analysis of various Oct - 2a effector regions in the context of the GAL4 DNA - binding domain revealed that Oct - 2a contains two functionally different activation domains at the N and the C termini.	Oct - 2a effector regions,41,66,Gene/Protein	GAL4 DNA - binding domain,89,114,Gene/Protein	Oct - 2a,129,137,Gene/Protein	activation domains,174,192,Gene/Protein	N and the C termini,200,219,Gene/Protein	"[{""token"": ""Oct - 2a effector regions"", ""start_span"": 41, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""GAL4 DNA - binding domain"", ""start_span"": 89, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2a"", ""start_span"": 129, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""activation domains"", ""start_span"": 174, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""N and the C termini"", ""start_span"": 200, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	valid
Exogenous IL - 2, which restitutes the proliferative response of the anti - CD3 - and anti - CD28 - treated Rel - / - T cells, restores production of IL - 5, TNF - alpha, and IFN - gamma, but not IL - 3 and GM - CSF expression to approximately normal levels.	IL - 2,10,16,Gene/Protein	TNF - alpha,158,169,Gene/Protein	IFN - gamma,175,186,Gene/Protein	IL - 3,196,202,Gene/Protein	GM - CSF,207,215,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 10, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 158, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 175, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 196, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 207, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	valid
Moreover, gp120 induces tyrosine phosphorylation of signal transducer and activator of transcription ( STAT - 1 alpha) as well as the Janus kinase ( JAK2) in glial cells.	gp120,10,15,Gene/Protein	signal transducer and activator of transcription,52,100,Gene/Protein	STAT - 1 alpha,103,117,Gene/Protein	Janus kinase,134,146,Gene/Protein	JAK2,149,153,Gene/Protein	"[{""token"": ""gp120"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer and activator of transcription"", ""start_span"": 52, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""STAT - 1 alpha"", ""start_span"": 103, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase"", ""start_span"": 134, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	valid
Paclitaxel and other drugs that disturb microtubule dynamics kill cells in a Fas / Fas ligand ( FasL) - dependent manner; antibody to FasL inhibits paclitaxel - induced apoptosis.	microtubule,40,51,Gene/Protein	Fas,77,80,Gene/Protein	/ Fas ligand,81,93,Gene/Protein	FasL,96,100,Gene/Protein	FasL,134,138,Gene/Protein	"[{""token"": ""microtubule"", ""start_span"": 40, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""Fas"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""/ Fas ligand"", ""start_span"": 81, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""FasL"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""FasL"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene/Protein""}]"	valid
Because STAT6 activation is essential for IL - 4 - induced gene expression, we examined the ability of type I and type II IFNs to regulate activation of STAT6 by IL - 4 in primary human monocytes.	STAT6,8,13,Gene/Protein	IL - 4,42,48,Gene/Protein	IFNs,122,126,Gene/Protein	STAT6,153,158,Gene/Protein	IL - 4,162,168,Gene/Protein	"[{""token"": ""STAT6"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""IFNs"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	valid
Here, we report a model of CD28 costimulation using PMA plus the natural ligand CD80 that resulted in very limited stimulation of IL - 2, as evidenced by both cytokine production and IL - 2 promoter stimulation.	CD28,27,31,Gene/Protein	natural ligand CD80,65,84,Gene/Protein	IL - 2,130,136,Gene/Protein	cytokine,159,167,Gene/Protein	IL - 2 promoter,183,198,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""natural ligand CD80"", ""start_span"": 65, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 159, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 183, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	valid
We have found that the recruitment of EKLF to 5 ' HS3 depends on the presence of 5 ' HS2 in cis, but the recruitment to 5 ' HS2 does not depend on 5 ' HS3.	EKLF,38,42,Gene/Protein	5 ' HS3,46,53,Gene/Protein	5 ' HS2,81,88,Gene/Protein	5 ' HS2,120,127,Gene/Protein	5 ' HS3,147,154,Gene/Protein	"[{""token"": ""EKLF"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""5 ' HS3"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""5 ' HS2"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""5 ' HS2"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""5 ' HS3"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	valid
The resulting diminished phosphorylation of c - Jun and JunD at their NH ( 2) - termini decreases the ability of these nuclear proteins to autostimulate the expression of the c - Jun and JunD genes, thus leading to lower production of c - Jun and JunD.	c - Jun,44,51,Gene/Protein	JunD,56,60,Gene/Protein	c - Jun and JunD genes,175,197,Gene/Protein	c - Jun,235,242,Gene/Protein	JunD,247,251,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun and JunD genes"", ""start_span"": 175, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 235, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Gene/Protein""}]"	valid
Expression of wild - type SHP1 had a very small effect on the TCR - induced tyrosine phosphorylation of ZAP - 70 and Syk, even when SHP1 was overexpressed 20 - 100 - fold over endogenous SHP1.	wild - type SHP1,14,30,Gene/Protein	ZAP - 70,104,112,Gene/Protein	Syk,117,120,Gene/Protein	SHP1,132,136,Gene/Protein	endogenous SHP1,176,191,Gene/Protein	"[{""token"": ""wild - type SHP1"", ""start_span"": 14, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""ZAP - 70"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Syk"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""endogenous SHP1"", ""start_span"": 176, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	valid
A factor in bovine colostrum ( colostrum inhibitory factor, CIF) inhibits interleukin 2 ( IL2) production in activated T helper cells by blocking the accumulation of IL2 mRNA.	colostrum inhibitory factor,31,58,Gene/Protein	CIF,60,63,Gene/Protein	interleukin 2,74,87,Gene/Protein	IL2,90,93,Gene/Protein	IL2 mRNA,166,174,Gene/Protein	"[{""token"": ""colostrum inhibitory factor"", ""start_span"": 31, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""CIF"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2"", ""start_span"": 74, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""IL2"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""IL2 mRNA"", ""start_span"": 166, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	valid
Using a combination of bacterial motility assays in platelet extracts with Escherichia coli expressing the Shigella IcsA protein and in vitro analysis of reconstituted systems from purified proteins, we show here that the bacterial protein IcsA binds N - WASP and activates it in a Cdc42 - like fashion.	Shigella IcsA protein,107,128,Gene/Protein	purified proteins,181,198,Gene/Protein	bacterial protein IcsA,222,244,Gene/Protein	N - WASP,251,259,Gene/Protein	Cdc42,282,287,Gene/Protein	"[{""token"": ""Shigella IcsA protein"", ""start_span"": 107, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""purified proteins"", ""start_span"": 181, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""bacterial protein IcsA"", ""start_span"": 222, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""N - WASP"", ""start_span"": 251, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""Cdc42"", ""start_span"": 282, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	valid
Analysis of targets that could mediate these phenotypic changes indicated that c - Maf likely plays a key role in myeloid cell development through dual mechanisms; inhibition of a select set of c - Myb regulated targets, such as Bcl - 2 and CD13 / APN, coupled with the activation of as yet undefined differentiation - promoting genes.	c - Maf,79,86,Gene/Protein	c - Myb,194,201,Gene/Protein	Bcl - 2,229,236,Gene/Protein	CD13 / APN,241,251,Gene/Protein	differentiation - promoting genes,301,334,Gene/Protein	"[{""token"": ""c - Maf"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""c - Myb"", ""start_span"": 194, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 229, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""CD13 / APN"", ""start_span"": 241, ""end_span"": 251, ""type"": ""Gene/Protein""}, {""token"": ""differentiation - promoting genes"", ""start_span"": 301, ""end_span"": 334, ""type"": ""Gene/Protein""}]"	valid
To better understand the assembly mechanism for the progesterone receptor ( PR), we have developed cell - free systems for studying interactions of PR, hsp90, and other associated proteins.	progesterone receptor,52,73,Gene/Protein	PR,76,78,Gene/Protein	PR,148,150,Gene/Protein	hsp90,152,157,Gene/Protein	associated proteins,169,188,Gene/Protein	"[{""token"": ""progesterone receptor"", ""start_span"": 52, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""PR"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""PR"", ""start_span"": 148, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""hsp90"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""associated proteins"", ""start_span"": 169, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	valid
These interactions require ATP / Mg2 + and when ATP is limiting the PR complex is altered to one containing the proteins p60 and p48, but lacking immunophilins and p23.	PR,68,70,Gene/Protein	p60,121,124,Gene/Protein	p48,129,132,Gene/Protein	immunophilins,146,159,Gene/Protein	p23,164,167,Gene/Protein	"[{""token"": ""PR"", ""start_span"": 68, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""p60"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""p48"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""immunophilins"", ""start_span"": 146, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""p23"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	valid
Therefore, IRF - 1 may be an important contributor to IL - 12 signaling, and we speculate that the defective IL - 12 responses seen in IRF - 1 - / - mice might be attributable, in part, to the absence of this transcription factor.	IRF - 1,11,18,Gene/Protein	IL - 12,54,61,Gene/Protein	IL - 12,109,116,Gene/Protein	IRF,135,138,Gene/Protein	transcription factor,209,229,Gene/Protein	"[{""token"": ""IRF - 1"", ""start_span"": 11, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""IRF"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 209, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	valid
Messenger RNA production coding for IL - 8, RANTES, and MCP - 1 showed parallel variations to the production of the correspondent proteins.	Messenger RNA,0,13,Gene/Protein	IL - 8,36,42,Gene/Protein	RANTES,44,50,Gene/Protein	MCP - 1,56,63,Gene/Protein	correspondent proteins,116,138,Gene/Protein	"[{""token"": ""Messenger RNA"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""RANTES"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""correspondent proteins"", ""start_span"": 116, ""end_span"": 138, ""type"": ""Gene/Protein""}]"	valid
Additionally, virus reactivation in resting PBMCs infected in vitro with HIV - 1 was found to be specifically induced by ligands of the CDR2 - loop in domain 1 ( D1) of CD4 ( virus envelope and anti - CD4 monoclonal antibodies).	CDR2 - loop,136,147,Gene/Protein	domain 1,151,159,Gene/Protein	D1,162,164,Gene/Protein	CD4,169,172,Gene/Protein	virus envelope and anti - CD4 monoclonal antibodies,175,226,Gene/Protein	"[{""token"": ""CDR2 - loop"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""domain 1"", ""start_span"": 151, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""D1"", ""start_span"": 162, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""virus envelope and anti - CD4 monoclonal antibodies"", ""start_span"": 175, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	valid
We have identified an E box around - 260 and a YY1 binding site around - 300 relative to the transcription start site.	E box,22,27,Gene/Protein	- 260,35,40,Gene/Protein	YY1 binding site,47,63,Gene/Protein	- 300,71,76,Gene/Protein	transcription start site,93,117,Gene/Protein	"[{""token"": ""E box"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""- 260"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""YY1 binding site"", ""start_span"": 47, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""- 300"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""transcription start site"", ""start_span"": 93, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	valid
Here, we investigate the role of Rho in regulating the distribution of the monocyte - binding receptors E - selectin, ICAM - 1, and VCAM - 1 in human endothelial cells.	Rho,33,36,Gene/Protein	monocyte - binding receptors,75,103,Gene/Protein	E - selectin,104,116,Gene/Protein	ICAM - 1,118,126,Gene/Protein	VCAM - 1,132,140,Gene/Protein	"[{""token"": ""Rho"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""monocyte - binding receptors"", ""start_span"": 75, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 104, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	valid
C3 transferase and cytochalasin D did not alter the expression levels of monocyte - binding receptors on endothelial cells, but did inhibit clustering of E - selectin, ICAM - 1, and VCAM - 1 on the cell surface induced by monocyte adhesion or cross - linking antibodies.	monocyte - binding receptors,73,101,Gene/Protein	E - selectin,154,166,Gene/Protein	ICAM - 1,168,176,Gene/Protein	VCAM - 1,182,190,Gene/Protein	cross - linking antibodies,243,269,Gene/Protein	"[{""token"": ""monocyte - binding receptors"", ""start_span"": 73, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 154, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 182, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""cross - linking antibodies"", ""start_span"": 243, ""end_span"": 269, ""type"": ""Gene/Protein""}]"	valid
Previous studies have characterized the CD28 augmentation of TCR - mediated signaling in peripheral blood T cells through transcriptional activation of an IL - 2 promoter CD28 response element ( CD28RE), along with enhanced mRNA stability.	CD28,40,44,Gene/Protein	TCR,61,64,Gene/Protein	IL - 2,155,161,Gene/Protein	CD28 response element,171,192,Gene/Protein	CD28RE,195,201,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""CD28 response element"", ""start_span"": 171, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""CD28RE"", ""start_span"": 195, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	valid
CTLA - 4 ligation inhibited CD3 / CD28 - induced IL - 2 mRNA accumulation by inhibiting IL - 2 transcription, which appears to be mediated in part through decreasing NF - AT accumulation in the nuclei.	CTLA - 4,0,8,Gene/Protein	CD28,34,38,Gene/Protein	IL - 2 mRNA,49,60,Gene/Protein	IL - 2,88,94,Gene/Protein	NF - AT,166,173,Gene/Protein	"[{""token"": ""CTLA - 4"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 mRNA"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 88, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	valid
There was, however, a significant difference in the amounts of the nuclear protein, REF - 1 ( which regulates AP - 1 DNA binding by altering the redox status of FOS and JUN proteins), in alveolar macrophages compared with monocytes.	nuclear protein,67,82,Gene/Protein	REF - 1,84,91,Gene/Protein	AP - 1,110,116,Gene/Protein	FOS,161,164,Gene/Protein	JUN proteins,169,181,Gene/Protein	"[{""token"": ""nuclear protein"", ""start_span"": 67, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""REF - 1"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 110, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""FOS"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""JUN proteins"", ""start_span"": 169, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	valid
Here we report that in erythroid cells, GATA - 1 strongly induces the expression of the anti - apoptotic protein bcl - xL, but not the related proteins bcl - 2 and mcl - 1.	GATA - 1,40,48,Gene/Protein	anti - apoptotic protein,88,112,Gene/Protein	bcl - xL,113,121,Gene/Protein	bcl - 2,152,159,Gene/Protein	mcl - 1,164,171,Gene/Protein	"[{""token"": ""GATA - 1"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""anti - apoptotic protein"", ""start_span"": 88, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""bcl - xL"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""bcl - 2"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""mcl - 1"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	valid
Gel supershift assays demonstrated that thrombin induced binding of NF - kappa Bp65 ( Rel A) to downstream NF - kappa B site of the ICAM - 1 promoter.	thrombin,40,48,Gene/Protein	NF - kappa Bp65,68,83,Gene/Protein	Rel A,86,91,Gene/Protein	NF - kappa B site,107,124,Gene/Protein	ICAM - 1 promoter,132,149,Gene/Protein	"[{""token"": ""thrombin"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa Bp65"", ""start_span"": 68, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""Rel A"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 107, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1 promoter"", ""start_span"": 132, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	valid
Thrombin receptor activation peptide, a 14 - amino - acid peptide representing the new NH2 terminus of proteolytically activated receptor - 1, mimicked thrombin ' s action in inducing ICAM - 1 expression.	Thrombin,0,8,Gene/Protein	NH2 terminus,87,99,Gene/Protein	receptor - 1,129,141,Gene/Protein	thrombin,152,160,Gene/Protein	ICAM - 1,184,192,Gene/Protein	"[{""token"": ""Thrombin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""NH2 terminus"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""receptor - 1"", ""start_span"": 129, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""thrombin"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 184, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	valid
These data indicate that thrombin activates endothelial ICAM - 1 expression and polymorphonuclear leukocyte adhesion by NF - kappa Bp65 binding to the downstream NF - kappa B site of ICAM - 1 promoter after proteolytically activated receptor - 1 activation.	thrombin,25,33,Gene/Protein	ICAM - 1,56,64,Gene/Protein	NF - kappa Bp65,120,135,Gene/Protein	NF - kappa B site,162,179,Gene/Protein	ICAM - 1 promoter,183,200,Gene/Protein	"[{""token"": ""thrombin"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa Bp65"", ""start_span"": 120, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 162, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1 promoter"", ""start_span"": 183, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	valid
Here we demonstrate that both Smad6 and Smad7 are human bone morphogenetic protein - 2 ( hBMP - 2) - inducible antagonists of hBMP - 2 - induced growth arrest and apoptosis in mouse B cell hybridoma HS - 72 cells.	Smad6,30,35,Gene/Protein	Smad7,40,45,Gene/Protein	human bone morphogenetic protein - 2,50,86,Gene/Protein	hBMP - 2,89,97,Gene/Protein	hBMP - 2,126,134,Gene/Protein	"[{""token"": ""Smad6"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""Smad7"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""human bone morphogenetic protein - 2"", ""start_span"": 50, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""hBMP - 2"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""hBMP - 2"", ""start_span"": 126, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	valid
PG490 also inhibits PMA - stimulated activation of a chimeric transcription factor in which the C - terminal TA1 transactivation domain of NF - kappaB p65 is fused to the DNA binding domain of GAL4.	chimeric transcription factor,53,82,Gene/Protein	C - terminal TA1 transactivation domain,96,135,Gene/Protein	NF - kappaB p65,139,154,Gene/Protein	DNA binding domain,171,189,Gene/Protein	GAL4,193,197,Gene/Protein	"[{""token"": ""chimeric transcription factor"", ""start_span"": 53, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal TA1 transactivation domain"", ""start_span"": 96, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB p65"", ""start_span"": 139, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding domain"", ""start_span"": 171, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""GAL4"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	valid
We investigated the MAPk kinase ( MKK) that activates p38 MAPk in response to LPS, the p38 MAPk isoforms that are activated as part of this pathway, and the functional responses affected by p38 MAPk activation.	MAPk kinase,20,31,Gene/Protein	MKK,34,37,Gene/Protein	p38 MAPk,54,62,Gene/Protein	p38 MAPk isoforms,87,104,Gene/Protein	p38 MAPk,190,198,Gene/Protein	"[{""token"": ""MAPk kinase"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""MKK"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPk"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPk isoforms"", ""start_span"": 87, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPk"", ""start_span"": 190, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	valid
Activation of MHC class II promoters requires binding of at least three distinct multi - protein complexes ( RFX, X2BP and NF - Y).	MHC class II promoters,14,36,Gene/Protein	multi - protein complexes,81,106,Gene/Protein	RFX,109,112,Gene/Protein	X2BP,114,118,Gene/Protein	NF - Y,123,129,Gene/Protein	"[{""token"": ""MHC class II promoters"", ""start_span"": 14, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""multi - protein complexes"", ""start_span"": 81, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""RFX"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""X2BP"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""NF - Y"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	valid
By using the yeast two - hybrid system, we also show that EVI1 ( contained in its entirety in MDS1 / EVI1 and AML1 / MDS1 / EVI1) physically interacts with SMAD3, which is an intracellular mediator of TGF - beta1 signaling.	EVI1,58,62,Gene/Protein	MDS1 / EVI1,94,105,Gene/Protein	AML1 / MDS1 / EVI1,110,128,Gene/Protein	SMAD3,156,161,Gene/Protein	TGF - beta1,201,212,Gene/Protein	"[{""token"": ""EVI1"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""MDS1 / EVI1"", ""start_span"": 94, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""AML1 / MDS1 / EVI1"", ""start_span"": 110, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""SMAD3"", ""start_span"": 156, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 201, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	valid
Unlike the proposed role of Cbl as a negative regulator, our results suggest that the Cbl homologue Cbl - b has a positive role in T - cell signaling, most likely via a direct interaction with the upstream kinase Zap - 70.	Cbl,28,31,Gene/Protein	Cbl,86,89,Gene/Protein	Cbl - b,100,107,Gene/Protein	upstream kinase,197,212,Gene/Protein	Zap - 70,213,221,Gene/Protein	"[{""token"": ""Cbl"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""Cbl"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""Cbl - b"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""upstream kinase"", ""start_span"": 197, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""Zap - 70"", ""start_span"": 213, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	valid
Although overexpressed Egr - 1 was ineffective, overexpressed Egr - 2 was as potent as Egr - 3 in inducing fasL promoter - dependent reporter constructs in T cell hybridomas and HeLa cells, and both up - regulated endogenous fasL mRNA in HeLa cells.	Egr - 1,23,30,Gene/Protein	Egr - 2,62,69,Gene/Protein	Egr - 3,87,94,Gene/Protein	fasL promoter - dependent reporter constructs,107,152,Gene/Protein	fasL mRNA,225,234,Gene/Protein	"[{""token"": ""Egr - 1"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 2"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 3"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""fasL promoter - dependent reporter constructs"", ""start_span"": 107, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""fasL mRNA"", ""start_span"": 225, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	valid
Members of the cyclic adenosine monophosphate ( cAMP) response element binding ( CREB) / activating transcription factor 1 ( ATF - 1) family of transcription factors bind three 21 - bp repeats ( Tax - responsive element - 1, or TRE - 1) within the viral promoter and are important for basal and Tax - mediated transcription.	transcription factors,144,165,Gene/Protein	21 - bp repeats,177,192,Gene/Protein	Tax - responsive element - 1,195,223,Gene/Protein	TRE - 1,228,235,Gene/Protein	viral promoter,248,262,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 144, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""21 - bp repeats"", ""start_span"": 177, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""Tax - responsive element - 1"", ""start_span"": 195, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""TRE - 1"", ""start_span"": 228, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""viral promoter"", ""start_span"": 248, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	valid
Among these hypersensitive sites, two transcriptional control elements were found, one in the first intron of the GATA - 3 gene and the other between 8. 3 and 5. 9 kilobases 5 ' from the GATA - 3 transcriptional initiation site.	hypersensitive sites,12,32,Gene/Protein	transcriptional control elements,38,70,Gene/Protein	first intron,94,106,Gene/Protein	GATA - 3 gene,114,127,Gene/Protein	GATA - 3 transcriptional initiation site,187,227,Gene/Protein	"[{""token"": ""hypersensitive sites"", ""start_span"": 12, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional control elements"", ""start_span"": 38, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""first intron"", ""start_span"": 94, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 3 gene"", ""start_span"": 114, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 3 transcriptional initiation site"", ""start_span"": 187, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	valid
Transcriptional regulation of the alpha2 integrin gene in cells undergoing megakaryocytic differentiation requires a core promoter between bp - 30 and - 92, a silencer between bp - 92 and - 351, and megakaryocytic enhancers in the distal 5 ' flank.	alpha2 integrin gene,34,54,Gene/Protein	core promoter,117,130,Gene/Protein	silencer,159,167,Gene/Protein	megakaryocytic enhancers,199,223,Gene/Protein	distal 5 ' flank,231,247,Gene/Protein	"[{""token"": ""alpha2 integrin gene"", ""start_span"": 34, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""core promoter"", ""start_span"": 117, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""silencer"", ""start_span"": 159, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""megakaryocytic enhancers"", ""start_span"": 199, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""distal 5 ' flank"", ""start_span"": 231, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	valid
IL - 10 preincubation resulted in the inhibition of gene expression for several IFN - induced genes, such as IP - 10, ISG54, and intercellular adhesion molecule - 1.	IL - 10,0,7,Gene/Protein	IFN - induced genes,80,99,Gene/Protein	IP - 10,109,116,Gene/Protein	ISG54,118,123,Gene/Protein	intercellular adhesion molecule - 1,129,164,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""IFN - induced genes"", ""start_span"": 80, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""IP - 10"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""ISG54"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 129, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	valid
The endothelial expression of vascular cell adhesion molecule - 1 ( VCAM - 1), E - selectin, and intercellular adhesion molecule - 1 was monitored by cell surface enzyme immunoassays or flow cytometry, and steady - state levels of VCAM - 1 mRNA were assessed by Northern blot analysis.	vascular cell adhesion molecule - 1,30,65,Gene/Protein	VCAM - 1,68,76,Gene/Protein	E - selectin,79,91,Gene/Protein	intercellular adhesion molecule - 1,97,132,Gene/Protein	VCAM - 1 mRNA,231,244,Gene/Protein	"[{""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 30, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 79, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 97, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1 mRNA"", ""start_span"": 231, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	valid
The importance of BCL2 and Stat3 on IL - 6 - induced macrophage - differentiation and apoptosis was studied with 1A9 - M cells expressing human BCL2 or a dominant - negative form of Stat3, respectively.	BCL2,18,22,Gene/Protein	Stat3,27,32,Gene/Protein	IL - 6,36,42,Gene/Protein	human BCL2,138,148,Gene/Protein	Stat3,182,187,Gene/Protein	"[{""token"": ""BCL2"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""human BCL2"", ""start_span"": 138, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 182, ""end_span"": 187, ""type"": ""Gene/Protein""}]"	valid
Interleukin - 8 ( IL - 8) is a chemokine that belongs to the alpha - chemokine or CXC subfamily and is produced by a wide variety of human cells, including monocytes and polymorphonuclear cells ( PMN).	Interleukin - 8,0,15,Gene/Protein	IL - 8,18,24,Gene/Protein	chemokine,31,40,Gene/Protein	alpha - chemokine,61,78,Gene/Protein	CXC subfamily,82,95,Gene/Protein	"[{""token"": ""Interleukin - 8"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""chemokine"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""alpha - chemokine"", ""start_span"": 61, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""CXC subfamily"", ""start_span"": 82, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	valid
The suggested roles of the downstream 3 ' regions acting as a Locus Control Region ( LCR), have allowed comparisons to be made between the regulation of the IgH locus with other model systems whose gene expression is governed by LCR activity.	downstream 3 ' regions,27,49,Gene/Protein	Locus Control Region,62,82,Gene/Protein	LCR,85,88,Gene/Protein	IgH locus,157,166,Gene/Protein	LCR,229,232,Gene/Protein	"[{""token"": ""downstream 3 ' regions"", ""start_span"": 27, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Locus Control Region"", ""start_span"": 62, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""LCR"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""IgH locus"", ""start_span"": 157, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""LCR"", ""start_span"": 229, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	valid
Cooperation of binding sites for STAT6 and NF kappa B / rel in the IL - 4 - induced up - regulation of the human IgE germline promoter.	binding sites,15,28,Gene/Protein	STAT6,33,38,Gene/Protein	NF kappa B / rel,43,59,Gene/Protein	IL - 4,67,73,Gene/Protein	human IgE germline promoter,107,134,Gene/Protein	"[{""token"": ""binding sites"", ""start_span"": 15, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B / rel"", ""start_span"": 43, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""human IgE germline promoter"", ""start_span"": 107, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	valid
IL - 2 and T cell antigen receptor complex induction of STAT3alpha serine 727 phosphorylation is dependent on the activity of the MEK / ERK pathway.	IL - 2,0,6,Gene/Protein	T cell antigen receptor complex,11,42,Gene/Protein	STAT3alpha,56,66,Gene/Protein	MEK,130,133,Gene/Protein	/ ERK,134,139,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""T cell antigen receptor complex"", ""start_span"": 11, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""STAT3alpha"", ""start_span"": 56, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""MEK"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""/ ERK"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	valid
Transcription factor NF - kappa B must be released from cytoplasmic inhibitory molecules ( I kappa Bs) in order to move to the nucleus and to activate its target genes.	Transcription factor,0,20,Gene/Protein	NF - kappa B,21,33,Gene/Protein	cytoplasmic inhibitory molecules,56,88,Gene/Protein	I kappa Bs,91,101,Gene/Protein	target genes,155,167,Gene/Protein	"[{""token"": ""Transcription factor"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 21, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic inhibitory molecules"", ""start_span"": 56, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""I kappa Bs"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""target genes"", ""start_span"": 155, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	valid
Further, M. tuberculosis and its tuberculin, purified protein derivative, induced the degradation of I kappa B - alpha and the expression of I kappa B - alpha mRNA, and purified protein derivative induced the activation of NF - kappa B in monocytes.	tuberculin,33,43,Gene/Protein	purified protein derivative,45,72,Gene/Protein	I kappa B - alpha,101,118,Gene/Protein	I kappa B - alpha mRNA,141,163,Gene/Protein	NF - kappa B,223,235,Gene/Protein	"[{""token"": ""tuberculin"", ""start_span"": 33, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""purified protein derivative"", ""start_span"": 45, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B - alpha"", ""start_span"": 101, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B - alpha mRNA"", ""start_span"": 141, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 223, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	valid
Both cytokines induced assembly of STAT5A and STAT5B containing complexes capable of binding to the interferon - gamma activation sequence ( GAS), and these complexes rapidly translocated ( within 1 min) into the nucleus of IL - 2 - or IL - 7 - treated cells.	cytokines,5,14,Gene/Protein	STAT5A,35,41,Gene/Protein	STAT5B,46,52,Gene/Protein	interferon - gamma activation sequence,100,138,Gene/Protein	GAS,141,144,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 5, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""STAT5A"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""STAT5B"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""interferon - gamma activation sequence"", ""start_span"": 100, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""GAS"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	valid
The POU transcription factors Oct - 1 and Oct - 2 regulate the activity of octamer - dependent promoters, including those that direct transcription from rearranged immunoglobulin genes.	POU transcription factors,4,29,Gene/Protein	Oct - 1,30,37,Gene/Protein	Oct - 2,42,49,Gene/Protein	octamer - dependent promoters,75,104,Gene/Protein	immunoglobulin genes,164,184,Gene/Protein	"[{""token"": ""POU transcription factors"", ""start_span"": 4, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""octamer - dependent promoters"", ""start_span"": 75, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin genes"", ""start_span"": 164, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	valid
The tax protein of human T - cell leukemia virus type 1 mediates the transactivation of the c - sis / platelet - derived growth factor - B promoter through interactions with the zinc finger transcription factors Sp1 and NGFI - A / Egr - 1.	tax protein,4,15,Gene/Protein	c - sis / platelet - derived growth factor - B promoter,92,147,Gene/Protein	zinc finger transcription factors,178,211,Gene/Protein	Sp1,212,215,Gene/Protein	NGFI - A / Egr - 1,220,238,Gene/Protein	"[{""token"": ""tax protein"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""c - sis / platelet - derived growth factor - B promoter"", ""start_span"": 92, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger transcription factors"", ""start_span"": 178, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""NGFI - A / Egr - 1"", ""start_span"": 220, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	valid
One ATF / CRE motif is located in the distal promoter at the nuclear matrix - associated Site IV, and the second motif is present in the proximal promoter at Site I.	ATF / CRE motif,4,19,Gene/Protein	distal promoter,38,53,Gene/Protein	nuclear matrix - associated Site IV,61,96,Gene/Protein	proximal promoter,137,154,Gene/Protein	Site I,158,164,Gene/Protein	"[{""token"": ""ATF / CRE motif"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""distal promoter"", ""start_span"": 38, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""nuclear matrix - associated Site IV"", ""start_span"": 61, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""proximal promoter"", ""start_span"": 137, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""Site I"", ""start_span"": 158, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	valid
Neither the PLC gamma 1 overexpression induced by IFN nor the increased hydrolytic activity of the enzyme appear to be affected by pretreatment of the cells with the protein tyrosine kinase inhibitor genistein, which is known to prevent the association of ISGF3 components.	PLC gamma 1,12,23,Gene/Protein	IFN,50,53,Gene/Protein	enzyme,99,105,Gene/Protein	tyrosine kinase,174,189,Gene/Protein	ISGF3,256,261,Gene/Protein	"[{""token"": ""PLC gamma 1"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""enzyme"", ""start_span"": 99, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine kinase"", ""start_span"": 174, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""ISGF3"", ""start_span"": 256, ""end_span"": 261, ""type"": ""Gene/Protein""}]"	valid
Moreover, anti - TNF - alpha inhibited HIV - 1 long terminal repeat ( LTR) - driven transcription of a reporter gene in primary T cells in response to activation, either in the presence or the absence of HIV - 1 Tat.	anti - TNF - alpha,10,28,Gene/Protein	HIV - 1 long terminal repeat,39,67,Gene/Protein	LTR,70,73,Gene/Protein	reporter gene,103,116,Gene/Protein	HIV - 1 Tat,204,215,Gene/Protein	"[{""token"": ""anti - TNF - alpha"", ""start_span"": 10, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat"", ""start_span"": 39, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene"", ""start_span"": 103, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 Tat"", ""start_span"": 204, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	valid
These results indicate that JAK2 / STAT5 activation is a common JAK / STAT pathway for hIL - 5 - mediated signal in these cells.	JAK2,28,32,Gene/Protein	/ STAT5,33,40,Gene/Protein	JAK,64,67,Gene/Protein	/ STAT,68,74,Gene/Protein	hIL - 5,87,94,Gene/Protein	"[{""token"": ""JAK2"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""/ STAT5"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""/ STAT"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""hIL - 5"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene/Protein""}]"	valid
The pp52 promoter contains an initiator specifying the unique 5 ' terminus of pp52 mRNA, tandem pairs of Ets and SP1 motifs, and a lone C / EBP motif.	pp52 promoter,4,17,Gene/Protein	5 ' terminus,62,74,Gene/Protein	pp52 mRNA,78,87,Gene/Protein	Ets and SP1 motifs,105,123,Gene/Protein	lone C / EBP motif,131,149,Gene/Protein	"[{""token"": ""pp52 promoter"", ""start_span"": 4, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""5 ' terminus"", ""start_span"": 62, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""pp52 mRNA"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""Ets and SP1 motifs"", ""start_span"": 105, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""lone C / EBP motif"", ""start_span"": 131, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	valid
In a previous study, we demonstrated that bufalin, which is an active principle of Chinese medicine, chan ' su, caused apoptosis in human leukemia U937 cells by anomalous activation of mitogen - activated protein kinase ( MAPK) via the signaling pathway of Ras, Raf - 1, and MAPK kinase - 1.	mitogen - activated protein kinase,185,219,Gene/Protein	MAPK,222,226,Gene/Protein	Ras,257,260,Gene/Protein	Raf - 1,262,269,Gene/Protein	MAPK kinase - 1,275,290,Gene/Protein	"[{""token"": ""mitogen - activated protein kinase"", ""start_span"": 185, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 222, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 257, ""end_span"": 260, ""type"": ""Gene/Protein""}, {""token"": ""Raf - 1"", ""start_span"": 262, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""MAPK kinase - 1"", ""start_span"": 275, ""end_span"": 290, ""type"": ""Gene/Protein""}]"	valid
Signaling through CD40 with soluble CD40 ligand stimulated fibroblast activation, as evidenced by mobilization of nuclear factor - kappaB and by induction of the proinflammatory and chemoattractant cytokines IL - 6 and IL - 8.	CD40,18,22,Gene/Protein	CD40,36,40,Gene/Protein	cytokines,198,207,Gene/Protein	IL - 6,208,214,Gene/Protein	IL - 8,219,225,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 198, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 208, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 219, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	valid
In fact, mAb L243 but not the staphylococcal superantigens, staphylococcal exotoxin toxic shock syndrome toxin - I or staphylococcal enterotoxin B, regulate the NF - kappa B binding activity.	mAb L243,9,17,Gene/Protein	staphylococcal superantigens,30,58,Gene/Protein	staphylococcal exotoxin toxic shock syndrome toxin - I,60,114,Gene/Protein	staphylococcal enterotoxin B,118,146,Gene/Protein	NF - kappa B,161,173,Gene/Protein	"[{""token"": ""mAb L243"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""staphylococcal superantigens"", ""start_span"": 30, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""staphylococcal exotoxin toxic shock syndrome toxin - I"", ""start_span"": 60, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""staphylococcal enterotoxin B"", ""start_span"": 118, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 161, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	valid
Functional analysis of monocytic THP - 1 cells transfected with plasmids containing various lengths of TNF - alpha promoter localized enhancer elements in a region ( - 182 to - 37 base pairs ( bp)) that were required for optimal transcription of the TNF - alpha gene in response to LPS.	plasmids,64,72,Gene/Protein	TNF - alpha promoter,103,123,Gene/Protein	enhancer elements,134,151,Gene/Protein	- 182 to - 37 base pairs,166,190,Gene/Protein	TNF - alpha gene,250,266,Gene/Protein	"[{""token"": ""plasmids"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha promoter"", ""start_span"": 103, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""enhancer elements"", ""start_span"": 134, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""- 182 to - 37 base pairs"", ""start_span"": 166, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha gene"", ""start_span"": 250, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	valid
IL - 10 inhibition of IFN - gamma - induced ICAM - 1 expression was apparent as early as 3 hours and was blocked by an anti - IL - 10 antibody but not by an isotype - matched control antibody.	IL - 10,0,7,Gene/Protein	IFN - gamma,22,33,Gene/Protein	ICAM - 1,44,52,Gene/Protein	anti - IL - 10 antibody,119,142,Gene/Protein	isotype - matched control antibody,157,191,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 22, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""anti - IL - 10 antibody"", ""start_span"": 119, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""isotype - matched control antibody"", ""start_span"": 157, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	valid
While the activation of JAK2, Shc, Erk, and STAT5 proteins correlated with hGM - CSF - mediated cell growth, cellular differentiation occurred in the absence of activation of these signal transduction pathways.	JAK2,24,28,Gene/Protein	Shc,30,33,Gene/Protein	Erk,35,38,Gene/Protein	STAT5 proteins,44,58,Gene/Protein	hGM - CSF,75,84,Gene/Protein	"[{""token"": ""JAK2"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""Shc"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""Erk"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""STAT5 proteins"", ""start_span"": 44, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""hGM - CSF"", ""start_span"": 75, ""end_span"": 84, ""type"": ""Gene/Protein""}]"	valid
Molecular cloning and characterization of a cDNA, CHEMR1, encoding a chemokine receptor with a homology to the human C - C chemokine receptor, CCR - 4.	cDNA,44,48,Gene/Protein	CHEMR1,50,56,Gene/Protein	chemokine receptor,69,87,Gene/Protein	human C - C chemokine receptor,111,141,Gene/Protein	CCR - 4,143,150,Gene/Protein	"[{""token"": ""cDNA"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""CHEMR1"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""chemokine receptor"", ""start_span"": 69, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""human C - C chemokine receptor"", ""start_span"": 111, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""CCR - 4"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	valid
Human immunodeficiency virus type 1 ( HIV - 1) Tat, an early regulatory protein that is critical for viral gene expression and replication, transactivates the HIV - 1 long terminal repeat ( LTR) via its binding to the transactivation response element ( TAR) and, along with other cellular factors, increases viral transcription initiation and elongation.	regulatory protein,61,79,Gene/Protein	HIV - 1 long terminal repeat,159,187,Gene/Protein	LTR,190,193,Gene/Protein	transactivation response element,218,250,Gene/Protein	TAR,253,256,Gene/Protein	"[{""token"": ""regulatory protein"", ""start_span"": 61, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat"", ""start_span"": 159, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 190, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""transactivation response element"", ""start_span"": 218, ""end_span"": 250, ""type"": ""Gene/Protein""}, {""token"": ""TAR"", ""start_span"": 253, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	valid
In this study, a combined pharmacologic and genetic strategy using two PKC ( NF - kappa B) inhibitors, pentoxifylline ( PTX) and Go - 6976, and a stably expressed anti - Tat single - chain intracellular antibody ( sFv intrabody) was employed to obtain cooperative inhibition of both HIV - 1 LTR - driven gene expression and HIV - 1 replication.	PKC,71,74,Gene/Protein	NF - kappa B,77,89,Gene/Protein	anti - Tat single - chain intracellular antibody,163,211,Gene/Protein	sFv intrabody,214,227,Gene/Protein	LTR,291,294,Gene/Protein	"[{""token"": ""PKC"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""anti - Tat single - chain intracellular antibody"", ""start_span"": 163, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""sFv intrabody"", ""start_span"": 214, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 291, ""end_span"": 294, ""type"": ""Gene/Protein""}]"	valid
We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an impaired nuclear translocation of the Rel proteins c - Rel, RelA / p65 and NF - kappa B1 / p50, whereas the nuclear appearance of RelB remains unaffected.	Rel proteins,180,192,Gene/Protein	c - Rel,193,200,Gene/Protein	RelA / p65,202,212,Gene/Protein	NF - kappa B1 / p50,217,236,Gene/Protein	RelB,272,276,Gene/Protein	"[{""token"": ""Rel proteins"", ""start_span"": 180, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 193, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""RelA / p65"", ""start_span"": 202, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B1 / p50"", ""start_span"": 217, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 272, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	valid
Accordingly, immunoblot experiments showed that amongst NF - kappa B / Rel proteins, RelA and p50 are mobilized to the nucleus following microglial cell stimulation with A beta ( 25 - 35) plus IFN gamma.	NF - kappa B,56,68,Gene/Protein	/ Rel proteins,69,83,Gene/Protein	RelA,85,89,Gene/Protein	p50,94,97,Gene/Protein	IFN gamma,193,202,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 56, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""/ Rel proteins"", ""start_span"": 69, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""IFN gamma"", ""start_span"": 193, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	valid
EMS analyses utilizing a series of mutated pp repeat elements demonstrate that the nucleotide sequence requirements for U1 ( U1A / U1B) and U2 formation are separable from those required for C1 - C3 formation.	mutated pp repeat elements,35,61,Gene/Protein	U1,120,122,Gene/Protein	U1A / U1B,125,134,Gene/Protein	U2,140,142,Gene/Protein	C1 - C3,191,198,Gene/Protein	"[{""token"": ""mutated pp repeat elements"", ""start_span"": 35, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""U1"", ""start_span"": 120, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""U1A / U1B"", ""start_span"": 125, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""U2"", ""start_span"": 140, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""C1 - C3"", ""start_span"": 191, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	valid
Induction of STAT3 is inhibited by both the serine / threonine protein kinase inhibitor H - 7 and the immunosuppressive drug rapamycin and requires de novo protein synthesis, demonstrating novel coupling between sIg and STAT proteins that differs from the classical paradigm for STAT induction by cytokine receptors.	STAT3,13,18,Gene/Protein	sIg,212,215,Gene/Protein	STAT proteins,220,233,Gene/Protein	STAT,279,283,Gene/Protein	cytokine receptors,297,315,Gene/Protein	"[{""token"": ""STAT3"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""sIg"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""STAT proteins"", ""start_span"": 220, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""STAT"", ""start_span"": 279, ""end_span"": 283, ""type"": ""Gene/Protein""}, {""token"": ""cytokine receptors"", ""start_span"": 297, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	valid
The human TF promoter contains binding sites for the transcription factors AP - 1, c - Rel / p65, Egr - 1, and Sp1.	human TF promoter,4,21,Gene/Protein	AP - 1,75,81,Gene/Protein	c - Rel / p65,83,96,Gene/Protein	Egr - 1,98,105,Gene/Protein	Sp1,111,114,Gene/Protein	"[{""token"": ""human TF promoter"", ""start_span"": 4, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel / p65"", ""start_span"": 83, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}]"	valid
Using the yeast two - hybrid system to screen for proteins which interact with Tax1, we isolated the B subunit of the CCAAT binding protein NF - Y from a HeLa cDNA library.	Tax1,79,83,Gene/Protein	B subunit,101,110,Gene/Protein	CCAAT binding protein,118,139,Gene/Protein	NF - Y,140,146,Gene/Protein	HeLa cDNA library,154,171,Gene/Protein	"[{""token"": ""Tax1"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""B subunit"", ""start_span"": 101, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""CCAAT binding protein"", ""start_span"": 118, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""NF - Y"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""HeLa cDNA library"", ""start_span"": 154, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	valid
Using a mitogenically incompetent human G - CSFR mutant in which Pro639 and Pro641 were substituted by alanine, the box 1 PDP motif was found to be required for activation of Jak kinases, tyrosine phosphorylation of the G - CSFR, and recruitment of Stat proteins.	mitogenically incompetent human G - CSFR mutant,8,55,Gene/Protein	box 1 PDP motif,116,131,Gene/Protein	Jak kinases,175,186,Gene/Protein	G - CSFR,220,228,Gene/Protein	Stat proteins,249,262,Gene/Protein	"[{""token"": ""mitogenically incompetent human G - CSFR mutant"", ""start_span"": 8, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""box 1 PDP motif"", ""start_span"": 116, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""Jak kinases"", ""start_span"": 175, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""G - CSFR"", ""start_span"": 220, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""Stat proteins"", ""start_span"": 249, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	valid
Activation of the Jak - Stat pathway correlates with proliferative signaling by the G - CSFR and requires the membrane - proximal box 1 PXP motif, which is conserved in members of the cytokine receptor superfamily.	Jak,18,21,Gene/Protein	- Stat,22,28,Gene/Protein	G - CSFR,84,92,Gene/Protein	membrane - proximal box 1 PXP motif,110,145,Gene/Protein	cytokine receptor superfamily,184,213,Gene/Protein	"[{""token"": ""Jak"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""- Stat"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""G - CSFR"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""membrane - proximal box 1 PXP motif"", ""start_span"": 110, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""cytokine receptor superfamily"", ""start_span"": 184, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	valid
GC efficiently suppressed IL - 5 synthesis of T - cell clones activated via either T - cell receptor ( TCR) or IL - 2 receptor ( IL - 2R).	IL - 5,26,32,Gene/Protein	T - cell receptor,83,100,Gene/Protein	TCR,103,106,Gene/Protein	IL - 2 receptor,111,126,Gene/Protein	IL - 2R,129,136,Gene/Protein	"[{""token"": ""IL - 5"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""T - cell receptor"", ""start_span"": 83, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor"", ""start_span"": 111, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R"", ""start_span"": 129, ""end_span"": 136, ""type"": ""Gene/Protein""}]"	valid
In addition, RFX1 can bind simultaneously, most likely as a heterodimer, with the transcription factor MIBP1 to NRE gamma.	RFX1,13,17,Gene/Protein	heterodimer,60,71,Gene/Protein	transcription factor,82,102,Gene/Protein	MIBP1,103,108,Gene/Protein	NRE gamma,112,121,Gene/Protein	"[{""token"": ""RFX1"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""heterodimer"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 82, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""MIBP1"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""NRE gamma"", ""start_span"": 112, ""end_span"": 121, ""type"": ""Gene/Protein""}]"	valid
We found that NFATx1 DNA binding activity and interaction with AP - 1 polypeptides were dependent on its central Rel similarity region and that transcriptional activation was reduced by deletions of either its N - terminal domain or its C - terminal domain, suggesting the presence of intrinsic transcriptional activation motifs in both regions.	NFATx1,14,20,Gene/Protein	central Rel similarity region,105,134,Gene/Protein	N - terminal domain,210,229,Gene/Protein	C - terminal domain,237,256,Gene/Protein	intrinsic transcriptional activation motifs,285,328,Gene/Protein	"[{""token"": ""NFATx1"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""central Rel similarity region"", ""start_span"": 105, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal domain"", ""start_span"": 210, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal domain"", ""start_span"": 237, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""intrinsic transcriptional activation motifs"", ""start_span"": 285, ""end_span"": 328, ""type"": ""Gene/Protein""}]"	valid
NO is produced from at least three different NO synthase ( NOS) isoforms: neuronal NOS ( nNOS), endothelial NOS, and immunologic NOS ( iNOS).	neuronal NOS,74,86,Gene/Protein	nNOS,89,93,Gene/Protein	endothelial NOS,96,111,Gene/Protein	immunologic NOS,117,132,Gene/Protein	iNOS,135,139,Gene/Protein	"[{""token"": ""neuronal NOS"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""nNOS"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""endothelial NOS"", ""start_span"": 96, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""immunologic NOS"", ""start_span"": 117, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""iNOS"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	valid
The transcriptional regulatory elements of many inducible T - cell genes contain adjacent or overlapping binding sites for the Ets and NF - kappaB / NFAT families of transcription factors.	transcriptional regulatory elements,4,39,Gene/Protein	inducible T - cell genes,48,72,Gene/Protein	overlapping binding sites,93,118,Gene/Protein	Ets and NF - kappaB / NFAT families,127,162,Gene/Protein	transcription factors,166,187,Gene/Protein	"[{""token"": ""transcriptional regulatory elements"", ""start_span"": 4, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""inducible T - cell genes"", ""start_span"": 48, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""overlapping binding sites"", ""start_span"": 93, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""Ets and NF - kappaB / NFAT families"", ""start_span"": 127, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 166, ""end_span"": 187, ""type"": ""Gene/Protein""}]"	valid
Nuclear factor of activated T cells and AP - 1 are insufficient for IL - 2 promoter activation: requirement for CD28 up - regulation of RE / AP.	Nuclear factor of activated T cells,0,35,Gene/Protein	AP - 1,40,46,Gene/Protein	IL - 2 promoter,68,83,Gene/Protein	CD28,112,116,Gene/Protein	RE / AP,136,143,Gene/Protein	"[{""token"": ""Nuclear factor of activated T cells"", ""start_span"": 0, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 68, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""RE / AP"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	valid
Under these conditions HUVEC adhesion molecules, E - selectin, VCAM - 1 and ICAM - 1, were increased at 3 h with only ICAM - 1 remaining overexpressed at 24 h.	HUVEC adhesion molecules,23,47,Gene/Protein	E - selectin,49,61,Gene/Protein	VCAM - 1,63,71,Gene/Protein	ICAM - 1,76,84,Gene/Protein	ICAM - 1,118,126,Gene/Protein	"[{""token"": ""HUVEC adhesion molecules"", ""start_span"": 23, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 49, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 63, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	valid
These data indicate specific modulation of the CREB / ATF - 1 family of transcription factors by the CD2 signalling pathway and suggest CD2 receptor modulation of CRE - mediated transcription following ligand engagement ( e. g. cell - to - cell contact).	CREB / ATF - 1 family,47,68,Gene/Protein	transcription factors,72,93,Gene/Protein	CD2,101,104,Gene/Protein	CD2,136,139,Gene/Protein	CRE,163,166,Gene/Protein	"[{""token"": ""CREB / ATF - 1 family"", ""start_span"": 47, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 72, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""CRE"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	valid
Interleukin - 10 ( IL - 10) and transforming growth factor beta ( TGF - beta) are inhibitory for B and T cells, IgE production, and mast cell proliferation, and they induce apoptosis in eosinophils.	Interleukin - 10,0,16,Gene/Protein	IL - 10,19,26,Gene/Protein	transforming growth factor beta,32,63,Gene/Protein	TGF - beta,66,76,Gene/Protein	IgE,112,115,Gene/Protein	"[{""token"": ""Interleukin - 10"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""transforming growth factor beta"", ""start_span"": 32, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene/Protein""}]"	valid
The IL - 10 gene polymorphism was a C - to - A exchange 571 base pairs upstream from the translation start site and was present between consensus binding sequences for Sp1 and elevated total serum.	IL - 10,4,11,Gene/Protein	571 base pairs upstream,56,79,Gene/Protein	translation start site,89,111,Gene/Protein	consensus binding sequences,136,163,Gene/Protein	Sp1,168,171,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""571 base pairs upstream"", ""start_span"": 56, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""translation start site"", ""start_span"": 89, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""consensus binding sequences"", ""start_span"": 136, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 168, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	valid
We investigated the function of the evolutionary conserved X2 box in the promoter of the HLA - DRA gene from the human major histocompatibility complex ( MHC) in resting and activated B cells.	X2 box,59,65,Gene/Protein	promoter,73,81,Gene/Protein	HLA - DRA gene,89,103,Gene/Protein	human major histocompatibility complex,113,151,Gene/Protein	MHC,154,157,Gene/Protein	"[{""token"": ""X2 box"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DRA gene"", ""start_span"": 89, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""human major histocompatibility complex"", ""start_span"": 113, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""MHC"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	valid
Cross - linking of FcR, on the THP - 1 monocytic cell line, by immune complexes resulted in both activation of the transcription factor NF - kappaB and interleukin 1 production.	FcR,19,22,Gene/Protein	immune complexes,63,79,Gene/Protein	transcription factor,115,135,Gene/Protein	NF - kappaB,136,147,Gene/Protein	interleukin 1,152,165,Gene/Protein	"[{""token"": ""FcR"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""immune complexes"", ""start_span"": 63, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 115, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 1"", ""start_span"": 152, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	valid
Neither the E12 nor the E47 product of the E2A gene nor the wild - type HLF protein was able to protect the cells from apoptosis induced by IL - 3 deprivation.	E12,12,15,Gene/Protein	E47,24,27,Gene/Protein	E2A gene,43,51,Gene/Protein	wild - type HLF protein,60,83,Gene/Protein	IL - 3,140,146,Gene/Protein	"[{""token"": ""E12"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""E47"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""E2A gene"", ""start_span"": 43, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""wild - type HLF protein"", ""start_span"": 60, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	valid
Progesterone effectively blocked a broad spectrum of K + channels, reducing both Kv1. 3 and charybdotoxin - resistant components of KV current and KCa current in T cells, as well as blocking several cloned KV channels expressed in cell lines.	K + channels,53,65,Gene/Protein	charybdotoxin - resistant components,92,128,Gene/Protein	KV,132,134,Gene/Protein	KCa,147,150,Gene/Protein	cloned KV channels,199,217,Gene/Protein	"[{""token"": ""K + channels"", ""start_span"": 53, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""charybdotoxin - resistant components"", ""start_span"": 92, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""KV"", ""start_span"": 132, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""KCa"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""cloned KV channels"", ""start_span"": 199, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	valid
It was proposed that the mechanism of antiviral action of S9a was on the host cell, by blocking TNF - alpha transcription via a Tat - induced tar - independent loop, which decreases downstream NF - kappaB activation of HIV - 1 long terminal repeat ( LTR).	TNF - alpha,96,107,Gene/Protein	Tat,128,131,Gene/Protein	NF - kappaB,193,204,Gene/Protein	HIV - 1 long terminal repeat,219,247,Gene/Protein	LTR,250,253,Gene/Protein	"[{""token"": ""TNF - alpha"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""Tat"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 193, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat"", ""start_span"": 219, ""end_span"": 247, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 250, ""end_span"": 253, ""type"": ""Gene/Protein""}]"	valid
PDBu + iono induced equally high IL - 2 levels in both groups and, when stimulated with plate - bound anti - CD3 monoclonal antibody ( mAb), the IL - 2 secretion by neonatal cells was undetectable and adult cells produced low amounts of IL - 2 ( mean 331 + / - 86 pg / ml).	IL - 2,33,39,Gene/Protein	anti - CD3 monoclonal antibody,102,132,Gene/Protein	mAb,135,138,Gene/Protein	IL - 2,145,151,Gene/Protein	IL - 2,237,243,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3 monoclonal antibody"", ""start_span"": 102, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""mAb"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 237, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	valid
Our results suggest that reduced IL - 2 production by neonatal T cells is specific for anti - CD3 and anti - CD3 + anti - CD28 - mediated stimulation and that these activators can not effectively activate the ROI - NF - kappa B signalling pathway in neonatal T cells.	IL - 2,33,39,Gene/Protein	anti - CD3,87,97,Gene/Protein	anti - CD3,102,112,Gene/Protein	anti - CD28,115,126,Gene/Protein	- NF - kappa B,213,227,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 87, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 102, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD28"", ""start_span"": 115, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""- NF - kappa B"", ""start_span"": 213, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	valid
The Duffy protein is a receptor for the Plasmodium vivax erythrocyte - binding protein and is also a receptor for various chemokines ( thus renamed Duffy Antigen Receptor for Chemokines [ DARC]).	Duffy protein,4,17,Gene/Protein	Plasmodium vivax erythrocyte - binding protein,40,86,Gene/Protein	chemokines,122,132,Gene/Protein	Duffy Antigen Receptor for Chemokines,148,185,Gene/Protein	DARC,188,192,Gene/Protein	"[{""token"": ""Duffy protein"", ""start_span"": 4, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""Plasmodium vivax erythrocyte - binding protein"", ""start_span"": 40, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""chemokines"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""Duffy Antigen Receptor for Chemokines"", ""start_span"": 148, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""DARC"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	valid
The transcription factors active at the IL - 2 promoter were differentially influenced: upon down - modulation of okadaic acid - sensitive phosphatases, transactivation by octamer, NF - kappa B, and NF of activated T cells proteins was abrogated, while transactivation by AP - 1 proteins was even enhanced.	transcription factors,4,25,Gene/Protein	IL - 2 promoter,40,55,Gene/Protein	okadaic acid - sensitive phosphatases,114,151,Gene/Protein	NF - kappa B,181,193,Gene/Protein	NF of activated T cells proteins,199,231,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 4, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 40, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""okadaic acid - sensitive phosphatases"", ""start_span"": 114, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 181, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""NF of activated T cells proteins"", ""start_span"": 199, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	valid
However, the change in p130 phosphorylation in response to alpha - IFN occurs before dephosphorylation of pRb is complete because loss of p130 Form 3 occurs throughout the cell cycle prior to complete arrest in G1, whereas pRb is dephosphorylated only in G1.	p130,23,27,Gene/Protein	alpha - IFN,59,70,Gene/Protein	pRb,106,109,Gene/Protein	p130 Form 3,138,149,Gene/Protein	pRb,223,226,Gene/Protein	"[{""token"": ""p130"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""alpha - IFN"", ""start_span"": 59, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""pRb"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""p130 Form 3"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""pRb"", ""start_span"": 223, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	valid
This pathway resulted in the induction of the transcription factors NF - kappa B, NF - AT, and proteins binding to the CD28 response element of the IL - 2 promoter.	transcription factors,46,67,Gene/Protein	NF - kappa B,68,80,Gene/Protein	NF - AT,82,89,Gene/Protein	CD28,119,123,Gene/Protein	IL - 2 promoter,148,163,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 46, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 148, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	valid
We first demonstrate, in human and mouse intraspecies hybrids, the coordinate suppression of MHC class II, Ii ( invariant chain) and HLA - DM gene transcription, and the release of the silencing by the addition of interferon gamma.	MHC class II,93,105,Gene/Protein	Ii,107,109,Gene/Protein	invariant chain,112,127,Gene/Protein	HLA - DM gene,133,146,Gene/Protein	interferon gamma,214,230,Gene/Protein	"[{""token"": ""MHC class II"", ""start_span"": 93, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Ii"", ""start_span"": 107, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""invariant chain"", ""start_span"": 112, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DM gene"", ""start_span"": 133, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""interferon gamma"", ""start_span"": 214, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	valid
In contrast, a mutant of Tax termed M22, which does not induce NF - kappaB, fails to activate either IKKalpha or IKKbeta.	Tax,25,28,Gene/Protein	M22,36,39,Gene/Protein	NF - kappaB,63,74,Gene/Protein	IKKalpha,101,109,Gene/Protein	IKKbeta,113,120,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""M22"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""IKKalpha"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene/Protein""}]"	valid
IL - 7 did not maintain v - Abl - mediated differentiation arrest of the pre - B cells, as activation of NF - kappaB and RAG gene transcription was unaffected by IL - 7.	IL - 7,0,6,Gene/Protein	v - Abl,24,31,Gene/Protein	NF - kappaB,105,116,Gene/Protein	RAG gene,121,129,Gene/Protein	IL - 7,162,168,Gene/Protein	"[{""token"": ""IL - 7"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""v - Abl"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""RAG gene"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	valid
Functional analysis of the promoter by transient transfection assays indicated that synergistic action between an SP - 1 - like element at - 21 / - 12, a GATA site at - 59 / - 54, and a novel regulatory element, CPRE ( - GGACTACAG -) at - 49 / - 41, is essential for the promoter activity in murine erythroleukemia ( MEL) cells.	SP - 1 - like element,114,135,Gene/Protein	GATA site,154,163,Gene/Protein	novel regulatory element,186,210,Gene/Protein	CPRE,212,216,Gene/Protein	GGACTACAG,221,230,Gene/Protein	"[{""token"": ""SP - 1 - like element"", ""start_span"": 114, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""GATA site"", ""start_span"": 154, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""novel regulatory element"", ""start_span"": 186, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""CPRE"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""GGACTACAG"", ""start_span"": 221, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	valid
Here we investigated the impact of retinoid X receptor ( RXR), retinoic acid receptor ( RAR), and of the c - erbA / thyroid hormone ( T3) receptor ( c - erbA / TR) on growth and differentiation of erythroid cells using an in vitro culture system of stem cell factor - dependent erythroid progenitors.	retinoid X receptor,35,54,Gene/Protein	RXR,57,60,Gene/Protein	retinoic acid receptor,63,85,Gene/Protein	RAR,88,91,Gene/Protein	c - erbA / TR,149,162,Gene/Protein	"[{""token"": ""retinoid X receptor"", ""start_span"": 35, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""RXR"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""retinoic acid receptor"", ""start_span"": 63, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""RAR"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""c - erbA / TR"", ""start_span"": 149, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	valid
The activation of NF - kappaB has been recognized to regulate a number of genes necessary for normal T cell responses including IL - 2, IL - 6, IL - 8, and several T cell surface receptors.	NF - kappaB,18,29,Gene/Protein	IL - 2,128,134,Gene/Protein	IL - 6,136,142,Gene/Protein	IL - 8,144,150,Gene/Protein	T cell surface receptors,164,188,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""T cell surface receptors"", ""start_span"": 164, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	valid
SLP - 76 was not required for TCR - induced tyrosine phosphorylation of most proteins, but was required for optimal tyrosine phosphorylation and activation of phospholipase C - gamma1 ( PLC - gamma1), as well as Ras pathway activation.	SLP - 76,0,8,Gene/Protein	TCR,30,33,Gene/Protein	phospholipase C - gamma1,159,183,Gene/Protein	PLC - gamma1,186,198,Gene/Protein	Ras,212,215,Gene/Protein	"[{""token"": ""SLP - 76"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""phospholipase C - gamma1"", ""start_span"": 159, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""PLC - gamma1"", ""start_span"": 186, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	valid
Dominant negative forms of Stat1alpha or Stat3 promoted the EPO - induced erythroid differentiation of UT - 7 / GM cells, even in the presence of granulocyte - macrophage colony - stimulating factor, although this cytokine never induced erythroid differentiation of the parent UT - 7 / GM cells with or without EPO.	Stat1alpha,27,37,Gene/Protein	Stat3,41,46,Gene/Protein	EPO,60,63,Gene/Protein	granulocyte - macrophage colony - stimulating factor,146,198,Gene/Protein	EPO,311,314,Gene/Protein	"[{""token"": ""Stat1alpha"", ""start_span"": 27, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 146, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 311, ""end_span"": 314, ""type"": ""Gene/Protein""}]"	valid
Data obtained by electrophoretic mobility shift assay suggested that the activated Stat - 3 protein associates with the human serum - inducible element ( hSIE) DNA - probe derived from the interferon - gamma activated site ( GAS) in the c - fos promoter, a common DNA sequence for Stat protein binding.	activated Stat - 3 protein,73,99,Gene/Protein	interferon - gamma activated site,189,222,Gene/Protein	GAS,225,228,Gene/Protein	c - fos promoter,237,253,Gene/Protein	Stat protein,281,293,Gene/Protein	"[{""token"": ""activated Stat - 3 protein"", ""start_span"": 73, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""interferon - gamma activated site"", ""start_span"": 189, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""GAS"", ""start_span"": 225, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""c - fos promoter"", ""start_span"": 237, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""Stat protein"", ""start_span"": 281, ""end_span"": 293, ""type"": ""Gene/Protein""}]"	valid
BACKGROUND: The class II transactivator ( CIITA) is a bi - or multifunctional domain protein that acts as a transcriptional activator and plays a critical role in the expression of MHC class II genes.	class II transactivator,16,39,Gene/Protein	CIITA,42,47,Gene/Protein	bi - or multifunctional domain protein,54,92,Gene/Protein	transcriptional activator,108,133,Gene/Protein	MHC class II genes,181,199,Gene/Protein	"[{""token"": ""class II transactivator"", ""start_span"": 16, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""bi - or multifunctional domain protein"", ""start_span"": 54, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activator"", ""start_span"": 108, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""MHC class II genes"", ""start_span"": 181, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	valid
Macrophages in human atheroma contain PPARgamma: differentiation - dependent peroxisomal proliferator - activated receptor gamma ( PPARgamma) expression and reduction of MMP - 9 activity through PPARgamma activation in mononuclear phagocytes in vitro.	PPARgamma,38,47,Gene/Protein	differentiation - dependent peroxisomal proliferator - activated receptor gamma,49,128,Gene/Protein	PPARgamma,131,140,Gene/Protein	MMP - 9,170,177,Gene/Protein	PPARgamma,195,204,Gene/Protein	"[{""token"": ""PPARgamma"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""differentiation - dependent peroxisomal proliferator - activated receptor gamma"", ""start_span"": 49, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""PPARgamma"", ""start_span"": 131, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 170, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""PPARgamma"", ""start_span"": 195, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	valid
The observation that IL - 4 can differentially regulate the expression of TGF - alpha and TGF - beta1 suggests that IL - 4 may serve as a physiologic molecular switch of TGF expression by the infiltrating eosinophils in wound healing and carcinogenesis.	IL - 4,21,27,Gene/Protein	TGF - alpha,74,85,Gene/Protein	TGF - beta1,90,101,Gene/Protein	IL - 4,116,122,Gene/Protein	TGF,170,173,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""TGF - alpha"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 90, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""TGF"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	valid
These findings show that IL - 13 and IL - 4 have the ability to regulate NK and T cell activation and that IL - 13 is a potent regulator of STAT6 and JAK3 in these cell types.	IL - 13,25,32,Gene/Protein	IL - 4,37,43,Gene/Protein	IL - 13,107,114,Gene/Protein	STAT6,140,145,Gene/Protein	JAK3,150,154,Gene/Protein	"[{""token"": ""IL - 13"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	valid
Activation of the HIV - 1 provirus correlated with the activation of binding of 55 - and 85 - kDa proteins to the kappa B enhancer and binding of the 50 - kDa HLP - 1 protein to the LBP - 1 sequences of the HIV - 1 long terminal repeat.	55 - and 85 - kDa proteins,80,106,Gene/Protein	kappa B enhancer,114,130,Gene/Protein	50 - kDa HLP - 1 protein,150,174,Gene/Protein	LBP - 1 sequences,182,199,Gene/Protein	HIV - 1 long terminal repeat,207,235,Gene/Protein	"[{""token"": ""55 - and 85 - kDa proteins"", ""start_span"": 80, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""kappa B enhancer"", ""start_span"": 114, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""50 - kDa HLP - 1 protein"", ""start_span"": 150, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""LBP - 1 sequences"", ""start_span"": 182, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat"", ""start_span"": 207, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	valid
Transcriptional activation of the macrophage colony - stimulating factor gene by IL - 2 is associated with secretion of bioactive macrophage colony - stimulating factor protein by monocytes and involves activation of the transcription factor NF - kappa B.	macrophage colony - stimulating factor gene,34,77,Gene/Protein	IL - 2,81,87,Gene/Protein	macrophage colony - stimulating factor protein,130,176,Gene/Protein	transcription factor,221,241,Gene/Protein	NF - kappa B,242,254,Gene/Protein	"[{""token"": ""macrophage colony - stimulating factor gene"", ""start_span"": 34, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""macrophage colony - stimulating factor protein"", ""start_span"": 130, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 221, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 242, ""end_span"": 254, ""type"": ""Gene/Protein""}]"	valid
Transcriptional activation of the M - CSF gene by IL - 2 is preceded by enhanced binding activity of the transcription factor NF - kappa B to its recognition sequence in the 5 ' regulatory enhancer region of the M - CSF gene.	M - CSF gene,34,46,Gene/Protein	IL - 2,50,56,Gene/Protein	transcription factor,105,125,Gene/Protein	NF - kappa B,126,138,Gene/Protein	M - CSF gene,212,224,Gene/Protein	"[{""token"": ""M - CSF gene"", ""start_span"": 34, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 105, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF gene"", ""start_span"": 212, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	valid
Northern analysis demonstrated coordinate downregulation of alpha globin and gamma globin in addition to the two lineage - restricted transcription factors, SCL and GATA - 1.	alpha globin,60,72,Gene/Protein	gamma globin,77,89,Gene/Protein	transcription factors,134,155,Gene/Protein	SCL,157,160,Gene/Protein	GATA - 1,165,173,Gene/Protein	"[{""token"": ""alpha globin"", ""start_span"": 60, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""gamma globin"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 134, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""SCL"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	valid
To determine whether the defect in the patient ' s T lymphocytes involved a trans - acting factor common to the affected lymphokine genes, we examined the ability of nuclear factors from the patient ' s T lymphocytes to bind response elements present in the regulatory region of IL2.	trans - acting factor,76,97,Gene/Protein	lymphokine genes,121,137,Gene/Protein	nuclear factors,166,181,Gene/Protein	regulatory region,258,275,Gene/Protein	IL2,279,282,Gene/Protein	"[{""token"": ""trans - acting factor"", ""start_span"": 76, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""lymphokine genes"", ""start_span"": 121, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factors"", ""start_span"": 166, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""regulatory region"", ""start_span"": 258, ""end_span"": 275, ""type"": ""Gene/Protein""}, {""token"": ""IL2"", ""start_span"": 279, ""end_span"": 282, ""type"": ""Gene/Protein""}]"	valid
In contrast, the binding of the nuclear factor of activated T cells ( NF - AT) to its response element in the IL2 enhancer and to an NF - AT - like response element present in the IL4 enhancer was abnormal.	nuclear factor of activated T cells,32,67,Gene/Protein	NF - AT,70,77,Gene/Protein	IL2 enhancer,110,122,Gene/Protein	NF - AT - like response element,133,164,Gene/Protein	IL4 enhancer,180,192,Gene/Protein	"[{""token"": ""nuclear factor of activated T cells"", ""start_span"": 32, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IL2 enhancer"", ""start_span"": 110, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT - like response element"", ""start_span"": 133, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""IL4 enhancer"", ""start_span"": 180, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	valid
Few known genes ( IL - 2, members of the IL - 8 family, interferon - gamma) are induced in T cells only through the combined effect of phorbol myristic acetate ( PMA) and a Ca ( 2 +) - ionophore, and expression of only these genes can be fully suppressed by Cyclosporin A ( CyA).	genes,10,15,Gene/Protein	IL - 2,18,24,Gene/Protein	IL - 8 family,41,54,Gene/Protein	interferon - gamma,56,74,Gene/Protein	genes,225,230,Gene/Protein	"[{""token"": ""genes"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8 family"", ""start_span"": 41, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""interferon - gamma"", ""start_span"": 56, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""genes"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	valid
Competition with an AP - 1 motif or with anti - Jun and anti - Fos antibodies abolished binding to the NFAT motif in both T and B cells, indicating that Jun and Fos are critical for NFAT complex formation in both cell types.	AP - 1 motif,20,32,Gene/Protein	anti - Jun,41,51,Gene/Protein	anti - Fos antibodies,56,77,Gene/Protein	NFAT motif,103,113,Gene/Protein	NFAT complex,182,194,Gene/Protein	"[{""token"": ""AP - 1 motif"", ""start_span"": 20, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""anti - Jun"", ""start_span"": 41, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""anti - Fos antibodies"", ""start_span"": 56, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""NFAT motif"", ""start_span"": 103, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""NFAT complex"", ""start_span"": 182, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	valid
IFN - MCP was not inhibited by infection with dl343, despite the production of large amounts of both early ( E1B, p55) and late ( hexon) Ad proteins.	IFN,0,3,Gene/Protein	E1B,109,112,Gene/Protein	p55,114,117,Gene/Protein	hexon,130,135,Gene/Protein	Ad proteins,137,148,Gene/Protein	"[{""token"": ""IFN"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""E1B"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""p55"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""hexon"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""Ad proteins"", ""start_span"": 137, ""end_span"": 148, ""type"": ""Gene/Protein""}]"	valid
Globin chains ( alpha, beta and gamma) were clearly detectable by affinity chromatography in UT - 7 Epo but not in UT - 7 cells.	Globin chains,0,13,Gene/Protein	alpha,16,21,Gene/Protein	beta,23,27,Gene/Protein	gamma,32,37,Gene/Protein	UT - 7 Epo,93,103,Gene/Protein	"[{""token"": ""Globin chains"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""alpha"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""beta"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""gamma"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""UT - 7 Epo"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Gene/Protein""}]"	valid
This paper describes how the expression of the monocyte - macrophage Ag, CD14, and the low affinity Fc receptor for IgE, CD23, were inversely regulated during VitD3 - and RA - induced monocytic differentiation of human U - 937 monoblasts.	monocyte - macrophage Ag,47,71,Gene/Protein	CD14,73,77,Gene/Protein	affinity Fc receptor,91,111,Gene/Protein	IgE,116,119,Gene/Protein	CD23,121,125,Gene/Protein	"[{""token"": ""monocyte - macrophage Ag"", ""start_span"": 47, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""affinity Fc receptor"", ""start_span"": 91, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	valid
Increased c - jun, jun - B, and jun - D expression above basal levels and increased transcriptional activity of AP - 1 / TPA responsive elements fused to chloramphenicol acetyl - transferase vectors were observed in T cells treated with TPA alone or in combination with dexamethasone.	c - jun,10,17,Gene/Protein	jun - B,19,26,Gene/Protein	jun - D,32,39,Gene/Protein	AP - 1 / TPA responsive elements,112,144,Gene/Protein	chloramphenicol acetyl - transferase vectors,154,198,Gene/Protein	"[{""token"": ""c - jun"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""jun - B"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""jun - D"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 / TPA responsive elements"", ""start_span"": 112, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyl - transferase vectors"", ""start_span"": 154, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	valid
A novel T cell - specific negative regulatory element ( NRE) composed of two protein - binding sites were mapped in the 5 ' flanking region of the IL - 4 gene: - 311CTCCCTTCT - 303 ( NRE - I) and - 288CTTTTTGCTT - TGC - 300 ( NRE - II).	novel T cell - specific negative regulatory element,2,53,Gene/Protein	NRE,56,59,Gene/Protein	IL - 4 gene,147,158,Gene/Protein	NRE - I,183,190,Gene/Protein	NRE - II,226,234,Gene/Protein	"[{""token"": ""novel T cell - specific negative regulatory element"", ""start_span"": 2, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""NRE"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 gene"", ""start_span"": 147, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""NRE - I"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""NRE - II"", ""start_span"": 226, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	valid
Blockade of the DNA - binding complexes with an anti - Fos mAb demonstrated a direct participation of c - Fos in the AP - 1 complexes induced by anti - AIM mAb.	DNA - binding complexes,16,39,Gene/Protein	anti - Fos mAb,48,62,Gene/Protein	c - Fos,102,109,Gene/Protein	AP - 1 complexes,117,133,Gene/Protein	anti - AIM mAb,145,159,Gene/Protein	"[{""token"": ""DNA - binding complexes"", ""start_span"": 16, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""anti - Fos mAb"", ""start_span"": 48, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 complexes"", ""start_span"": 117, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""anti - AIM mAb"", ""start_span"": 145, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	valid
The endothelium plays a critical role in inflammation by directing circulating leukocytes into extravascular tissues by expressing adhesive molecules for leukocytes [ e. g., endothelial - leukocyte adhesion molecule 1 ( ELAM - 1) and intercellular adhesion molecule 1 ( ICAM - 1)].	adhesive molecules,131,149,Gene/Protein	endothelial - leukocyte adhesion molecule 1,174,217,Gene/Protein	ELAM - 1,220,228,Gene/Protein	intercellular adhesion molecule 1,234,267,Gene/Protein	ICAM - 1,270,278,Gene/Protein	"[{""token"": ""adhesive molecules"", ""start_span"": 131, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""endothelial - leukocyte adhesion molecule 1"", ""start_span"": 174, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""ELAM - 1"", ""start_span"": 220, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule 1"", ""start_span"": 234, ""end_span"": 267, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 270, ""end_span"": 278, ""type"": ""Gene/Protein""}]"	valid
The conversion of the TCEd to a ' perfect ' NF - kB binding site leads to a tighter binding of NF - kB to TCEd DNA and, as a functional consequence, to the activity of the ' converted ' TCEd motifs in HeLa cells.	TCEd,22,26,Gene/Protein	' perfect ' NF - kB binding site,32,64,Gene/Protein	NF - kB,95,102,Gene/Protein	TCEd DNA,106,114,Gene/Protein	' converted ' TCEd motifs,172,197,Gene/Protein	"[{""token"": ""TCEd"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""' perfect ' NF - kB binding site"", ""start_span"": 32, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""TCEd DNA"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""' converted ' TCEd motifs"", ""start_span"": 172, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	valid
In lymphocytes activated either by PHA or OKT3 ( but not in resting cells), a 50 - kDa species cross - reacting with a monoclonal antibody against the intestinal vitamin D receptor was detected.	PHA,35,38,Gene/Protein	OKT3,42,46,Gene/Protein	50 - kDa species,78,94,Gene/Protein	monoclonal antibody,119,138,Gene/Protein	intestinal vitamin D receptor,151,180,Gene/Protein	"[{""token"": ""PHA"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""OKT3"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""50 - kDa species"", ""start_span"": 78, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""monoclonal antibody"", ""start_span"": 119, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""intestinal vitamin D receptor"", ""start_span"": 151, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	valid
Previously, a nuclear factor, IRF - 1 ( interferon regulatory factor 1), which binds to type I IFN and some IFN - inducible gene promoters, was identified and cloned.	nuclear factor,14,28,Gene/Protein	IRF - 1,30,37,Gene/Protein	interferon regulatory factor 1,40,70,Gene/Protein	type I IFN,88,98,Gene/Protein	IFN - inducible gene promoters,108,138,Gene/Protein	"[{""token"": ""nuclear factor"", ""start_span"": 14, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""interferon regulatory factor 1"", ""start_span"": 40, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""type I IFN"", ""start_span"": 88, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IFN - inducible gene promoters"", ""start_span"": 108, ""end_span"": 138, ""type"": ""Gene/Protein""}]"	valid
Transforming growth factor - beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA.	Transforming growth factor - beta,0,33,Gene/Protein	human B lymphocyte Ig,45,66,Gene/Protein	membrane form,126,139,Gene/Protein	secreted form,147,160,Gene/Protein	Ig mRNA,164,171,Gene/Protein	"[{""token"": ""Transforming growth factor - beta"", ""start_span"": 0, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""human B lymphocyte Ig"", ""start_span"": 45, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""membrane form"", ""start_span"": 126, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""secreted form"", ""start_span"": 147, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""Ig mRNA"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	valid
We have isolated a human cDNA clone encoding a zinc finger protein ( NF - E1) that binds to the negative - acting segment of the kappa E3 ' enhancer.	human cDNA clone,19,35,Gene/Protein	zinc finger protein,47,66,Gene/Protein	NF - E1,69,76,Gene/Protein	negative - acting segment,96,121,Gene/Protein	kappa E3 ' enhancer,129,148,Gene/Protein	"[{""token"": ""human cDNA clone"", ""start_span"": 19, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger protein"", ""start_span"": 47, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""NF - E1"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""negative - acting segment"", ""start_span"": 96, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""kappa E3 ' enhancer"", ""start_span"": 129, ""end_span"": 148, ""type"": ""Gene/Protein""}]"	valid
TCF - 1 alpha is currently unique among the newly emerging family of DNA - binding regulatory proteins that share the HMG motif in that it is a highly tissue - specific RNA polymerase II transcription factor.	TCF - 1 alpha,0,13,Gene/Protein	DNA - binding regulatory proteins,69,102,Gene/Protein	HMG motif,118,127,Gene/Protein	highly tissue - specific RNA polymerase II,144,186,Gene/Protein	transcription factor,187,207,Gene/Protein	"[{""token"": ""TCF - 1 alpha"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding regulatory proteins"", ""start_span"": 69, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""HMG motif"", ""start_span"": 118, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""highly tissue - specific RNA polymerase II"", ""start_span"": 144, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 187, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	valid
Moreover, M - CSF - induced expression of the fos - related gene, fra - 1, was delayed compared to that for both c - fos and fos - B.	M - CSF,10,17,Gene/Protein	fos - related gene,46,64,Gene/Protein	fra - 1,66,73,Gene/Protein	c - fos,113,120,Gene/Protein	fos - B,125,132,Gene/Protein	"[{""token"": ""M - CSF"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""fos - related gene"", ""start_span"": 46, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""fra - 1"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""fos - B"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Gene/Protein""}]"	valid
In contrast, mild oxidation with glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.	glucose oxidase,33,48,Gene/Protein	p75,70,73,Gene/Protein	p85,78,81,Gene/Protein	p50,109,112,Gene/Protein	p55,117,120,Gene/Protein	"[{""token"": ""glucose oxidase"", ""start_span"": 33, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""p75"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""p85"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""p55"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}]"	valid
A transcription factor, NF - AT, which is essential for early T - cell gene activation, seems to be a specific target of cyclosporin A and FK506 action because transcription directed by this protein is blocked in T cells treated with these drugs, with little or no effect on other transcription factors such as AP - 1 and NF - kappa B.	transcription factor,2,22,Gene/Protein	NF - AT,24,31,Gene/Protein	transcription factors,281,302,Gene/Protein	AP - 1,311,317,Gene/Protein	NF - kappa B,322,334,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 2, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 281, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 311, ""end_span"": 317, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 322, ""end_span"": 334, ""type"": ""Gene/Protein""}]"	valid
From information available in the literature on the substrate specificity of the three enzymes, it is clear that a cysteine is not accepted in any of the S2, S1, S1 ', and S2 ' subsites of cathepsin B and L, and not in the S1 and S1 ' subsites of cathepsin D.	enzymes,87,94,Gene/Protein	cathepsin B and L,189,206,Gene/Protein	S1,223,225,Gene/Protein	S1 ',230,234,Gene/Protein	cathepsin D,247,258,Gene/Protein	"[{""token"": ""enzymes"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""cathepsin B and L"", ""start_span"": 189, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""S1"", ""start_span"": 223, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""S1 '"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""cathepsin D"", ""start_span"": 247, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	valid
Starting with a replication - incompetent molecular clone of human immunodeficiency virus type 1, lacking all the NF - kappa B and Sp1 binding sites present in the native long terminal repeat ( LTR), proviruses containing reconstructed LTRs with individual or combinations of NF - kappa B and Sp1 elements were generated and evaluated for their capacity to produce virus progeny following transfection - cocultivation.	NF - kappa B and Sp1 binding sites,114,148,Gene/Protein	native long terminal repeat,164,191,Gene/Protein	LTR,194,197,Gene/Protein	reconstructed LTRs,222,240,Gene/Protein	NF - kappa B and Sp1 elements,276,305,Gene/Protein	"[{""token"": ""NF - kappa B and Sp1 binding sites"", ""start_span"": 114, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""native long terminal repeat"", ""start_span"": 164, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""reconstructed LTRs"", ""start_span"": 222, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B and Sp1 elements"", ""start_span"": 276, ""end_span"": 305, ""type"": ""Gene/Protein""}]"	valid
The defensin sensitivities of Salmonella typhimurium strains with mutations in the phoP / phoQ two - component virulence regulon were tested by using purified defensins NP - 1 and NP - 2.	defensin,4,12,Gene/Protein	phoP / phoQ two - component virulence regulon,83,128,Gene/Protein	purified defensins,150,168,Gene/Protein	NP - 1,169,175,Gene/Protein	NP - 2,180,186,Gene/Protein	"[{""token"": ""defensin"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""phoP / phoQ two - component virulence regulon"", ""start_span"": 83, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""purified defensins"", ""start_span"": 150, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""NP - 1"", ""start_span"": 169, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""NP - 2"", ""start_span"": 180, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	valid
Competition experiments did not reveal any high - affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility ( MHC) genes, suggesting that BSAP is a regulator of a different set of B - lymphoid - specific genes.	high - affinity binding site,43,71,Gene/Protein	BSAP,76,80,Gene/Protein	regulatory regions,90,108,Gene/Protein	BSAP,195,199,Gene/Protein	B - lymphoid - specific genes,237,266,Gene/Protein	"[{""token"": ""high - affinity binding site"", ""start_span"": 43, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""regulatory regions"", ""start_span"": 90, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 195, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""B - lymphoid - specific genes"", ""start_span"": 237, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	valid
The same agents induce transcription from the interleukin - 2 receptor alpha - chain and interleukin - 2 genes, depending on promoter elements that bind the inducible transcription factor NF - kappa B ( or an NF - kappa B - like factor).	interleukin - 2 receptor alpha - chain and interleukin - 2 genes,46,110,Gene/Protein	promoter elements,125,142,Gene/Protein	inducible transcription factor,157,187,Gene/Protein	NF - kappa B,188,200,Gene/Protein	NF - kappa B - like factor,209,235,Gene/Protein	"[{""token"": ""interleukin - 2 receptor alpha - chain and interleukin - 2 genes"", ""start_span"": 46, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""promoter elements"", ""start_span"": 125, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""inducible transcription factor"", ""start_span"": 157, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 188, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B - like factor"", ""start_span"": 209, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	valid
Transcription factor IID ( TFIID) binds to the TATA box promoter element and regulates the expression of most eukaryotic genes transcribed by RNA polymerase II.	Transcription factor IID,0,24,Gene/Protein	TFIID,27,32,Gene/Protein	TATA box promoter element,47,72,Gene/Protein	eukaryotic genes,110,126,Gene/Protein	RNA polymerase II,142,159,Gene/Protein	"[{""token"": ""Transcription factor IID"", ""start_span"": 0, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""TFIID"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""TATA box promoter element"", ""start_span"": 47, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""eukaryotic genes"", ""start_span"": 110, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""RNA polymerase II"", ""start_span"": 142, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	valid
Human T - cell leukemia virus types I ( HTLV - I) and II ( HTLV - II) have two nonstructural trans - acting regulatory genes, tax and rex, located in the 3 ' region of the viral genome.	nonstructural trans - acting regulatory genes,79,124,Gene/Protein	tax,126,129,Gene/Protein	rex,134,137,Gene/Protein	3 ' region,154,164,Gene/Protein	viral genome,172,184,Gene/Protein	"[{""token"": ""nonstructural trans - acting regulatory genes"", ""start_span"": 79, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""tax"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""rex"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""3 ' region"", ""start_span"": 154, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""viral genome"", ""start_span"": 172, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	valid
This similarity in expression and the fact that NFAT - 1 has been shown to bind functional sequences in HIV - LTR suggest a role for NFAT - 1 in dermal activation of the HIV - LTR.	NFAT - 1,48,56,Gene/Protein	functional sequences,80,100,Gene/Protein	HIV - LTR,104,113,Gene/Protein	NFAT - 1,133,141,Gene/Protein	HIV - LTR,170,179,Gene/Protein	"[{""token"": ""NFAT - 1"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""functional sequences"", ""start_span"": 80, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""HIV - LTR"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""NFAT - 1"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""HIV - LTR"", ""start_span"": 170, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	valid
Treatment of immunoprecipitated NFATp from untreated HT - 2 cells with calcineurin resulted in the dephosphorylation of NFATp, demonstrating that NFATp is an in vitro substrate for calcineurin.	NFATp,32,37,Gene/Protein	calcineurin,71,82,Gene/Protein	NFATp,120,125,Gene/Protein	NFATp,146,151,Gene/Protein	calcineurin,181,192,Gene/Protein	"[{""token"": ""NFATp"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 71, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 181, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	valid
Since many cytokines that activate Jak kinases also lead to the tyrosine phosphorylation and activation of members of the Stat family of transcription factors, the ability of IL - 2 to trigger Stat phosphorylation was examined.	cytokines,11,20,Gene/Protein	Jak kinases,35,46,Gene/Protein	Stat family,122,133,Gene/Protein	transcription factors,137,158,Gene/Protein	IL - 2,175,181,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 11, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""Jak kinases"", ""start_span"": 35, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""Stat family"", ""start_span"": 122, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 137, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 175, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	valid
To identify osteoblast - specific cis - acting elements and trans - acting factors, we initiated an analysis of the promoter of a mouse osteocalcin gene, an osteoblast - specific gene.	osteoblast - specific cis - acting elements,12,55,Gene/Protein	trans - acting factors,60,82,Gene/Protein	promoter,116,124,Gene/Protein	mouse osteocalcin gene,130,152,Gene/Protein	osteoblast - specific gene,157,183,Gene/Protein	"[{""token"": ""osteoblast - specific cis - acting elements"", ""start_span"": 12, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""trans - acting factors"", ""start_span"": 60, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""mouse osteocalcin gene"", ""start_span"": 130, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""osteoblast - specific gene"", ""start_span"": 157, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	valid
These studies are the first to determine the structure and organization of the 5 ' end of the thromboxane receptor gene and demonstrate that thromboxane receptor gene expression can be regulated by activation of protein kinase C via induction of an AP - 2 - like nuclear factor binding to upstream promoter elements.	thromboxane receptor gene,94,119,Gene/Protein	thromboxane receptor gene,141,166,Gene/Protein	protein kinase C,212,228,Gene/Protein	AP - 2 - like nuclear factor,249,277,Gene/Protein	upstream promoter elements,289,315,Gene/Protein	"[{""token"": ""thromboxane receptor gene"", ""start_span"": 94, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""thromboxane receptor gene"", ""start_span"": 141, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 212, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2 - like nuclear factor"", ""start_span"": 249, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""upstream promoter elements"", ""start_span"": 289, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	valid
Inhibition of endogenous C / EBP proteins, using either an excess of C / EBP binding sites or a trans - dominant negative inhibitor, demonstrated that C / EBP proteins are required for basal and activated levels of HIV - 1 LTR transcription in the promonocytic cell line U937.	endogenous C / EBP proteins,14,41,Gene/Protein	C / EBP binding sites,69,90,Gene/Protein	trans - dominant negative inhibitor,96,131,Gene/Protein	C / EBP proteins,151,167,Gene/Protein	HIV - 1 LTR,215,226,Gene/Protein	"[{""token"": ""endogenous C / EBP proteins"", ""start_span"": 14, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP binding sites"", ""start_span"": 69, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""trans - dominant negative inhibitor"", ""start_span"": 96, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP proteins"", ""start_span"": 151, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 215, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	valid
Since expression of the viruses is in large part regulated by the sequence elements in their long terminal repeats ( LTRs), this study was directed to an analysis of the regulatory elements in the HIV - 2 LTR.	sequence elements,66,83,Gene/Protein	long terminal repeats,93,114,Gene/Protein	LTRs,117,121,Gene/Protein	regulatory elements,170,189,Gene/Protein	HIV - 2 LTR,197,208,Gene/Protein	"[{""token"": ""sequence elements"", ""start_span"": 66, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""long terminal repeats"", ""start_span"": 93, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""LTRs"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""regulatory elements"", ""start_span"": 170, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 2 LTR"", ""start_span"": 197, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	valid
Protein phosphorylation has an important role in the regulation of these two factors: ( 1) it induces the transactivating capacity of the AP - 1 protein c - Jun; and ( 2) it is involved in the release of the cytoplasmic inhibitor, I kappa B, from NF - kappa B, allowing translocation of the latter into the nucleus.	AP - 1 protein,138,152,Gene/Protein	c - Jun,153,160,Gene/Protein	cytoplasmic inhibitor,208,229,Gene/Protein	I kappa B,231,240,Gene/Protein	NF - kappa B,247,259,Gene/Protein	"[{""token"": ""AP - 1 protein"", ""start_span"": 138, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic inhibitor"", ""start_span"": 208, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 231, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 247, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	valid
In all cell lines investigated, the NF - kappa B complexes induced following CD30 engagement were shown to contain p50 NF - kappa B1, p65 RelA, and possibly other transcription factors.	NF - kappa B complexes,36,58,Gene/Protein	CD30,77,81,Gene/Protein	p50 NF - kappa B1,115,132,Gene/Protein	p65 RelA,134,142,Gene/Protein	transcription factors,163,184,Gene/Protein	"[{""token"": ""NF - kappa B complexes"", ""start_span"": 36, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""CD30"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""p50 NF - kappa B1"", ""start_span"": 115, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""p65 RelA"", ""start_span"": 134, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 163, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	valid
The present study demonstrates that triggering of complement receptors CR1 ( CD35) and CR3 ( CD11b / CD18) enhances viral replication in HIV - infected human monocytic cells.	complement receptors,50,70,Gene/Protein	CR1,71,74,Gene/Protein	CD35,77,81,Gene/Protein	CR3,87,90,Gene/Protein	CD11b / CD18,93,105,Gene/Protein	"[{""token"": ""complement receptors"", ""start_span"": 50, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CR1"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""CD35"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""CR3"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""CD11b / CD18"", ""start_span"": 93, ""end_span"": 105, ""type"": ""Gene/Protein""}]"	valid
Immunoprecipitation of the gp 160 - induced nuclear extracts with polyclonal antibodies to Fos and Jun proteins indicates that AP - 1 complex is comprised of members of these family of proteins.	gp 160,27,33,Gene/Protein	polyclonal antibodies,66,87,Gene/Protein	Fos,91,94,Gene/Protein	Jun proteins,99,111,Gene/Protein	AP - 1 complex,127,141,Gene/Protein	"[{""token"": ""gp 160"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""polyclonal antibodies"", ""start_span"": 66, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""Fos"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""Jun proteins"", ""start_span"": 99, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 complex"", ""start_span"": 127, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	valid
The present study demonstrates that both the ubiquitous and lymphoid - cell - specific octamer transcription factors ( OTF - 1 and OTF - 2, respectively) interact specifically with each of the two conserved sequence elements, forming either homo - or heterodimeric complexes.	ubiquitous and lymphoid - cell - specific octamer transcription factors,45,116,Gene/Protein	OTF - 1,119,126,Gene/Protein	OTF - 2,131,138,Gene/Protein	conserved sequence elements,197,224,Gene/Protein	homo - or heterodimeric complexes,241,274,Gene/Protein	"[{""token"": ""ubiquitous and lymphoid - cell - specific octamer transcription factors"", ""start_span"": 45, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 1"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 2"", ""start_span"": 131, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""conserved sequence elements"", ""start_span"": 197, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""homo - or heterodimeric complexes"", ""start_span"": 241, ""end_span"": 274, ""type"": ""Gene/Protein""}]"	test
The lymphoid cell specific octamer binding protein of 60 kd ( OTF - 2A) specifically stimulates Ig promoters which consist essentially of a TATA - box and an octamer sequence upstream of it.	lymphoid cell specific octamer binding protein,4,50,Gene/Protein	OTF - 2A,62,70,Gene/Protein	Ig promoters,96,108,Gene/Protein	TATA - box,140,150,Gene/Protein	octamer sequence,158,174,Gene/Protein	"[{""token"": ""lymphoid cell specific octamer binding protein"", ""start_span"": 4, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 2A"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""Ig promoters"", ""start_span"": 96, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""TATA - box"", ""start_span"": 140, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""octamer sequence"", ""start_span"": 158, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	test
From several findings, including the absence of OTF - 2B ( but not OTF - 2A) from a lymphocyte line that can not respond to the IgH enhancer, we propose a role of the novel octamer factor in the long range activation by the IgH enhancer.	OTF - 2B,48,56,Gene/Protein	OTF - 2A,67,75,Gene/Protein	IgH enhancer,128,140,Gene/Protein	novel octamer factor,167,187,Gene/Protein	IgH enhancer,224,236,Gene/Protein	"[{""token"": ""OTF - 2B"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 2A"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""IgH enhancer"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""novel octamer factor"", ""start_span"": 167, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""IgH enhancer"", ""start_span"": 224, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	test
We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P / CAF.	EKLF,13,17,Gene/Protein	acetylated transcription factor,24,55,Gene/Protein	CBP,92,95,Gene/Protein	p300,97,101,Gene/Protein	P / CAF,107,114,Gene/Protein	"[{""token"": ""EKLF"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""acetylated transcription factor"", ""start_span"": 24, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""CBP"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""p300"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""P / CAF"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene/Protein""}]"	test
However, its interactions with these histone acetyltransferases are not equivalent, as CBP and p300, but not P / CAF, utilize EKLF as a substrate for in vitro acetylation within its trans - activation region.	histone acetyltransferases,37,63,Gene/Protein	CBP,87,90,Gene/Protein	p300,95,99,Gene/Protein	P / CAF,109,116,Gene/Protein	EKLF,126,130,Gene/Protein	"[{""token"": ""histone acetyltransferases"", ""start_span"": 37, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""CBP"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""p300"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""P / CAF"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene/Protein""}]"	test
The functional effects of these interactions are that CBP and p300, but not P / CAF, enhance EKLF ' s transcriptional activation of the beta - globin promoter in erythroid cells.	CBP,54,57,Gene/Protein	p300,62,66,Gene/Protein	P / CAF,76,83,Gene/Protein	EKLF,93,97,Gene/Protein	beta - globin promoter,136,158,Gene/Protein	"[{""token"": ""CBP"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""p300"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""P / CAF"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin promoter"", ""start_span"": 136, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	test
Expression cloning with this region of DNA now shows that tegument protein VP22 and the viral dUTPase, encoded by genes UL49 and UL50, respectively, are T - cell antigens.	tegument protein,58,74,Gene/Protein	VP22,75,79,Gene/Protein	viral dUTPase,88,101,Gene/Protein	genes UL49 and UL50,114,133,Gene/Protein	T - cell antigens,153,170,Gene/Protein	"[{""token"": ""tegument protein"", ""start_span"": 58, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""VP22"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""viral dUTPase"", ""start_span"": 88, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""genes UL49 and UL50"", ""start_span"": 114, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""T - cell antigens"", ""start_span"": 153, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	test
Blocking mAbs against CD18 and CD11b abrogated fibrinogen - induced NF - kappa B activation.	mAbs,9,13,Gene/Protein	CD18,22,26,Gene/Protein	CD11b,31,36,Gene/Protein	fibrinogen,47,57,Gene/Protein	NF - kappa B,68,80,Gene/Protein	"[{""token"": ""mAbs"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""CD18"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""fibrinogen"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Gene/Protein""}]"	test
Furthermore, the inhibition of B cell differentiation by CD40 engagement could not be overcome by either mitogens or cytokines, but could be reversed by antibodies that interfere with the CD40 / gp39 interaction.	CD40,57,61,Gene/Protein	mitogens,105,113,Gene/Protein	cytokines,117,126,Gene/Protein	CD40,188,192,Gene/Protein	gp39,195,199,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""mitogens"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 117, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""gp39"", ""start_span"": 195, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	test
Induction of early B cell factor ( EBF) and multiple B lineage genes by the basic helix - loop - helix transcription factor E12.	early B cell factor,13,32,Gene/Protein	EBF,35,38,Gene/Protein	multiple B lineage genes,44,68,Gene/Protein	basic helix - loop - helix transcription factor,76,123,Gene/Protein	E12,124,127,Gene/Protein	"[{""token"": ""early B cell factor"", ""start_span"": 13, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""EBF"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""multiple B lineage genes"", ""start_span"": 44, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""basic helix - loop - helix transcription factor"", ""start_span"": 76, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""E12"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene/Protein""}]"	test
Transient transfection of HeLa cells with chimeric plasmids containing wild - type or mutant SRR from the tissue factor promoter showed that intact Sp1 sites are necessary for basal promoter activity, whereas the integrity of Egr - 1 sites was required for hypoxia - enhanced expression.	chimeric plasmids,42,59,Gene/Protein	wild - type or mutant SRR,71,96,Gene/Protein	tissue factor promoter,106,128,Gene/Protein	intact Sp1 sites,141,157,Gene/Protein	Egr - 1 sites,226,239,Gene/Protein	"[{""token"": ""chimeric plasmids"", ""start_span"": 42, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""wild - type or mutant SRR"", ""start_span"": 71, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""tissue factor promoter"", ""start_span"": 106, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""intact Sp1 sites"", ""start_span"": 141, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1 sites"", ""start_span"": 226, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	test
Abeta stimulated the rapid, transient activation of extracellular signal - regulated kinase 1 ( ERK1) and ERK2 in microglia and ERK2 in THP1 monocytes.	Abeta,0,5,Gene/Protein	extracellular signal - regulated kinase 1,52,93,Gene/Protein	ERK1,96,100,Gene/Protein	ERK2,106,110,Gene/Protein	ERK2,128,132,Gene/Protein	"[{""token"": ""Abeta"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""extracellular signal - regulated kinase 1"", ""start_span"": 52, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""ERK2"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""ERK2"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}]"	test
Exposure of microglia and THP1 monocytes to Abeta resulted in the activation of RSK1 and RSK2 and phosphorylation of cAMP response element - binding protein at Ser133, providing a mechanism for Abeta - induced changes in gene expression	Abeta,44,49,Gene/Protein	RSK1,80,84,Gene/Protein	RSK2,89,93,Gene/Protein	cAMP response element - binding protein,117,156,Gene/Protein	Abeta,194,199,Gene/Protein	"[{""token"": ""Abeta"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""RSK1"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""RSK2"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""cAMP response element - binding protein"", ""start_span"": 117, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""Abeta"", ""start_span"": 194, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	test
The paired box containing gene PAX - 5 encodes the transcription factor BSAP ( B - cell - specific activator protein), which plays a key role in B - lymphocyte development.	paired box containing gene,4,30,Gene/Protein	PAX - 5,31,38,Gene/Protein	transcription factor,51,71,Gene/Protein	BSAP,72,76,Gene/Protein	B - cell - specific activator protein,79,116,Gene/Protein	"[{""token"": ""paired box containing gene"", ""start_span"": 4, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""PAX - 5"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 51, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific activator protein"", ""start_span"": 79, ""end_span"": 116, ""type"": ""Gene/Protein""}]"	test
CS at 50 - 200 microM reduced tumor necrosis factor ( TNF), interleukin - 1 ( IL - 1), and IL - 6 activities in the culture supernatants from LPS - stimulated human blood monocytes without cytotoxicity.	tumor necrosis factor,30,51,Gene/Protein	TNF,54,57,Gene/Protein	interleukin - 1,60,75,Gene/Protein	IL - 1,78,84,Gene/Protein	IL - 6,91,97,Gene/Protein	"[{""token"": ""tumor necrosis factor"", ""start_span"": 30, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1"", ""start_span"": 60, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Gene/Protein""}]"	test
In TF - 1 cells, an erythroleukemia cell line, granulocyte - macrophage colony - stimulating factor ( GM - CSF) and erythropoietin ( Epo) greatly enhanced Bcl - 3 expression at both the protein and mRNA levels in association with stimulation of proliferation.	granulocyte - macrophage colony - stimulating factor,47,99,Gene/Protein	GM - CSF,102,110,Gene/Protein	erythropoietin,116,130,Gene/Protein	Epo,133,136,Gene/Protein	Bcl - 3,155,162,Gene/Protein	"[{""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 47, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""erythropoietin"", ""start_span"": 116, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Epo"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 3"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	test
Bcl - 3 in nuclear extracts of TF - 1 cells bound to a kappaB enhancer in the c - myb promoter together with NF - kappaB2 / p52 and this binding activity was enhanced by GM - CSF stimulation.	Bcl - 3,0,7,Gene/Protein	kappaB enhancer,55,70,Gene/Protein	c - myb promoter,78,94,Gene/Protein	NF - kappaB2 / p52,109,127,Gene/Protein	GM - CSF,170,178,Gene/Protein	"[{""token"": ""Bcl - 3"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""kappaB enhancer"", ""start_span"": 55, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""c - myb promoter"", ""start_span"": 78, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB2 / p52"", ""start_span"": 109, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 170, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	test
By using purified human erythroid colony - forming cells ( ECFC), we have found that SCF and EPO synergistically activate MAP kinase ( MAPK, ERK1 / 2), which correlates with the cell growth and thus may be responsible for the synergistic effects.	SCF,85,88,Gene/Protein	EPO,93,96,Gene/Protein	MAP kinase,122,132,Gene/Protein	MAPK,135,139,Gene/Protein	ERK1 / 2,141,149,Gene/Protein	"[{""token"": ""SCF"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""MAP kinase"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""ERK1 / 2"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	test
To further characterize the consequences of this biased co - stimulatory dependency, we employed a well - defined system of transfected CHO cells expressing human MHC class II together with CD80, CD86 or CD80 and CD86.	human MHC class II,157,175,Gene/Protein	CD80,190,194,Gene/Protein	CD86,196,200,Gene/Protein	CD80,204,208,Gene/Protein	CD86,213,217,Gene/Protein	"[{""token"": ""human MHC class II"", ""start_span"": 157, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""CD80"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 196, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""CD80"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 213, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	test
In human T - cell lymphotropic virus - I infected cells, the Mr 42, 000 long open reading frame protein encoded in part by the pX region of this virus may act as a transacting transcriptional activator that induces IL - 2 receptor gene transcription, thus providing an explanation for the constant association of IL - 2 receptor expression with adult T - cell lymphotropic virus - I infection of lymphoid cells.	open reading frame protein,77,103,Gene/Protein	pX region,127,136,Gene/Protein	transacting transcriptional activator,164,201,Gene/Protein	IL - 2 receptor gene,215,235,Gene/Protein	IL - 2 receptor,313,328,Gene/Protein	"[{""token"": ""open reading frame protein"", ""start_span"": 77, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""pX region"", ""start_span"": 127, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""transacting transcriptional activator"", ""start_span"": 164, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor gene"", ""start_span"": 215, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor"", ""start_span"": 313, ""end_span"": 328, ""type"": ""Gene/Protein""}]"	test
Overexpression of Rel proteins demonstrated that p65 - expressing Jurkat cells transcribed equally well a nuclear factor kappabeta reporter construct when costimulated with B7 - 1 or LFA - 3, but transcription of IL - 2 promoter or CD28 response element ( CD28RE) - driven reporters was superior in B7 - 1 - costimulated cells.	Rel proteins,18,30,Gene/Protein	nuclear factor kappabeta reporter construct,106,149,Gene/Protein	B7 - 1,173,179,Gene/Protein	LFA - 3,183,190,Gene/Protein	IL - 2 promoter,213,228,Gene/Protein	"[{""token"": ""Rel proteins"", ""start_span"": 18, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappabeta reporter construct"", ""start_span"": 106, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""B7 - 1"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""LFA - 3"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 213, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	test
We suggest that the transition from an autocrine LFA - 3 - driven immune response to a B7 - - induced paracrine immune response involves the activation of c - Jun and p65, which target the CD28RE region of the IL - 2 promoter.	LFA - 3,49,56,Gene/Protein	c - Jun,155,162,Gene/Protein	p65,167,170,Gene/Protein	CD28RE,189,195,Gene/Protein	IL - 2 promoter,210,225,Gene/Protein	"[{""token"": ""LFA - 3"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""CD28RE"", ""start_span"": 189, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 210, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	test
To assess HUVEC activation, E - selectin expression was measured by enzyme - linked immunosorbent assay ( ELISA), Northern blot analysis for E - selectin - specific mRNA, and electrophoretic gel mobility shift assay ( EMSA) for NF - kappa B, a transcription factor necessary for E - selectin gene activation.	E - selectin,28,40,Gene/Protein	E - selectin - specific mRNA,141,169,Gene/Protein	NF - kappa B,228,240,Gene/Protein	transcription factor,244,264,Gene/Protein	E - selectin gene,279,296,Gene/Protein	"[{""token"": ""E - selectin"", ""start_span"": 28, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin - specific mRNA"", ""start_span"": 141, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 228, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 244, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin gene"", ""start_span"": 279, ""end_span"": 296, ""type"": ""Gene/Protein""}]"	test
Thus, positive / negative regulation of the IL - 18Ralpha by the major inductive cytokines ( IL - 12 and IL - 4) determines the capacity of IL - 18 to polarize an immune response.	IL - 18Ralpha,44,57,Gene/Protein	cytokines,81,90,Gene/Protein	IL - 12,93,100,Gene/Protein	IL - 4,105,111,Gene/Protein	IL - 18,140,147,Gene/Protein	"[{""token"": ""IL - 18Ralpha"", ""start_span"": 44, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 81, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""IL - 18"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	test
Inhibition of pro - inflammatory transcription factors such as activator protein ( AP) - 1, signal transducers and activators of transcription ( STATs), nuclear factor of activated T cells ( NFAT) and nuclear factor ( NF) - kappa B is thought to be a major action of glucocorticoids.	pro - inflammatory transcription factors,14,54,Gene/Protein	signal transducers and activators of transcription,92,142,Gene/Protein	STATs,145,150,Gene/Protein	nuclear factor of activated T cells,153,188,Gene/Protein	NFAT,191,195,Gene/Protein	"[{""token"": ""pro - inflammatory transcription factors"", ""start_span"": 14, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers and activators of transcription"", ""start_span"": 92, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""STATs"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 153, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	test
To examine the roles of the transcription factors activator protein - 1 ( AP - 1) and nuclear factor - kappaB ( NF - kappaB), electrophoretic mobility shift assay ( EMSA) was performed.	transcription factors,28,49,Gene/Protein	activator protein - 1,50,71,Gene/Protein	AP - 1,74,80,Gene/Protein	nuclear factor - kappaB,86,109,Gene/Protein	NF - kappaB,112,123,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 28, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""activator protein - 1"", ""start_span"": 50, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappaB"", ""start_span"": 86, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 112, ""end_span"": 123, ""type"": ""Gene/Protein""}]"	test
We analyzed intracellular pathways modulating surface densities of CD80 and CD86 in B cells activated through ligation of the Ag receptor, and the adhesion molecule CD54.	CD80,67,71,Gene/Protein	CD86,76,80,Gene/Protein	Ag receptor,126,137,Gene/Protein	adhesion molecule,147,164,Gene/Protein	CD54,165,169,Gene/Protein	"[{""token"": ""CD80"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""Ag receptor"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""adhesion molecule"", ""start_span"": 147, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""CD54"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	test
TRAF2 - mediated NF - kappaB activation, AP - 1 induction and JAK3 / STAT activation may result in sustained proliferation leading to lymphoma.	TRAF2,0,5,Gene/Protein	NF - kappaB,17,28,Gene/Protein	AP - 1,41,47,Gene/Protein	JAK3,62,66,Gene/Protein	STAT,69,73,Gene/Protein	"[{""token"": ""TRAF2"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""STAT"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene/Protein""}]"	test
Macrophage stimulation with Murabutide, an HIV - suppressive muramyl peptide derivative, selectively activates extracellular signal - regulated kinases 1 and 2, C / EBPbeta and STAT1: role of CD14 and Toll - like receptors 2 and 4.	extracellular signal - regulated kinases 1 and 2,111,159,Gene/Protein	C / EBPbeta,161,172,Gene/Protein	STAT1,177,182,Gene/Protein	CD14,192,196,Gene/Protein	Toll - like receptors 2 and 4,201,230,Gene/Protein	"[{""token"": ""extracellular signal - regulated kinases 1 and 2"", ""start_span"": 111, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""C / EBPbeta"", ""start_span"": 161, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 177, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""Toll - like receptors 2 and 4"", ""start_span"": 201, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	test
The transcriptional coactivator OBF - 1, which interacts with Oct - 1 and Oct - 2 and the octamer site DNA, has been shown to be critical for development of a normal immune response and the formation of germinal centers in secondary lymphoid organs.	transcriptional coactivator,4,31,Gene/Protein	OBF - 1,32,39,Gene/Protein	Oct - 1,62,69,Gene/Protein	Oct - 2,74,81,Gene/Protein	octamer site DNA,90,106,Gene/Protein	"[{""token"": ""transcriptional coactivator"", ""start_span"": 4, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""OBF - 1"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""octamer site DNA"", ""start_span"": 90, ""end_span"": 106, ""type"": ""Gene/Protein""}]"	test
This interaction is mediated by the C - terminal part of Siah - 1 and by residues in the N - terminus of OBF - 1, partly distinct from the residues required for formation of a complex with the Oct POU domains and the DNA.	C - terminal,36,48,Gene/Protein	Siah - 1,57,65,Gene/Protein	N - terminus,89,101,Gene/Protein	OBF - 1,105,112,Gene/Protein	Oct POU domains,193,208,Gene/Protein	"[{""token"": ""C - terminal"", ""start_span"": 36, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""Siah - 1"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""N - terminus"", ""start_span"": 89, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""OBF - 1"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Oct POU domains"", ""start_span"": 193, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	test
Thus, our findings demonstrate that the constitutive activation of Akt - 1 regulates macrophage survival through Mcl - 1, which is independent of caspases, NF - kappaB, or Bad.	Akt - 1,67,74,Gene/Protein	Mcl - 1,113,120,Gene/Protein	caspases,146,154,Gene/Protein	NF - kappaB,156,167,Gene/Protein	Bad,172,175,Gene/Protein	"[{""token"": ""Akt - 1"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""Mcl - 1"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""caspases"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""Bad"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	test
Galectin - 10 ( gal - 10, also known as Charcot - Leyden crystal protein) is a member of the galectin family of beta - galactoside binding proteins that is expressed uniquely in eosinophilic and basophilic leukocytes.	Galectin - 10,0,13,Gene/Protein	gal - 10,16,24,Gene/Protein	Charcot - Leyden crystal protein,40,72,Gene/Protein	galectin family,93,108,Gene/Protein	beta - galactoside binding proteins,112,147,Gene/Protein	"[{""token"": ""Galectin - 10"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""gal - 10"", ""start_span"": 16, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""Charcot - Leyden crystal protein"", ""start_span"": 40, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""galectin family"", ""start_span"": 93, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""beta - galactoside binding proteins"", ""start_span"": 112, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	test
By supershift analysis, we demonstrate binding of the transcription factors Sp1 and Oct1 to the consensus GC box and the Oct site, respectively.	transcription factors,54,75,Gene/Protein	Sp1,76,79,Gene/Protein	Oct1,84,88,Gene/Protein	consensus GC box,96,112,Gene/Protein	Oct site,121,129,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 54, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""Oct1"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""consensus GC box"", ""start_span"": 96, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Oct site"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	test
Fatty acids are ligands for peroxisome proliferator - activated receptor - gamma ( PPARgamma), and the upregulation of adipophilin mRNA by PPARgamma agonists like 15d - PGJ ( 2) and ciglitazone indicates that PPARgamma may mediate the induction of adipophilin expression in human blood monocytes.	peroxisome proliferator - activated receptor - gamma,28,80,Gene/Protein	PPARgamma,83,92,Gene/Protein	adipophilin mRNA,119,135,Gene/Protein	PPARgamma,139,148,Gene/Protein	PPARgamma,209,218,Gene/Protein	"[{""token"": ""peroxisome proliferator - activated receptor - gamma"", ""start_span"": 28, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""PPARgamma"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""adipophilin mRNA"", ""start_span"": 119, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""PPARgamma"", ""start_span"": 139, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""PPARgamma"", ""start_span"": 209, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	test
In distinction to drug - free maturing dendritic cells, 2. 5 micromol / L sulfasalazine upregulated the levels of CD14 and CD68 and downregulated the levels of CD40, CD80, and CD83 ( for all CD markers, p < 0. 03 for difference between measurements in the absence and the presence of sulfasalazine).	CD14,114,118,Gene/Protein	CD68,123,127,Gene/Protein	CD40,160,164,Gene/Protein	CD80,166,170,Gene/Protein	CD83,176,180,Gene/Protein	"[{""token"": ""CD14"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""CD68"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""CD80"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""CD83"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	test
Furthermore, enhanced HIV - 1 transcription in gp34 - stimulated ACH - 2 / OX40 cells was dependent on the kappa B site of the HIV - 1 long terminal repeat, and the OX40 - gp34 interaction activated NF - kappa B consisting of p50 and p65 subunits.	gp34,47,51,Gene/Protein	kappa B site,107,119,Gene/Protein	HIV - 1 long terminal repeat,127,155,Gene/Protein	NF - kappa B,199,211,Gene/Protein	p50 and p65 subunits,226,246,Gene/Protein	"[{""token"": ""gp34"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""kappa B site"", ""start_span"": 107, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat"", ""start_span"": 127, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 199, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""p50 and p65 subunits"", ""start_span"": 226, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	test
B cell antigen receptor ligation resulted in enhanced tyrosine phosphorylation of STAT5 in BTK - deficient chicken B cells reconstituted with wild type human BTK but not in BTK - deficient chicken B cells reconstituted with kinase - inactive mutant BTK.	STAT5,82,87,Gene/Protein	BTK,91,94,Gene/Protein	wild type human BTK,142,161,Gene/Protein	BTK,173,176,Gene/Protein	kinase - inactive mutant BTK,224,252,Gene/Protein	"[{""token"": ""STAT5"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""BTK"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""wild type human BTK"", ""start_span"": 142, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""BTK"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""kinase - inactive mutant BTK"", ""start_span"": 224, ""end_span"": 252, ""type"": ""Gene/Protein""}]"	test
In nonstimulated T cells a repressor complex containing NF - IL6, JunB, c - Fos and Fra - 1 is formed on the AP - 1 ( IL - 2 / d) site and represses IL - 2 promoter activity.	NF - IL6,56,64,Gene/Protein	JunB,66,70,Gene/Protein	c - Fos,72,79,Gene/Protein	Fra - 1,84,91,Gene/Protein	IL - 2 promoter,149,164,Gene/Protein	"[{""token"": ""NF - IL6"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""JunB"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""Fra - 1"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 149, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	test
EMSAs with Abs specific for various protein factors of the AP - 1 family revealed that multiple members of the Jun family are involved in the regulation of the h2B4 gene.	Abs,11,14,Gene/Protein	protein factors,36,51,Gene/Protein	AP - 1 family,59,72,Gene/Protein	Jun family,111,121,Gene/Protein	h2B4 gene,160,169,Gene/Protein	"[{""token"": ""Abs"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""protein factors"", ""start_span"": 36, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 family"", ""start_span"": 59, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""Jun family"", ""start_span"": 111, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""h2B4 gene"", ""start_span"": 160, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	test
Levels of the IFNgamma - inducible factor IFN consensus sequence binding protein ( ICSBP), a negative trans - acting regulator of some IFNgamma - inducible genes, were quantified.	IFNgamma,14,22,Gene/Protein	IFN consensus sequence binding protein,42,80,Gene/Protein	ICSBP,83,88,Gene/Protein	negative trans - acting regulator,93,126,Gene/Protein	IFNgamma - inducible genes,135,161,Gene/Protein	"[{""token"": ""IFNgamma"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""IFN consensus sequence binding protein"", ""start_span"": 42, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""ICSBP"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""negative trans - acting regulator"", ""start_span"": 93, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma - inducible genes"", ""start_span"": 135, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	test
The results from the present study indicate that Smad3, Smad4, and Smad7, at least in part, serve as mediators linking TGF - beta1 to transcriptional regulation of IgA switching related gene and regulation of IgA class switching.	Smad3,49,54,Gene/Protein	Smad4,56,61,Gene/Protein	Smad7,67,72,Gene/Protein	TGF - beta1,119,130,Gene/Protein	IgA switching related gene,164,190,Gene/Protein	"[{""token"": ""Smad3"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Smad4"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""Smad7"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 119, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""IgA switching related gene"", ""start_span"": 164, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	test
Upon B cell receptor ( BCR) engagement and coculture with activated CD4 + T cells, these lymphocytes upregulated pol zeta, downregulated pol eta, and mutated the Ig and bcl - 6 genes.	B cell receptor,5,20,Gene/Protein	BCR,23,26,Gene/Protein	pol zeta,113,121,Gene/Protein	pol eta,137,144,Gene/Protein	Ig and bcl - 6 genes,162,182,Gene/Protein	"[{""token"": ""B cell receptor"", ""start_span"": 5, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""BCR"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""pol zeta"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""pol eta"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""Ig and bcl - 6 genes"", ""start_span"": 162, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	test
These data indicate that Cot kinase up - regulates COX - 2 promoter - driven transcription through the NFAT response elements, being the Cot kinase - induced NFAT - dependent transactivation presumably implicated in this up - regulation.	Cot kinase,25,35,Gene/Protein	COX - 2 promoter,51,67,Gene/Protein	NFAT response elements,103,125,Gene/Protein	Cot kinase,137,147,Gene/Protein	NFAT,158,162,Gene/Protein	"[{""token"": ""Cot kinase"", ""start_span"": 25, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""COX - 2 promoter"", ""start_span"": 51, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""NFAT response elements"", ""start_span"": 103, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""Cot kinase"", ""start_span"": 137, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	test
The acquisition of one Ly - 49 receptor, Ly - 49A is strictly dependent on the transcriptional trans - acting factor T cell - specific factor - 1 ( TCF - 1).	Ly - 49 receptor,23,39,Gene/Protein	Ly - 49A,41,49,Gene/Protein	transcriptional trans - acting factor,79,116,Gene/Protein	T cell - specific factor - 1,117,145,Gene/Protein	TCF - 1,148,155,Gene/Protein	"[{""token"": ""Ly - 49 receptor"", ""start_span"": 23, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""Ly - 49A"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional trans - acting factor"", ""start_span"": 79, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""T cell - specific factor - 1"", ""start_span"": 117, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	test
Therefore, besides TCF - 1 binding to the proximal promoter, Ly - 49 acquisition may also be regulated by TCF - 1 binding to more distant cis - acting elements and / or by regulating the expression of additional trans - acting factors.	TCF - 1,19,26,Gene/Protein	proximal promoter,42,59,Gene/Protein	TCF - 1,106,113,Gene/Protein	cis - acting elements,138,159,Gene/Protein	trans - acting factors,212,234,Gene/Protein	"[{""token"": ""TCF - 1"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""proximal promoter"", ""start_span"": 42, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""cis - acting elements"", ""start_span"": 138, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""trans - acting factors"", ""start_span"": 212, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	test
Because the promoters of these chemokine genes contain kappaB binding sites, we assessed the possible role of nuclear factor - kappaB ( NF - kappaB) in controlling induction of the genes through beta ( 2) integrin engagement.	promoters,12,21,Gene/Protein	chemokine genes,31,46,Gene/Protein	kappaB binding sites,55,75,Gene/Protein	nuclear factor - kappaB,110,133,Gene/Protein	NF - kappaB,136,147,Gene/Protein	"[{""token"": ""promoters"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""chemokine genes"", ""start_span"": 31, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""kappaB binding sites"", ""start_span"": 55, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappaB"", ""start_span"": 110, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	test
Electrophoretic mobility shift assays showed that sCD23 or antibodies to CD11b or to CD11c up - regulated DNA - binding activity of NF - kappaB.	sCD23,50,55,Gene/Protein	antibodies,59,69,Gene/Protein	CD11b,73,78,Gene/Protein	CD11c,85,90,Gene/Protein	NF - kappaB,132,143,Gene/Protein	"[{""token"": ""sCD23"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 59, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""CD11c"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 132, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	test
Additional experiments showed that all - trans - retinoic acid causes large induction of the transcription factor STAT1, while IFN - gamma causes activation of STAT1 such that it binds to the GAS / Sp1 site in the ACAT - 1 P1 promoter.	transcription factor STAT1,93,119,Gene/Protein	IFN - gamma,127,138,Gene/Protein	STAT1,160,165,Gene/Protein	GAS / Sp1 site,192,206,Gene/Protein	ACAT - 1 P1 promoter,214,234,Gene/Protein	"[{""token"": ""transcription factor STAT1"", ""start_span"": 93, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 127, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""GAS / Sp1 site"", ""start_span"": 192, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""ACAT - 1 P1 promoter"", ""start_span"": 214, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	test
Requirement for p38 and p44 / p42 mitogen - activated protein kinases in RAGE - mediated nuclear factor - kappaB transcriptional activation and cytokine secretion.	p38,16,19,Gene/Protein	p44 / p42,24,33,Gene/Protein	mitogen - activated protein kinases,34,69,Gene/Protein	RAGE,73,77,Gene/Protein	nuclear factor - kappaB,89,112,Gene/Protein	"[{""token"": ""p38"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""p44 / p42"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinases"", ""start_span"": 34, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""RAGE"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappaB"", ""start_span"": 89, ""end_span"": 112, ""type"": ""Gene/Protein""}]"	test
The NF - kappaB response was blocked with a synthetic peptide corresponding to the putative ligand - binding domain of RAGE, with anti - RAGE antiserum, and by coexpression of truncated receptors lacking the intracellular domain.	putative ligand - binding domain,83,115,Gene/Protein	RAGE,119,123,Gene/Protein	RAGE,137,141,Gene/Protein	truncated receptors,176,195,Gene/Protein	intracellular domain,208,228,Gene/Protein	"[{""token"": ""putative ligand - binding domain"", ""start_span"": 83, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""RAGE"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""RAGE"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""truncated receptors"", ""start_span"": 176, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""intracellular domain"", ""start_span"": 208, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	test
Costimulation with OKT - 3 and IL - 2 optimally induced secretion of IFN - gamma, TNF - alpha, and IL - 5, which was not decreased by CD45 signals.	OKT - 3,19,26,Gene/Protein	IL - 2,31,37,Gene/Protein	IFN - gamma,69,80,Gene/Protein	TNF - alpha,82,93,Gene/Protein	IL - 5,99,105,Gene/Protein	"[{""token"": ""OKT - 3"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 99, ""end_span"": 105, ""type"": ""Gene/Protein""}]"	test
Plasmin - induced expression of cytokines and tissue factor in human monocytes involves AP - 1 and IKKbeta - mediated NF - kappaB activation.	Plasmin,0,7,Gene/Protein	cytokines,32,41,Gene/Protein	tissue factor,46,59,Gene/Protein	AP - 1,88,94,Gene/Protein	IKKbeta,99,106,Gene/Protein	"[{""token"": ""Plasmin"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 32, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""tissue factor"", ""start_span"": 46, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 88, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Gene/Protein""}]"	test
While it has been shown that progenitor cells of P. vera patients are hypersensitive to several growth factors including erythropoietin, insulin - like growth factor - 1, thrombopoietin, interleukin - 3, and granulocyte / monocyte colony - stimulating factor, the molecular pathogenesis of this disease remains unknown.	erythropoietin,121,135,Gene/Protein	insulin - like growth factor - 1,137,169,Gene/Protein	thrombopoietin,171,185,Gene/Protein	interleukin - 3,187,202,Gene/Protein	granulocyte / monocyte colony - stimulating factor,208,258,Gene/Protein	"[{""token"": ""erythropoietin"", ""start_span"": 121, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""insulin - like growth factor - 1"", ""start_span"": 137, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""thrombopoietin"", ""start_span"": 171, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 3"", ""start_span"": 187, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte / monocyte colony - stimulating factor"", ""start_span"": 208, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	test
Mutation of the nonconsensus - 150 AP - 1 site to a consensus AP - 1 site, or insertion of a CD28RE / AP - 1 consensus site upstream of the native - 150 CD28RE / AP - 1 site restored transactivation of the altered promoter.	nonconsensus - 150 AP - 1 site,16,46,Gene/Protein	consensus AP - 1 site,52,73,Gene/Protein	CD28RE / AP - 1 consensus site,93,123,Gene/Protein	- 150 CD28RE / AP - 1 site,147,173,Gene/Protein	promoter,214,222,Gene/Protein	"[{""token"": ""nonconsensus - 150 AP - 1 site"", ""start_span"": 16, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""consensus AP - 1 site"", ""start_span"": 52, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""CD28RE / AP - 1 consensus site"", ""start_span"": 93, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""- 150 CD28RE / AP - 1 site"", ""start_span"": 147, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 214, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	test
A m ultipotent immature myeloid cell population was produced from a basic fibroblast growth factor ( bFGF) - dependent hematopoietic stem cell line, A - 6, when cultured with stem cell factor ( SCF) replacing bFGF.	basic fibroblast growth factor,68,98,Gene/Protein	bFGF,101,105,Gene/Protein	stem cell factor,175,191,Gene/Protein	SCF,194,197,Gene/Protein	bFGF,209,213,Gene/Protein	"[{""token"": ""basic fibroblast growth factor"", ""start_span"": 68, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""bFGF"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""stem cell factor"", ""start_span"": 175, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""bFGF"", ""start_span"": 209, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	test
Among various cytokines, interleukin - 3 ( IL - 3) induced erythroid precursor cells that expressed the erythroid - specific GATA - 1 and beta - major globin.	cytokines,14,23,Gene/Protein	interleukin - 3,25,40,Gene/Protein	IL - 3,43,49,Gene/Protein	erythroid - specific GATA - 1,104,133,Gene/Protein	beta - major globin,138,157,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 14, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 3"", ""start_span"": 25, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 43, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""erythroid - specific GATA - 1"", ""start_span"": 104, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""beta - major globin"", ""start_span"": 138, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	test
Gads acts by linking SLP - 76, bound by the carboxy - terminal Gads SH3 domain, to tyrosine phosphorylated LAT which contains binding sites for the Gads SH2 domain.	Gads,0,4,Gene/Protein	SLP - 76,21,29,Gene/Protein	carboxy - terminal Gads SH3 domain,44,78,Gene/Protein	tyrosine phosphorylated LAT,83,110,Gene/Protein	Gads SH2 domain,148,163,Gene/Protein	"[{""token"": ""Gads"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""SLP - 76"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""carboxy - terminal Gads SH3 domain"", ""start_span"": 44, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine phosphorylated LAT"", ""start_span"": 83, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""Gads SH2 domain"", ""start_span"": 148, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	test
Genes encoding CBFbeta ( CBFB), and one of the DNA - binding CBFalpha subunits, Runx1 ( also known as CBFalpha2, AML1, and PEBP2alphaB), are required for normal hematopoiesis and are also frequent targets of chromosomal translocations in acute leukemias in humans.	Genes encoding CBFbeta,0,22,Gene/Protein	CBFB,25,29,Gene/Protein	CBFalpha2,102,111,Gene/Protein	AML1,113,117,Gene/Protein	PEBP2alphaB,123,134,Gene/Protein	"[{""token"": ""Genes encoding CBFbeta"", ""start_span"": 0, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CBFB"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""CBFalpha2"", ""start_span"": 102, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""AML1"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2alphaB"", ""start_span"": 123, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	test
The implication of EBV in the skin lesions was determined by the presence of EBV - DNA, EBV - encoded nuclear RNA ( EBER) and a clonality of EBV - DNA fragments containing the terminal repeats.	EBV - DNA,77,86,Gene/Protein	EBV - encoded nuclear RNA,88,113,Gene/Protein	EBER,116,120,Gene/Protein	EBV - DNA fragments,141,160,Gene/Protein	terminal repeats,176,192,Gene/Protein	"[{""token"": ""EBV - DNA"", ""start_span"": 77, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""EBV - encoded nuclear RNA"", ""start_span"": 88, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""EBER"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""EBV - DNA fragments"", ""start_span"": 141, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""terminal repeats"", ""start_span"": 176, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	test
To gain further insight into the relationship of Runx2 to other lymphomagenic pathways, we tested the effect of combining the CD2 - Runx2 transgene either with a Pim1 transgene ( E ( mu) - Pim1) or with the p53 null genotype, as each of these displays independent synergy with Myc.	Runx2,49,54,Gene/Protein	CD2 - Runx2 transgene,126,147,Gene/Protein	Pim1 transgene,162,176,Gene/Protein	p53,207,210,Gene/Protein	Myc,277,280,Gene/Protein	"[{""token"": ""Runx2"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""CD2 - Runx2 transgene"", ""start_span"": 126, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""Pim1 transgene"", ""start_span"": 162, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 207, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""Myc"", ""start_span"": 277, ""end_span"": 280, ""type"": ""Gene/Protein""}]"	test
Bright ( B cell regulator of IgH transcription) is a B cell - specific, matrix associating region - binding protein that transactivates gene expression from the IgH intronic enhancer ( E mu).	Bright,0,6,Gene/Protein	B cell regulator of IgH transcription,9,46,Gene/Protein	matrix associating region - binding protein,72,115,Gene/Protein	IgH intronic enhancer,161,182,Gene/Protein	E mu,185,189,Gene/Protein	"[{""token"": ""Bright"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""B cell regulator of IgH transcription"", ""start_span"": 9, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""matrix associating region - binding protein"", ""start_span"": 72, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""IgH intronic enhancer"", ""start_span"": 161, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""E mu"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	test
Gadd45gamma, a family member of the growth arrest and DNA damage - inducible gene family 45 ( Gadd45), is strongly induced by interleukin - 2 ( IL - 2) in peripheral T cells.	Gadd45gamma,0,11,Gene/Protein	growth arrest and DNA damage - inducible gene family 45,36,91,Gene/Protein	Gadd45,94,100,Gene/Protein	interleukin - 2,126,141,Gene/Protein	IL - 2,144,150,Gene/Protein	"[{""token"": ""Gadd45gamma"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""growth arrest and DNA damage - inducible gene family 45"", ""start_span"": 36, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""Gadd45"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 126, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	test
The p38 MAP kinase as well as other members of the p38 MAP kinase pathway, including MKK3, MKK6, ATF - 2 and Elk - 1, were activated in homocysteine - treated cells.	p38 MAP kinase,4,18,Gene/Protein	MKK3,85,89,Gene/Protein	MKK6,91,95,Gene/Protein	ATF - 2,97,104,Gene/Protein	Elk - 1,109,116,Gene/Protein	"[{""token"": ""p38 MAP kinase"", ""start_span"": 4, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""MKK3"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""MKK6"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""ATF - 2"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""Elk - 1"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}]"	test
Surface immunoglobulin and IL - 4R utilize at least partially distinct pathways to produce Fas - resistance that differentially depend on PKC and STAT6, respectively.	Surface immunoglobulin,0,22,Gene/Protein	IL - 4R,27,34,Gene/Protein	Fas,91,94,Gene/Protein	PKC,138,141,Gene/Protein	STAT6,146,151,Gene/Protein	"[{""token"": ""Surface immunoglobulin"", ""start_span"": 0, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""Fas"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	test
While IL - 6 - directed CD4 + Th2 differentiation is mediated by IL - 4, inhibition of Th1 differentiation by IL - 6 is independent of IL - 4.	IL - 6,6,12,Gene/Protein	CD4,24,27,Gene/Protein	IL - 4,65,71,Gene/Protein	IL - 6,110,116,Gene/Protein	IL - 4,135,141,Gene/Protein	"[{""token"": ""IL - 6"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 110, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	test
This interaction is reciprocal, since C / EBP dimer binding to a strong C / EBP site leads to enhanced CREB - 1 recruitment to ATF / CREB sites that are weakly bound by CREB.	C / EBP dimer,38,51,Gene/Protein	C / EBP site,72,84,Gene/Protein	CREB - 1,103,111,Gene/Protein	ATF / CREB sites,127,143,Gene/Protein	CREB,169,173,Gene/Protein	"[{""token"": ""C / EBP dimer"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP site"", ""start_span"": 72, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""CREB - 1"", ""start_span"": 103, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""ATF / CREB sites"", ""start_span"": 127, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	test
The Runt family transcription factor CBFalpha2 ( AML1, PEBP2alphaB, or Runx1) is required by hematopoietic stem cells and expressed at high levels in T - lineage cells.	Runt family transcription factor,4,36,Gene/Protein	CBFalpha2,37,46,Gene/Protein	AML1,49,53,Gene/Protein	PEBP2alphaB,55,66,Gene/Protein	Runx1,71,76,Gene/Protein	"[{""token"": ""Runt family transcription factor"", ""start_span"": 4, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""CBFalpha2"", ""start_span"": 37, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""AML1"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2alphaB"", ""start_span"": 55, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""Runx1"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene/Protein""}]"	test
PI3 - K induction of GM - CSF appears to be at the transcriptional level and, consistently, we demonstrate that PI3 - K is also involved in the constitutive induction of AP - 1 and NF - kappaB, which characterizes Theileria - infected leucocytes.	PI3 - K,0,7,Gene/Protein	GM - CSF,21,29,Gene/Protein	PI3 - K,112,119,Gene/Protein	AP - 1,170,176,Gene/Protein	NF - kappaB,181,192,Gene/Protein	"[{""token"": ""PI3 - K"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""PI3 - K"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 181, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	test
Furthermore, AP - 4, unlike E47, did not act as a transactivator, which is in agreement with previous studies on intact kappa promoters, showing that transcription is absent when the octamer element has been mutated.	AP - 4,13,19,Gene/Protein	E47,28,31,Gene/Protein	transactivator,50,64,Gene/Protein	kappa promoters,120,135,Gene/Protein	octamer element,183,198,Gene/Protein	"[{""token"": ""AP - 4"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""E47"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""transactivator"", ""start_span"": 50, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""kappa promoters"", ""start_span"": 120, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""octamer element"", ""start_span"": 183, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	test
Based on these data, and the conservation of the 5 ' - CAGCTG - 3 ' motif among human and murine kappa promoters, we propose that AP - 4 is the major ligand for Ig - kappa promoter E - boxes.	5 ' - CAGCTG - 3 ' motif,49,73,Gene/Protein	human and murine kappa promoters,80,112,Gene/Protein	AP - 4,130,136,Gene/Protein	major ligand,144,156,Gene/Protein	Ig - kappa promoter E - boxes,161,190,Gene/Protein	"[{""token"": ""5 ' - CAGCTG - 3 ' motif"", ""start_span"": 49, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""human and murine kappa promoters"", ""start_span"": 80, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""AP - 4"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""major ligand"", ""start_span"": 144, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""Ig - kappa promoter E - boxes"", ""start_span"": 161, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	test
The DNA binding domain of the Drosophila transcription factor ( Antennapedia), a 60 amino acid protein, is rapidly taken up by cells and has been fused to selected antigens to enhance their immunogenicity.	DNA binding domain,4,22,Gene/Protein	Drosophila transcription factor,30,61,Gene/Protein	Antennapedia,64,76,Gene/Protein	60 amino acid protein,81,102,Gene/Protein	antigens,164,172,Gene/Protein	"[{""token"": ""DNA binding domain"", ""start_span"": 4, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""Drosophila transcription factor"", ""start_span"": 30, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""Antennapedia"", ""start_span"": 64, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""60 amino acid protein"", ""start_span"": 81, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""antigens"", ""start_span"": 164, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	test
Activation of FasL occurs via the NFAT - dependent induction of Egr3, as demonstrated by the ability of exogenously provided NFATp to restore Egr - dependent FasL promoter activity in DKO lymph node cells.	FasL,14,18,Gene/Protein	NFAT,34,38,Gene/Protein	Egr3,64,68,Gene/Protein	NFATp,125,130,Gene/Protein	Egr,142,145,Gene/Protein	"[{""token"": ""FasL"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Egr3"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Egr"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	test
Combined corticosteroid / granulocyte colony - stimulating factor ( G - CSF) therapy in the treatment of severe congenital neutropenia unresponsive to G - CSF: Activated glucocorticoid receptors synergize with G - CSF signals.	granulocyte colony - stimulating factor,26,65,Gene/Protein	G - CSF,68,75,Gene/Protein	G - CSF,151,158,Gene/Protein	glucocorticoid receptors,170,194,Gene/Protein	G - CSF,210,217,Gene/Protein	"[{""token"": ""granulocyte colony - stimulating factor"", ""start_span"": 26, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""glucocorticoid receptors"", ""start_span"": 170, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 210, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	test
Interestingly, the retinoid also inhibited in FCS - stimulated cells the protein expression of two mesangial adhesion molecules, fibronectin and osteopontin, but it did not modify the protein expression of intercellular adhesion molecule - 1 and vascular adhesion molecule - 1.	mesangial adhesion molecules,99,127,Gene/Protein	fibronectin,129,140,Gene/Protein	osteopontin,145,156,Gene/Protein	intercellular adhesion molecule - 1,206,241,Gene/Protein	vascular adhesion molecule - 1,246,276,Gene/Protein	"[{""token"": ""mesangial adhesion molecules"", ""start_span"": 99, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 129, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""osteopontin"", ""start_span"": 145, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 206, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""vascular adhesion molecule - 1"", ""start_span"": 246, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	test
CD3 / CD28 - promoted CREB - CBP interaction was dependent on p38 mitogen - activated protein kinase ( MAPK) and calcium / calmodulin - dependent protein kinase ( CaMK) IV in addition to the previously identified extracellular signal - regulated kinase pathway.	CD3 / CD28,0,10,Gene/Protein	CREB,22,26,Gene/Protein	CBP,29,32,Gene/Protein	p38 mitogen - activated protein kinase,62,100,Gene/Protein	MAPK,103,107,Gene/Protein	"[{""token"": ""CD3 / CD28"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""CBP"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""p38 mitogen - activated protein kinase"", ""start_span"": 62, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene/Protein""}]"	test
Thus, the IL - 2 promoter region contains novel distal regulatory elements that can be addressed by the AHR to induce IL - 2 and can cooperate with the proximal promoter	IL - 2 promoter region,10,32,Gene/Protein	distal regulatory elements,48,74,Gene/Protein	AHR,104,107,Gene/Protein	IL - 2,118,124,Gene/Protein	proximal promoter,152,169,Gene/Protein	"[{""token"": ""IL - 2 promoter region"", ""start_span"": 10, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""distal regulatory elements"", ""start_span"": 48, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""AHR"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""proximal promoter"", ""start_span"": 152, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	test
Electrophoretic mobility shift assays showed that Tax induced strong binding activity to an AP - 1 site in CTLL - 2, whereas Tax703 did not, indicating that the induction of binding activity to the AP - 1 site is essential for the transcriptional activation by Tax.	Tax,50,53,Gene/Protein	AP - 1 site,92,103,Gene/Protein	Tax703,125,131,Gene/Protein	AP - 1 site,198,209,Gene/Protein	Tax,261,264,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 site"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Tax703"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 site"", ""start_span"": 198, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 261, ""end_span"": 264, ""type"": ""Gene/Protein""}]"	test
Our results suggest that Tax activates the transcription of cellular genes with AP - 1 sites by inducing the DNA - binding activity of AP - 1 proteins in T cells, a mechanism distinct from those of CRE - like and kappaB elements.	Tax,25,28,Gene/Protein	cellular genes,60,74,Gene/Protein	AP - 1 sites,80,92,Gene/Protein	AP - 1 proteins,135,150,Gene/Protein	CRE - like and kappaB elements,198,228,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""cellular genes"", ""start_span"": 60, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 sites"", ""start_span"": 80, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 proteins"", ""start_span"": 135, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""CRE - like and kappaB elements"", ""start_span"": 198, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	test
ATF - 2 mutant thymocytes treated with anti - CD3 antibody in vitro demonstrated reduced induction of c - Jun, JunB, JunD and Fra - 2.	anti - CD3 antibody,39,58,Gene/Protein	c - Jun,102,109,Gene/Protein	JunB,111,115,Gene/Protein	JunD,117,121,Gene/Protein	Fra - 2,126,133,Gene/Protein	"[{""token"": ""anti - CD3 antibody"", ""start_span"": 39, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""JunB"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Fra - 2"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Gene/Protein""}]"	test
Activity of the distal region of the human immunodeficiency virus ( HIV - 1) long terminal repeat ( LTR), which contains binding sites for the Ets - 1 and USF - 1 proteins, is integral for HIV - 1 replication.	distal region,16,29,Gene/Protein	long terminal repeat,77,97,Gene/Protein	LTR,100,103,Gene/Protein	binding sites,121,134,Gene/Protein	Ets - 1 and USF - 1 proteins,143,171,Gene/Protein	"[{""token"": ""distal region"", ""start_span"": 16, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""long terminal repeat"", ""start_span"": 77, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 121, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""Ets - 1 and USF - 1 proteins"", ""start_span"": 143, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	test
Apoptosis induction could be abrogated mainly by antibodies against tumour necrosis factor - alpha ( TNF - alpha) and, to a lesser extent, by antibodies against IFN - gamma.	antibodies,49,59,Gene/Protein	tumour necrosis factor - alpha,68,98,Gene/Protein	TNF - alpha,101,112,Gene/Protein	antibodies,142,152,Gene/Protein	IFN - gamma,161,172,Gene/Protein	"[{""token"": ""antibodies"", ""start_span"": 49, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""tumour necrosis factor - alpha"", ""start_span"": 68, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 142, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 161, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	test
The role of the chemokine binding stromal - derived factor 1 ( SDF - 1) in normal human megakaryopoiesis at the cellular and molecular levels and its comparison with that of thrombopoietin ( TPO) have not been determined.	chemokine,16,25,Gene/Protein	stromal - derived factor 1,34,60,Gene/Protein	SDF - 1,63,70,Gene/Protein	thrombopoietin,174,188,Gene/Protein	TPO,191,194,Gene/Protein	"[{""token"": ""chemokine"", ""start_span"": 16, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""stromal - derived factor 1"", ""start_span"": 34, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""SDF - 1"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""thrombopoietin"", ""start_span"": 174, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""TPO"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	test
It was also found that though inhibition of phosphatidyl - inositol 3 - kinase ( PI - 3K) by LY294002 in alpha ( IIb) beta ( 3) ( +) cells induced apoptosis and inhibited chemotaxis adhesion and the secretion of MMP - 9 and VEGF, the inhibition of MAPK p42 / 44 ( by the MEK inhibitor U0126) had no effect on the survival, proliferation, and migration of these cells.	phosphatidyl - inositol 3 - kinase,44,78,Gene/Protein	PI - 3K,81,88,Gene/Protein	MMP - 9,212,219,Gene/Protein	VEGF,224,228,Gene/Protein	MAPK p42 / 44,248,261,Gene/Protein	"[{""token"": ""phosphatidyl - inositol 3 - kinase"", ""start_span"": 44, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""PI - 3K"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 212, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""VEGF"", ""start_span"": 224, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""MAPK p42 / 44"", ""start_span"": 248, ""end_span"": 261, ""type"": ""Gene/Protein""}]"	test
Accordingly, PI - 3K is involved in TPO - mediated inhibition of apoptosis, TPO - and SDF - 1 - regulated adhesion to fibrinogen and vitronectin, and SDF - 1 - mediated migration.	PI - 3K,13,20,Gene/Protein	TPO,36,39,Gene/Protein	fibrinogen,118,128,Gene/Protein	vitronectin,133,144,Gene/Protein	SDF - 1,150,157,Gene/Protein	"[{""token"": ""PI - 3K"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""TPO"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""fibrinogen"", ""start_span"": 118, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""vitronectin"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""SDF - 1"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	test
In the five - protein system, Hip prevents inhibition of assembly by the hsp70 co - chaperone BAG - 1, and cotransfection of Hip with BAG - 1 opposes BAG - 1 reduction of steroid binding activity in COS cells.	Hip,30,33,Gene/Protein	hsp70 co - chaperone BAG - 1,73,101,Gene/Protein	Hip,125,128,Gene/Protein	BAG - 1,134,141,Gene/Protein	BAG - 1,150,157,Gene/Protein	"[{""token"": ""Hip"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""hsp70 co - chaperone BAG - 1"", ""start_span"": 73, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Hip"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""BAG - 1"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""BAG - 1"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	test
The predominant inducible form of the NF - kappa B transcription factor is a heteromeric complex containing two Rel - related DNA - binding subunits, termed p65 and p50.	NF - kappa B transcription factor,38,71,Gene/Protein	heteromeric complex,77,96,Gene/Protein	Rel - related DNA - binding subunits,112,148,Gene/Protein	termed p65,150,160,Gene/Protein	p50,165,168,Gene/Protein	"[{""token"": ""NF - kappa B transcription factor"", ""start_span"": 38, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""heteromeric complex"", ""start_span"": 77, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""Rel - related DNA - binding subunits"", ""start_span"": 112, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""termed p65"", ""start_span"": 150, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	test
Transient transfection studies in MLA - 144 T cells revealed that constructs containing mutations in the AP - 1 site almost completely abolished CAT activity while mutation of the Elf - 1 site or the NF - IL - 3 site, a previously described nuclear protein binding site ( bp. - 155 to - 148) in the IL - 3 promoter, reduced CAT activity to < 25% of the activity given by wild - type constructs.	AP - 1 site,105,116,Gene/Protein	Elf - 1 site,180,192,Gene/Protein	NF - IL - 3 site,200,216,Gene/Protein	nuclear protein binding site,241,269,Gene/Protein	IL - 3 promoter,299,314,Gene/Protein	"[{""token"": ""AP - 1 site"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""Elf - 1 site"", ""start_span"": 180, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL - 3 site"", ""start_span"": 200, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""nuclear protein binding site"", ""start_span"": 241, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3 promoter"", ""start_span"": 299, ""end_span"": 314, ""type"": ""Gene/Protein""}]"	test
We located the transcription initiation site and showed that the CD4 core promoter ( positions - 40 to + 16) lacks a classical ` ` TATA ' ' or initiator positioning consensus sequence but directs precise and efficient transcription when coupled to the ubiquitously active simian virus 40 enhancer.	transcription initiation site,15,44,Gene/Protein	CD4 core promoter,65,82,Gene/Protein	positions - 40 to + 16,85,107,Gene/Protein	initiator positioning consensus sequence,143,183,Gene/Protein	simian virus 40 enhancer,272,296,Gene/Protein	"[{""token"": ""transcription initiation site"", ""start_span"": 15, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""CD4 core promoter"", ""start_span"": 65, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""positions - 40 to + 16"", ""start_span"": 85, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""initiator positioning consensus sequence"", ""start_span"": 143, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""simian virus 40 enhancer"", ""start_span"": 272, ""end_span"": 296, ""type"": ""Gene/Protein""}]"	test
These regions are designated YI ( amino acids [ aa] 1 to 25), YII ( aa 51 to 102), and YIII ( aa 228 to 245).	YI,29,31,Gene/Protein	YII,62,65,Gene/Protein	aa 51 to 102,68,80,Gene/Protein	YIII,87,91,Gene/Protein	aa 228 to 245,94,107,Gene/Protein	"[{""token"": ""YI"", ""start_span"": 29, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""YII"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""aa 51 to 102"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""YIII"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""aa 228 to 245"", ""start_span"": 94, ""end_span"": 107, ""type"": ""Gene/Protein""}]"	test
Combined with the observation that the mouse c - Rel and human RelA proteins also interact with TBP and TFIIB in vitro, these results suggest that association with basal transcription factors is important for the transcriptional activities of Rel family proteins.	mouse c - Rel and human RelA proteins,39,76,Gene/Protein	TBP,96,99,Gene/Protein	TFIIB,104,109,Gene/Protein	basal transcription factors,164,191,Gene/Protein	Rel family proteins,243,262,Gene/Protein	"[{""token"": ""mouse c - Rel and human RelA proteins"", ""start_span"": 39, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""TBP"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""TFIIB"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""basal transcription factors"", ""start_span"": 164, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""Rel family proteins"", ""start_span"": 243, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	test
Electrophoretic mobility shift assays using a DNA oligomer containing the NFIL - 2B binding site indicated that IL - 4 inhibited the NFIL - 2B complex and that the NFIL - 2B DNA binding factor is distinct from AP - 1.	NFIL - 2B binding site,74,96,Gene/Protein	IL - 4,112,118,Gene/Protein	NFIL - 2B complex,133,150,Gene/Protein	NFIL - 2B DNA binding factor,164,192,Gene/Protein	AP -,210,214,Gene/Protein	"[{""token"": ""NFIL - 2B binding site"", ""start_span"": 74, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""NFIL - 2B complex"", ""start_span"": 133, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""NFIL - 2B DNA binding factor"", ""start_span"": 164, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""AP -"", ""start_span"": 210, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	test
Some liberated dimers were retained in the cytoplasm, however, through binding to newly synthesized I kappa B alpha, a finding which strongly suggests ( i) that the LPS - induced signal causes dissociation of complexes rather than preventing their association and ( ii) that dissociation results from modification of I kappa B alpha and not of c - rel or p65.	liberated dimers,5,21,Gene/Protein	I kappa B alpha,100,115,Gene/Protein	I kappa B alpha,317,332,Gene/Protein	c - rel,344,351,Gene/Protein	p65,355,358,Gene/Protein	"[{""token"": ""liberated dimers"", ""start_span"": 5, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 100, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 317, ""end_span"": 332, ""type"": ""Gene/Protein""}, {""token"": ""c - rel"", ""start_span"": 344, ""end_span"": 351, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 355, ""end_span"": 358, ""type"": ""Gene/Protein""}]"	test
In view of the homology between the NF - P motif and other Ets proto - oncoprotein - binding sites, it is postulated that NF - P1 and NF - P2 belong to the Ets protein family.	NF - P motif,36,48,Gene/Protein	Ets proto - oncoprotein - binding sites,59,98,Gene/Protein	NF - P1,122,129,Gene/Protein	NF - P2,134,141,Gene/Protein	Ets protein family,156,174,Gene/Protein	"[{""token"": ""NF - P motif"", ""start_span"": 36, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""Ets proto - oncoprotein - binding sites"", ""start_span"": 59, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""NF - P1"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""NF - P2"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""Ets protein family"", ""start_span"": 156, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	test
In human monocytic and lymphoblastoid T - cell lines, induction of NF - kappa B by PC - PLC resulted in clear induction of luciferase expression vectors placed under the control of synthetic kappa B enhancers or wild type, but not kappa B - mutated, HIV long terminal repeat constructs.	NF - kappa B,67,79,Gene/Protein	PC - PLC,83,91,Gene/Protein	luciferase,123,133,Gene/Protein	synthetic kappa B enhancers,181,208,Gene/Protein	HIV long terminal repeat constructs,250,285,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 67, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""PC - PLC"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""luciferase"", ""start_span"": 123, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""synthetic kappa B enhancers"", ""start_span"": 181, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""HIV long terminal repeat constructs"", ""start_span"": 250, ""end_span"": 285, ""type"": ""Gene/Protein""}]"	test
Virus infection does not appear to alter the amount of RelA ( p65) or NFKB1 ( p50) but rather affects the capacity of I kappa B alpha to sequester RelA ( p65), therefore leading to constitutive levels of RelA DNA binding activity and to increased levels of NF - kappa B - dependent gene activity.	RelA,55,59,Gene/Protein	p65,62,65,Gene/Protein	NFKB1,70,75,Gene/Protein	p50,78,81,Gene/Protein	I kappa B alpha,118,133,Gene/Protein	"[{""token"": ""RelA"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""NFKB1"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 118, ""end_span"": 133, ""type"": ""Gene/Protein""}]"	test
In primary T lymphocytes we show that CD28 ligation leads to the rapid intracellular formation of reactive oxygen intermediates ( ROIs) which are required for CD28 - mediated activation of the NF - kappa B / CD28 - responsive complex and IL - 2 expression.	CD28,38,42,Gene/Protein	CD28,159,163,Gene/Protein	NF - kappa B,193,205,Gene/Protein	CD28 - responsive complex,208,233,Gene/Protein	IL - 2,238,244,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 193, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""CD28 - responsive complex"", ""start_span"": 208, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 238, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
In particular, two interleukins ( ILs), IL - 2 and IL - 12, have been shown to be potent inducers of IFN - gamma gene expression in both T cells and LGL.	interleukins,19,31,Gene/Protein	ILs,34,37,Gene/Protein	IL - 2,40,46,Gene/Protein	IL - 12,51,58,Gene/Protein	IFN - gamma,101,112,Gene/Protein	"[{""token"": ""interleukins"", ""start_span"": 19, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""ILs"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene/Protein""}]"	train
In this report we present evidence that the cell line NK3. 3 derived from human NK cells, responds to both IL - 2 and IL - 12, as measured by increases in IFN - gamma and granulocyte - macrophage colony - stimulating factor ( GM - CSF) cytoplasmic mRNA and protein expression.	IL - 2,107,113,Gene/Protein	IL - 12,118,125,Gene/Protein	IFN - gamma,155,166,Gene/Protein	granulocyte - macrophage colony - stimulating factor,171,223,Gene/Protein	GM - CSF,226,234,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 171, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 226, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
We further demonstrate that the p95vav - induced NFAT activation is not mimicked by Ras activation, though its function is dependent upon Ras and Raf.	p95vav,32,38,Gene/Protein	NFAT,49,53,Gene/Protein	Ras,84,87,Gene/Protein	Ras,138,141,Gene/Protein	Raf,146,149,Gene/Protein	"[{""token"": ""p95vav"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""Raf"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
PEBP2 alpha A1, alpha B1, and alpha B2 proteins bound the PEBP2 site within the mouse GM - CSF promoter.	PEBP2 alpha A1,0,14,Gene/Protein	alpha B1,16,24,Gene/Protein	alpha B2 proteins,30,47,Gene/Protein	PEBP2 site,58,68,Gene/Protein	mouse GM - CSF promoter,80,103,Gene/Protein	"[{""token"": ""PEBP2 alpha A1"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""alpha B1"", ""start_span"": 16, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""alpha B2 proteins"", ""start_span"": 30, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2 site"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""mouse GM - CSF promoter"", ""start_span"": 80, ""end_span"": 103, ""type"": ""Gene/Protein""}]"	train
The protein products of this gene contain the basic - helix - loop - helix motif characteristic of a large family of transcription factors that bind to the canonical DNA sequence CANNTG as protein heterodimers.	protein products,4,20,Gene/Protein	basic - helix - loop - helix motif,46,80,Gene/Protein	transcription factors,117,138,Gene/Protein	canonical DNA sequence CANNTG,156,185,Gene/Protein	protein heterodimers,189,209,Gene/Protein	"[{""token"": ""protein products"", ""start_span"": 4, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""basic - helix - loop - helix motif"", ""start_span"": 46, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 117, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""canonical DNA sequence CANNTG"", ""start_span"": 156, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""protein heterodimers"", ""start_span"": 189, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
Interleukin - 2 ( IL - 2) rapidly activated Stat5 in fresh PBL, and Stat3 and Stat5 in preactivated PBL.	Interleukin - 2,0,15,Gene/Protein	IL - 2,18,24,Gene/Protein	Stat5,44,49,Gene/Protein	Stat3,68,73,Gene/Protein	Stat5,78,83,Gene/Protein	"[{""token"": ""Interleukin - 2"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Gene/Protein""}]"	train
Rather, hEpoR transcription activity depends on coordination between Sp1 and GATA - 1 with other cell - specific factors, including possibly other Sp1 - like binding proteins, to provide high level, tissue - specific expression.	hEpoR,8,13,Gene/Protein	Sp1,69,72,Gene/Protein	GATA - 1,77,85,Gene/Protein	cell - specific factors,97,120,Gene/Protein	Sp1 - like binding proteins,147,174,Gene/Protein	"[{""token"": ""hEpoR"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 77, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""cell - specific factors"", ""start_span"": 97, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 - like binding proteins"", ""start_span"": 147, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
We have identified a cDNA clone, DR - nm23, differentially expressed in a blast - crisis cDNA library, which has approximately 70% sequence similarity to the putative metastatic suppressor genes, nm23 - H1 and nm23 - H2.	cDNA clone,21,31,Gene/Protein	DR - nm23,33,42,Gene/Protein	putative metastatic suppressor genes,158,194,Gene/Protein	nm23 - H1,196,205,Gene/Protein	nm23 - H2,210,219,Gene/Protein	"[{""token"": ""cDNA clone"", ""start_span"": 21, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""DR - nm23"", ""start_span"": 33, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""putative metastatic suppressor genes"", ""start_span"": 158, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""nm23 - H1"", ""start_span"": 196, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""nm23 - H2"", ""start_span"": 210, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Our results demonstrate that transcriptional regulation of the Fc gamma RIC gene by IFN - gamma involves the binding of STAT1 alpha to a 17 - bp GAS homology in the proximal promoter.	Fc gamma RIC gene,63,80,Gene/Protein	IFN - gamma,84,95,Gene/Protein	STAT1 alpha,120,131,Gene/Protein	17 - bp GAS homology,137,157,Gene/Protein	proximal promoter,165,182,Gene/Protein	"[{""token"": ""Fc gamma RIC gene"", ""start_span"": 63, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 alpha"", ""start_span"": 120, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""17 - bp GAS homology"", ""start_span"": 137, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""proximal promoter"", ""start_span"": 165, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
This inhibition was paralleled by reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar after stimulation by either IL - 1 alpha, IL - 1 beta, IL - 4, tumor necrosis factor ( TNF alpha), or bacterial lipopolysaccharide.	IL - 1 alpha,200,212,Gene/Protein	IL - 1 beta,214,225,Gene/Protein	IL - 4,227,233,Gene/Protein	tumor necrosis factor,235,256,Gene/Protein	TNF alpha,259,268,Gene/Protein	"[{""token"": ""IL - 1 alpha"", ""start_span"": 200, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 beta"", ""start_span"": 214, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 227, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 235, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""TNF alpha"", ""start_span"": 259, ""end_span"": 268, ""type"": ""Gene/Protein""}]"	train
The interleukin - 5 / receptor interaction activates Lyn and Jak2 tyrosine kinases and propagates signals via the Ras - Raf - 1 - MAP kinase and the Jak - STAT pathways in eosinophils.	interleukin - 5,4,19,Gene/Protein	Lyn and Jak2 tyrosine kinases,53,82,Gene/Protein	Ras - Raf - 1 - MAP kinase,114,140,Gene/Protein	Jak,149,152,Gene/Protein	- STAT,153,159,Gene/Protein	"[{""token"": ""interleukin - 5"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""Lyn and Jak2 tyrosine kinases"", ""start_span"": 53, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""Ras - Raf - 1 - MAP kinase"", ""start_span"": 114, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""Jak"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""- STAT"", ""start_span"": 153, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
RB and a novel E2F - 1 binding protein in MHC class II deficient B - cell lines and normal IFN - gamma induction of the class IL transactivator CIITA in class II non - inducible RB - defective tumor lines.	RB,0,2,Gene/Protein	E2F - 1 binding protein,15,38,Gene/Protein	IFN - gamma,91,102,Gene/Protein	class IL transactivator,120,143,Gene/Protein	CIITA,144,149,Gene/Protein	"[{""token"": ""RB"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 1 binding protein"", ""start_span"": 15, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""class IL transactivator"", ""start_span"": 120, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
In contrast, integrin ligation with antibodies induces tyrosine phosphorylation of Syk but not of FAK or paxillin.	integrin,13,21,Gene/Protein	antibodies,36,46,Gene/Protein	Syk,83,86,Gene/Protein	FAK,98,101,Gene/Protein	paxillin,105,113,Gene/Protein	"[{""token"": ""integrin"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""Syk"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""FAK"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""paxillin"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Gene/Protein""}]"	train
Transient transfection assays with EGR - 1 promoter fragments linked to the chloramphenicol acetyltransferase ( CAT) gene demonstrated that PWM induced EGR - 1 transcription is conferred by the CArG motif ( C C [ AT] 6GG) in the EGR - 1 promoter.	EGR - 1 promoter fragments,35,61,Gene/Protein	PWM,140,143,Gene/Protein	EGR - 1,152,159,Gene/Protein	CArG motif,194,204,Gene/Protein	EGR - 1 promoter,229,245,Gene/Protein	"[{""token"": ""EGR - 1 promoter fragments"", ""start_span"": 35, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""PWM"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""EGR - 1"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""CArG motif"", ""start_span"": 194, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""EGR - 1 promoter"", ""start_span"": 229, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
Induction of VCAM - 1 and E - selectin surface expression by TNF was dose - dependently reduced by aspirin over the same range, while induction of intercellular adhesion molecule - 1 ( ICAM - 1) was hardly affected.	VCAM - 1,13,21,Gene/Protein	E - selectin,26,38,Gene/Protein	TNF,61,64,Gene/Protein	intercellular adhesion molecule - 1,147,182,Gene/Protein	ICAM - 1,185,193,Gene/Protein	"[{""token"": ""VCAM - 1"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 26, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 147, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 185, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
rBPI21, a recombinant N - terminal fragment of human bactericidal / permeability - increasing protein ( BPI), inhibited LPS - induced E - selectin expression when added at the same time as, and up to 6 h after, LPS.	rBPI21,0,6,Gene/Protein	recombinant N - terminal fragment,10,43,Gene/Protein	human bactericidal / permeability - increasing protein,47,101,Gene/Protein	BPI,104,107,Gene/Protein	E - selectin,134,146,Gene/Protein	"[{""token"": ""rBPI21"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""recombinant N - terminal fragment"", ""start_span"": 10, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""human bactericidal / permeability - increasing protein"", ""start_span"": 47, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""BPI"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 134, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
By using recombinant proteins, we confirmed that AP - 1, NF - ATp, and a higher order NF - ATp / AP - 1 complex could all form with the hCLEO element, and we have also defined the sequence requirements for binding of each of these complexes.	recombinant proteins,9,29,Gene/Protein	AP - 1,49,55,Gene/Protein	NF - ATp,57,65,Gene/Protein	NF - ATp / AP - 1 complex,86,111,Gene/Protein	hCLEO element,136,149,Gene/Protein	"[{""token"": ""recombinant proteins"", ""start_span"": 9, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATp"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATp / AP - 1 complex"", ""start_span"": 86, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""hCLEO element"", ""start_span"": 136, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency.	MHC class II gene,6,23,Gene/Protein	carboxyl terminus,54,71,Gene/Protein	CIITA,75,80,Gene/Protein	defective genes,93,108,Gene/Protein	MHC,120,123,Gene/Protein	"[{""token"": ""MHC class II gene"", ""start_span"": 6, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""carboxyl terminus"", ""start_span"": 54, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""defective genes"", ""start_span"": 93, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""MHC"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}]"	train
The transactivation of multiple cis elements, especially S and X2, of the DR alpha proximal promoter in group II CID cells is CIITA dependent.	multiple cis elements,23,44,Gene/Protein	S,57,58,Gene/Protein	X2,63,65,Gene/Protein	DR alpha proximal promoter,74,100,Gene/Protein	CIITA,126,131,Gene/Protein	"[{""token"": ""multiple cis elements"", ""start_span"": 23, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""S"", ""start_span"": 57, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""X2"", ""start_span"": 63, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""DR alpha proximal promoter"", ""start_span"": 74, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}]"	train
Transcriptional regulation of the human alpha - like globin genes, embryonic zeta 2 and adult alpha, during erythroid development is mediated by a distal enhancer, HS - 40.	human alpha - like globin genes,34,65,Gene/Protein	embryonic zeta 2,67,83,Gene/Protein	adult alpha,88,99,Gene/Protein	distal enhancer,147,162,Gene/Protein	HS - 40,164,171,Gene/Protein	"[{""token"": ""human alpha - like globin genes"", ""start_span"": 34, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""embryonic zeta 2"", ""start_span"": 67, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""adult alpha"", ""start_span"": 88, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""distal enhancer"", ""start_span"": 147, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""HS - 40"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
Three of these HS - 40 enhancer motifs, 5 ' NF - E2 / AP1, GT II, and GATA - 1 ( c), positively regulate the zeta 2 - globin promoter activity in embryonic / fetal erythroid K562 cells and the adult alpha - globin promoter activity in adult erythroid MEL cells.	HS - 40 enhancer motifs,15,38,Gene/Protein	5 ' NF - E2 / AP1,40,57,Gene/Protein	GT II,59,64,Gene/Protein	zeta 2 - globin promoter,109,133,Gene/Protein	adult alpha - globin promoter,193,222,Gene/Protein	"[{""token"": ""HS - 40 enhancer motifs"", ""start_span"": 15, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""5 ' NF - E2 / AP1"", ""start_span"": 40, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""GT II"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""zeta 2 - globin promoter"", ""start_span"": 109, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""adult alpha - globin promoter"", ""start_span"": 193, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
Interaction between the stage selector element ( SSE) in the proximal gamma - globin promoter and hypersensitivity site 2 in the locus control region partly mediates the competitive silencing of the beta - globin promoter in the fetal developmental stage.	stage selector element,24,46,Gene/Protein	proximal gamma - globin promoter,61,93,Gene/Protein	hypersensitivity site 2,98,121,Gene/Protein	locus control region,129,149,Gene/Protein	beta - globin promoter,199,221,Gene/Protein	"[{""token"": ""stage selector element"", ""start_span"": 24, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""proximal gamma - globin promoter"", ""start_span"": 61, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""hypersensitivity site 2"", ""start_span"": 98, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""locus control region"", ""start_span"": 129, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin promoter"", ""start_span"": 199, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
Utilizing transient transfection assays in the fetal erythroid cell line, K562, we have shown that the core enhancer of hypersensitivity site 2 can preferentially interact with the proximal gamma - promoter in the absence of the SSE, completely silencing a linked beta - promoter.	core enhancer,103,116,Gene/Protein	hypersensitivity site 2,120,143,Gene/Protein	proximal gamma - promoter,181,206,Gene/Protein	SSE,229,232,Gene/Protein	linked beta - promoter,257,279,Gene/Protein	"[{""token"": ""core enhancer"", ""start_span"": 103, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""hypersensitivity site 2"", ""start_span"": 120, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""proximal gamma - promoter"", ""start_span"": 181, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""SSE"", ""start_span"": 229, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""linked beta - promoter"", ""start_span"": 257, ""end_span"": 279, ""type"": ""Gene/Protein""}]"	train
Insertion of oligonucleotides spanning the DQB X - box ( but not the DQB - W region or the DQB Y - box) upstream of - 141 in a DRA reporter plasmid rescued expression to nearly wild - type levels.	DQB X - box,43,54,Gene/Protein	DQB - W region,69,83,Gene/Protein	DQB Y - box,91,102,Gene/Protein	upstream of - 141,104,121,Gene/Protein	DRA reporter plasmid,127,147,Gene/Protein	"[{""token"": ""DQB X - box"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""DQB - W region"", ""start_span"": 69, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""DQB Y - box"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""upstream of - 141"", ""start_span"": 104, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""DRA reporter plasmid"", ""start_span"": 127, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	train
The ZEBRA activation region was replaced with the potent acid activation region from the herpes simplex virus VP16 protein or with the activation region of the EBV R protein.	ZEBRA activation region,4,27,Gene/Protein	acid activation region,57,79,Gene/Protein	herpes simplex virus VP16 protein,89,122,Gene/Protein	activation region,135,152,Gene/Protein	EBV R protein,160,173,Gene/Protein	"[{""token"": ""ZEBRA activation region"", ""start_span"": 4, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""acid activation region"", ""start_span"": 57, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""herpes simplex virus VP16 protein"", ""start_span"": 89, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""activation region"", ""start_span"": 135, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""EBV R protein"", ""start_span"": 160, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Thus, TAL1 activation in these patients may result from subtle alterations in cis - acting regulatory sequences ( affecting expression of a single TAL1 allele) or changes in trans - acting factors that control TAL1 transcription ( affecting expression of both TAL1 alleles).	TAL1,6,10,Gene/Protein	cis - acting regulatory sequences,78,111,Gene/Protein	single TAL1 allele,140,158,Gene/Protein	TAL1,210,214,Gene/Protein	TAL1 alleles,260,272,Gene/Protein	"[{""token"": ""TAL1"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""cis - acting regulatory sequences"", ""start_span"": 78, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""single TAL1 allele"", ""start_span"": 140, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""TAL1"", ""start_span"": 210, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""TAL1 alleles"", ""start_span"": 260, ""end_span"": 272, ""type"": ""Gene/Protein""}]"	train
Moreover, IL - 5 induced at least two DNA - binding complexes, using nuclear extracts from normal human eosinophils and the IL - 6 / interferon - gamma response element of the ICAM - 1 promoter ( ICAM - 1 pIRE) in an electromobility shift assay.	IL - 5,10,16,Gene/Protein	DNA - binding complexes,38,61,Gene/Protein	IL - 6 / interferon - gamma response element,124,168,Gene/Protein	ICAM - 1 promoter,176,193,Gene/Protein	ICAM - 1 pIRE,196,209,Gene/Protein	"[{""token"": ""IL - 5"", ""start_span"": 10, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding complexes"", ""start_span"": 38, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 / interferon - gamma response element"", ""start_span"": 124, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1 promoter"", ""start_span"": 176, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1 pIRE"", ""start_span"": 196, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
IL - 3 and granulocyte - macrophage colony - stimulating factor induced, similar to IL - 5, two DNA - binding complexes in human eosinophils, including Stat1 alpha.	IL - 3,0,6,Gene/Protein	granulocyte - macrophage colony - stimulating factor,11,63,Gene/Protein	IL - 5,84,90,Gene/Protein	DNA - binding complexes,96,119,Gene/Protein	Stat1 alpha,152,163,Gene/Protein	"[{""token"": ""IL - 3"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 11, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding complexes"", ""start_span"": 96, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""Stat1 alpha"", ""start_span"": 152, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
Several studies have established that Tat releases an elongation block to the transcription of HIV long terminal repeat ( LTR); however, it is not known whether this mechanism alone is sufficient to explain the block to HIV replication in human T cells when Tat is absent.	Tat,38,41,Gene/Protein	elongation block,54,70,Gene/Protein	HIV long terminal repeat,95,119,Gene/Protein	LTR,122,125,Gene/Protein	Tat,258,261,Gene/Protein	"[{""token"": ""Tat"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""elongation block"", ""start_span"": 54, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""HIV long terminal repeat"", ""start_span"": 95, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""Tat"", ""start_span"": 258, ""end_span"": 261, ""type"": ""Gene/Protein""}]"	train
CBF consists of two subunits, a DNA binding subunit, CBF alpha, and a second subunit, CBF beta, that stimulates the DNA binding activity of CBF alpha.	CBF,0,3,Gene/Protein	DNA binding subunit,32,51,Gene/Protein	CBF alpha,53,62,Gene/Protein	CBF beta,86,94,Gene/Protein	CBF alpha,140,149,Gene/Protein	"[{""token"": ""CBF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding subunit"", ""start_span"": 32, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""CBF alpha"", ""start_span"": 53, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CBF beta"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""CBF alpha"", ""start_span"": 140, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
A DNA response element ( TR2RE - SV40) for the TR2 orphan receptor, a member of the steroid - thyroid hormone receptor superfamily, has been identified in the simian virus 40 ( SV40) + 55 region ( nucleotide numbers 368 - 389, 5 ' - GTTAAGGTTCGTAGGTCATG - 3 ').	DNA response element,2,22,Gene/Protein	TR2RE - SV40,25,37,Gene/Protein	TR2 orphan receptor,47,66,Gene/Protein	steroid - thyroid hormone receptor superfamily,84,130,Gene/Protein	nucleotide numbers 368 - 389,197,225,Gene/Protein	"[{""token"": ""DNA response element"", ""start_span"": 2, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""TR2RE - SV40"", ""start_span"": 25, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""TR2 orphan receptor"", ""start_span"": 47, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""steroid - thyroid hormone receptor superfamily"", ""start_span"": 84, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""nucleotide numbers 368 - 389"", ""start_span"": 197, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	train
The previously characterized factors J kappa, PU. 1, and AML1 bind to the LMP - 1 E2RE, along with six other unidentified factors ( LBF2 to LBF7).	J kappa,37,44,Gene/Protein	AML1,57,61,Gene/Protein	LMP - 1 E2RE,74,86,Gene/Protein	LBF2,132,136,Gene/Protein	LBF7,140,144,Gene/Protein	"[{""token"": ""J kappa"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""AML1"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""LMP - 1 E2RE"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""LBF2"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""LBF7"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
LBF2 was found only in epithelial cell lines, whereas LBF3, LBF5, LBF6, and LBF7 were not cell type specific.	LBF2,0,4,Gene/Protein	LBF3,54,58,Gene/Protein	LBF5,60,64,Gene/Protein	LBF6,66,70,Gene/Protein	LBF7,76,80,Gene/Protein	"[{""token"": ""LBF2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""LBF3"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""LBF5"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""LBF6"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""LBF7"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}]"	train
LBF3, LBF5, LBF6, or LBF7 may also be involved, since their binding sites also contribute to EBNA - 2 responsiveness.	LBF3,0,4,Gene/Protein	LBF5,6,10,Gene/Protein	LBF6,12,16,Gene/Protein	LBF7,21,25,Gene/Protein	EBNA - 2,93,101,Gene/Protein	"[{""token"": ""LBF3"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""LBF5"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""LBF6"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""LBF7"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""EBNA - 2"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Gene/Protein""}]"	train
The PEBP2 alpha A and PEBP2 alpha B genes encode the DNA - binding subunit of a murine transcription factor, PEBP2, which is implicated as a T - cell - specific transcriptional regulator.	PEBP2 alpha A and PEBP2 alpha B genes,4,41,Gene/Protein	DNA - binding subunit,53,74,Gene/Protein	murine transcription factor,80,107,Gene/Protein	PEBP2,109,114,Gene/Protein	T - cell - specific transcriptional regulator,141,186,Gene/Protein	"[{""token"": ""PEBP2 alpha A and PEBP2 alpha B genes"", ""start_span"": 4, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding subunit"", ""start_span"": 53, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""murine transcription factor"", ""start_span"": 80, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""T - cell - specific transcriptional regulator"", ""start_span"": 141, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
The inducible factors NK - kappa B, beta E2, CD28RC, and AP - 1 are not expressed in resting cells and are twofold lower in anergized as compared with activated cells.	inducible factors,4,21,Gene/Protein	NK - kappa B,22,34,Gene/Protein	beta E2,36,43,Gene/Protein	CD28RC,45,51,Gene/Protein	AP - 1,57,63,Gene/Protein	"[{""token"": ""inducible factors"", ""start_span"": 4, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""NK - kappa B"", ""start_span"": 22, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""beta E2"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""CD28RC"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene/Protein""}]"	train
When the supplemented cytokine was switched from GM - CSF to EPO, hemoglobin synthesis in M - TAT / GM - CSF cells increased rapidly ( within 5 h), and the level of GATA - 1 mRNA increased.	cytokine,22,30,Gene/Protein	GM - CSF,49,57,Gene/Protein	EPO,61,64,Gene/Protein	hemoglobin,66,76,Gene/Protein	GATA - 1 mRNA,165,178,Gene/Protein	"[{""token"": ""cytokine"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""hemoglobin"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1 mRNA"", ""start_span"": 165, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
In order to investigate the mechanism of the regulation of cdc2 mRNA expression in hematopoietic cells, we isolated the 5 ' - flanking sequence of the cdc2 gene and found the putative E2F binding site at the position of nucleotides - 124 to - 117.	cdc2 mRNA,59,68,Gene/Protein	5 ' - flanking sequence,120,143,Gene/Protein	cdc2 gene,151,160,Gene/Protein	binding site,188,200,Gene/Protein	nucleotides - 124 to - 117,220,246,Gene/Protein	"[{""token"": ""cdc2 mRNA"", ""start_span"": 59, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - flanking sequence"", ""start_span"": 120, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""cdc2 gene"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""binding site"", ""start_span"": 188, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""nucleotides - 124 to - 117"", ""start_span"": 220, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
A predominance of p50 NF - kappa B moieties and possibly p50 homodimers or closely related species, rather than the p50 - p56 heterodimer of NF - kappa B that is the predominant NF - kappa B species in most T lymphocytic and monocytic cells, is demonstrated in the nuclei of U1 cells.	p50 NF - kappa B moieties,18,43,Gene/Protein	p50 homodimers,57,71,Gene/Protein	p50 - p56 heterodimer,116,137,Gene/Protein	NF - kappa B,141,153,Gene/Protein	NF - kappa B,178,190,Gene/Protein	"[{""token"": ""p50 NF - kappa B moieties"", ""start_span"": 18, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""p50 homodimers"", ""start_span"": 57, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""p50 - p56 heterodimer"", ""start_span"": 116, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 141, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 178, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
The demonstration that NF - kappa B can regulate I kappa B alpha / MAD - 3 gene transcription in other cell types suggested that the rapid increase in steady - state I kappa B alpha / MAD - 3 mRNA levels we observed within 30 min of monocyte adherence would result from NF - kappa B - dependent transcriptional stimulation of the I kappa B alpha / MAD - 3 gene.	NF - kappa B,23,35,Gene/Protein	I kappa B alpha / MAD - 3 gene,49,79,Gene/Protein	I kappa B alpha / MAD - 3 mRNA,166,196,Gene/Protein	NF - kappa B,270,282,Gene/Protein	I kappa B alpha / MAD - 3 gene,330,360,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha / MAD - 3 gene"", ""start_span"": 49, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha / MAD - 3 mRNA"", ""start_span"": 166, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 270, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha / MAD - 3 gene"", ""start_span"": 330, ""end_span"": 360, ""type"": ""Gene/Protein""}]"	train
To study this element and its role in class II gene regulation further, a cDNA library was screened with oligonucleotide probes containing both the S element and the nearby J element of the human DPA gene.	class II gene,38,51,Gene/Protein	cDNA library,74,86,Gene/Protein	S element,148,157,Gene/Protein	J element,173,182,Gene/Protein	human DPA gene,190,204,Gene/Protein	"[{""token"": ""class II gene"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""cDNA library"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""S element"", ""start_span"": 148, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""J element"", ""start_span"": 173, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""human DPA gene"", ""start_span"": 190, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	train
The 160 N - terminal amino acids in the nonfinger region of clone 18 are highly homologous with similar regions of several other human, mouse, and Drosophila sequences, defining a subfamily of Kruppel - like zinc finger proteins termed TAB ( tramtrack [ ttk] - associated box) here.	160 N - terminal amino acids,4,32,Gene/Protein	nonfinger region,40,56,Gene/Protein	clone 18,60,68,Gene/Protein	zinc finger proteins,208,228,Gene/Protein	TAB,236,239,Gene/Protein	"[{""token"": ""160 N - terminal amino acids"", ""start_span"": 4, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""nonfinger region"", ""start_span"": 40, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""clone 18"", ""start_span"": 60, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger proteins"", ""start_span"": 208, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""TAB"", ""start_span"": 236, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP - 1, Oct - 2, and retinoic acid receptor.	composite octamer motif,40,63,Gene/Protein	interleukin 2 enhancer,71,93,Gene/Protein	AP - 1,97,103,Gene/Protein	Oct - 2,105,112,Gene/Protein	retinoic acid receptor,118,140,Gene/Protein	"[{""token"": ""composite octamer motif"", ""start_span"": 40, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2 enhancer"", ""start_span"": 71, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""retinoic acid receptor"", ""start_span"": 118, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
The truncation resulted from limited proteolysis of p65 during cellular extraction which released particular lysosomal serine proteases, such as elastase, cathepsin G, and proteinase 3.	p65,52,55,Gene/Protein	lysosomal serine proteases,109,135,Gene/Protein	elastase,145,153,Gene/Protein	cathepsin G,155,166,Gene/Protein	proteinase 3,172,184,Gene/Protein	"[{""token"": ""p65"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""lysosomal serine proteases"", ""start_span"": 109, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""elastase"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""cathepsin G"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""proteinase 3"", ""start_span"": 172, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
Recent biochemical and genetic studies indicate that in addition to the octamer - binding proteins Oct - 1 and Oct - 2, other B cell components are required for lymphoid - restricted, octamer site - mediated immunoglobulin gene promoter activity.	octamer - binding proteins,72,98,Gene/Protein	Oct - 1,99,106,Gene/Protein	Oct - 2,111,118,Gene/Protein	B cell components,126,143,Gene/Protein	immunoglobulin gene promoter,208,236,Gene/Protein	"[{""token"": ""octamer - binding proteins"", ""start_span"": 72, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""B cell components"", ""start_span"": 126, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin gene promoter"", ""start_span"": 208, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
Using a genetic screen in yeast, we have isolated B cell - derived cDNAs encoding Oct - binding factor 1 ( OBF - 1), a novel protein that specifically associates with Oct - 1 and Oct - 2.	B cell - derived cDNAs,50,72,Gene/Protein	Oct - binding factor 1,82,104,Gene/Protein	OBF - 1,107,114,Gene/Protein	Oct - 1,167,174,Gene/Protein	Oct - 2,179,186,Gene/Protein	"[{""token"": ""B cell - derived cDNAs"", ""start_span"": 50, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""Oct - binding factor 1"", ""start_span"": 82, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""OBF - 1"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 167, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 179, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
Increased [ Ca2 +] i activates Ca2 + / calmodulin - dependent kinases including the multifunctional Ca2 + / calmodulin - dependent protein kinase II ( CaM - K II), as well as calcineurin, a type 2B protein phosphatase.	Ca2 + / calmodulin - dependent kinases,31,69,Gene/Protein	Ca2 + / calmodulin - dependent protein kinase II,100,148,Gene/Protein	CaM - K II,151,161,Gene/Protein	calcineurin,175,186,Gene/Protein	type 2B protein phosphatase,190,217,Gene/Protein	"[{""token"": ""Ca2 + / calmodulin - dependent kinases"", ""start_span"": 31, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Ca2 + / calmodulin - dependent protein kinase II"", ""start_span"": 100, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""CaM - K II"", ""start_span"": 151, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 175, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""type 2B protein phosphatase"", ""start_span"": 190, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	train
Induction of ICAM - 1 and LFA - 3 by Tax1 of human T - cell leukemia virus type 1 and mechanism of down - regulation of ICAM - 1 or LFA - 1 in adult - T - cell - leukemia cell lines.	ICAM - 1,13,21,Gene/Protein	LFA - 3,26,33,Gene/Protein	Tax1,37,41,Gene/Protein	ICAM - 1,120,128,Gene/Protein	LFA - 1,132,139,Gene/Protein	"[{""token"": ""ICAM - 1"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""LFA - 3"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""Tax1"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""LFA - 1"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
The present study was undertaken to determine the role of HTLV - I TaxI in the up - regulation of ICAM - I and LFA - 3 in human T cells transformed with HTLV - I and the mechanism of down - regulation of ICAM - I and LFA - I in ATL - derived cell lines.	HTLV - I TaxI,58,71,Gene/Protein	ICAM - I,98,106,Gene/Protein	LFA - 3,111,118,Gene/Protein	ICAM - I,204,212,Gene/Protein	LFA - I,217,224,Gene/Protein	"[{""token"": ""HTLV - I TaxI"", ""start_span"": 58, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - I"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""LFA - 3"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - I"", ""start_span"": 204, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""LFA - I"", ""start_span"": 217, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
Western blot and phosphorylation analyses demonstrate that the synergistic effect on NF - kappa B functional activity is independent of I kappa B alpha ( MAD3) - NF - kappa B dissociation in the cytosol and is not associated with I kappa B nuclear translocation.	NF - kappa B,85,97,Gene/Protein	I kappa B alpha,136,151,Gene/Protein	MAD3,154,158,Gene/Protein	NF - kappa B,162,174,Gene/Protein	I kappa B,230,239,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 136, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""MAD3"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 162, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 230, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Antigen receptor signals prolong NF - kappa B - DNA interaction, probably by functionally antagonizing the IL - 1 - induced synthesis of a protein ( s) responsible for the transient NF - kappa B - DNA interaction and consequently synergistically enhance IL - 1 - induced NF - kappa B - dependent gene transcription.	NF - kappa B,33,45,Gene/Protein	IL - 1,107,113,Gene/Protein	NF - kappa B,182,194,Gene/Protein	IL - 1,254,260,Gene/Protein	NF - kappa B,271,283,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 33, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 182, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 254, ""end_span"": 260, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 271, ""end_span"": 283, ""type"": ""Gene/Protein""}]"	train
The human platelet - activating factor receptor ( PAFR) gene is transcribed by two distinct promoters ( promoter 1 and promoter 2) to generate two transcripts ( designated as PAFR transcript 1 and PAFR transcript 2), though their open reading frames are identical.	promoters,92,101,Gene/Protein	promoter 1,104,114,Gene/Protein	promoter 2,119,129,Gene/Protein	PAFR transcript 1,175,192,Gene/Protein	PAFR transcript 2,197,214,Gene/Protein	"[{""token"": ""promoters"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""promoter 1"", ""start_span"": 104, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""promoter 2"", ""start_span"": 119, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""PAFR transcript 1"", ""start_span"": 175, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""PAFR transcript 2"", ""start_span"": 197, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
By primer extension analysis to discriminate two transcripts, we found that the levels of PAFR transcript 1 ( leukocyte - type), but not PAFR transcript 2 ( tissue - type), are upregulated by PAF as well as by 12 - O - tetradecanoylphorbol - 13 - acetate ( TPA) in the human stomach cancer cell line ( JR - St cells) which expresses both functional PAFR transcript 1 and PAFR transcript 2 endogenously.	PAFR transcript 1,90,107,Gene/Protein	PAFR transcript 2,137,154,Gene/Protein	PAF,192,195,Gene/Protein	PAFR transcript 1,349,366,Gene/Protein	PAFR transcript 2,371,388,Gene/Protein	"[{""token"": ""PAFR transcript 1"", ""start_span"": 90, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""PAFR transcript 2"", ""start_span"": 137, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""PAFR transcript 1"", ""start_span"": 349, ""end_span"": 366, ""type"": ""Gene/Protein""}, {""token"": ""PAFR transcript 2"", ""start_span"": 371, ""end_span"": 388, ""type"": ""Gene/Protein""}]"	train
Functional analysis of the promoter 1 with a transient expression assay using chloramphenicol acetyltransferase ( CAT) gene as a reporter showed that both PAF and TPA activated the promoter 1 but not the deleted promoter lacking the three consensus binding sites for NF - kappa B located from - 571 bp to - 459 bp.	promoter 1,27,37,Gene/Protein	PAF,155,158,Gene/Protein	promoter 1,181,191,Gene/Protein	consensus binding sites,239,262,Gene/Protein	NF - kappa B,267,279,Gene/Protein	"[{""token"": ""promoter 1"", ""start_span"": 27, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""promoter 1"", ""start_span"": 181, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""consensus binding sites"", ""start_span"": 239, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 267, ""end_span"": 279, ""type"": ""Gene/Protein""}]"	train
Our results define the NF - kappa B system as an intermediate event in CD40 signaling and suggest that the CD40 pathway can influence the expression of B cell - associated genes with NF - kappa B consensus sites.	NF - kappa B,23,35,Gene/Protein	CD40,71,75,Gene/Protein	CD40,107,111,Gene/Protein	B cell - associated genes,152,177,Gene/Protein	NF - kappa B consensus sites,183,211,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""B cell - associated genes"", ""start_span"": 152, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B consensus sites"", ""start_span"": 183, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Co - stimulation of T - lymphocytes by T - cell receptor ( TcR) occupancy and activation of the CD28 surface molecule results in enhanced proliferation and interleukin 2 ( IL - 2) production.	T - cell receptor,39,56,Gene/Protein	TcR,59,62,Gene/Protein	CD28 surface molecule,96,117,Gene/Protein	interleukin 2,156,169,Gene/Protein	IL - 2,172,178,Gene/Protein	"[{""token"": ""T - cell receptor"", ""start_span"": 39, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""TcR"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CD28 surface molecule"", ""start_span"": 96, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2"", ""start_span"": 156, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Calcineurin activates transcription from the GM - CSF promoter in synergy with either protein kinase C or NF - kappa B / AP - 1 in T cells.	Calcineurin,0,11,Gene/Protein	GM - CSF promoter,45,62,Gene/Protein	protein kinase C,86,102,Gene/Protein	NF - kappa B,106,118,Gene/Protein	/ AP - 1,119,127,Gene/Protein	"[{""token"": ""Calcineurin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF promoter"", ""start_span"": 45, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 86, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 106, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""/ AP - 1"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Gene/Protein""}]"	train
Expression of a constitutively active calcineurin ( CN), a Ca2 + / calmodulin - dependent protein phosphatase, potentiated by two fold the transcriptional activation by NF - kappa B / AP - 1.	calcineurin,38,49,Gene/Protein	CN,52,54,Gene/Protein	Ca2 + / calmodulin - dependent protein phosphatase,59,109,Gene/Protein	NF - kappa B,169,181,Gene/Protein	/ AP - 1,182,190,Gene/Protein	"[{""token"": ""calcineurin"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""CN"", ""start_span"": 52, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Ca2 + / calmodulin - dependent protein phosphatase"", ""start_span"": 59, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 169, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""/ AP - 1"", ""start_span"": 182, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
Based on sequence homology we identified two binding motifs for Pit - 1 and seven half - sites for glucocorticoid receptor / progesterone receptor ( PR) binding.	binding motifs,45,59,Gene/Protein	Pit - 1,64,71,Gene/Protein	half - sites,82,94,Gene/Protein	glucocorticoid receptor / progesterone receptor,99,146,Gene/Protein	PR,149,151,Gene/Protein	"[{""token"": ""binding motifs"", ""start_span"": 45, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""Pit - 1"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""half - sites"", ""start_span"": 82, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""glucocorticoid receptor / progesterone receptor"", ""start_span"": 99, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""PR"", ""start_span"": 149, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	train
Mouse thymoma line EL - 4 cells produce cytokines such as interleukin ( IL) - 2, IL - 3, IL - 4, IL - 10, and granulocyte - macrophage colony - stimulating factor in response to phorbol 12 - myristate 13 - acetate ( PMA).	cytokines,40,49,Gene/Protein	IL - 3,81,87,Gene/Protein	IL - 4,89,95,Gene/Protein	IL - 10,97,104,Gene/Protein	granulocyte - macrophage colony - stimulating factor,110,162,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 40, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 110, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
In electromobility shift assays both NF - kappa B ( P65 or P65 / P50 heterodimer) and NF - AT bound to the P sequence.	NF - kappa B,37,49,Gene/Protein	P65,52,55,Gene/Protein	P65 / P50 heterodimer,59,80,Gene/Protein	NF - AT,86,93,Gene/Protein	P sequence,107,117,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""P65"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""P65 / P50 heterodimer"", ""start_span"": 59, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""P sequence"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
Similar to its effect on IL - 2 induction, cyclosporin A ( CsA) inhibited the synergistic activation of JNK, and a competitive inhibitor of Jun phosphorylation by JNK inhibited IL - 2 promoter activation.	IL - 2,25,31,Gene/Protein	JNK,104,107,Gene/Protein	Jun,140,143,Gene/Protein	JNK,163,166,Gene/Protein	IL - 2 promoter,177,192,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 177, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
RESULTS: BZLF1 ( ZEBRA) or early gene products ( EA - R and EA - D / BHLF1 / NotI) were detected in a small proportion ( < 0. 01 - 5%) of tumour cells in eight of these 17 cases by immunohistochemistry and in situ hybridization.	BZLF1,9,14,Gene/Protein	ZEBRA,17,22,Gene/Protein	early gene products,27,46,Gene/Protein	EA - R,49,55,Gene/Protein	EA - D / BHLF1 / NotI,60,81,Gene/Protein	"[{""token"": ""BZLF1"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""ZEBRA"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""early gene products"", ""start_span"": 27, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""EA - R"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""EA - D / BHLF1 / NotI"", ""start_span"": 60, ""end_span"": 81, ""type"": ""Gene/Protein""}]"	train
When cells were stimulated with anti - CD3 mAb or PMA / A23187, a complex formation of NF - kappa B ( p50 / p65) heterodimer with the kappa B sequence was induced.	anti - CD3 mAb,32,46,Gene/Protein	NF - kappa B,87,99,Gene/Protein	p50,102,105,Gene/Protein	/ p65,106,111,Gene/Protein	kappa B sequence,134,150,Gene/Protein	"[{""token"": ""anti - CD3 mAb"", ""start_span"": 32, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""/ p65"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""kappa B sequence"", ""start_span"": 134, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
Characterization of NF ( P), the nuclear factor that interacts with the regulatory P sequence ( 5 ' - CGAAAATTTCC - 3 ') of the human interleukin - 4 gene: relationship to NF - kappa B and NF - AT.	nuclear factor,33,47,Gene/Protein	P sequence,83,93,Gene/Protein	human interleukin - 4 gene,128,154,Gene/Protein	NF - kappa B,172,184,Gene/Protein	NF - AT,189,196,Gene/Protein	"[{""token"": ""nuclear factor"", ""start_span"": 33, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""P sequence"", ""start_span"": 83, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""human interleukin - 4 gene"", ""start_span"": 128, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 172, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
Cell adhesion to endothelial cells stimulated by tumor necrosis factor - alpha ( TNF) is due to induction of surface receptors, such as vascular cell adhesion molecule - 1 ( VCAM - 1).	stimulated by tumor necrosis factor - alpha,35,78,Gene/Protein	TNF,81,84,Gene/Protein	surface receptors,109,126,Gene/Protein	vascular cell adhesion molecule - 1,136,171,Gene/Protein	VCAM - 1,174,182,Gene/Protein	"[{""token"": ""stimulated by tumor necrosis factor - alpha"", ""start_span"": 35, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""surface receptors"", ""start_span"": 109, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 136, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 174, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
Activation of the enhancer in non - B cells upon overexpression of the basic helix - loop - helix ( bHLH) protein E2A appears to be mediated not only by the binding of E2A to its cognate E box but also by the resulting displacement of a repressor from that same site.	enhancer,18,26,Gene/Protein	E2A,114,117,Gene/Protein	E2A,168,171,Gene/Protein	E box,187,192,Gene/Protein	repressor,237,246,Gene/Protein	"[{""token"": ""enhancer"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 168, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""E box"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""repressor"", ""start_span"": 237, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
It is suggested that constitutive expression of c - myb mRNA is necessary for Hm - induced differentiation, and that a decrease in the amount of c - myb mRNA induced by antisense myb RNA expression suppresses Hm - induced differentiation.	c - myb mRNA,48,60,Gene/Protein	Hm,78,80,Gene/Protein	c - myb mRNA,145,157,Gene/Protein	antisense myb RNA,169,186,Gene/Protein	Hm,209,211,Gene/Protein	"[{""token"": ""c - myb mRNA"", ""start_span"": 48, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""Hm"", ""start_span"": 78, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""c - myb mRNA"", ""start_span"": 145, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""antisense myb RNA"", ""start_span"": 169, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""Hm"", ""start_span"": 209, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Both LAM - and LPS - inducible IL - 6 promoter activity was localized to a DNA fragment, positions - 158 to - 49, by deletion analysis and chloramphenicol acetyltransferase assay.	LAM,5,8,Gene/Protein	LPS - inducible IL - 6 promoter,15,46,Gene/Protein	DNA fragment,75,87,Gene/Protein	- 158 to - 49,99,112,Gene/Protein	chloramphenicol acetyltransferase,139,172,Gene/Protein	"[{""token"": ""LAM"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""LPS - inducible IL - 6 promoter"", ""start_span"": 15, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""DNA fragment"", ""start_span"": 75, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""- 158 to - 49"", ""start_span"": 99, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase"", ""start_span"": 139, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
Both wild - type and chimeric HLF proteins displayed transcriptional activator properties in lymphoid and nonlymphoid cells on reporter genes containing HLF or C / EBP consensus binding sites.	wild - type,5,16,Gene/Protein	chimeric HLF proteins,21,42,Gene/Protein	transcriptional activator,53,78,Gene/Protein	reporter genes,127,141,Gene/Protein	HLF or C / EBP consensus binding sites,153,191,Gene/Protein	"[{""token"": ""wild - type"", ""start_span"": 5, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""chimeric HLF proteins"", ""start_span"": 21, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activator"", ""start_span"": 53, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""reporter genes"", ""start_span"": 127, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""HLF or C / EBP consensus binding sites"", ""start_span"": 153, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
Here we report the characterization of a nuclear complex from human monocytic cells that bound to a kappa B - like site, 5 ' - CGGAGTTTCC - 3 ', in the 5 ' - flanking region of the human TF gene.	nuclear complex,41,56,Gene/Protein	kappa B - like site,100,119,Gene/Protein	5 ' - CGGAGTTTCC - 3 ',121,143,Gene/Protein	5 ' - flanking region,152,173,Gene/Protein	human TF gene,181,194,Gene/Protein	"[{""token"": ""nuclear complex"", ""start_span"": 41, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - like site"", ""start_span"": 100, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - CGGAGTTTCC - 3 '"", ""start_span"": 121, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - flanking region"", ""start_span"": 152, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""human TF gene"", ""start_span"": 181, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
We show here that soluble TN inhibits proliferation of human T cells in response to alpha CD3 Ab co - immobilized with the extracellular matrix protein fibronectin ( FN).	TN,26,28,Gene/Protein	alpha CD3 Ab,84,96,Gene/Protein	extracellular matrix protein,123,151,Gene/Protein	fibronectin,152,163,Gene/Protein	FN,166,168,Gene/Protein	"[{""token"": ""TN"", ""start_span"": 26, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""alpha CD3 Ab"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""extracellular matrix protein"", ""start_span"": 123, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 152, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 166, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
Human immunodeficiency virus type 1 ( HIV - 1) negative factor ( Nef) has been shown to down - regulate the transcription factors NF - kappa B and AP - 1 in vitro.	negative factor,47,62,Gene/Protein	Nef,65,68,Gene/Protein	transcription factors,108,129,Gene/Protein	NF - kappa B,130,142,Gene/Protein	AP - 1,147,153,Gene/Protein	"[{""token"": ""negative factor"", ""start_span"": 47, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""Nef"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 108, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 130, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
Because the Nef protein does not affect the surface expression of the CD3 - TCR complex, we conclude that the Nef protein down - regulates the transcriptional factors NF - kappa B and AP - 1 in T cells in vitro through an effect on the TCR - dependent signal transduction pathway.	Nef,12,15,Gene/Protein	CD3,70,73,Gene/Protein	Nef,110,113,Gene/Protein	NF - kappa B,167,179,Gene/Protein	AP - 1,184,190,Gene/Protein	"[{""token"": ""Nef"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Nef"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 167, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
The AP - 1 complex consists of distinct protein heterodimers encoded by the proto - oncogene c - fos and c - jun mRNA whose gene expression can be induced by TPA, cyclic AMP and growth factors.	AP - 1,4,10,Gene/Protein	protein heterodimers,40,60,Gene/Protein	proto - oncogene c - fos,76,100,Gene/Protein	c - jun mRNA,105,117,Gene/Protein	growth factors,178,192,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""protein heterodimers"", ""start_span"": 40, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""proto - oncogene c - fos"", ""start_span"": 76, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""c - jun mRNA"", ""start_span"": 105, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""growth factors"", ""start_span"": 178, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
The regulation of interleukin - 2 receptor alpha chain ( IL - 2R alpha) expression and nuclear factor ( NF) activation by protein kinase C ( PKC) in resting T cells, has been studied.	interleukin - 2 receptor alpha chain,18,54,Gene/Protein	IL - 2R alpha,57,70,Gene/Protein	nuclear factor,87,101,Gene/Protein	protein kinase C,122,138,Gene/Protein	PKC,141,144,Gene/Protein	"[{""token"": ""interleukin - 2 receptor alpha chain"", ""start_span"": 18, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 57, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor"", ""start_span"": 87, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 122, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
Human interleukin - 13 activates the interleukin - 4 - dependent transcription factor NF - IL4 sharing a DNA binding motif with an interferon - gamma - induced nuclear binding factor.	Human interleukin - 13,0,22,Gene/Protein	interleukin - 4 - dependent transcription factor,37,85,Gene/Protein	NF - IL4,86,94,Gene/Protein	DNA binding motif,105,122,Gene/Protein	interferon - gamma - induced nuclear binding factor,131,182,Gene/Protein	"[{""token"": ""Human interleukin - 13"", ""start_span"": 0, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 4 - dependent transcription factor"", ""start_span"": 37, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL4"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding motif"", ""start_span"": 105, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""interferon - gamma - induced nuclear binding factor"", ""start_span"": 131, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
We provide evidence that in monocytes as well as in T lymphocytes both IL - 4 and IL - 13 activate the same recently identified transcription factor NF - IL4 which binds to the specific responsive element IL - 4RE.	IL - 4,71,77,Gene/Protein	IL - 13,82,89,Gene/Protein	transcription factor,128,148,Gene/Protein	NF - IL4,149,157,Gene/Protein	specific responsive element IL - 4RE,177,213,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 128, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL4"", ""start_span"": 149, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""specific responsive element IL - 4RE"", ""start_span"": 177, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
Although these heterodimers do not recognize a classical thyroid hormone response element ( TRE) characterized by direct repeat separated by four nucleotides ( DR + 4), PPAR behaves as a dominant negative regulator of thyroid hormone ( TH) action.	heterodimers,15,27,Gene/Protein	thyroid hormone response element,57,89,Gene/Protein	TRE,92,95,Gene/Protein	DR + 4,160,166,Gene/Protein	PPAR,169,173,Gene/Protein	"[{""token"": ""heterodimers"", ""start_span"": 15, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""thyroid hormone response element"", ""start_span"": 57, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""TRE"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""DR + 4"", ""start_span"": 160, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""PPAR"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
A 55 - kDa isoform, I kappa B gamma - 2, lacks the 190 C - terminal amino acids of p70 I kappa B gamma.	55 - kDa isoform,2,18,Gene/Protein	I kappa B gamma - 2,20,39,Gene/Protein	190 C - terminal amino acids,51,79,Gene/Protein	p70,83,86,Gene/Protein	I kappa B gamma,87,102,Gene/Protein	"[{""token"": ""55 - kDa isoform"", ""start_span"": 2, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma - 2"", ""start_span"": 20, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""190 C - terminal amino acids"", ""start_span"": 51, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""p70"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma"", ""start_span"": 87, ""end_span"": 102, ""type"": ""Gene/Protein""}]"	train
In contrast to p70 I kappa B gamma, which is a cytoplasmic protein, I kappa B gamma - 1 is found in both the cytoplasm and nucleus, whereas I kappa B gamma - 2 is predominantly nuclear.	p70,15,18,Gene/Protein	I kappa B gamma,19,34,Gene/Protein	cytoplasmic protein,47,66,Gene/Protein	I kappa B gamma - 1,68,87,Gene/Protein	I kappa B gamma - 2,140,159,Gene/Protein	"[{""token"": ""p70"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma"", ""start_span"": 19, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic protein"", ""start_span"": 47, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma - 1"", ""start_span"": 68, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma - 2"", ""start_span"": 140, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
While p70 I kappa B gamma inhibits p50 -, p65 -, and c - Rel - mediated transactivation and / or DNA binding, both I kappa B gamma - 1 and I kappa B gamma - 2 are specific for p50 and have different affinities for this subunit.	p70,6,9,Gene/Protein	I kappa B gamma,10,25,Gene/Protein	I kappa B gamma - 1,115,134,Gene/Protein	I kappa B gamma - 2,139,158,Gene/Protein	p50,176,179,Gene/Protein	"[{""token"": ""p70"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma"", ""start_span"": 10, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma - 1"", ""start_span"": 115, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma - 2"", ""start_span"": 139, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
Two anti - MHC class II Ab, L227 and 2. 06, inhibited the growth of B104 cells, although 2. 06, but not L227, needed to be further cross - linked with a goat anti - mouse IgG Ab ( GAM) to show the effect.	anti - MHC class II Ab,4,26,Gene/Protein	L227,28,32,Gene/Protein	L227,104,108,Gene/Protein	goat anti - mouse IgG Ab,153,177,Gene/Protein	GAM,180,183,Gene/Protein	"[{""token"": ""anti - MHC class II Ab"", ""start_span"": 4, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""L227"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""L227"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""goat anti - mouse IgG Ab"", ""start_span"": 153, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""GAM"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
Elements necessary for the steroid hormone 1 alpha, 25 - dihydroxyvitamin D3 ( 1 alpha, 25 - ( OH) 2D3) to induce a biological response include the presence of specific intracellular receptors ( vitamin D3 receptors ( VDR)) and modulation of gene expression via hormone - activated receptor binding to regulatory regions of target genes.	intracellular receptors,169,192,Gene/Protein	vitamin D3 receptors,195,215,Gene/Protein	VDR,218,221,Gene/Protein	regulatory regions,302,320,Gene/Protein	target genes,324,336,Gene/Protein	"[{""token"": ""intracellular receptors"", ""start_span"": 169, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""vitamin D3 receptors"", ""start_span"": 195, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""VDR"", ""start_span"": 218, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""regulatory regions"", ""start_span"": 302, ""end_span"": 320, ""type"": ""Gene/Protein""}, {""token"": ""target genes"", ""start_span"": 324, ""end_span"": 336, ""type"": ""Gene/Protein""}]"	train
Two other sites display disparate effects on IL - 2 gene expression in different T leukemia cell lines: the distal purine box ( - 291 to - 277) and the proximal purine box sites ( - 145 to - 128).	IL - 2 gene,45,56,Gene/Protein	distal purine box,108,125,Gene/Protein	- 291 to - 277,128,142,Gene/Protein	proximal purine box sites,152,177,Gene/Protein	- 145 to - 128,180,194,Gene/Protein	"[{""token"": ""IL - 2 gene"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""distal purine box"", ""start_span"": 108, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""- 291 to - 277"", ""start_span"": 128, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""proximal purine box sites"", ""start_span"": 152, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""- 145 to - 128"", ""start_span"": 180, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
CD14 Sp1 site oligonucleotides bound preferentially to a 105 - kDa Sp1 species, which is present in higher relative levels in monocytic than non - monocytic cells, suggesting that modification of Sp1, such as phosphorylation, may explain how the Sp1 site mediates monocytic specific promoter activity.	CD14,0,4,Gene/Protein	Sp1,5,8,Gene/Protein	105 - kDa Sp1 species,57,78,Gene/Protein	Sp1,196,199,Gene/Protein	Sp1,246,249,Gene/Protein	"[{""token"": ""CD14"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""105 - kDa Sp1 species"", ""start_span"": 57, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 246, ""end_span"": 249, ""type"": ""Gene/Protein""}]"	train
Furthermore, we confirmed the previous report that FK506 suppressed the PMA / ionomycin - induced activation through authentic kappa B site of immunoglobulin ( Ig) gene, to which NF - kappa B binding was also decreased by FK506, indicating that both IL - 8 kappa B - like site and Ig kappa B site are FK506 - sensitive in spite of the difference of binding factors.	kappa B site,127,139,Gene/Protein	NF - kappa B,179,191,Gene/Protein	IL - 8 kappa B - like site,250,276,Gene/Protein	kappa B site,284,296,Gene/Protein	binding factors,349,364,Gene/Protein	"[{""token"": ""kappa B site"", ""start_span"": 127, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 179, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8 kappa B - like site"", ""start_span"": 250, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""kappa B site"", ""start_span"": 284, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""binding factors"", ""start_span"": 349, ""end_span"": 364, ""type"": ""Gene/Protein""}]"	train
Our results indicate that not only the reported IL - 2 NF - AT and NFIL - 2A sites and Ig kappa B site, but also the IL - 8 AP - 1 and kappa B - like sites are terminals of FK506 - sensitive pathway involving Ca2 + mobilization.	IL - 2 NF - AT and NFIL - 2A sites,48,82,Gene/Protein	kappa B site,90,102,Gene/Protein	IL - 8,117,123,Gene/Protein	AP - 1,124,130,Gene/Protein	kappa B - like sites,135,155,Gene/Protein	"[{""token"": ""IL - 2 NF - AT and NFIL - 2A sites"", ""start_span"": 48, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""kappa B site"", ""start_span"": 90, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - like sites"", ""start_span"": 135, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	train
The binding sites fulfil the required criteria for specific steroid binding sites however differ somewhat from the classic androgen receptors from genital skin fibroblast: in fertile adult males ( n = 20) the binding sites showed ( 1) a high affinity for testosterone ( 1. 32 + / - 0. 49 nM; mean + / - SD), ( 2) a saturable capacity ( 184 + / - 52 binding sites per cell; mean + / - SD), and ( 3) a characteristic competitive binding profile for other steroid hormones ( relative binding affinities: testosterone = dihydrotestosterone > 17 beta - estradiol > progesterone, whereas aldosterone, 17 - hydroxy - progesterone and cortisol did not compete appreciably).	binding sites,4,17,Gene/Protein	steroid binding sites,60,81,Gene/Protein	androgen receptors,123,141,Gene/Protein	binding sites,209,222,Gene/Protein	binding sites,349,362,Gene/Protein	"[{""token"": ""binding sites"", ""start_span"": 4, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""steroid binding sites"", ""start_span"": 60, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""androgen receptors"", ""start_span"": 123, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 209, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 349, ""end_span"": 362, ""type"": ""Gene/Protein""}]"	train
Sequence homology, single nucleotide mutations, and anti - CD28 Ab stimulation studies established that the NF - kappa B - like sequence in the promoter of the IL - 8 gene functioned as a CD28 response element.	anti - CD28 Ab,52,66,Gene/Protein	NF - kappa B - like sequence,108,136,Gene/Protein	promoter,144,152,Gene/Protein	IL - 8 gene,160,171,Gene/Protein	CD28 response element,188,209,Gene/Protein	"[{""token"": ""anti - CD28 Ab"", ""start_span"": 52, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B - like sequence"", ""start_span"": 108, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8 gene"", ""start_span"": 160, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""CD28 response element"", ""start_span"": 188, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
We have examined the possibility that stimulation of phospholipase D ( PLD) may regulate activation of transcription factor AP - 1 in human T cells by transfecting human T lymphocyte Jurkat cells with a plasmid containing an AP - 1 enhancer element and a chloramphenicol acetyltransferase reporter gene.	phospholipase D,53,68,Gene/Protein	PLD,71,74,Gene/Protein	transcription factor AP - 1,103,130,Gene/Protein	AP - 1 enhancer element,225,248,Gene/Protein	chloramphenicol acetyltransferase reporter gene,255,302,Gene/Protein	"[{""token"": ""phospholipase D"", ""start_span"": 53, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""PLD"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor AP - 1"", ""start_span"": 103, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 enhancer element"", ""start_span"": 225, ""end_span"": 248, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase reporter gene"", ""start_span"": 255, ""end_span"": 302, ""type"": ""Gene/Protein""}]"	train
The increases in AP - 1 enhancer activity induced by PA or anti - CD3 mAb were efficiently abrogated by the presence of propranolol, an inhibitor of PA phosphohydrolase and protein kinase C ( PKC).	AP - 1 enhancer,17,32,Gene/Protein	anti - CD3 mAb,59,73,Gene/Protein	phosphohydrolase,152,168,Gene/Protein	protein kinase C,173,189,Gene/Protein	PKC,192,195,Gene/Protein	"[{""token"": ""AP - 1 enhancer"", ""start_span"": 17, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3 mAb"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""phosphohydrolase"", ""start_span"": 152, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 173, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Upregulation of bcl - 2 by the Epstein - Barr virus latent membrane protein LMP1: a B - cell - specific response that is delayed relative to NF - kappa B activation and to induction of cell surface markers.	bcl - 2,16,23,Gene/Protein	Epstein - Barr virus latent membrane protein,31,75,Gene/Protein	LMP1,76,80,Gene/Protein	NF - kappa B,141,153,Gene/Protein	cell surface markers,185,205,Gene/Protein	"[{""token"": ""bcl - 2"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""Epstein - Barr virus latent membrane protein"", ""start_span"": 31, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 141, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""cell surface markers"", ""start_span"": 185, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
Although two cases expressed CD4, no case expressed CD2, CD3, or CD8 and no case showed clonal rearrangement of genes encoding the T - cell receptor ( TCR beta, gamma, delta).	CD4,29,32,Gene/Protein	CD2,52,55,Gene/Protein	CD3,57,60,Gene/Protein	CD8,65,68,Gene/Protein	T - cell receptor,131,148,Gene/Protein	"[{""token"": ""CD4"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""CD8"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""T - cell receptor"", ""start_span"": 131, ""end_span"": 148, ""type"": ""Gene/Protein""}]"	train
IL - 1 beta and IL - 6 genes contain AP - 1 binding sites as regulatory elements, the AP - 1 protein being composed of c - jun and c - fos gene products.	IL - 1 beta and IL - 6 genes,0,28,Gene/Protein	AP - 1 binding sites,37,57,Gene/Protein	regulatory elements,61,80,Gene/Protein	AP - 1,86,92,Gene/Protein	c - jun and c - fos gene products,119,152,Gene/Protein	"[{""token"": ""IL - 1 beta and IL - 6 genes"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 binding sites"", ""start_span"": 37, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""regulatory elements"", ""start_span"": 61, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""c - jun and c - fos gene products"", ""start_span"": 119, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
Deletion analyses of the pCD41 ORF - A and the use of promoter constructs further mapped an internal functional promoter within the pCD41 sequence that can direct the synthesis of the trans - activating protein.	pCD41,25,30,Gene/Protein	ORF - A,31,38,Gene/Protein	promoter constructs,54,73,Gene/Protein	pCD41,132,137,Gene/Protein	trans - activating protein,184,210,Gene/Protein	"[{""token"": ""pCD41"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""ORF - A"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""promoter constructs"", ""start_span"": 54, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""pCD41"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""trans - activating protein"", ""start_span"": 184, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
Analysis of truncated LTRs confirmed that inhibition of LTR activation was not mediated through NF - kappa B - binding activity but through the region containing the negative responding elements ( NREs).	LTRs,22,26,Gene/Protein	LTR,56,59,Gene/Protein	NF - kappa B,96,108,Gene/Protein	negative responding elements,166,194,Gene/Protein	NREs,197,201,Gene/Protein	"[{""token"": ""LTRs"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 96, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""negative responding elements"", ""start_span"": 166, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""NREs"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
Overproduction of NFKB2 ( lyt - 10) and c - Rel: a mechanism for HTLV - I Tax - mediated trans - activation via the NF - kappa B signalling pathway.	NFKB2,18,23,Gene/Protein	lyt - 10,26,34,Gene/Protein	c - Rel,40,47,Gene/Protein	HTLV - I Tax,65,77,Gene/Protein	NF - kappa B,116,128,Gene/Protein	"[{""token"": ""NFKB2"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""lyt - 10"", ""start_span"": 26, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""HTLV - I Tax"", ""start_span"": 65, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 116, ""end_span"": 128, ""type"": ""Gene/Protein""}]"	train
We propose that NFKB2 synthesis and processing allows continuous nuclear expression of an otherwise cytoplasmic protein and, in conjunction with overexpression of c - Rel, NFKB2 alters the NF - kappa B signalling pathway and contributes to leukemic transformation of T cells by HTLV - I.	NFKB2,16,21,Gene/Protein	cytoplasmic protein,100,119,Gene/Protein	c - Rel,163,170,Gene/Protein	NFKB2,172,177,Gene/Protein	NF - kappa B,189,201,Gene/Protein	"[{""token"": ""NFKB2"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic protein"", ""start_span"": 100, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""NFKB2"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 189, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
The last 13 amino acids containing a PXQXT / S sequence are highly conserved in human and simian EBV LMP1 but do not bind TRAF3, suggesting a distinct role for this conserved region of LMP1.	last 13 amino acids,4,23,Gene/Protein	PXQXT / S sequence,37,55,Gene/Protein	LMP1,101,105,Gene/Protein	TRAF3,122,127,Gene/Protein	LMP1,185,189,Gene/Protein	"[{""token"": ""last 13 amino acids"", ""start_span"": 4, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""PXQXT / S sequence"", ""start_span"": 37, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""TRAF3"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
The NF - kappa B inhibitor, tepoxalin, suppresses surface expression of the cell adhesion molecules CD62E, CD11b / CD18 and CD106.	NF - kappa B,4,16,Gene/Protein	cell adhesion molecules,76,99,Gene/Protein	CD62E,100,105,Gene/Protein	CD11b / CD18,107,119,Gene/Protein	CD106,124,129,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""cell adhesion molecules"", ""start_span"": 76, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""CD62E"", ""start_span"": 100, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""CD11b / CD18"", ""start_span"": 107, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""CD106"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	train
The BZLF1 gene promoter ( Zp) was activated by crosslinking of cell surface immunoglobulin ( Ig) with anti - Ig antibody in B cells, even in the absence of other viral genes.	BZLF1 gene promoter,4,23,Gene/Protein	Zp,26,28,Gene/Protein	cell surface immunoglobulin,63,90,Gene/Protein	Ig,93,95,Gene/Protein	anti - Ig antibody,102,120,Gene/Protein	"[{""token"": ""BZLF1 gene promoter"", ""start_span"": 4, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""Zp"", ""start_span"": 26, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""cell surface immunoglobulin"", ""start_span"": 63, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""Ig"", ""start_span"": 93, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""anti - Ig antibody"", ""start_span"": 102, ""end_span"": 120, ""type"": ""Gene/Protein""}]"	train
Pervanadate induced activation of the tyrosine kinases lck and fyn ( 4 - and 3 - fold respectively) and a dramatic increase in tyrosine phosphorylation of cellular proteins, notably phospholipase C gamma 1.	tyrosine kinases,38,54,Gene/Protein	lck,55,58,Gene/Protein	fyn,63,66,Gene/Protein	cellular proteins,155,172,Gene/Protein	phospholipase C gamma 1,182,205,Gene/Protein	"[{""token"": ""tyrosine kinases"", ""start_span"": 38, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""lck"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""fyn"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""cellular proteins"", ""start_span"": 155, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""phospholipase C gamma 1"", ""start_span"": 182, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
TCR signaling was triggered by treating Jurkat T cells with PHA or anti - CD3 Abs, and NF - kappaB activation was monitored by electrophoretic mobility shift assays and / or by kappaB - dependent reporter assays.	TCR,0,3,Gene/Protein	PHA,60,63,Gene/Protein	anti - CD3 Abs,67,81,Gene/Protein	NF - kappaB,87,98,Gene/Protein	kappaB,177,183,Gene/Protein	"[{""token"": ""TCR"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3 Abs"", ""start_span"": 67, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 87, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""kappaB"", ""start_span"": 177, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
Contrary to the idea that protein kinase C is involved in TCR - mediated activation of NF - kappaB, high doses of staurosporine did not interfere with activation of NF - kappaB by PHA, while the same dose of staurosporine completely blocked activation by PMA.	protein kinase C,26,42,Gene/Protein	TCR,58,61,Gene/Protein	NF - kappaB,87,98,Gene/Protein	NF - kappaB,165,176,Gene/Protein	PHA,180,183,Gene/Protein	"[{""token"": ""protein kinase C"", ""start_span"": 26, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 87, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 165, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
Consistent with these observations, coexpression of constitutively active forms of Raf - 1 and calcineurin synergistically induced kappaB - dependent reporter activity, suggesting a physiologically relevant functional interaction between the kinase and the phosphatase.	Raf - 1,83,90,Gene/Protein	calcineurin,95,106,Gene/Protein	kappaB,131,137,Gene/Protein	kinase,242,248,Gene/Protein	phosphatase,257,268,Gene/Protein	"[{""token"": ""Raf - 1"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""kappaB"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""kinase"", ""start_span"": 242, ""end_span"": 248, ""type"": ""Gene/Protein""}, {""token"": ""phosphatase"", ""start_span"": 257, ""end_span"": 268, ""type"": ""Gene/Protein""}]"	train
These results demonstrate that CD40, like sIg, may employ PKC in producing select outcomes, that individual B cell receptors may signal downstream events via both PKC - dependent and PKC - independent pathways, and that multiple signal transduction pathways may be used to activate the expression of closely related genes.	CD40,31,35,Gene/Protein	sIg,42,45,Gene/Protein	PKC,58,61,Gene/Protein	B cell receptors,108,124,Gene/Protein	genes,316,321,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""sIg"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""B cell receptors"", ""start_span"": 108, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""genes"", ""start_span"": 316, ""end_span"": 321, ""type"": ""Gene/Protein""}]"	train
Sequence analysis revealed that PB1 is composed of adjacent binding sites for Ets and AP - 1 transcription factors.	PB1,32,35,Gene/Protein	adjacent binding sites,51,73,Gene/Protein	Ets,78,81,Gene/Protein	AP - 1,86,92,Gene/Protein	transcription factors,93,114,Gene/Protein	"[{""token"": ""PB1"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""adjacent binding sites"", ""start_span"": 51, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Ets"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 93, ""end_span"": 114, ""type"": ""Gene/Protein""}]"	train
High doses of sodium salicylate suppressed NF - kappa B p65 mRNA accumulation, resulting in suppression of total NF - kappa B, p50 on tissue oligonucleotide had no effects on lipopolysaccharide - induced NF - kappa B activation.	NF - kappa B,43,55,Gene/Protein	p65 mRNA,56,64,Gene/Protein	NF - kappa B,113,125,Gene/Protein	p50,127,130,Gene/Protein	NF - kappa B,204,216,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 43, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""p65 mRNA"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 113, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 204, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
Interferon regulatory factor 2 ( IRF - 2) is a transcriptional regulatory protein that terminates interferon beta expression initiated by interferon regulatory factor 1.	Interferon regulatory factor 2,0,30,Gene/Protein	IRF - 2,33,40,Gene/Protein	transcriptional regulatory protein,47,81,Gene/Protein	interferon beta,98,113,Gene/Protein	interferon regulatory factor 1,138,168,Gene/Protein	"[{""token"": ""Interferon regulatory factor 2"", ""start_span"": 0, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 2"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulatory protein"", ""start_span"": 47, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""interferon beta"", ""start_span"": 98, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""interferon regulatory factor 1"", ""start_span"": 138, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
The MNDA mRNA level in primary granulocytes was unaffected by addition of interferon alpha and other agents including interferon gamma, endotoxin, poly ( I). poly ( C), and FMLP.	MNDA mRNA,4,13,Gene/Protein	interferon alpha,74,90,Gene/Protein	interferon gamma,118,134,Gene/Protein	endotoxin,136,145,Gene/Protein	FMLP,173,177,Gene/Protein	"[{""token"": ""MNDA mRNA"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""interferon alpha"", ""start_span"": 74, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""interferon gamma"", ""start_span"": 118, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""endotoxin"", ""start_span"": 136, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""FMLP"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
In addition, electrophoretic mobility shift and supershift assays revealed that important NF - kappaB binding activity composed of at least p50, p65, and c - Rel NF - kappaB subunits was present in nuclei of CD40 - stimulated B cells.	NF - kappaB,90,101,Gene/Protein	p50,140,143,Gene/Protein	p65,145,148,Gene/Protein	c - Rel,154,161,Gene/Protein	NF - kappaB subunits,162,182,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 90, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB subunits"", ""start_span"": 162, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
G0S3 is a member of a set of putative G0 / G1 switch regulatory genes ( G0S genes) selected by screening cDNA libraries prepared from human blood mononuclear cells cultured for 2 hr with lectin and cycloheximide.	G0S3,0,4,Gene/Protein	putative G0 / G1 switch regulatory genes,29,69,Gene/Protein	G0S genes,72,81,Gene/Protein	cDNA libraries,105,119,Gene/Protein	lectin,187,193,Gene/Protein	"[{""token"": ""G0S3"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""putative G0 / G1 switch regulatory genes"", ""start_span"": 29, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""G0S genes"", ""start_span"": 72, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""cDNA libraries"", ""start_span"": 105, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""lectin"", ""start_span"": 187, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
The Pan gene encodes at least two distinct transcripts, Pan - 1 and Pan - 2 ( also known as E47 and E12, respectively), by the mechanism of alternative RNA splicing.	Pan gene,4,12,Gene/Protein	Pan - 1,56,63,Gene/Protein	Pan - 2,68,75,Gene/Protein	E47,92,95,Gene/Protein	E12,100,103,Gene/Protein	"[{""token"": ""Pan gene"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""Pan - 1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Pan - 2"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""E47"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""E12"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}]"	train
We have developed a monoclonal antibody, Yae, which is specific for Pan / E2A proteins, and have used the Yae antibody to examine a variety of endocrine and nonendocrine cell lineages for differences in Pan / E2A protein expression, subcellular localization, and heteromeric complex formation.	monoclonal antibody,20,39,Gene/Protein	Yae,41,44,Gene/Protein	Pan / E2A proteins,68,86,Gene/Protein	Yae antibody,106,118,Gene/Protein	E2A protein,209,220,Gene/Protein	"[{""token"": ""monoclonal antibody"", ""start_span"": 20, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""Yae"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Pan / E2A proteins"", ""start_span"": 68, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""Yae antibody"", ""start_span"": 106, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""E2A protein"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Gene/Protein""}]"	train
Nuclear factor - kappa B ( NF - kappa B) is a transcription factor that binds to the consensus DNA sequence in the cis - acting elements of various genes.	Nuclear factor - kappa B,0,24,Gene/Protein	NF - kappa B,27,39,Gene/Protein	consensus DNA sequence,85,107,Gene/Protein	cis - acting elements,115,136,Gene/Protein	various genes,140,153,Gene/Protein	"[{""token"": ""Nuclear factor - kappa B"", ""start_span"": 0, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 27, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""consensus DNA sequence"", ""start_span"": 85, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""cis - acting elements"", ""start_span"": 115, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""various genes"", ""start_span"": 140, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
Stimulation of DND39 cells with IL - 4 or anti - CD40 monoclonal antibody ( mAb) activated phosphatidylinositol 3 - kinase and subsequently induced nuclear expression of NF - kappa B, which was identified by electrophoretic mobility shift assays.	IL - 4,32,38,Gene/Protein	anti - CD40 monoclonal antibody,42,73,Gene/Protein	mAb,76,79,Gene/Protein	phosphatidylinositol 3 - kinase,91,122,Gene/Protein	NF - kappa B,170,182,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD40 monoclonal antibody"", ""start_span"": 42, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""mAb"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 91, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 170, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
These results indicate that NF - kappa B activity is commonly inducible in DND39 cells by IL - 4 and anti - CD40 mAb and suggest that NF - kappa B sensitive to NAC may play a role in regulating IgE synthesis in B cells.	NF - kappa B,28,40,Gene/Protein	IL - 4,90,96,Gene/Protein	anti - CD40 mAb,101,116,Gene/Protein	NF - kappa B,134,146,Gene/Protein	IgE,194,197,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 28, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 90, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD40 mAb"", ""start_span"": 101, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 134, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
RT - PCR demonstrated that NL of both subtypes expressed EBNAI of the QUK splice pattern, the latent membrane proteins, LMP1 and 2 and the BamHI A rightward transcripts in the absence of EBNA2 mRNAs, compatible with the latency type II pattern.	EBNAI,57,62,Gene/Protein	latent membrane proteins,94,118,Gene/Protein	LMP1 and 2,120,130,Gene/Protein	BamHI A rightward transcripts,139,168,Gene/Protein	EBNA2 mRNAs,187,198,Gene/Protein	"[{""token"": ""EBNAI"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""latent membrane proteins"", ""start_span"": 94, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""LMP1 and 2"", ""start_span"": 120, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""BamHI A rightward transcripts"", ""start_span"": 139, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""EBNA2 mRNAs"", ""start_span"": 187, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
Autoregulation of the NF - kappa B transactivator RelA ( p65) by multiple cytoplasmic inhibitors containing ankyrin motifs.	NF - kappa B transactivator,22,49,Gene/Protein	RelA,50,54,Gene/Protein	p65,57,60,Gene/Protein	cytoplasmic inhibitors,74,96,Gene/Protein	ankyrin motifs,108,122,Gene/Protein	"[{""token"": ""NF - kappa B transactivator"", ""start_span"": 22, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic inhibitors"", ""start_span"": 74, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""ankyrin motifs"", ""start_span"": 108, ""end_span"": 122, ""type"": ""Gene/Protein""}]"	train
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not Stat1 and blocked IL - 10 - induced Stat3 phosphorylation in a cell - free system.	phosphorylated form,81,100,Gene/Protein	Stat3,116,121,Gene/Protein	Stat1,130,135,Gene/Protein	IL - 10,148,155,Gene/Protein	Stat3,166,171,Gene/Protein	"[{""token"": ""phosphorylated form"", ""start_span"": 81, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
These data demonstrate that Stat3 but not Stat1 or Stat5 is directly recruited to the ligand - activated IL - 10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.	Stat3,28,33,Gene/Protein	Stat1,42,47,Gene/Protein	Stat5,51,56,Gene/Protein	ligand - activated IL - 10 receptor,86,121,Gene/Protein	receptor intracellular domain sequences,159,198,Gene/Protein	"[{""token"": ""Stat3"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""ligand - activated IL - 10 receptor"", ""start_span"": 86, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""receptor intracellular domain sequences"", ""start_span"": 159, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
Impaired silencing of gamma - globin expression identifies EKLF as the first transcription factor participating quantitatively in the gamma - globin to beta - globin switch.	gamma - globin,22,36,Gene/Protein	EKLF,59,63,Gene/Protein	transcription factor,77,97,Gene/Protein	gamma - globin,134,148,Gene/Protein	beta - globin,152,165,Gene/Protein	"[{""token"": ""gamma - globin"", ""start_span"": 22, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 77, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""gamma - globin"", ""start_span"": 134, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin"", ""start_span"": 152, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
Here, we show that zinc addition in a serum - and lipopolysaccharide - free cell culture system leads to significantly enhanced levels of interleukin 1 beta ( IL - 1 beta) and tumour necrosis factor alpha ( TNF - alpha) and to expression of the corresponding mRNA in human peripheral blood mononuclear cells ( PBMC).	interleukin 1 beta,138,156,Gene/Protein	IL - 1 beta,159,170,Gene/Protein	tumour necrosis factor alpha,176,204,Gene/Protein	TNF - alpha,207,218,Gene/Protein	mRNA,259,263,Gene/Protein	"[{""token"": ""interleukin 1 beta"", ""start_span"": 138, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 beta"", ""start_span"": 159, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""tumour necrosis factor alpha"", ""start_span"": 176, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 207, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 259, ""end_span"": 263, ""type"": ""Gene/Protein""}]"	train
Addition of the - 176 to - 96 sequence to the 4X NF - AT - Oct construct did not impart the ability to be affected by anergy, but addition of the - 236 to - 96 sequence did, demonstrating that anergy is an active inhibitory process and that more than the presence of the - 150 AP - 1 binding site ( - 152 to - 147) is required to mediate the effect.	- 176 to - 96 sequence,16,38,Gene/Protein	4X NF - AT - Oct construct,46,72,Gene/Protein	- 236 to - 96 sequence,146,168,Gene/Protein	- 150 AP - 1 binding site,271,296,Gene/Protein	- 152 to - 147,299,313,Gene/Protein	"[{""token"": ""- 176 to - 96 sequence"", ""start_span"": 16, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""4X NF - AT - Oct construct"", ""start_span"": 46, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""- 236 to - 96 sequence"", ""start_span"": 146, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""- 150 AP - 1 binding site"", ""start_span"": 271, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""- 152 to - 147"", ""start_span"": 299, ""end_span"": 313, ""type"": ""Gene/Protein""}]"	train
Site - directed mutagenesis of these cis elements demonstrated that Cp activity is highly dependent on the presence of a properly positioned CCAAT box, with the dependence on the distal CCAAT box apparent only when the proximal CCAAT box was deleted or mutated.	cis elements,37,49,Gene/Protein	Cp,68,70,Gene/Protein	CCAAT box,141,150,Gene/Protein	distal CCAAT box,179,195,Gene/Protein	proximal CCAAT box,219,237,Gene/Protein	"[{""token"": ""cis elements"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Cp"", ""start_span"": 68, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CCAAT box"", ""start_span"": 141, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""distal CCAAT box"", ""start_span"": 179, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""proximal CCAAT box"", ""start_span"": 219, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	train
To examine the molecular basis of constitutive NF - kappaB DNA - binding activity in HIV1 - infected cells, we analyzed the phosphorylation and turnover of IkappaBalpha protein, the activity of the double - stranded RNA - dependent protein kinase ( PKR) and the intracellular levels of NF - kappaB subunits in the PLB - 985 and U937 myeloid cell models.	NF - kappaB,47,58,Gene/Protein	IkappaBalpha,156,168,Gene/Protein	double - stranded RNA - dependent protein kinase,198,246,Gene/Protein	PKR,249,252,Gene/Protein	NF - kappaB subunits,286,306,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 156, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""double - stranded RNA - dependent protein kinase"", ""start_span"": 198, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""PKR"", ""start_span"": 249, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB subunits"", ""start_span"": 286, ""end_span"": 306, ""type"": ""Gene/Protein""}]"	train
A dramatic increase in the intracellular levels of NF - kappaB subunits c - Rel and NF - kappaB2 p100 and a moderate increase in NF - kappaB2 p52 and RelA ( p65) were detected in HIV - 1 - infected cells, whereas NF - kappaB1 p105 / p50 levels were not altered relative to the levels in uninfected cells.	NF - kappaB,51,62,Gene/Protein	c - Rel,72,79,Gene/Protein	NF - kappaB2 p100,84,101,Gene/Protein	NF - kappaB2 p52,129,145,Gene/Protein	NF - kappaB1 p105 / p50,213,236,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB2 p100"", ""start_span"": 84, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB2 p52"", ""start_span"": 129, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB1 p105 / p50"", ""start_span"": 213, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
Moreover, alteration of any one of these features ( e. g., cis - element, trans - factor, or cell - specific background) switched c - Jun to a transcriptional activator of the rPRL promoter.	cis - element,59,72,Gene/Protein	trans - factor,74,88,Gene/Protein	c - Jun,130,137,Gene/Protein	transcriptional activator,143,168,Gene/Protein	rPRL promoter,176,189,Gene/Protein	"[{""token"": ""cis - element"", ""start_span"": 59, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""trans - factor"", ""start_span"": 74, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activator"", ""start_span"": 143, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""rPRL promoter"", ""start_span"": 176, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
In HeLa nonpituitary cells, c - Jun alone activated the rPRL promoter via the most proximal GHF - 1 / Pit - 1 binding site, footprint I, and synergized with GHF - 1.	c - Jun,28,35,Gene/Protein	rPRL promoter,56,69,Gene/Protein	GHF - 1 / Pit - 1 binding site,92,122,Gene/Protein	footprint I,124,135,Gene/Protein	GHF - 1,157,164,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""rPRL promoter"", ""start_span"": 56, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""GHF - 1 / Pit - 1 binding site"", ""start_span"": 92, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""footprint I"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""GHF - 1"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
NGFI - B / nur77 and its related genes constitute a family and the NGFI - B / nur77 family consists of three subtypes, named nur77 alpha, nur77 beta, nur77 gamma.	NGFI - B / nur77,0,16,Gene/Protein	NGFI - B / nur77 family,67,90,Gene/Protein	nur77 alpha,125,136,Gene/Protein	nur77 beta,138,148,Gene/Protein	nur77 gamma,150,161,Gene/Protein	"[{""token"": ""NGFI - B / nur77"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""NGFI - B / nur77 family"", ""start_span"": 67, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""nur77 alpha"", ""start_span"": 125, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""nur77 beta"", ""start_span"": 138, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""nur77 gamma"", ""start_span"": 150, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
As glucocorticoids regulate interferon - alpha ( IFN alpha) production, we hypothesized that IFN alpha, a cytokine produced predominantly by monocytes in AIDS, should be increased in cortisol - resistant AIDS, attributing the lack of cortisol inhibition to IFN alpha production.	interferon - alpha,28,46,Gene/Protein	IFN alpha,49,58,Gene/Protein	IFN alpha,93,102,Gene/Protein	cytokine,106,114,Gene/Protein	IFN alpha,257,266,Gene/Protein	"[{""token"": ""interferon - alpha"", ""start_span"": 28, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""IFN alpha"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""IFN alpha"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""IFN alpha"", ""start_span"": 257, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
Although the CRE site is necessary, optimal induction of bcl - 2 expression requires participation of the upstream regulatory element, suggesting that phosphorylation of CREB alters its interaction with the upstream regulatory element.	CRE site,13,21,Gene/Protein	bcl - 2,57,64,Gene/Protein	upstream regulatory element,106,133,Gene/Protein	CREB,170,174,Gene/Protein	upstream regulatory element,207,234,Gene/Protein	"[{""token"": ""CRE site"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""bcl - 2"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""upstream regulatory element"", ""start_span"": 106, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""upstream regulatory element"", ""start_span"": 207, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
Other DNA elements present include a cluster of Myb sites, several Ets, an Ets related PU. 1 site and an Sp1 site located within 600 bp of the transcription start sites.	DNA elements,6,18,Gene/Protein	Myb sites,48,57,Gene/Protein	Ets,67,70,Gene/Protein	Sp1 site,105,113,Gene/Protein	transcription start sites,143,168,Gene/Protein	"[{""token"": ""DNA elements"", ""start_span"": 6, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""Myb sites"", ""start_span"": 48, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Ets"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 site"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""transcription start sites"", ""start_span"": 143, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
The SH3 domains of Grb2 form a stable complex with SOS1 and two proteins of 75 kD and 120 kD, which undergo tyrosine phosphorylation in Fc gamma RIIA stimulated cells.	SH3 domains,4,15,Gene/Protein	Grb2,19,23,Gene/Protein	SOS1,51,55,Gene/Protein	75 kD,76,81,Gene/Protein	120 kD,86,92,Gene/Protein	"[{""token"": ""SH3 domains"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""Grb2"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""SOS1"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""75 kD"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""120 kD"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}]"	train
The variant Id - 3L protein is functionally distinguishable from conventional Id - 3 since in in vitro DNA mobility shift assays, it was greatly impaired in its ability to abrogate binding of the basic helix - loop - helix protein, E47, to an E box recognition sequence.	Id - 3L protein,12,27,Gene/Protein	Id - 3,78,84,Gene/Protein	helix - loop - helix protein,202,230,Gene/Protein	E47,232,235,Gene/Protein	E box recognition sequence,243,269,Gene/Protein	"[{""token"": ""Id - 3L protein"", ""start_span"": 12, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""Id - 3"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""helix - loop - helix protein"", ""start_span"": 202, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""E47"", ""start_span"": 232, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""E box recognition sequence"", ""start_span"": 243, ""end_span"": 269, ""type"": ""Gene/Protein""}]"	train
Elevated cAMP did not prevent nuclear translocation of p50 / p65 and c - Rel / p65 heterodimers, decrease nuclear translocation of p65, or significantly modify TNFalpha - induced phosphorylation of p65.	p50 / p65,55,64,Gene/Protein	c - Rel / p65 heterodimers,69,95,Gene/Protein	p65,131,134,Gene/Protein	TNFalpha,160,168,Gene/Protein	p65,198,201,Gene/Protein	"[{""token"": ""p50 / p65"", ""start_span"": 55, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel / p65 heterodimers"", ""start_span"": 69, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 160, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
Functional studies demonstrated that transcriptional activation of a plasmid containing multimerized kappaB sites by p65 was inhibited by agents that elevate cAMP and by overexpression of the catalytic subunit of PKA.	plasmid,69,76,Gene/Protein	multimerized kappaB sites,88,113,Gene/Protein	p65,117,120,Gene/Protein	catalytic subunit,192,209,Gene/Protein	PKA,213,216,Gene/Protein	"[{""token"": ""plasmid"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""multimerized kappaB sites"", ""start_span"": 88, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""catalytic subunit"", ""start_span"": 192, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""PKA"", ""start_span"": 213, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
The BCL6 gene encodes a 95 - kDa protein containing six C - terminal zinc - finger motifs and an N - terminal POZ domain, suggesting that it may function as a transcription factor.	BCL6 gene,4,13,Gene/Protein	95 - kDa protein,24,40,Gene/Protein	C - terminal zinc - finger motifs,56,89,Gene/Protein	N - terminal POZ domain,97,120,Gene/Protein	transcription factor,159,179,Gene/Protein	"[{""token"": ""BCL6 gene"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""95 - kDa protein"", ""start_span"": 24, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal zinc - finger motifs"", ""start_span"": 56, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal POZ domain"", ""start_span"": 97, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 159, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
We find that OCA - B binds DNA directly in the major groove between the two subdomains of the POU domain, requiring both an A at the fifth position of the octamer element and contact with the POU domain.	OCA - B,13,20,Gene/Protein	POU domain,94,104,Gene/Protein	fifth position,133,147,Gene/Protein	octamer element,155,170,Gene/Protein	POU domain,192,202,Gene/Protein	"[{""token"": ""OCA - B"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""POU domain"", ""start_span"": 94, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""fifth position"", ""start_span"": 133, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""octamer element"", ""start_span"": 155, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""POU domain"", ""start_span"": 192, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
A 4 - or 10 - bp insertion between muE3 and muB inactivated the mu enhancer in S194 plasma cells but did not affect in vitro binding of Ets - 1, PU. 1, or the muE3 - binding protein TFE3, alone or in pairwise combinations.	muE3,35,39,Gene/Protein	muB,44,47,Gene/Protein	mu enhancer,64,75,Gene/Protein	muE3 - binding protein,159,181,Gene/Protein	TFE3,182,186,Gene/Protein	"[{""token"": ""muE3"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""muB"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""mu enhancer"", ""start_span"": 64, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""muE3 - binding protein"", ""start_span"": 159, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""TFE3"", ""start_span"": 182, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
NFAT1 possesses two transactivation domains whose sequences are not conserved in the other NFAT - family proteins, and a conserved DNA - binding domain that mediates the recruitment of cooperating nuclear transcription factors even when it is expressed in the absence of other regions of the protein.	NFAT1,0,5,Gene/Protein	transactivation domains,20,43,Gene/Protein	NFAT - family proteins,91,113,Gene/Protein	DNA - binding domain,131,151,Gene/Protein	nuclear transcription factors,197,226,Gene/Protein	"[{""token"": ""NFAT1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""transactivation domains"", ""start_span"": 20, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""NFAT - family proteins"", ""start_span"": 91, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding domain"", ""start_span"": 131, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""nuclear transcription factors"", ""start_span"": 197, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	train
Comparison of the different combinations of GC and cytokines / LPS revealed differences in the level of GC - dependent enhancement of sialoadhesin expression, with IFN - beta and IL - 4 being more potent than IFN - gamma and LPS.	cytokines,51,60,Gene/Protein	sialoadhesin,134,146,Gene/Protein	IFN - beta,164,174,Gene/Protein	IL - 4,179,185,Gene/Protein	IFN - gamma,209,220,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""sialoadhesin"", ""start_span"": 134, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""IFN - beta"", ""start_span"": 164, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 179, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Gene/Protein""}]"	train
We found that the adenylate cyclase activator, forskolin, inhibits anti - CD3 - induced shift in Lck electrophoretic mobility, suggesting an intervention at the TCR - coupled phosphoinositide turnover that precedes the activation of PKC.	adenylate cyclase,18,35,Gene/Protein	anti - CD3,67,77,Gene/Protein	Lck,97,100,Gene/Protein	TCR,161,164,Gene/Protein	PKC,233,236,Gene/Protein	"[{""token"": ""adenylate cyclase"", ""start_span"": 18, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""Lck"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 233, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
To further analyze potential cross points between positively and negatively regulating signaling pathways in T cells, we tested the effects of activators of the adenylate cyclase or PKA on two parallel mitogen - activated protein kinase signaling pathways mediated by extracellular signal - regulated kinase ( ERK) and c - Jun N - terminal kinase.	adenylate cyclase,161,178,Gene/Protein	PKA,182,185,Gene/Protein	extracellular signal - regulated kinase,268,307,Gene/Protein	ERK,310,313,Gene/Protein	c - Jun N - terminal kinase,319,346,Gene/Protein	"[{""token"": ""adenylate cyclase"", ""start_span"": 161, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""PKA"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""extracellular signal - regulated kinase"", ""start_span"": 268, ""end_span"": 307, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 310, ""end_span"": 313, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun N - terminal kinase"", ""start_span"": 319, ""end_span"": 346, ""type"": ""Gene/Protein""}]"	train
Major STAT complexes activated by G - CSF - R / IL - 7R alpha contained STAT1 or STAT5, while some formation of STAT3 - containing complexes was also seen.	STAT complexes,6,20,Gene/Protein	G - CSF - R / IL - 7R alpha,34,61,Gene/Protein	STAT1,72,77,Gene/Protein	STAT5,81,86,Gene/Protein	STAT3 - containing complexes,112,140,Gene/Protein	"[{""token"": ""STAT complexes"", ""start_span"": 6, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF - R / IL - 7R alpha"", ""start_span"": 34, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""STAT3 - containing complexes"", ""start_span"": 112, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
Here we show that CaMKIV / Gr induces the transcription factor activation protein 1 ( AP - 1) alone or in synergy with T cell mitogens and with the p21ras oncoprotein.	CaMKIV / Gr,18,29,Gene/Protein	transcription factor activation protein 1,42,83,Gene/Protein	AP - 1,86,92,Gene/Protein	T cell mitogens,119,134,Gene/Protein	p21ras oncoprotein,148,166,Gene/Protein	"[{""token"": ""CaMKIV / Gr"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor activation protein 1"", ""start_span"": 42, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""T cell mitogens"", ""start_span"": 119, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""p21ras oncoprotein"", ""start_span"": 148, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
Treatment of B lymphocytes with the cytokine IL - 4 ( IL - 4), in the absence of prior activation, induces a weak up - regulation of VDR expression but fails to generate vitamin D - responsive element ( VDRE) - reactive nuclear protein complexes or to initiate the genomic transcription of 25 - hydroxyvitamin D3 24 - hydroxylase.	cytokine,36,44,Gene/Protein	IL - 4,45,51,Gene/Protein	IL - 4,54,60,Gene/Protein	VDR,133,136,Gene/Protein	25 - hydroxyvitamin D3 24 - hydroxylase,290,329,Gene/Protein	"[{""token"": ""cytokine"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""VDR"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""25 - hydroxyvitamin D3 24 - hydroxylase"", ""start_span"": 290, ""end_span"": 329, ""type"": ""Gene/Protein""}]"	train
Tax is localized to the DNA through its interaction with the site - specific activators cyclic AMP - responsive element - binding protein, NF - kappaB, and serum response factor.	Tax,0,3,Gene/Protein	site - specific activators,61,87,Gene/Protein	cyclic AMP - responsive element - binding protein,88,137,Gene/Protein	NF - kappaB,139,150,Gene/Protein	serum response factor,156,177,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""site - specific activators"", ""start_span"": 61, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""cyclic AMP - responsive element - binding protein"", ""start_span"": 88, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""serum response factor"", ""start_span"": 156, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
Downregulation of LPS - induced AP - 1 was accompanied, and thus possibly explained, by a reduced expression at mRNA level of the two major components of the AP - 1 complex, namely c - fos and c - jun as determined by Northern experiments.	LPS - induced AP - 1,18,38,Gene/Protein	mRNA,112,116,Gene/Protein	AP - 1 complex,158,172,Gene/Protein	c - fos,181,188,Gene/Protein	c - jun,193,200,Gene/Protein	"[{""token"": ""LPS - induced AP - 1"", ""start_span"": 18, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 complex"", ""start_span"": 158, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 181, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 193, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
NF - IL6 mRNA levels were not affected by IL - 10 or IL - 4, suggesting that IL - 4 affects binding activity of preexisting NF - IL6.	NF - IL6 mRNA,0,13,Gene/Protein	IL - 10,42,49,Gene/Protein	IL - 4,53,59,Gene/Protein	IL - 4,77,83,Gene/Protein	NF - IL6,124,132,Gene/Protein	"[{""token"": ""NF - IL6 mRNA"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Gene/Protein""}]"	train
Similarly, the complexes binding the consensus AP - 1 TRE and jun TRE - like motifs in cells exposed to oxidative signals or PHA / PMA were indistinguishable, being composed of c - Fos, c - Jun, and JunD.	consensus AP - 1 TRE,37,57,Gene/Protein	jun TRE - like motifs,62,83,Gene/Protein	c - Fos,177,184,Gene/Protein	c - Jun,186,193,Gene/Protein	JunD,199,203,Gene/Protein	"[{""token"": ""consensus AP - 1 TRE"", ""start_span"": 37, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""jun TRE - like motifs"", ""start_span"": 62, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 186, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
Electrophoretic mobility shift assay ( EMSA) and supershift assay using an NF - kappa B binding sequence from the kappa light chain as a probe, revealed that both p65 ( RelA) and c - Rel were present in CD40 - stimulated B cells.	NF - kappa B binding sequence,75,104,Gene/Protein	kappa light chain,114,131,Gene/Protein	p65,163,166,Gene/Protein	RelA,169,173,Gene/Protein	c - Rel,179,186,Gene/Protein	"[{""token"": ""NF - kappa B binding sequence"", ""start_span"": 75, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""kappa light chain"", ""start_span"": 114, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 179, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
Like LPS, purified native B. burgdorferi OspA and synthetic analogs of OspA, OspB, and two T. pallidum lipoproteins ( Tpp47 and Tpp17) all induced NF - kappa B translocation in THP - 1 human monocytoid cells.	OspA,41,45,Gene/Protein	OspB,77,81,Gene/Protein	Tpp47,118,123,Gene/Protein	Tpp17,128,133,Gene/Protein	NF - kappa B,147,159,Gene/Protein	"[{""token"": ""OspA"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""OspB"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""Tpp47"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""Tpp17"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 147, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
In addition to SP100 homology regions, one LYSP100 cDNA isoform contains a bromodomain and a PHD / TTC domain, which are present in a variety of transcriptional regulatory proteins.	SP100 homology regions,15,37,Gene/Protein	LYSP100 cDNA isoform,43,63,Gene/Protein	bromodomain,75,86,Gene/Protein	PHD / TTC domain,93,109,Gene/Protein	transcriptional regulatory proteins,145,180,Gene/Protein	"[{""token"": ""SP100 homology regions"", ""start_span"": 15, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""LYSP100 cDNA isoform"", ""start_span"": 43, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""bromodomain"", ""start_span"": 75, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""PHD / TTC domain"", ""start_span"": 93, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulatory proteins"", ""start_span"": 145, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
We found that GIG18 was rapidly induced to comparable levels by both AR and GR, demonstrating that AR can indeed function as a transcriptional activator in S49 cells and, moreover, that GIG18 induction may be a marker of early apoptotic events in steroid - treated cells.	GIG18,14,19,Gene/Protein	AR,69,71,Gene/Protein	GR,76,78,Gene/Protein	AR,99,101,Gene/Protein	GIG18,186,191,Gene/Protein	"[{""token"": ""GIG18"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""AR"", ""start_span"": 69, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""AR"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""GIG18"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
Expression of dominant negative N17Rac also prevents TCR and p21ras activation of NFAT, but without interfering with the ERK - 2 pathway.	dominant negative N17Rac,14,38,Gene/Protein	TCR,53,56,Gene/Protein	p21ras,61,67,Gene/Protein	NFAT,82,86,Gene/Protein	ERK - 2,121,128,Gene/Protein	"[{""token"": ""dominant negative N17Rac"", ""start_span"": 14, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""p21ras"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""ERK - 2"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}]"	train
Thus, p21ras regulation of NFAT in T cells requires the activity of multiple effector pathways including those regulated by MAPKK - 1 / ERK - 2 and Rac - 1.	p21ras,6,12,Gene/Protein	NFAT,27,31,Gene/Protein	MAPKK - 1,124,133,Gene/Protein	/ ERK - 2,134,143,Gene/Protein	Rac - 1,148,155,Gene/Protein	"[{""token"": ""p21ras"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""MAPKK - 1"", ""start_span"": 124, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""/ ERK - 2"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""Rac - 1"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	train
In contrast to IL - 2 and IFN - alpha, IL - 12 induced strong tyrosine phosphorylation of STAT4 and variable weak phosphorylation of STAT3.	IL - 2,15,21,Gene/Protein	IFN - alpha,26,37,Gene/Protein	IL - 12,39,46,Gene/Protein	STAT4,90,95,Gene/Protein	STAT3,133,138,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 15, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""STAT4"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}]"	train
Differential phosphorylation and consequent differential activation of both separate and overlapping STAT proteins by IL - 2, IL - 12, and IFN - alpha may provide a molecular basis for the similarities and differences in the actions of these cytokines on NK cells.	STAT proteins,101,114,Gene/Protein	IL - 2,118,124,Gene/Protein	IL - 12,126,133,Gene/Protein	IFN - alpha,139,150,Gene/Protein	cytokines,242,251,Gene/Protein	"[{""token"": ""STAT proteins"", ""start_span"": 101, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 242, ""end_span"": 251, ""type"": ""Gene/Protein""}]"	train
In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL - 2 are unresponsive to IFN - gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1 ( alpha), a signal transducer and activator of transcription.	TCR,90,93,Gene/Protein	IL - 2,112,118,Gene/Protein	IFN - gamma,139,150,Gene/Protein	jak kinases,193,204,Gene/Protein	transcription factor,213,233,Gene/Protein	"[{""token"": ""TCR"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""jak kinases"", ""start_span"": 193, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 213, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
Our data suggest that IL - 13 utilizes IL - 4R and its signaling pathway, and JAK2 may play an important role in the function of IL - 4R and IL - 13R in colon cancer cells.	IL - 13,22,29,Gene/Protein	IL - 4R,39,46,Gene/Protein	JAK2,78,82,Gene/Protein	IL - 4R,129,136,Gene/Protein	IL - 13R,141,149,Gene/Protein	"[{""token"": ""IL - 13"", ""start_span"": 22, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R"", ""start_span"": 129, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13R"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
Incubation of B - chronic lymphocytic leukemia ( B - CLL) cells with phorbol esters resulted in the phosphorylation of two major PKC substrates, MARCKS ( myristoylated, alanine - rich C kinase substrate) and MRP ( MARCKS - related protein), and of a third protein, with an apparent m. w. of 60, 000 that was the most prominent protein kinase C substrate in these cells.	PKC substrates,129,143,Gene/Protein	MARCKS,145,151,Gene/Protein	MRP,208,211,Gene/Protein	MARCKS - related protein,214,238,Gene/Protein	protein kinase C substrate,327,353,Gene/Protein	"[{""token"": ""PKC substrates"", ""start_span"": 129, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""MARCKS"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""MRP"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""MARCKS - related protein"", ""start_span"": 214, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C substrate"", ""start_span"": 327, ""end_span"": 353, ""type"": ""Gene/Protein""}]"	train
COS - 1 cells, co - expressing the human IL - 10R and individual STAT proteins, confirmed a preference of the IL - 10R for STAT3 and STAT1.	IL - 10R,41,49,Gene/Protein	STAT proteins,65,78,Gene/Protein	IL - 10R,110,118,Gene/Protein	STAT3,123,128,Gene/Protein	STAT1,133,138,Gene/Protein	"[{""token"": ""IL - 10R"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""STAT proteins"", ""start_span"": 65, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10R"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}]"	train
A gel retardation experiment with synthetic double - stranded oligonucleotides showed that activated NF - kappa B consisting of p50 / p65 heterodimer bound to all four putative NF - kappa B DNA probes, suggesting that all four putative NF - kappa B recognition sites play an important role in inducible TNF - alpha expression.	NF - kappa B,101,113,Gene/Protein	p50 / p65 heterodimer,128,149,Gene/Protein	NF - kappa B DNA probes,177,200,Gene/Protein	NF - kappa B recognition sites,236,266,Gene/Protein	TNF - alpha,303,314,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""p50 / p65 heterodimer"", ""start_span"": 128, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B DNA probes"", ""start_span"": 177, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B recognition sites"", ""start_span"": 236, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 303, ""end_span"": 314, ""type"": ""Gene/Protein""}]"	train
C - terminal activating and inhibitory domains determine the transactivation potential of BSAP ( Pax - 5), Pax - 2 and Pax - 8.	C - terminal activating and inhibitory domains,0,46,Gene/Protein	BSAP,90,94,Gene/Protein	Pax - 5,97,104,Gene/Protein	Pax - 2,107,114,Gene/Protein	Pax - 8,119,126,Gene/Protein	"[{""token"": ""C - terminal activating and inhibitory domains"", ""start_span"": 0, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 2"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 8"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	train
The same arrangement of positively and negatively acting sequences has been conserved in the mammalian Pax - 2 and Pax - 8, the zebrafish Pax - b as well as the sea urchin Pax - 258 proteins.	positively and negatively acting sequences,24,66,Gene/Protein	mammalian Pax - 2,93,110,Gene/Protein	Pax - 8,115,122,Gene/Protein	zebrafish Pax - b,128,145,Gene/Protein	sea urchin Pax - 258 proteins,161,190,Gene/Protein	"[{""token"": ""positively and negatively acting sequences"", ""start_span"": 24, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""mammalian Pax - 2"", ""start_span"": 93, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 8"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""zebrafish Pax - b"", ""start_span"": 128, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""sea urchin Pax - 258 proteins"", ""start_span"": 161, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
CD36 is a cell surface glycoprotein composed of a single polypeptide chain, which interacts with thrombospondin, collagens type I and IV, oxidized low density lipoprotein, fatty acids, anionic phospholipids, and erythrocytes parasitized with Plasmodium falciparum.	CD36,0,4,Gene/Protein	glycoprotein,23,35,Gene/Protein	thrombospondin,97,111,Gene/Protein	collagens type I and IV,113,136,Gene/Protein	low density lipoprotein,147,170,Gene/Protein	"[{""token"": ""CD36"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""glycoprotein"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""thrombospondin"", ""start_span"": 97, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""collagens type I and IV"", ""start_span"": 113, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""low density lipoprotein"", ""start_span"": 147, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
In this study, we examined the expression of two T - cell - specific transcription factors ( TCF - 1 and GATA - 3) and one B - cell - specific transcription factor ( BSAP) in cultured H - RS cells by using a gel mobility shift assay.	T - cell - specific transcription factors,49,90,Gene/Protein	TCF - 1,93,100,Gene/Protein	GATA - 3,105,113,Gene/Protein	B - cell - specific transcription factor,123,163,Gene/Protein	BSAP,166,170,Gene/Protein	"[{""token"": ""T - cell - specific transcription factors"", ""start_span"": 49, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 3"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific transcription factor"", ""start_span"": 123, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
Active Raf - 1 phosphorylates and activates the mitogen - activated protein ( MAP) kinase / extracellular signal - regulated kinase kinase 1 ( MEK1), which in turn phosphorylates and activates the MAP kinases / extracellular signal regulated kinases, ERK1 and ERK2.	Raf - 1,7,14,Gene/Protein	MEK1,143,147,Gene/Protein	MAP kinases / extracellular signal regulated kinases,197,249,Gene/Protein	ERK1,251,255,Gene/Protein	ERK2,260,264,Gene/Protein	"[{""token"": ""Raf - 1"", ""start_span"": 7, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""MEK1"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""MAP kinases / extracellular signal regulated kinases"", ""start_span"": 197, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 251, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""ERK2"", ""start_span"": 260, ""end_span"": 264, ""type"": ""Gene/Protein""}]"	train
Expression of MEK1 - interfering mutants inhibited the stimulation of IL - 2 promoter - driven transcription and blocked the ability of constitutively active Ras and Raf - 1 to costimulate NF - AT activity with a calcium ionophore.	MEK1 - interfering mutants,14,40,Gene/Protein	IL - 2 promoter,70,85,Gene/Protein	Ras,158,161,Gene/Protein	Raf - 1,166,173,Gene/Protein	NF - AT,189,196,Gene/Protein	"[{""token"": ""MEK1 - interfering mutants"", ""start_span"": 14, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 70, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""Raf - 1"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
Transient expression of the luciferase reporter gene linked to serially deleted sequences of the 5 ' - flanking region of the IL - 9 gene has revealed several positive and negative regulatory elements involved in the basal and inducible expression of the IL - 9 gene in C5MJ2 cells.	luciferase reporter gene,28,52,Gene/Protein	5 ' - flanking region,97,118,Gene/Protein	IL - 9 gene,126,137,Gene/Protein	negative regulatory elements,172,200,Gene/Protein	IL - 9 gene,255,266,Gene/Protein	"[{""token"": ""luciferase reporter gene"", ""start_span"": 28, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - flanking region"", ""start_span"": 97, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9 gene"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""negative regulatory elements"", ""start_span"": 172, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9 gene"", ""start_span"": 255, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
This paper reports the expression of IL - 12R on a human gamma delta T cell line that responds to IL - 12 with enhanced cytolytic activity and increased expression of cytolytic effector molecules granzyme B and perforin.	IL - 12R,37,45,Gene/Protein	IL - 12,98,105,Gene/Protein	cytolytic effector molecules,167,195,Gene/Protein	granzyme B,196,206,Gene/Protein	perforin,211,219,Gene/Protein	"[{""token"": ""IL - 12R"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""cytolytic effector molecules"", ""start_span"": 167, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""granzyme B"", ""start_span"": 196, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""perforin"", ""start_span"": 211, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
hLH - 2 was mapped to chromosome 9Q33 - 34. 1, in the same region as the reciprocal translocation that creates the BCR - ABL chimera of the Philadelphia chromosome ( Ph '), the hallmark of CML; hLH - 2 was retained on the derivative 9 chromosome and is therefore centromeric of c - ABL.	hLH - 2,0,7,Gene/Protein	BCR - ABL chimera,115,132,Gene/Protein	hLH - 2,194,201,Gene/Protein	derivative 9 chromosome,222,245,Gene/Protein	c - ABL,278,285,Gene/Protein	"[{""token"": ""hLH - 2"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""BCR - ABL chimera"", ""start_span"": 115, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""hLH - 2"", ""start_span"": 194, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""derivative 9 chromosome"", ""start_span"": 222, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""c - ABL"", ""start_span"": 278, ""end_span"": 285, ""type"": ""Gene/Protein""}]"	train
p45 subunit of NF - E2 contains a basic - leucine zipper domain and dimerizes with the small Maf family protein to form functional NF - E2 complex.	p45 subunit,0,11,Gene/Protein	NF - E2,15,22,Gene/Protein	basic - leucine zipper domain,34,63,Gene/Protein	small Maf family protein,87,111,Gene/Protein	NF - E2 complex,131,146,Gene/Protein	"[{""token"": ""p45 subunit"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""NF - E2"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""basic - leucine zipper domain"", ""start_span"": 34, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""small Maf family protein"", ""start_span"": 87, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""NF - E2 complex"", ""start_span"": 131, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
Although p45 mRNA is transcribed from two different promoters, aNF - E2 promoter and fNF - E2 promoter, in erythroid and megakaryocytic lineage cells, p45 mRNA is transcribed only from aNF - E2 promoter.	p45 mRNA,9,17,Gene/Protein	aNF - E2 promoter,63,80,Gene/Protein	fNF - E2 promoter,85,102,Gene/Protein	p45 mRNA,151,159,Gene/Protein	aNF - E2 promoter,185,202,Gene/Protein	"[{""token"": ""p45 mRNA"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""aNF - E2 promoter"", ""start_span"": 63, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""fNF - E2 promoter"", ""start_span"": 85, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""p45 mRNA"", ""start_span"": 151, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""aNF - E2 promoter"", ""start_span"": 185, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
The protein products of the c - fos ( p62c - fos) and c - jun ( p39c - jun) genes are members of the AP - 1 transcription factor family and are thought to play important roles in the regulation of gene expression during the cell cycle.	c - fos,28,35,Gene/Protein	p62c - fos,38,48,Gene/Protein	c - jun,54,61,Gene/Protein	p39c - jun,64,74,Gene/Protein	AP - 1 transcription factor family,101,135,Gene/Protein	"[{""token"": ""c - fos"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""p62c - fos"", ""start_span"": 38, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""p39c - jun"", ""start_span"": 64, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 transcription factor family"", ""start_span"": 101, ""end_span"": 135, ""type"": ""Gene/Protein""}]"	train
We demonstrated an uncoupling of AP - 1 binding activity from p62c - fos, and p39c - jun AP - 1 activity was expressed more strongly in the G1 - and G2 / M - phase enriched samples than in the S - phase enriched samples of HL60 cells, while levels of nuclear p62c - fos and p39c - jun were constant.	AP - 1,33,39,Gene/Protein	p62c - fos,62,72,Gene/Protein	p39c - jun,78,88,Gene/Protein	AP - 1,89,95,Gene/Protein	nuclear p62c - fos and p39c - jun,251,284,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""p62c - fos"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""p39c - jun"", ""start_span"": 78, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""nuclear p62c - fos and p39c - jun"", ""start_span"": 251, ""end_span"": 284, ""type"": ""Gene/Protein""}]"	train
Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation.	STAT1,18,23,Gene/Protein	STAT2,29,34,Gene/Protein	STAT3,39,44,Gene/Protein	signalling complexes,57,77,Gene/Protein	cytokine,87,95,Gene/Protein	"[{""token"": ""STAT1"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""STAT2"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""signalling complexes"", ""start_span"": 57, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	train
LPS - stimulated monocytes showed an increased expression of p105 mRNA, the precursor of the p50 subunit of the transcription factor nuclear factor - kappa B ( NF - kappa B), while no effect was noticed on the expression of p65 mRNA.	p105 mRNA,61,70,Gene/Protein	p50 subunit,93,104,Gene/Protein	transcription factor nuclear factor - kappa B,112,157,Gene/Protein	NF - kappa B,160,172,Gene/Protein	p65 mRNA,224,232,Gene/Protein	"[{""token"": ""p105 mRNA"", ""start_span"": 61, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""p50 subunit"", ""start_span"": 93, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor nuclear factor - kappa B"", ""start_span"": 112, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 160, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""p65 mRNA"", ""start_span"": 224, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	train
Stimulation with LPS or IFN - gamma resulted in the expression of p50 and p65 subunits, while the combination of IFN - gamma plus LPS caused a further increase in the expression of NF - kappa B.	IFN - gamma,24,35,Gene/Protein	p50,66,69,Gene/Protein	p65 subunits,74,86,Gene/Protein	IFN - gamma,113,124,Gene/Protein	NF - kappa B,181,193,Gene/Protein	"[{""token"": ""IFN - gamma"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""p65 subunits"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 113, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 181, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
We propose that HIV - 1 tat may inhibit MIP - 1 alpha expression by inducing MNP - 1 expression in T - cells, probably by either competing with MNP - 2 for binding to the MIP - 1 alpha promoter or by sequestering it into inactive forms.	HIV - 1 tat,16,27,Gene/Protein	MIP - 1 alpha,40,53,Gene/Protein	MNP - 1,77,84,Gene/Protein	MNP - 2,144,151,Gene/Protein	MIP - 1 alpha promoter,171,193,Gene/Protein	"[{""token"": ""HIV - 1 tat"", ""start_span"": 16, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 1 alpha"", ""start_span"": 40, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""MNP - 1"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""MNP - 2"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 1 alpha promoter"", ""start_span"": 171, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
Moreover, deletion of either 5 ' or 3 ' NF - kappaB sites reduced IL - 1alpha promoter activity in MT - 2 cells and transactivation of the IL - 1alpha promoter by exogenous NF - kappaB and Tax in Jurkat cells.	5 ' or 3 ' NF - kappaB sites,29,57,Gene/Protein	IL - 1alpha promoter,66,86,Gene/Protein	IL - 1alpha promoter,139,159,Gene/Protein	NF - kappaB,173,184,Gene/Protein	Tax,189,192,Gene/Protein	"[{""token"": ""5 ' or 3 ' NF - kappaB sites"", ""start_span"": 29, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1alpha promoter"", ""start_span"": 66, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1alpha promoter"", ""start_span"": 139, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 173, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
DNase I footprinting assays revealed four distinct sites that bind myeloid nuclear proteins ( - 408 to - 386, - 293 to - 254, - 76 to - 65, and - 34 to + 3).	myeloid nuclear proteins,67,91,Gene/Protein	- 408 to - 386,94,108,Gene/Protein	- 293 to - 254,110,124,Gene/Protein	- 76 to - 65,126,138,Gene/Protein	- 34 to + 3,144,155,Gene/Protein	"[{""token"": ""myeloid nuclear proteins"", ""start_span"": 67, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""- 408 to - 386"", ""start_span"": 94, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""- 293 to - 254"", ""start_span"": 110, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""- 76 to - 65"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""- 34 to + 3"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	train
Granulocyte - macrophage colony - stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93fes, STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes.	Granulocyte - macrophage colony - stimulating factor,0,52,Gene/Protein	JAK2,64,68,Gene/Protein	p93fes,109,115,Gene/Protein	STAT1 p91,117,126,Gene/Protein	STAT3 p92,132,141,Gene/Protein	"[{""token"": ""Granulocyte - macrophage colony - stimulating factor"", ""start_span"": 0, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""p93fes"", ""start_span"": 109, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 p91"", ""start_span"": 117, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""STAT3 p92"", ""start_span"": 132, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	train
In order to better characterize the human gammac promoter and define the minimal tissue - specific promoter region, progressive 5 ' - deletion constructs of a segment extending 1053 base pairs upstream of the major transcription start site were generated and tested for promoter activity in various hematopoietic and nonhematopoietic cell types.	human gammac promoter,36,57,Gene/Protein	minimal tissue - specific promoter region,73,114,Gene/Protein	5 ' - deletion constructs,128,153,Gene/Protein	1053 base pairs upstream,177,201,Gene/Protein	major transcription start site,209,239,Gene/Protein	"[{""token"": ""human gammac promoter"", ""start_span"": 36, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""minimal tissue - specific promoter region"", ""start_span"": 73, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - deletion constructs"", ""start_span"": 128, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""1053 base pairs upstream"", ""start_span"": 177, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""major transcription start site"", ""start_span"": 209, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Genetic characterization of transactivation of the human T - cell leukemia virus type 1 promoter: Binding of Tax to Tax - responsive element 1 is mediated by the cyclic AMP - responsive members of the CREB / ATF family of transcription factors.	human T - cell leukemia virus type 1 promoter,51,96,Gene/Protein	Tax,109,112,Gene/Protein	Tax - responsive element 1,116,142,Gene/Protein	cyclic AMP - responsive members,162,193,Gene/Protein	CREB / ATF family,201,218,Gene/Protein	"[{""token"": ""human T - cell leukemia virus type 1 promoter"", ""start_span"": 51, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Tax - responsive element 1"", ""start_span"": 116, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""cyclic AMP - responsive members"", ""start_span"": 162, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""CREB / ATF family"", ""start_span"": 201, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
Analysis of different CREB mutants with this genetic system indicated that the C - terminal 92 amino acid residues, which include the basic domain and the leucine zipper, are necessary and sufficient to mediate transactivation by Tax.	CREB mutants,22,34,Gene/Protein	C - terminal 92 amino acid residues,79,114,Gene/Protein	basic domain,134,146,Gene/Protein	leucine zipper,155,169,Gene/Protein	Tax,230,233,Gene/Protein	"[{""token"": ""CREB mutants"", ""start_span"": 22, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal 92 amino acid residues"", ""start_span"": 79, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""basic domain"", ""start_span"": 134, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""leucine zipper"", ""start_span"": 155, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 230, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
To identify cellular proteins binding to TRE - 1 in a Tax - dependent manner, this strain was also used to screen a library of human cDNAs fused to GAD.	cellular proteins,12,29,Gene/Protein	TRE - 1,41,48,Gene/Protein	Tax,54,57,Gene/Protein	human cDNAs,127,138,Gene/Protein	GAD,148,151,Gene/Protein	"[{""token"": ""cellular proteins"", ""start_span"": 12, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""TRE - 1"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""human cDNAs"", ""start_span"": 127, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""GAD"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	train
When fused to GAD, the C - terminal region of Ku was able to activate transcription via TRE - 1 but this activation was not dependent on Tax.	GAD,14,17,Gene/Protein	C - terminal region,23,42,Gene/Protein	Ku,46,48,Gene/Protein	TRE - 1,88,95,Gene/Protein	Tax,137,140,Gene/Protein	"[{""token"": ""GAD"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal region"", ""start_span"": 23, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Ku"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""TRE - 1"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
Oligonucleotides containing the IL - 13 or IL - 4 P element sites specifically bound the transcriptional activator protein, nuclear factor - activated T cells, preformed ( NF - ATp), when incubated with nuclear protein extracts from activated T cells.	IL - 13,32,39,Gene/Protein	IL - 4 P element sites,43,65,Gene/Protein	transcriptional activator protein,89,122,Gene/Protein	nuclear factor - activated T cells,124,158,Gene/Protein	NF - ATp,172,180,Gene/Protein	"[{""token"": ""IL - 13"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 P element sites"", ""start_span"": 43, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activator protein"", ""start_span"": 89, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - activated T cells"", ""start_span"": 124, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATp"", ""start_span"": 172, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
Because the primed T cells contain higher levels of nuclear NF - ATp, capable of binding to P elements of the IL - 4 and IL - 13 promoters, than do freshly - isolated T cells, the NF - AT - binding P elements are attractive candidates to mediate the coordinate expression of these two cytokine genes.	nuclear NF - ATp,52,68,Gene/Protein	P elements,92,102,Gene/Protein	IL - 4 and IL - 13 promoters,110,138,Gene/Protein	NF - AT - binding P elements,180,208,Gene/Protein	cytokine genes,285,299,Gene/Protein	"[{""token"": ""nuclear NF - ATp"", ""start_span"": 52, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""P elements"", ""start_span"": 92, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 and IL - 13 promoters"", ""start_span"": 110, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT - binding P elements"", ""start_span"": 180, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 285, ""end_span"": 299, ""type"": ""Gene/Protein""}]"	train
In resting T lymphocytes, the transcription factor NF - kappaB is sequestered in the cytoplasm via interactions with members of the I kappa B family of inhibitors, including IkappaBalpha and IkappaBbeta.	transcription factor,30,50,Gene/Protein	NF - kappaB,51,62,Gene/Protein	I kappa B family,132,148,Gene/Protein	IkappaBalpha,174,186,Gene/Protein	IkappaBbeta,191,202,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 30, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B family"", ""start_span"": 132, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 174, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBbeta"", ""start_span"": 191, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
Nevertheless, in the two leukemia cell lines transient overexpression of p16 reestablished the normal regulation of thymidine kinase, paralleled by an increase of the underphosphorylated form of retinoblastoma protein and decrease of free E2F bound to its motif in the thymidine kinase promoter.	p16,73,76,Gene/Protein	thymidine kinase,116,132,Gene/Protein	retinoblastoma protein,195,217,Gene/Protein	E2F,239,242,Gene/Protein	thymidine kinase promoter,269,294,Gene/Protein	"[{""token"": ""p16"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""thymidine kinase"", ""start_span"": 116, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""retinoblastoma protein"", ""start_span"": 195, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 239, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""thymidine kinase promoter"", ""start_span"": 269, ""end_span"": 294, ""type"": ""Gene/Protein""}]"	train
DNase I footprinting indicated that nuclear factors from activated T lymphocytes bound a promoter - proximal site, META ( P), and a promoter - distal site, META ( D +), within the 400 - base pair META region.	DNase I,0,7,Gene/Protein	nuclear factors,36,51,Gene/Protein	promoter - proximal site,89,113,Gene/Protein	promoter - distal site,132,154,Gene/Protein	400 - base pair META region,180,207,Gene/Protein	"[{""token"": ""DNase I"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factors"", ""start_span"": 36, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""promoter - proximal site"", ""start_span"": 89, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""promoter - distal site"", ""start_span"": 132, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""400 - base pair META region"", ""start_span"": 180, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
ICSAT is structurally most closely related to the previously cloned ICSBP, a member of the IFN regulatory factor ( IRF) family of proteins that binds to interferon consensus sequences ( ICSs) found in many promoters of the IFN - regulated genes.	ICSAT,0,5,Gene/Protein	ICSBP,68,73,Gene/Protein	interferon consensus sequences,153,183,Gene/Protein	ICSs,186,190,Gene/Protein	IFN - regulated genes,223,244,Gene/Protein	"[{""token"": ""ICSAT"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""ICSBP"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""interferon consensus sequences"", ""start_span"": 153, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""ICSs"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""IFN - regulated genes"", ""start_span"": 223, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
The class II transactivator ( CIITA) and B cell octamer - binding protein 1 / octamer - binding factor 1 / Oct coactivator from B cells ( Bob1 / OBF - 1 / OCA - B) represent two B cell - specific transcriptional coactivators.	class II transactivator,4,27,Gene/Protein	CIITA,30,35,Gene/Protein	B cell octamer - binding protein 1 / octamer - binding factor 1 / Oct coactivator,41,122,Gene/Protein	Bob1 / OBF - 1 / OCA - B,138,162,Gene/Protein	B cell - specific transcriptional coactivators,178,224,Gene/Protein	"[{""token"": ""class II transactivator"", ""start_span"": 4, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""B cell octamer - binding protein 1 / octamer - binding factor 1 / Oct coactivator"", ""start_span"": 41, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Bob1 / OBF - 1 / OCA - B"", ""start_span"": 138, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""B cell - specific transcriptional coactivators"", ""start_span"": 178, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
Here we show that HHV - 6 upregulates Zebra gene transcription through a cyclic AMP - responsive element ( CRE) located within the Zebra promoter ( Zp).	Zebra gene,38,48,Gene/Protein	cyclic AMP - responsive element,73,104,Gene/Protein	CRE,107,110,Gene/Protein	Zebra promoter,131,145,Gene/Protein	Zp,148,150,Gene/Protein	"[{""token"": ""Zebra gene"", ""start_span"": 38, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""cyclic AMP - responsive element"", ""start_span"": 73, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""CRE"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""Zebra promoter"", ""start_span"": 131, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""Zp"", ""start_span"": 148, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
The expression of cell surface markers including the interleukin 2 receptor alpha ( IL - 2R alpha) chain ( CD25), CD69 and L - selectin ( CD62) is normal in mitogen - activated Rel - / - T cells, but cytokine production is impaired.	CD25,107,111,Gene/Protein	CD69,114,118,Gene/Protein	L - selectin,123,135,Gene/Protein	CD62,138,142,Gene/Protein	cytokine,200,208,Gene/Protein	"[{""token"": ""CD25"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""CD69"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""L - selectin"", ""start_span"": 123, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""CD62"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 200, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	train
We analyzed expression of AP - 1, NF - kappa B, NF - AT, and octamer binding transcription factors, which are known to be involved in the regulation of IL - 2 gene promoter activity.	AP - 1,26,32,Gene/Protein	NF - kappa B,34,46,Gene/Protein	NF - AT,48,55,Gene/Protein	octamer binding transcription factors,61,98,Gene/Protein	IL - 2,152,158,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 34, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""octamer binding transcription factors"", ""start_span"": 61, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 152, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
In contrast, anergic CD4 + T cells contained severely reduced levels of AP - 1 and Fos / Jun - containing NF - AT complexes but expressed significant amounts of NF - kappa B and Oct binding proteins after SEA stimulation.	AP - 1,72,78,Gene/Protein	Fos / Jun - containing NF - AT complexes,83,123,Gene/Protein	NF - kappa B,161,173,Gene/Protein	Oct binding proteins,178,198,Gene/Protein	SEA,205,208,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 72, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""Fos / Jun - containing NF - AT complexes"", ""start_span"": 83, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 161, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""Oct binding proteins"", ""start_span"": 178, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""SEA"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	train
It has been shown that TCR stimulation requires both the membrane tyrosine phosphatase, CD45, and the Src - family kinase, Lck, to result in cellular activation.	TCR,23,26,Gene/Protein	membrane tyrosine phosphatase,57,86,Gene/Protein	CD45,88,92,Gene/Protein	Src - family kinase,102,121,Gene/Protein	Lck,123,126,Gene/Protein	"[{""token"": ""TCR"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""membrane tyrosine phosphatase"", ""start_span"": 57, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""CD45"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""Src - family kinase"", ""start_span"": 102, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Lck"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	train
Our data suggest that although CD45 and Lck are not required for Fas signaling, JNK activation may play an important role transducing distal signals that lead to apoptosis after Fas ligation.	CD45,31,35,Gene/Protein	Lck,40,43,Gene/Protein	Fas,65,68,Gene/Protein	JNK,80,83,Gene/Protein	Fas,178,181,Gene/Protein	"[{""token"": ""CD45"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""Lck"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""Fas"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""Fas"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
Analysis of various Tax mutants suggested that galectin - 3 promoter induction is dependent on activation of the cyclic - AMP - responsive element binding protein / activation transcription factor family of transcription factors and, to a lesser extent, nuclear factor - kappa B / Rel induction.	Tax mutants,20,31,Gene/Protein	galectin - 3 promoter,47,68,Gene/Protein	cyclic - AMP - responsive element binding protein / activation transcription factor family,113,203,Gene/Protein	transcription factors,207,228,Gene/Protein	nuclear factor - kappa B / Rel,254,284,Gene/Protein	"[{""token"": ""Tax mutants"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""galectin - 3 promoter"", ""start_span"": 47, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""cyclic - AMP - responsive element binding protein / activation transcription factor family"", ""start_span"": 113, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 207, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappa B / Rel"", ""start_span"": 254, ""end_span"": 284, ""type"": ""Gene/Protein""}]"	train
Polyubiquitinylated c - Jun, wbFos, and wbJun, but not E220K - ubiquitinylated c - Jun, were readily degraded by the ATP - dependent 26 S multicatalytic proteases.	c - Jun,20,27,Gene/Protein	wbFos,29,34,Gene/Protein	wbJun,40,45,Gene/Protein	E220K - ubiquitinylated c - Jun,55,86,Gene/Protein	ATP - dependent 26 S multicatalytic proteases,117,162,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""wbFos"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""wbJun"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""E220K - ubiquitinylated c - Jun"", ""start_span"": 55, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""ATP - dependent 26 S multicatalytic proteases"", ""start_span"": 117, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
These results suggest that the temporal control of c - Jun and c - Fos may be regulated through the ubiquitinylation pathways, and the ubiquitinylation of c - Jun and c - Fos may in turn be regulated in response to the heterodimerization between them and the cooperation between E220K and E3 mediated polyubiquitinylation.	c - Jun,51,58,Gene/Protein	c - Fos,63,70,Gene/Protein	c - Jun,155,162,Gene/Protein	c - Fos,167,174,Gene/Protein	E220K,279,284,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 167, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""E220K"", ""start_span"": 279, ""end_span"": 284, ""type"": ""Gene/Protein""}]"	train
Signal transducers and activators of transcription ( STATs) are rapidly phosphorylated on tyrosine residues in response to cytokine and growth factor stimulation of cell surface receptors.	Signal transducers and activators of transcription,0,50,Gene/Protein	STATs,53,58,Gene/Protein	cytokine,123,131,Gene/Protein	growth factor,136,149,Gene/Protein	cell surface receptors,165,187,Gene/Protein	"[{""token"": ""Signal transducers and activators of transcription"", ""start_span"": 0, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""STATs"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""growth factor"", ""start_span"": 136, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""cell surface receptors"", ""start_span"": 165, ""end_span"": 187, ""type"": ""Gene/Protein""}]"	train
Tyrosine kinase - dependent, and not protein kinase C - dependent, pathways mediate CD23 - triggered NF - kappaB activation but do not participate in the direct phosphorylation of IkappaBalpha.	Tyrosine kinase,0,15,Gene/Protein	protein kinase C,37,53,Gene/Protein	CD23,84,88,Gene/Protein	NF - kappaB,101,112,Gene/Protein	IkappaBalpha,180,192,Gene/Protein	"[{""token"": ""Tyrosine kinase"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 37, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 180, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
Phosphorylated Bcl - 2 can not bind calcineurin, and NFAT activation, FasL expression, and apoptosis can occur after Bcl - 2 phosphorylation.	Bcl - 2,15,22,Gene/Protein	calcineurin,36,47,Gene/Protein	NFAT,53,57,Gene/Protein	FasL,70,74,Gene/Protein	Bcl - 2,117,124,Gene/Protein	"[{""token"": ""Bcl - 2"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 36, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""FasL"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Gene/Protein""}]"	train
These in vivo anti - inflammatory effects of IL - 11 were associated with reduced NF - kappaB activation in lung, reduced levels of tumor necrosis factor alpha ( TNF - alpha) in bronchoalveolar lavage ( BAL) fluids, and diminished up - regulation of lung vascular ICAM - 1.	IL - 11,45,52,Gene/Protein	NF - kappaB,82,93,Gene/Protein	tumor necrosis factor alpha,132,159,Gene/Protein	TNF - alpha,162,173,Gene/Protein	lung vascular ICAM - 1,250,272,Gene/Protein	"[{""token"": ""IL - 11"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 132, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 162, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""lung vascular ICAM - 1"", ""start_span"": 250, ""end_span"": 272, ""type"": ""Gene/Protein""}]"	train
These data indicate that IL - 11 is a regulatory cytokine in the lung and that, like other members of this family, its anti - inflammatory properties appear to be linked to its suppression of NF - kappaB activation, diminished production of TNF - alpha, and reduced up - regulation of lung vascular ICAM - 1.	IL - 11,25,32,Gene/Protein	regulatory cytokine,38,57,Gene/Protein	NF - kappaB,192,203,Gene/Protein	TNF - alpha,241,252,Gene/Protein	lung vascular ICAM - 1,285,307,Gene/Protein	"[{""token"": ""IL - 11"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""regulatory cytokine"", ""start_span"": 38, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 192, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 241, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""lung vascular ICAM - 1"", ""start_span"": 285, ""end_span"": 307, ""type"": ""Gene/Protein""}]"	train
The Jak family of tyrosine kinases are known to mediate some of the effects of cytokines or hematopoietic growth factors by recruitment and tyrosine phosphorylation of a variety of Stat ( signal transducers and activators of transcription) proteins.	tyrosine kinases,18,34,Gene/Protein	cytokines,79,88,Gene/Protein	hematopoietic growth factors,92,120,Gene/Protein	Stat,181,185,Gene/Protein	signal transducers and activators of transcription,188,238,Gene/Protein	"[{""token"": ""tyrosine kinases"", ""start_span"": 18, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""hematopoietic growth factors"", ""start_span"": 92, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""Stat"", ""start_span"": 181, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers and activators of transcription"", ""start_span"": 188, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	train
Cytotoxicity markers assessed include tumor cell killing, IL - 1 secretion, reactive oxygen intermediate release, nitric oxide synthetase activity as measured by the release of reactive nitrogen intermediates, complement receptor - 1 cell surface protein, and TNF - alpha protein presence.	Cytotoxicity markers,0,20,Gene/Protein	IL - 1,58,64,Gene/Protein	nitric oxide synthetase,114,137,Gene/Protein	complement receptor - 1 cell surface protein,210,254,Gene/Protein	TNF - alpha protein,260,279,Gene/Protein	"[{""token"": ""Cytotoxicity markers"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""nitric oxide synthetase"", ""start_span"": 114, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""complement receptor - 1 cell surface protein"", ""start_span"": 210, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha protein"", ""start_span"": 260, ""end_span"": 279, ""type"": ""Gene/Protein""}]"	train
These findings demonstrate that IFNs inhibit IL - 4 - induced activation of STAT6 and STAT6 - dependent gene expression, at least in part, by inducing expression of SOCS - 1.	IFNs,32,36,Gene/Protein	IL - 4,45,51,Gene/Protein	STAT6,76,81,Gene/Protein	STAT6,86,91,Gene/Protein	SOCS - 1,165,173,Gene/Protein	"[{""token"": ""IFNs"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""SOCS - 1"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Body weight, body mass index, body fat, lean body mass, blood - glucose, cholesterol, HDL - cholesterol, triglyceride, beta - lipoproteins, insulin, gonadotropin, estradiol, testosterone, SHBG, T3, T4 and TSH levels as well as estradiol and progesterone receptor levels in excised tumor were studied in 40 patients with breast cancer prior to conservative treatment.	HDL - cholesterol,86,103,Gene/Protein	beta - lipoproteins,119,138,Gene/Protein	SHBG,188,192,Gene/Protein	T3,194,196,Gene/Protein	T4,198,200,Gene/Protein	"[{""token"": ""HDL - cholesterol"", ""start_span"": 86, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""beta - lipoproteins"", ""start_span"": 119, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""SHBG"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""T3"", ""start_span"": 194, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""T4"", ""start_span"": 198, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
Taken together, these results suggest that IL - 10 - activated STAT1 has a specificity in binding to the GAS - motif sequences, whereas IFN - gamma - activated STAT1 and STAT5 have a broader spectrum in binding to the GAS - motif sequences.	IL - 10 - activated STAT1,43,68,Gene/Protein	GAS - motif sequences,105,126,Gene/Protein	IFN - gamma - activated STAT1,136,165,Gene/Protein	STAT5,170,175,Gene/Protein	GAS - motif sequences,218,239,Gene/Protein	"[{""token"": ""IL - 10 - activated STAT1"", ""start_span"": 43, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""GAS - motif sequences"", ""start_span"": 105, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma - activated STAT1"", ""start_span"": 136, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""GAS - motif sequences"", ""start_span"": 218, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Transcription factor NF kappa B ( nuclear factor kappa B) is induced in T lymphocytes from young individuals following activation with a variety of stimuli including anti - CD3, phorbol myristate acetate ( PMA), and tumor necrosis factor - alpha ( TNF - alpha).	NF kappa B,21,31,Gene/Protein	nuclear factor kappa B,34,56,Gene/Protein	anti - CD3,166,176,Gene/Protein	tumor necrosis factor - alpha,216,245,Gene/Protein	TNF - alpha,248,259,Gene/Protein	"[{""token"": ""NF kappa B"", ""start_span"": 21, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappa B"", ""start_span"": 34, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 166, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 216, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 248, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	train
Promoter assays revealed CD28 - dependent effects on both NF - kappaB and AP - 1, but not on NF - AT or the intact IL - 2 promoter.	CD28,25,29,Gene/Protein	NF - kappaB,58,69,Gene/Protein	AP - 1,74,80,Gene/Protein	NF - AT,93,100,Gene/Protein	IL - 2 promoter,115,130,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 58, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Gene/Protein""}]"	train
Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL - 2 and the IL - 2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL - 2.	Abs,73,76,Gene/Protein	IL - 2,85,91,Gene/Protein	IL - 2 receptor,100,115,Gene/Protein	CD28,166,170,Gene/Protein	IL - 2,190,196,Gene/Protein	"[{""token"": ""Abs"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor"", ""start_span"": 100, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 190, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
We have recently shown that the expression of Tax protected the mouse T - cell line CTLL - 2 against apoptosis induced by interleukin - 2 ( IL - 2) deprivation and converted its growth from being IL - 2 dependent to being IL - 2 independent.	Tax,46,49,Gene/Protein	interleukin - 2,122,137,Gene/Protein	IL - 2,140,146,Gene/Protein	IL - 2,196,202,Gene/Protein	IL - 2,222,228,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 122, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 196, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 222, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	train
Compared with IL - 2, CD3 ligation induces a delayed Stat3 binding to oligonucleotide probes from the ICAM - 1 and IL - 2R alpha promoter.	IL - 2,14,20,Gene/Protein	CD3,22,25,Gene/Protein	Stat3,53,58,Gene/Protein	ICAM - 1,102,110,Gene/Protein	IL - 2R alpha promoter,115,137,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha promoter"", ""start_span"": 115, ""end_span"": 137, ""type"": ""Gene/Protein""}]"	train
Consistent with these data, CD40 signals up - regulate c - jun but not c - fos mRNA and alter the transcription factor ATF2 but not the Raf - 1 protein.	CD40,28,32,Gene/Protein	c - jun but not c - fos mRNA,55,83,Gene/Protein	transcription factor,98,118,Gene/Protein	ATF2,119,123,Gene/Protein	Raf - 1 protein,136,151,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""c - jun but not c - fos mRNA"", ""start_span"": 55, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 98, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""ATF2"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""Raf - 1 protein"", ""start_span"": 136, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	train
TNF is the major inducer of NF - kappaB and particularly of the p50 - p65 complex, whereas IL - 7 acts as a cofactor by sustaining the expression of the p75 TNF receptor.	TNF,0,3,Gene/Protein	NF - kappaB,28,39,Gene/Protein	p50 - p65 complex,64,81,Gene/Protein	IL - 7,91,97,Gene/Protein	p75 TNF receptor,153,169,Gene/Protein	"[{""token"": ""TNF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""p50 - p65 complex"", ""start_span"": 64, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""p75 TNF receptor"", ""start_span"": 153, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
In addition to Bcl - x, a known CD40 - regulated antiapoptotic molecule, we identified a related antiapoptotic molecule, A1 / Bfl - 1, as a CD40 - inducible gene.	Bcl - x,15,22,Gene/Protein	CD40 - regulated antiapoptotic molecule,32,71,Gene/Protein	antiapoptotic molecule,97,119,Gene/Protein	A1 / Bfl - 1,121,133,Gene/Protein	CD40 - inducible gene,140,161,Gene/Protein	"[{""token"": ""Bcl - x"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CD40 - regulated antiapoptotic molecule"", ""start_span"": 32, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""antiapoptotic molecule"", ""start_span"": 97, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""A1 / Bfl - 1"", ""start_span"": 121, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""CD40 - inducible gene"", ""start_span"": 140, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
These findings indicate that MBP is selective among the eosinophil granule proteins as a stimulus for neutrophil IL - 8 release and, further, that stimulation of neutrophil IL - 8 release by MBP involves both transcriptional and posttranscriptional regulation.	MBP,29,32,Gene/Protein	eosinophil granule proteins,56,83,Gene/Protein	IL - 8,113,119,Gene/Protein	IL - 8,173,179,Gene/Protein	MBP,191,194,Gene/Protein	"[{""token"": ""MBP"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""eosinophil granule proteins"", ""start_span"": 56, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
The flow of information from calcium - mobilizing receptors to nuclear factor of activated T cells ( NFAT) - dependent genes is critically dependent on interaction between the phosphatase calcineurin and the transcription factor NFAT.	calcium - mobilizing receptors,29,59,Gene/Protein	phosphatase,176,187,Gene/Protein	calcineurin,188,199,Gene/Protein	transcription factor,208,228,Gene/Protein	NFAT,229,233,Gene/Protein	"[{""token"": ""calcium - mobilizing receptors"", ""start_span"": 29, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""phosphatase"", ""start_span"": 176, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 188, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 208, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 229, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
In the current study, we show 9 - cis retinoic acid ( RA), a ligand for the nuclear hormone receptor retinoid X receptor ( RXR) and retinoic acid receptor ( RAR), markedly induces the expression of MCP - 1.	nuclear hormone receptor retinoid X receptor,76,120,Gene/Protein	RXR,123,126,Gene/Protein	retinoic acid receptor,132,154,Gene/Protein	RAR,157,160,Gene/Protein	MCP - 1,198,205,Gene/Protein	"[{""token"": ""nuclear hormone receptor retinoid X receptor"", ""start_span"": 76, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""RXR"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""retinoic acid receptor"", ""start_span"": 132, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""RAR"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
Reporter gene experiments finally showed that transcription from promoters of STAT5 target genes can be specifically induced by challenging cells with IL - 4, and that both STAT5a and STAT5b can contribute to IL - 4 - triggered transcriptional control.	STAT5,78,83,Gene/Protein	IL - 4,151,157,Gene/Protein	STAT5a,173,179,Gene/Protein	STAT5b,184,190,Gene/Protein	IL - 4,209,215,Gene/Protein	"[{""token"": ""STAT5"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""STAT5a"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""STAT5b"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 209, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
Adenoviruses encode proteins that block responses to interferons, intrinsic cellular apoptosis, killing by CD8 ( +) cytotoxic T lymphocytes and killing by the death ligands TNF, Fas ligand and TRAIL.	interferons,53,64,Gene/Protein	death ligands,159,172,Gene/Protein	TNF,173,176,Gene/Protein	Fas ligand,178,188,Gene/Protein	TRAIL,193,198,Gene/Protein	"[{""token"": ""interferons"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""death ligands"", ""start_span"": 159, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""Fas ligand"", ""start_span"": 178, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""TRAIL"", ""start_span"": 193, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
Our results provide the first evidence that both GATA - 1 and C / EBPbeta synergistically transactivate the promoter of an eosinophil - specific granule protein gene and that FOG may act as a negative cofactor for the eosinophil lineage, unlike its positively regulatory function for the erythroid and megakaryocyte lineages.	GATA - 1,49,57,Gene/Protein	C / EBPbeta,62,73,Gene/Protein	promoter,108,116,Gene/Protein	eosinophil - specific granule protein gene,123,165,Gene/Protein	FOG,175,178,Gene/Protein	"[{""token"": ""GATA - 1"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""C / EBPbeta"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""eosinophil - specific granule protein gene"", ""start_span"": 123, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""FOG"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
These analyses demonstrated that the [ 3H] aldosterone - MBP - HBD complex is at least associated with hsp90 in reticulocyte lysate and that the HBD of hMR is sufficient to bind hsp90.	MBP - HBD complex,57,74,Gene/Protein	hsp90,103,108,Gene/Protein	HBD,145,148,Gene/Protein	hMR,152,155,Gene/Protein	hsp90,178,183,Gene/Protein	"[{""token"": ""MBP - HBD complex"", ""start_span"": 57, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""hsp90"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""HBD"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""hMR"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""hsp90"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
By using Jurkat and primary human T lymphocytes, we demonstrate that the simultaneous activation of two second messengers of the TCR - initiated signal transduction, protein kinase C ( PKC) and calcineurin, results in the synergistic activation of the IkappaBalpha kinase ( IKK) complex but not of another putative IkappaBalpha kinase, p90 ( rsk).	TCR,129,132,Gene/Protein	protein kinase C,166,182,Gene/Protein	PKC,185,188,Gene/Protein	calcineurin,194,205,Gene/Protein	putative IkappaBalpha kinase,306,334,Gene/Protein	"[{""token"": ""TCR"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 166, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 194, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""putative IkappaBalpha kinase"", ""start_span"": 306, ""end_span"": 334, ""type"": ""Gene/Protein""}]"	train
mRNA levels for IL - 13R alpha1, but not IL - 4R alpha, were markedly decreased in in vitro monocyte - derived macrophages ( MDMac), and with increasing time of monocytes in culture correlated with the loss of IL - 13 regulation of lipopolysaccharide - induced TNF - alpha production.	mRNA,0,4,Gene/Protein	IL - 13R alpha1,16,31,Gene/Protein	IL - 4R alpha,41,54,Gene/Protein	IL - 13,210,217,Gene/Protein	TNF - alpha,261,272,Gene/Protein	"[{""token"": ""mRNA"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13R alpha1"", ""start_span"": 16, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R alpha"", ""start_span"": 41, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 210, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 261, ""end_span"": 272, ""type"": ""Gene/Protein""}]"	train
IL - 13 activation of STAT6 was reduced in MDMac which was associated with diminished IL - 13 - induced expression of CD23 and MHC class II.	IL - 13,0,7,Gene/Protein	STAT6,22,27,Gene/Protein	IL - 13,86,93,Gene/Protein	CD23,118,122,Gene/Protein	MHC class II,127,139,Gene/Protein	"[{""token"": ""IL - 13"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""MHC class II"", ""start_span"": 127, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
In addition, it has been established that tumor necrosis factor - alpha ( TNF - alpha) can activate the expression of wild type p53 in concert with the nuclear transcription factor, NF - kappa B.	tumor necrosis factor - alpha,42,71,Gene/Protein	TNF - alpha,74,85,Gene/Protein	wild type p53,118,131,Gene/Protein	nuclear transcription factor,152,180,Gene/Protein	NF - kappa B,182,194,Gene/Protein	"[{""token"": ""tumor necrosis factor - alpha"", ""start_span"": 42, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""wild type p53"", ""start_span"": 118, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""nuclear transcription factor"", ""start_span"": 152, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 182, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
To understand the function of AML1 during B cell differentiation, we analyzed regulatory regions of B cell - specific genes for potential AML1 - binding sites and have identified a putative AML1 - binding site in the promoter of the B cell - specific tyrosine kinase gene, blk.	AML1,30,34,Gene/Protein	regulatory regions,78,96,Gene/Protein	B cell - specific genes,100,123,Gene/Protein	AML1 - binding sites,138,158,Gene/Protein	AML1 - binding site,190,209,Gene/Protein	"[{""token"": ""AML1"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""regulatory regions"", ""start_span"": 78, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""B cell - specific genes"", ""start_span"": 100, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""AML1 - binding sites"", ""start_span"": 138, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""AML1 - binding site"", ""start_span"": 190, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
Physical interaction of AML1 with BSAP correlates with functional cooperativity in transfection studies where AML1 and BSAP synergistically activate blk promoter transcription by more than 50 - fold.	AML1,24,28,Gene/Protein	BSAP,34,38,Gene/Protein	AML1,110,114,Gene/Protein	BSAP,119,123,Gene/Protein	blk,149,152,Gene/Protein	"[{""token"": ""AML1"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""AML1"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""blk"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
These results demonstrate physical and functional interactions between AML1 and BSAP and suggest that AML1 is an important factor for regulating a critical B cell - specific gene, blk.	AML1,71,75,Gene/Protein	BSAP,80,84,Gene/Protein	AML1,102,106,Gene/Protein	B cell - specific gene,156,178,Gene/Protein	blk,180,183,Gene/Protein	"[{""token"": ""AML1"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""AML1"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""B cell - specific gene"", ""start_span"": 156, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""blk"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
Tumor cell lines with a defective retinoblastoma gene are unable to transcribe the HLA class II genes in response to IFN - gamma treatment, and reconstitution of functional Rb rescues IFN - gamma - induced class II gene expression.	retinoblastoma gene,34,53,Gene/Protein	HLA class II genes,83,101,Gene/Protein	IFN - gamma,117,128,Gene/Protein	Rb,173,175,Gene/Protein	class II gene,206,219,Gene/Protein	"[{""token"": ""retinoblastoma gene"", ""start_span"": 34, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""HLA class II genes"", ""start_span"": 83, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 117, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 173, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""class II gene"", ""start_span"": 206, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
In addition, BLPs stimulated nuclear factor - kappaB, a transcriptional activator of multiple host defense genes, and activated the respiratory burst through hTLR2.	BLPs,13,17,Gene/Protein	nuclear factor - kappaB,29,52,Gene/Protein	transcriptional activator,56,81,Gene/Protein	multiple host defense genes,85,112,Gene/Protein	hTLR2,158,163,Gene/Protein	"[{""token"": ""BLPs"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappaB"", ""start_span"": 29, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activator"", ""start_span"": 56, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""multiple host defense genes"", ""start_span"": 85, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""hTLR2"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
We show that TLR2 associates with the high - affinity LPS binding protein membrane CD14 to serve as an LPS receptor complex, and that LPS treatment enhances the oligomerization of TLR2.	TLR2,13,17,Gene/Protein	high - affinity LPS binding protein,38,73,Gene/Protein	CD14,83,87,Gene/Protein	LPS receptor complex,103,123,Gene/Protein	TLR2,180,184,Gene/Protein	"[{""token"": ""TLR2"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""high - affinity LPS binding protein"", ""start_span"": 38, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""LPS receptor complex"", ""start_span"": 103, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""TLR2"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
Furthermore, IL - 2 and IL - 12 synergistically induced IRF - 1, whereas IFN - alpha and IL - 12 did not.	IL - 2,13,19,Gene/Protein	IL - 12,24,31,Gene/Protein	IRF - 1,56,63,Gene/Protein	IFN - alpha,73,84,Gene/Protein	IL - 12,89,96,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 73, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Gene/Protein""}]"	train
First, STAT4 was required for the IL - 12 - dependent transactivation of an IRF - 1 reporter construct, and second, STAT4 binding to the IRF - 1 promoter was shown using EMSA.	STAT4,7,12,Gene/Protein	IL - 12,34,41,Gene/Protein	IRF - 1 reporter construct,76,102,Gene/Protein	STAT4,116,121,Gene/Protein	IRF - 1 promoter,137,153,Gene/Protein	"[{""token"": ""STAT4"", ""start_span"": 7, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1 reporter construct"", ""start_span"": 76, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""STAT4"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1 promoter"", ""start_span"": 137, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
In contrast to IL - 12, no up - regulation of IRF - 1 was found in IL - 4 - stimulated cells, and IL - 4 did not block IL - 12 - dependent up - regulation of IRF - 1.	IL - 12,15,22,Gene/Protein	IRF - 1,46,53,Gene/Protein	IL - 4,67,73,Gene/Protein	IL - 12,119,126,Gene/Protein	IRF - 1,158,165,Gene/Protein	"[{""token"": ""IL - 12"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 158, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
The correlation between C5a - induced kappaB binding activity and IL - 8 gene expression was examined in the RAW264. 7 macrophage cells using reporter genes directed by the kappaB sequence from IkappaBalpha and IL - 8 promoter regions.	kappaB,38,44,Gene/Protein	IL - 8,66,72,Gene/Protein	kappaB sequence,173,188,Gene/Protein	IkappaBalpha,194,206,Gene/Protein	IL - 8 promoter regions,211,234,Gene/Protein	"[{""token"": ""kappaB"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""kappaB sequence"", ""start_span"": 173, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 194, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8 promoter regions"", ""start_span"": 211, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
We have constructed an HIV - 1 genome carrying the cDNA of a proteolysis - resistant nuclear factor - kappaB inhibitor ( IkappaB - alphaS32 / 36A) in the nef region.	HIV - 1 genome,23,37,Gene/Protein	cDNA,51,55,Gene/Protein	proteolysis - resistant nuclear factor - kappaB inhibitor,61,118,Gene/Protein	IkappaB - alphaS32 / 36A,121,145,Gene/Protein	nef region,154,164,Gene/Protein	"[{""token"": ""HIV - 1 genome"", ""start_span"": 23, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""cDNA"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""proteolysis - resistant nuclear factor - kappaB inhibitor"", ""start_span"": 61, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB - alphaS32 / 36A"", ""start_span"": 121, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""nef region"", ""start_span"": 154, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
We developed retroviral vectors in which the constitutive viral enhancer in the U3 region of the 3 ' LTR is replaced by an autoregulatory enhancer of the erythroid - specific GATA - 1 transcription factor gene.	constitutive viral enhancer,45,72,Gene/Protein	U3 region,80,89,Gene/Protein	3 ' LTR,97,104,Gene/Protein	autoregulatory enhancer,123,146,Gene/Protein	erythroid - specific GATA - 1 transcription factor gene,154,209,Gene/Protein	"[{""token"": ""constitutive viral enhancer"", ""start_span"": 45, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""U3 region"", ""start_span"": 80, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""3 ' LTR"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""autoregulatory enhancer"", ""start_span"": 123, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""erythroid - specific GATA - 1 transcription factor gene"", ""start_span"": 154, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
LMP1 needs only 11 amino acids to activate NF - kappaB or synergize with TRADD in NF - kappaB activation, while TNFR1 requires approximately 70 residues.	LMP1,0,4,Gene/Protein	NF - kappaB,43,54,Gene/Protein	TRADD,73,78,Gene/Protein	NF - kappaB,82,93,Gene/Protein	TNFR1,112,117,Gene/Protein	"[{""token"": ""LMP1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""TRADD"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""TNFR1"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
Further, LMP1 does not require TRADD residues 294 to 312 for NF - kappaB activation, while TNFR1 requires TRADD residues 296 to 302.	LMP1,9,13,Gene/Protein	TRADD,31,36,Gene/Protein	NF - kappaB,61,72,Gene/Protein	TNFR1,91,96,Gene/Protein	TRADD,106,111,Gene/Protein	"[{""token"": ""LMP1"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""TRADD"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""TNFR1"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""TRADD"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Gene/Protein""}]"	train
Unlike TNFR1, LMP1 can interact directly with receptor - interacting protein ( RIP) and stably associates with RIP in EBV - transformed lymphoblastoid cell lines.	TNFR1,7,12,Gene/Protein	LMP1,14,18,Gene/Protein	receptor - interacting protein,46,76,Gene/Protein	RIP,79,82,Gene/Protein	RIP,111,114,Gene/Protein	"[{""token"": ""TNFR1"", ""start_span"": 7, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""receptor - interacting protein"", ""start_span"": 46, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""RIP"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""RIP"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}]"	train
We identified this 92 - kDa protein as STAT5, but not as STATs1, 3, and 6 nor c - fes and vav protooncogene products, and demonstrated its translocation to the nucleus, enhancement of specific DNA binding capacity, and potentiation of trancriptional activity by GM - CSF.	92 - kDa protein,19,35,Gene/Protein	STAT5,39,44,Gene/Protein	c - fes,78,85,Gene/Protein	vav protooncogene products,90,116,Gene/Protein	GM - CSF,262,270,Gene/Protein	"[{""token"": ""92 - kDa protein"", ""start_span"": 19, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""c - fes"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""vav protooncogene products"", ""start_span"": 90, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 262, ""end_span"": 270, ""type"": ""Gene/Protein""}]"	train
Mutation of Aiolos - binding sites within the Bcl - 2 promoter inhibits transactivation of the reporter gene luciferase, suggesting direct control of Bcl - 2 expression by Aiolos.	Aiolos - binding sites,12,34,Gene/Protein	Bcl - 2 promoter,46,62,Gene/Protein	reporter gene luciferase,95,119,Gene/Protein	Bcl - 2,150,157,Gene/Protein	Aiolos,172,178,Gene/Protein	"[{""token"": ""Aiolos - binding sites"", ""start_span"": 12, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2 promoter"", ""start_span"": 46, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene luciferase"", ""start_span"": 95, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""Aiolos"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Our results suggest that the induction of STAT1 and STAT5 by Tax enhances cytokine - induced functions of virus - infected T - cells, hence the induction may play a role in IL - 2 - dependent transformation steps of T - cells by HTLV - 1.	STAT1,42,47,Gene/Protein	STAT5,52,57,Gene/Protein	Tax,61,64,Gene/Protein	cytokine,74,82,Gene/Protein	IL - 2,173,179,Gene/Protein	"[{""token"": ""STAT1"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
IL - 4R are thought to be composed of the IL - 4R alpha chain ( IL - 4R alpha) and either the IL - 2R gamma chain or the IL - 13R alpha chain.	IL - 4R,0,7,Gene/Protein	IL - 4R alpha chain,42,61,Gene/Protein	IL - 4R alpha,64,77,Gene/Protein	IL - 2R gamma chain,94,113,Gene/Protein	IL - 13R alpha chain,121,141,Gene/Protein	"[{""token"": ""IL - 4R"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R alpha chain"", ""start_span"": 42, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R alpha"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R gamma chain"", ""start_span"": 94, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13R alpha chain"", ""start_span"": 121, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	train
We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP - 1, and DRIP205, a subunit of the DRIP coactivator complex.	VDR,52,55,Gene/Protein	RXR,78,81,Gene/Protein	GRIP - 1,83,91,Gene/Protein	DRIP205,97,104,Gene/Protein	DRIP coactivator complex,123,147,Gene/Protein	"[{""token"": ""VDR"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""RXR"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""GRIP - 1"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""DRIP205"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""DRIP coactivator complex"", ""start_span"": 123, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	train
Compared with the interaction of VDR with RXR or GRIP - 1, the differentiation dose - response most closely correlated to the ligand - dependent recruitment of the DRIP coactivator complex to VDR and to the ability of the receptor to activate transcription in a cell - free system.	VDR,33,36,Gene/Protein	RXR,42,45,Gene/Protein	GRIP - 1,49,57,Gene/Protein	DRIP coactivator complex,164,188,Gene/Protein	VDR,192,195,Gene/Protein	"[{""token"": ""VDR"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""RXR"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""GRIP - 1"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""DRIP coactivator complex"", ""start_span"": 164, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""VDR"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Following T cell antigen receptor stimulation, SLP - 76 and Vav both undergo tyrosine phosphorylation and associate with each other via the SH2 domain of Vav and phosphorylated tyrosines of SLP - 76.	T cell antigen receptor,10,33,Gene/Protein	SLP - 76,47,55,Gene/Protein	Vav,60,63,Gene/Protein	Vav,154,157,Gene/Protein	SLP - 76,190,198,Gene/Protein	"[{""token"": ""T cell antigen receptor"", ""start_span"": 10, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""SLP - 76"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""Vav"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Vav"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""SLP - 76"", ""start_span"": 190, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
Consequently, inhibition of NF - kappaB nuclear translocation and the expression of dominant negative mutant forms of components of the NF - kappaB activation pathway, such as IkappaBalpha or p65, prompt rapid apoptosis of T. parva - transformed T cells.	NF - kappaB,28,39,Gene/Protein	dominant negative mutant,84,108,Gene/Protein	NF - kappaB,136,147,Gene/Protein	IkappaBalpha,176,188,Gene/Protein	p65,192,195,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""dominant negative mutant"", ""start_span"": 84, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 176, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Based on these and our recent findings of associations between Ikaros and Mi - 2 - HDAC, we propose that Ikaros family members modulate gene expression during lymphocyte development by recruiting distinct histone deacetylase complexes to specific promoters.	Ikaros,63,69,Gene/Protein	Mi - 2 - HDAC,74,87,Gene/Protein	Ikaros family members,105,126,Gene/Protein	histone deacetylase complexes,205,234,Gene/Protein	specific promoters,238,256,Gene/Protein	"[{""token"": ""Ikaros"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Mi - 2 - HDAC"", ""start_span"": 74, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""Ikaros family members"", ""start_span"": 105, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""histone deacetylase complexes"", ""start_span"": 205, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""specific promoters"", ""start_span"": 238, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
PI3 - kinase activity was an upstream activator of PKB / Akt because the PI3 - kinase inhibitor LY294002 blocked both constitutive PKB / Akt and factor - dependent PKB / Akt activity.	PI3 - kinase,0,12,Gene/Protein	PKB / Akt,51,60,Gene/Protein	PI3 - kinase,73,85,Gene/Protein	PKB / Akt,131,140,Gene/Protein	PKB / Akt,164,173,Gene/Protein	"[{""token"": ""PI3 - kinase"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""PKB / Akt"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""PI3 - kinase"", ""start_span"": 73, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""PKB / Akt"", ""start_span"": 131, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""PKB / Akt"", ""start_span"": 164, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Constitutive STAT5 activity, activated through an unknown pathway not including JAK2 or EPOR, may act in concert with the constitutive PI3 - kinase / PKB / Akt pathway to protect the EPO - independent HCD57 - SREI cells from apoptosis and promote limited proliferation.	STAT5,13,18,Gene/Protein	JAK2,80,84,Gene/Protein	EPOR,88,92,Gene/Protein	PI3 - kinase,135,147,Gene/Protein	/ PKB / Akt,148,159,Gene/Protein	"[{""token"": ""STAT5"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""EPOR"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""PI3 - kinase"", ""start_span"": 135, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""/ PKB / Akt"", ""start_span"": 148, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
Likewise, NF - AT1 mRNA and NF - AT4 mRNA have been detected in resting eosinophils, and their levels can be significantly up - regulated by the Th2 - associated cytokines IL - 4 and IL - 5.	NF - AT1 mRNA,10,23,Gene/Protein	NF - AT4 mRNA,28,41,Gene/Protein	Th2 - associated cytokines,145,171,Gene/Protein	IL - 4,172,178,Gene/Protein	IL - 5,183,189,Gene/Protein	"[{""token"": ""NF - AT1 mRNA"", ""start_span"": 10, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT4 mRNA"", ""start_span"": 28, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""Th2 - associated cytokines"", ""start_span"": 145, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 183, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
We show here that the transcriptional co - activators CBP / p300 bind to and control the activity of the inducible N - terminal transactivation domain of NF - ATc, TAD - A.	transcriptional co - activators,22,53,Gene/Protein	CBP / p300,54,64,Gene/Protein	inducible N - terminal transactivation domain,105,150,Gene/Protein	NF - ATc,154,162,Gene/Protein	TAD - A,164,171,Gene/Protein	"[{""token"": ""transcriptional co - activators"", ""start_span"": 22, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""CBP / p300"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""inducible N - terminal transactivation domain"", ""start_span"": 105, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATc"", ""start_span"": 154, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""TAD - A"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
Constitutive active versions of c - Raf and Rac synergistically enhance the CBP / p300 - mediated increase of TAD - A activity, indicating the important role CBP / p300 plays in the integration of T cell activation signals.	c - Raf,32,39,Gene/Protein	Rac,44,47,Gene/Protein	CBP / p300,76,86,Gene/Protein	TAD - A,110,117,Gene/Protein	CBP / p300,158,168,Gene/Protein	"[{""token"": ""c - Raf"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""Rac"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""CBP / p300"", ""start_span"": 76, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""TAD - A"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""CBP / p300"", ""start_span"": 158, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
We demonstrate here that a third region encompassing a proline rich sequence within the 33 bp repetitive stretch of LMP1 ' s C - terminus is required for the activation of Janus kinase 3 ( JAK3).	proline rich sequence,55,76,Gene/Protein	LMP1,116,120,Gene/Protein	C - terminus,125,137,Gene/Protein	Janus kinase 3,172,186,Gene/Protein	JAK3,189,193,Gene/Protein	"[{""token"": ""proline rich sequence"", ""start_span"": 55, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""C - terminus"", ""start_span"": 125, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase 3"", ""start_span"": 172, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
These results reveal a novel activating region in the LMP1 C - terminus and identify the JAK / STAT pathway as a target of this viral integral membrane protein in B cells.	LMP1,54,58,Gene/Protein	C - terminus,59,71,Gene/Protein	JAK,89,92,Gene/Protein	/ STAT,93,99,Gene/Protein	viral integral membrane protein,128,159,Gene/Protein	"[{""token"": ""LMP1"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""C - terminus"", ""start_span"": 59, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""/ STAT"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""viral integral membrane protein"", ""start_span"": 128, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
Composite elements are regulatory modules of promoters or enhancers that consist of binding sites of two different but synergizing transcription factors.	Composite elements,0,18,Gene/Protein	regulatory modules,23,41,Gene/Protein	promoters,45,54,Gene/Protein	enhancers,58,67,Gene/Protein	transcription factors,131,152,Gene/Protein	"[{""token"": ""Composite elements"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""regulatory modules"", ""start_span"": 23, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 45, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""enhancers"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 131, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
Mutation of the E box abolished USF / c - Myc - mediated up - regulation of CXCR4 promoter activity, and mutation of the YY1 binding site was associated with unresponsiveness to YY1 - mediated inhibition.	E box,16,21,Gene/Protein	USF / c - Myc,32,45,Gene/Protein	CXCR4,76,81,Gene/Protein	YY1 binding site,121,137,Gene/Protein	YY1,178,181,Gene/Protein	"[{""token"": ""E box"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""USF / c - Myc"", ""start_span"": 32, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""CXCR4"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""YY1 binding site"", ""start_span"": 121, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""YY1"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
Taken together these results indicate that STAT1 plays a pivotal role in the differentiation / maturation process of monocytes as an early transcription factor initially activated by adherence and then able to modulate the expression of functional genes, such as ICAM - 1 and FcgammaRI.	STAT1,43,48,Gene/Protein	transcription factor,139,159,Gene/Protein	functional genes,237,253,Gene/Protein	ICAM - 1,263,271,Gene/Protein	FcgammaRI,276,285,Gene/Protein	"[{""token"": ""STAT1"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 139, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""functional genes"", ""start_span"": 237, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 263, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""FcgammaRI"", ""start_span"": 276, ""end_span"": 285, ""type"": ""Gene/Protein""}]"	train
Strict dependence of HS I activity on a GATA site implies that assembly of a protein complex containing a GATA - factor, presumably GATA - 1 or GATA - 2, is critical to activating or maintaining its function.	HS I,21,25,Gene/Protein	GATA site,40,49,Gene/Protein	GATA - factor,106,119,Gene/Protein	GATA - 1,132,140,Gene/Protein	GATA - 2,144,152,Gene/Protein	"[{""token"": ""HS I"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""GATA site"", ""start_span"": 40, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""GATA - factor"", ""start_span"": 106, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 2"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
At least in the case of the IL1B promoter, repression did not seem to involve another factor whose activity is affected by the NSAIDs, NFkappaB as the IL1B promoter fragment used in our studies is not NFkappaB responsive and binds specifically to HSF1.	IL1B promoter,28,41,Gene/Protein	NFkappaB,135,143,Gene/Protein	IL1B promoter fragment,151,173,Gene/Protein	NFkappaB,201,209,Gene/Protein	HSF1,247,251,Gene/Protein	"[{""token"": ""IL1B promoter"", ""start_span"": 28, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 135, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""IL1B promoter fragment"", ""start_span"": 151, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 201, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""HSF1"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Gene/Protein""}]"	train
Analogous to costimulation via CD28, this activity is mediated through activation of Rel / kappaB, a family of transcription factors known to regulate IL - 2 and other activation - inducible proteins.	CD28,31,35,Gene/Protein	Rel / kappaB,85,97,Gene/Protein	transcription factors,111,132,Gene/Protein	IL - 2,151,157,Gene/Protein	activation - inducible proteins,168,199,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""Rel / kappaB"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 111, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""activation - inducible proteins"", ""start_span"": 168, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
In contrast to transcriptional activation in PBMC, EMSA revealed that CD28 coligation of CD2 - activated LPMC does not result in increased binding of trans - factors to the CD28RE, nor did Western blots detect changes in I - kappaBalpha or I - kappaBbeta levels following CD28 coligation.	CD28,70,74,Gene/Protein	CD28RE,173,179,Gene/Protein	I - kappaBalpha,221,236,Gene/Protein	I - kappaBbeta,240,254,Gene/Protein	CD28,272,276,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""CD28RE"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""I - kappaBalpha"", ""start_span"": 221, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""I - kappaBbeta"", ""start_span"": 240, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 272, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	train
Upon HBsAg stimulation, expression of IFN - gamma, IL - 2, IL - 4, and IL - 10 was detected in 41%, 8%, 41%, and 50% of the patients, respectively.	HBsAg,5,10,Gene/Protein	IFN - gamma,38,49,Gene/Protein	IL - 2,51,57,Gene/Protein	IL - 4,59,65,Gene/Protein	IL - 10,71,78,Gene/Protein	"[{""token"": ""HBsAg"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene/Protein""}]"	train
In these experiments, SOCS - 3 associated with Jak1 and inhibited Jak1 phosphorylation, and this inhibition was markedly enhanced by the presence of IL - 2 receptor beta chain ( IL - 2Rbeta).	SOCS - 3,22,30,Gene/Protein	Jak1,47,51,Gene/Protein	Jak1,66,70,Gene/Protein	IL - 2 receptor beta chain,149,175,Gene/Protein	IL - 2Rbeta,178,189,Gene/Protein	"[{""token"": ""SOCS - 3"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor beta chain"", ""start_span"": 149, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2Rbeta"", ""start_span"": 178, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
Moreover, following IL - 2 stimulation of T cells, SOCS - 3 was able to interact with the IL - 2 receptor complex, and in particular tyrosine phosphorylated Jak1 and IL - 2Rbeta.	IL - 2,20,26,Gene/Protein	SOCS - 3,51,59,Gene/Protein	IL - 2 receptor complex,90,113,Gene/Protein	tyrosine phosphorylated Jak1,133,161,Gene/Protein	IL - 2Rbeta,166,177,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""SOCS - 3"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor complex"", ""start_span"": 90, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine phosphorylated Jak1"", ""start_span"": 133, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2Rbeta"", ""start_span"": 166, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
Additionally, in lymphocytes expressing SOCS - 3 but not CIS, IL - 2 - induced tyrosine phosphorylation of STAT5b was markedly reduced, while there was only a weak effect on IL - 3 - mediated STAT5b tyrosine phosphorylation.	SOCS - 3,40,48,Gene/Protein	CIS,57,60,Gene/Protein	IL - 2,62,68,Gene/Protein	STAT5b,107,113,Gene/Protein	IL - 3 - mediated STAT5b,174,198,Gene/Protein	"[{""token"": ""SOCS - 3"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""CIS"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""STAT5b"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3 - mediated STAT5b"", ""start_span"": 174, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
We recently developed an assay in which nuclear export of the shuttling transcription factor NFAT ( nuclear factor of activated T cells) can be reconstituted in permeabilized cells with the GTPase Ran and the nuclear export receptor CRM1.	transcription factor NFAT,72,97,Gene/Protein	nuclear factor of activated T cells,100,135,Gene/Protein	GTPase,190,196,Gene/Protein	Ran,197,200,Gene/Protein	CRM1,233,237,Gene/Protein	"[{""token"": ""transcription factor NFAT"", ""start_span"": 72, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 100, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""GTPase"", ""start_span"": 190, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""Ran"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""CRM1"", ""start_span"": 233, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	train
After preincubation of permeabilized cells with a Ran mutant that can not hydrolyze GTP ( RanQ69L), cytosol supports NFAT export, but CRM1 and Ran alone do not.	Ran mutant,50,60,Gene/Protein	RanQ69L,90,97,Gene/Protein	NFAT,117,121,Gene/Protein	CRM1,134,138,Gene/Protein	Ran,143,146,Gene/Protein	"[{""token"": ""Ran mutant"", ""start_span"": 50, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""RanQ69L"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""CRM1"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""Ran"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
The RanQ69L preincubation leads to accumulation of CRM1 at the cytoplasmic periphery of the nuclear pore complex ( NPC) in association with the p62 complex and Can / Nup214.	RanQ69L,4,11,Gene/Protein	CRM1,51,55,Gene/Protein	nuclear pore complex,92,112,Gene/Protein	NPC,115,118,Gene/Protein	p62 complex,144,155,Gene/Protein	"[{""token"": ""RanQ69L"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""CRM1"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""nuclear pore complex"", ""start_span"": 92, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""NPC"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""p62 complex"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	train
To determine activation status of the IL - 2R - associated ( Jak / STAT) pathway in the HTLV - I infected cells, we examined tyrosine phosphorylation of Jak3, STAT3, and STAT5 in several HTLV - I ( +) T - cell lines and in uncultured leukemic T cells isolated from patients with adult T - cell lymphoma / leukemia ( ATLL).	IL - 2R,38,45,Gene/Protein	Jak / STAT,61,71,Gene/Protein	Jak3,153,157,Gene/Protein	STAT3,159,164,Gene/Protein	STAT5,170,175,Gene/Protein	"[{""token"": ""IL - 2R"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""Jak / STAT"", ""start_span"": 61, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 159, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
We provide evidence here that virtually all human CD34 ( +) bone marrow cells express NF - kappaB that can be activated by exposure to phorbol 12 - myristate 13 - acetate and a variety of cytokines, eg, tumor necrosis factor alpha, interleukin - 3, and granulocyte - macrophage colony - stimulating factor.	NF - kappaB,86,97,Gene/Protein	cytokines,188,197,Gene/Protein	tumor necrosis factor alpha,203,230,Gene/Protein	interleukin - 3,232,247,Gene/Protein	granulocyte - macrophage colony - stimulating factor,253,305,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 188, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 203, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 3"", ""start_span"": 232, ""end_span"": 247, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 253, ""end_span"": 305, ""type"": ""Gene/Protein""}]"	train
Cloning of the 5 ' and 3 ' untranslated region ( UTR) of human keratinocyte PCD / DCoH revealed that it has 53 bp more of GC - rich 5 ' untranslated sequence than the published liver PCD / DCoH.	5 ' and 3 ' untranslated region,15,46,Gene/Protein	UTR,49,52,Gene/Protein	human keratinocyte PCD / DCoH,57,86,Gene/Protein	GC - rich 5 ' untranslated sequence,122,157,Gene/Protein	liver PCD / DCoH,177,193,Gene/Protein	"[{""token"": ""5 ' and 3 ' untranslated region"", ""start_span"": 15, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""UTR"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""human keratinocyte PCD / DCoH"", ""start_span"": 57, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""GC - rich 5 ' untranslated sequence"", ""start_span"": 122, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""liver PCD / DCoH"", ""start_span"": 177, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
It is perhaps possible that all of Stat4 actions on Th1 development may be exert directly by Stat4 at the IFN - gamma gene, however we suggest that, more likely, Stat4 may act to induce Th1 development through the induction of other non - cytokine genes, whose stable expression maintains the transcriptional state of a Th1 cell.	Stat4,35,40,Gene/Protein	Stat4,93,98,Gene/Protein	IFN - gamma gene,106,122,Gene/Protein	Stat4,162,167,Gene/Protein	non - cytokine genes,233,253,Gene/Protein	"[{""token"": ""Stat4"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Stat4"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma gene"", ""start_span"": 106, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Stat4"", ""start_span"": 162, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""non - cytokine genes"", ""start_span"": 233, ""end_span"": 253, ""type"": ""Gene/Protein""}]"	train
In contrast to that reported for human Jurkat T cells, we found that p38 MAPK, but not Jun NH2 - terminal kinase ( JNK), is weakly activated upon stimulation with either anti - CD3 or anti - CD28 in murine thymocytes and splenic T cells.	p38 MAPK,69,77,Gene/Protein	Jun NH2 - terminal kinase,87,112,Gene/Protein	JNK,115,118,Gene/Protein	anti - CD3,170,180,Gene/Protein	anti - CD28,184,195,Gene/Protein	"[{""token"": ""p38 MAPK"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""Jun NH2 - terminal kinase"", ""start_span"": 87, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 170, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD28"", ""start_span"": 184, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
In parallel, NAC was shown to down - regulate the production of cytokines by DC as well as their surface expression of HLA - DR, CD86 ( B7 - 2), and CD40 molecules both at the basal state and upon LPS activation.	cytokines,64,73,Gene/Protein	HLA - DR,119,127,Gene/Protein	CD86,129,133,Gene/Protein	B7 - 2,136,142,Gene/Protein	CD40 molecules,149,163,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DR"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""B7 - 2"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""CD40 molecules"", ""start_span"": 149, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
To examine the activation status of the transcription factors nuclear factor kappaB ( NF - kappaB) and heat shock factor - 1 ( HSF - 1), electrophoretic mobility shift assays were performed.	transcription factors,40,61,Gene/Protein	nuclear factor kappaB,62,83,Gene/Protein	NF - kappaB,86,97,Gene/Protein	heat shock factor - 1,103,124,Gene/Protein	HSF - 1,127,134,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 40, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappaB"", ""start_span"": 62, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""heat shock factor - 1"", ""start_span"": 103, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""HSF - 1"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
The ability of type I and type II IFNs to inhibit IL - 4 / IL - 13 - induced STAT6 activity is dose - and time - dependent, and is not unique to monocytes because IFNs induce the same effects in fibroblasts.	type I and type II IFNs,15,38,Gene/Protein	IL - 4,50,56,Gene/Protein	IL - 13,59,66,Gene/Protein	STAT6,77,82,Gene/Protein	IFNs,163,167,Gene/Protein	"[{""token"": ""type I and type II IFNs"", ""start_span"": 15, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IFNs"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
Furthermore, there was no increase in cyclin D - associated kinase activity upon HLA class I ligation, suggesting that cyclin E - dependent kinase activity mediates Rb inactivation, leading to E2F activation and cell proliferation.	cyclin D - associated kinase,38,66,Gene/Protein	HLA class I,81,92,Gene/Protein	cyclin E - dependent kinase,119,146,Gene/Protein	Rb,165,167,Gene/Protein	E2F,193,196,Gene/Protein	"[{""token"": ""cyclin D - associated kinase"", ""start_span"": 38, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""HLA class I"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""cyclin E - dependent kinase"", ""start_span"": 119, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 165, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
Switching the cells to the nonpermissive temperature led to a marked increase in globin gene expression and concomitant decrease in expression of Spi - 1, Fli - 1, and megakaryocytic genes in an erythropoietin - dependent manner.	globin gene,81,92,Gene/Protein	Spi - 1,146,153,Gene/Protein	Fli - 1,155,162,Gene/Protein	megakaryocytic genes,168,188,Gene/Protein	erythropoietin,195,209,Gene/Protein	"[{""token"": ""globin gene"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""Spi - 1"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""Fli - 1"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""megakaryocytic genes"", ""start_span"": 168, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""erythropoietin"", ""start_span"": 195, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
However, Spi - C may represent a novel subgroup within the Ets protein family, as it differed significantly from Spi - B and PU. 1 within helix 1 of the Ets domain.	Spi - C,9,16,Gene/Protein	Ets protein family,59,77,Gene/Protein	Spi - B,113,120,Gene/Protein	helix 1,138,145,Gene/Protein	Ets domain,153,163,Gene/Protein	"[{""token"": ""Spi - C"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""Ets protein family"", ""start_span"": 59, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""Spi - B"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""helix 1"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""Ets domain"", ""start_span"": 153, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
Lipopolysaccharide ( LPS) stimulation of human neutrophils is known to result in activation of p38 mitogen - activated protein kinase ( MAPk); however, the upstream activator ( s) of p38 MAPk is unknown, and consequences of p38 MAPk activation remain largely undefined.	p38 mitogen - activated protein kinase,95,133,Gene/Protein	MAPk,136,140,Gene/Protein	upstream activator,156,174,Gene/Protein	p38 MAPk,183,191,Gene/Protein	p38 MAPk,224,232,Gene/Protein	"[{""token"": ""p38 mitogen - activated protein kinase"", ""start_span"": 95, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""MAPk"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""upstream activator"", ""start_span"": 156, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPk"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPk"", ""start_span"": 224, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	train
These findings support a pathway by which LPS stimulation of neutrophils results in activation of MKK3, which in turn activates p38alpha MAPk, ultimately regulating adhesion, NF - kappaB activation, enhanced gene expression of TNF - alpha, and regulation of TNF - alpha synthesis.	MKK3,98,102,Gene/Protein	p38alpha MAPk,128,141,Gene/Protein	NF - kappaB,175,186,Gene/Protein	TNF - alpha,227,238,Gene/Protein	TNF - alpha,258,269,Gene/Protein	"[{""token"": ""MKK3"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""p38alpha MAPk"", ""start_span"": 128, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 175, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 227, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 258, ""end_span"": 269, ""type"": ""Gene/Protein""}]"	train
We took advantage of our monoclonal model of germinal center B cell differentiation, IgM + IgD + CL - 01 cells, to define the role of the I gamma 3 evolutionarily conserved sequence ( ECS) in the germline transcriptional activation of the human C gamma 3 gene.	I gamma 3,138,147,Gene/Protein	evolutionarily conserved sequence,148,181,Gene/Protein	ECS,184,187,Gene/Protein	germline,196,204,Gene/Protein	human C gamma 3 gene,239,259,Gene/Protein	"[{""token"": ""I gamma 3"", ""start_span"": 138, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""evolutionarily conserved sequence"", ""start_span"": 148, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""ECS"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""germline"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""human C gamma 3 gene"", ""start_span"": 239, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	train
Thus, the gamma 3 ECS is an inducible promoter containing cis elements that critically mediate CD40L and IL - 4 - triggered transcriptional activation of the human C gamma 3 gene.	gamma 3 ECS,10,21,Gene/Protein	cis elements,58,70,Gene/Protein	CD40L,95,100,Gene/Protein	IL - 4,105,111,Gene/Protein	human C gamma 3 gene,158,178,Gene/Protein	"[{""token"": ""gamma 3 ECS"", ""start_span"": 10, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""cis elements"", ""start_span"": 58, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CD40L"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""human C gamma 3 gene"", ""start_span"": 158, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
GrpL, a Grb2 - related adaptor protein, interacts with SLP - 76 to regulate nuclear factor of activated T cell activation.	GrpL,0,4,Gene/Protein	Grb2,8,12,Gene/Protein	adaptor protein,23,38,Gene/Protein	SLP - 76,55,63,Gene/Protein	nuclear factor of activated T cell,76,110,Gene/Protein	"[{""token"": ""GrpL"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""Grb2"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""adaptor protein"", ""start_span"": 23, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""SLP - 76"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cell"", ""start_span"": 76, ""end_span"": 110, ""type"": ""Gene/Protein""}]"	train
In - vitro cleavage of recombinant SP1 by recombinant caspase 3 ( CPP32) or caspase 7 ( Mch 3) results in similar cleavage products as those observed in vivo.	recombinant SP1,23,38,Gene/Protein	recombinant caspase 3,42,63,Gene/Protein	CPP32,66,71,Gene/Protein	caspase 7,76,85,Gene/Protein	Mch 3,88,93,Gene/Protein	"[{""token"": ""recombinant SP1"", ""start_span"": 23, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""recombinant caspase 3"", ""start_span"": 42, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""CPP32"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""caspase 7"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""Mch 3"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Gene/Protein""}]"	train
CD40 expression could be enhanced in CD40 - positive MM by stimulation with IFN - gamma and tumor necrosis factor - alpha but not by interleukin ( IL) - 1beta or CD40 triggering.	CD40,0,4,Gene/Protein	CD40,37,41,Gene/Protein	IFN - gamma,76,87,Gene/Protein	tumor necrosis factor - alpha,92,121,Gene/Protein	CD40,162,166,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 92, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
MDS1 / EVI1 enhances TGF - beta1 signaling and strengthens its growth - inhibitory effect but the leukemia - associated fusion protein AML1 / MDS1 / EVI1, product of the t ( 3; 21), abrogates growth - inhibition in response to TGF - beta1.	MDS1 / EVI1,0,11,Gene/Protein	TGF - beta1,21,32,Gene/Protein	leukemia - associated fusion protein,98,134,Gene/Protein	AML1 / MDS1 / EVI1,135,153,Gene/Protein	TGF - beta1,227,238,Gene/Protein	"[{""token"": ""MDS1 / EVI1"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 21, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""leukemia - associated fusion protein"", ""start_span"": 98, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""AML1 / MDS1 / EVI1"", ""start_span"": 135, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 227, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	train
However, although Wnt signals are known to inhibit the activity of the negative regulatory protein kinase glycogen synthase kinase - 3beta ( GSK - 3beta), resulting in increased levels of beta - catenin, we find no evidence for involvement of GSK - 3beta in Tcf - mediated transcription in T cells.	negative regulatory protein kinase,71,105,Gene/Protein	glycogen synthase kinase - 3beta,106,138,Gene/Protein	GSK - 3beta,141,152,Gene/Protein	beta - catenin,188,202,Gene/Protein	GSK - 3beta,243,254,Gene/Protein	"[{""token"": ""negative regulatory protein kinase"", ""start_span"": 71, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""glycogen synthase kinase - 3beta"", ""start_span"": 106, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""GSK - 3beta"", ""start_span"": 141, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""beta - catenin"", ""start_span"": 188, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""GSK - 3beta"", ""start_span"": 243, ""end_span"": 254, ""type"": ""Gene/Protein""}]"	train
Extracellular - regulated kinase 1 / 2, Jun N - terminal kinase, and c - Jun are involved in NF - kappa B - dependent IL - 6 expression in human monocytes.	Extracellular - regulated kinase 1 / 2,0,38,Gene/Protein	Jun N - terminal kinase,40,63,Gene/Protein	c - Jun,69,76,Gene/Protein	NF - kappa B,93,105,Gene/Protein	IL - 6,118,124,Gene/Protein	"[{""token"": ""Extracellular - regulated kinase 1 / 2"", ""start_span"": 0, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Jun N - terminal kinase"", ""start_span"": 40, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 93, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Gene/Protein""}]"	train
The biologic effects of RA are mediated by two distinct families of transcriptional factors: RA receptors ( RARs) and retinoid X receptors ( RXRs).	transcriptional factors,68,91,Gene/Protein	RA receptors,93,105,Gene/Protein	RARs,108,112,Gene/Protein	retinoid X receptors,118,138,Gene/Protein	RXRs,141,145,Gene/Protein	"[{""token"": ""transcriptional factors"", ""start_span"": 68, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""RA receptors"", ""start_span"": 93, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""RARs"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""retinoid X receptors"", ""start_span"": 118, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""RXRs"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	train
Cytokine effects on immunity and inflammation often depend on the transcription factors termed signal transducers and activators of transcription ( STATs), so STAT signaling pathways are candidates for influencing inflammatory disease.	Cytokine,0,8,Gene/Protein	transcription factors,66,87,Gene/Protein	signal transducers and activators of transcription,95,145,Gene/Protein	STATs,148,153,Gene/Protein	STAT,159,163,Gene/Protein	"[{""token"": ""Cytokine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 66, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers and activators of transcription"", ""start_span"": 95, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""STATs"", ""start_span"": 148, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""STAT"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
Furthermore, epithelial levels of activated Stat1 correlated with levels of expression for epithelial ICAM - 1, IRF - 1, and Stat1, and in turn, ICAM - 1 levels correlated with T - cell accumulation in tissue.	Stat1,44,49,Gene/Protein	epithelial ICAM - 1,91,110,Gene/Protein	IRF - 1,112,119,Gene/Protein	Stat1,125,130,Gene/Protein	ICAM - 1,145,153,Gene/Protein	"[{""token"": ""Stat1"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""epithelial ICAM - 1"", ""start_span"": 91, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
In this study, transient cotransfection of several GPIX promoter / reporter constructs into 293T kidney fibroblasts with a Fli - 1 expression vector shows that the oncogenic protein Fli - 1 can transactivate the GPIX promoter when an intact GPIX Ets site is present.	GPIX promoter / reporter constructs,51,86,Gene/Protein	Fli - 1 expression vector,123,148,Gene/Protein	Fli - 1,182,189,Gene/Protein	GPIX promoter,212,225,Gene/Protein	GPIX Ets site,241,254,Gene/Protein	"[{""token"": ""GPIX promoter / reporter constructs"", ""start_span"": 51, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""Fli - 1 expression vector"", ""start_span"": 123, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""Fli - 1"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""GPIX promoter"", ""start_span"": 212, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""GPIX Ets site"", ""start_span"": 241, ""end_span"": 254, ""type"": ""Gene/Protein""}]"	train
Furthermore, CoCl2 also caused time - dependent tyrosine phosphorylation of mitogen - activated protein ( MAP) kinase isoform ERK2 without significantly affecting ERK1, indicating ERK2 is the preferred substrate for upstream kinase of the MAPK pathway.	ERK2,126,130,Gene/Protein	ERK1,163,167,Gene/Protein	ERK2,180,184,Gene/Protein	upstream kinase,216,231,Gene/Protein	MAPK,239,243,Gene/Protein	"[{""token"": ""ERK2"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""ERK2"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""upstream kinase"", ""start_span"": 216, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 239, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
Our data suggests that CoCl2 - induced cellular signals directing increased expression of VCAM - 1 in HUVEC involve downstream activation of MAP kinase and NF - kappaB, while the phosphorylation of PECAM - 1 occurs as a result of activation of PKC.	VCAM - 1,90,98,Gene/Protein	MAP kinase,141,151,Gene/Protein	NF - kappaB,156,167,Gene/Protein	PECAM - 1,198,207,Gene/Protein	PKC,244,247,Gene/Protein	"[{""token"": ""VCAM - 1"", ""start_span"": 90, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""MAP kinase"", ""start_span"": 141, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""PECAM - 1"", ""start_span"": 198, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 244, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	train
Here we investigated the role and involvement of interleukin - 1 ( IL - 1) and tumor necrosis factor ( TNF - alpha) signal transducer molecules in LPS signaling in human dermal microvessel endothelial cells ( HDMEC) and THP - 1 monocytic cells.	interleukin - 1,49,64,Gene/Protein	IL - 1,67,73,Gene/Protein	tumor necrosis factor,79,100,Gene/Protein	TNF - alpha,103,114,Gene/Protein	signal transducer molecules,116,143,Gene/Protein	"[{""token"": ""interleukin - 1"", ""start_span"": 49, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 79, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 103, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer molecules"", ""start_span"": 116, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	train
RESULTS: We show that binding of IFN - gamma to human eosinophils initiated a series of events that resulted in the rapid tyrosine phosphorylation of not only the IFN - gammaRalpha chain but also Jak1, Jak2, and Stat1alpha.	IFN - gamma,33,44,Gene/Protein	IFN - gammaRalpha chain,163,186,Gene/Protein	Jak1,196,200,Gene/Protein	Jak2,202,206,Gene/Protein	Stat1alpha,212,222,Gene/Protein	"[{""token"": ""IFN - gamma"", ""start_span"": 33, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gammaRalpha chain"", ""start_span"": 163, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 196, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""Jak2"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""Stat1alpha"", ""start_span"": 212, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
Unexpectedly, we observed that an RXR - specific, rather than an RAR - specific, agonist induces terminal granulocytic differentiation of MPRO promyelocytes, and this differentiation is associated with activation of DNA response elements corresponding to RAR - RXR heterodimers rather than RXR - RXR homodimers.	RXR,34,37,Gene/Protein	RAR,65,68,Gene/Protein	DNA response elements,216,237,Gene/Protein	RAR - RXR heterodimers,255,277,Gene/Protein	RXR - RXR homodimers,290,310,Gene/Protein	"[{""token"": ""RXR"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""RAR"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""DNA response elements"", ""start_span"": 216, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""RAR - RXR heterodimers"", ""start_span"": 255, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""RXR - RXR homodimers"", ""start_span"": 290, ""end_span"": 310, ""type"": ""Gene/Protein""}]"	train
Using antibodies against the p50 and p65 subunits of NF - kappaB in EMSAs, the involvement of both p50 and p65 proteins was further demonstrated.	p50,29,32,Gene/Protein	p65 subunits,37,49,Gene/Protein	NF - kappaB,53,64,Gene/Protein	p50,99,102,Gene/Protein	p65 proteins,107,119,Gene/Protein	"[{""token"": ""p50"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""p65 subunits"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""p65 proteins"", ""start_span"": 107, ""end_span"": 119, ""type"": ""Gene/Protein""}]"	train
A loss - of - function mutation in Cbl - b disrupted the interaction between Cbl - b and Zap - 70 and nearly completely abrogated the Cbl - b - mediated activation of NFAT.	Cbl - b,35,42,Gene/Protein	Cbl - b,77,84,Gene/Protein	Zap - 70,89,97,Gene/Protein	Cbl - b,134,141,Gene/Protein	NFAT,167,171,Gene/Protein	"[{""token"": ""Cbl - b"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Cbl - b"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""Zap - 70"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""Cbl - b"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
Several new functions of Ras, such as downregulation of major histocompatibility complex molecules, upregulation of certain cytokines, growth factors and degradative enzymes have been uncovered in the last decade.	Ras,25,28,Gene/Protein	major histocompatibility complex molecules,56,98,Gene/Protein	cytokines,124,133,Gene/Protein	growth factors,135,149,Gene/Protein	degradative enzymes,154,173,Gene/Protein	"[{""token"": ""Ras"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""major histocompatibility complex molecules"", ""start_span"": 56, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 124, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""growth factors"", ""start_span"": 135, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""degradative enzymes"", ""start_span"": 154, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
This modulation of DNA binding activity mediated through the dephosphorylation of DP1 and E2F4 could help to explain the lack of in vivo DNA footprinting in late G1 and S phases of gene promoters negatively regulated through E2F sites and suggests a novel mechanism for controlling E2F transcriptional activity during the transition from quiescence to proliferation.	DP1,82,85,Gene/Protein	E2F4,90,94,Gene/Protein	gene promoters,181,195,Gene/Protein	E2F sites,225,234,Gene/Protein	E2F,282,285,Gene/Protein	"[{""token"": ""DP1"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""E2F4"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""gene promoters"", ""start_span"": 181, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""E2F sites"", ""start_span"": 225, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 282, ""end_span"": 285, ""type"": ""Gene/Protein""}]"	train
Ligation of either CD80 ( B7 - 1) or CD86 ( B7 - 2), two principal ligands for CD28, is thought to skew the immune response toward Th1 or Th2 differentiation.	CD80,19,23,Gene/Protein	B7 - 1,26,32,Gene/Protein	CD86,37,41,Gene/Protein	B7 - 2,44,50,Gene/Protein	CD28,79,83,Gene/Protein	"[{""token"": ""CD80"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""B7 - 1"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""B7 - 2"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}]"	train
Purified human peripheral T cells or Jurkat T cells were stimulated with Chinese hamster ovary ( CHO) cells expressing either human CD80 ( CHO - CD80) or human CD86 ( CHO - CD86) or with anti - CD28 monoclonal antibody ( mAb).	human CD80,126,136,Gene/Protein	CHO - CD80,139,149,Gene/Protein	human CD86,154,164,Gene/Protein	CHO - CD86,167,177,Gene/Protein	anti - CD28 monoclonal antibody,187,218,Gene/Protein	"[{""token"": ""human CD80"", ""start_span"": 126, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""CHO - CD80"", ""start_span"": 139, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""human CD86"", ""start_span"": 154, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""CHO - CD86"", ""start_span"": 167, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD28 monoclonal antibody"", ""start_span"": 187, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
Surprisingly, although stimulation of Jurkat T cells with either CHO - CD80 or anti - CD28 mAb resulted in robust tyrosine phosphorylation of CD28 itself, ligation with CHO - CD86 was unable to induce detectable CD28 tyrosyl phosphorylation over a range of stimulation conditions.	CHO - CD80,65,75,Gene/Protein	anti - CD28 mAb,79,94,Gene/Protein	CD28,142,146,Gene/Protein	CHO - CD86,169,179,Gene/Protein	CD28,212,216,Gene/Protein	"[{""token"": ""CHO - CD80"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD28 mAb"", ""start_span"": 79, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""CHO - CD86"", ""start_span"": 169, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
We hypothesized that activation of the protein kinase A signaling pathway may inhibit NF - kappaB - mediated transcription by phosphorylating proteins, such as cAMP response element - binding protein ( CREB), which compete for limiting amounts of the coactivator CBP.	protein kinase A,39,55,Gene/Protein	NF - kappaB,86,97,Gene/Protein	cAMP response element - binding protein,160,199,Gene/Protein	CREB,202,206,Gene/Protein	CBP,263,266,Gene/Protein	"[{""token"": ""protein kinase A"", ""start_span"": 39, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""cAMP response element - binding protein"", ""start_span"": 160, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""CBP"", ""start_span"": 263, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
These results suggest that activation of the protein kinase A pathway inhibits NF - kappaB transcription by phosphorylating CREB, which competes with p65 for limiting amounts of CBP.	protein kinase A,45,61,Gene/Protein	NF - kappaB,79,90,Gene/Protein	CREB,124,128,Gene/Protein	p65,150,153,Gene/Protein	CBP,178,181,Gene/Protein	"[{""token"": ""protein kinase A"", ""start_span"": 45, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""CBP"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
Thus, Egr - 2, in addition to Egr - 3, regulates FasL expression in activated normal T cells, and Egr - 2 is likely to play a direct role in aberrant fasL up - regulation in lpr / lpr and gld / gld CD4 ( -) CD8 ( -) T cells.	Egr - 2,6,13,Gene/Protein	Egr - 3,30,37,Gene/Protein	FasL,49,53,Gene/Protein	Egr - 2,98,105,Gene/Protein	fasL,150,154,Gene/Protein	"[{""token"": ""Egr - 2"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 3"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""FasL"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 2"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""fasL"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
Biochemically we show that the stimulated tyrosine phosphorylation of Vav, Shc, and ZAP - 70 itself is diminished, whereas that of Slp - 76 is increased in cells reconstituted with Delta.	Vav,70,73,Gene/Protein	Shc,75,78,Gene/Protein	ZAP - 70,84,92,Gene/Protein	Slp - 76,131,139,Gene/Protein	Delta,181,186,Gene/Protein	"[{""token"": ""Vav"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Shc"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""ZAP - 70"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""Slp - 76"", ""start_span"": 131, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""Delta"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
Cross - linking CD19 on early human B lineage cells induces the formation of a CD19 / Vav / phosphatidylinositol - 3 kinase complex, tyrosine phosphorylation of CD19 and Vav, and activation of the Ras pathway.	CD19,16,20,Gene/Protein	CD19 / Vav / phosphatidylinositol - 3 kinase complex,79,131,Gene/Protein	CD19,161,165,Gene/Protein	Vav,170,173,Gene/Protein	Ras,197,200,Gene/Protein	"[{""token"": ""CD19"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CD19 / Vav / phosphatidylinositol - 3 kinase complex"", ""start_span"": 79, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""Vav"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
Sequence analysis revealed the presence of a previously unrecognized composite binding site for both the Sp1 and NF - kappaB transcription factors at positions - 295 to - 286.	unrecognized composite binding site,56,91,Gene/Protein	Sp1,105,108,Gene/Protein	NF - kappaB,113,124,Gene/Protein	transcription factors,125,146,Gene/Protein	positions - 295 to - 286,150,174,Gene/Protein	"[{""token"": ""unrecognized composite binding site"", ""start_span"": 56, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 113, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 125, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""positions - 295 to - 286"", ""start_span"": 150, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
The study of NF - kappaB showed that oxLDLs led to a decrease of activation - induced p65 / p50 NF - kappaB heterodimer binding to DNA, whereas the presence of the constitutive nuclear form of p50 dimer was unchanged.	NF - kappaB,13,24,Gene/Protein	oxLDLs,37,43,Gene/Protein	activation - induced p65 / p50,65,95,Gene/Protein	NF - kappaB,96,107,Gene/Protein	p50 dimer,193,202,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""oxLDLs"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""activation - induced p65 / p50"", ""start_span"": 65, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""p50 dimer"", ""start_span"": 193, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
DOR1 ligation by a specific DOR1 agonist, deltorphin, augmented IL - 2 secretion by synergizing with signals from TCR - CD3 and CD28.	DOR1,0,4,Gene/Protein	DOR1,28,32,Gene/Protein	IL - 2,64,70,Gene/Protein	TCR - CD3,114,123,Gene/Protein	CD28,128,132,Gene/Protein	"[{""token"": ""DOR1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""DOR1"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""TCR - CD3"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}]"	train
Deltorphin also increased accumulation of AP - 1 transcription factor complexes, suggesting that DOR1 augments IL - 2 secretion by increasing the AP - 1 component of the NF - AT / AP - 1 transcription factor.	AP - 1 transcription factor complexes,42,79,Gene/Protein	DOR1,97,101,Gene/Protein	IL - 2,111,117,Gene/Protein	AP - 1 component,146,162,Gene/Protein	NF - AT / AP - 1 transcription factor,170,207,Gene/Protein	"[{""token"": ""AP - 1 transcription factor complexes"", ""start_span"": 42, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""DOR1"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 component"", ""start_span"": 146, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT / AP - 1 transcription factor"", ""start_span"": 170, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
This pathway involves the Rac1 and Cdc42 GTPases, two enzymes which are not required for NF - kappaB activation by IL - 1beta in epithelial cells.	Rac1,26,30,Gene/Protein	Cdc42,35,40,Gene/Protein	GTPases,41,48,Gene/Protein	NF - kappaB,89,100,Gene/Protein	IL - 1beta,115,125,Gene/Protein	"[{""token"": ""Rac1"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""Cdc42"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""GTPases"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 89, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 115, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	train
In conclusion, three different cell - specific pathways lead to NF - kappaB activation by IL - 1beta: a pathway dependent on ROI production by 5 - LOX in lymphoid cells, an ROI - and 5 - LOX - independent pathway in epithelial cells, and a pathway requiring ROI production by NADPH oxidase in monocytic cells.	NF - kappaB,64,75,Gene/Protein	IL - 1beta,90,100,Gene/Protein	5 - LOX,143,150,Gene/Protein	5 - LOX,183,190,Gene/Protein	NADPH oxidase,276,289,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 64, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""5 - LOX"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""5 - LOX"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""NADPH oxidase"", ""start_span"": 276, ""end_span"": 289, ""type"": ""Gene/Protein""}]"	train
These transcription factors are either not produced due to block of transcription of their respective genes ( Oct - 2, OBF - 1, PU. 1), or are rendered inactive posttranslationally ( NF - kappa B, E47).	transcription factors,6,27,Gene/Protein	Oct - 2,110,117,Gene/Protein	OBF - 1,119,126,Gene/Protein	NF - kappa B,183,195,Gene/Protein	E47,197,200,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 6, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""OBF - 1"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 183, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""E47"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
We demonstrate that a fusion protein composed of a C - terminal Hsp70 peptide and the p50 subunit of NF - kappaB was directed into the nucleus of cells, could bind DNA specifically, and activated Igkappa expression and TNFalpha production.	Hsp70,64,69,Gene/Protein	p50 subunit,86,97,Gene/Protein	NF - kappaB,101,112,Gene/Protein	Igkappa,196,203,Gene/Protein	TNFalpha,219,227,Gene/Protein	"[{""token"": ""Hsp70"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""p50 subunit"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Igkappa"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 219, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
These include ( 5 ' - 3 ') a composite NF - AT / ` ` AP - 1 ' ' element, a CD28 response element, an AP - 1 element, an NF - AT element, and the AP - 1 part of an AP - 1 / octamer composite element.	NF - AT / ` ` AP - 1 ' ' element,39,71,Gene/Protein	CD28 response element,75,96,Gene/Protein	AP - 1 element,101,115,Gene/Protein	NF - AT element,120,135,Gene/Protein	AP - 1 part of an AP - 1 / octamer composite element,145,197,Gene/Protein	"[{""token"": ""NF - AT / ` ` AP - 1 ' ' element"", ""start_span"": 39, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD28 response element"", ""start_span"": 75, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 element"", ""start_span"": 101, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT element"", ""start_span"": 120, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 part of an AP - 1 / octamer composite element"", ""start_span"": 145, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
IFN - alpha enhanced tyrosine phosphorylation of STAT1, STAT3, STAT4, STAT5a, and STAT5b.	IFN - alpha,0,11,Gene/Protein	STAT3,56,61,Gene/Protein	STAT4,63,68,Gene/Protein	STAT5a,70,76,Gene/Protein	STAT5b,82,88,Gene/Protein	"[{""token"": ""IFN - alpha"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""STAT4"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""STAT5a"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""STAT5b"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene/Protein""}]"	train
Functional association of Nmi with Stat5 and Stat1 in IL - 2 - and IFNgamma - mediated signaling.	Nmi,26,29,Gene/Protein	Stat5,35,40,Gene/Protein	Stat1,45,50,Gene/Protein	IL - 2,54,60,Gene/Protein	IFNgamma,67,75,Gene/Protein	"[{""token"": ""Nmi"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Gene/Protein""}]"	train
We evaluated two cytokine systems, IL - 2 and IFNgamma, and demonstrate that Nmi augments STAT - mediated transcription in response to these cytokines.	IL - 2,35,41,Gene/Protein	IFNgamma,46,54,Gene/Protein	Nmi,77,80,Gene/Protein	STAT,90,94,Gene/Protein	cytokines,141,150,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Nmi"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""STAT"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 141, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
Lactobacilli also increased tumor necrosis factor - alphaand interleukin - 1betaproduction and activated NF - kappaB in THP - 1 cells and increased tumor necrosis factor - alphaproduction by human monocytes.	tumor necrosis factor,28,49,Gene/Protein	interleukin,61,72,Gene/Protein	NF - kappaB,105,116,Gene/Protein	THP - 1 cells,120,133,Gene/Protein	tumor necrosis factor,148,169,Gene/Protein	"[{""token"": ""tumor necrosis factor"", ""start_span"": 28, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""interleukin"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""THP - 1 cells"", ""start_span"": 120, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 148, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
In addition, AR are not detectable on the surface of intact T cells when using anti - AR antibodies directed against the amino and carboxy terminus of the AR, although T cells contain AR, as revealed by reverse transcription - polymerase chain reactions and Western blotting.	AR,13,15,Gene/Protein	anti - AR antibodies,79,99,Gene/Protein	amino and carboxy terminus,121,147,Gene/Protein	AR,155,157,Gene/Protein	AR,184,186,Gene/Protein	"[{""token"": ""AR"", ""start_span"": 13, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""anti - AR antibodies"", ""start_span"": 79, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""amino and carboxy terminus"", ""start_span"": 121, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""AR"", ""start_span"": 155, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""AR"", ""start_span"": 184, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
Therefore, IL - 10 can directly inhibit STAT - dependent early response gene expression induced by both IFNalpha and IFNgamma in monocytes by suppressing the tyrosine phosphorylation of STAT1.	IL - 10,11,18,Gene/Protein	STAT - dependent early response gene,40,76,Gene/Protein	IFNalpha,104,112,Gene/Protein	IFNgamma,117,125,Gene/Protein	STAT1,186,191,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 11, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""STAT - dependent early response gene"", ""start_span"": 40, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""IFNalpha"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
We have analyzed the effects of interleukin - 10 ( IL - 10) on the entry of quiescent CD4 ( +) T cells into the cell cycle upon stimulation with the superantigen staphylococcal enterotoxin B ( SEB).	interleukin - 10,32,48,Gene/Protein	IL - 10,51,58,Gene/Protein	superantigen,149,161,Gene/Protein	staphylococcal enterotoxin B,162,190,Gene/Protein	SEB,193,196,Gene/Protein	"[{""token"": ""interleukin - 10"", ""start_span"": 32, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""superantigen"", ""start_span"": 149, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""staphylococcal enterotoxin B"", ""start_span"": 162, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""SEB"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
Inhibition of IL - 1R gene expression by IFN - gamma and IL - 10 was not due to down - regulation of surface IL - 4R because pretreatment with these cytokines did not decrease the number of IL - 4 binding sites per cell.	IL - 1R gene,14,26,Gene/Protein	IFN - gamma,41,52,Gene/Protein	IL - 10,57,64,Gene/Protein	surface IL - 4R,101,116,Gene/Protein	IL - 4,190,196,Gene/Protein	"[{""token"": ""IL - 1R gene"", ""start_span"": 14, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""surface IL - 4R"", ""start_span"": 101, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 190, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
These findings demonstrate that certain cytokines, including IFN - gamma and IL - 10, antagonize the ability of IL - 4 and IL - 13 to induce increased expression of the IL - 1RI and IL - 1RII genes in monocytes.	IFN - gamma,61,72,Gene/Protein	IL - 10,77,84,Gene/Protein	IL - 4,112,118,Gene/Protein	IL - 13,123,130,Gene/Protein	IL - 1RII genes,182,197,Gene/Protein	"[{""token"": ""IFN - gamma"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1RII genes"", ""start_span"": 182, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
Activation of NF - kappa B seems to play an important role in the regulation of many proinflammatory cytokine genes, but can not be the only mechanism, since several cytokine genes lack respective binding sites in their promoter regions.	NF - kappa B,14,26,Gene/Protein	proinflammatory cytokine genes,85,115,Gene/Protein	cytokine genes,166,180,Gene/Protein	binding sites,197,210,Gene/Protein	promoter regions,220,236,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 14, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""proinflammatory cytokine genes"", ""start_span"": 85, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 166, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 197, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""promoter regions"", ""start_span"": 220, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
Therefore, we additionally investigated other transcription factors of possible importance such as CREB, CTF, OTF - 1, and OTF - 2.	transcription factors,46,67,Gene/Protein	CREB,99,103,Gene/Protein	CTF,105,108,Gene/Protein	OTF - 1,110,117,Gene/Protein	OTF - 2,123,130,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 46, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""CTF"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 1"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 2"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}]"	train
Transcripts for osteoprotegerin ligand ( OPGL), an osteoclast differentiation factor ( also known as RANKL and TRANCE) are expressed, likely by adherent cells.	osteoprotegerin ligand,16,38,Gene/Protein	OPGL,41,45,Gene/Protein	osteoclast differentiation factor,51,84,Gene/Protein	RANKL,101,106,Gene/Protein	TRANCE,111,117,Gene/Protein	"[{""token"": ""osteoprotegerin ligand"", ""start_span"": 16, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""OPGL"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""osteoclast differentiation factor"", ""start_span"": 51, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""RANKL"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""TRANCE"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
By using PD - 98059 and SB203580, two potent and selective inhibitors of MEK1 ( a kinase upstream of ERK1 / 2) and p38, respectively, we have demonstrated that both ERK1 / 2 and p38 cascades play a key role in the production of IL - 8 by monocytes and PMN stimulated with bacterial fractions.	MEK1,73,77,Gene/Protein	kinase,82,88,Gene/Protein	ERK1 / 2,101,109,Gene/Protein	p38,115,118,Gene/Protein	IL - 8,228,234,Gene/Protein	"[{""token"": ""MEK1"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""kinase"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""ERK1 / 2"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""p38"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 228, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
The OCA - B and VP16 interactions with the Oct - 1 POU domain are sufficiently different to permit OCA - B and VP16 to bind the Oct - 1 POU domain simultaneously.	VP16,16,20,Gene/Protein	Oct - 1 POU domain,43,61,Gene/Protein	OCA - B,99,106,Gene/Protein	VP16,111,115,Gene/Protein	Oct - 1 POU domain,128,146,Gene/Protein	"[{""token"": ""VP16"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1 POU domain"", ""start_span"": 43, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""OCA - B"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""VP16"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1 POU domain"", ""start_span"": 128, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
TRADD associated with wild - type LMP1 but not with isoleucine - mutated LMP1 in mammalian cells, and TRADD constitutively associated with LMP1 in EBV - transformed cells.	TRADD,0,5,Gene/Protein	wild - type LMP1,22,38,Gene/Protein	LMP1,73,77,Gene/Protein	TRADD,102,107,Gene/Protein	LMP1,139,143,Gene/Protein	"[{""token"": ""TRADD"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""wild - type LMP1"", ""start_span"": 22, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""TRADD"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	train
O - side chain - specific mAb concurrently enhanced complement - dependent LPS uptake by monocytes through complement receptor - 1 ( CR1) and uptake by CHO - CD14 cells involving another heat - labile serum factor ( s) and cell - associated recognition molecule ( s).	O - side chain - specific mAb,0,29,Gene/Protein	complement receptor - 1,107,130,Gene/Protein	CR1,133,136,Gene/Protein	heat - labile serum factor,187,213,Gene/Protein	cell - associated recognition molecule,223,261,Gene/Protein	"[{""token"": ""O - side chain - specific mAb"", ""start_span"": 0, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""complement receptor - 1"", ""start_span"": 107, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""CR1"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""heat - labile serum factor"", ""start_span"": 187, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""cell - associated recognition molecule"", ""start_span"": 223, ""end_span"": 261, ""type"": ""Gene/Protein""}]"	train
EMSA showed that both constitutive and inducible complexes bound to CLE0, P, P2 and P4, whereas only a constitutive complex bound to P3.	CLE0,68,72,Gene/Protein	P,74,75,Gene/Protein	P2,77,79,Gene/Protein	P4,84,86,Gene/Protein	P3,133,135,Gene/Protein	"[{""token"": ""CLE0"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""P"", ""start_span"": 74, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""P2"", ""start_span"": 77, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""P4"", ""start_span"": 84, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""P3"", ""start_span"": 133, ""end_span"": 135, ""type"": ""Gene/Protein""}]"	train
This inhibition, which occurred with a parallel activation of c - Jun transactivating functions and expression, was reflected by transfection experiments at the IL - 2 promoter level, and involved not only the inhibition of NF - kappaB - driven reporter activation but also that of nuclear factor of activated T cells ( NFAT).	c - Jun,62,69,Gene/Protein	IL - 2 promoter,161,176,Gene/Protein	NF - kappaB,224,235,Gene/Protein	nuclear factor of activated T cells,282,317,Gene/Protein	NFAT,320,324,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 161, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 224, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 282, ""end_span"": 317, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 320, ""end_span"": 324, ""type"": ""Gene/Protein""}]"	train
We propose that the activation of an NFAT kinase by PDTC could be responsible for the rapid shuttling of the NFAT, therefore transiently converting the sustained transactivation of this transcription factor that occurs during lymphocyte activation, and show that c - Jun NH2 - terminal kinase ( JNK) can act by directly phosphorylating NFATp.	NFAT,37,41,Gene/Protein	transcription factor,186,206,Gene/Protein	c - Jun NH2 - terminal kinase,263,292,Gene/Protein	JNK,295,298,Gene/Protein	NFATp,336,341,Gene/Protein	"[{""token"": ""NFAT"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 186, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun NH2 - terminal kinase"", ""start_span"": 263, ""end_span"": 292, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 295, ""end_span"": 298, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 336, ""end_span"": 341, ""type"": ""Gene/Protein""}]"	train
Two other members of the family have been cloned more recently, A - myb and B - myb, which show sequence homology with c - myb in several domains, of which the DNA binding domain as well as other regulatory domains.	A - myb,64,71,Gene/Protein	B - myb,76,83,Gene/Protein	c - myb,119,126,Gene/Protein	DNA binding domain,160,178,Gene/Protein	regulatory domains,196,214,Gene/Protein	"[{""token"": ""A - myb"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""B - myb"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""c - myb"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding domain"", ""start_span"": 160, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""regulatory domains"", ""start_span"": 196, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
Sp3 mediates transcriptional activation of the leukocyte integrin genes CD11C and CD11B and cooperates with c - Jun to activate CD11C.	Sp3,0,3,Gene/Protein	leukocyte integrin genes,47,71,Gene/Protein	CD11C,72,77,Gene/Protein	CD11B,82,87,Gene/Protein	CD11C,128,133,Gene/Protein	"[{""token"": ""Sp3"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""leukocyte integrin genes"", ""start_span"": 47, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD11C"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""CD11B"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""CD11C"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Gene/Protein""}]"	train
In previous experiments, the - 70 to - 65 and - 121 to - 103 regions of the CD11c promoter and the - 66 to - 59 region of the CD11b promoter were shown to be essential for Sp1 - mediated activation of these genes.	- 70 to - 65 and - 121 to - 103 regions,29,68,Gene/Protein	CD11c promoter,76,90,Gene/Protein	- 66 to - 59 region,99,118,Gene/Protein	CD11b promoter,126,140,Gene/Protein	Sp1 -,172,177,Gene/Protein	"[{""token"": ""- 70 to - 65 and - 121 to - 103 regions"", ""start_span"": 29, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""CD11c promoter"", ""start_span"": 76, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""- 66 to - 59 region"", ""start_span"": 99, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""CD11b promoter"", ""start_span"": 126, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 -"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
In this study, we investigated the effect of ER alpha ( referred to throughout as ER) on DNA - binding activities of transcription factors involved in regulating the expression of erythroid - specific genes, and, in particular, the histone H5 gene.	ER alpha,45,53,Gene/Protein	ER,82,84,Gene/Protein	transcription factors,117,138,Gene/Protein	erythroid - specific genes,180,206,Gene/Protein	histone H5 gene,232,247,Gene/Protein	"[{""token"": ""ER alpha"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""ER"", ""start_span"": 82, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 117, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""erythroid - specific genes"", ""start_span"": 180, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""histone H5 gene"", ""start_span"": 232, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	train
These downstream sequence elements, termed DSE, can bind both AP - 1 and CREB / ATF transcription factors.	downstream sequence elements,6,34,Gene/Protein	DSE,43,46,Gene/Protein	AP - 1,62,68,Gene/Protein	CREB / ATF,73,83,Gene/Protein	transcription factors,84,105,Gene/Protein	"[{""token"": ""downstream sequence elements"", ""start_span"": 6, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""DSE"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""CREB / ATF"", ""start_span"": 73, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 84, ""end_span"": 105, ""type"": ""Gene/Protein""}]"	train
Repression of Cp activity required amino acids 207 to 368, which encompasses a region resembling a basic DBD adjacent to a leucine zipper DNA binding motif and a site which binds to the cellular factor CBF1 / RBP - Jkappa.	Cp,14,16,Gene/Protein	amino acids 207 to 368,35,57,Gene/Protein	basic DBD,99,108,Gene/Protein	leucine zipper DNA binding motif,123,155,Gene/Protein	cellular factor CBF1 / RBP - Jkappa,186,221,Gene/Protein	"[{""token"": ""Cp"", ""start_span"": 14, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""amino acids 207 to 368"", ""start_span"": 35, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""basic DBD"", ""start_span"": 99, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""leucine zipper DNA binding motif"", ""start_span"": 123, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""cellular factor CBF1 / RBP - Jkappa"", ""start_span"": 186, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
Finally, although it has been reported that EBNA3C can upregulate CD21 in some B cells, we were unable to demonstrate any effect of EBNA3C on reporter plasmids which contain the CD21 promoter.	EBNA3C,44,50,Gene/Protein	CD21,66,70,Gene/Protein	EBNA3C,132,138,Gene/Protein	reporter plasmids,142,159,Gene/Protein	CD21 promoter,178,191,Gene/Protein	"[{""token"": ""EBNA3C"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""CD21"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""EBNA3C"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""reporter plasmids"", ""start_span"": 142, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""CD21 promoter"", ""start_span"": 178, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
Considering that nuclear regulatory factor - kappa beta ( NF - kappa B) / Rel is a common regulatory element of the promoter region of the inflammatory cytokine genes, herein, we tested the hypothesis that acute ethanol affects NF - kappa B activation in human monocytes.	nuclear regulatory factor - kappa beta,17,55,Gene/Protein	regulatory element,90,108,Gene/Protein	promoter region,116,131,Gene/Protein	inflammatory cytokine genes,139,166,Gene/Protein	NF - kappa B,228,240,Gene/Protein	"[{""token"": ""nuclear regulatory factor - kappa beta"", ""start_span"": 17, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""regulatory element"", ""start_span"": 90, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""promoter region"", ""start_span"": 116, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""inflammatory cytokine genes"", ""start_span"": 139, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 228, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	train
Consequently, these results suggest that physiologically relevant concentrations of ethanol may affect production of inflammatory cytokines, such as tumor necrosis factor - alpha, interleukin - 1 beta, and interleukin - 6 by disrupting NF - kappa B signaling in monocytes.	inflammatory cytokines,117,139,Gene/Protein	tumor necrosis factor - alpha,149,178,Gene/Protein	interleukin - 1 beta,180,200,Gene/Protein	interleukin - 6,206,221,Gene/Protein	NF - kappa B,236,248,Gene/Protein	"[{""token"": ""inflammatory cytokines"", ""start_span"": 117, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 149, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1 beta"", ""start_span"": 180, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 6"", ""start_span"": 206, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 236, ""end_span"": 248, ""type"": ""Gene/Protein""}]"	train
The human G0 / G1 switch gene, G0S2, has potential NFAT - binding sites in the 5 ' flank and encodes a small basic potential phosphoprotein of unknown function.	human G0 / G1 switch gene,4,29,Gene/Protein	G0S2,31,35,Gene/Protein	NFAT - binding sites,51,71,Gene/Protein	5 ' flank,79,88,Gene/Protein	small basic potential phosphoprotein,103,139,Gene/Protein	"[{""token"": ""human G0 / G1 switch gene"", ""start_span"": 4, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""G0S2"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""NFAT - binding sites"", ""start_span"": 51, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""5 ' flank"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""small basic potential phosphoprotein"", ""start_span"": 103, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
For this purpose, human GATA - 3, either recombinant or in nuclear extracts, and three natural GATA elements of the HIV - 1 long terminal repeat ( sites 1, 2, and 3) were chosen, in which only site 2 is a noncanonical GATA site.	human GATA - 3,18,32,Gene/Protein	natural GATA elements,87,108,Gene/Protein	HIV - 1 long terminal repeat,116,144,Gene/Protein	site 2,193,199,Gene/Protein	GATA site,218,227,Gene/Protein	"[{""token"": ""human GATA - 3"", ""start_span"": 18, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""natural GATA elements"", ""start_span"": 87, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat"", ""start_span"": 116, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""site 2"", ""start_span"": 193, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""GATA site"", ""start_span"": 218, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
Flow cytometry analysis indicated that these cells were expressing high levels of vascular cell adhesion molecule 1 ( VCAM - 1 [ CD106]), a 110 - kDa member of the immunoglobulin gene superfamily, first identified on endothelial cells stimulated with inflammatory cytokines.	vascular cell adhesion molecule 1,82,115,Gene/Protein	VCAM - 1,118,126,Gene/Protein	CD106,129,134,Gene/Protein	immunoglobulin gene superfamily,164,195,Gene/Protein	inflammatory cytokines,251,273,Gene/Protein	"[{""token"": ""vascular cell adhesion molecule 1"", ""start_span"": 82, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""CD106"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin gene superfamily"", ""start_span"": 164, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""inflammatory cytokines"", ""start_span"": 251, ""end_span"": 273, ""type"": ""Gene/Protein""}]"	train
We now show that IL - 2 regulation of STAT3 proteins in T cells is a complex response involving activation of two forms of STAT3: 90 - kDa STAT3alpha and an 83 - kDa carboxyl - terminal truncated STAT3beta.	IL - 2,17,23,Gene/Protein	STAT3 proteins,38,52,Gene/Protein	STAT3,123,128,Gene/Protein	STAT3alpha,139,149,Gene/Protein	83 - kDa carboxyl - terminal truncated STAT3beta,157,205,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""STAT3 proteins"", ""start_span"": 38, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""STAT3alpha"", ""start_span"": 139, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""83 - kDa carboxyl - terminal truncated STAT3beta"", ""start_span"": 157, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
In vitro, the ICAM - 1 kappa B site appeared to bind RelA and c - Rel homodimers as well as heterodimers with NF - kappa B1, but weakly NF - kappa B1 homodimers.	ICAM - 1 kappa B site,14,35,Gene/Protein	RelA,53,57,Gene/Protein	c - Rel homodimers,62,80,Gene/Protein	NF - kappa B1,110,123,Gene/Protein	NF - kappa B1 homodimers,136,160,Gene/Protein	"[{""token"": ""ICAM - 1 kappa B site"", ""start_span"": 14, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel homodimers"", ""start_span"": 62, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B1"", ""start_span"": 110, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B1 homodimers"", ""start_span"": 136, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
Here we show that in E29. 1 T cell hybridoma I kappa B alpha and I kappa B beta are equally associated with p65 and that I kappa B beta is degraded in response to TNF alpha in contrast to what has been originally published.	I kappa B alpha,45,60,Gene/Protein	I kappa B beta,65,79,Gene/Protein	p65,108,111,Gene/Protein	I kappa B beta,121,135,Gene/Protein	TNF alpha,163,172,Gene/Protein	"[{""token"": ""I kappa B alpha"", ""start_span"": 45, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B beta"", ""start_span"": 65, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B beta"", ""start_span"": 121, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""TNF alpha"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
G28 - 5 IgG partially blocked, whereas G28 - 5 sFv augmented CD40 responses during stimulation with natural ligand ( gp39 - CD8 fusion protein).	G28 - 5 IgG,0,11,Gene/Protein	G28 - 5 sFv,39,50,Gene/Protein	CD40,61,65,Gene/Protein	natural ligand,100,114,Gene/Protein	gp39 - CD8 fusion protein,117,142,Gene/Protein	"[{""token"": ""G28 - 5 IgG"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""G28 - 5 sFv"", ""start_span"": 39, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""natural ligand"", ""start_span"": 100, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""gp39 - CD8 fusion protein"", ""start_span"": 117, ""end_span"": 142, ""type"": ""Gene/Protein""}]"	train
Promoter activity was increased by the transcription factors C / EBPbeta ( NF - IL6) and more strongly, by C / EBPdelta ( NF - IL6beta).	transcription factors,39,60,Gene/Protein	C / EBPbeta,61,72,Gene/Protein	NF - IL6,75,83,Gene/Protein	C / EBPdelta,107,119,Gene/Protein	NF - IL6beta,122,134,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 39, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""C / EBPbeta"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""C / EBPdelta"", ""start_span"": 107, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6beta"", ""start_span"": 122, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
The molecular mechanisms underlying the IL - 7 effect involve the upregulation of the DNA binding activity of NFAT ( 60%) and AP - 1 ( 120%), without affecting the activities of NFkappaB and CD28RC, which was confirmed by transfection assays.	IL - 7,40,46,Gene/Protein	NFAT,110,114,Gene/Protein	AP - 1,126,132,Gene/Protein	NFkappaB,178,186,Gene/Protein	CD28RC,191,197,Gene/Protein	"[{""token"": ""IL - 7"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""CD28RC"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
Since AP - 1 is part of the NFAT complex, we conclude that the IL - 7 - signaling pathway is involved in the activation of the fos and jun proteins of which AP - 1 consists.	AP - 1,6,12,Gene/Protein	NFAT complex,28,40,Gene/Protein	IL - 7,63,69,Gene/Protein	fos and jun proteins,127,147,Gene/Protein	AP - 1,157,163,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""NFAT complex"", ""start_span"": 28, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""fos and jun proteins"", ""start_span"": 127, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
Proteasome - dependent inhibitory kappa B alpha ( I kappa B alpha) and I kappa B beta degradation occurred downstream of CD40 ligation and preceded CD40 - mediated NF - kappa B nuclear translocation.	I kappa B alpha,50,65,Gene/Protein	I kappa B beta,71,85,Gene/Protein	CD40,121,125,Gene/Protein	CD40,148,152,Gene/Protein	NF - kappa B,164,176,Gene/Protein	"[{""token"": ""I kappa B alpha"", ""start_span"": 50, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B beta"", ""start_span"": 71, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 164, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
However, NF - kappa B activation was insufficient for CD40 - mediated up - regulation of B7 - 1, Fas, and CD23.	NF - kappa B,9,21,Gene/Protein	CD40,54,58,Gene/Protein	B7 - 1,89,95,Gene/Protein	Fas,97,100,Gene/Protein	CD23,106,110,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 9, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""B7 - 1"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""Fas"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene/Protein""}]"	train
One of the proteins that binds to these sites is TRAF2, a signal transduction molecule that is also utilized by TNFR1 to mediate the activation of several downstream kinases and transcription factors.	TRAF2,49,54,Gene/Protein	signal transduction molecule,58,86,Gene/Protein	TNFR1,112,117,Gene/Protein	kinases,166,173,Gene/Protein	transcription factors,178,199,Gene/Protein	"[{""token"": ""TRAF2"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""signal transduction molecule"", ""start_span"": 58, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""TNFR1"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""kinases"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 178, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
Low proliferative capacity was observed after 1 week in culture in the presence of stem cell factor ( SCF) + Flt - 3 ligand ( FL) + G - CSF.	stem cell factor,83,99,Gene/Protein	SCF,102,105,Gene/Protein	Flt - 3 ligand,109,123,Gene/Protein	FL,126,128,Gene/Protein	G - CSF,132,139,Gene/Protein	"[{""token"": ""stem cell factor"", ""start_span"": 83, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Flt - 3 ligand"", ""start_span"": 109, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""FL"", ""start_span"": 126, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
Recent studies from our laboratory have indicated that protein tyrosine phosphatase ( PTPase) inhibitors can down - modulate the tumor necrosis factor ( TNF) - mediated activation of the nuclear transcription factor NF - kappa B in ML - 1a, a monocytic cell line ( Singh and Aggarwal, J. Biol. Chem. 1995: 270: 10631).	protein tyrosine phosphatase,55,83,Gene/Protein	PTPase,86,92,Gene/Protein	tumor necrosis factor,129,150,Gene/Protein	TNF,153,156,Gene/Protein	nuclear transcription factor NF - kappa B,187,228,Gene/Protein	"[{""token"": ""protein tyrosine phosphatase"", ""start_span"": 55, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""PTPase"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 129, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""nuclear transcription factor NF - kappa B"", ""start_span"": 187, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	train
Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF - kappa B, we examined the effect of PTPase inhibitors on the TNF - mediated induction of intracellular adhesion molecule ( ICAM) - 1, vascular cell adhesion molecule ( VCAM) - 1 and endothelial leukocyte adhesion molecule ( ELAM) - 1.	TNF,6,9,Gene/Protein	adhesion molecules,50,68,Gene/Protein	NF - kappa B,155,167,Gene/Protein	PTPase,195,201,Gene/Protein	TNF,220,223,Gene/Protein	"[{""token"": ""TNF"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""adhesion molecules"", ""start_span"": 50, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 155, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""PTPase"", ""start_span"": 195, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 220, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
This inhibition is selective, as the activity of four other transcription factors, Oct - 1, TBP, Sp1 and STAT 5 was not affected.	transcription factors,60,81,Gene/Protein	Oct - 1,83,90,Gene/Protein	TBP,92,95,Gene/Protein	Sp1,97,100,Gene/Protein	STAT 5,105,111,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 60, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""TBP"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""STAT 5"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Gene/Protein""}]"	train
We also identified Sp1, Sp3, and NGFI - A / Egr - 1 as the primary nuclear transcription factors binding to TRE1 which mediate Tax responsiveness.	Sp1,19,22,Gene/Protein	NGFI - A / Egr - 1,33,51,Gene/Protein	primary nuclear transcription factors,59,96,Gene/Protein	TRE1,108,112,Gene/Protein	Tax,127,130,Gene/Protein	"[{""token"": ""Sp1"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""NGFI - A / Egr - 1"", ""start_span"": 33, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""primary nuclear transcription factors"", ""start_span"": 59, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""TRE1"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}]"	train
In summary, our data reveal a novel effector of LMP - 1, the SEK / JNK / c - Jun / AP - 1 pathway, which contributes to our understanding of the immortalizing and transforming potential of LMP - 1.	LMP - 1,48,55,Gene/Protein	JNK,67,70,Gene/Protein	c - Jun,73,80,Gene/Protein	AP - 1,83,89,Gene/Protein	LMP - 1,189,196,Gene/Protein	"[{""token"": ""LMP - 1"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 83, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""LMP - 1"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
Cloning of the cDNA encoding human SR - BP shows an open reading frame for a 223 - amino acid protein, which is homologous to the recently cloned sigma 1 receptor.	cDNA,15,19,Gene/Protein	human SR - BP,29,42,Gene/Protein	open reading frame,52,70,Gene/Protein	223 - amino acid protein,77,101,Gene/Protein	sigma 1 receptor,146,162,Gene/Protein	"[{""token"": ""cDNA"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""human SR - BP"", ""start_span"": 29, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""open reading frame"", ""start_span"": 52, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""223 - amino acid protein"", ""start_span"": 77, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""sigma 1 receptor"", ""start_span"": 146, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
The JAK ( Janus kinase) family of protein tyrosine kinases and the STATs ( signal transducers and activators of transcription) have been shown to be activated in response to a number of cytokines and growth factors.	protein tyrosine kinases,34,58,Gene/Protein	STATs,67,72,Gene/Protein	signal transducers and activators of transcription,75,125,Gene/Protein	cytokines,186,195,Gene/Protein	growth factors,200,214,Gene/Protein	"[{""token"": ""protein tyrosine kinases"", ""start_span"": 34, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""STATs"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers and activators of transcription"", ""start_span"": 75, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 186, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""growth factors"", ""start_span"": 200, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
METHODS AND RESULTS: Incubation of human whole blood with platelet - activating factor ( PAF, 1 mumol / L) evoked downregulation of L - selectin and upregulation of CD11 / CD18 adhesion receptors on neutrophils as measured by flow cytometry.	platelet - activating factor,58,86,Gene/Protein	PAF,89,92,Gene/Protein	L - selectin,132,144,Gene/Protein	CD11 / CD18,165,176,Gene/Protein	adhesion receptors,177,195,Gene/Protein	"[{""token"": ""platelet - activating factor"", ""start_span"": 58, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""L - selectin"", ""start_span"": 132, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""CD11 / CD18"", ""start_span"": 165, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""adhesion receptors"", ""start_span"": 177, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
In this paper, we demonstrate that PIF is Egr - 1 based on its recognition by anti - Egr - 1 antisera in gel mobility shift assays, even though the IL - 2Rbeta DNA binding motif differed substantially from the canonical Egr - 1 binding site.	PIF,35,38,Gene/Protein	Egr - 1,42,49,Gene/Protein	Egr - 1,85,92,Gene/Protein	IL - 2Rbeta DNA binding motif,148,177,Gene/Protein	Egr - 1 binding site,220,240,Gene/Protein	"[{""token"": ""PIF"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2Rbeta DNA binding motif"", ""start_span"": 148, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1 binding site"", ""start_span"": 220, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	train
In contrast, when HSF2 - beta is expressed at levels exceeding those of endogenous HSF2 - alpha, the hemin - induced DNA binding activity and transcription of heat shock genes are repressed, whereas overexpression of HSF2 - alpha results in an enhanced hemin response.	HSF2 - beta,18,29,Gene/Protein	endogenous HSF2 - alpha,72,95,Gene/Protein	heat shock genes,159,175,Gene/Protein	HSF2 - alpha,217,229,Gene/Protein	hemin,253,258,Gene/Protein	"[{""token"": ""HSF2 - beta"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""endogenous HSF2 - alpha"", ""start_span"": 72, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""heat shock genes"", ""start_span"": 159, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""HSF2 - alpha"", ""start_span"": 217, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""hemin"", ""start_span"": 253, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	train
A membrane - proximal region that contains the BOX1 consensus sequence is required for IL - 9 - induced cell proliferation and tyrosine phosphorylation of Janus kinases ( JAKs).	membrane - proximal region,2,28,Gene/Protein	BOX1 consensus sequence,47,70,Gene/Protein	IL - 9,87,93,Gene/Protein	Janus kinases,155,168,Gene/Protein	JAKs,171,175,Gene/Protein	"[{""token"": ""membrane - proximal region"", ""start_span"": 2, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""BOX1 consensus sequence"", ""start_span"": 47, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinases"", ""start_span"": 155, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""JAKs"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
Deletion of this region significantly impaired IL - 9 - induced cell growth, activation of JAK kinases, insulin receptor substrate - 2, and STAT3 and expression of early response genes.	IL - 9,47,53,Gene/Protein	JAK kinases,91,102,Gene/Protein	insulin receptor substrate - 2,104,134,Gene/Protein	STAT3,140,145,Gene/Protein	early response genes,164,184,Gene/Protein	"[{""token"": ""IL - 9"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""JAK kinases"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""insulin receptor substrate - 2"", ""start_span"": 104, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""early response genes"", ""start_span"": 164, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
A point mutation changing YLPQ into YLPA greatly reduced IL - 9 - induced activation of STAT3 and expression of c - myc but did not affect cell proliferation.	YLPQ,26,30,Gene/Protein	YLPA,36,40,Gene/Protein	IL - 9,57,63,Gene/Protein	STAT3,88,93,Gene/Protein	c - myc,112,119,Gene/Protein	"[{""token"": ""YLPQ"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""YLPA"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene/Protein""}]"	train
By using several HBD subfragments, the mAb 18C7 epitope was located in the N - terminal region of the HBD from Thr729 to Leu765.	HBD subfragments,17,33,Gene/Protein	mAb 18C7 epitope,39,55,Gene/Protein	N - terminal region,75,94,Gene/Protein	HBD,102,105,Gene/Protein	Thr729 to Leu765,111,127,Gene/Protein	"[{""token"": ""HBD subfragments"", ""start_span"": 17, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""mAb 18C7 epitope"", ""start_span"": 39, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal region"", ""start_span"": 75, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""HBD"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Thr729 to Leu765"", ""start_span"": 111, ""end_span"": 127, ""type"": ""Gene/Protein""}]"	train
Here we show that ETS1 can transactivate a GM - CSF reporter construct in unstimulated Jurkat cells, providing that either NFkappaB or AP1 transcription factors are supplied by co - transfection.	ETS1,18,22,Gene/Protein	GM - CSF reporter construct,43,70,Gene/Protein	NFkappaB,123,131,Gene/Protein	AP1,135,138,Gene/Protein	transcription factors,139,160,Gene/Protein	"[{""token"": ""ETS1"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF reporter construct"", ""start_span"": 43, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""AP1"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 139, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
Fine mapping by in vivo footprinting demonstrated five transcription factor binding sites that are occupied in both resting and activated peripheral blood T lymphocytes; these are tandem CRE motifs, a Sp1 site, an overlapping Egr - 1 / Sp1 site, and a novel palindromic octamer sequence ( POS).	tandem CRE motifs,180,197,Gene/Protein	Sp1 site,201,209,Gene/Protein	Egr - 1 / Sp1 site,226,244,Gene/Protein	palindromic octamer sequence,258,286,Gene/Protein	POS,289,292,Gene/Protein	"[{""token"": ""tandem CRE motifs"", ""start_span"": 180, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 site"", ""start_span"": 201, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1 / Sp1 site"", ""start_span"": 226, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""palindromic octamer sequence"", ""start_span"": 258, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""POS"", ""start_span"": 289, ""end_span"": 292, ""type"": ""Gene/Protein""}]"	train
Unlike published studies with pyrrolidinedithiocar, which specifically inhibited vascular cell adhesion molecule 1 ( VCAM - 1), NAC inhibited IL - 1 beta - induced mRNA and cell surface expression of both E - selectin and VCAM - 1.	vascular cell adhesion molecule 1,81,114,Gene/Protein	VCAM - 1,117,125,Gene/Protein	IL - 1 beta - induced mRNA,142,168,Gene/Protein	E - selectin,205,217,Gene/Protein	VCAM - 1,222,230,Gene/Protein	"[{""token"": ""vascular cell adhesion molecule 1"", ""start_span"": 81, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 beta - induced mRNA"", ""start_span"": 142, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 205, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 222, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
Therefore, we have constructed a single cDNA that encodes a single - chain protein, called Flexi - 12, which retains all of the biological characteristics of recombinant IL - 12 ( rIL - 12).	cDNA,40,44,Gene/Protein	single - chain protein,60,82,Gene/Protein	Flexi - 12,91,101,Gene/Protein	IL - 12,170,177,Gene/Protein	rIL - 12,180,188,Gene/Protein	"[{""token"": ""cDNA"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""single - chain protein"", ""start_span"": 60, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""Flexi - 12"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 170, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""rIL - 12"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
Next, in an effort to determine critical transcription factors that regulate CD95 ligand expression, we demonstrate a cyclosporin A - sensitive nuclear factor - AT response element in the promoter region of this gene that is critical for optimal CD95 ligand reporter activity in stimulated T cells.	transcription factors,41,62,Gene/Protein	CD95 ligand,77,88,Gene/Protein	cyclosporin A - sensitive nuclear factor - AT response element,118,180,Gene/Protein	promoter region,188,203,Gene/Protein	CD95 ligand,246,257,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 41, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CD95 ligand"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""cyclosporin A - sensitive nuclear factor - AT response element"", ""start_span"": 118, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""promoter region"", ""start_span"": 188, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""CD95 ligand"", ""start_span"": 246, ""end_span"": 257, ""type"": ""Gene/Protein""}]"	train
Stimulation of cells with IFN - alpha leads to the assembly of IFN - stimulated gene factor 3 transcription factor complex formed by STAT1, STAT2, and p48 protein.	IFN - alpha,26,37,Gene/Protein	IFN - stimulated gene factor 3 transcription factor complex,63,122,Gene/Protein	STAT1,133,138,Gene/Protein	STAT2,140,145,Gene/Protein	p48 protein,151,162,Gene/Protein	"[{""token"": ""IFN - alpha"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""IFN - stimulated gene factor 3 transcription factor complex"", ""start_span"": 63, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""STAT2"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""p48 protein"", ""start_span"": 151, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
This suggests that higher intracellular levels of STAT1, STAT2, and p48 protein may result in enhanced signal transduction for cytokines utilizing these transcription factors.	STAT1,50,55,Gene/Protein	STAT2,57,62,Gene/Protein	p48 protein,68,79,Gene/Protein	cytokines,127,136,Gene/Protein	transcription factors,153,174,Gene/Protein	"[{""token"": ""STAT1"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""STAT2"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""p48 protein"", ""start_span"": 68, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 127, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 153, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
Effects of TPA, bryostatin 1, and retinoic acid on PO - B, AP - 1, and AP - 2 DNA binding during HL - 60 differentiation.	TPA,11,14,Gene/Protein	bryostatin 1,16,28,Gene/Protein	PO - B,51,57,Gene/Protein	AP - 1,59,65,Gene/Protein	AP - 2,71,77,Gene/Protein	"[{""token"": ""TPA"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""bryostatin 1"", ""start_span"": 16, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""PO - B"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene/Protein""}]"	train
Aggregation was likely caused by the up - regulated surface expression of adhesion molecules including integrin alpha, L - selectin, ICAM - 3, and H - CAM.	adhesion molecules,74,92,Gene/Protein	integrin alpha,103,117,Gene/Protein	L - selectin,119,131,Gene/Protein	ICAM - 3,133,141,Gene/Protein	H - CAM,147,154,Gene/Protein	"[{""token"": ""adhesion molecules"", ""start_span"": 74, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""integrin alpha"", ""start_span"": 103, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""L - selectin"", ""start_span"": 119, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 3"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""H - CAM"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
We show here that c - Raf, which is at the helm of the classic MAP - Erk cascade, contributes to IL - 2 induction through a distal enhancer element spanning the nucleotides from positions - 502 to - 413 in front of the transcriptional start site of the IL - 2 gene.	c - Raf,18,25,Gene/Protein	Erk,69,72,Gene/Protein	IL - 2,97,103,Gene/Protein	distal enhancer element,124,147,Gene/Protein	IL - 2 gene,253,264,Gene/Protein	"[{""token"": ""c - Raf"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""Erk"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""distal enhancer element"", ""start_span"": 124, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 gene"", ""start_span"": 253, ""end_span"": 264, ""type"": ""Gene/Protein""}]"	train
Introduction of point mutations suppressing GABP binding to the DSE interfered with the induction of the distal enhancer and the entire IL - 2 promoter - enhancer, while overexpression of both GABP factors enhanced the IL - 2 promoter - enhancer induction.	DSE,64,67,Gene/Protein	distal enhancer,105,120,Gene/Protein	IL - 2 promoter - enhancer,136,162,Gene/Protein	GABP factors,193,205,Gene/Protein	IL - 2 promoter - enhancer,219,245,Gene/Protein	"[{""token"": ""DSE"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""distal enhancer"", ""start_span"": 105, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter - enhancer"", ""start_span"": 136, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""GABP factors"", ""start_span"": 193, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter - enhancer"", ""start_span"": 219, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
In conjunction with previously published data on c - Raf - induced phosphorylation of GABP factors ( E. Flory, A. Hoffmeyer, U. Smola, U. R. Rapp, and J. T. Bruder, J. Virol. 70: 2260 - 2268, 1996), these results indicate a contribution of GABP factors to the Raf - mediated enhancement of IL - 2 induction during T - cell activation.	c - Raf,49,56,Gene/Protein	GABP factors,86,98,Gene/Protein	GABP factors,240,252,Gene/Protein	Raf,260,263,Gene/Protein	IL - 2,290,296,Gene/Protein	"[{""token"": ""c - Raf"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""GABP factors"", ""start_span"": 86, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""GABP factors"", ""start_span"": 240, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""Raf"", ""start_span"": 260, ""end_span"": 263, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 290, ""end_span"": 296, ""type"": ""Gene/Protein""}]"	train
We found that IL - 2, interferon - alpha ( IFN - alpha), and IFN - beta inhibited IL - 2 deprivation apoptosis in Th0, Th1, and Th2 clones.	IL - 2,14,20,Gene/Protein	interferon - alpha,22,40,Gene/Protein	IFN - alpha,43,54,Gene/Protein	IFN - beta,61,71,Gene/Protein	IL - 2,82,88,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""interferon - alpha"", ""start_span"": 22, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IFN - beta"", ""start_span"": 61, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene/Protein""}]"	train
We also found that IL - 2 protects T cell clones from IL - 2 deprivation apoptosis accompanying active proliferation and enhanced expression of P53, Rb and Bcl - xL proteins.	IL - 2,19,25,Gene/Protein	IL - 2,54,60,Gene/Protein	P53,144,147,Gene/Protein	Rb,149,151,Gene/Protein	Bcl - xL proteins,156,173,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""P53"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 149, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - xL proteins"", ""start_span"": 156, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
In this study, we investigated the mechanism by which IL - 10 downregulates expression of intercellular adhesion molecule - 1 ( ICAM - 1) on the cell surface of normal human monocytes activated with interferon - gamma ( IFN - gamma).	IL - 10,54,61,Gene/Protein	intercellular adhesion molecule - 1,90,125,Gene/Protein	ICAM - 1,128,136,Gene/Protein	interferon - gamma,199,217,Gene/Protein	IFN - gamma,220,231,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 90, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""interferon - gamma"", ""start_span"": 199, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 220, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
Nuclear run - on transcription assays showed that IL - 10 inhibited the rate of IFN - gamma - induced transcription of the ICAM - 1 gene, and mRNA stability studies showed that IL - 10 did not alter the half - life of IFN - gamma - induced ICAM - 1 message.	IL - 10,50,57,Gene/Protein	IFN - gamma,80,91,Gene/Protein	ICAM - 1 gene,123,136,Gene/Protein	IL - 10,177,184,Gene/Protein	IFN - gamma - induced ICAM - 1 message,218,256,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1 gene"", ""start_span"": 123, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma - induced ICAM - 1 message"", ""start_span"": 218, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
We have previously shown that in T cells the PI3 - K inhibitor, wortmannin, interferes with activation of the mitogen - activated kinase, Erk2, after T cell receptor ( TcR) stimulation.	PI3 - K,45,52,Gene/Protein	mitogen - activated kinase,110,136,Gene/Protein	Erk2,138,142,Gene/Protein	T cell receptor,150,165,Gene/Protein	TcR,168,171,Gene/Protein	"[{""token"": ""PI3 - K"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated kinase"", ""start_span"": 110, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""Erk2"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""T cell receptor"", ""start_span"": 150, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""TcR"", ""start_span"": 168, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
Following TcR stimulation, activation of Erk2 was only inhibited by a previously described truncated form of p85 that can not bind the catalytic subunit, but not by other constructs of p85.	TcR,10,13,Gene/Protein	Erk2,41,45,Gene/Protein	truncated form of p85,91,112,Gene/Protein	catalytic subunit,135,152,Gene/Protein	p85,185,188,Gene/Protein	"[{""token"": ""TcR"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""Erk2"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""truncated form of p85"", ""start_span"": 91, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""catalytic subunit"", ""start_span"": 135, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""p85"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
Most interestingly, the N - terminal SH2 domain had an inhibitory effect, whereas a mutant p85 containing only the two SH2 domains enhanced basal NFAT activity in a Ras - dependent manner.	N - terminal SH2 domain,24,47,Gene/Protein	mutant p85,84,94,Gene/Protein	two SH2 domains,115,130,Gene/Protein	NFAT,146,150,Gene/Protein	Ras,165,168,Gene/Protein	"[{""token"": ""N - terminal SH2 domain"", ""start_span"": 24, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""mutant p85"", ""start_span"": 84, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""two SH2 domains"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
Nonetheless, CREB, Ets - 1, and AML1 bind and activate cooperatively and very efficiently through the nonconsensus binding sites at the core promoter region.	CREB,13,17,Gene/Protein	Ets - 1,19,26,Gene/Protein	AML1,32,36,Gene/Protein	nonconsensus binding sites,102,128,Gene/Protein	core promoter region,136,156,Gene/Protein	"[{""token"": ""CREB"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""Ets - 1"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""AML1"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""nonconsensus binding sites"", ""start_span"": 102, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""core promoter region"", ""start_span"": 136, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
Binding assays using 125I - labeled C - C chemokines in mammalian cells indicated that CHEMR1 did not bind MIP - 1alpha, RANTES, or MIP - 1beta, whereas CCR - 1 binds MIP - 1alpha and RANTES.	125I - labeled C - C chemokines,21,52,Gene/Protein	CHEMR1,87,93,Gene/Protein	CCR - 1,153,160,Gene/Protein	MIP - 1alpha,167,179,Gene/Protein	RANTES,184,190,Gene/Protein	"[{""token"": ""125I - labeled C - C chemokines"", ""start_span"": 21, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""CHEMR1"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""CCR - 1"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 1alpha"", ""start_span"": 167, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""RANTES"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
Cyclin A was observed after 4 days of costimulation with anti CD2 + CD28 whereas stimulation by anti CD2 or anti CD28 alone was not effective.	Cyclin A,0,8,Gene/Protein	anti CD2,57,65,Gene/Protein	CD28,68,72,Gene/Protein	anti CD2,96,104,Gene/Protein	anti CD28,108,117,Gene/Protein	"[{""token"": ""Cyclin A"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""anti CD2"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""anti CD2"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""anti CD28"", ""start_span"": 108, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
An enhancer - blocking element ( BEAD - 1, for blocking element alpha / delta 1) was localized to a 2. 0 - kb region 3 ' of TCR delta gene segments and 5 ' of TCR alpha joining gene segments within this locus.	enhancer - blocking element,3,30,Gene/Protein	BEAD - 1,33,41,Gene/Protein	element alpha / delta 1,56,79,Gene/Protein	TCR delta gene segments,124,147,Gene/Protein	TCR alpha joining gene segments,159,190,Gene/Protein	"[{""token"": ""enhancer - blocking element"", ""start_span"": 3, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""BEAD - 1"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""element alpha / delta 1"", ""start_span"": 56, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""TCR delta gene segments"", ""start_span"": 124, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""TCR alpha joining gene segments"", ""start_span"": 159, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
In vivo footprinting identified protected regions over the known high affinity B cell lineage - specific activator protein ( BSAP) site, the low affinity BSAP site, a SP1 / Egr - 1 site termed the CD19 GC box, and two novel sites named the AT box and PyG box.	low affinity BSAP site,141,163,Gene/Protein	SP1 / Egr - 1 site,167,185,Gene/Protein	CD19 GC box,197,208,Gene/Protein	AT box,240,246,Gene/Protein	PyG box,251,258,Gene/Protein	"[{""token"": ""low affinity BSAP site"", ""start_span"": 141, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""SP1 / Egr - 1 site"", ""start_span"": 167, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""CD19 GC box"", ""start_span"": 197, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""AT box"", ""start_span"": 240, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""PyG box"", ""start_span"": 251, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	train
To test this latter possibility, a chimeric receptor containing the extracellular domain of c - kit ( the stem cell factor ( SCF) receptor) and the cytoplasmic and transmembrane domains of the IL - 4R alpha chain was generated.	chimeric receptor,35,52,Gene/Protein	extracellular domain,68,88,Gene/Protein	c - kit,92,99,Gene/Protein	cytoplasmic and transmembrane domains,148,185,Gene/Protein	IL - 4R alpha chain,193,212,Gene/Protein	"[{""token"": ""chimeric receptor"", ""start_span"": 35, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""extracellular domain"", ""start_span"": 68, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""c - kit"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic and transmembrane domains"", ""start_span"": 148, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R alpha chain"", ""start_span"": 193, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	train
SCF - mediated ligation of kit / IL - 4R alpha is sufficient to elicit IL - 4 - specific gene expression, including up - regulation of CD23 and synthesis of germ - line epsilon transcripts.	SCF,0,3,Gene/Protein	kit / IL - 4R alpha,27,46,Gene/Protein	IL - 4,71,77,Gene/Protein	CD23,135,139,Gene/Protein	germ - line epsilon transcripts,157,188,Gene/Protein	"[{""token"": ""SCF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""kit / IL - 4R alpha"", ""start_span"": 27, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""germ - line epsilon transcripts"", ""start_span"": 157, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP - Jkappa or nuclear localization sequences retain the ability to associate with RBP - Jkappa and activate transcription.	NOTCH1,19,25,Gene/Protein	primary binding site,45,65,Gene/Protein	RBP - Jkappa,70,82,Gene/Protein	nuclear localization sequences,86,116,Gene/Protein	RBP - Jkappa,154,166,Gene/Protein	"[{""token"": ""NOTCH1"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""primary binding site"", ""start_span"": 45, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""RBP - Jkappa"", ""start_span"": 70, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""nuclear localization sequences"", ""start_span"": 86, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""RBP - Jkappa"", ""start_span"": 154, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
EMS analyses performed with nuclear extracts from Tax - expressing Jurkat cells and HTLV - I - transformed peripheral blood mononuclear cells demonstrate that Tax prevents the formation of U1 ( U1A / U1B) and U2 DNA - protein complexes.	Tax,50,53,Gene/Protein	U1,189,191,Gene/Protein	U1A / U1B,194,203,Gene/Protein	U2,209,211,Gene/Protein	DNA - protein complexes,212,235,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""U1"", ""start_span"": 189, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""U1A / U1B"", ""start_span"": 194, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""U2"", ""start_span"": 209, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""DNA - protein complexes"", ""start_span"": 212, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
The nuclear factor kappaB ( NF - kappaB) is thought to be crucially involved in the gene activation of several cytokines, including tumor necrosis factor alpha ( TNF).	nuclear factor kappaB,4,25,Gene/Protein	NF - kappaB,28,39,Gene/Protein	cytokines,111,120,Gene/Protein	tumor necrosis factor alpha,132,159,Gene/Protein	TNF,162,165,Gene/Protein	"[{""token"": ""nuclear factor kappaB"", ""start_span"": 4, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 111, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 132, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
Human neutrophil elastase proteolytically activates the platelet integrin alphaIIbbeta3 through cleavage of the carboxyl terminus of the alphaIIb subunit heavy chain.	Human neutrophil elastase,0,25,Gene/Protein	platelet integrin,56,73,Gene/Protein	alphaIIbbeta3,74,87,Gene/Protein	carboxyl terminus,112,129,Gene/Protein	alphaIIb subunit heavy chain,137,165,Gene/Protein	"[{""token"": ""Human neutrophil elastase"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""platelet integrin"", ""start_span"": 56, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""alphaIIbbeta3"", ""start_span"": 74, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""carboxyl terminus"", ""start_span"": 112, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""alphaIIb subunit heavy chain"", ""start_span"": 137, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
Using flow cytometry analysis, NE was shown to trigger a time - dependent binding of PAC - 1 and AP - 5, two monoclonal antibodies specific for the activated and ligand - occupied conformers of alphaIIbbeta3.	NE,31,33,Gene/Protein	PAC - 1,85,92,Gene/Protein	AP - 5,97,103,Gene/Protein	monoclonal antibodies,109,130,Gene/Protein	alphaIIbbeta3,194,207,Gene/Protein	"[{""token"": ""NE"", ""start_span"": 31, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""PAC - 1"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""AP - 5"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""monoclonal antibodies"", ""start_span"": 109, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""alphaIIbbeta3"", ""start_span"": 194, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
By contrast, phosphatidic acid accumulation, pleckstrin phosphorylation, and calcium mobilization produced by the combination of NE and threshold of cathepsin G were not significantly different from those measured with threshold of cathepsin G alone ( p > 0. 05), indicating that the phospholipase C / protein kinase C pathway is not involved in the potentiation of aggregation.	NE,129,131,Gene/Protein	cathepsin G,149,160,Gene/Protein	cathepsin G,232,243,Gene/Protein	phospholipase C,284,299,Gene/Protein	/ protein kinase C,300,318,Gene/Protein	"[{""token"": ""NE"", ""start_span"": 129, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""cathepsin G"", ""start_span"": 149, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""cathepsin G"", ""start_span"": 232, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""phospholipase C"", ""start_span"": 284, ""end_span"": 299, ""type"": ""Gene/Protein""}, {""token"": ""/ protein kinase C"", ""start_span"": 300, ""end_span"": 318, ""type"": ""Gene/Protein""}]"	train
The foregoing data, as well as the requirement of catalytically active NE to trigger alphaIIbbeta3 activation and potentiate threshold of cathepsin G - initiated platelet aggregation, led us to examine whether the structure of this integrin was affected by NE.	NE,71,73,Gene/Protein	alphaIIbbeta3,85,98,Gene/Protein	cathepsin G,138,149,Gene/Protein	integrin,232,240,Gene/Protein	NE,257,259,Gene/Protein	"[{""token"": ""NE"", ""start_span"": 71, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""alphaIIbbeta3"", ""start_span"": 85, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""cathepsin G"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""integrin"", ""start_span"": 232, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""NE"", ""start_span"": 257, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	train
Using electrophoretic mobility shift assays, the levels of nuclear regulatory proteins recognizing the AP - 1 consensus TRE motif, the proximal c - jun TRE - like promoter element, and the c - fos serum response element ( SRE) were determined in resting and stimulated T cells.	nuclear regulatory proteins,59,86,Gene/Protein	AP - 1 consensus TRE motif,103,129,Gene/Protein	proximal c - jun TRE - like promoter element,135,179,Gene/Protein	c - fos serum response element,189,219,Gene/Protein	SRE,222,225,Gene/Protein	"[{""token"": ""nuclear regulatory proteins"", ""start_span"": 59, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 consensus TRE motif"", ""start_span"": 103, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""proximal c - jun TRE - like promoter element"", ""start_span"": 135, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""c - fos serum response element"", ""start_span"": 189, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""SRE"", ""start_span"": 222, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	train
In the present study we have examined the immune modulating effects of RA on IL - 2 mRNA, another important cytokine for B cell immunoglobulin production, the expression of IL - 2 receptors on T cells, and the RA nuclear receptors.	IL - 2 mRNA,77,88,Gene/Protein	cytokine,108,116,Gene/Protein	immunoglobulin,128,142,Gene/Protein	IL - 2 receptors,173,189,Gene/Protein	RA nuclear receptors,210,230,Gene/Protein	"[{""token"": ""IL - 2 mRNA"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin"", ""start_span"": 128, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptors"", ""start_span"": 173, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""RA nuclear receptors"", ""start_span"": 210, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
The increase in IL - 6 luciferase activity occurs in the absence of the multiple response region, the area of the IL - 6 promoter responsive to IL - 1, TNF alpha, cyclic amp, and phorbol 12 - myristate 13 - acetate.	IL - 6,16,22,Gene/Protein	luciferase,23,33,Gene/Protein	IL - 6 promoter,114,129,Gene/Protein	IL - 1,144,150,Gene/Protein	TNF alpha,152,161,Gene/Protein	"[{""token"": ""IL - 6"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""luciferase"", ""start_span"": 23, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 promoter"", ""start_span"": 114, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""TNF alpha"", ""start_span"": 152, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
ALY, a context - dependent coactivator of LEF - 1 and AML - 1, is required for TCRalpha enhancer function.	ALY,0,3,Gene/Protein	context - dependent coactivator,7,38,Gene/Protein	LEF - 1,42,49,Gene/Protein	AML - 1,54,61,Gene/Protein	TCRalpha enhancer,79,96,Gene/Protein	"[{""token"": ""ALY"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""context - dependent coactivator"", ""start_span"": 7, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""AML - 1"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""TCRalpha enhancer"", ""start_span"": 79, ""end_span"": 96, ""type"": ""Gene/Protein""}]"	train
In the mouse Th2 D10 cells and in the human Th2 clones, POS - 1 ( designated POS - 1b) contains NF - IL6beta, Jun, and NF - ATc / p.	POS - 1,56,63,Gene/Protein	POS - 1b,77,85,Gene/Protein	NF - IL6beta,96,108,Gene/Protein	Jun,110,113,Gene/Protein	NF - ATc / p,119,131,Gene/Protein	"[{""token"": ""POS - 1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""POS - 1b"", ""start_span"": 77, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6beta"", ""start_span"": 96, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATc / p"", ""start_span"": 119, ""end_span"": 131, ""type"": ""Gene/Protein""}]"	train
Jak3 is constitutively associated with CD40, and this interaction requires a proline - rich sequence in the membrane - proximal region of CD40.	Jak3,0,4,Gene/Protein	CD40,39,43,Gene/Protein	proline - rich sequence,77,100,Gene/Protein	membrane - proximal region,108,134,Gene/Protein	CD40,138,142,Gene/Protein	"[{""token"": ""Jak3"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""proline - rich sequence"", ""start_span"": 77, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""membrane - proximal region"", ""start_span"": 108, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}]"	train
Using various constructs expressing a lacZ reporter gene under the control of the intact or three deleted forms of HIV - 1 LTR, we obtained evidence that the kappaB regulatory elements located in the U3 region are involved in cell - to - cell activation of HIV - 1 LTR.	lacZ reporter gene,38,56,Gene/Protein	HIV - 1 LTR,115,126,Gene/Protein	kappaB regulatory elements,158,184,Gene/Protein	U3 region,200,209,Gene/Protein	HIV - 1 LTR,257,268,Gene/Protein	"[{""token"": ""lacZ reporter gene"", ""start_span"": 38, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 115, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""kappaB regulatory elements"", ""start_span"": 158, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""U3 region"", ""start_span"": 200, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 257, ""end_span"": 268, ""type"": ""Gene/Protein""}]"	train
We now report that dimers consisting of p50 NFkappaB1, p65 RelA, and / or c - Rel are present in neutrophils and that the greater part of these protein complexes is physically associated with cytoplasmic IkappaB - alpha in resting cells.	p50 NFkappaB1,40,53,Gene/Protein	p65 RelA,55,63,Gene/Protein	c - Rel,74,81,Gene/Protein	protein complexes,144,161,Gene/Protein	cytoplasmic IkappaB - alpha,192,219,Gene/Protein	"[{""token"": ""p50 NFkappaB1"", ""start_span"": 40, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""p65 RelA"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""protein complexes"", ""start_span"": 144, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic IkappaB - alpha"", ""start_span"": 192, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Mutational analysis showed that optimal transcriptional activity required the GATA sequence at position - 24, and gel - shift assays further showed that the GATA - 2 transcription factor, but not GATA - 1, bound to this region of the PECAM - 1 promoter.	GATA sequence,78,91,Gene/Protein	- 24,104,108,Gene/Protein	GATA - 2 transcription factor,157,186,Gene/Protein	GATA - 1,196,204,Gene/Protein	PECAM - 1 promoter,234,252,Gene/Protein	"[{""token"": ""GATA sequence"", ""start_span"": 78, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""- 24"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 2 transcription factor"", ""start_span"": 157, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""PECAM - 1 promoter"", ""start_span"": 234, ""end_span"": 252, ""type"": ""Gene/Protein""}]"	train
Dexamethasone ( 10 ( - 8) M) repressed chloramphenicol acetyltransferase ( CAT) production by 75% in the wild - type fragment but not in a deletion mutant lacking the 19 - bp site.	chloramphenicol acetyltransferase,39,72,Gene/Protein	CAT,75,78,Gene/Protein	wild - type fragment,105,125,Gene/Protein	deletion mutant,139,154,Gene/Protein	19 - bp site,167,179,Gene/Protein	"[{""token"": ""chloramphenicol acetyltransferase"", ""start_span"": 39, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""wild - type fragment"", ""start_span"": 105, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""deletion mutant"", ""start_span"": 139, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""19 - bp site"", ""start_span"": 167, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
Expression of the HIV - 1 transactivator Tat recapitulated this phenotype and was associated with increased IL - 2 secretion in response to costimulation with CD3 plus CD28.	HIV - 1 transactivator,18,40,Gene/Protein	Tat,41,44,Gene/Protein	IL - 2,108,114,Gene/Protein	CD3,159,162,Gene/Protein	CD28,168,172,Gene/Protein	"[{""token"": ""HIV - 1 transactivator"", ""start_span"": 18, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Tat"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
When cells were exposed to C5b - 9, GTP - bound Ras in anti - C5b - 9 immunoprecipitates was increased 3. 2 - fold at 2 min, while GTP - bound Ras in anti - Ras immunoprecipitates was increased 2 - fold at 10 min.	C5b - 9,27,34,Gene/Protein	GTP - bound Ras,36,51,Gene/Protein	anti - C5b - 9 immunoprecipitates,55,88,Gene/Protein	GTP - bound Ras,131,146,Gene/Protein	anti - Ras immunoprecipitates,150,179,Gene/Protein	"[{""token"": ""C5b - 9"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""GTP - bound Ras"", ""start_span"": 36, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""anti - C5b - 9 immunoprecipitates"", ""start_span"": 55, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""GTP - bound Ras"", ""start_span"": 131, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""anti - Ras immunoprecipitates"", ""start_span"": 150, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
The role of mitogen - activated protein kinase ( MAPK) pathway on TCC - inducible mitotic signaling was evaluated by assessing DNA synthesis and activator protein 1 ( AP - 1) DNA - binding activity.	mitogen - activated protein kinase,12,46,Gene/Protein	MAPK,49,53,Gene/Protein	TCC,66,69,Gene/Protein	activator protein 1,145,164,Gene/Protein	AP - 1,167,173,Gene/Protein	"[{""token"": ""mitogen - activated protein kinase"", ""start_span"": 12, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""TCC"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""activator protein 1"", ""start_span"": 145, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 167, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
In addition to the existing isoform ( Pax - 5, which we have named Pax - 5a), we have isolated three new isoforms, Pax - 5b, Pax - 5d, and Pax - 5e, from murine spleen and B - lymphoid cell lines using library screenings and polymerase chain reaction amplification.	Pax - 5,38,45,Gene/Protein	Pax - 5a,67,75,Gene/Protein	Pax - 5b,115,123,Gene/Protein	Pax - 5d,125,133,Gene/Protein	Pax - 5e,139,147,Gene/Protein	"[{""token"": ""Pax - 5"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5a"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5b"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5d"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5e"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	train
Here we report that overexpression of Syk in the Lck - negative JCaM1 cells enabled the T cell antigen receptor / CD3 complex to induce a normal activation of the mitogen - activated protein kinase ( MAPK) pathway and expression of a nuclear factor of activated T cells reporter construct.	Syk,38,41,Gene/Protein	T cell antigen receptor / CD3 complex,88,125,Gene/Protein	mitogen - activated protein kinase,163,197,Gene/Protein	MAPK,200,204,Gene/Protein	nuclear factor of activated T cells,234,269,Gene/Protein	"[{""token"": ""Syk"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""T cell antigen receptor / CD3 complex"", ""start_span"": 88, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 163, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 234, ""end_span"": 269, ""type"": ""Gene/Protein""}]"	train
A Y341 - - > F mutant of Syk, which is deficient in its interaction with phospholipase Cy1 and Vav, was less efficient than wild - type Syk.	F mutant,13,21,Gene/Protein	Syk,25,28,Gene/Protein	phospholipase Cy1,73,90,Gene/Protein	Vav,95,98,Gene/Protein	wild - type Syk,124,139,Gene/Protein	"[{""token"": ""F mutant"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""Syk"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""phospholipase Cy1"", ""start_span"": 73, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""Vav"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""wild - type Syk"", ""start_span"": 124, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
Characterization of the NF - kappa B1 promoter identified an Egr - 1 site which was found to be essential for both the PMA / PHA - mediated induction as well as the synergistic activation observed after the expression of the RelA subunit of NF - kappa B and Egr - 1.	NF - kappa B1 promoter,24,46,Gene/Protein	Egr - 1 site,61,73,Gene/Protein	PHA,125,128,Gene/Protein	NF - kappa B,241,253,Gene/Protein	Egr - 1,258,265,Gene/Protein	"[{""token"": ""NF - kappa B1 promoter"", ""start_span"": 24, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1 site"", ""start_span"": 61, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 241, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1"", ""start_span"": 258, ""end_span"": 265, ""type"": ""Gene/Protein""}]"	train
In this report, we describe the cloning of human GATA - 4 ( hGATA - 4) and show that hGATA - 4 selectively interacts with the - 70 GATA site within the IL - 5 proximal promoter region.	human GATA - 4,43,57,Gene/Protein	hGATA - 4,60,69,Gene/Protein	hGATA - 4,85,94,Gene/Protein	- 70 GATA site,126,140,Gene/Protein	IL - 5 proximal promoter region,152,183,Gene/Protein	"[{""token"": ""human GATA - 4"", ""start_span"": 43, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""hGATA - 4"", ""start_span"": 60, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""hGATA - 4"", ""start_span"": 85, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""- 70 GATA site"", ""start_span"": 126, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5 proximal promoter region"", ""start_span"": 152, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
ATL - 16T cells express mRNA of three GATA - binding proteins, hGATA - 2, hGATA - 3 and hGATA - 4, and each of them has a potential to bind to the consensus ( A / T) GATA ( G / A) motif.	mRNA,24,28,Gene/Protein	GATA - binding proteins,38,61,Gene/Protein	hGATA - 2,63,72,Gene/Protein	hGATA - 3,74,83,Gene/Protein	hGATA - 4,88,97,Gene/Protein	"[{""token"": ""mRNA"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""GATA - binding proteins"", ""start_span"": 38, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""hGATA - 2"", ""start_span"": 63, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""hGATA - 3"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""hGATA - 4"", ""start_span"": 88, ""end_span"": 97, ""type"": ""Gene/Protein""}]"	train
We also show that calcineurin associated with the N - terminal domain of NFATx1 at multiple docking sites and caused a reduction of size, indicative of dephosphorylation, in NFATx1.	calcineurin,18,29,Gene/Protein	N - terminal domain,50,69,Gene/Protein	NFATx1,73,79,Gene/Protein	multiple docking sites,83,105,Gene/Protein	NFATx1,174,180,Gene/Protein	"[{""token"": ""calcineurin"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal domain"", ""start_span"": 50, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""NFATx1"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""multiple docking sites"", ""start_span"": 83, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""NFATx1"", ""start_span"": 174, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
NO derived from nNOS in glia inhibits the transcription factor nuclear factor kappaB ( NF kappaB) as NOS inhibitors enhance basal NF kappaB activation.	nNOS,16,20,Gene/Protein	transcription factor,42,62,Gene/Protein	nuclear factor kappaB,63,84,Gene/Protein	NF kappaB,87,96,Gene/Protein	NF kappaB,130,139,Gene/Protein	"[{""token"": ""nNOS"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 42, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappaB"", ""start_span"": 63, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""NF kappaB"", ""start_span"": 87, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""NF kappaB"", ""start_span"": 130, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
Our data suggest that nNOS in astrocytes regulates NF kappaB activity and iNOS expression, and indicate a novel regulatory role for nNOS in tonically suppressing central nervous system, NF kappaB - regulated genes.	nNOS,22,26,Gene/Protein	NF kappaB,51,60,Gene/Protein	iNOS,74,78,Gene/Protein	nNOS,132,136,Gene/Protein	NF kappaB - regulated genes,186,213,Gene/Protein	"[{""token"": ""nNOS"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""NF kappaB"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""iNOS"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""nNOS"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""NF kappaB - regulated genes"", ""start_span"": 186, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
A chimeric IL - 6 receptor, comprised of the intracellular tail of the IL - 6 receptor subunit gp130 fused to the extracellular domain of the epidermal growth factor ( EGF) receptor, was stably transfected into SKW6. 4 cells.	IL - 6 receptor,11,26,Gene/Protein	intracellular tail,45,63,Gene/Protein	IL - 6 receptor subunit,71,94,Gene/Protein	gp130,95,100,Gene/Protein	extracellular domain,114,134,Gene/Protein	"[{""token"": ""IL - 6 receptor"", ""start_span"": 11, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""intracellular tail"", ""start_span"": 45, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 receptor subunit"", ""start_span"": 71, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""gp130"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""extracellular domain"", ""start_span"": 114, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
To define further the relation between Stat3 activation and enhanced IgM production, we determined the effect of chimeric gp130 on the transcriptional activation of a genetic element linked to immunoglobulin production, namely the immunoglobulin heavy chain enhancer ( IgH - enhancer).	Stat3,39,44,Gene/Protein	IgM,69,72,Gene/Protein	immunoglobulin,193,207,Gene/Protein	immunoglobulin heavy chain enhancer,231,266,Gene/Protein	IgH - enhancer,269,283,Gene/Protein	"[{""token"": ""Stat3"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IgM"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin"", ""start_span"": 193, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin heavy chain enhancer"", ""start_span"": 231, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""IgH - enhancer"", ""start_span"": 269, ""end_span"": 283, ""type"": ""Gene/Protein""}]"	train
NF - Y is formed by three subunits, A, B, and C, all of which are necessary for DNA binding.	NF - Y,0,6,Gene/Protein	subunits,26,34,Gene/Protein	A,36,37,Gene/Protein	B,39,40,Gene/Protein	C,46,47,Gene/Protein	"[{""token"": ""NF - Y"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""subunits"", ""start_span"": 26, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""A"", ""start_span"": 36, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""B"", ""start_span"": 39, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""C"", ""start_span"": 46, ""end_span"": 47, ""type"": ""Gene/Protein""}]"	train
Furthermore a dominant negative form of AML1, AML1a, totally suppressed granulocytic differentiation otherwise induced by granulocyte colony - stimulating factor when AML1a was overexpressed in 32Dc13 murine myeloid cells.	dominant negative form,14,36,Gene/Protein	AML1,40,44,Gene/Protein	AML1a,46,51,Gene/Protein	granulocyte colony - stimulating factor,122,161,Gene/Protein	AML1a,167,172,Gene/Protein	"[{""token"": ""dominant negative form"", ""start_span"": 14, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""AML1"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""AML1a"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte colony - stimulating factor"", ""start_span"": 122, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""AML1a"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
Both MAP ERK kinase kinase - 1 ( MEKK1) and Raf are activated strongly by FMLP, but minimally by PAF.	MAP ERK kinase kinase - 1,5,30,Gene/Protein	MEKK1,33,38,Gene/Protein	Raf,44,47,Gene/Protein	FMLP,74,78,Gene/Protein	PAF,97,100,Gene/Protein	"[{""token"": ""MAP ERK kinase kinase - 1"", ""start_span"": 5, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""MEKK1"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Raf"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""FMLP"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}]"	train
These TRAF binding domains were shown to be functionally important for the RANK - dependent induction of NF - kappaB and c - Jun NH2 - terminal kinase activities.	TRAF binding domains,6,26,Gene/Protein	RANK,75,79,Gene/Protein	NF - kappaB,105,116,Gene/Protein	c - Jun,121,128,Gene/Protein	NH2 - terminal kinase,129,150,Gene/Protein	"[{""token"": ""TRAF binding domains"", ""start_span"": 6, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""RANK"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""NH2 - terminal kinase"", ""start_span"": 129, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
An NH2 - terminal truncation mutant of TRAF6 inhibited RANKL - mediated NF - kappaB activation, but failed to affect constitutive signaling induced by receptor overexpression, revealing a selective role for TRAF6 in ligand - induced activation events.	NH2 - terminal truncation mutant,3,35,Gene/Protein	TRAF6,39,44,Gene/Protein	RANKL,55,60,Gene/Protein	NF - kappaB,72,83,Gene/Protein	TRAF6,207,212,Gene/Protein	"[{""token"": ""NH2 - terminal truncation mutant"", ""start_span"": 3, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""TRAF6"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""RANKL"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""TRAF6"", ""start_span"": 207, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	train
Bone marrow samples from 33 patients affected by MM and MGUS, and 8 patients not affected by lymphoproliferative diseases were studied for expression of c - Jun ( a component of the transcription factor AP - 1) and glutathione - S - transferase pi ( GST - pi) using immunocytochemical methods.	c - Jun,153,160,Gene/Protein	transcription factor,182,202,Gene/Protein	AP - 1,203,209,Gene/Protein	glutathione - S - transferase pi,215,247,Gene/Protein	GST - pi,250,258,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 182, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 203, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""glutathione - S - transferase pi"", ""start_span"": 215, ""end_span"": 247, ""type"": ""Gene/Protein""}, {""token"": ""GST - pi"", ""start_span"": 250, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	train
The IL - 3, IL - 5 and GM - CSF receptors share a common signal transducer that possesses no intrinsic kinase domain.	IL - 3,4,10,Gene/Protein	IL - 5,12,18,Gene/Protein	GM - CSF receptors,23,41,Gene/Protein	common signal transducer,50,74,Gene/Protein	intrinsic kinase domain,93,116,Gene/Protein	"[{""token"": ""IL - 3"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF receptors"", ""start_span"": 23, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""common signal transducer"", ""start_span"": 50, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""intrinsic kinase domain"", ""start_span"": 93, ""end_span"": 116, ""type"": ""Gene/Protein""}]"	train
Using Wp reporter constructs in in vitro transfection assays, we found that Wp was 11 - to 190 - fold more active in B cell than in non - B cell lines and that three regions of the promoter ( termed UAS1, UAS2, and UAS3) contributed to transcriptional activation.	Wp reporter constructs,6,28,Gene/Protein	promoter,181,189,Gene/Protein	UAS1,199,203,Gene/Protein	UAS2,205,209,Gene/Protein	UAS3,215,219,Gene/Protein	"[{""token"": ""Wp reporter constructs"", ""start_span"": 6, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""UAS1"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""UAS2"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""UAS3"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
T cell receptor ( TCR) stimulation induces rapid tyrosine phosphorylation of cellular proteins, including Cbl, a protooncogene product whose function remains unclear.	T cell receptor,0,15,Gene/Protein	TCR,18,21,Gene/Protein	cellular proteins,77,94,Gene/Protein	Cbl,106,109,Gene/Protein	protooncogene product,113,134,Gene/Protein	"[{""token"": ""T cell receptor"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""cellular proteins"", ""start_span"": 77, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""Cbl"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""protooncogene product"", ""start_span"": 113, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
Addition of an anti - TNF alpha antibody decreased by 40% E - selectin and ICAM - 1 induction and suppressed PAI - 1 overproduction with a weak effect on vWf.	anti - TNF alpha antibody,15,40,Gene/Protein	E - selectin,58,70,Gene/Protein	ICAM - 1,75,83,Gene/Protein	PAI - 1,109,116,Gene/Protein	vWf,154,157,Gene/Protein	"[{""token"": ""anti - TNF alpha antibody"", ""start_span"": 15, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 58, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""PAI - 1"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""vWf"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
Phosphorylation of CREB occurred through a herbimycin A and Rp - cAMP - sensitive pathway, suggesting phosphorylation required antecedent activation of both protein tyrosine kinases ( PTK) and protein kinase A ( PKA).	CREB,19,23,Gene/Protein	protein tyrosine kinases,157,181,Gene/Protein	PTK,184,187,Gene/Protein	protein kinase A,193,209,Gene/Protein	PKA,212,215,Gene/Protein	"[{""token"": ""CREB"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""protein tyrosine kinases"", ""start_span"": 157, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""PTK"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase A"", ""start_span"": 193, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""PKA"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
IFN regulatory factor 1 ( IRF - 1) is a transcription factor activated by either CD40 or cytokines.	IFN regulatory factor 1,0,23,Gene/Protein	IRF - 1,26,33,Gene/Protein	transcription factor,40,60,Gene/Protein	CD40,81,85,Gene/Protein	cytokines,89,98,Gene/Protein	"[{""token"": ""IFN regulatory factor 1"", ""start_span"": 0, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 40, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 89, ""end_span"": 98, ""type"": ""Gene/Protein""}]"	train
Human monocytic cells express interleukin - 1beta ( IL - 1beta) when stimulated with the extracellular matrix glycoprotein, fibronectin ( FN).	interleukin - 1beta,30,49,Gene/Protein	IL - 1beta,52,62,Gene/Protein	extracellular matrix glycoprotein,89,122,Gene/Protein	fibronectin,124,135,Gene/Protein	FN,138,140,Gene/Protein	"[{""token"": ""interleukin - 1beta"", ""start_span"": 30, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 52, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""extracellular matrix glycoprotein"", ""start_span"": 89, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 138, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
Protein kinase C ( PKC) activation is considered important for this process; however, the metabolic steps at which PKC acts upon to mediate the FN - induced IL - 1beta response remain unclear.	Protein kinase C,0,16,Gene/Protein	PKC,19,22,Gene/Protein	PKC,115,118,Gene/Protein	FN,144,146,Gene/Protein	IL - 1beta,157,167,Gene/Protein	"[{""token"": ""Protein kinase C"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 144, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 157, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
These studies revealed that Calphostin C inhibited the nuclear translocation of the transcription factor activator protein - 1 ( AP - 1) which is considered necessary for FN induction of IL - 1beta gene transcription, and prevented the transcription of the IL - 1beta gene.	transcription factor activator protein - 1,84,126,Gene/Protein	AP - 1,129,135,Gene/Protein	FN,171,173,Gene/Protein	IL - 1beta,187,197,Gene/Protein	IL - 1beta gene,257,272,Gene/Protein	"[{""token"": ""transcription factor activator protein - 1"", ""start_span"": 84, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 171, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 187, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta gene"", ""start_span"": 257, ""end_span"": 272, ""type"": ""Gene/Protein""}]"	train
TRAMP, a novel apoptosis - mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas ( Apo - 1 / CD95).	TRAMP,0,5,Gene/Protein	apoptosis - mediating receptor,15,45,Gene/Protein	tumor necrosis factor receptor 1,72,104,Gene/Protein	Fas,109,112,Gene/Protein	Apo - 1 / CD95,115,129,Gene/Protein	"[{""token"": ""TRAMP"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""apoptosis - mediating receptor"", ""start_span"": 15, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor receptor 1"", ""start_span"": 72, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""Fas"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Apo - 1 / CD95"", ""start_span"": 115, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	train
First, a substantial number of cells can express class II molecules in the absence of CIITA, albeit at 5 - fold reduced levels, most notably dendritic cells in s. c. lymph nodes; therefore, the CIITA gene can not be an absolute ' master gene ' controlling the expression of class II molecules, as had been thought.	class II molecules,49,67,Gene/Protein	CIITA,86,91,Gene/Protein	CIITA gene,194,204,Gene/Protein	master gene,230,241,Gene/Protein	class II molecules,274,292,Gene/Protein	"[{""token"": ""class II molecules"", ""start_span"": 49, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""CIITA gene"", ""start_span"": 194, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""master gene"", ""start_span"": 230, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""class II molecules"", ""start_span"": 274, ""end_span"": 292, ""type"": ""Gene/Protein""}]"	train
Granzyme B gene transcription is induced in activated lymphocytes upon antigenic stimulation, and several regulatory regions including CBF, AP - 1, and Ikaros binding sites have been shown to be essential in the control of granzyme B promoter activation.	regulatory regions,106,124,Gene/Protein	CBF,135,138,Gene/Protein	AP - 1,140,146,Gene/Protein	Ikaros binding sites,152,172,Gene/Protein	granzyme B promoter,223,242,Gene/Protein	"[{""token"": ""regulatory regions"", ""start_span"": 106, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""CBF"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""Ikaros binding sites"", ""start_span"": 152, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""granzyme B promoter"", ""start_span"": 223, ""end_span"": 242, ""type"": ""Gene/Protein""}]"	train
We demonstrated the presence of a polymorphism in the promoter region of the IL - 10 gene and four in the TGF - beta gene promoters ( 3 in TGF - beta1 and 1 in TGF - beta2).	promoter region,54,69,Gene/Protein	IL - 10 gene,77,89,Gene/Protein	TGF - beta gene promoters,106,131,Gene/Protein	TGF - beta1,139,150,Gene/Protein	TGF - beta2,160,171,Gene/Protein	"[{""token"": ""promoter region"", ""start_span"": 54, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10 gene"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta gene promoters"", ""start_span"": 106, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta2"", ""start_span"": 160, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
We, therefore, conclude that signals generated by the convergence of the MAPK and the calcineurin / NFAT pathway are necessary and sufficient for the activation of the IL - 2 promoter by Tpl - 2.	MAPK,73,77,Gene/Protein	calcineurin,86,97,Gene/Protein	/ NFAT,98,104,Gene/Protein	IL - 2 promoter,168,183,Gene/Protein	Tpl - 2,187,194,Gene/Protein	"[{""token"": ""MAPK"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""/ NFAT"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 168, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""Tpl - 2"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
Interleukin - 5 ( IL - 5) and granulocyte macrophage - colony stimulating factor ( GM - CSF) are important cytokines for the proliferation, differentiation, and activation of myeloid lineages.	Interleukin - 5,0,15,Gene/Protein	IL - 5,18,24,Gene/Protein	granulocyte macrophage - colony stimulating factor,30,80,Gene/Protein	GM - CSF,83,91,Gene/Protein	cytokines,107,116,Gene/Protein	"[{""token"": ""Interleukin - 5"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte macrophage - colony stimulating factor"", ""start_span"": 30, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 107, ""end_span"": 116, ""type"": ""Gene/Protein""}]"	train
The gene encoding the retinoic acid - synthesizing enzyme aldehyde dehydrogenase 1 ( Aldh1), initially called Hdg - 1, was found to be ectopically activated by HOX11 in this system.	retinoic acid - synthesizing enzyme,22,57,Gene/Protein	aldehyde dehydrogenase 1,58,82,Gene/Protein	Aldh1,85,90,Gene/Protein	Hdg - 1,110,117,Gene/Protein	HOX11,160,165,Gene/Protein	"[{""token"": ""retinoic acid - synthesizing enzyme"", ""start_span"": 22, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""aldehyde dehydrogenase 1"", ""start_span"": 58, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""Aldh1"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""Hdg - 1"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""HOX11"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
NF - X2, which contains members of the AP - 1 / ATF / CREB families of transcription factors, interacts with the X2 box ( 5 ' - TGCGTCA - 3 ') from positions - 97 to - 91 in the DRA promoter.	NF - X2,0,7,Gene/Protein	AP - 1 / ATF / CREB families,39,67,Gene/Protein	transcription factors,71,92,Gene/Protein	X2 box,113,119,Gene/Protein	DRA promoter,178,190,Gene/Protein	"[{""token"": ""NF - X2"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 / ATF / CREB families"", ""start_span"": 39, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 71, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""X2 box"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""DRA promoter"", ""start_span"": 178, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
Since the co - expression with a dominant negative c - Fos abolished the responsiveness to TPA, we conclude that activated transcription of the DRA gene depends on interactions between the X2 box and NF - X2, which contains c - Fos.	c - Fos,51,58,Gene/Protein	DRA gene,144,152,Gene/Protein	X2 box,189,195,Gene/Protein	NF - X2,200,207,Gene/Protein	c - Fos,224,231,Gene/Protein	"[{""token"": ""c - Fos"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""DRA gene"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""X2 box"", ""start_span"": 189, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""NF - X2"", ""start_span"": 200, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 224, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
The 5 ' - positive regulatory unit, consisting of the promoter and the 5 ' enhancer, is already active at the CD4 - CD8 - double - negative ( DN) stage of development.	5 ' - positive regulatory unit,4,34,Gene/Protein	promoter,54,62,Gene/Protein	5 ' enhancer,71,83,Gene/Protein	CD4,110,113,Gene/Protein	CD8,116,119,Gene/Protein	"[{""token"": ""5 ' - positive regulatory unit"", ""start_span"": 4, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""5 ' enhancer"", ""start_span"": 71, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""CD8"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Gene/Protein""}]"	train
However, we show that mutant forms of E1A that no longer bind p300 / CBP can still interact directly with Stat1 ( via E1A N - terminal and Stat1 C - terminal residues) and block IFNgamma - driven, Stat1 - dependent gene activation and consequent function during early - phase infection in the natural host cell.	E1A,38,41,Gene/Protein	p300 / CBP,62,72,Gene/Protein	Stat1,106,111,Gene/Protein	E1A N - terminal and Stat1 C - terminal residues,118,166,Gene/Protein	Stat1,197,202,Gene/Protein	"[{""token"": ""E1A"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""p300 / CBP"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""E1A N - terminal and Stat1 C - terminal residues"", ""start_span"": 118, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 197, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
The results provide a distinct and more specific mechanism for E1A - mediated immune suppression and an alternative model of IFNgamma - driven enhanceosome formation that may allow for other adaptors ( in addition to p300 / CBP) to link Stat1 to the basal transcription complex.	E1A,63,66,Gene/Protein	IFNgamma,125,133,Gene/Protein	p300 / CBP,217,227,Gene/Protein	Stat1,237,242,Gene/Protein	basal transcription complex,250,277,Gene/Protein	"[{""token"": ""E1A"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""p300 / CBP"", ""start_span"": 217, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 237, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""basal transcription complex"", ""start_span"": 250, ""end_span"": 277, ""type"": ""Gene/Protein""}]"	train
To understand the molecular mechanisms of functional synergy between TAL1 and LMO in tumorigenesis and transcriptional regulation, we tried to identify downstream target genes regulated by TAL1 and LMO by a subtractive PCR method.	TAL1,69,73,Gene/Protein	LMO,78,81,Gene/Protein	downstream target genes,152,175,Gene/Protein	TAL1,189,193,Gene/Protein	LMO,198,201,Gene/Protein	"[{""token"": ""TAL1"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""LMO"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""downstream target genes"", ""start_span"": 152, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""TAL1"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""LMO"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
Exogenously transfected TAL1 and LMO, but not either alone, induced RALDH2 expression in a T - ALL cell line, HPB - ALL, not expressing endogeneous TAL1 or LMO.	TAL1,24,28,Gene/Protein	LMO,33,36,Gene/Protein	RALDH2,68,74,Gene/Protein	TAL1,148,152,Gene/Protein	LMO,156,159,Gene/Protein	"[{""token"": ""TAL1"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""LMO"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""RALDH2"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""TAL1"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""LMO"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
Taken together, our findings indicate that signaling via CD27 on B cells induces IgE synthesis, in cooperation with IL - 4 and CD40 signaling, by promoting the generation of plasma cells through up - regulation of positive regulatory domain I - binding factor - 1.	CD27,57,61,Gene/Protein	IgE,81,84,Gene/Protein	IL - 4,116,122,Gene/Protein	CD40,127,131,Gene/Protein	positive regulatory domain I - binding factor - 1,214,263,Gene/Protein	"[{""token"": ""CD27"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""positive regulatory domain I - binding factor - 1"", ""start_span"": 214, ""end_span"": 263, ""type"": ""Gene/Protein""}]"	train
To study the regulatory mechanism of gp91phox gene expression in eosinophils, we transiently transfected eosinophil - committed HL - 60 - C15 cells with gp91phox promoter constructs, and identified a negative element from bp - 267 to - 246 of the gp91phox gene, the deletion of which caused an 83% increase in promoter activity.	gp91phox gene,37,50,Gene/Protein	gp91phox promoter constructs,153,181,Gene/Protein	negative element,200,216,Gene/Protein	- 267 to - 246,225,239,Gene/Protein	gp91phox gene,247,260,Gene/Protein	"[{""token"": ""gp91phox gene"", ""start_span"": 37, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""gp91phox promoter constructs"", ""start_span"": 153, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""negative element"", ""start_span"": 200, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""- 267 to - 246"", ""start_span"": 225, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""gp91phox gene"", ""start_span"": 247, ""end_span"": 260, ""type"": ""Gene/Protein""}]"	train
Uncoupling activation - dependent HS1 phosphorylation from nuclear factor of activated T cells transcriptional activation in Jurkat T cells: differential signaling through CD3 and the costimulatory receptors CD2 and CD28.	HS1,34,37,Gene/Protein	nuclear factor of activated T cells,59,94,Gene/Protein	CD3,172,175,Gene/Protein	CD2,208,211,Gene/Protein	CD28,216,220,Gene/Protein	"[{""token"": ""HS1"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 59, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 216, ""end_span"": 220, ""type"": ""Gene/Protein""}]"	train
Using the specific MAPK / extracellular signal - regulated kinase kinase ( MAPK kinase) inhibitor PD98059, we found that MAPK activation is necessary for FcR - dependent activation of the nuclear factor NF - kappaB.	MAPK,19,23,Gene/Protein	MAPK,75,79,Gene/Protein	FcR,154,157,Gene/Protein	nuclear factor,188,202,Gene/Protein	NF - kappaB,203,214,Gene/Protein	"[{""token"": ""MAPK"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""FcR"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor"", ""start_span"": 188, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 203, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A - HLF.	AD1,4,7,Gene/Protein	AD2,12,15,Gene/Protein	E2A,43,46,Gene/Protein	chimeric oncoprotein,99,119,Gene/Protein	E2A - HLF,120,129,Gene/Protein	"[{""token"": ""AD1"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""AD2"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""chimeric oncoprotein"", ""start_span"": 99, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""E2A - HLF"", ""start_span"": 120, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	train
In addition, IL - 6 and IL - 2 synergistically induce homo - and heterodimerized STAT1 alpha and STAT3 in both NK and T cells, consistent with their reported synergism in modulating perforin gene expression.	IL - 6,13,19,Gene/Protein	IL - 2,24,30,Gene/Protein	STAT1 alpha,81,92,Gene/Protein	STAT3,97,102,Gene/Protein	perforin gene,182,195,Gene/Protein	"[{""token"": ""IL - 6"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 alpha"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""perforin gene"", ""start_span"": 182, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
In vitro studies identify three essential elements of the TATA - less blr1 core promoter that confer cell type - and differentiation - specific expression in the B cells of both humans and mice, a functional promoter region ( - 36 with respect to the transcription start site), a NF - kappaB motif ( + 44), and a noncanonical octamer motif ( + 157).	TATA - less blr1 core promoter,58,88,Gene/Protein	functional promoter region,197,223,Gene/Protein	transcription start site,251,275,Gene/Protein	NF - kappaB motif,280,297,Gene/Protein	noncanonical octamer motif,313,339,Gene/Protein	"[{""token"": ""TATA - less blr1 core promoter"", ""start_span"": 58, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""functional promoter region"", ""start_span"": 197, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""transcription start site"", ""start_span"": 251, ""end_span"": 275, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB motif"", ""start_span"": 280, ""end_span"": 297, ""type"": ""Gene/Protein""}, {""token"": ""noncanonical octamer motif"", ""start_span"": 313, ""end_span"": 339, ""type"": ""Gene/Protein""}]"	train
Last, we have identified two open reading frames ( ORFs) of HHV - 6, U86 and U89 from the immediate - early locus A, that can transactivate the CD4 promoter in HeLa cells.	open reading frames,29,48,Gene/Protein	ORFs,51,55,Gene/Protein	U86,69,72,Gene/Protein	U89,77,80,Gene/Protein	CD4 promoter,144,156,Gene/Protein	"[{""token"": ""open reading frames"", ""start_span"": 29, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""ORFs"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""U86"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""U89"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""CD4 promoter"", ""start_span"": 144, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
Inv ( 16) ( p13; q22) fuses the gene encoding the beta subunit of Pebp2 to the MYH11 gene encoding a smooth muscle myosin heavy chain ( Smmhc).	beta subunit,50,62,Gene/Protein	Pebp2,66,71,Gene/Protein	MYH11 gene,79,89,Gene/Protein	smooth muscle myosin heavy chain,101,133,Gene/Protein	Smmhc,136,141,Gene/Protein	"[{""token"": ""beta subunit"", ""start_span"": 50, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""Pebp2"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""MYH11 gene"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""smooth muscle myosin heavy chain"", ""start_span"": 101, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""Smmhc"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	train
In 1G5, a Jurkat - derived T cell line stably transfected with a luciferase gene driven by HIV - 1 long terminal repeat ( LTR), we found that PGE2 markedly enhanced HIV - 1 LTR - mediated reporter gene activity.	luciferase gene,65,80,Gene/Protein	HIV - 1 long terminal repeat,91,119,Gene/Protein	LTR,122,125,Gene/Protein	HIV - 1 LTR,165,176,Gene/Protein	reporter gene,188,201,Gene/Protein	"[{""token"": ""luciferase gene"", ""start_span"": 65, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat"", ""start_span"": 91, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 165, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene"", ""start_span"": 188, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
Human neutrophils can be induced to actively transcribe a number of early - response genes, in particular those encoding cytokines, chemokines, and the high - affinity surface receptor for IgG, FcgammaRI.	early - response genes,68,90,Gene/Protein	cytokines,121,130,Gene/Protein	chemokines,132,142,Gene/Protein	IgG,189,192,Gene/Protein	FcgammaRI,194,203,Gene/Protein	"[{""token"": ""early - response genes"", ""start_span"": 68, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 121, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""chemokines"", ""start_span"": 132, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""FcgammaRI"", ""start_span"": 194, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
Co - transfections with expression plasmids for Sp1 and AP - 2 further emphasized the important role of these transcription factors in both basal and PMA - enhanced LAL expression.	expression plasmids,24,43,Gene/Protein	Sp1,48,51,Gene/Protein	AP - 2,56,62,Gene/Protein	transcription factors,110,131,Gene/Protein	LAL,165,168,Gene/Protein	"[{""token"": ""expression plasmids"", ""start_span"": 24, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 110, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""LAL"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
LMP1 contains two domains that activate the transcription factor NF - kappaB, one through interactions with TRAF proteins and the other with the TRADD protein.	LMP1,0,4,Gene/Protein	transcription factor,44,64,Gene/Protein	NF - kappaB,65,76,Gene/Protein	TRAF proteins,108,121,Gene/Protein	TRADD protein,145,158,Gene/Protein	"[{""token"": ""LMP1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 44, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 65, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""TRAF proteins"", ""start_span"": 108, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""TRADD protein"", ""start_span"": 145, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
Cell surface markers in the YJ cells were positive for CD33 and were negative for CD34, CD16 and CD23.	Cell surface markers,0,20,Gene/Protein	CD33,55,59,Gene/Protein	CD34,82,86,Gene/Protein	CD16,88,92,Gene/Protein	CD23,97,101,Gene/Protein	"[{""token"": ""Cell surface markers"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CD33"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""CD34"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}]"	train
Although IFN - gamma alone did not induce CD23 mRNA transcription, Northern blot analysis revealed a transient up - regulation of the IL - 4 - induced CD23 mRNA by IFN - gamma within 2 h of IFN - gamma treatment in these tonsillar cells.	IFN - gamma,9,20,Gene/Protein	CD23 mRNA,42,51,Gene/Protein	IL - 4 - induced CD23 mRNA,134,160,Gene/Protein	IFN - gamma,164,175,Gene/Protein	IFN - gamma,190,201,Gene/Protein	"[{""token"": ""IFN - gamma"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CD23 mRNA"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 - induced CD23 mRNA"", ""start_span"": 134, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 164, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 190, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
Indeed, when Tax is coexpressed with the E2F - 1 transcription factor in CEM T - cells, which lack expression of p16 ( INK4A), it strongly potentiates the E2F - dependent activation of a reporter construct driven by a promoter containing E2F binding sites.	Tax,13,16,Gene/Protein	E2F - 1,41,48,Gene/Protein	transcription factor,49,69,Gene/Protein	E2F,155,158,Gene/Protein	E2F binding sites,238,255,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 1"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 49, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""E2F binding sites"", ""start_span"": 238, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
Inhibition of iNO synthase ( iNOS) activity with N omega - monomethyl - L - arginine in endothelial - RAW264. 7 cocultures, stimulated with murine - specific IFN - gamma and LPS, decreased iNO production by 86%, augmented VCAM - 1 and iNOS expression in endothelial and RAW264. 7 cells, respectively, and increased monocyte adhesion to the endothelial cell surface.	iNO synthase,14,26,Gene/Protein	iNOS,29,33,Gene/Protein	murine - specific IFN - gamma,140,169,Gene/Protein	VCAM - 1,222,230,Gene/Protein	iNOS,235,239,Gene/Protein	"[{""token"": ""iNO synthase"", ""start_span"": 14, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""iNOS"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""murine - specific IFN - gamma"", ""start_span"": 140, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 222, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""iNOS"", ""start_span"": 235, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Effector pathways for this guanine nucleotide binding protein in T cells are mediated by the serine / threonine kinase Raf - 1 and the Ras - related GTPase Rac - 1.	guanine nucleotide binding protein,27,61,Gene/Protein	serine / threonine kinase,93,118,Gene/Protein	Raf - 1,119,126,Gene/Protein	Ras - related GTPase,135,155,Gene/Protein	Rac - 1,156,163,Gene/Protein	"[{""token"": ""guanine nucleotide binding protein"", ""start_span"": 27, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""serine / threonine kinase"", ""start_span"": 93, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""Raf - 1"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""Ras - related GTPase"", ""start_span"": 135, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""Rac - 1"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
In contrast, p21ras signals are unable to induce Akt / PKB activity in T cell nor is Ras function required for Akt / PKB activation in response to the TCR.	p21ras,13,19,Gene/Protein	Akt / PKB,49,58,Gene/Protein	Ras,85,88,Gene/Protein	Akt / PKB,111,120,Gene/Protein	TCR,151,154,Gene/Protein	"[{""token"": ""p21ras"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""Akt / PKB"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""Akt / PKB"", ""start_span"": 111, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
The induction of IL - 5 gene expression by GATA - 3 involves high affinity binding of GATA - 3 to an inverted GATA repeat in the IL - 5 promoter.	IL - 5 gene,17,28,Gene/Protein	GATA - 3,43,51,Gene/Protein	GATA - 3,86,94,Gene/Protein	GATA repeat,110,121,Gene/Protein	IL - 5 promoter,129,144,Gene/Protein	"[{""token"": ""IL - 5 gene"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 3"", ""start_span"": 43, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 3"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""GATA repeat"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5 promoter"", ""start_span"": 129, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
In T lymphocytes from NF - ATp - deficient mice, the expression of CD25 is severely impaired, leading to a delayed IL - 2 receptor expression after T cell receptor ( TCR) / CD3 stimulation.	NF - ATp,22,30,Gene/Protein	CD25,67,71,Gene/Protein	IL - 2 receptor,115,130,Gene/Protein	TCR,166,169,Gene/Protein	CD3,173,176,Gene/Protein	"[{""token"": ""NF - ATp"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""CD25"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
The two Duffy polymorphic antigens, Fya and Fyb ( coded by the FY * A and FY * B alleles), are present on erythrocyte membranes.	Duffy polymorphic antigens,8,34,Gene/Protein	Fya,36,39,Gene/Protein	Fyb,44,47,Gene/Protein	FY * A and FY * B alleles,63,88,Gene/Protein	erythrocyte membranes,106,127,Gene/Protein	"[{""token"": ""Duffy polymorphic antigens"", ""start_span"": 8, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""Fya"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""Fyb"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""FY * A and FY * B alleles"", ""start_span"": 63, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""erythrocyte membranes"", ""start_span"": 106, ""end_span"": 127, ""type"": ""Gene/Protein""}]"	train
FK506. FKBP12 drug - immunophilin complexes inhibited the interaction of NFAT with activated calcineurin much more effectively than they inhibited the interaction with inactive calcineurin, suggesting that part of the interaction with activated calcineurin involved the enzyme active site.	NFAT,73,77,Gene/Protein	calcineurin,93,104,Gene/Protein	calcineurin,177,188,Gene/Protein	calcineurin,245,256,Gene/Protein	enzyme active site,270,288,Gene/Protein	"[{""token"": ""NFAT"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 93, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 177, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 245, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""enzyme active site"", ""start_span"": 270, ""end_span"": 288, ""type"": ""Gene/Protein""}]"	train
Upon cell activation, displacement of the autoinhibitory domain by calmodulin binding allows NFAT to bind additionally to the calcineurin active site, thus positioning NFAT for immediate dephosphorylation at functional phosphoserine residues.	autoinhibitory domain,42,63,Gene/Protein	calmodulin,67,77,Gene/Protein	NFAT,93,97,Gene/Protein	calcineurin active site,126,149,Gene/Protein	NFAT,168,172,Gene/Protein	"[{""token"": ""autoinhibitory domain"", ""start_span"": 42, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""calmodulin"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin active site"", ""start_span"": 126, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
Specific families of receptors, kinases, transcription factors, and cysteine proteases, termed caspases, are involved in the apoptotic cascade leading to proteolysis of specific substrates and to morphological changes associated with programmed cell death.	receptors,21,30,Gene/Protein	kinases,32,39,Gene/Protein	transcription factors,41,62,Gene/Protein	cysteine proteases,68,86,Gene/Protein	termed caspases,88,103,Gene/Protein	"[{""token"": ""receptors"", ""start_span"": 21, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""kinases"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 41, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""cysteine proteases"", ""start_span"": 68, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""termed caspases"", ""start_span"": 88, ""end_span"": 103, ""type"": ""Gene/Protein""}]"	train
We conclude that although cell cycle arrest induced by alpha - IFN may be mediated in part by formation of a complex containing p130 and E2F - 4, alpha - IFN does not induce hyperphosphorylation of E2F - 4, which characterizes primary hemopoietic cells in G0.	alpha - IFN,55,66,Gene/Protein	p130,128,132,Gene/Protein	E2F - 4,137,144,Gene/Protein	alpha - IFN,146,157,Gene/Protein	E2F - 4,198,205,Gene/Protein	"[{""token"": ""alpha - IFN"", ""start_span"": 55, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""p130"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 4"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""alpha - IFN"", ""start_span"": 146, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 4"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
The transcription factors c - myb and C / EBP alpha regulate the monocytic / myeloic gene MRP14.	transcription factors,4,25,Gene/Protein	c - myb,26,33,Gene/Protein	C / EBP alpha,38,51,Gene/Protein	monocytic / myeloic gene,65,89,Gene/Protein	MRP14,90,95,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 4, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""c - myb"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP alpha"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""monocytic / myeloic gene"", ""start_span"": 65, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""MRP14"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	train
To investigate the transcriptional regulation of these genes we cotransfected constructs expressing CAT under control of the MRP14 promoter and expression constructs of C / EBP alpha and v - myb, two transcription factors involved in myeloid / monocytic differentiation.	CAT,100,103,Gene/Protein	MRP14 promoter,125,139,Gene/Protein	C / EBP alpha,169,182,Gene/Protein	v - myb,187,194,Gene/Protein	transcription factors,200,221,Gene/Protein	"[{""token"": ""CAT"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""MRP14 promoter"", ""start_span"": 125, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP alpha"", ""start_span"": 169, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""v - myb"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 200, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
Analysis of the regulation of the p40 gene promoter revealed that ASA inhibited NF - kappaB activation and binding to the p40 - kappaB site in the p40 promoter, leading to transcriptional repression of the p40 gene.	p40 gene promoter,34,51,Gene/Protein	NF - kappaB,80,91,Gene/Protein	p40 - kappaB site,122,139,Gene/Protein	p40 promoter,147,159,Gene/Protein	p40 gene,206,214,Gene/Protein	"[{""token"": ""p40 gene promoter"", ""start_span"": 34, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""p40 - kappaB site"", ""start_span"": 122, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""p40 promoter"", ""start_span"": 147, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""p40 gene"", ""start_span"": 206, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
We have isolated NFATx, which is one of four members of the NFAT family of transcription factors and is preferentially expressed in the thymus and peripheral blood leukocytes, and an isoform of NFATx, NFATx1.	NFATx,17,22,Gene/Protein	NFAT family,60,71,Gene/Protein	transcription factors,75,96,Gene/Protein	NFATx,194,199,Gene/Protein	NFATx1,201,207,Gene/Protein	"[{""token"": ""NFATx"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""NFAT family"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 75, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""NFATx"", ""start_span"": 194, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""NFATx1"", ""start_span"": 201, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
These data demonstrate that the 15 - amino acid sequence of NFATx1 is a major transactivation sequence required for induction of genes by NFATx1 in T cells and possibly regulates NFAT activity through tissue - specific alternative splicing.	15 - amino acid sequence,32,56,Gene/Protein	NFATx1,60,66,Gene/Protein	major transactivation sequence,72,102,Gene/Protein	NFATx1,138,144,Gene/Protein	NFAT,179,183,Gene/Protein	"[{""token"": ""15 - amino acid sequence"", ""start_span"": 32, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""NFATx1"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""major transactivation sequence"", ""start_span"": 72, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""NFATx1"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
Upregulation of interleukin 6 and granulocyte colony - stimulating factor receptors by transcription factor CCAAT enhancer binding protein alpha ( C / EBP alpha) is critical for granulopoiesis.	interleukin 6,16,29,Gene/Protein	granulocyte colony - stimulating factor receptors,34,83,Gene/Protein	transcription factor,87,107,Gene/Protein	CCAAT enhancer binding protein alpha,108,144,Gene/Protein	C / EBP alpha,147,160,Gene/Protein	"[{""token"": ""interleukin 6"", ""start_span"": 16, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte colony - stimulating factor receptors"", ""start_span"": 34, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 87, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""CCAAT enhancer binding protein alpha"", ""start_span"": 108, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP alpha"", ""start_span"": 147, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
To elucidate the role of retinoic acid ( RA) in anti - CD40 + interleukin - 4 ( IL - 4) - mediated B - cell activation, the effect of 10 ( - 12) to 10 ( - 6) mol / L RA was studied in anti - CD40 ( 1 microgram / mL) + IL - 4 ( 5 ng / mL) - mediated proliferation and Ig synthesis by human peripheral blood mononuclear cells ( PBMC) and B cells in healthy donors.	anti - CD40,48,59,Gene/Protein	interleukin - 4,62,77,Gene/Protein	IL - 4,80,86,Gene/Protein	anti - CD40,184,195,Gene/Protein	IL - 4,218,224,Gene/Protein	"[{""token"": ""anti - CD40"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 4"", ""start_span"": 62, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD40"", ""start_span"": 184, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 218, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
Transfection of kinase - deficient mutants of IKKalpha and IKKbeta into either human Jurkat T or 293 cells also inhibits NF - kappaB - dependent reporter gene expression induced by Tax.	IKKalpha,46,54,Gene/Protein	IKKbeta,59,66,Gene/Protein	NF - kappaB,121,132,Gene/Protein	reporter gene,145,158,Gene/Protein	Tax,181,184,Gene/Protein	"[{""token"": ""IKKalpha"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene"", ""start_span"": 145, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
Phosphorylation of the IkappaB cytoplasmic inhibitors, IkappaBalpha, IkappaBbeta, and IkappaBepsilon, by these kinases triggers proteolytic degradation and the release of NF - kappaB / Rel proteins into the nucleus.	IkappaB cytoplasmic inhibitors,23,53,Gene/Protein	IkappaBalpha,55,67,Gene/Protein	IkappaBbeta,69,80,Gene/Protein	IkappaBepsilon,86,100,Gene/Protein	NF - kappaB / Rel proteins,171,197,Gene/Protein	"[{""token"": ""IkappaB cytoplasmic inhibitors"", ""start_span"": 23, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 55, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBbeta"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBepsilon"", ""start_span"": 86, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB / Rel proteins"", ""start_span"": 171, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
In transfection experiments, overexpression of wild type IKK1, a dominant negative mutant IKK1 ( K44M), or wild type IKK2 did not affect LPS - induced kappaB - dependent transcription in monocytic cells.	IKK1,57,61,Gene/Protein	dominant negative mutant IKK1,65,94,Gene/Protein	K44M,97,101,Gene/Protein	wild type IKK2,107,121,Gene/Protein	kappaB,151,157,Gene/Protein	"[{""token"": ""IKK1"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""dominant negative mutant IKK1"", ""start_span"": 65, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""K44M"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""wild type IKK2"", ""start_span"": 107, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""kappaB"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
IL - 7 also delayed the decreases in the levels of c - Myc, Bcl - 2, and Bcl - xL that occur upon loss of v - Abl kinase activity.	IL - 7,0,6,Gene/Protein	c - Myc,51,58,Gene/Protein	Bcl - 2,60,67,Gene/Protein	Bcl - xL,73,81,Gene/Protein	v - Abl,106,113,Gene/Protein	"[{""token"": ""IL - 7"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""c - Myc"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - xL"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""v - Abl"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Gene/Protein""}]"	train
These results identify a potential role for IL - 7 signaling pathways in transformation by v - Abl while demonstrating that a combination of IL - 4 and IL - 7 signaling can not substitute for an active v - Abl kinase in transformed pre - B cells.	IL - 7,44,50,Gene/Protein	v - Abl,91,98,Gene/Protein	IL - 4,141,147,Gene/Protein	IL - 7,152,158,Gene/Protein	v - Abl,202,209,Gene/Protein	"[{""token"": ""IL - 7"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""v - Abl"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 152, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""v - Abl"", ""start_span"": 202, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
The ML - 1 human myeloblastic leukemia cells used in this study proliferate when treated with insulin - like growth factor I and transferrin but differentiate to monocytes when exposed to tumor necrosis factor alpha or transforming growth factor beta1, or to macrophage - like cells when treated with both these cytokines.	insulin - like growth factor I,94,124,Gene/Protein	transferrin,129,140,Gene/Protein	tumor necrosis factor alpha,188,215,Gene/Protein	transforming growth factor beta1,219,251,Gene/Protein	cytokines,312,321,Gene/Protein	"[{""token"": ""insulin - like growth factor I"", ""start_span"": 94, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""transferrin"", ""start_span"": 129, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 188, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""transforming growth factor beta1"", ""start_span"": 219, ""end_span"": 251, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 312, ""end_span"": 321, ""type"": ""Gene/Protein""}]"	train
In contrast, induction of differentiation but not of proliferation was followed by a 25 - to 30 - fold increase in the nuclear level of the tumor suppressor proteins p53 ( wild type), pRb, and p130 / Rb2 and of the p53 - dependent cyclin kinase inhibitor p21 / Cip1.	tumor suppressor proteins p53,140,169,Gene/Protein	pRb,184,187,Gene/Protein	p130 / Rb2,193,203,Gene/Protein	p53 - dependent cyclin kinase inhibitor,215,254,Gene/Protein	p21 / Cip1,255,265,Gene/Protein	"[{""token"": ""tumor suppressor proteins p53"", ""start_span"": 140, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""pRb"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""p130 / Rb2"", ""start_span"": 193, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""p53 - dependent cyclin kinase inhibitor"", ""start_span"": 215, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""p21 / Cip1"", ""start_span"": 255, ""end_span"": 265, ""type"": ""Gene/Protein""}]"	train
Over a 3 - week course of IL - 2 therapy, in most patients the binding patterns of AP - 1, Sp1, and NF - kappaB proteins changed to resemble those seen in PBMC activated by IL - 2 in vitro.	IL - 2,26,32,Gene/Protein	AP - 1,83,89,Gene/Protein	Sp1,91,94,Gene/Protein	NF - kappaB,100,111,Gene/Protein	IL - 2,173,179,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 83, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 100, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
V14Rho binds strongly to protein kinase Calpha ( PKCalpha) in vivo; however, deletion of the CAAX site on V14Rho severely diminished this association.	V14Rho,0,6,Gene/Protein	protein kinase Calpha,25,46,Gene/Protein	PKCalpha,49,57,Gene/Protein	CAAX site,93,102,Gene/Protein	V14Rho,106,112,Gene/Protein	"[{""token"": ""V14Rho"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase Calpha"", ""start_span"": 25, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""PKCalpha"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""CAAX site"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""V14Rho"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Gene/Protein""}]"	train
Activation of nonreceptor protein tyrosine kinases ( PTKs) is essential for T cell receptor ( TCR) responsiveness; however, the function of individual PTK substrates is often uncertain.	nonreceptor protein tyrosine kinases,14,50,Gene/Protein	PTKs,53,57,Gene/Protein	T cell receptor,76,91,Gene/Protein	TCR,94,97,Gene/Protein	PTK substrates,151,165,Gene/Protein	"[{""token"": ""nonreceptor protein tyrosine kinases"", ""start_span"": 14, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""PTKs"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""T cell receptor"", ""start_span"": 76, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""PTK substrates"", ""start_span"": 151, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
We recently determined that erythropoietin ( EPO) activates 3 members of the signal transducer and activator of transcription ( STAT) family, Stat1alpha, Stat3, and Stat5, in the human EPO - dependent cell lines, UT - 7 and UT - 7 / EPO ( Kirito et al, J Biol Chem 272: 16507, 1997).	erythropoietin,28,42,Gene/Protein	EPO,45,48,Gene/Protein	Stat1alpha,142,152,Gene/Protein	Stat3,154,159,Gene/Protein	Stat5,165,170,Gene/Protein	"[{""token"": ""erythropoietin"", ""start_span"": 28, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""Stat1alpha"", ""start_span"": 142, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
Full activity can be restored by the combined action of recombinant PC4 and the PC4 - depleted USA fraction, thus suggesting a joint requirement for PC4 and another, USA - derived component ( s) for optimal function of Oct - 1 / OCA - B in the reconstituted system.	PC4,68,71,Gene/Protein	PC4,80,83,Gene/Protein	PC4,149,152,Gene/Protein	Oct - 1,219,226,Gene/Protein	/ OCA - B,227,236,Gene/Protein	"[{""token"": ""PC4"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""PC4"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""PC4"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 219, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""/ OCA - B"", ""start_span"": 227, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
Cross - linking of MHC - I mediated tyrosine phosphorylation of Tyk2, but not Jak1, Jak2, and Jak3.	MHC - I,19,26,Gene/Protein	Tyk2,64,68,Gene/Protein	Jak1,78,82,Gene/Protein	Jak2,84,88,Gene/Protein	Jak3,94,98,Gene/Protein	"[{""token"": ""MHC - I"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""Tyk2"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""Jak2"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}]"	train
The biological effects of RA are mediated by two distinct families of transcription factors: retinoic acid receptors ( RARs) and retinoid X receptors ( RXRs).	transcription factors,70,91,Gene/Protein	retinoic acid receptors,93,116,Gene/Protein	RARs,119,123,Gene/Protein	retinoid X receptors,129,149,Gene/Protein	RXRs,152,156,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 70, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""retinoic acid receptors"", ""start_span"": 93, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""RARs"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""retinoid X receptors"", ""start_span"": 129, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""RXRs"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
The human toll signaling pathway: divergence of nuclear factor kappaB and JNK / SAPK activation upstream of tumor necrosis factor receptor - associated factor 6 ( TRAF6).	nuclear factor kappaB,48,69,Gene/Protein	JNK,74,77,Gene/Protein	/ SAPK,78,84,Gene/Protein	tumor necrosis factor receptor - associated factor 6,108,160,Gene/Protein	TRAF6,163,168,Gene/Protein	"[{""token"": ""nuclear factor kappaB"", ""start_span"": 48, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""/ SAPK"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor receptor - associated factor 6"", ""start_span"": 108, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""TRAF6"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
We demonstrate here that TRAIL ( TNF - related apoptosis - inducing ligand), a recently identified DIL, also activates NFkappaB in lymphoid cell lines in a kinetic similar to TNFalpha.	TRAIL,25,30,Gene/Protein	TNF - related apoptosis - inducing ligand,33,74,Gene/Protein	DIL,99,102,Gene/Protein	NFkappaB,119,127,Gene/Protein	TNFalpha,175,183,Gene/Protein	"[{""token"": ""TRAIL"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""TNF - related apoptosis - inducing ligand"", ""start_span"": 33, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""DIL"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 175, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
The characterization of Pax - 5 - deficient pro - B cells demonstrated an important role of BSAP in the regulation of the CD19, mb - 1 ( Ig alpha) and N - myc genes as well as in the developmental pathway controlling VH - to - DHJH recombination at the immunoglobulin heavy - chain ( IgH) locus.	BSAP,92,96,Gene/Protein	CD19,122,126,Gene/Protein	mb - 1,128,134,Gene/Protein	Ig alpha,137,145,Gene/Protein	N - myc genes,151,164,Gene/Protein	"[{""token"": ""BSAP"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""mb - 1"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""Ig alpha"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""N - myc genes"", ""start_span"": 151, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P / CAF.	EKLF,13,17,Gene/Protein	acetylated transcription factor,24,55,Gene/Protein	CBP,92,95,Gene/Protein	p300,97,101,Gene/Protein	P / CAF,107,114,Gene/Protein	"[{""token"": ""EKLF"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""acetylated transcription factor"", ""start_span"": 24, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""CBP"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""p300"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""P / CAF"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene/Protein""}]"	train
The functional effects of these interactions are that CBP and p300, but not P / CAF, enhance EKLF ' s transcriptional activation of the beta - globin promoter in erythroid cells.	CBP,54,57,Gene/Protein	p300,62,66,Gene/Protein	P / CAF,76,83,Gene/Protein	EKLF,93,97,Gene/Protein	beta - globin promoter,136,158,Gene/Protein	"[{""token"": ""CBP"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""p300"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""P / CAF"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin promoter"", ""start_span"": 136, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
Expression cloning with this region of DNA now shows that tegument protein VP22 and the viral dUTPase, encoded by genes UL49 and UL50, respectively, are T - cell antigens.	tegument protein,58,74,Gene/Protein	VP22,75,79,Gene/Protein	viral dUTPase,88,101,Gene/Protein	genes UL49 and UL50,114,133,Gene/Protein	T - cell antigens,153,170,Gene/Protein	"[{""token"": ""tegument protein"", ""start_span"": 58, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""VP22"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""viral dUTPase"", ""start_span"": 88, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""genes UL49 and UL50"", ""start_span"": 114, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""T - cell antigens"", ""start_span"": 153, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
Blocking mAbs against CD18 and CD11b abrogated fibrinogen - induced NF - kappa B activation.	mAbs,9,13,Gene/Protein	CD18,22,26,Gene/Protein	CD11b,31,36,Gene/Protein	fibrinogen,47,57,Gene/Protein	NF - kappa B,68,80,Gene/Protein	"[{""token"": ""mAbs"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""CD18"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""fibrinogen"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Gene/Protein""}]"	train
Cells were subsequently stimulated with 1) PMA for 24 h, inducing CAT activity by 2. 6 - fold, 2) fibrinogen / Mn2 + for 2 h, inducing CAT activity by 3. 2 - fold, or 3) costimulation with fibrinogen and PMA, inducing 5. 7 - fold the CAT activity induced by PMA alone.	CAT,66,69,Gene/Protein	fibrinogen,98,108,Gene/Protein	CAT,135,138,Gene/Protein	fibrinogen,189,199,Gene/Protein	CAT,234,237,Gene/Protein	"[{""token"": ""CAT"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""fibrinogen"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""fibrinogen"", ""start_span"": 189, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	train
To gain a better understanding of the impact of long terminal repeat ( LTR) sequence diversity on LTR - directed gene expression in cells of the central nervous system ( CNS) and immune system, we amplified and cloned LTRs from proviral DNA in HIV - 1 - infected peripheral blood.	long terminal repeat,48,68,Gene/Protein	LTR,71,74,Gene/Protein	LTR - directed gene,98,117,Gene/Protein	LTRs,218,222,Gene/Protein	proviral DNA,228,240,Gene/Protein	"[{""token"": ""long terminal repeat"", ""start_span"": 48, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""LTR - directed gene"", ""start_span"": 98, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""LTRs"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""proviral DNA"", ""start_span"": 228, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	train
Both Dex and CsA inhibited the binding of transcription factors AP - 1 and NF - AT, but not of NF - kB and OCT - 1 / OAF, to their corresponding sites on the IL - 2 gene promoter.	AP - 1,64,70,Gene/Protein	NF - AT,75,82,Gene/Protein	NF - kB,95,102,Gene/Protein	OCT - 1 / OAF,107,120,Gene/Protein	IL - 2 gene promoter,158,178,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""OCT - 1 / OAF"", ""start_span"": 107, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 gene promoter"", ""start_span"": 158, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Most of the target genes for NF - kappa B are of relevance for the immune response and can be grouped into those encoding cytokines, cell surface receptors, acute phase proteins and viral genomes, such as that of human immunodeficiency virus type 1 ( HIV - 1).	NF - kappa B,29,41,Gene/Protein	cytokines,122,131,Gene/Protein	cell surface receptors,133,155,Gene/Protein	acute phase proteins,157,177,Gene/Protein	viral genomes,182,195,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 29, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 122, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""cell surface receptors"", ""start_span"": 133, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""acute phase proteins"", ""start_span"": 157, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""viral genomes"", ""start_span"": 182, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Overexpression of cJun or JunD, but not JunB, also eliminates the requirement for PMA, indicating that many but not all Jun - and Fos - related proteins functionally activate NF - AT - dependent transcription in the presence of the cytoplasmic component.	cJun,18,22,Gene/Protein	JunD,26,30,Gene/Protein	JunB,40,44,Gene/Protein	Jun - and Fos - related proteins,120,152,Gene/Protein	NF - AT,175,182,Gene/Protein	"[{""token"": ""cJun"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""JunB"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Jun - and Fos - related proteins"", ""start_span"": 120, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
Here we report that binding of human IL - 2 to its binding site leads to transcriptional activation of the macrophage CSF ( M - CSF) gene in Mo resulting in accumulation of M - CSF mRNA and subsequent release of bioactive M - CSF protein as demonstrated by ELISA and inhibition of IL - 2 induced release of an activity - stimulating growth of monocyte - type colonies by a neutralizing anti - M - CSF antibody.	human IL - 2,31,43,Gene/Protein	M - CSF mRNA,173,185,Gene/Protein	M - CSF protein,222,237,Gene/Protein	IL - 2,281,287,Gene/Protein	anti - M - CSF antibody,386,409,Gene/Protein	"[{""token"": ""human IL - 2"", ""start_span"": 31, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF mRNA"", ""start_span"": 173, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF protein"", ""start_span"": 222, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 281, ""end_span"": 287, ""type"": ""Gene/Protein""}, {""token"": ""anti - M - CSF antibody"", ""start_span"": 386, ""end_span"": 409, ""type"": ""Gene/Protein""}]"	train
They are part of the high affinity IgE receptor in mast cells, basophils, Langerhans cells, and possibly other cells; a component of the low affinity receptor for IgG ( Fc gamma RIIIA or CD16) in natural killer cells and macrophages; and part of the T cell antigen receptor in subsets of T cells.	high affinity IgE receptor,21,47,Gene/Protein	IgG,163,166,Gene/Protein	Fc gamma RIIIA,169,183,Gene/Protein	CD16,187,191,Gene/Protein	T cell antigen receptor,250,273,Gene/Protein	"[{""token"": ""high affinity IgE receptor"", ""start_span"": 21, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""Fc gamma RIIIA"", ""start_span"": 169, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 187, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""T cell antigen receptor"", ""start_span"": 250, ""end_span"": 273, ""type"": ""Gene/Protein""}]"	train
In the present study, analysis of the interleukin - 2 ( IL - 2) gene activation shows that naive human helper T cells ( cord blood CD4 + T cells, adult CD4 + CD45RO - T cells) regulate IL - 2 transcription by a mechanism involving both a silencer and an activator acting on the purine - rich IL - 2 promoter elements ( NF - AT binding sites).	IL - 2,56,62,Gene/Protein	silencer,238,246,Gene/Protein	activator,254,263,Gene/Protein	purine - rich IL - 2 promoter elements,278,316,Gene/Protein	NF - AT binding sites,319,340,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""silencer"", ""start_span"": 238, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""activator"", ""start_span"": 254, ""end_span"": 263, ""type"": ""Gene/Protein""}, {""token"": ""purine - rich IL - 2 promoter elements"", ""start_span"": 278, ""end_span"": 316, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT binding sites"", ""start_span"": 319, ""end_span"": 340, ""type"": ""Gene/Protein""}]"	train
We demonstrate evidence suggesting that redox regulation of NF kappa B by Trx might be exerted at a step after dissociation of the inhibitory molecule I kappa B, a cytosolic - anchoring protein for NF kappa B.	NF kappa B,60,70,Gene/Protein	Trx,74,77,Gene/Protein	I kappa B,151,160,Gene/Protein	cytosolic - anchoring protein,164,193,Gene/Protein	NF kappa B,198,208,Gene/Protein	"[{""token"": ""NF kappa B"", ""start_span"": 60, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""Trx"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""cytosolic - anchoring protein"", ""start_span"": 164, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 198, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	train
Our studies demonstrate for the first time that CD3 antigen - derived signals and CD2 antigen - derived signals are synergistic in inducing the emergence of transcription factors that bind to the NF - AT1, AP - 1, and NF - kB sites located in the promoter / enhancer region of the IL - 2 gene.	CD3,48,51,Gene/Protein	CD2 antigen,82,93,Gene/Protein	transcription factors,157,178,Gene/Protein	promoter / enhancer region,247,273,Gene/Protein	IL - 2,281,287,Gene/Protein	"[{""token"": ""CD3"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""CD2 antigen"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 157, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""promoter / enhancer region"", ""start_span"": 247, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 281, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
Increase of IL - 2R alpha gene transcription involves the enhanced binding of the transcription factor NF - kappa B to its consensus sequence in the 5 ' - regulatory region of the IL - 2R alpha gene.	IL - 2R alpha gene,12,30,Gene/Protein	NF - kappa B,103,115,Gene/Protein	consensus sequence,123,141,Gene/Protein	5 ' - regulatory region,149,172,Gene/Protein	IL - 2R alpha gene,180,198,Gene/Protein	"[{""token"": ""IL - 2R alpha gene"", ""start_span"": 12, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""consensus sequence"", ""start_span"": 123, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - regulatory region"", ""start_span"": 149, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha gene"", ""start_span"": 180, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
To dissect the molecular basis for the unusually persistent transcription of the IL - 2R alpha gene, we analyzed nuclear NF - kappa B binding to a radiolabeled IL - 2R alpha kappa B - specific oligonucleotide probe during the time course of CD2 + CD28 activation.	IL - 2R alpha gene,81,99,Gene/Protein	NF - kappa B,121,133,Gene/Protein	IL - 2R alpha,160,173,Gene/Protein	CD2,241,244,Gene/Protein	CD28,247,251,Gene/Protein	"[{""token"": ""IL - 2R alpha gene"", ""start_span"": 81, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 121, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 160, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 241, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Gene/Protein""}]"	train
After stimulation, two new kappa B - specific complexes were identified as NF - kappa B p50 - p65 heterodimer and putative c - Rel homodimer or c - Rel - p65 heterodimer.	kappa B - specific complexes,27,55,Gene/Protein	NF - kappa B,75,87,Gene/Protein	p50 - p65 heterodimer,88,109,Gene/Protein	c - Rel homodimer,123,140,Gene/Protein	c - Rel - p65 heterodimer,144,169,Gene/Protein	"[{""token"": ""kappa B - specific complexes"", ""start_span"": 27, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 75, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""p50 - p65 heterodimer"", ""start_span"": 88, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel homodimer"", ""start_span"": 123, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel - p65 heterodimer"", ""start_span"": 144, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
NF - AT is thought to consist of two components: a ubiquitous, inducible nuclear component that we have identified as Fos and Jun proteins, and a preexisting, T cell - specific component ( NF - ATp) which is the target for the immunosuppressive agents cyclosporin A ( CsA) and FK506.	NF - AT,0,7,Gene/Protein	Fos,118,121,Gene/Protein	Jun proteins,126,138,Gene/Protein	T cell - specific component,159,186,Gene/Protein	NF - ATp,189,197,Gene/Protein	"[{""token"": ""NF - AT"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""Fos"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Jun proteins"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""T cell - specific component"", ""start_span"": 159, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATp"", ""start_span"": 189, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
The transcription factor E2F activates the expression of multiple genes involved in cell proliferation, such as c - myc and the dihydrofolate reductase gene.	transcription factor,4,24,Gene/Protein	E2F,25,28,Gene/Protein	genes,66,71,Gene/Protein	c - myc,112,119,Gene/Protein	dihydrofolate reductase gene,128,156,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 4, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""genes"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""dihydrofolate reductase gene"", ""start_span"": 128, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
Nuclear factor NF - kB, activation protein 1 ( AP - 1), OCT - 1, and NF - IL - 2B binding activity were normal.	Nuclear factor NF - kB,0,22,Gene/Protein	activation protein 1,24,44,Gene/Protein	AP - 1,47,53,Gene/Protein	OCT - 1,56,63,Gene/Protein	NF - IL - 2B,69,81,Gene/Protein	"[{""token"": ""Nuclear factor NF - kB"", ""start_span"": 0, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""activation protein 1"", ""start_span"": 24, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""OCT - 1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL - 2B"", ""start_span"": 69, ""end_span"": 81, ""type"": ""Gene/Protein""}]"	train
To ascertain whether the abnormal NF - AT binding activity was related to an impaired function, we transfected patient and control T lymphocytes with constructs containing the reporter gene encoding chloramphenicol acetyl transferase ( CAT) under the control of the entire IL2 regulatory region or of multimers of individual enhancer sequences.	NF - AT,34,41,Gene/Protein	chloramphenicol acetyl transferase,199,233,Gene/Protein	CAT,236,239,Gene/Protein	IL2 regulatory region,273,294,Gene/Protein	enhancer sequences,325,343,Gene/Protein	"[{""token"": ""NF - AT"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyl transferase"", ""start_span"": 199, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 236, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""IL2 regulatory region"", ""start_span"": 273, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""enhancer sequences"", ""start_span"": 325, ""end_span"": 343, ""type"": ""Gene/Protein""}]"	train
Using these drugs as probes, chemists and biologists have uncovered several intracellular signalling molecules bridging the generation of second - messenger Ca2 + ions and the transcriptional activation of IL - 2, among which are calmodulin, calcineurin and the nuclear factor of activated T cells ( NF - AT).	IL - 2,206,212,Gene/Protein	calmodulin,230,240,Gene/Protein	calcineurin,242,253,Gene/Protein	nuclear factor of activated T cells,262,297,Gene/Protein	NF - AT,300,307,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 206, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""calmodulin"", ""start_span"": 230, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 242, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 262, ""end_span"": 297, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 300, ""end_span"": 307, ""type"": ""Gene/Protein""}]"	train
Both p105 and p98 were found to form stable complexes with other Rel / NF - kappa B family members, including p65 and c - Rel.	p105,5,9,Gene/Protein	p98,14,17,Gene/Protein	Rel / NF - kappa B family members,65,98,Gene/Protein	p65,110,113,Gene/Protein	c - Rel,118,125,Gene/Protein	"[{""token"": ""p105"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""p98"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""Rel / NF - kappa B family members"", ""start_span"": 65, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	train
One of the essential proteins which bound to the enhancer was similar or identical to members of the C / EBP family of transcription factors required for both IL - 1 - and LPS - specific induction of the IL - 6 gene ( i. e., the NF - IL6 proteins).	C / EBP family,101,115,Gene/Protein	transcription factors,119,140,Gene/Protein	IL - 1,159,165,Gene/Protein	IL - 6 gene,204,215,Gene/Protein	NF - IL6 proteins,229,246,Gene/Protein	"[{""token"": ""C / EBP family"", ""start_span"": 101, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 119, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 159, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 gene"", ""start_span"": 204, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6 proteins"", ""start_span"": 229, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
This function has been attributed to the coordinated binding of subunits of NF - kappa B to distinct regions of the promoter elements of numerous genes, including cytokines, growth factor receptors, and adhesion molecules.	NF - kappa B,76,88,Gene/Protein	promoter elements,116,133,Gene/Protein	cytokines,163,172,Gene/Protein	growth factor receptors,174,197,Gene/Protein	adhesion molecules,203,221,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 76, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""promoter elements"", ""start_span"": 116, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""growth factor receptors"", ""start_span"": 174, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""adhesion molecules"", ""start_span"": 203, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
In contrast to the type I receptor, the type II IL - 1R has a small cytoplasmic tail, and it is not clear whether this receptor is a signal - transducing or a regulatory molecule.	type I receptor,19,34,Gene/Protein	type II IL - 1R,40,55,Gene/Protein	cytoplasmic tail,68,84,Gene/Protein	signal - transducing,133,153,Gene/Protein	regulatory molecule,159,178,Gene/Protein	"[{""token"": ""type I receptor"", ""start_span"": 19, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""type II IL - 1R"", ""start_span"": 40, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic tail"", ""start_span"": 68, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""signal - transducing"", ""start_span"": 133, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""regulatory molecule"", ""start_span"": 159, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
However, a hybrid receptor composed of the extracellular and transmembrane regions of the human type II interleukin - 1 fused to the cytoplasmic domain of the human type I IL - 1R was capable of transducing a signal across the membrane resulting in a pattern of gene activation identical to that mediated by the type I IL - 1R.	extracellular and transmembrane regions,43,82,Gene/Protein	human type II interleukin - 1,90,119,Gene/Protein	cytoplasmic domain,133,151,Gene/Protein	human type I IL - 1R,159,179,Gene/Protein	type I IL - 1R,312,326,Gene/Protein	"[{""token"": ""extracellular and transmembrane regions"", ""start_span"": 43, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""human type II interleukin - 1"", ""start_span"": 90, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic domain"", ""start_span"": 133, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""human type I IL - 1R"", ""start_span"": 159, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""type I IL - 1R"", ""start_span"": 312, ""end_span"": 326, ""type"": ""Gene/Protein""}]"	train
When the wild - type hGR and hGR - Ile 729 were expressed in CV - 1 cells that were cotransfected with the mouse mammary tumor virus long terminal repeat fused to the chloramphenicol acetyl transferase ( CAT) gene, the hGR - Ile 729 conferred a fourfold decrease in apparent potency on dexamethasone stimulation of CAT activity.	wild - type hGR,9,24,Gene/Protein	hGR - Ile 729,29,42,Gene/Protein	mouse mammary tumor virus long terminal repeat,107,153,Gene/Protein	hGR - Ile 729,219,232,Gene/Protein	CAT,315,318,Gene/Protein	"[{""token"": ""wild - type hGR"", ""start_span"": 9, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""hGR - Ile 729"", ""start_span"": 29, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""mouse mammary tumor virus long terminal repeat"", ""start_span"": 107, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""hGR - Ile 729"", ""start_span"": 219, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 315, ""end_span"": 318, ""type"": ""Gene/Protein""}]"	train
Using transfection and reporter gene assays specifically designed for primary T lymphocytes in conjunction with gel retardation assays, Western blot analyses and UV cross - linking studies, we found that c - Jun, c - Fos, and octamer - binding proteins play a major role in transcriptional activation of the IL3 gene via their interaction with two specific regions contained within the IL3 5 ' - flanking sequence.	c - Jun,204,211,Gene/Protein	c - Fos,213,220,Gene/Protein	octamer - binding proteins,226,252,Gene/Protein	IL3 gene,308,316,Gene/Protein	IL3 5 ' - flanking sequence,386,413,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 204, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 213, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""octamer - binding proteins"", ""start_span"": 226, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""IL3 gene"", ""start_span"": 308, ""end_span"": 316, ""type"": ""Gene/Protein""}, {""token"": ""IL3 5 ' - flanking sequence"", ""start_span"": 386, ""end_span"": 413, ""type"": ""Gene/Protein""}]"	train
These kappa B enhancer elements are recognized by a structurally related family of interactive proteins that includes p50, p65, and the product of the c - rel protooncogene ( c - Rel).	kappa B enhancer elements,6,31,Gene/Protein	p50,118,121,Gene/Protein	p65,123,126,Gene/Protein	c - rel protooncogene,151,172,Gene/Protein	c - Rel,175,182,Gene/Protein	"[{""token"": ""kappa B enhancer elements"", ""start_span"": 6, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""c - rel protooncogene"", ""start_span"": 151, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
We therefore propose a model whereby a core NFAT complex consisting of Jun, Fos, and a constitutive nuclear factor is formed in both T and B cells, but an additional factor and / or post - translational modification of a factor, missing in B cells, might be required for transactivation by NFAT.	NFAT complex,44,56,Gene/Protein	Jun,71,74,Gene/Protein	Fos,76,79,Gene/Protein	constitutive nuclear factor,87,114,Gene/Protein	NFAT,290,294,Gene/Protein	"[{""token"": ""NFAT complex"", ""start_span"": 44, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""Fos"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""constitutive nuclear factor"", ""start_span"": 87, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 290, ""end_span"": 294, ""type"": ""Gene/Protein""}]"	train
The reactivity of murine monoclonal antibodies, anti - CD4 - FITC, anti - CD8 - FITC, anti - CD2 - FITC and anti - calla - FITC, were analyzed using flow cytometry.	murine monoclonal antibodies,18,46,Gene/Protein	anti - CD4 - FITC,48,65,Gene/Protein	anti - CD8 - FITC,67,84,Gene/Protein	anti - CD2 - FITC,86,103,Gene/Protein	anti - calla - FITC,108,127,Gene/Protein	"[{""token"": ""murine monoclonal antibodies"", ""start_span"": 18, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD4 - FITC"", ""start_span"": 48, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD8 - FITC"", ""start_span"": 67, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD2 - FITC"", ""start_span"": 86, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""anti - calla - FITC"", ""start_span"": 108, ""end_span"": 127, ""type"": ""Gene/Protein""}]"	train
Group 1 contains G0S24 and the rat and mouse TIS11 genes ( also known as TTP, Nup475, and Zfp36).	G0S24,17,22,Gene/Protein	rat and mouse TIS11 genes,31,56,Gene/Protein	TTP,73,76,Gene/Protein	Nup475,78,84,Gene/Protein	Zfp36,90,95,Gene/Protein	"[{""token"": ""G0S24"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""rat and mouse TIS11 genes"", ""start_span"": 31, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""TTP"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""Nup475"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""Zfp36"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	train
G0S24 has potential sites for transcription factors in the 5 ' flank and intron; these include a serum response element.	G0S24,0,5,Gene/Protein	transcription factors,30,51,Gene/Protein	5 ' flank,59,68,Gene/Protein	intron,73,79,Gene/Protein	serum response element,97,119,Gene/Protein	"[{""token"": ""G0S24"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 30, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""5 ' flank"", ""start_span"": 59, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""intron"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""serum response element"", ""start_span"": 97, ""end_span"": 119, ""type"": ""Gene/Protein""}]"	train
We studied the functional interaction between human embryonic zeta 2 globin promoter and the alpha globin regulatory element ( HS - 40) located 40 kb upstream of the zeta 2 globin gene.	human embryonic zeta 2 globin promoter,46,84,Gene/Protein	alpha globin regulatory element,93,124,Gene/Protein	HS - 40,127,134,Gene/Protein	40 kb upstream,144,158,Gene/Protein	zeta 2 globin gene,166,184,Gene/Protein	"[{""token"": ""human embryonic zeta 2 globin promoter"", ""start_span"": 46, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""alpha globin regulatory element"", ""start_span"": 93, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""HS - 40"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""40 kb upstream"", ""start_span"": 144, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""zeta 2 globin gene"", ""start_span"": 166, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
The interleukin 2 CD28 - responsive complex contains at least three members of the NF kappa B family: c - Rel, p50, and p65.	interleukin 2 CD28 - responsive complex,4,43,Gene/Protein	NF kappa B family,83,100,Gene/Protein	c - Rel,102,109,Gene/Protein	p50,111,114,Gene/Protein	p65,120,123,Gene/Protein	"[{""token"": ""interleukin 2 CD28 - responsive complex"", ""start_span"": 4, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B family"", ""start_span"": 83, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}]"	train
In this report, we show that in human peripheral blood T cells, CD28 - mediated signal transduction involves the rel family proteins - - c - Rel, p50, and p65.	CD28,64,68,Gene/Protein	rel family proteins,113,132,Gene/Protein	c - Rel,137,144,Gene/Protein	p50,146,149,Gene/Protein	p65,155,158,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""rel family proteins"", ""start_span"": 113, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
Treatment of peripheral blood T cells with phorbol 12 - myristate 13 - acetate ( PMA) and anti - CD28 monoclonal antibody ( mAb) results in augmentation of nuclear c - Rel, p50, and p65, and this augmentation can occur in the presence of the immunosuppressant cyclosporin A.	anti - CD28 monoclonal antibody,90,121,Gene/Protein	mAb,124,127,Gene/Protein	nuclear c - Rel,156,171,Gene/Protein	p50,173,176,Gene/Protein	p65,182,185,Gene/Protein	"[{""token"": ""anti - CD28 monoclonal antibody"", ""start_span"": 90, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""mAb"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""nuclear c - Rel"", ""start_span"": 156, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Gene/Protein""}]"	train
The functional significance of c - Rel involvement in the CD28 - responsive complex is demonstrated by transient transfection analysis, where cotransfection of c - Rel augments the level of expression of a chloramphenicol acetyltransferase reporter gene linked to the CD28 - responsive element.	c - Rel,31,38,Gene/Protein	CD28 - responsive complex,58,83,Gene/Protein	c - Rel,160,167,Gene/Protein	chloramphenicol acetyltransferase reporter gene,206,253,Gene/Protein	CD28 - responsive element,268,293,Gene/Protein	"[{""token"": ""c - Rel"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""CD28 - responsive complex"", ""start_span"": 58, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 160, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase reporter gene"", ""start_span"": 206, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""CD28 - responsive element"", ""start_span"": 268, ""end_span"": 293, ""type"": ""Gene/Protein""}]"	train
Tax co - transfected with reporter constructs into Jurkat cells maximally activated HTLV - I - LTR - CAT and kappa B - fos - CAT and also activated LT - 293 to a lesser extent.	Tax,0,3,Gene/Protein	reporter constructs,26,45,Gene/Protein	HTLV - I - LTR - CAT,84,104,Gene/Protein	kappa B - fos - CAT,109,128,Gene/Protein	LT - 293,148,156,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""reporter constructs"", ""start_span"": 26, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""HTLV - I - LTR - CAT"", ""start_span"": 84, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - fos - CAT"", ""start_span"": 109, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""LT - 293"", ""start_span"": 148, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
These studies, the first to demonstrate induction of LT promoter activity over basal levels, indicate that HTLV - I tax causes low - level activation of both endogenous LT and the LT promoter, at least in part through activation of NF - kappa B.	LT promoter,53,64,Gene/Protein	HTLV - I tax,107,119,Gene/Protein	LT,169,171,Gene/Protein	LT promoter,180,191,Gene/Protein	NF - kappa B,232,244,Gene/Protein	"[{""token"": ""LT promoter"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""HTLV - I tax"", ""start_span"": 107, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""LT"", ""start_span"": 169, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""LT promoter"", ""start_span"": 180, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 232, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
TSH - R expression levels were variable, but displayed a close correlation to the expression of thyroid peroxidase ( r = 0. 703; P < 0. 05), thyroglobulin ( r = 0. 817; P < 0. 01), and the nuclear oncogene c - fos ( r = 0. 935; P < 0. 001), but not c - myc.	TSH - R,0,7,Gene/Protein	thyroid peroxidase,96,114,Gene/Protein	thyroglobulin,141,154,Gene/Protein	nuclear oncogene c - fos,189,213,Gene/Protein	c - myc,249,256,Gene/Protein	"[{""token"": ""TSH - R"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""thyroid peroxidase"", ""start_span"": 96, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""thyroglobulin"", ""start_span"": 141, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""nuclear oncogene c - fos"", ""start_span"": 189, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 249, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
Overall, TSH - R transcript levels were low or absent in those thyroids in which expression of the major histocompatibility complex class I or II ( MHC I or II) was high, thus establishing an inverse relation ( MHC I, r = - 0. 791; P < 0. 01; MHC II, r = - 0. 784; P < 0. 01).	TSH - R,9,16,Gene/Protein	major histocompatibility complex class I or II,99,145,Gene/Protein	MHC I or II,148,159,Gene/Protein	MHC I,211,216,Gene/Protein	MHC II,243,249,Gene/Protein	"[{""token"": ""TSH - R"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""major histocompatibility complex class I or II"", ""start_span"": 99, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""MHC I or II"", ""start_span"": 148, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""MHC I"", ""start_span"": 211, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""MHC II"", ""start_span"": 243, ""end_span"": 249, ""type"": ""Gene/Protein""}]"	train
TPA - GR synergism was determined to have occurred at the GR - responsive element ( GRE) level by functional analysis of deletion mutants or synthetic GRE oligonucleotides driving chloramphenicol acetyl - transferase expression.	GR - responsive element,58,81,Gene/Protein	GRE,84,87,Gene/Protein	deletion mutants,121,137,Gene/Protein	synthetic GRE oligonucleotides,141,171,Gene/Protein	chloramphenicol acetyl - transferase,180,216,Gene/Protein	"[{""token"": ""GR - responsive element"", ""start_span"": 58, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""GRE"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""deletion mutants"", ""start_span"": 121, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""synthetic GRE oligonucleotides"", ""start_span"": 141, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyl - transferase"", ""start_span"": 180, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
The ability of Jun proteins to cooperate with GR in T cells has been investigated after transfection of c - jun, jun - B, or jun - D expression vectors, which augmented GR - dependent transcription from either MMTV LTR or GRE.	Jun proteins,15,27,Gene/Protein	GR,46,48,Gene/Protein	GR,169,171,Gene/Protein	MMTV LTR,210,218,Gene/Protein	GRE,222,225,Gene/Protein	"[{""token"": ""Jun proteins"", ""start_span"": 15, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 169, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""MMTV LTR"", ""start_span"": 210, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""GRE"", ""start_span"": 222, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	train
We have shown previously that EBNA2 transactivates the promoters of the latent membrane antigens LMP, TP1 and TP2.	EBNA2,30,35,Gene/Protein	latent membrane antigens,72,96,Gene/Protein	LMP,97,100,Gene/Protein	TP1,102,105,Gene/Protein	TP2,110,113,Gene/Protein	"[{""token"": ""EBNA2"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""latent membrane antigens"", ""start_span"": 72, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""LMP"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""TP1"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""TP2"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene/Protein""}]"	train
In vitro DNase I footprinting analysis revealed six hGATA - 3 binding sites in the U3 region ( the transcriptional regulatory domain) of the HIV - 1 LTR.	DNase I,9,16,Gene/Protein	hGATA - 3 binding sites,52,75,Gene/Protein	U3 region,83,92,Gene/Protein	transcriptional regulatory domain,99,132,Gene/Protein	HIV - 1 LTR,141,152,Gene/Protein	"[{""token"": ""DNase I"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""hGATA - 3 binding sites"", ""start_span"": 52, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""U3 region"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulatory domain"", ""start_span"": 99, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 141, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
The E2A gene encodes transcription factors of the helix - loop - helix family that are implicated in cell - specific gene expression as part of dimeric complexes that interact with E box enhancer elements.	E2A gene,4,12,Gene/Protein	transcription factors,21,42,Gene/Protein	helix - loop - helix family,50,77,Gene/Protein	dimeric complexes,144,161,Gene/Protein	E box enhancer elements,181,204,Gene/Protein	"[{""token"": ""E2A gene"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 21, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""helix - loop - helix family"", ""start_span"": 50, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""dimeric complexes"", ""start_span"": 144, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""E box enhancer elements"", ""start_span"": 181, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	train
In light of the evidence showing physical and functional interactions between Oct factors and OCA - B, we propose a mechanism of action for OCA - B and discuss the implications of OCA - B for the transcriptional regulation of other tissue - specific promoters.	Oct factors,78,89,Gene/Protein	OCA - B,94,101,Gene/Protein	OCA - B,140,147,Gene/Protein	OCA - B,180,187,Gene/Protein	tissue - specific promoters,232,259,Gene/Protein	"[{""token"": ""Oct factors"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""OCA - B"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""OCA - B"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""OCA - B"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""tissue - specific promoters"", ""start_span"": 232, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	train
Five members of this family ( MYC, SCL, TAL - 2, LYL - 1 and E2A) are implicated in oncogenic events in human lymphoid tumors because of their consistent involvement in chromosomal translocations.	MYC,30,33,Gene/Protein	SCL,35,38,Gene/Protein	TAL - 2,40,47,Gene/Protein	LYL - 1,49,56,Gene/Protein	E2A,61,64,Gene/Protein	"[{""token"": ""MYC"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""SCL"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""TAL - 2"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""LYL - 1"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}]"	train
Oct - 2 is a transcription factor that binds specifically to octamer DNA motifs in the promoters of immunoglobulin and interleukin - 2 genes.	Oct - 2,0,7,Gene/Protein	transcription factor,13,33,Gene/Protein	octamer DNA motifs,61,79,Gene/Protein	promoters,87,96,Gene/Protein	immunoglobulin and interleukin - 2 genes,100,140,Gene/Protein	"[{""token"": ""Oct - 2"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 13, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""octamer DNA motifs"", ""start_span"": 61, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 87, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin and interleukin - 2 genes"", ""start_span"": 100, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
We have shown that the Z gene product, which binds to AP - 1 sites as a homodimer and has sequence similarity to c - Fos, can efficiently activate the EBV early promoter, BMRF1, in certain cell types ( i. e., HeLa cells) but not others ( i. e., Jurkat cells).	Z gene product,23,37,Gene/Protein	AP - 1 sites,54,66,Gene/Protein	c - Fos,113,120,Gene/Protein	EBV early promoter,151,169,Gene/Protein	BMRF1,171,176,Gene/Protein	"[{""token"": ""Z gene product"", ""start_span"": 23, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 sites"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""EBV early promoter"", ""start_span"": 151, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""BMRF1"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
That the c - myb oncogene product can interact synergistically with an EBV - encoded member of the leucine zipper protein family suggests c - myb is likely to engage in similar interactions with cellularly encoded transcription factors.	c - myb oncogene product,9,33,Gene/Protein	EBV - encoded member,71,91,Gene/Protein	leucine zipper protein family,99,128,Gene/Protein	c - myb,138,145,Gene/Protein	cellularly encoded transcription factors,195,235,Gene/Protein	"[{""token"": ""c - myb oncogene product"", ""start_span"": 9, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""EBV - encoded member"", ""start_span"": 71, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""leucine zipper protein family"", ""start_span"": 99, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""c - myb"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""cellularly encoded transcription factors"", ""start_span"": 195, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
In this study multiple NF - kappa B related polypeptides ranging from 85 to 45 kDa were examined for their capacity to interact with the PRDII regulatory element of interferon beta and were shown to possess distinct intrinsic DNA binding affinities for this NF - kappa B site and form multiple DNA binding homo - and heterodimer complexes in co - renaturation experiments.	NF - kappa B related polypeptides,23,56,Gene/Protein	PRDII regulatory element,137,161,Gene/Protein	interferon beta,165,180,Gene/Protein	NF - kappa B site,258,275,Gene/Protein	multiple DNA binding homo - and heterodimer complexes,285,338,Gene/Protein	"[{""token"": ""NF - kappa B related polypeptides"", ""start_span"": 23, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""PRDII regulatory element"", ""start_span"": 137, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""interferon beta"", ""start_span"": 165, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 258, ""end_span"": 275, ""type"": ""Gene/Protein""}, {""token"": ""multiple DNA binding homo - and heterodimer complexes"", ""start_span"": 285, ""end_span"": 338, ""type"": ""Gene/Protein""}]"	train
Furthermore, using DNA templates containing two copies of the PRDII domain linked to the rabbit beta globin gene, the purified polypeptides specifically stimulated NF - kappa B dependent transcription in an in vitro reconstitution assay as heterodimers but not as p50 homodimers.	DNA templates,19,32,Gene/Protein	PRDII domain,62,74,Gene/Protein	rabbit beta globin gene,89,112,Gene/Protein	NF - kappa B,164,176,Gene/Protein	p50 homodimers,264,278,Gene/Protein	"[{""token"": ""DNA templates"", ""start_span"": 19, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""PRDII domain"", ""start_span"": 62, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""rabbit beta globin gene"", ""start_span"": 89, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 164, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""p50 homodimers"", ""start_span"": 264, ""end_span"": 278, ""type"": ""Gene/Protein""}]"	train
We report here that interleukin 2 ( IL - 2) acts on human blood monocytes by enhancing binding activity of the transcription factor NF - kappa B to its consensus sequence in the 5 ' regulatory enhancer region of the IL - 2 receptor alpha chain ( p55).	interleukin 2,20,33,Gene/Protein	IL - 2,36,42,Gene/Protein	transcription factor NF - kappa B,111,144,Gene/Protein	IL - 2 receptor alpha chain,216,243,Gene/Protein	p55,246,249,Gene/Protein	"[{""token"": ""interleukin 2"", ""start_span"": 20, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor NF - kappa B"", ""start_span"": 111, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor alpha chain"", ""start_span"": 216, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""p55"", ""start_span"": 246, ""end_span"": 249, ""type"": ""Gene/Protein""}]"	train
Transient - transfection experiments in embryonal carcinoma cells demonstrate a functional cooperation between p50B and RelB or p65 in transactivation of a reporter plasmid dependent on a kappa B site.	p50B,111,115,Gene/Protein	RelB,120,124,Gene/Protein	p65,128,131,Gene/Protein	reporter plasmid,156,172,Gene/Protein	kappa B site,188,200,Gene/Protein	"[{""token"": ""p50B"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""reporter plasmid"", ""start_span"": 156, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""kappa B site"", ""start_span"": 188, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
We have investigated whether a palmitate conjugate of a human monoclonal antibody specific for thyroglobulin ( TG) could function as a surrogate TG receptor on blood mononuclear cells separated into fractions enriched for T cells or depleted of T cells ( non - T cells).	palmitate conjugate,31,50,Gene/Protein	human monoclonal antibody,56,81,Gene/Protein	thyroglobulin,95,108,Gene/Protein	TG,111,113,Gene/Protein	surrogate TG receptor,135,156,Gene/Protein	"[{""token"": ""palmitate conjugate"", ""start_span"": 31, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""human monoclonal antibody"", ""start_span"": 56, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""thyroglobulin"", ""start_span"": 95, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""TG"", ""start_span"": 111, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""surrogate TG receptor"", ""start_span"": 135, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
The proto - oncogene products c - Fos and c - Jun heterodimerize through their leucine zippers to form the AP - 1 transcription factor.	proto - oncogene products,4,29,Gene/Protein	c - Fos,30,37,Gene/Protein	c - Jun,42,49,Gene/Protein	leucine zippers,79,94,Gene/Protein	AP - 1 transcription factor,107,134,Gene/Protein	"[{""token"": ""proto - oncogene products"", ""start_span"": 4, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""leucine zippers"", ""start_span"": 79, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 transcription factor"", ""start_span"": 107, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
A cis - acting element ( P sequence) resides in the 5 ' upstream region; no additional DNA segments with enhancer activity were identified in the human IL - 4 gene.	cis - acting element,2,22,Gene/Protein	P sequence,25,35,Gene/Protein	5 ' upstream region,52,71,Gene/Protein	DNA segments,87,99,Gene/Protein	human IL - 4 gene,146,163,Gene/Protein	"[{""token"": ""cis - acting element"", ""start_span"": 2, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""P sequence"", ""start_span"": 25, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""5 ' upstream region"", ""start_span"": 52, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""DNA segments"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""human IL - 4 gene"", ""start_span"": 146, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
The P sequence does not share homology with the 5 ' upstream sequence of the IL - 2 gene, even though surrounding sequences of the IL - 4 gene share high homology with the IL - 2 gene.	P sequence,4,14,Gene/Protein	5 ' upstream sequence,48,69,Gene/Protein	IL - 2 gene,77,88,Gene/Protein	IL - 4 gene,131,142,Gene/Protein	IL - 2 gene,172,183,Gene/Protein	"[{""token"": ""P sequence"", ""start_span"": 4, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""5 ' upstream sequence"", ""start_span"": 48, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 gene"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 gene"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 gene"", ""start_span"": 172, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
The v - erbA oncogene, a mutated version of the thyroid hormone receptor alpha ( c - erbA / TR - alpha), inhibits erythroid differentiation and constitutively represses transcription of certain erythrocyte genes, suggesting a normal function of the proto - oncogene c - erbA in erythropoiesis.	v - erbA oncogene,4,21,Gene/Protein	thyroid hormone receptor alpha,48,78,Gene/Protein	c - erbA / TR - alpha,81,102,Gene/Protein	erythrocyte genes,194,211,Gene/Protein	proto - oncogene c - erbA,249,274,Gene/Protein	"[{""token"": ""v - erbA oncogene"", ""start_span"": 4, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""thyroid hormone receptor alpha"", ""start_span"": 48, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""c - erbA / TR - alpha"", ""start_span"": 81, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""erythrocyte genes"", ""start_span"": 194, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""proto - oncogene c - erbA"", ""start_span"": 249, ""end_span"": 274, ""type"": ""Gene/Protein""}]"	train
The AP - 1 site at - 150 bp, but not the NF - kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter.	AP - 1 site,4,15,Gene/Protein	- 150 bp,19,27,Gene/Protein	NF - kappa B site,41,58,Gene/Protein	protein kinase C,103,119,Gene/Protein	interleukin 2 promoter,127,149,Gene/Protein	"[{""token"": ""AP - 1 site"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""- 150 bp"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 41, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 103, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2 promoter"", ""start_span"": 127, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
In contrast, mutations in the AP - 1 site located at - 150 bp almost completely abrogate induction of the IL - 2 promoter, and appearance of an inducible nuclear factor binding to this site is sensitive to PKC depletion.	AP - 1 site,30,41,Gene/Protein	- 150 bp,53,61,Gene/Protein	IL - 2 promoter,106,121,Gene/Protein	inducible nuclear factor,144,168,Gene/Protein	PKC,206,209,Gene/Protein	"[{""token"": ""AP - 1 site"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""- 150 bp"", ""start_span"": 53, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 106, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""inducible nuclear factor"", ""start_span"": 144, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
The active nuclear form of the NF - kappa B transcription factor complex is composed of two DNA binding subunits, NF - kappa B p65 and NF - kappa B p50, both of which share extensive N - terminal sequence homology with the v - rel oncogene product.	NF - kappa B transcription factor complex,31,72,Gene/Protein	DNA binding subunits,92,112,Gene/Protein	NF - kappa B p65,114,130,Gene/Protein	NF - kappa B p50,135,151,Gene/Protein	v - rel oncogene product,223,247,Gene/Protein	"[{""token"": ""NF - kappa B transcription factor complex"", ""start_span"": 31, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding subunits"", ""start_span"": 92, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B p65"", ""start_span"": 114, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B p50"", ""start_span"": 135, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""v - rel oncogene product"", ""start_span"": 223, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	train
On the basis of binding, reconstitution and cotransfection experiments, we propose that activation of NF - AT occurs in at least two stages: a CsA - sensitive stage involving modification and / or translocation of the pre - existing NF - AT complex, and a CsA - insensitive stage involving the addition of newly synthesized Fos or Fos / Jun proteins to the pre - existing complex.	NF - AT,102,109,Gene/Protein	NF - AT complex,233,248,Gene/Protein	Fos,324,327,Gene/Protein	Fos / Jun proteins,331,349,Gene/Protein	pre - existing complex,357,379,Gene/Protein	"[{""token"": ""NF - AT"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT complex"", ""start_span"": 233, ""end_span"": 248, ""type"": ""Gene/Protein""}, {""token"": ""Fos"", ""start_span"": 324, ""end_span"": 327, ""type"": ""Gene/Protein""}, {""token"": ""Fos / Jun proteins"", ""start_span"": 331, ""end_span"": 349, ""type"": ""Gene/Protein""}, {""token"": ""pre - existing complex"", ""start_span"": 357, ""end_span"": 379, ""type"": ""Gene/Protein""}]"	train
The proto - oncoprotein c - Rel is a member of the nuclear factor kappa B transcription factor family, which includes the p50 and p65 subunits of nuclear factor kappa B.	proto - oncoprotein c - Rel,4,31,Gene/Protein	nuclear factor kappa B transcription factor family,51,101,Gene/Protein	p50,122,125,Gene/Protein	p65 subunits,130,142,Gene/Protein	nuclear factor kappa B,146,168,Gene/Protein	"[{""token"": ""proto - oncoprotein c - Rel"", ""start_span"": 4, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappa B transcription factor family"", ""start_span"": 51, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""p65 subunits"", ""start_span"": 130, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappa B"", ""start_span"": 146, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
We show here that c - Rel binds to kappa B sites as homodimers as well as heterodimers with p50.	c - Rel,18,25,Gene/Protein	kappa B sites,35,48,Gene/Protein	homodimers,52,62,Gene/Protein	heterodimers,74,86,Gene/Protein	p50,92,95,Gene/Protein	"[{""token"": ""c - Rel"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""kappa B sites"", ""start_span"": 35, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""homodimers"", ""start_span"": 52, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""heterodimers"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	train
We therefore screened a T - cell cDNA library under low - stringency conditions with a probe from the DNA binding domain of Ets - 1 and isolated a novel Ets family member, Elf - 1.	T - cell cDNA,24,37,Gene/Protein	DNA binding domain,102,120,Gene/Protein	Ets - 1,124,131,Gene/Protein	novel Ets family member,147,170,Gene/Protein	Elf - 1,172,179,Gene/Protein	"[{""token"": ""T - cell cDNA"", ""start_span"": 24, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding domain"", ""start_span"": 102, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""Ets - 1"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""novel Ets family member"", ""start_span"": 147, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""Elf - 1"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
We have previously reported the presence of a transcriptional control element with the properties of a silencer extending from - 392 to - 177 bp relative to the cap site of the human epsilon - globin - encoding gene [ Cao et al., Proc. Natl. Acad. Sci. USA 86 ( 1989) 5306 - 5309].	transcriptional control element,46,77,Gene/Protein	silencer,103,111,Gene/Protein	- 392 to - 177 bp,127,144,Gene/Protein	cap site,161,169,Gene/Protein	human epsilon - globin - encoding gene,177,215,Gene/Protein	"[{""token"": ""transcriptional control element"", ""start_span"": 46, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""silencer"", ""start_span"": 103, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""- 392 to - 177 bp"", ""start_span"": 127, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""cap site"", ""start_span"": 161, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""human epsilon - globin - encoding gene"", ""start_span"": 177, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
Much attention has been focused on the interaction of Tat with a specific RNA target termed TAR ( transactivation responsive) which is present in the leader sequence of all HIV - 1 mRNAs.	Tat,54,57,Gene/Protein	RNA target,74,84,Gene/Protein	TAR,92,95,Gene/Protein	transactivation responsive,98,124,Gene/Protein	HIV - 1 mRNAs,173,186,Gene/Protein	"[{""token"": ""Tat"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""RNA target"", ""start_span"": 74, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""TAR"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""transactivation responsive"", ""start_span"": 98, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 mRNAs"", ""start_span"": 173, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
The HTLV - I LTR contains three conserved regulatory elements known as 21 base pair repeats which are required for stimulation of gene expression by the transactivator protein tax.	HTLV - I LTR,4,16,Gene/Protein	regulatory elements,42,61,Gene/Protein	21 base pair repeats,71,91,Gene/Protein	transactivator protein,153,175,Gene/Protein	tax,176,179,Gene/Protein	"[{""token"": ""HTLV - I LTR"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""regulatory elements"", ""start_span"": 42, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""21 base pair repeats"", ""start_span"": 71, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""transactivator protein"", ""start_span"": 153, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""tax"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
This factor is composed of a DNA - binding protein ( ISGF3 gamma), which normally is present in the cytoplasm, and other IFN - alpha - activated proteins which preexist as latent cytoplasmic precursors ( ISGF3 alpha).	DNA - binding protein,29,50,Gene/Protein	ISGF3 gamma,53,64,Gene/Protein	IFN - alpha - activated proteins,121,153,Gene/Protein	latent cytoplasmic precursors,172,201,Gene/Protein	ISGF3 alpha,204,215,Gene/Protein	"[{""token"": ""DNA - binding protein"", ""start_span"": 29, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""ISGF3 gamma"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha - activated proteins"", ""start_span"": 121, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""latent cytoplasmic precursors"", ""start_span"": 172, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""ISGF3 alpha"", ""start_span"": 204, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
Activation of expression of genes encoding transcription factors: c - fos and c - jun and formation of AP1 transcriptional complex in human monocytes was investigated.	genes,28,33,Gene/Protein	transcription factors,43,64,Gene/Protein	c - fos,66,73,Gene/Protein	c - jun,78,85,Gene/Protein	AP1 transcriptional complex,103,130,Gene/Protein	"[{""token"": ""genes"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 43, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""AP1 transcriptional complex"", ""start_span"": 103, ""end_span"": 130, ""type"": ""Gene/Protein""}]"	train
The sites and their corresponding nuclear binding factors include: NF - kappa B, AP - 1, AP - 3, OCT - 1, and NF - AT.	NF - kappa B,67,79,Gene/Protein	AP - 1,81,87,Gene/Protein	AP - 3,89,95,Gene/Protein	OCT - 1,97,104,Gene/Protein	NF - AT,110,117,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 67, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""AP - 3"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""OCT - 1"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
Only the activities for NF - AT and AP - 1 sites require two signals for optimal induction, i. e., PMA plus either lectin or antibody to the CD3 or CD28 surface molecules.	NF - AT and AP - 1 sites,24,48,Gene/Protein	lectin,115,121,Gene/Protein	antibody,125,133,Gene/Protein	CD3,141,144,Gene/Protein	CD28 surface molecules,148,170,Gene/Protein	"[{""token"": ""NF - AT and AP - 1 sites"", ""start_span"": 24, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""lectin"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""CD28 surface molecules"", ""start_span"": 148, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
The effect of constitutive Tax expression on the interaction of NF - kappa B with its recognition sequence and on NF - kappa B - dependent gene expression was examined in T lymphoid Jurkat cell lines ( 19D and 9J) stably transformed with a Tax expression vector.	Tax,27,30,Gene/Protein	NF - kappa B,64,76,Gene/Protein	recognition sequence,86,106,Gene/Protein	NF - kappa B,114,126,Gene/Protein	Tax expression vector,240,261,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 64, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""recognition sequence"", ""start_span"": 86, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 114, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""Tax expression vector"", ""start_span"": 240, ""end_span"": 261, ""type"": ""Gene/Protein""}]"	train
A nuclear factor NF - GM2 that interacts with a regulatory region of the GM - CSF gene essential for its induction in responses to T - cell activation: purification from human T - cell leukemia line Jurkat cells and similarity to NF - kappa B.	nuclear factor,2,16,Gene/Protein	NF - GM2,17,25,Gene/Protein	regulatory region,48,65,Gene/Protein	GM - CSF gene,73,86,Gene/Protein	NF - kappa B,230,242,Gene/Protein	"[{""token"": ""nuclear factor"", ""start_span"": 2, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""NF - GM2"", ""start_span"": 17, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""regulatory region"", ""start_span"": 48, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF gene"", ""start_span"": 73, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 230, ""end_span"": 242, ""type"": ""Gene/Protein""}]"	train
Electrophoretically purified p50 alone can form a protein - DNA complex, but in the mixture, p50 associates preferentially with p65 to form the NF - GM2 complex.	p50,29,32,Gene/Protein	protein - DNA complex,50,71,Gene/Protein	p50,93,96,Gene/Protein	p65,128,131,Gene/Protein	NF - GM2 complex,144,160,Gene/Protein	"[{""token"": ""p50"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""protein - DNA complex"", ""start_span"": 50, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""NF - GM2 complex"", ""start_span"": 144, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
One of the induced transcripts ( MAD - 3) encodes a protein of 317 amino acids with one domain containing five tandem repeats of the cdc10 / ankyrin motif, which is 60% similar ( 46% identical) to the ankyrin repeat region of the precursor of NF - kappa B / KBF1 p50.	MAD - 3,33,40,Gene/Protein	five tandem repeats,106,125,Gene/Protein	cdc10 / ankyrin motif,133,154,Gene/Protein	ankyrin repeat region,201,222,Gene/Protein	NF - kappa B / KBF1 p50,243,266,Gene/Protein	"[{""token"": ""MAD - 3"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""five tandem repeats"", ""start_span"": 106, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""cdc10 / ankyrin motif"", ""start_span"": 133, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""ankyrin repeat region"", ""start_span"": 201, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B / KBF1 p50"", ""start_span"": 243, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
In addition, the 65 - kD protein associated with the p50 subunit of NF - kappa B and the kappa B probe to form a complex with the same electrophoretic mobility as the NF - kappa B - DNA complex.	65 - kD protein,17,32,Gene/Protein	p50 subunit,53,64,Gene/Protein	NF - kappa B,68,80,Gene/Protein	kappa B probe,89,102,Gene/Protein	NF - kappa B - DNA complex,167,193,Gene/Protein	"[{""token"": ""65 - kD protein"", ""start_span"": 17, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""p50 subunit"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""kappa B probe"", ""start_span"": 89, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B - DNA complex"", ""start_span"": 167, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
Macrophage - colony - stimulating factor ( M - CSF), also referred to as CSF - 1, regulates the survival, growth, differentiation and functional activity of monocytes by binding to a single class of high - affinity cell surface receptors, known to be the product of the c - fms protooncogene.	Macrophage - colony - stimulating factor,0,40,Gene/Protein	M - CSF,43,50,Gene/Protein	CSF - 1,73,80,Gene/Protein	high - affinity cell surface receptors,199,237,Gene/Protein	c - fms protooncogene,270,291,Gene/Protein	"[{""token"": ""Macrophage - colony - stimulating factor"", ""start_span"": 0, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""CSF - 1"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""high - affinity cell surface receptors"", ""start_span"": 199, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""c - fms protooncogene"", ""start_span"": 270, ""end_span"": 291, ""type"": ""Gene/Protein""}]"	train
The results suggest that M - CSF induction of M - CSF involves G proteins, PKC and NF kappa B.	M - CSF,25,32,Gene/Protein	M - CSF,46,53,Gene/Protein	G proteins,63,73,Gene/Protein	PKC,75,78,Gene/Protein	NF kappa B,83,93,Gene/Protein	"[{""token"": ""M - CSF"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""G proteins"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 83, ""end_span"": 93, ""type"": ""Gene/Protein""}]"	train
NAC and other thiol compounds also blocked the activation of NF - kappa B by cycloheximide, double - stranded RNA, calcium ionophore, TNF - alpha, active phorbol ester, interleukin - 1, lipopolysaccharide and lectin.	NF - kappa B,61,73,Gene/Protein	double - stranded RNA,92,113,Gene/Protein	TNF - alpha,134,145,Gene/Protein	interleukin - 1,169,184,Gene/Protein	lectin,209,215,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 61, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""double - stranded RNA"", ""start_span"": 92, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 134, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1"", ""start_span"": 169, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""lectin"", ""start_span"": 209, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
The most likely interpretation of our results is that both the ubiquitous transcription factor, OTF - 1, and the B - cell - specific transcription factor, OTF - 2, can activate U2 snRNA transcription.	transcription factor,74,94,Gene/Protein	OTF - 1,96,103,Gene/Protein	B - cell - specific transcription factor,113,153,Gene/Protein	OTF - 2,155,162,Gene/Protein	U2 snRNA,177,185,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 74, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 1"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific transcription factor"", ""start_span"": 113, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 2"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""U2 snRNA"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene/Protein""}]"	train
Purified NF - kB is also able to bind to the TCEd, but TCF - 1 binds stronger than NF - kB to TCEd DNA.	Purified NF - kB,0,16,Gene/Protein	TCEd,45,49,Gene/Protein	TCF - 1,55,62,Gene/Protein	NF - kB,83,90,Gene/Protein	TCEd,94,98,Gene/Protein	"[{""token"": ""Purified NF - kB"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""TCEd"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""TCEd"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}]"	train
Moreover, Tax1 activated expression of two other transcription factors having zinc finger motifs, Egr - 1 and Egr - 2, in the same cells.	Tax1,10,14,Gene/Protein	transcription factors,49,70,Gene/Protein	zinc finger motifs,78,96,Gene/Protein	Egr - 1,98,105,Gene/Protein	Egr - 2,110,117,Gene/Protein	"[{""token"": ""Tax1"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 49, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger motifs"", ""start_span"": 78, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 2"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
The PMA induction of c - fos mRNA correlated well with TNF gene induction; expression of genes encoding other proteins in the AP - 1 complex ( junB and junD) were also induced by PMA.	c - fos mRNA,21,33,Gene/Protein	TNF,55,58,Gene/Protein	AP - 1 complex,126,140,Gene/Protein	junB,143,147,Gene/Protein	junD,152,156,Gene/Protein	"[{""token"": ""c - fos mRNA"", ""start_span"": 21, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 complex"", ""start_span"": 126, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""junB"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""junD"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
Internal labeling with [ 35S] methionine and immunoprecipitation with anti - IgM, anti - kappa, and anti - lambda antibodies revealed a striking reduction in kappa L chain in the presence of TGF - beta.	anti - IgM,70,80,Gene/Protein	anti - kappa,82,94,Gene/Protein	anti - lambda antibodies,100,124,Gene/Protein	kappa L chain,158,171,Gene/Protein	TGF - beta,191,201,Gene/Protein	"[{""token"": ""anti - IgM"", ""start_span"": 70, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""anti - kappa"", ""start_span"": 82, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""anti - lambda antibodies"", ""start_span"": 100, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""kappa L chain"", ""start_span"": 158, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta"", ""start_span"": 191, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
Furthermore, a significant decrease in the switch from the membrane forms of mu and gamma to their respective secreted forms was noted in the presence of TGF - beta.	membrane forms,59,73,Gene/Protein	mu,77,79,Gene/Protein	gamma,84,89,Gene/Protein	secreted forms,110,124,Gene/Protein	TGF - beta,154,164,Gene/Protein	"[{""token"": ""membrane forms"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""mu"", ""start_span"": 77, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""gamma"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""secreted forms"", ""start_span"": 110, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta"", ""start_span"": 154, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
A family of transcriptional activators has recently been identified in chickens; these transcriptional activators recognize a common consensus motif ( WGATAR) through a conserved C4 zinc finger DNA - binding domain.	transcriptional activators,12,38,Gene/Protein	transcriptional activators,87,113,Gene/Protein	consensus motif,133,148,Gene/Protein	WGATAR,151,157,Gene/Protein	C4 zinc finger DNA - binding domain,179,214,Gene/Protein	"[{""token"": ""transcriptional activators"", ""start_span"": 12, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activators"", ""start_span"": 87, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""consensus motif"", ""start_span"": 133, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""WGATAR"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""C4 zinc finger DNA - binding domain"", ""start_span"": 179, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
Isolation of a candidate repressor / activator, NF - E1 ( YY - 1, delta), that binds to the immunoglobulin kappa 3 ' enhancer and the immunoglobulin heavy - chain mu E1 site.	NF - E1,48,55,Gene/Protein	YY - 1,58,64,Gene/Protein	delta,66,71,Gene/Protein	immunoglobulin kappa 3 ' enhancer,92,125,Gene/Protein	immunoglobulin heavy - chain mu E1 site,134,173,Gene/Protein	"[{""token"": ""NF - E1"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""YY - 1"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""delta"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin kappa 3 ' enhancer"", ""start_span"": 92, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin heavy - chain mu E1 site"", ""start_span"": 134, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
The HIV - TF1 - binding site in HIV LTR was similar to the site recognized by upstream stimulatory factor ( USF) in the adenovirus major late promoter.	HIV - TF1 - binding site,4,28,Gene/Protein	HIV LTR,32,39,Gene/Protein	upstream stimulatory factor,78,105,Gene/Protein	USF,108,111,Gene/Protein	adenovirus major late promoter,120,150,Gene/Protein	"[{""token"": ""HIV - TF1 - binding site"", ""start_span"": 4, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""HIV LTR"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""upstream stimulatory factor"", ""start_span"": 78, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""USF"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""adenovirus major late promoter"", ""start_span"": 120, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
Cysteine and NAC also inhibit NF - kappa B activity as determined by electrophoretic mobility shift assays and chloramphenicol acetyl - transferase ( CAT) gene expression under control of NF - kappa B binding sites in uninfected cells.	NF - kappa B,30,42,Gene/Protein	chloramphenicol acetyl - transferase,111,147,Gene/Protein	CAT,150,153,Gene/Protein	NF - kappa B,188,200,Gene/Protein	binding sites,201,214,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 30, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyl - transferase"", ""start_span"": 111, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 188, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 201, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
The TCF - 1 alpha cDNA contains a single 68 - amino - acid domain that is homologous to a region conserved among high - mobility group ( HMG) and nonhistone chromosomal proteins.	TCF - 1 alpha cDNA,4,22,Gene/Protein	68 - amino - acid domain,41,65,Gene/Protein	high - mobility group,113,134,Gene/Protein	HMG,137,140,Gene/Protein	nonhistone chromosomal proteins,146,177,Gene/Protein	"[{""token"": ""TCF - 1 alpha cDNA"", ""start_span"": 4, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""68 - amino - acid domain"", ""start_span"": 41, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""high - mobility group"", ""start_span"": 113, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""HMG"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""nonhistone chromosomal proteins"", ""start_span"": 146, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
Expression of full - length and mutant cDNA clones in bacteria reveal that the single HMG motif, which is predicted to contain two extended alpha - helical segments, is sufficient to direct the sequence - specific binding of TCF - 1 alpha to DNA.	full - length,14,27,Gene/Protein	mutant cDNA clones,32,50,Gene/Protein	single HMG motif,79,95,Gene/Protein	alpha - helical segments,140,164,Gene/Protein	TCF - 1 alpha,225,238,Gene/Protein	"[{""token"": ""full - length"", ""start_span"": 14, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""mutant cDNA clones"", ""start_span"": 32, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""single HMG motif"", ""start_span"": 79, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""alpha - helical segments"", ""start_span"": 140, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1 alpha"", ""start_span"": 225, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	train
These findings therefore suggest that the HTLV - I enhancer contains multiple functional elements, including binding sites for at least CREB - and NF - kappa B - like factors, which synergistically cooperate in activation of the HTLV - I enhancer in response to p40tax.	HTLV - I enhancer,42,59,Gene/Protein	multiple functional elements,69,97,Gene/Protein	CREB - and NF - kappa B - like factors,136,174,Gene/Protein	HTLV - I enhancer,229,246,Gene/Protein	p40tax,262,268,Gene/Protein	"[{""token"": ""HTLV - I enhancer"", ""start_span"": 42, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""multiple functional elements"", ""start_span"": 69, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""CREB - and NF - kappa B - like factors"", ""start_span"": 136, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""HTLV - I enhancer"", ""start_span"": 229, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""p40tax"", ""start_span"": 262, ""end_span"": 268, ""type"": ""Gene/Protein""}]"	train
Although three sites in the TNF - alpha promoter ( kappa 1, kappa 2, and kappa 3) specifically bind the transcription factor NF - kappa B in lymphoid nuclear extracts, TNF - alpha mRNA induction by PMA does not correlate with NF - kappa B binding activities displayed by different T and B cell lines.	TNF - alpha promoter,28,48,Gene/Protein	transcription factor,104,124,Gene/Protein	NF - kappa B,125,137,Gene/Protein	TNF - alpha mRNA,168,184,Gene/Protein	NF - kappa B,226,238,Gene/Protein	"[{""token"": ""TNF - alpha promoter"", ""start_span"": 28, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 104, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 125, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha mRNA"", ""start_span"": 168, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 226, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	train
TCF - 1, a T cell - specific transcription factor of the HMG box family, interacts with sequence motifs in the TCR beta and TCR delta enhancers.	TCF - 1,0,7,Gene/Protein	T cell - specific transcription factor,11,49,Gene/Protein	HMG box family,57,71,Gene/Protein	sequence motifs,88,103,Gene/Protein	TCR beta and TCR delta enhancers,111,143,Gene/Protein	"[{""token"": ""TCF - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""T cell - specific transcription factor"", ""start_span"": 11, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""HMG box family"", ""start_span"": 57, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""sequence motifs"", ""start_span"": 88, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""TCR beta and TCR delta enhancers"", ""start_span"": 111, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	train
Here, we show by gel retardation analysis that TCF - 1 specifically recognizes the T beta 5 element of the TCR beta enhancer and the T delta 7 element of the TCR delta enhancer.	TCF - 1,47,54,Gene/Protein	T beta 5 element,83,99,Gene/Protein	TCR beta enhancer,107,124,Gene/Protein	T delta 7 element,133,150,Gene/Protein	TCR delta enhancer,158,176,Gene/Protein	"[{""token"": ""TCF - 1"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""T beta 5 element"", ""start_span"": 83, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""TCR beta enhancer"", ""start_span"": 107, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""T delta 7 element"", ""start_span"": 133, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""TCR delta enhancer"", ""start_span"": 158, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
The regulatory effect of insulin on the specific binding power of glucocorticoid receptor ( GR) of human leukocytes was assessed by the unoccupied receptor sites capable of combining with [ 3H] labelled dexamethasone measured at 3 and 24 h after incubation with various concentrations of insulin added to the medium.	insulin,25,32,Gene/Protein	glucocorticoid receptor,66,89,Gene/Protein	GR,92,94,Gene/Protein	unoccupied receptor sites,136,161,Gene/Protein	insulin,288,295,Gene/Protein	"[{""token"": ""insulin"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""glucocorticoid receptor"", ""start_span"": 66, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 92, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""unoccupied receptor sites"", ""start_span"": 136, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""insulin"", ""start_span"": 288, ""end_span"": 295, ""type"": ""Gene/Protein""}]"	train
An analysis of the immediate promoter of the human erythroid ALAS gene revealed several putative erythroid - specific cis - acting elements including both a GATA - 1 and an NF - E2 binding site.	immediate promoter,19,37,Gene/Protein	human erythroid ALAS gene,45,70,Gene/Protein	erythroid - specific cis - acting elements,97,139,Gene/Protein	GATA - 1,157,165,Gene/Protein	NF - E2 binding site,173,193,Gene/Protein	"[{""token"": ""immediate promoter"", ""start_span"": 19, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""human erythroid ALAS gene"", ""start_span"": 45, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""erythroid - specific cis - acting elements"", ""start_span"": 97, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 157, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""NF - E2 binding site"", ""start_span"": 173, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
To dissect the molecular basis for the unusual persistent expression of the IL - 2 and IL - 2 - R alpha genes in these IARC 301 T cells, we have analyzed the interactions of constitutively expressed nuclear proteins with the 5 ' flanking regions of the IL - 2 and IL - 2 - R alpha genes using both DNase I footprinting and gel retardation techniques.	IL - 2 and IL - 2 - R alpha genes,76,109,Gene/Protein	constitutively expressed nuclear proteins,174,215,Gene/Protein	5 ' flanking regions,225,245,Gene/Protein	IL - 2 and IL - 2 - R alpha genes,253,286,Gene/Protein	DNase I,298,305,Gene/Protein	"[{""token"": ""IL - 2 and IL - 2 - R alpha genes"", ""start_span"": 76, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""constitutively expressed nuclear proteins"", ""start_span"": 174, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""5 ' flanking regions"", ""start_span"": 225, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 and IL - 2 - R alpha genes"", ""start_span"": 253, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""DNase I"", ""start_span"": 298, ""end_span"": 305, ""type"": ""Gene/Protein""}]"	train
TCF - 1 contained a single DNA - binding HMG box most closely related to similar boxes in the putative mammalian sex - determining gene SRY and in the Schizosaccharomyces pombe Mc mating type gene.	TCF - 1,0,7,Gene/Protein	DNA - binding HMG box,27,48,Gene/Protein	putative mammalian sex - determining gene,94,135,Gene/Protein	SRY,136,139,Gene/Protein	Schizosaccharomyces pombe Mc mating type gene,151,196,Gene/Protein	"[{""token"": ""TCF - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding HMG box"", ""start_span"": 27, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""putative mammalian sex - determining gene"", ""start_span"": 94, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""SRY"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""Schizosaccharomyces pombe Mc mating type gene"", ""start_span"": 151, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
During latent Epstein - Barr virus ( EBV) infection of human B lymphocytes, six viral nuclear antigen ( EBNAs) are expressed from long primary transcripts by means of alternative splicing and alternative polyadenylylation sites.	six viral nuclear antigen,76,101,Gene/Protein	EBNAs,104,109,Gene/Protein	long primary transcripts,130,154,Gene/Protein	alternative splicing,167,187,Gene/Protein	alternative polyadenylylation sites,192,227,Gene/Protein	"[{""token"": ""six viral nuclear antigen"", ""start_span"": 76, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""EBNAs"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""long primary transcripts"", ""start_span"": 130, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""alternative splicing"", ""start_span"": 167, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""alternative polyadenylylation sites"", ""start_span"": 192, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
We demonstrate that JunD, a component of the AP - 1 transcription factor complex, activates transcription of the human proenkephalin gene in a fashion that is completely dependent upon the cAMP - dependent protein kinase, protein kinase A.	JunD,20,24,Gene/Protein	AP - 1 transcription factor complex,45,80,Gene/Protein	human proenkephalin gene,113,137,Gene/Protein	cAMP - dependent protein kinase,189,220,Gene/Protein	protein kinase A,222,238,Gene/Protein	"[{""token"": ""JunD"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 transcription factor complex"", ""start_span"": 45, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""human proenkephalin gene"", ""start_span"": 113, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""cAMP - dependent protein kinase"", ""start_span"": 189, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase A"", ""start_span"": 222, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	train
Binding of the drug inhibits isomerase activity, but studies with other prolyl isomerase inhibitors and analysis of cyclosporin - resistant mutants in yeast suggest that the effects of the drug result from the formation of an inhibitory complex between the drug and isomerase, and not from inhibition of isomerase activity.	isomerase,29,38,Gene/Protein	isomerase,79,88,Gene/Protein	inhibitory complex,226,244,Gene/Protein	isomerase,266,275,Gene/Protein	isomerase,304,313,Gene/Protein	"[{""token"": ""isomerase"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""isomerase"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""inhibitory complex"", ""start_span"": 226, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""isomerase"", ""start_span"": 266, ""end_span"": 275, ""type"": ""Gene/Protein""}, {""token"": ""isomerase"", ""start_span"": 304, ""end_span"": 313, ""type"": ""Gene/Protein""}]"	train
We report on a computer algorithm capable of predicting the location of T - helper - cell epitopes in protein antigen ( Ag) by analysing the Ag amino acid sequence.	T - helper - cell epitopes,72,98,Gene/Protein	protein antigen,102,117,Gene/Protein	Ag,120,122,Gene/Protein	Ag,141,143,Gene/Protein	amino acid sequence,144,163,Gene/Protein	"[{""token"": ""T - helper - cell epitopes"", ""start_span"": 72, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""protein antigen"", ""start_span"": 102, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Ag"", ""start_span"": 120, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Ag"", ""start_span"": 141, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""amino acid sequence"", ""start_span"": 144, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
This gene encodes a protein with duplicated cysteine - rich regions called LIM domains, which show homology to zinc - binding proteins and to iron - sulfur centers of ferredoxins.	cysteine - rich regions,44,67,Gene/Protein	LIM domains,75,86,Gene/Protein	zinc - binding proteins,111,134,Gene/Protein	iron - sulfur centers,142,163,Gene/Protein	ferredoxins,167,178,Gene/Protein	"[{""token"": ""cysteine - rich regions"", ""start_span"": 44, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""LIM domains"", ""start_span"": 75, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""zinc - binding proteins"", ""start_span"": 111, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""iron - sulfur centers"", ""start_span"": 142, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""ferredoxins"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Therefore, chromosome bands 11p15 ( rhombotin) and 11p13 ( Rhom - 2) are consistent sites of chromosome translocation in T - cell leukemia, with the 11p15 target more rarely involved.	chromosome bands 11p15,11,33,Gene/Protein	rhombotin,36,45,Gene/Protein	11p13,51,56,Gene/Protein	Rhom - 2,59,67,Gene/Protein	11p15 target,149,161,Gene/Protein	"[{""token"": ""chromosome bands 11p15"", ""start_span"": 11, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""rhombotin"", ""start_span"": 36, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""11p13"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""Rhom - 2"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""11p15 target"", ""start_span"": 149, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
Our results show that the structure of this promoter only permits productive interactions of the two transcription factors Sp1 and CP1 with the basal transcription machinery in the presence of enhancer sequences.	promoter,44,52,Gene/Protein	transcription factors,101,122,Gene/Protein	Sp1,123,126,Gene/Protein	CP1,131,134,Gene/Protein	enhancer sequences,193,211,Gene/Protein	"[{""token"": ""promoter"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 101, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""CP1"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""enhancer sequences"", ""start_span"": 193, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
We have examined the binding of nuclear proteins and recombinant thyroid hormone receptors ( TRs) to the palindromic thyroid hormone responsive element AGGTCATGACCT ( TREp) using a gel electrophoretic mobility shift assay.	nuclear proteins,32,48,Gene/Protein	recombinant thyroid hormone receptors,53,90,Gene/Protein	TRs,93,96,Gene/Protein	palindromic thyroid hormone responsive element,105,151,Gene/Protein	TREp,167,171,Gene/Protein	"[{""token"": ""nuclear proteins"", ""start_span"": 32, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""recombinant thyroid hormone receptors"", ""start_span"": 53, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""TRs"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""palindromic thyroid hormone responsive element"", ""start_span"": 105, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""TREp"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
TR alpha 1 and TR beta 2 each formed a single major TR: TREp complex which comigrated with the least retarded complex formed by GH3 NE, while TR beta 1 formed multiple complexes suggesting that it can bind to TREp as an oligomer.	TR alpha 1,0,10,Gene/Protein	TR beta 2,15,24,Gene/Protein	TR beta 1,142,151,Gene/Protein	TREp,209,213,Gene/Protein	oligomer,220,228,Gene/Protein	"[{""token"": ""TR alpha 1"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""TR beta 2"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""TR beta 1"", ""start_span"": 142, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""TREp"", ""start_span"": 209, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""oligomer"", ""start_span"": 220, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	train
Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding, suggesting that the carboxyl - terminus of the TRs is essential for interaction with nuclear proteins.	TR alpha 1,14,24,Gene/Protein	amino acid 210,28,42,Gene/Protein	carboxyl - terminus,155,174,Gene/Protein	TRs,182,185,Gene/Protein	nuclear proteins,220,236,Gene/Protein	"[{""token"": ""TR alpha 1"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""amino acid 210"", ""start_span"": 28, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""carboxyl - terminus"", ""start_span"": 155, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""TRs"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""nuclear proteins"", ""start_span"": 220, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
This ` ` octamer ` ` in the context of DRA appears capable of binding both the ubiquitous ( OTF - 1) and lymphoid - specific ( OTF - 2) ` ` octamer ' ' binding proteins, but at least one other distinct ` ` octamer ' ' complex was found.	octamer,9,16,Gene/Protein	DRA,39,42,Gene/Protein	ubiquitous,79,89,Gene/Protein	OTF - 1,92,99,Gene/Protein	` ` octamer ' ' complex,202,225,Gene/Protein	"[{""token"": ""octamer"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""DRA"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitous"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 1"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""` ` octamer ' ' complex"", ""start_span"": 202, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	train
Demonstration of the complete dependence on the Y box in this system suggests that, despite its demonstrated importance in the DRA promoter, the DRA ` ` octamer ' ' does not utilize OTF - 2 in a manner analogous to immunoglobulin promoters in B cells.	Y box,48,53,Gene/Protein	DRA promoter,127,139,Gene/Protein	DRA ` ` octamer ' ',145,164,Gene/Protein	OTF - 2,182,189,Gene/Protein	immunoglobulin promoters,215,239,Gene/Protein	"[{""token"": ""Y box"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""DRA promoter"", ""start_span"": 127, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""DRA ` ` octamer ' '"", ""start_span"": 145, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 2"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin promoters"", ""start_span"": 215, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Erythroid - specific genes contain binding sites for NF - E1 ( also called GF - 1 and Eryf - 1; refs 1 - 3 respectively), the principal DNA - binding protein of the erythrocytic lineage.	Erythroid - specific genes,0,26,Gene/Protein	NF - E1,53,60,Gene/Protein	GF - 1,75,81,Gene/Protein	Eryf - 1,86,94,Gene/Protein	DNA - binding protein,136,157,Gene/Protein	"[{""token"": ""Erythroid - specific genes"", ""start_span"": 0, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""NF - E1"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""GF - 1"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""Eryf - 1"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding protein"", ""start_span"": 136, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
Because insertion mutations in phoP are polar on phoQ, we constructed strains that expressed the PhoQ protein in the absence of PhoP to test whether resistance to defensin requires only the phoQ gene product.	phoP,31,35,Gene/Protein	phoQ,49,53,Gene/Protein	PhoQ protein,97,109,Gene/Protein	PhoP,128,132,Gene/Protein	phoQ gene product,190,207,Gene/Protein	"[{""token"": ""phoP"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""phoQ"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""PhoQ protein"", ""start_span"": 97, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""PhoP"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""phoQ gene product"", ""start_span"": 190, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
We also tested for the ability of defensins NP - 1, NP - 5, and HNP - 1 to activate pag expression and found that these peptides have no effect.	defensins,34,43,Gene/Protein	NP - 1,44,50,Gene/Protein	NP - 5,52,58,Gene/Protein	HNP - 1,64,71,Gene/Protein	pag,84,87,Gene/Protein	"[{""token"": ""defensins"", ""start_span"": 34, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""NP - 1"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""NP - 5"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""HNP - 1"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""pag"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene/Protein""}]"	train
Our finding that induction of NF - kappa B by tumor necrosis factor or antibody to CD3 is not sufficient to induce HIV enhancer - dependent transcription in cloned T cells contrasts with results obtained in most lymphoblastoid T - cell lines and indicates that normal T lymphocytes differ from tumoral T cells in terms of requirements for HIV LTR activation.	NF - kappa B,30,42,Gene/Protein	tumor necrosis factor,46,67,Gene/Protein	antibody to CD3,71,86,Gene/Protein	HIV enhancer,115,127,Gene/Protein	HIV LTR,339,346,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 30, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 46, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""antibody to CD3"", ""start_span"": 71, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""HIV enhancer"", ""start_span"": 115, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""HIV LTR"", ""start_span"": 339, ""end_span"": 346, ""type"": ""Gene/Protein""}]"	train
Moreover, BSAP is clearly a B - cell - specific transcription factor, as a wild - type but not a mutant TSAP - binding site of the sea urchin functions only in transfected B cells as an upstream promoter element.	BSAP,10,14,Gene/Protein	B - cell - specific transcription factor,28,68,Gene/Protein	wild - type,75,86,Gene/Protein	mutant TSAP - binding site,97,123,Gene/Protein	upstream promoter element,186,211,Gene/Protein	"[{""token"": ""BSAP"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific transcription factor"", ""start_span"": 28, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""wild - type"", ""start_span"": 75, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""mutant TSAP - binding site"", ""start_span"": 97, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""upstream promoter element"", ""start_span"": 186, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
This sequence motif is a binding site for nuclear proteins, the so - called octamer transcription factors ( Oct or OTF factors).	sequence motif,5,19,Gene/Protein	nuclear proteins,42,58,Gene/Protein	octamer transcription factors,76,105,Gene/Protein	Oct,108,111,Gene/Protein	OTF factors,115,126,Gene/Protein	"[{""token"": ""sequence motif"", ""start_span"": 5, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""nuclear proteins"", ""start_span"": 42, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""octamer transcription factors"", ""start_span"": 76, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Oct"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""OTF factors"", ""start_span"": 115, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	train
Here we report that the formation of two distinct mitogen - inducible DNA - binding complexes, the kappa B complex within the HIV enhancer and the NFAT - 1 complex within the interleukin - 2 enhancer, is inhibited in the presence of CsA.	mitogen - inducible DNA - binding complexes,50,93,Gene/Protein	kappa B complex,99,114,Gene/Protein	HIV enhancer,126,138,Gene/Protein	NFAT - 1 complex,147,163,Gene/Protein	interleukin - 2 enhancer,175,199,Gene/Protein	"[{""token"": ""mitogen - inducible DNA - binding complexes"", ""start_span"": 50, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""kappa B complex"", ""start_span"": 99, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""HIV enhancer"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""NFAT - 1 complex"", ""start_span"": 147, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 enhancer"", ""start_span"": 175, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
B - cell - specific transcription of this gene was dependent on the octamer element 5 ' - ATGCAAAG - 3 ', located in the upstream region of this promoter and in the promoters of all other immunoglobulin heavy - and light - chain genes.	octamer element,68,83,Gene/Protein	upstream region,121,136,Gene/Protein	promoter,145,153,Gene/Protein	promoters,165,174,Gene/Protein	immunoglobulin heavy - and light - chain genes,188,234,Gene/Protein	"[{""token"": ""octamer element"", ""start_span"": 68, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""upstream region"", ""start_span"": 121, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 165, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin heavy - and light - chain genes"", ""start_span"": 188, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
The interaction of purified octamer transcription factors 1 and 2 ( OTF1 and OTF2) with the MOPC 141 promoter was studied by using electrophoretic mobility shift assays and DNase I footprinting.	octamer transcription factors,28,57,Gene/Protein	OTF1,68,72,Gene/Protein	OTF2,77,81,Gene/Protein	MOPC 141 promoter,92,109,Gene/Protein	DNase I,173,180,Gene/Protein	"[{""token"": ""octamer transcription factors"", ""start_span"": 28, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""OTF1"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""OTF2"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""MOPC 141 promoter"", ""start_span"": 92, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""DNase I"", ""start_span"": 173, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
The N element bound a transcription factor, NTF, that is ubiquitous in cell - type distribution, and NTF was distinct from any of the previously described proteins that bind to similar sequences.	N element,4,13,Gene/Protein	transcription factor,22,42,Gene/Protein	NTF,44,47,Gene/Protein	NTF,101,104,Gene/Protein	previously described proteins,134,163,Gene/Protein	"[{""token"": ""N element"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 22, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""NTF"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""NTF"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""previously described proteins"", ""start_span"": 134, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
The expression of the gene encoding the granulocyte - macrophage colony - stimulating factor ( GM - CSF) is induced upon activation of T cells with phytohemagglutinin and active phorbolester and upon expression of tax1, a transactivating protein of the human T - cell leukemia virus type I.	granulocyte - macrophage colony - stimulating factor,40,92,Gene/Protein	GM - CSF,95,103,Gene/Protein	phytohemagglutinin,148,166,Gene/Protein	tax1,214,218,Gene/Protein	transactivating protein,222,245,Gene/Protein	"[{""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 40, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 95, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""phytohemagglutinin"", ""start_span"": 148, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""tax1"", ""start_span"": 214, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""transactivating protein"", ""start_span"": 222, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
As shown by a methylation interference analysis and oligonucleotide competition experiments, purified NF - kappa B binds at positions - 82 to - 91 ( GGGAACTACC) of the GM - CSF promoter sequence with an affinity similar to that with which it binds to the biologically functional kappa B motif in the beta interferon promoter ( GGGAAATTCC).	NF - kappa B,102,114,Gene/Protein	positions - 82 to - 91,124,146,Gene/Protein	GM - CSF promoter,168,185,Gene/Protein	biologically functional kappa B motif,255,292,Gene/Protein	beta interferon promoter,300,324,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 102, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""positions - 82 to - 91"", ""start_span"": 124, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF promoter"", ""start_span"": 168, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""biologically functional kappa B motif"", ""start_span"": 255, ""end_span"": 292, ""type"": ""Gene/Protein""}, {""token"": ""beta interferon promoter"", ""start_span"": 300, ""end_span"": 324, ""type"": ""Gene/Protein""}]"	train
We hypothesized that adherence itself might be an important trigger for a sequence of gene activation culminating in cells with increased mRNA encoding profibrotic growth factors such as platelet - derived growth factor B subunit ( PDGF [ B]) and transforming growth factor - beta ( TGF - beta).	mRNA,138,142,Gene/Protein	growth factors,164,178,Gene/Protein	platelet - derived growth factor B subunit,187,229,Gene/Protein	transforming growth factor - beta,247,280,Gene/Protein	TGF - beta,283,293,Gene/Protein	"[{""token"": ""mRNA"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""growth factors"", ""start_span"": 164, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""platelet - derived growth factor B subunit"", ""start_span"": 187, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""transforming growth factor - beta"", ""start_span"": 247, ""end_span"": 280, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta"", ""start_span"": 283, ""end_span"": 293, ""type"": ""Gene/Protein""}]"	train
The Epstein - Barr virus ( EBV) BMRF1 promoter for early antigen ( EA - D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell - specific manner.	early antigen,51,64,Gene/Protein	EA - D,67,73,Gene/Protein	EBV transactivators,95,114,Gene/Protein	BRLF1,116,121,Gene/Protein	BZLF1,126,131,Gene/Protein	"[{""token"": ""early antigen"", ""start_span"": 51, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""EA - D"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""EBV transactivators"", ""start_span"": 95, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""BRLF1"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""BZLF1"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}]"	train
In epithelial cells, the Z transactivator alone produced maximal stimulation of the EA - D promoter; the effect of R and Z together was no greater than that of Z alone.	Z transactivator,25,41,Gene/Protein	EA - D promoter,84,99,Gene/Protein	R,115,116,Gene/Protein	Z,121,122,Gene/Protein	Z,160,161,Gene/Protein	"[{""token"": ""Z transactivator"", ""start_span"": 25, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""EA - D promoter"", ""start_span"": 84, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""R"", ""start_span"": 115, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""Z"", ""start_span"": 121, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Z"", ""start_span"": 160, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
After the recent discovery that the cyclosporin A - binding protein cyclophilin is identical to peptidylprolyl cis - trans isomerase, a cellular binding protein for FK506 was found to be distinct from cyclophilin but to have the same enzymatic activity.	cyclosporin A - binding protein,36,67,Gene/Protein	cyclophilin,68,79,Gene/Protein	peptidylprolyl cis - trans isomerase,96,132,Gene/Protein	cellular binding protein,136,160,Gene/Protein	cyclophilin,201,212,Gene/Protein	"[{""token"": ""cyclosporin A - binding protein"", ""start_span"": 36, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""cyclophilin"", ""start_span"": 68, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""peptidylprolyl cis - trans isomerase"", ""start_span"": 96, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""cellular binding protein"", ""start_span"": 136, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""cyclophilin"", ""start_span"": 201, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	train
To determine whether enhancer elements in addition to the highly conserved octamer ( OCTA) - nucleotide motif are important for lymphoid - specific expression of the immunoglobulin heavy - chain ( IgH) gene, we have investigated the effect of mutating the binding site for a putative additional lymphoid - specific transcription factor, designated NF - microB, in the murine IgH enhancer.	enhancer elements,21,38,Gene/Protein	binding site,256,268,Gene/Protein	putative additional lymphoid - specific transcription factor,275,335,Gene/Protein	NF - microB,348,359,Gene/Protein	murine IgH enhancer,368,387,Gene/Protein	"[{""token"": ""enhancer elements"", ""start_span"": 21, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""binding site"", ""start_span"": 256, ""end_span"": 268, ""type"": ""Gene/Protein""}, {""token"": ""putative additional lymphoid - specific transcription factor"", ""start_span"": 275, ""end_span"": 335, ""type"": ""Gene/Protein""}, {""token"": ""NF - microB"", ""start_span"": 348, ""end_span"": 359, ""type"": ""Gene/Protein""}, {""token"": ""murine IgH enhancer"", ""start_span"": 368, ""end_span"": 387, ""type"": ""Gene/Protein""}]"	train
While the HIV - 2 and HIV - 1 tat genes and T - cell activators apparently employ independent modes of action, the CMV transactivator in combination with the HIV - 2 tat or T - cell activators may employ a gene activation pathway with some common and some distinct components.	HIV - 1 tat genes,22,39,Gene/Protein	T - cell activators,44,63,Gene/Protein	CMV transactivator,115,133,Gene/Protein	HIV - 2 tat,158,169,Gene/Protein	T - cell activators,173,192,Gene/Protein	"[{""token"": ""HIV - 1 tat genes"", ""start_span"": 22, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""T - cell activators"", ""start_span"": 44, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""CMV transactivator"", ""start_span"": 115, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 2 tat"", ""start_span"": 158, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""T - cell activators"", ""start_span"": 173, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
Fibronectin synergized with anti - CD3 antibody to promote CD4 cell proliferation in a serum - free culture system whereas no proliferation was observed when CD4 cells were cultured with anti - CD3 alone or fibronectin alone.	Fibronectin,0,11,Gene/Protein	anti - CD3 antibody,28,47,Gene/Protein	CD4,59,62,Gene/Protein	anti - CD3,187,197,Gene/Protein	fibronectin,207,218,Gene/Protein	"[{""token"": ""Fibronectin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3 antibody"", ""start_span"": 28, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 187, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 207, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
In an analysis of the molecular mechanism by which IL - 2 message was generated, we showed that a fibronectin - VLA - 5 fibronectin receptor interaction may contribute an independent signal distinct from the CD3 pathway of activation by the induction of an AP - 1 transcriptional factor.	IL - 2,51,57,Gene/Protein	fibronectin,98,109,Gene/Protein	fibronectin receptor,120,140,Gene/Protein	CD3,208,211,Gene/Protein	AP - 1 transcriptional factor,257,286,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin receptor"", ""start_span"": 120, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 transcriptional factor"", ""start_span"": 257, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	train
Two complementary DNAs were isolated that encode proteins, denoted ITF - 1 and ITF - 2, that are expressed in a variety of cell types and bind the microE5 / kappa 2 motif found in both heavy and kappa light chain enhancers.	complementary DNAs,4,22,Gene/Protein	ITF - 1,67,74,Gene/Protein	ITF - 2,79,86,Gene/Protein	microE5 / kappa 2 motif,147,170,Gene/Protein	heavy and kappa light chain enhancers,185,222,Gene/Protein	"[{""token"": ""complementary DNAs"", ""start_span"": 4, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""ITF - 1"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""ITF - 2"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""microE5 / kappa 2 motif"", ""start_span"": 147, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""heavy and kappa light chain enhancers"", ""start_span"": 185, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
The relationship of the N - Oct proteins to Oct - 1 and Oct - 2A was analyzed by proteolytic clipping bandshift assays and by their reactivity towards antisera raised against recombinant Oct - 1 and Oct - 2A proteins.	N - Oct proteins,24,40,Gene/Protein	Oct - 1,44,51,Gene/Protein	Oct - 2A,56,64,Gene/Protein	Oct - 1,187,194,Gene/Protein	Oct - 2A,199,207,Gene/Protein	"[{""token"": ""N - Oct proteins"", ""start_span"": 24, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2A"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2A"", ""start_span"": 199, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
These results suggest that OTF - 1, without OTF - 2, is sufficient for transcription of immunoglobulin genes and that OTF - 2 alone is not responsible for the B - cell - specific regulation of immunoglobulin gene expression.	OTF - 1,27,34,Gene/Protein	OTF - 2,44,51,Gene/Protein	immunoglobulin genes,88,108,Gene/Protein	OTF - 2,118,125,Gene/Protein	immunoglobulin gene,193,212,Gene/Protein	"[{""token"": ""OTF - 1"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 2"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin genes"", ""start_span"": 88, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""OTF - 2"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin gene"", ""start_span"": 193, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	train
Addition of phosphorothioate oligonucleotides that contained the octamer consensus to Jurkat T leukemia cells inhibited interleukin - 2 ( IL - 2) secretion to a degree similar to that observed with a mutated octamer site in the IL - 2 enhancer.	octamer consensus,65,82,Gene/Protein	interleukin - 2,120,135,Gene/Protein	IL - 2,138,144,Gene/Protein	mutated octamer site,200,220,Gene/Protein	IL - 2 enhancer,228,243,Gene/Protein	"[{""token"": ""octamer consensus"", ""start_span"": 65, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 120, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""mutated octamer site"", ""start_span"": 200, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 enhancer"", ""start_span"": 228, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
Several lines of evidence are compatible with the hypothesis that Epstein - Barr virus ( EBV) nuclear antigen 2 ( EBNA - 2) or leader protein ( EBNA - LP) affects expression of the EBV latent infection membrane protein LMP1.	EBNA - 2,114,122,Gene/Protein	leader protein,127,141,Gene/Protein	EBNA - LP,144,153,Gene/Protein	EBV latent infection membrane protein,181,218,Gene/Protein	LMP1,219,223,Gene/Protein	"[{""token"": ""EBNA - 2"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""leader protein"", ""start_span"": 127, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""EBNA - LP"", ""start_span"": 144, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""EBV latent infection membrane protein"", ""start_span"": 181, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 219, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
The carboxy - terminal half of the HBx protein was preferentially recognized by antibodies from patients with chronic hepatitis and contained a short immunodominant antigenic region with at least two major nonoverlapping epitopes.	carboxy - terminal half,4,27,Gene/Protein	HBx protein,35,46,Gene/Protein	antibodies,80,90,Gene/Protein	immunodominant antigenic region,150,181,Gene/Protein	nonoverlapping epitopes,206,229,Gene/Protein	"[{""token"": ""carboxy - terminal half"", ""start_span"": 4, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""HBx protein"", ""start_span"": 35, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 80, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""immunodominant antigenic region"", ""start_span"": 150, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""nonoverlapping epitopes"", ""start_span"": 206, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
In the DRA promoter, one of these cis - acting regulatory motifs is the X2 - box to which nuclear factor X2 ( NF - X2) binds.	DRA promoter,7,19,Gene/Protein	cis - acting regulatory motifs,34,64,Gene/Protein	X2 - box,72,80,Gene/Protein	nuclear factor X2,90,107,Gene/Protein	NF - X2,110,117,Gene/Protein	"[{""token"": ""DRA promoter"", ""start_span"": 7, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""cis - acting regulatory motifs"", ""start_span"": 34, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""X2 - box"", ""start_span"": 72, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor X2"", ""start_span"": 90, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""NF - X2"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
This cDNA clone was isolated by expression cDNA cloning, and encodes the human c - Jun protein, which together with c - Fos forms the heterodimeric activator protein - 1 transcription complex.	cDNA clone,5,15,Gene/Protein	cDNA,43,47,Gene/Protein	human c - Jun protein,73,94,Gene/Protein	c - Fos,116,123,Gene/Protein	heterodimeric activator protein - 1 transcription complex,134,191,Gene/Protein	"[{""token"": ""cDNA clone"", ""start_span"": 5, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""cDNA"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""human c - Jun protein"", ""start_span"": 73, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""heterodimeric activator protein - 1 transcription complex"", ""start_span"": 134, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
In this work we show that the monoclonal antibody KN 382 / EC1 raised against the rabbit 59 - kDa protein reacts with 9S, untransformed glucocorticoid receptor complexes in cytosol prepared from human IM - 9 lymphocytes but not with 4S salt - transformed receptors.	monoclonal antibody KN 382 / EC1,30,62,Gene/Protein	rabbit 59 - kDa protein,82,105,Gene/Protein	9S,118,120,Gene/Protein	untransformed glucocorticoid receptor complexes,122,169,Gene/Protein	4S salt - transformed receptors,233,264,Gene/Protein	"[{""token"": ""monoclonal antibody KN 382 / EC1"", ""start_span"": 30, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""rabbit 59 - kDa protein"", ""start_span"": 82, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""9S"", ""start_span"": 118, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""untransformed glucocorticoid receptor complexes"", ""start_span"": 122, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""4S salt - transformed receptors"", ""start_span"": 233, ""end_span"": 264, ""type"": ""Gene/Protein""}]"	train
The cDNA sequence has an 813 - bp open reading frame ( ORF) whose predicted amino acid sequence is 97. 6% identical to the 272 carboxy - terminal amino acids of the human ets - 1 protein.	cDNA sequence,4,17,Gene/Protein	813 - bp open reading frame,25,52,Gene/Protein	ORF,55,58,Gene/Protein	272 carboxy - terminal amino acids,123,157,Gene/Protein	human ets - 1 protein,165,186,Gene/Protein	"[{""token"": ""cDNA sequence"", ""start_span"": 4, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""813 - bp open reading frame"", ""start_span"": 25, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""ORF"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""272 carboxy - terminal amino acids"", ""start_span"": 123, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""human ets - 1 protein"", ""start_span"": 165, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
B - cell - specific activator protein ( BSAP) is a recently identified member of the Pax - gene family of transcription factors; in the lymphoid system, BSAP is produced only in B cells.	B - cell - specific activator protein,0,37,Gene/Protein	BSAP,40,44,Gene/Protein	Pax - gene family,85,102,Gene/Protein	transcription factors,106,127,Gene/Protein	BSAP,153,157,Gene/Protein	"[{""token"": ""B - cell - specific activator protein"", ""start_span"": 0, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Pax - gene family"", ""start_span"": 85, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 106, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
The MZF - 1 protein contains 13 C2H2 zinc fingers arranged in bipartite DNA binding domains containing zinc fingers through 4 and, in the carboxy - terminus, 5 through 13.	MZF - 1,4,11,Gene/Protein	C2H2 zinc fingers,32,49,Gene/Protein	DNA binding domains,72,91,Gene/Protein	zinc fingers,103,115,Gene/Protein	carboxy - terminus,138,156,Gene/Protein	"[{""token"": ""MZF - 1"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""C2H2 zinc fingers"", ""start_span"": 32, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding domains"", ""start_span"": 72, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""zinc fingers"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""carboxy - terminus"", ""start_span"": 138, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
HSF exhibits the properties of a transcriptional activator, as judged from the stimulatory activity of transiently overexpressed HSF3 measured by using a heat shock element - containing reporter construct and as independently assayed by the activity of a chimeric GAL4 - HSF3 protein on a GAL4 reporter construct.	transcriptional activator,33,58,Gene/Protein	transiently overexpressed HSF3,103,133,Gene/Protein	heat shock element - containing reporter construct,154,204,Gene/Protein	chimeric GAL4 - HSF3 protein,255,283,Gene/Protein	GAL4 reporter construct,289,312,Gene/Protein	"[{""token"": ""transcriptional activator"", ""start_span"": 33, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""transiently overexpressed HSF3"", ""start_span"": 103, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""heat shock element - containing reporter construct"", ""start_span"": 154, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""chimeric GAL4 - HSF3 protein"", ""start_span"": 255, ""end_span"": 283, ""type"": ""Gene/Protein""}, {""token"": ""GAL4 reporter construct"", ""start_span"": 289, ""end_span"": 312, ""type"": ""Gene/Protein""}]"	train
We report here that the nuclear factor of activated T cells ( NFATp), a cyclosporin A ( CsA) - sensitive factor that regulates the transcription of several cytokines, mediates CD16 - induced activation of cytokine genes in human NK cells.	nuclear factor,24,38,Gene/Protein	NFATp,62,67,Gene/Protein	cytokines,156,165,Gene/Protein	CD16,176,180,Gene/Protein	cytokine genes,205,219,Gene/Protein	"[{""token"": ""nuclear factor"", ""start_span"": 24, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 156, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 205, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
These results provide the first direct evidence that both CsA - sensitive transcription factors, NFATp and NFATc, are expressed in human NK cells, and that their activation and / or expression can be regulated in primary cells by a single stimulus, that, in the case of CD16 in NK cells, results in early activation of NFATp and subsequently induced expression of NFATc mRNA.	CsA - sensitive transcription factors,58,95,Gene/Protein	NFATp,97,102,Gene/Protein	NFATc,107,112,Gene/Protein	NFATp,319,324,Gene/Protein	NFATc mRNA,364,374,Gene/Protein	"[{""token"": ""CsA - sensitive transcription factors"", ""start_span"": 58, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""NFATc"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 319, ""end_span"": 324, ""type"": ""Gene/Protein""}, {""token"": ""NFATc mRNA"", ""start_span"": 364, ""end_span"": 374, ""type"": ""Gene/Protein""}]"	train
p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 ( SH2) domain, but otherwise are immunologically distinct from Stat1.	p94,0,3,Gene/Protein	p95,8,11,Gene/Protein	Stat1,32,37,Gene/Protein	phosphorylation site,45,65,Gene/Protein	Stat1,155,160,Gene/Protein	"[{""token"": ""p94"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""p95"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""phosphorylation site"", ""start_span"": 45, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
Thus, after 4 hr of exposure to SEA and SEB, the expression of IL - 2R beta was down - regulated, IL - 2R gamma was slightly up - regulated, while IL - 2R alpha remained largely unaffected.	SEA,32,35,Gene/Protein	SEB,40,43,Gene/Protein	IL - 2R beta,63,75,Gene/Protein	IL - 2R gamma,98,111,Gene/Protein	IL - 2R alpha,147,160,Gene/Protein	"[{""token"": ""SEA"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""SEB"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 63, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R gamma"", ""start_span"": 98, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 147, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
Transcription factors belonging to the NF - kappa B family are controlled by inhibitory I kappa B proteins, mainly I kappa B alpha and I kappa B beta.	Transcription factors,0,21,Gene/Protein	NF - kappa B family,39,58,Gene/Protein	inhibitory I kappa B proteins,77,106,Gene/Protein	I kappa B alpha,115,130,Gene/Protein	I kappa B beta,135,149,Gene/Protein	"[{""token"": ""Transcription factors"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B family"", ""start_span"": 39, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""inhibitory I kappa B proteins"", ""start_span"": 77, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B beta"", ""start_span"": 135, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
Additionally, it inhibited the production of LTB4 ( IC50 = 0. 5 microM) and the cytokines IL - 2, IL - 6 and TNF alpha ( IC50 = 10 - 12 microM).	LTB4,45,49,Gene/Protein	cytokines,80,89,Gene/Protein	IL - 2,90,96,Gene/Protein	IL - 6,98,104,Gene/Protein	TNF alpha,109,118,Gene/Protein	"[{""token"": ""LTB4"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 80, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 90, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""TNF alpha"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Gene/Protein""}]"	train
This requirement has been attributed to the activation of the transcription factor NF - kappa B, which synergizes with the constitutive transcription factor Sp1 to drive the HIV - 1 promoter.	transcription factor,62,82,Gene/Protein	NF - kappa B,83,95,Gene/Protein	constitutive transcription factor,123,156,Gene/Protein	Sp1,157,160,Gene/Protein	HIV - 1 promoter,174,190,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 62, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 83, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""constitutive transcription factor"", ""start_span"": 123, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 promoter"", ""start_span"": 174, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
DCs express high levels of all known NF - kappa B and Rel proteins, with activity residing primarily within RelB, p50, and p65.	NF - kappa B,37,49,Gene/Protein	Rel proteins,54,66,Gene/Protein	RelB,108,112,Gene/Protein	p50,114,117,Gene/Protein	p65,123,126,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Rel proteins"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	train
The sequence of one of these elements, OSE2, is identical to the DNA - binding site of the PEBP2 alpha / AML - 1 transcription factors, the mammalian homologues of the Drosophila Runt protein.	elements,29,37,Gene/Protein	DNA - binding site,65,83,Gene/Protein	PEBP2 alpha / AML - 1 transcription factors,91,134,Gene/Protein	mammalian homologues,140,160,Gene/Protein	Drosophila Runt protein,168,191,Gene/Protein	"[{""token"": ""elements"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding site"", ""start_span"": 65, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2 alpha / AML - 1 transcription factors"", ""start_span"": 91, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""mammalian homologues"", ""start_span"": 140, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""Drosophila Runt protein"", ""start_span"": 168, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
Initiation binding repressor, a factor that binds to the transcription initiation site of the histone h5 gene, is a glycosylated member of a family of cell growth regulators [ corrected] [ published erratum appears in Mol Cell Biol 1996 Feb; 16 ( 2): 735]	Initiation binding repressor,0,28,Gene/Protein	transcription initiation site,57,86,Gene/Protein	histone h5 gene,94,109,Gene/Protein	glycosylated member,116,135,Gene/Protein	cell growth regulators,151,173,Gene/Protein	"[{""token"": ""Initiation binding repressor"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""transcription initiation site"", ""start_span"": 57, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""histone h5 gene"", ""start_span"": 94, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""glycosylated member"", ""start_span"": 116, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""cell growth regulators"", ""start_span"": 151, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Initiation binding repressor [ corrected] ( IBR) is a chicken erythrocyte factor ( apparent molecular mass, 70 to 73 kDa) that binds to the sequences spanning the transcription initiation site of the histone h5 gene, repressing its transcription.	Initiation binding repressor,0,28,Gene/Protein	IBR,44,47,Gene/Protein	chicken erythrocyte factor,54,80,Gene/Protein	transcription initiation site,163,192,Gene/Protein	histone h5 gene,200,215,Gene/Protein	"[{""token"": ""Initiation binding repressor"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""IBR"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""chicken erythrocyte factor"", ""start_span"": 54, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""transcription initiation site"", ""start_span"": 163, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""histone h5 gene"", ""start_span"": 200, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
The evolutionarily conserved N - terminal half of IBR / F harbors the DNA - binding / dimerization domain ( outer limits, 127 to 283), one or several casein kinase II sites ( 37 to 67), and a bipartite nuclear localization signal ( 89 to 106) which appears to be necessary for nuclear targeting.	N - terminal half,29,46,Gene/Protein	IBR / F,50,57,Gene/Protein	DNA - binding / dimerization domain,70,105,Gene/Protein	casein kinase II sites,150,172,Gene/Protein	bipartite nuclear localization signal,192,229,Gene/Protein	"[{""token"": ""N - terminal half"", ""start_span"": 29, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""IBR / F"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding / dimerization domain"", ""start_span"": 70, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""casein kinase II sites"", ""start_span"": 150, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""bipartite nuclear localization signal"", ""start_span"": 192, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
We also found that tumor necrosis factor - alpha ( TNF - alpha) is capable of inducing the surface expression of the CD69 molecule as well as the promoter activity of fusion plasmids that contain 5 ' - flanking sequences of the CD69 gene, suggesting that this cytokine may regulate in vivo the expression of CD69.	tumor necrosis factor - alpha,19,48,Gene/Protein	TNF - alpha,51,62,Gene/Protein	CD69,117,121,Gene/Protein	CD69,228,232,Gene/Protein	CD69,308,312,Gene/Protein	"[{""token"": ""tumor necrosis factor - alpha"", ""start_span"": 19, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CD69"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""CD69"", ""start_span"": 228, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""CD69"", ""start_span"": 308, ""end_span"": 312, ""type"": ""Gene/Protein""}]"	train
A major transcription initiation site was located in three human tissues approximately 560 bp upstream from the translation initiation codon and 380 bp upstream from any previously identified transcription initiation site.	transcription initiation site,8,37,Gene/Protein	560 bp upstream,87,102,Gene/Protein	translation initiation codon,112,140,Gene/Protein	380 bp upstream,145,160,Gene/Protein	transcription initiation site,192,221,Gene/Protein	"[{""token"": ""transcription initiation site"", ""start_span"": 8, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""560 bp upstream"", ""start_span"": 87, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""translation initiation codon"", ""start_span"": 112, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""380 bp upstream"", ""start_span"": 145, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""transcription initiation site"", ""start_span"": 192, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
Mutational analyses of I kappa B alpha and competition experiments with the synthetic peptides identified major phosphorylation sites by the bound kinase as Ser and Thr residues in the C - terminal acidic domain of I kappa B alpha.	I kappa B,23,32,Gene/Protein	phosphorylation sites,112,133,Gene/Protein	kinase,147,153,Gene/Protein	C - terminal acidic domain,185,211,Gene/Protein	I kappa B alpha,215,230,Gene/Protein	"[{""token"": ""I kappa B"", ""start_span"": 23, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""phosphorylation sites"", ""start_span"": 112, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""kinase"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal acidic domain"", ""start_span"": 185, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 215, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
These results suggested that the bound kinase is involved in the signaling pathway of LPS by inducing the phosphorylation of the C - terminal region of I kappa B alpha and subsequent dissociation of the NF - kappa B. I kappa B alpha complex.	bound kinase,33,45,Gene/Protein	C - terminal region,129,148,Gene/Protein	I kappa B alpha,152,167,Gene/Protein	NF - kappa B,203,215,Gene/Protein	I kappa B alpha complex,217,240,Gene/Protein	"[{""token"": ""bound kinase"", ""start_span"": 33, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal region"", ""start_span"": 129, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 152, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 203, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha complex"", ""start_span"": 217, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	train
In transient transfection assays, Bik promotes cell death in a manner similar to the death - promoting members of the Bcl - 2 family, Bax and Bak.	Bik,34,37,Gene/Protein	death - promoting members,85,110,Gene/Protein	Bcl - 2 family,118,132,Gene/Protein	Bax,134,137,Gene/Protein	Bak,142,145,Gene/Protein	"[{""token"": ""Bik"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""death - promoting members"", ""start_span"": 85, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2 family"", ""start_span"": 118, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""Bax"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Bak"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	train
Here we report that cross - linking of Fc gamma RI or Fc gamma RII by adherent human IgG or by specific anti - Fc gamma R mAb activates HIV - 1 gene expression in the human monocytic cell line BF24 and increased HIV RNA expression in monocytes from HIV infected patients as assayed by reverse transcription - PCR.	Fc gamma RI,39,50,Gene/Protein	Fc gamma RII,54,66,Gene/Protein	adherent human IgG,70,88,Gene/Protein	anti - Fc gamma R mAb,104,125,Gene/Protein	HIV RNA,212,219,Gene/Protein	"[{""token"": ""Fc gamma RI"", ""start_span"": 39, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""Fc gamma RII"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""adherent human IgG"", ""start_span"": 70, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""anti - Fc gamma R mAb"", ""start_span"": 104, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""HIV RNA"", ""start_span"": 212, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Cis - acting elements with NF kappa B, AP - 1 and ETS - like motifs have been identified in the promoter region of the GM - CSF gene, which are important for transcriptional activity following PMA and ionomycin stimulation.	Cis - acting elements,0,21,Gene/Protein	NF kappa B,27,37,Gene/Protein	AP - 1,39,45,Gene/Protein	ETS - like motifs,50,67,Gene/Protein	GM - CSF gene,119,132,Gene/Protein	"[{""token"": ""Cis - acting elements"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 27, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""ETS - like motifs"", ""start_span"": 50, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF gene"", ""start_span"": 119, ""end_span"": 132, ""type"": ""Gene/Protein""}]"	train
A strong repressor element, termed nuclear inhibitory protein ( NIP), was previously mapped to a segment of the IL - 3 promoter between nucleotides - 271 and - 250.	repressor element,9,26,Gene/Protein	nuclear inhibitory protein,35,61,Gene/Protein	NIP,64,67,Gene/Protein	IL - 3 promoter,112,127,Gene/Protein	nucleotides - 271 and - 250,136,163,Gene/Protein	"[{""token"": ""repressor element"", ""start_span"": 9, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""nuclear inhibitory protein"", ""start_span"": 35, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""NIP"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3 promoter"", ""start_span"": 112, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""nucleotides - 271 and - 250"", ""start_span"": 136, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
Nuclear factor of activated T cells ( NFAT) was originally described as a T - cell - specific transcription factor athat supported the activation of cytokine gene expression and mediated the immunoregulatory effects of cyclosporin A ( CsA).	Nuclear factor of activated T cells,0,35,Gene/Protein	NFAT,38,42,Gene/Protein	T - cell - specific transcription factor,74,114,Gene/Protein	cytokine,149,157,Gene/Protein	immunoregulatory,191,207,Gene/Protein	"[{""token"": ""Nuclear factor of activated T cells"", ""start_span"": 0, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""T - cell - specific transcription factor"", ""start_span"": 74, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 149, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""immunoregulatory"", ""start_span"": 191, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
The lymphoid - specific transcription factor Oct - 2a contains two transcriptional activation domains which are located within the N - terminal and C - terminal regions.	lymphoid - specific transcription factor,4,44,Gene/Protein	Oct - 2a,45,53,Gene/Protein	transcriptional activation domains,67,101,Gene/Protein	N - terminal,131,143,Gene/Protein	C - terminal regions,148,168,Gene/Protein	"[{""token"": ""lymphoid - specific transcription factor"", ""start_span"": 4, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2a"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activation domains"", ""start_span"": 67, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal"", ""start_span"": 131, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal regions"", ""start_span"": 148, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
A pair of restriction fragment length polymorphisms ( RFLPs), one of which hybridizes to the TCR constant region C beta 1 and the other to the C beta 2 gene, has been identified, suggesting these may be genotypic markers for an extended region of the TCR beta locus.	restriction fragment length polymorphisms,10,51,Gene/Protein	RFLPs,54,59,Gene/Protein	TCR constant region C beta 1,93,121,Gene/Protein	C beta 2 gene,143,156,Gene/Protein	TCR beta locus,251,265,Gene/Protein	"[{""token"": ""restriction fragment length polymorphisms"", ""start_span"": 10, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""RFLPs"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""TCR constant region C beta 1"", ""start_span"": 93, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""C beta 2 gene"", ""start_span"": 143, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""TCR beta locus"", ""start_span"": 251, ""end_span"": 265, ""type"": ""Gene/Protein""}]"	train
This phenomenon is due to mutually exclusive binding of NF - ATp and NF - kappa B to the P sequence, an element located 69 bp upstream of the IL4 transcription initiation site.	NF - ATp,56,64,Gene/Protein	NF - kappa B,69,81,Gene/Protein	P sequence,89,99,Gene/Protein	69 bp upstream,120,134,Gene/Protein	IL4 transcription initiation site,142,175,Gene/Protein	"[{""token"": ""NF - ATp"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 69, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""P sequence"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""69 bp upstream"", ""start_span"": 120, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""IL4 transcription initiation site"", ""start_span"": 142, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
Thus, competition between two general transcriptional activators, RelA and NF - ATp, mediates the inhibitory effect of protein kinase C stimulation on IL4 expression and may contribute to differential gene expression in TH cells.	transcriptional activators,38,64,Gene/Protein	RelA,66,70,Gene/Protein	NF - ATp,75,83,Gene/Protein	protein kinase C,119,135,Gene/Protein	IL4,151,154,Gene/Protein	"[{""token"": ""transcriptional activators"", ""start_span"": 38, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATp"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 119, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""IL4"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
SFs blocked the sustained activity of transcription factor Stat1, but not Stat3, during the priming period, and Stat1 activity was differentially regulated by cytokines in parallel with their positive or negative regulation of IFN - gamma production.	transcription factor Stat1,38,64,Gene/Protein	Stat3,74,79,Gene/Protein	Stat1,112,117,Gene/Protein	cytokines,159,168,Gene/Protein	IFN - gamma,227,238,Gene/Protein	"[{""token"": ""transcription factor Stat1"", ""start_span"": 38, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 159, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 227, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	train
The effect of LPS and TNF - alpha is mediated by their ability to induce nuclear translocation of the DNA - binding heterodimer NF - kappa B ( p50 / p65), which binds to a specific sequence in the HIV - long terminal repeat.	TNF - alpha,22,33,Gene/Protein	DNA - binding heterodimer,102,127,Gene/Protein	NF - kappa B,128,140,Gene/Protein	p50 / p65,143,152,Gene/Protein	HIV - long terminal repeat,197,223,Gene/Protein	"[{""token"": ""TNF - alpha"", ""start_span"": 22, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding heterodimer"", ""start_span"": 102, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""p50 / p65"", ""start_span"": 143, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""HIV - long terminal repeat"", ""start_span"": 197, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
A naturally occurring mutation ( - 175 T - C) in the area bound by HMG - I results in overexpression of gamma - globin in adult red blood cells ( HPFH) and up - regulation of the gamma - globin promoter in in vitro expression assays; HMG - I does not bind to this mutant sequence.	HMG - I,67,74,Gene/Protein	gamma - globin,104,118,Gene/Protein	gamma - globin promoter,179,202,Gene/Protein	HMG - I,234,241,Gene/Protein	mutant sequence,264,279,Gene/Protein	"[{""token"": ""HMG - I"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""gamma - globin"", ""start_span"": 104, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""gamma - globin promoter"", ""start_span"": 179, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""HMG - I"", ""start_span"": 234, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""mutant sequence"", ""start_span"": 264, ""end_span"": 279, ""type"": ""Gene/Protein""}]"	train
Treatment of T cells with the selective PKC inhibitor GF109203X abrogates the PMA - induced IkB alpha phosphorylation / degradation irrespective of activation of Ca ( 2 +) - dependent pathways, but not the phosphorylation and degradation of IkB alpha induced by TNF - alpha, a PKC - independent stimulus.	PKC,40,43,Gene/Protein	IkB alpha,92,101,Gene/Protein	IkB alpha,241,250,Gene/Protein	TNF - alpha,262,273,Gene/Protein	PKC,277,280,Gene/Protein	"[{""token"": ""PKC"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""IkB alpha"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IkB alpha"", ""start_span"": 241, ""end_span"": 250, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 262, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 277, ""end_span"": 280, ""type"": ""Gene/Protein""}]"	train
These results indicate that Ca ( 2 +) - dependent pathways, including the phosphatase calcineurin, participate in the regulation of NF - kappa B in a cell specific fashion and synergize with PKC - dependent and - independent pathways at the level of IkB alpha phosphorylation and degradation.	phosphatase,74,85,Gene/Protein	calcineurin,86,97,Gene/Protein	NF - kappa B,132,144,Gene/Protein	PKC,191,194,Gene/Protein	IkB alpha,250,259,Gene/Protein	"[{""token"": ""phosphatase"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 132, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""IkB alpha"", ""start_span"": 250, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	train
We show that the expression of four cell genes, cdc - 2, cyclin E, CD23, and cyclin D2, are up - regulated approximately 100 - fold as a result of EBV - mediated immortalization.	cell genes,36,46,Gene/Protein	cdc - 2,48,55,Gene/Protein	cyclin E,57,65,Gene/Protein	CD23,67,71,Gene/Protein	cyclin D2,77,86,Gene/Protein	"[{""token"": ""cell genes"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""cdc - 2"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""cyclin E"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""cyclin D2"", ""start_span"": 77, ""end_span"": 86, ""type"": ""Gene/Protein""}]"	train
In our attempt to identify chemokine receptors that are related to Burkitt ' s lymphoma receptor 1 ( BLR1) and are expressed in activated lymphocytes we used RT - PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2.	chemokine receptors,27,46,Gene/Protein	Burkitt ' s lymphoma receptor 1,67,98,Gene/Protein	BLR1,101,105,Gene/Protein	seven transmembrane receptor,215,243,Gene/Protein	BLR2,251,255,Gene/Protein	"[{""token"": ""chemokine receptors"", ""start_span"": 27, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""Burkitt ' s lymphoma receptor 1"", ""start_span"": 67, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""BLR1"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""seven transmembrane receptor"", ""start_span"": 215, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""BLR2"", ""start_span"": 251, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
In Jurkat T cells, the ZIP site serves as an activator for IL - 2 gene expression, and a combination of ZIP and NFAT binding sites is required for maximal IL - 2 promoter activity.	ZIP site,23,31,Gene/Protein	IL - 2,59,65,Gene/Protein	ZIP,104,107,Gene/Protein	NFAT binding sites,112,130,Gene/Protein	IL - 2 promoter,155,170,Gene/Protein	"[{""token"": ""ZIP site"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""ZIP"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""NFAT binding sites"", ""start_span"": 112, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 155, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
First, we show that mutations in the LEF - 1 - binding site inhibit the activity of multimerized copies of the HIV - 1 enhancer in Jurkat T cells, and that LEF - 1 / GAL4 can activate a GAL4 - substituted HIV - 1 enhancer 80 - to 100 - fold in vivo.	LEF - 1 - binding site,37,59,Gene/Protein	multimerized copies,84,103,Gene/Protein	HIV - 1 enhancer,111,127,Gene/Protein	LEF - 1 / GAL4,156,170,Gene/Protein	GAL4 - substituted HIV - 1 enhancer,186,221,Gene/Protein	"[{""token"": ""LEF - 1 - binding site"", ""start_span"": 37, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""multimerized copies"", ""start_span"": 84, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 enhancer"", ""start_span"": 111, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1 / GAL4"", ""start_span"": 156, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""GAL4 - substituted HIV - 1 enhancer"", ""start_span"": 186, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
Individually or collectively, none of the three enhancer - binding proteins ( LEF - 1, Ets - 1, and TFE - 3) could activate transcription in the absence of Sp1.	enhancer - binding proteins,48,75,Gene/Protein	LEF - 1,78,85,Gene/Protein	Ets - 1,87,94,Gene/Protein	TFE - 3,100,107,Gene/Protein	Sp1,156,159,Gene/Protein	"[{""token"": ""enhancer - binding proteins"", ""start_span"": 48, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""Ets - 1"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""TFE - 3"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
The stimulatory effects of gp160 are mediated through the CD4 molecule, since treatment of gp160 with soluble CD4 - IgG abrogates its activity, and CD4 negative T cell lines fail to be stimulated with gp160.	gp160,27,32,Gene/Protein	CD4 molecule,58,70,Gene/Protein	gp160,91,96,Gene/Protein	CD4 - IgG,110,119,Gene/Protein	gp160,201,206,Gene/Protein	"[{""token"": ""gp160"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""CD4 molecule"", ""start_span"": 58, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""gp160"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""CD4 - IgG"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""gp160"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
Transient transfection experiments show that several elements in the promoter - proximal region of the IL - 2R alpha gene contribute to IL - 1 responsiveness, most importantly an NF - kappa B site conserved in the human and mouse gene.	promoter - proximal region,69,95,Gene/Protein	IL - 2R alpha gene,103,121,Gene/Protein	IL - 1,136,142,Gene/Protein	NF - kappa B site,179,196,Gene/Protein	human and mouse gene,214,234,Gene/Protein	"[{""token"": ""promoter - proximal region"", ""start_span"": 69, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha gene"", ""start_span"": 103, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 179, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""human and mouse gene"", ""start_span"": 214, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
In addition, when used together IL - 2 and IL - 12 synergized in the induction of IFN - gamma and GM - CSF and this synergy was attributed to an increased accumulation and stability of the IFN - gamma and GM - CSF mRNAs.	IL - 2,32,38,Gene/Protein	IL - 12,43,50,Gene/Protein	IFN - gamma,82,93,Gene/Protein	GM - CSF,98,106,Gene/Protein	IFN - gamma and GM - CSF mRNAs,189,219,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma and GM - CSF mRNAs"", ""start_span"": 189, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Since the terminal events of erythropoiesis are controlled by the glycoprotein hormone erythropoietin ( Epo), we investigated whether the expression or activity of the TAL1 gene and its protein products were affected by Epo in splenic erythroblasts from mice infected with an anemia - inducing strain of Friend virus ( FVA cells).	glycoprotein hormone erythropoietin,66,101,Gene/Protein	Epo,104,107,Gene/Protein	TAL1 gene,168,177,Gene/Protein	protein products,186,202,Gene/Protein	Epo,220,223,Gene/Protein	"[{""token"": ""glycoprotein hormone erythropoietin"", ""start_span"": 66, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Epo"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""TAL1 gene"", ""start_span"": 168, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""protein products"", ""start_span"": 186, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""Epo"", ""start_span"": 220, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
The deduced amino acid sequence similarity to the proteins encoded by these two latter genes is approximately 65% and includes domains and amino acid residues ( the leucine zipper - like and the RGD domain, a serine and a histidine residue in the NH2 - and in the COOH - terminal portion of the protein, respectively) postulated to be important for nm23 function.	leucine zipper - like,165,186,Gene/Protein	RGD domain,195,205,Gene/Protein	NH2 -,247,252,Gene/Protein	COOH - terminal portion,264,287,Gene/Protein	nm23,349,353,Gene/Protein	"[{""token"": ""leucine zipper - like"", ""start_span"": 165, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""RGD domain"", ""start_span"": 195, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""NH2 -"", ""start_span"": 247, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""COOH - terminal portion"", ""start_span"": 264, ""end_span"": 287, ""type"": ""Gene/Protein""}, {""token"": ""nm23"", ""start_span"": 349, ""end_span"": 353, ""type"": ""Gene/Protein""}]"	train
We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ human interleukin - 2, - 4, - 5 and - 13 and human and mouse granulocyte / macrophage - colony stimulating factor ( GM - CSF)].	conserved motif,31,46,Gene/Protein	promoters,54,63,Gene/Protein	T - cell - expressed cytokines,75,105,Gene/Protein	human and mouse granulocyte / macrophage - colony stimulating factor,153,221,Gene/Protein	GM - CSF,224,232,Gene/Protein	"[{""token"": ""conserved motif"", ""start_span"": 31, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""T - cell - expressed cytokines"", ""start_span"": 75, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""human and mouse granulocyte / macrophage - colony stimulating factor"", ""start_span"": 153, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 224, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	train
Together, these results suggest that phosphorylation of I kappa B alpha, mediated through both the TNF - alpha - inducible and the PP - 2A - opposing kinases, may serve to target I kappa B alpha for proteasome - mediated degradation.	I kappa B alpha,56,71,Gene/Protein	TNF - alpha,99,110,Gene/Protein	PP - 2A - opposing kinases,131,157,Gene/Protein	I kappa B alpha,179,194,Gene/Protein	proteasome,199,209,Gene/Protein	"[{""token"": ""I kappa B alpha"", ""start_span"": 56, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""PP - 2A - opposing kinases"", ""start_span"": 131, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 179, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""proteasome"", ""start_span"": 199, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
The Ah receptor recognizes DNA binding sites for the B cell transcription factor, BSAP: a possible mechanism for dioxin - mediated alteration of CD19 gene expression in human B lymphocytes.	Ah receptor,4,15,Gene/Protein	DNA binding sites,27,44,Gene/Protein	B cell transcription factor,53,80,Gene/Protein	BSAP,82,86,Gene/Protein	CD19 gene,145,154,Gene/Protein	"[{""token"": ""Ah receptor"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding sites"", ""start_span"": 27, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""B cell transcription factor"", ""start_span"": 53, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""CD19 gene"", ""start_span"": 145, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
This observation, together with the fact that both GM - CSF and IL - 2 respond to TCR signals via NFAT, implies a high degree of conservation in the regulation of cytokine gene expression in T cells.	GM - CSF,51,59,Gene/Protein	IL - 2,64,70,Gene/Protein	TCR,82,85,Gene/Protein	NFAT,98,102,Gene/Protein	cytokine,163,171,Gene/Protein	"[{""token"": ""GM - CSF"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
IL - 10 treatment of both T cells and monocytes results in the ligand - induced tyrosine phosphorylation of tyk2 and Jak1, but not Jak2 or Jak3.	IL - 10,0,7,Gene/Protein	tyk2,108,112,Gene/Protein	Jak1,117,121,Gene/Protein	Jak2,131,135,Gene/Protein	Jak3,139,143,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""tyk2"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Jak2"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	train
Alanine substitutions introduced at two serine residues positioned within this N - terminal regulatory region of I kappa B alpha also yielded constitutive repressors that escaped from Tax - induced turnover and that potently inhibited immune activation pathways for NF - kappa B induction, including those initiated from antigen and cytokine receptors.	N - terminal regulatory region,79,109,Gene/Protein	I kappa B alpha,113,128,Gene/Protein	Tax,184,187,Gene/Protein	NF - kappa B,266,278,Gene/Protein	antigen and cytokine receptors,321,351,Gene/Protein	"[{""token"": ""N - terminal regulatory region"", ""start_span"": 79, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 113, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 266, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""antigen and cytokine receptors"", ""start_span"": 321, ""end_span"": 351, ""type"": ""Gene/Protein""}]"	train
Human peripheral blood monocytes responded to stimulation of platelet - activating factor ( PAF) with up - regulation of the transcript for heparin - binding epidermal growth factor - like growth factor ( HB - EGF), a potent mitogen for vascular smooth muscle cells.	platelet - activating factor,61,89,Gene/Protein	PAF,92,95,Gene/Protein	heparin - binding epidermal growth factor - like growth factor,140,202,Gene/Protein	HB - EGF,205,213,Gene/Protein	potent mitogen,218,232,Gene/Protein	"[{""token"": ""platelet - activating factor"", ""start_span"": 61, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""heparin - binding epidermal growth factor - like growth factor"", ""start_span"": 140, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""HB - EGF"", ""start_span"": 205, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""potent mitogen"", ""start_span"": 218, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	train
These functions of PAF appeared to be mediated through the cell surface PAF receptors, as two PAF receptor antagonists, WEB 2086 and L - 659, 989, blocked both the up - regulation of HB - EGF mRNA and kappa B binding activity induced by PAF.	PAF,19,22,Gene/Protein	cell surface PAF receptors,59,85,Gene/Protein	PAF,94,97,Gene/Protein	HB - EGF mRNA,183,196,Gene/Protein	PAF,237,240,Gene/Protein	"[{""token"": ""PAF"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""cell surface PAF receptors"", ""start_span"": 59, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""HB - EGF mRNA"", ""start_span"": 183, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 237, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	train
ZEBRA is a bZIP transcriptional activator which binds as a dimer to 7 - bp response elements within EBV promoters and is directly involved in the stimulation of virus replication at the EBV lytic origin.	ZEBRA,0,5,Gene/Protein	bZIP transcriptional activator,11,41,Gene/Protein	7 - bp response elements,68,92,Gene/Protein	EBV promoters,100,113,Gene/Protein	EBV lytic origin,186,202,Gene/Protein	"[{""token"": ""ZEBRA"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""bZIP transcriptional activator"", ""start_span"": 11, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""7 - bp response elements"", ""start_span"": 68, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""EBV promoters"", ""start_span"": 100, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""EBV lytic origin"", ""start_span"": 186, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
The promoters were used without enhancers, or with enhancers derived from the beta - globin locus control region and the alpha - globin HS - 40 enhancer.	promoters,4,13,Gene/Protein	enhancers,32,41,Gene/Protein	enhancers,51,60,Gene/Protein	beta - globin locus control region,78,112,Gene/Protein	alpha - globin HS - 40 enhancer,121,152,Gene/Protein	"[{""token"": ""promoters"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""enhancers"", ""start_span"": 32, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""enhancers"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin locus control region"", ""start_span"": 78, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""alpha - globin HS - 40 enhancer"", ""start_span"": 121, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
When transfected into K562 cells, which express zeta - globin, comparable amounts of activity were obtained from the - 557 and - 417 zeta - luciferase constructs and the alpha - luciferase constructs when no enhancers or the alpha - globin locus enhancers were used.	zeta - globin,48,61,Gene/Protein	- 557 and - 417 zeta - luciferase constructs,117,161,Gene/Protein	alpha - luciferase constructs,170,199,Gene/Protein	enhancers,208,217,Gene/Protein	alpha - globin locus enhancers,225,255,Gene/Protein	"[{""token"": ""zeta - globin"", ""start_span"": 48, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""- 557 and - 417 zeta - luciferase constructs"", ""start_span"": 117, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""alpha - luciferase constructs"", ""start_span"": 170, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""enhancers"", ""start_span"": 208, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""alpha - globin locus enhancers"", ""start_span"": 225, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
Moreover, the data comparing the effects of activated Ras and PKC mutants suggest that PKC - alpha, p21ras, and PKC - epsilon are not positioned linearly on a single signal transduction pathway.	activated Ras,44,57,Gene/Protein	PKC mutants,62,73,Gene/Protein	PKC - alpha,87,98,Gene/Protein	p21ras,100,106,Gene/Protein	PKC - epsilon,112,125,Gene/Protein	"[{""token"": ""activated Ras"", ""start_span"": 44, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""PKC mutants"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""PKC - alpha"", ""start_span"": 87, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""p21ras"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""PKC - epsilon"", ""start_span"": 112, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	train
Signaling by a wide variety of cytokines, including interferons, interleukins, and growth factors, involves activation of JAK kinases and Stat ( Signal transducers and activators of transcription) proteins.	cytokines,31,40,Gene/Protein	interferons,52,63,Gene/Protein	interleukins,65,77,Gene/Protein	growth factors,83,97,Gene/Protein	JAK kinases,122,133,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""interferons"", ""start_span"": 52, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""interleukins"", ""start_span"": 65, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""growth factors"", ""start_span"": 83, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""JAK kinases"", ""start_span"": 122, ""end_span"": 133, ""type"": ""Gene/Protein""}]"	train
In EBV - positive cases of Hodgkin ' s disease, the EBERs, EBNA1, and the LMPs are expressed ( latency II), whereas in Burkitt ' s lymphoma ( BL) only the EBERs and EBNA1 have been detected ( latency I).	EBERs,52,57,Gene/Protein	EBNA1,59,64,Gene/Protein	LMPs,74,78,Gene/Protein	EBERs,155,160,Gene/Protein	EBNA1,165,170,Gene/Protein	"[{""token"": ""EBERs"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""EBNA1"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""LMPs"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""EBERs"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""EBNA1"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
In HeLa cells stably transfected with the HIV - 1 tat gene ( HeLa - tat cells), expression of the Tat protein enhanced both TNF - induced activation of NF - kappa B and TNF - mediated cytotoxicity.	HIV - 1 tat gene,42,58,Gene/Protein	Tat protein,98,109,Gene/Protein	TNF,124,127,Gene/Protein	NF - kappa B,152,164,Gene/Protein	TNF,169,172,Gene/Protein	"[{""token"": ""HIV - 1 tat gene"", ""start_span"": 42, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""Tat protein"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 152, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
EBNA - 2 is known to interact with the cellular DNA - binding protein J kappa and is recruited to promoters containing the GTGGGAA J kappa recognition sequence.	EBNA - 2,0,8,Gene/Protein	cellular DNA - binding protein,39,69,Gene/Protein	J kappa,70,77,Gene/Protein	promoters,98,107,Gene/Protein	J kappa recognition sequence,131,159,Gene/Protein	"[{""token"": ""EBNA - 2"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""cellular DNA - binding protein"", ""start_span"": 39, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""J kappa"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 98, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""J kappa recognition sequence"", ""start_span"": 131, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
In this study, we show that an activation - deficient glucocorticoid receptor mutant is as effective as the wild - type receptor in repression of AP - 1 activity, inhibition of interleukin - 2 production, inhibition of c - myc expression and induction of apoptosis.	activation - deficient glucocorticoid receptor mutant,31,84,Gene/Protein	wild - type receptor,108,128,Gene/Protein	AP - 1,146,152,Gene/Protein	interleukin - 2,177,192,Gene/Protein	c - myc,219,226,Gene/Protein	"[{""token"": ""activation - deficient glucocorticoid receptor mutant"", ""start_span"": 31, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""wild - type receptor"", ""start_span"": 108, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 146, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 177, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 219, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	train
Insertion of this chimeric promoter ( ISG15 LTR) upstream of the human IFNA2 gene directed high levels of IFN synthesis in Tat - expressing cells, while this promoter was not responsive to tumor necrosis factor alpha - mediated activation.	chimeric promoter,18,35,Gene/Protein	ISG15 LTR,38,47,Gene/Protein	human IFNA2 gene,65,81,Gene/Protein	IFN,106,109,Gene/Protein	tumor necrosis factor alpha,189,216,Gene/Protein	"[{""token"": ""chimeric promoter"", ""start_span"": 18, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""ISG15 LTR"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""human IFNA2 gene"", ""start_span"": 65, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 189, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
Selected transfected clones produced low levels of IFN A ( IFNA) constitutively, and their abilities to express interleukin - 2 and interleukin - 2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.	IFN A,51,56,Gene/Protein	IFNA,59,63,Gene/Protein	interleukin - 2,112,127,Gene/Protein	interleukin - 2 receptor,132,156,Gene/Protein	phytohemagglutinin,179,197,Gene/Protein	"[{""token"": ""IFN A"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""IFNA"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 112, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 receptor"", ""start_span"": 132, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""phytohemagglutinin"", ""start_span"": 179, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
Flow cytometric analysis also showed that at 72 h of virus exposure fewer T cells from the elderly produced interferon - gamma ( IFN - gamma), suggesting a link between the magnitude of the Fos and Jun and IFN - gamma responses.	interferon - gamma,108,126,Gene/Protein	IFN - gamma,129,140,Gene/Protein	Fos,190,193,Gene/Protein	Jun,198,201,Gene/Protein	IFN - gamma,206,217,Gene/Protein	"[{""token"": ""interferon - gamma"", ""start_span"": 108, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 129, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""Fos"", ""start_span"": 190, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 206, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	train
The cis - acting region, GM - kappa B / GC - box ( positions - 95 and - 73), within the murine GM - CSF gene promoter is required for maximal induction by stimulation with phorbol - 12 - myristate acetate ( PMA) and calcium ionophore ( A23187) in T cells.	cis - acting region,4,23,Gene/Protein	GM - kappa B / GC - box,25,48,Gene/Protein	positions - 95,51,65,Gene/Protein	- 73,70,74,Gene/Protein	murine GM - CSF gene promoter,88,117,Gene/Protein	"[{""token"": ""cis - acting region"", ""start_span"": 4, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""GM - kappa B / GC - box"", ""start_span"": 25, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""positions - 95"", ""start_span"": 51, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""- 73"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""murine GM - CSF gene promoter"", ""start_span"": 88, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
Therefore, we propose that the TPA / calcium - activated AP - 1 / OAP element is the main target of positive or negative regulatory signals influencing the IL - 2 octamer motif, through synergism with Oct - 2 and antagonism by RAR.	AP - 1,57,63,Gene/Protein	/ OAP,64,69,Gene/Protein	IL - 2 octamer motif,156,176,Gene/Protein	Oct - 2,201,208,Gene/Protein	RAR,227,230,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""/ OAP"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 octamer motif"", ""start_span"": 156, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 201, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""RAR"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
Induction of TaxI in a human T - cell line Jurkat carrying the TaxI gene under the metallothionein promoter led to increases in mRNA and surface expression of ICAM - I.	TaxI,13,17,Gene/Protein	TaxI gene,63,72,Gene/Protein	metallothionein promoter,83,107,Gene/Protein	mRNA,128,132,Gene/Protein	ICAM - I,159,167,Gene/Protein	"[{""token"": ""TaxI"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""TaxI gene"", ""start_span"": 63, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""metallothionein promoter"", ""start_span"": 83, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - I"", ""start_span"": 159, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF - kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.	PAFR,71,75,Gene/Protein	PAF,95,98,Gene/Protein	NF - kappa B,107,119,Gene/Protein	protein kinase C,170,186,Gene/Protein	PAF,190,193,Gene/Protein	"[{""token"": ""PAFR"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 107, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 170, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""PAF"", ""start_span"": 190, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
T lymphocyte activation and interleukin - 2 ( IL - 2) production require at least two signals, generated by phorbol ester ( TPA) and Ca2 + ionophore or costimulation of the T cell receptor ( TCR) and the CD28 auxiliary receptor.	interleukin - 2,28,43,Gene/Protein	IL - 2,46,52,Gene/Protein	T cell receptor,173,188,Gene/Protein	TCR,191,194,Gene/Protein	CD28 auxiliary receptor,204,227,Gene/Protein	"[{""token"": ""interleukin - 2"", ""start_span"": 28, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""T cell receptor"", ""start_span"": 173, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""CD28 auxiliary receptor"", ""start_span"": 204, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
It seems therefore that PGE2, by elevating cAMP levels, interferes with the activation pathway for NF - kappa B but not for NF - AT, AP - 1 or CLE0 binding protein.	PGE2,24,28,Gene/Protein	NF - kappa B,99,111,Gene/Protein	NF - AT,124,131,Gene/Protein	AP - 1,133,139,Gene/Protein	CLE0 binding protein,143,163,Gene/Protein	"[{""token"": ""PGE2"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 99, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 133, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""CLE0 binding protein"", ""start_span"": 143, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
Stimulation of the CD28 cell surface molecule delivers costimulatory signals essential for lymphokine production in activated T cells via a conserved sequence element found in the promoter of several lymphokine genes.	CD28 cell surface molecule,19,45,Gene/Protein	lymphokine,91,101,Gene/Protein	conserved sequence element,140,166,Gene/Protein	promoter,180,188,Gene/Protein	lymphokine genes,200,216,Gene/Protein	"[{""token"": ""CD28 cell surface molecule"", ""start_span"": 19, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""lymphokine"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""conserved sequence element"", ""start_span"": 140, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""lymphokine genes"", ""start_span"": 200, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
In addition, a new combination isoform containing Oct2a ' s amino terminal insert ( exon 7a) and Oct2b ' s carboxy terminal insert ( exon 13) was found that created a novel large isoform, Oct2ab.	Oct2a ' s amino terminal insert,50,81,Gene/Protein	exon 7a,84,91,Gene/Protein	Oct2b ' s carboxy terminal insert,97,130,Gene/Protein	exon 13,133,140,Gene/Protein	Oct2ab,188,194,Gene/Protein	"[{""token"": ""Oct2a ' s amino terminal insert"", ""start_span"": 50, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""exon 7a"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""Oct2b ' s carboxy terminal insert"", ""start_span"": 97, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""exon 13"", ""start_span"": 133, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""Oct2ab"", ""start_span"": 188, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
Acetylsalicylic acid and sodium salicylate inhibit LPS - induced NF - kappa B / c - Rel nuclear translocation, and synthesis of tissue factor ( TF) and tumor necrosis factor alfa ( TNF - alpha) in human monocytes.	NF - kappa B / c - Rel,65,87,Gene/Protein	tissue factor,128,141,Gene/Protein	TF,144,146,Gene/Protein	tumor necrosis factor alfa,152,178,Gene/Protein	TNF - alpha,181,192,Gene/Protein	"[{""token"": ""NF - kappa B / c - Rel"", ""start_span"": 65, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""tissue factor"", ""start_span"": 128, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""TF"", ""start_span"": 144, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alfa"", ""start_span"": 152, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 181, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
In the present study, we showed that CD14 + adherent human monocytes can differentiate into CD1 + relB + dendritic cells ( DC) by the combination of GM - CSF plus interleukin - 4 ( IL - 4) and that they differentiate into tartrate - resistant acid phosphatase ( TRAP) - positive osteoclast - like multinucleated giant cells ( MGC) by the combination of M - CSF plus IL - 4.	GM - CSF,149,157,Gene/Protein	interleukin - 4,163,178,Gene/Protein	IL - 4,181,187,Gene/Protein	M - CSF,353,360,Gene/Protein	IL - 4,366,372,Gene/Protein	"[{""token"": ""GM - CSF"", ""start_span"": 149, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 4"", ""start_span"": 163, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 181, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF"", ""start_span"": 353, ""end_span"": 360, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 366, ""end_span"": 372, ""type"": ""Gene/Protein""}]"	train
NH2 - terminal amino acid sequence analysis identified the 140 - kDa surface antigen for mAb J393 as CD43 / leukosialin, the major sialoglycoprotein of leukocytes.	NH2,0,3,Gene/Protein	140 - kDa surface antigen,59,84,Gene/Protein	mAb J393,89,97,Gene/Protein	CD43 / leukosialin,101,119,Gene/Protein	sialoglycoprotein,131,148,Gene/Protein	"[{""token"": ""NH2"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""140 - kDa surface antigen"", ""start_span"": 59, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""mAb J393"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""CD43 / leukosialin"", ""start_span"": 101, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""sialoglycoprotein"", ""start_span"": 131, ""end_span"": 148, ""type"": ""Gene/Protein""}]"	train
While Jurkat cells co - expressed two discrete cell - surface isoforms of CD43, recognized by mAb J393 and mAb G10 - 2, respectively, only J393 / CD43 signaled apoptosis.	cell - surface isoforms,47,70,Gene/Protein	CD43,74,78,Gene/Protein	mAb J393,94,102,Gene/Protein	mAb G10 - 2,107,118,Gene/Protein	J393 / CD43,139,150,Gene/Protein	"[{""token"": ""cell - surface isoforms"", ""start_span"": 47, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CD43"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""mAb J393"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""mAb G10 - 2"", ""start_span"": 107, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""J393 / CD43"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
Induction of fra - 1 following engagement of CD40 did not require protein synthesis, suggesting that the PKC - dependent linkage between CD40 and fra - 1 is direct.	fra - 1,13,20,Gene/Protein	CD40,45,49,Gene/Protein	PKC,105,108,Gene/Protein	CD40,137,141,Gene/Protein	fra - 1,146,153,Gene/Protein	"[{""token"": ""fra - 1"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""fra - 1"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
Association of TRAF1, TRAF2, and TRAF3 with an Epstein - Barr virus LMP1 domain important for B - lymphocyte transformation: role in NF - kappaB activation.	TRAF1,15,20,Gene/Protein	TRAF2,22,27,Gene/Protein	TRAF3,33,38,Gene/Protein	Epstein - Barr virus LMP1 domain,47,79,Gene/Protein	NF - kappaB,133,144,Gene/Protein	"[{""token"": ""TRAF1"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""TRAF3"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Epstein - Barr virus LMP1 domain"", ""start_span"": 47, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
Calcineurin stimulates the NF - kappa B element by enhancing inactivation of I kappa B / MAD3, an inhibitor of NF - kappa B, thereby increasing the amount of nuclear NF - kappa B DNA binding activity.	Calcineurin,0,11,Gene/Protein	NF - kappa B element,27,47,Gene/Protein	I kappa B / MAD3,77,93,Gene/Protein	NF - kappa B,111,123,Gene/Protein	NF - kappa B,166,178,Gene/Protein	"[{""token"": ""Calcineurin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B element"", ""start_span"": 27, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B / MAD3"", ""start_span"": 77, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 111, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 166, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
In all cells tested, IL - 10 activated Stat1 and Stat3 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.	IL - 10,21,28,Gene/Protein	Stat1,39,44,Gene/Protein	Stat3,49,54,Gene/Protein	DNA binding complexes,99,120,Gene/Protein	transcription factors,172,193,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding complexes"", ""start_span"": 99, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 172, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
Using a structure - function mutagenesis approach, two tyrosine residues ( Tyr427 and Tyr477) in the intracellular domain of the murine IL - 10 receptor were found to be redundantly required for receptor function and for activation of Stat3 but not for Stat1 or Stat5.	intracellular domain,101,121,Gene/Protein	IL - 10,136,143,Gene/Protein	Stat3,235,240,Gene/Protein	Stat1,253,258,Gene/Protein	Stat5,262,267,Gene/Protein	"[{""token"": ""intracellular domain"", ""start_span"": 101, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 235, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 253, ""end_span"": 258, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 262, ""end_span"": 267, ""type"": ""Gene/Protein""}]"	train
To examine whether an active negative regulatory process occurs, we created a reporter construct containing as an enhancer four copies of the NF - AT site and one copy of the octamer site ( 4X NF - AT - Oct).	reporter construct,78,96,Gene/Protein	enhancer,114,122,Gene/Protein	NF - AT site,142,154,Gene/Protein	octamer site,175,187,Gene/Protein	4X NF - AT - Oct,190,206,Gene/Protein	"[{""token"": ""reporter construct"", ""start_span"": 78, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""enhancer"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT site"", ""start_span"": 142, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""octamer site"", ""start_span"": 175, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""4X NF - AT - Oct"", ""start_span"": 190, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
During Epstein - Barr virus latent infection of B lymphocytes in vitro, six viral nuclear antigens ( EBNAs) are expressed from one of two promoters, Cp or Wp, whose activities are mutually exclusive.	viral nuclear antigens,76,98,Gene/Protein	EBNAs,101,106,Gene/Protein	promoters,138,147,Gene/Protein	Cp,149,151,Gene/Protein	Wp,155,157,Gene/Protein	"[{""token"": ""viral nuclear antigens"", ""start_span"": 76, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""EBNAs"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 138, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""Cp"", ""start_span"": 149, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""Wp"", ""start_span"": 155, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
Constitutive expression of IFN - alpha5 and IFN - beta was detected in different lymphoid cells including peripheral blood mononuclear cells from normal individuals following amplification of IFN mRNA by reverse transcriptase - polymerase chain reaction and direct sequencing of the amplified product.	IFN - alpha5,27,39,Gene/Protein	IFN - beta,44,54,Gene/Protein	IFN mRNA,192,200,Gene/Protein	reverse transcriptase,204,225,Gene/Protein	amplified product,283,300,Gene/Protein	"[{""token"": ""IFN - alpha5"", ""start_span"": 27, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""IFN - beta"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IFN mRNA"", ""start_span"": 192, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""reverse transcriptase"", ""start_span"": 204, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""amplified product"", ""start_span"": 283, ""end_span"": 300, ""type"": ""Gene/Protein""}]"	train
Thus, IL - 2 - induced IL - 2R alpha promoter activity requires a complex upstream element, which appears to contain binding sites for both positive and negative regulatory factors.	IL - 2,6,12,Gene/Protein	IL - 2R alpha promoter,23,45,Gene/Protein	complex upstream element,66,90,Gene/Protein	binding sites,117,130,Gene/Protein	positive and negative regulatory factors,140,180,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha promoter"", ""start_span"": 23, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""complex upstream element"", ""start_span"": 66, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 117, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""positive and negative regulatory factors"", ""start_span"": 140, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
We report here on the identification of a 17 kDa variant of the 14 kDa Id - 3 protein termed Id - 3L ( long version) which possesses a unique 60 amino acid carboxy - terminus generated by read through of a ' coding intron ' and alternative splicing.	17 kDa variant,42,56,Gene/Protein	14 kDa Id - 3,64,77,Gene/Protein	Id - 3L,93,100,Gene/Protein	60 amino acid carboxy - terminus,142,174,Gene/Protein	coding intron,208,221,Gene/Protein	"[{""token"": ""17 kDa variant"", ""start_span"": 42, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""14 kDa Id - 3"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""Id - 3L"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""60 amino acid carboxy - terminus"", ""start_span"": 142, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""coding intron"", ""start_span"": 208, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
In this study, we examined the molecular mechanism by which agents that elevate intracellular cAMP inhibit the expression of the tumor necrosis factor alpha ( TNFalpha), tissue factor, endothelial leukocyte adhesion molecule - 1, and vascular cell adhesion molecule - 1 genes.	tumor necrosis factor alpha,129,156,Gene/Protein	TNFalpha,159,167,Gene/Protein	tissue factor,170,183,Gene/Protein	endothelial leukocyte adhesion molecule - 1,185,228,Gene/Protein	vascular cell adhesion molecule - 1 genes,234,275,Gene/Protein	"[{""token"": ""tumor necrosis factor alpha"", ""start_span"": 129, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 159, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""tissue factor"", ""start_span"": 170, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""endothelial leukocyte adhesion molecule - 1"", ""start_span"": 185, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""vascular cell adhesion molecule - 1 genes"", ""start_span"": 234, ""end_span"": 275, ""type"": ""Gene/Protein""}]"	train
Three subtypes of retinoic acid receptors ( RAR), termed RAR alpha, RAR beta, and RAR gamma, have been described.	retinoic acid receptors,18,41,Gene/Protein	RAR,44,47,Gene/Protein	RAR alpha,57,66,Gene/Protein	RAR beta,68,76,Gene/Protein	RAR gamma,82,91,Gene/Protein	"[{""token"": ""retinoic acid receptors"", ""start_span"": 18, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""RAR"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""RAR alpha"", ""start_span"": 57, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""RAR beta"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""RAR gamma"", ""start_span"": 82, ""end_span"": 91, ""type"": ""Gene/Protein""}]"	train
When single - point mutation was introduced to each GC box, EBS, and GT box in PFP9a20, at least 3 - fold less CAT activity was observed in CTLL - R8 cells.	GC box,52,58,Gene/Protein	EBS,60,63,Gene/Protein	GT box,69,75,Gene/Protein	PFP9a20,79,86,Gene/Protein	CAT,111,114,Gene/Protein	"[{""token"": ""GC box"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""EBS"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""GT box"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""PFP9a20"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}]"	train
A major obstacle in understanding the signaling events that follow CD28 receptor ligation arises from the fact that CD28 acts as a costimulus to TCR engagement, making it difficult to assess the relative contribution of CD28 signals as distinct from those of the TCR.	CD28,67,71,Gene/Protein	CD28,116,120,Gene/Protein	TCR,145,148,Gene/Protein	CD28,220,224,Gene/Protein	TCR,263,266,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 220, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 263, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
This was identified as the mRNA encoding the transcription factor egr - 1, which is expressed with fast kinetics in T and NK cells upon IL - 2, but not IL - 12, stimulation.	mRNA,27,31,Gene/Protein	transcription factor,45,65,Gene/Protein	egr - 1,66,73,Gene/Protein	IL - 2,136,142,Gene/Protein	IL - 12,152,159,Gene/Protein	"[{""token"": ""mRNA"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 45, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""egr - 1"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
GM - CSF gene activation in T cells is known to involve the transcription factors nuclear factor - kappa B, AP - 1, NFAT, and Sp1.	GM - CSF gene,0,13,Gene/Protein	transcription factors,60,81,Gene/Protein	nuclear factor - kappa B,82,106,Gene/Protein	AP - 1,108,114,Gene/Protein	NFAT,116,120,Gene/Protein	"[{""token"": ""GM - CSF gene"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 60, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappa B"", ""start_span"": 82, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}]"	train
To better understand the contribution of the GR N - terminal transactivation domain in mediating murine thymocyte apoptosis, we stably transfected GR, GR variants, and the androgen receptor ( AR) into receptor - negative S49 murine thymoma cells.	GR N - terminal transactivation domain,45,83,Gene/Protein	GR,147,149,Gene/Protein	GR variants,151,162,Gene/Protein	androgen receptor,172,189,Gene/Protein	AR,192,194,Gene/Protein	"[{""token"": ""GR N - terminal transactivation domain"", ""start_span"": 45, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 147, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""GR variants"", ""start_span"": 151, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""androgen receptor"", ""start_span"": 172, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""AR"", ""start_span"": 192, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
Latent membrane protein 1 and, to a lesser extent, EBV nuclear antigen 2 mediated the increase in p53 levels via activation of the NF - kappaB transcription factor.	Latent membrane protein 1,0,25,Gene/Protein	EBV nuclear antigen 2,51,72,Gene/Protein	p53,98,101,Gene/Protein	NF - kappaB,131,142,Gene/Protein	transcription factor,143,163,Gene/Protein	"[{""token"": ""Latent membrane protein 1"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""EBV nuclear antigen 2"", ""start_span"": 51, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 143, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
In chloramphenicol acetyltransferase assays, utilizing the transient transfection of a chloramphenicol acetyltransferase reporter plasmid containing the IL - 6 gene promoter, IL - 4, but not IL - 10, suppressed the transcriptional activity of the IL - 6 gene promoter stimulated by PMA and LPS.	chloramphenicol acetyltransferase,3,36,Gene/Protein	chloramphenicol acetyltransferase reporter plasmid,87,137,Gene/Protein	IL - 6 gene promoter,153,173,Gene/Protein	IL - 4,175,181,Gene/Protein	IL - 10,191,198,Gene/Protein	"[{""token"": ""chloramphenicol acetyltransferase"", ""start_span"": 3, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase reporter plasmid"", ""start_span"": 87, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 gene promoter"", ""start_span"": 153, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 175, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 191, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
These results suggest that IL - 4 may inhibit the transcription of the IL - 6 gene by affecting NF - kappaB binding activity, while IL - 10 may inhibit the IL - 6 mRNA levels post - transcriptionally, without suppressing promoter activity.	IL - 4,27,33,Gene/Protein	IL - 6 gene,71,82,Gene/Protein	NF - kappaB,96,107,Gene/Protein	IL - 10,132,139,Gene/Protein	IL - 6 mRNA,156,167,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 gene"", ""start_span"": 71, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 mRNA"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
Costimulation of U1 cells with LPS plus GM - CSF resulted in the accumulation of steady - state levels of HIV RNA; however, only a weak induction of HIV long terminal repeat - driven transcription, which was not associated with the activation of the cellular transcription factor nuclear factor - kappa B, was noted.	GM - CSF,40,48,Gene/Protein	HIV RNA,106,113,Gene/Protein	HIV long terminal repeat,149,173,Gene/Protein	cellular transcription factor,250,279,Gene/Protein	nuclear factor - kappa B,280,304,Gene/Protein	"[{""token"": ""GM - CSF"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""HIV RNA"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""HIV long terminal repeat"", ""start_span"": 149, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""cellular transcription factor"", ""start_span"": 250, ""end_span"": 279, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappa B"", ""start_span"": 280, ""end_span"": 304, ""type"": ""Gene/Protein""}]"	train
r - hTBP - 1 and rhu TNFR: Fc also decreased p24 antigen synthesized by U1 cells in response to other stimuli, including phytohemagglutinin ( PHA) - induced supernatant, granulocyte - macrophage colony - stimulating factor, interleukin - 6, and TNF.	r - hTBP - 1,0,12,Gene/Protein	p24 antigen,45,56,Gene/Protein	granulocyte - macrophage colony - stimulating factor,170,222,Gene/Protein	interleukin - 6,224,239,Gene/Protein	TNF,245,248,Gene/Protein	"[{""token"": ""r - hTBP - 1"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""p24 antigen"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 170, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 6"", ""start_span"": 224, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 245, ""end_span"": 248, ""type"": ""Gene/Protein""}]"	train
The effects of IFN - gamma on the transcription factors were specific, since no change was observed in the expression of NF - IL - 6 or I kappa B alpha, the inhibitor of NF - kappa B.	IFN - gamma,15,26,Gene/Protein	transcription factors,34,55,Gene/Protein	NF - IL - 6,121,132,Gene/Protein	I kappa B alpha,136,151,Gene/Protein	NF - kappa B,170,182,Gene/Protein	"[{""token"": ""IFN - gamma"", ""start_span"": 15, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 34, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL - 6"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 136, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 170, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
Electrophoretic mobility shift analyses demonstrated that the 151 - bp region contains nuclear protein binding sites for Sp1, PU. 1, and / or Elf - 1, and a novel factor.	151 - bp region,62,77,Gene/Protein	nuclear protein binding sites,87,116,Gene/Protein	Sp1,121,124,Gene/Protein	Elf - 1,142,149,Gene/Protein	novel factor,157,169,Gene/Protein	"[{""token"": ""151 - bp region"", ""start_span"": 62, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""nuclear protein binding sites"", ""start_span"": 87, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""Elf - 1"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""novel factor"", ""start_span"": 157, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
This shows that in a eukaryotic nucleus, Tax specifically interacts with the basic domain - leucine zipper region of ATF - 1, CREB, and CREM.	Tax,41,44,Gene/Protein	basic domain - leucine zipper region,77,113,Gene/Protein	ATF - 1,117,124,Gene/Protein	CREB,126,130,Gene/Protein	CREM,136,140,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""basic domain - leucine zipper region"", ""start_span"": 77, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""ATF - 1"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""CREM"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
Like IkappaBalpha, Tax - mediated breakdown of IkappaBbeta in transfected T lymphocytes is blocked either by cell - permeable proteasome inhibitors or by mutation Of IkappaBbeta at two serine residues present within its N - terminal region.	IkappaBalpha,5,17,Gene/Protein	Tax,19,22,Gene/Protein	IkappaBbeta,47,58,Gene/Protein	IkappaBbeta,166,177,Gene/Protein	N - terminal region,220,239,Gene/Protein	"[{""token"": ""IkappaBalpha"", ""start_span"": 5, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBbeta"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBbeta"", ""start_span"": 166, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal region"", ""start_span"": 220, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Mutation of the consensus AP - 1 / CRE site within ZII abolished the inducibility of Zp by HHV - 6, whereas positioning of the ZII domain upstream of the beta - globin minimal promoter conferred responsiveness following HHV - 6 infection.	consensus AP - 1 / CRE site,16,43,Gene/Protein	ZII,51,54,Gene/Protein	Zp,85,87,Gene/Protein	ZII domain,127,137,Gene/Protein	beta - globin minimal promoter,154,184,Gene/Protein	"[{""token"": ""consensus AP - 1 / CRE site"", ""start_span"": 16, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""ZII"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Zp"", ""start_span"": 85, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""ZII domain"", ""start_span"": 127, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin minimal promoter"", ""start_span"": 154, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
Structure / function analysis of various Oct - 2a effector regions in the context of the GAL4 DNA - binding domain revealed that Oct - 2a contains two functionally different activation domains at the N and the C termini.	Oct - 2a effector regions,41,66,Gene/Protein	GAL4 DNA - binding domain,89,114,Gene/Protein	Oct - 2a,129,137,Gene/Protein	activation domains,174,192,Gene/Protein	N and the C termini,200,219,Gene/Protein	"[{""token"": ""Oct - 2a effector regions"", ""start_span"": 41, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""GAL4 DNA - binding domain"", ""start_span"": 89, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2a"", ""start_span"": 129, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""activation domains"", ""start_span"": 174, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""N and the C termini"", ""start_span"": 200, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Exogenous IL - 2, which restitutes the proliferative response of the anti - CD3 - and anti - CD28 - treated Rel - / - T cells, restores production of IL - 5, TNF - alpha, and IFN - gamma, but not IL - 3 and GM - CSF expression to approximately normal levels.	IL - 2,10,16,Gene/Protein	TNF - alpha,158,169,Gene/Protein	IFN - gamma,175,186,Gene/Protein	IL - 3,196,202,Gene/Protein	GM - CSF,207,215,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 10, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 158, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 175, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 196, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 207, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
Moreover, gp120 induces tyrosine phosphorylation of signal transducer and activator of transcription ( STAT - 1 alpha) as well as the Janus kinase ( JAK2) in glial cells.	gp120,10,15,Gene/Protein	signal transducer and activator of transcription,52,100,Gene/Protein	STAT - 1 alpha,103,117,Gene/Protein	Janus kinase,134,146,Gene/Protein	JAK2,149,153,Gene/Protein	"[{""token"": ""gp120"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer and activator of transcription"", ""start_span"": 52, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""STAT - 1 alpha"", ""start_span"": 103, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase"", ""start_span"": 134, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
Paclitaxel and other drugs that disturb microtubule dynamics kill cells in a Fas / Fas ligand ( FasL) - dependent manner; antibody to FasL inhibits paclitaxel - induced apoptosis.	microtubule,40,51,Gene/Protein	Fas,77,80,Gene/Protein	/ Fas ligand,81,93,Gene/Protein	FasL,96,100,Gene/Protein	FasL,134,138,Gene/Protein	"[{""token"": ""microtubule"", ""start_span"": 40, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""Fas"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""/ Fas ligand"", ""start_span"": 81, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""FasL"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""FasL"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene/Protein""}]"	train
Because STAT6 activation is essential for IL - 4 - induced gene expression, we examined the ability of type I and type II IFNs to regulate activation of STAT6 by IL - 4 in primary human monocytes.	STAT6,8,13,Gene/Protein	IL - 4,42,48,Gene/Protein	IFNs,122,126,Gene/Protein	STAT6,153,158,Gene/Protein	IL - 4,162,168,Gene/Protein	"[{""token"": ""STAT6"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""IFNs"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
Here, we report a model of CD28 costimulation using PMA plus the natural ligand CD80 that resulted in very limited stimulation of IL - 2, as evidenced by both cytokine production and IL - 2 promoter stimulation.	CD28,27,31,Gene/Protein	natural ligand CD80,65,84,Gene/Protein	IL - 2,130,136,Gene/Protein	cytokine,159,167,Gene/Protein	IL - 2 promoter,183,198,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""natural ligand CD80"", ""start_span"": 65, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 159, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 183, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
We have found that the recruitment of EKLF to 5 ' HS3 depends on the presence of 5 ' HS2 in cis, but the recruitment to 5 ' HS2 does not depend on 5 ' HS3.	EKLF,38,42,Gene/Protein	5 ' HS3,46,53,Gene/Protein	5 ' HS2,81,88,Gene/Protein	5 ' HS2,120,127,Gene/Protein	5 ' HS3,147,154,Gene/Protein	"[{""token"": ""EKLF"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""5 ' HS3"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""5 ' HS2"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""5 ' HS2"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""5 ' HS3"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
The resulting diminished phosphorylation of c - Jun and JunD at their NH ( 2) - termini decreases the ability of these nuclear proteins to autostimulate the expression of the c - Jun and JunD genes, thus leading to lower production of c - Jun and JunD.	c - Jun,44,51,Gene/Protein	JunD,56,60,Gene/Protein	c - Jun and JunD genes,175,197,Gene/Protein	c - Jun,235,242,Gene/Protein	JunD,247,251,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun and JunD genes"", ""start_span"": 175, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 235, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Gene/Protein""}]"	train
Expression of wild - type SHP1 had a very small effect on the TCR - induced tyrosine phosphorylation of ZAP - 70 and Syk, even when SHP1 was overexpressed 20 - 100 - fold over endogenous SHP1.	wild - type SHP1,14,30,Gene/Protein	ZAP - 70,104,112,Gene/Protein	Syk,117,120,Gene/Protein	SHP1,132,136,Gene/Protein	endogenous SHP1,176,191,Gene/Protein	"[{""token"": ""wild - type SHP1"", ""start_span"": 14, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""ZAP - 70"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Syk"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""endogenous SHP1"", ""start_span"": 176, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
A factor in bovine colostrum ( colostrum inhibitory factor, CIF) inhibits interleukin 2 ( IL2) production in activated T helper cells by blocking the accumulation of IL2 mRNA.	colostrum inhibitory factor,31,58,Gene/Protein	CIF,60,63,Gene/Protein	interleukin 2,74,87,Gene/Protein	IL2,90,93,Gene/Protein	IL2 mRNA,166,174,Gene/Protein	"[{""token"": ""colostrum inhibitory factor"", ""start_span"": 31, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""CIF"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2"", ""start_span"": 74, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""IL2"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""IL2 mRNA"", ""start_span"": 166, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
Using a combination of bacterial motility assays in platelet extracts with Escherichia coli expressing the Shigella IcsA protein and in vitro analysis of reconstituted systems from purified proteins, we show here that the bacterial protein IcsA binds N - WASP and activates it in a Cdc42 - like fashion.	Shigella IcsA protein,107,128,Gene/Protein	purified proteins,181,198,Gene/Protein	bacterial protein IcsA,222,244,Gene/Protein	N - WASP,251,259,Gene/Protein	Cdc42,282,287,Gene/Protein	"[{""token"": ""Shigella IcsA protein"", ""start_span"": 107, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""purified proteins"", ""start_span"": 181, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""bacterial protein IcsA"", ""start_span"": 222, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""N - WASP"", ""start_span"": 251, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""Cdc42"", ""start_span"": 282, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
Analysis of targets that could mediate these phenotypic changes indicated that c - Maf likely plays a key role in myeloid cell development through dual mechanisms; inhibition of a select set of c - Myb regulated targets, such as Bcl - 2 and CD13 / APN, coupled with the activation of as yet undefined differentiation - promoting genes.	c - Maf,79,86,Gene/Protein	c - Myb,194,201,Gene/Protein	Bcl - 2,229,236,Gene/Protein	CD13 / APN,241,251,Gene/Protein	differentiation - promoting genes,301,334,Gene/Protein	"[{""token"": ""c - Maf"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""c - Myb"", ""start_span"": 194, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 229, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""CD13 / APN"", ""start_span"": 241, ""end_span"": 251, ""type"": ""Gene/Protein""}, {""token"": ""differentiation - promoting genes"", ""start_span"": 301, ""end_span"": 334, ""type"": ""Gene/Protein""}]"	train
To better understand the assembly mechanism for the progesterone receptor ( PR), we have developed cell - free systems for studying interactions of PR, hsp90, and other associated proteins.	progesterone receptor,52,73,Gene/Protein	PR,76,78,Gene/Protein	PR,148,150,Gene/Protein	hsp90,152,157,Gene/Protein	associated proteins,169,188,Gene/Protein	"[{""token"": ""progesterone receptor"", ""start_span"": 52, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""PR"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""PR"", ""start_span"": 148, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""hsp90"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""associated proteins"", ""start_span"": 169, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
These interactions require ATP / Mg2 + and when ATP is limiting the PR complex is altered to one containing the proteins p60 and p48, but lacking immunophilins and p23.	PR,68,70,Gene/Protein	p60,121,124,Gene/Protein	p48,129,132,Gene/Protein	immunophilins,146,159,Gene/Protein	p23,164,167,Gene/Protein	"[{""token"": ""PR"", ""start_span"": 68, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""p60"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""p48"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""immunophilins"", ""start_span"": 146, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""p23"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
Therefore, IRF - 1 may be an important contributor to IL - 12 signaling, and we speculate that the defective IL - 12 responses seen in IRF - 1 - / - mice might be attributable, in part, to the absence of this transcription factor.	IRF - 1,11,18,Gene/Protein	IL - 12,54,61,Gene/Protein	IL - 12,109,116,Gene/Protein	IRF,135,138,Gene/Protein	transcription factor,209,229,Gene/Protein	"[{""token"": ""IRF - 1"", ""start_span"": 11, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""IRF"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 209, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
Messenger RNA production coding for IL - 8, RANTES, and MCP - 1 showed parallel variations to the production of the correspondent proteins.	Messenger RNA,0,13,Gene/Protein	IL - 8,36,42,Gene/Protein	RANTES,44,50,Gene/Protein	MCP - 1,56,63,Gene/Protein	correspondent proteins,116,138,Gene/Protein	"[{""token"": ""Messenger RNA"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""RANTES"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""correspondent proteins"", ""start_span"": 116, ""end_span"": 138, ""type"": ""Gene/Protein""}]"	train
Additionally, virus reactivation in resting PBMCs infected in vitro with HIV - 1 was found to be specifically induced by ligands of the CDR2 - loop in domain 1 ( D1) of CD4 ( virus envelope and anti - CD4 monoclonal antibodies).	CDR2 - loop,136,147,Gene/Protein	domain 1,151,159,Gene/Protein	D1,162,164,Gene/Protein	CD4,169,172,Gene/Protein	virus envelope and anti - CD4 monoclonal antibodies,175,226,Gene/Protein	"[{""token"": ""CDR2 - loop"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""domain 1"", ""start_span"": 151, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""D1"", ""start_span"": 162, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""virus envelope and anti - CD4 monoclonal antibodies"", ""start_span"": 175, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	train
We have identified an E box around - 260 and a YY1 binding site around - 300 relative to the transcription start site.	E box,22,27,Gene/Protein	- 260,35,40,Gene/Protein	YY1 binding site,47,63,Gene/Protein	- 300,71,76,Gene/Protein	transcription start site,93,117,Gene/Protein	"[{""token"": ""E box"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""- 260"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""YY1 binding site"", ""start_span"": 47, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""- 300"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""transcription start site"", ""start_span"": 93, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
Here, we investigate the role of Rho in regulating the distribution of the monocyte - binding receptors E - selectin, ICAM - 1, and VCAM - 1 in human endothelial cells.	Rho,33,36,Gene/Protein	monocyte - binding receptors,75,103,Gene/Protein	E - selectin,104,116,Gene/Protein	ICAM - 1,118,126,Gene/Protein	VCAM - 1,132,140,Gene/Protein	"[{""token"": ""Rho"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""monocyte - binding receptors"", ""start_span"": 75, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 104, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
C3 transferase and cytochalasin D did not alter the expression levels of monocyte - binding receptors on endothelial cells, but did inhibit clustering of E - selectin, ICAM - 1, and VCAM - 1 on the cell surface induced by monocyte adhesion or cross - linking antibodies.	monocyte - binding receptors,73,101,Gene/Protein	E - selectin,154,166,Gene/Protein	ICAM - 1,168,176,Gene/Protein	VCAM - 1,182,190,Gene/Protein	cross - linking antibodies,243,269,Gene/Protein	"[{""token"": ""monocyte - binding receptors"", ""start_span"": 73, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 154, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 182, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""cross - linking antibodies"", ""start_span"": 243, ""end_span"": 269, ""type"": ""Gene/Protein""}]"	train
Previous studies have characterized the CD28 augmentation of TCR - mediated signaling in peripheral blood T cells through transcriptional activation of an IL - 2 promoter CD28 response element ( CD28RE), along with enhanced mRNA stability.	CD28,40,44,Gene/Protein	TCR,61,64,Gene/Protein	IL - 2,155,161,Gene/Protein	CD28 response element,171,192,Gene/Protein	CD28RE,195,201,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""CD28 response element"", ""start_span"": 171, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""CD28RE"", ""start_span"": 195, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
CTLA - 4 ligation inhibited CD3 / CD28 - induced IL - 2 mRNA accumulation by inhibiting IL - 2 transcription, which appears to be mediated in part through decreasing NF - AT accumulation in the nuclei.	CTLA - 4,0,8,Gene/Protein	CD28,34,38,Gene/Protein	IL - 2 mRNA,49,60,Gene/Protein	IL - 2,88,94,Gene/Protein	NF - AT,166,173,Gene/Protein	"[{""token"": ""CTLA - 4"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 mRNA"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 88, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
There was, however, a significant difference in the amounts of the nuclear protein, REF - 1 ( which regulates AP - 1 DNA binding by altering the redox status of FOS and JUN proteins), in alveolar macrophages compared with monocytes.	nuclear protein,67,82,Gene/Protein	REF - 1,84,91,Gene/Protein	AP - 1,110,116,Gene/Protein	FOS,161,164,Gene/Protein	JUN proteins,169,181,Gene/Protein	"[{""token"": ""nuclear protein"", ""start_span"": 67, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""REF - 1"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 110, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""FOS"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""JUN proteins"", ""start_span"": 169, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
Here we report that in erythroid cells, GATA - 1 strongly induces the expression of the anti - apoptotic protein bcl - xL, but not the related proteins bcl - 2 and mcl - 1.	GATA - 1,40,48,Gene/Protein	anti - apoptotic protein,88,112,Gene/Protein	bcl - xL,113,121,Gene/Protein	bcl - 2,152,159,Gene/Protein	mcl - 1,164,171,Gene/Protein	"[{""token"": ""GATA - 1"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""anti - apoptotic protein"", ""start_span"": 88, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""bcl - xL"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""bcl - 2"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""mcl - 1"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
Gel supershift assays demonstrated that thrombin induced binding of NF - kappa Bp65 ( Rel A) to downstream NF - kappa B site of the ICAM - 1 promoter.	thrombin,40,48,Gene/Protein	NF - kappa Bp65,68,83,Gene/Protein	Rel A,86,91,Gene/Protein	NF - kappa B site,107,124,Gene/Protein	ICAM - 1 promoter,132,149,Gene/Protein	"[{""token"": ""thrombin"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa Bp65"", ""start_span"": 68, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""Rel A"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 107, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1 promoter"", ""start_span"": 132, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
Thrombin receptor activation peptide, a 14 - amino - acid peptide representing the new NH2 terminus of proteolytically activated receptor - 1, mimicked thrombin ' s action in inducing ICAM - 1 expression.	Thrombin,0,8,Gene/Protein	NH2 terminus,87,99,Gene/Protein	receptor - 1,129,141,Gene/Protein	thrombin,152,160,Gene/Protein	ICAM - 1,184,192,Gene/Protein	"[{""token"": ""Thrombin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""NH2 terminus"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""receptor - 1"", ""start_span"": 129, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""thrombin"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 184, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
These data indicate that thrombin activates endothelial ICAM - 1 expression and polymorphonuclear leukocyte adhesion by NF - kappa Bp65 binding to the downstream NF - kappa B site of ICAM - 1 promoter after proteolytically activated receptor - 1 activation.	thrombin,25,33,Gene/Protein	ICAM - 1,56,64,Gene/Protein	NF - kappa Bp65,120,135,Gene/Protein	NF - kappa B site,162,179,Gene/Protein	ICAM - 1 promoter,183,200,Gene/Protein	"[{""token"": ""thrombin"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa Bp65"", ""start_span"": 120, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 162, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1 promoter"", ""start_span"": 183, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
Here we demonstrate that both Smad6 and Smad7 are human bone morphogenetic protein - 2 ( hBMP - 2) - inducible antagonists of hBMP - 2 - induced growth arrest and apoptosis in mouse B cell hybridoma HS - 72 cells.	Smad6,30,35,Gene/Protein	Smad7,40,45,Gene/Protein	human bone morphogenetic protein - 2,50,86,Gene/Protein	hBMP - 2,89,97,Gene/Protein	hBMP - 2,126,134,Gene/Protein	"[{""token"": ""Smad6"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""Smad7"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""human bone morphogenetic protein - 2"", ""start_span"": 50, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""hBMP - 2"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""hBMP - 2"", ""start_span"": 126, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
PG490 also inhibits PMA - stimulated activation of a chimeric transcription factor in which the C - terminal TA1 transactivation domain of NF - kappaB p65 is fused to the DNA binding domain of GAL4.	chimeric transcription factor,53,82,Gene/Protein	C - terminal TA1 transactivation domain,96,135,Gene/Protein	NF - kappaB p65,139,154,Gene/Protein	DNA binding domain,171,189,Gene/Protein	GAL4,193,197,Gene/Protein	"[{""token"": ""chimeric transcription factor"", ""start_span"": 53, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal TA1 transactivation domain"", ""start_span"": 96, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB p65"", ""start_span"": 139, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding domain"", ""start_span"": 171, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""GAL4"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
We investigated the MAPk kinase ( MKK) that activates p38 MAPk in response to LPS, the p38 MAPk isoforms that are activated as part of this pathway, and the functional responses affected by p38 MAPk activation.	MAPk kinase,20,31,Gene/Protein	MKK,34,37,Gene/Protein	p38 MAPk,54,62,Gene/Protein	p38 MAPk isoforms,87,104,Gene/Protein	p38 MAPk,190,198,Gene/Protein	"[{""token"": ""MAPk kinase"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""MKK"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPk"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPk isoforms"", ""start_span"": 87, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPk"", ""start_span"": 190, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
Activation of MHC class II promoters requires binding of at least three distinct multi - protein complexes ( RFX, X2BP and NF - Y).	MHC class II promoters,14,36,Gene/Protein	multi - protein complexes,81,106,Gene/Protein	RFX,109,112,Gene/Protein	X2BP,114,118,Gene/Protein	NF - Y,123,129,Gene/Protein	"[{""token"": ""MHC class II promoters"", ""start_span"": 14, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""multi - protein complexes"", ""start_span"": 81, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""RFX"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""X2BP"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""NF - Y"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	train
By using the yeast two - hybrid system, we also show that EVI1 ( contained in its entirety in MDS1 / EVI1 and AML1 / MDS1 / EVI1) physically interacts with SMAD3, which is an intracellular mediator of TGF - beta1 signaling.	EVI1,58,62,Gene/Protein	MDS1 / EVI1,94,105,Gene/Protein	AML1 / MDS1 / EVI1,110,128,Gene/Protein	SMAD3,156,161,Gene/Protein	TGF - beta1,201,212,Gene/Protein	"[{""token"": ""EVI1"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""MDS1 / EVI1"", ""start_span"": 94, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""AML1 / MDS1 / EVI1"", ""start_span"": 110, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""SMAD3"", ""start_span"": 156, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 201, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	train
Unlike the proposed role of Cbl as a negative regulator, our results suggest that the Cbl homologue Cbl - b has a positive role in T - cell signaling, most likely via a direct interaction with the upstream kinase Zap - 70.	Cbl,28,31,Gene/Protein	Cbl,86,89,Gene/Protein	Cbl - b,100,107,Gene/Protein	upstream kinase,197,212,Gene/Protein	Zap - 70,213,221,Gene/Protein	"[{""token"": ""Cbl"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""Cbl"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""Cbl - b"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""upstream kinase"", ""start_span"": 197, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""Zap - 70"", ""start_span"": 213, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
Although overexpressed Egr - 1 was ineffective, overexpressed Egr - 2 was as potent as Egr - 3 in inducing fasL promoter - dependent reporter constructs in T cell hybridomas and HeLa cells, and both up - regulated endogenous fasL mRNA in HeLa cells.	Egr - 1,23,30,Gene/Protein	Egr - 2,62,69,Gene/Protein	Egr - 3,87,94,Gene/Protein	fasL promoter - dependent reporter constructs,107,152,Gene/Protein	fasL mRNA,225,234,Gene/Protein	"[{""token"": ""Egr - 1"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 2"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 3"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""fasL promoter - dependent reporter constructs"", ""start_span"": 107, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""fasL mRNA"", ""start_span"": 225, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
Members of the cyclic adenosine monophosphate ( cAMP) response element binding ( CREB) / activating transcription factor 1 ( ATF - 1) family of transcription factors bind three 21 - bp repeats ( Tax - responsive element - 1, or TRE - 1) within the viral promoter and are important for basal and Tax - mediated transcription.	transcription factors,144,165,Gene/Protein	21 - bp repeats,177,192,Gene/Protein	Tax - responsive element - 1,195,223,Gene/Protein	TRE - 1,228,235,Gene/Protein	viral promoter,248,262,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 144, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""21 - bp repeats"", ""start_span"": 177, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""Tax - responsive element - 1"", ""start_span"": 195, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""TRE - 1"", ""start_span"": 228, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""viral promoter"", ""start_span"": 248, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	train
Among these hypersensitive sites, two transcriptional control elements were found, one in the first intron of the GATA - 3 gene and the other between 8. 3 and 5. 9 kilobases 5 ' from the GATA - 3 transcriptional initiation site.	hypersensitive sites,12,32,Gene/Protein	transcriptional control elements,38,70,Gene/Protein	first intron,94,106,Gene/Protein	GATA - 3 gene,114,127,Gene/Protein	GATA - 3 transcriptional initiation site,187,227,Gene/Protein	"[{""token"": ""hypersensitive sites"", ""start_span"": 12, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional control elements"", ""start_span"": 38, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""first intron"", ""start_span"": 94, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 3 gene"", ""start_span"": 114, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 3 transcriptional initiation site"", ""start_span"": 187, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
Transcriptional regulation of the alpha2 integrin gene in cells undergoing megakaryocytic differentiation requires a core promoter between bp - 30 and - 92, a silencer between bp - 92 and - 351, and megakaryocytic enhancers in the distal 5 ' flank.	alpha2 integrin gene,34,54,Gene/Protein	core promoter,117,130,Gene/Protein	silencer,159,167,Gene/Protein	megakaryocytic enhancers,199,223,Gene/Protein	distal 5 ' flank,231,247,Gene/Protein	"[{""token"": ""alpha2 integrin gene"", ""start_span"": 34, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""core promoter"", ""start_span"": 117, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""silencer"", ""start_span"": 159, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""megakaryocytic enhancers"", ""start_span"": 199, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""distal 5 ' flank"", ""start_span"": 231, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	train
IL - 10 preincubation resulted in the inhibition of gene expression for several IFN - induced genes, such as IP - 10, ISG54, and intercellular adhesion molecule - 1.	IL - 10,0,7,Gene/Protein	IFN - induced genes,80,99,Gene/Protein	IP - 10,109,116,Gene/Protein	ISG54,118,123,Gene/Protein	intercellular adhesion molecule - 1,129,164,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""IFN - induced genes"", ""start_span"": 80, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""IP - 10"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""ISG54"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 129, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
The endothelial expression of vascular cell adhesion molecule - 1 ( VCAM - 1), E - selectin, and intercellular adhesion molecule - 1 was monitored by cell surface enzyme immunoassays or flow cytometry, and steady - state levels of VCAM - 1 mRNA were assessed by Northern blot analysis.	vascular cell adhesion molecule - 1,30,65,Gene/Protein	VCAM - 1,68,76,Gene/Protein	E - selectin,79,91,Gene/Protein	intercellular adhesion molecule - 1,97,132,Gene/Protein	VCAM - 1 mRNA,231,244,Gene/Protein	"[{""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 30, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 79, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 97, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1 mRNA"", ""start_span"": 231, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
The importance of BCL2 and Stat3 on IL - 6 - induced macrophage - differentiation and apoptosis was studied with 1A9 - M cells expressing human BCL2 or a dominant - negative form of Stat3, respectively.	BCL2,18,22,Gene/Protein	Stat3,27,32,Gene/Protein	IL - 6,36,42,Gene/Protein	human BCL2,138,148,Gene/Protein	Stat3,182,187,Gene/Protein	"[{""token"": ""BCL2"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""human BCL2"", ""start_span"": 138, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 182, ""end_span"": 187, ""type"": ""Gene/Protein""}]"	train
Interleukin - 8 ( IL - 8) is a chemokine that belongs to the alpha - chemokine or CXC subfamily and is produced by a wide variety of human cells, including monocytes and polymorphonuclear cells ( PMN).	Interleukin - 8,0,15,Gene/Protein	IL - 8,18,24,Gene/Protein	chemokine,31,40,Gene/Protein	alpha - chemokine,61,78,Gene/Protein	CXC subfamily,82,95,Gene/Protein	"[{""token"": ""Interleukin - 8"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""chemokine"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""alpha - chemokine"", ""start_span"": 61, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""CXC subfamily"", ""start_span"": 82, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	train
The suggested roles of the downstream 3 ' regions acting as a Locus Control Region ( LCR), have allowed comparisons to be made between the regulation of the IgH locus with other model systems whose gene expression is governed by LCR activity.	downstream 3 ' regions,27,49,Gene/Protein	Locus Control Region,62,82,Gene/Protein	LCR,85,88,Gene/Protein	IgH locus,157,166,Gene/Protein	LCR,229,232,Gene/Protein	"[{""token"": ""downstream 3 ' regions"", ""start_span"": 27, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Locus Control Region"", ""start_span"": 62, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""LCR"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""IgH locus"", ""start_span"": 157, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""LCR"", ""start_span"": 229, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	train
Cooperation of binding sites for STAT6 and NF kappa B / rel in the IL - 4 - induced up - regulation of the human IgE germline promoter.	binding sites,15,28,Gene/Protein	STAT6,33,38,Gene/Protein	NF kappa B / rel,43,59,Gene/Protein	IL - 4,67,73,Gene/Protein	human IgE germline promoter,107,134,Gene/Protein	"[{""token"": ""binding sites"", ""start_span"": 15, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B / rel"", ""start_span"": 43, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""human IgE germline promoter"", ""start_span"": 107, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
IL - 2 and T cell antigen receptor complex induction of STAT3alpha serine 727 phosphorylation is dependent on the activity of the MEK / ERK pathway.	IL - 2,0,6,Gene/Protein	T cell antigen receptor complex,11,42,Gene/Protein	STAT3alpha,56,66,Gene/Protein	MEK,130,133,Gene/Protein	/ ERK,134,139,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""T cell antigen receptor complex"", ""start_span"": 11, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""STAT3alpha"", ""start_span"": 56, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""MEK"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""/ ERK"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
Transcription factor NF - kappa B must be released from cytoplasmic inhibitory molecules ( I kappa Bs) in order to move to the nucleus and to activate its target genes.	Transcription factor,0,20,Gene/Protein	NF - kappa B,21,33,Gene/Protein	cytoplasmic inhibitory molecules,56,88,Gene/Protein	I kappa Bs,91,101,Gene/Protein	target genes,155,167,Gene/Protein	"[{""token"": ""Transcription factor"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 21, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic inhibitory molecules"", ""start_span"": 56, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""I kappa Bs"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""target genes"", ""start_span"": 155, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
Further, M. tuberculosis and its tuberculin, purified protein derivative, induced the degradation of I kappa B - alpha and the expression of I kappa B - alpha mRNA, and purified protein derivative induced the activation of NF - kappa B in monocytes.	tuberculin,33,43,Gene/Protein	purified protein derivative,45,72,Gene/Protein	I kappa B - alpha,101,118,Gene/Protein	I kappa B - alpha mRNA,141,163,Gene/Protein	NF - kappa B,223,235,Gene/Protein	"[{""token"": ""tuberculin"", ""start_span"": 33, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""purified protein derivative"", ""start_span"": 45, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B - alpha"", ""start_span"": 101, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B - alpha mRNA"", ""start_span"": 141, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 223, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
Both cytokines induced assembly of STAT5A and STAT5B containing complexes capable of binding to the interferon - gamma activation sequence ( GAS), and these complexes rapidly translocated ( within 1 min) into the nucleus of IL - 2 - or IL - 7 - treated cells.	cytokines,5,14,Gene/Protein	STAT5A,35,41,Gene/Protein	STAT5B,46,52,Gene/Protein	interferon - gamma activation sequence,100,138,Gene/Protein	GAS,141,144,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 5, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""STAT5A"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""STAT5B"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""interferon - gamma activation sequence"", ""start_span"": 100, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""GAS"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
The POU transcription factors Oct - 1 and Oct - 2 regulate the activity of octamer - dependent promoters, including those that direct transcription from rearranged immunoglobulin genes.	POU transcription factors,4,29,Gene/Protein	Oct - 1,30,37,Gene/Protein	Oct - 2,42,49,Gene/Protein	octamer - dependent promoters,75,104,Gene/Protein	immunoglobulin genes,164,184,Gene/Protein	"[{""token"": ""POU transcription factors"", ""start_span"": 4, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""octamer - dependent promoters"", ""start_span"": 75, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin genes"", ""start_span"": 164, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
The tax protein of human T - cell leukemia virus type 1 mediates the transactivation of the c - sis / platelet - derived growth factor - B promoter through interactions with the zinc finger transcription factors Sp1 and NGFI - A / Egr - 1.	tax protein,4,15,Gene/Protein	c - sis / platelet - derived growth factor - B promoter,92,147,Gene/Protein	zinc finger transcription factors,178,211,Gene/Protein	Sp1,212,215,Gene/Protein	NGFI - A / Egr - 1,220,238,Gene/Protein	"[{""token"": ""tax protein"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""c - sis / platelet - derived growth factor - B promoter"", ""start_span"": 92, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger transcription factors"", ""start_span"": 178, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""NGFI - A / Egr - 1"", ""start_span"": 220, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	train
One ATF / CRE motif is located in the distal promoter at the nuclear matrix - associated Site IV, and the second motif is present in the proximal promoter at Site I.	ATF / CRE motif,4,19,Gene/Protein	distal promoter,38,53,Gene/Protein	nuclear matrix - associated Site IV,61,96,Gene/Protein	proximal promoter,137,154,Gene/Protein	Site I,158,164,Gene/Protein	"[{""token"": ""ATF / CRE motif"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""distal promoter"", ""start_span"": 38, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""nuclear matrix - associated Site IV"", ""start_span"": 61, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""proximal promoter"", ""start_span"": 137, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""Site I"", ""start_span"": 158, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
Neither the PLC gamma 1 overexpression induced by IFN nor the increased hydrolytic activity of the enzyme appear to be affected by pretreatment of the cells with the protein tyrosine kinase inhibitor genistein, which is known to prevent the association of ISGF3 components.	PLC gamma 1,12,23,Gene/Protein	IFN,50,53,Gene/Protein	enzyme,99,105,Gene/Protein	tyrosine kinase,174,189,Gene/Protein	ISGF3,256,261,Gene/Protein	"[{""token"": ""PLC gamma 1"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""enzyme"", ""start_span"": 99, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine kinase"", ""start_span"": 174, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""ISGF3"", ""start_span"": 256, ""end_span"": 261, ""type"": ""Gene/Protein""}]"	train
Moreover, anti - TNF - alpha inhibited HIV - 1 long terminal repeat ( LTR) - driven transcription of a reporter gene in primary T cells in response to activation, either in the presence or the absence of HIV - 1 Tat.	anti - TNF - alpha,10,28,Gene/Protein	HIV - 1 long terminal repeat,39,67,Gene/Protein	LTR,70,73,Gene/Protein	reporter gene,103,116,Gene/Protein	HIV - 1 Tat,204,215,Gene/Protein	"[{""token"": ""anti - TNF - alpha"", ""start_span"": 10, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat"", ""start_span"": 39, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene"", ""start_span"": 103, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 Tat"", ""start_span"": 204, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
These results indicate that JAK2 / STAT5 activation is a common JAK / STAT pathway for hIL - 5 - mediated signal in these cells.	JAK2,28,32,Gene/Protein	/ STAT5,33,40,Gene/Protein	JAK,64,67,Gene/Protein	/ STAT,68,74,Gene/Protein	hIL - 5,87,94,Gene/Protein	"[{""token"": ""JAK2"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""/ STAT5"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""/ STAT"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""hIL - 5"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene/Protein""}]"	train
The pp52 promoter contains an initiator specifying the unique 5 ' terminus of pp52 mRNA, tandem pairs of Ets and SP1 motifs, and a lone C / EBP motif.	pp52 promoter,4,17,Gene/Protein	5 ' terminus,62,74,Gene/Protein	pp52 mRNA,78,87,Gene/Protein	Ets and SP1 motifs,105,123,Gene/Protein	lone C / EBP motif,131,149,Gene/Protein	"[{""token"": ""pp52 promoter"", ""start_span"": 4, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""5 ' terminus"", ""start_span"": 62, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""pp52 mRNA"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""Ets and SP1 motifs"", ""start_span"": 105, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""lone C / EBP motif"", ""start_span"": 131, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
In a previous study, we demonstrated that bufalin, which is an active principle of Chinese medicine, chan ' su, caused apoptosis in human leukemia U937 cells by anomalous activation of mitogen - activated protein kinase ( MAPK) via the signaling pathway of Ras, Raf - 1, and MAPK kinase - 1.	mitogen - activated protein kinase,185,219,Gene/Protein	MAPK,222,226,Gene/Protein	Ras,257,260,Gene/Protein	Raf - 1,262,269,Gene/Protein	MAPK kinase - 1,275,290,Gene/Protein	"[{""token"": ""mitogen - activated protein kinase"", ""start_span"": 185, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 222, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 257, ""end_span"": 260, ""type"": ""Gene/Protein""}, {""token"": ""Raf - 1"", ""start_span"": 262, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""MAPK kinase - 1"", ""start_span"": 275, ""end_span"": 290, ""type"": ""Gene/Protein""}]"	train
Signaling through CD40 with soluble CD40 ligand stimulated fibroblast activation, as evidenced by mobilization of nuclear factor - kappaB and by induction of the proinflammatory and chemoattractant cytokines IL - 6 and IL - 8.	CD40,18,22,Gene/Protein	CD40,36,40,Gene/Protein	cytokines,198,207,Gene/Protein	IL - 6,208,214,Gene/Protein	IL - 8,219,225,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 198, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 208, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 219, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	train
In fact, mAb L243 but not the staphylococcal superantigens, staphylococcal exotoxin toxic shock syndrome toxin - I or staphylococcal enterotoxin B, regulate the NF - kappa B binding activity.	mAb L243,9,17,Gene/Protein	staphylococcal superantigens,30,58,Gene/Protein	staphylococcal exotoxin toxic shock syndrome toxin - I,60,114,Gene/Protein	staphylococcal enterotoxin B,118,146,Gene/Protein	NF - kappa B,161,173,Gene/Protein	"[{""token"": ""mAb L243"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""staphylococcal superantigens"", ""start_span"": 30, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""staphylococcal exotoxin toxic shock syndrome toxin - I"", ""start_span"": 60, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""staphylococcal enterotoxin B"", ""start_span"": 118, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 161, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Functional analysis of monocytic THP - 1 cells transfected with plasmids containing various lengths of TNF - alpha promoter localized enhancer elements in a region ( - 182 to - 37 base pairs ( bp)) that were required for optimal transcription of the TNF - alpha gene in response to LPS.	plasmids,64,72,Gene/Protein	TNF - alpha promoter,103,123,Gene/Protein	enhancer elements,134,151,Gene/Protein	- 182 to - 37 base pairs,166,190,Gene/Protein	TNF - alpha gene,250,266,Gene/Protein	"[{""token"": ""plasmids"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha promoter"", ""start_span"": 103, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""enhancer elements"", ""start_span"": 134, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""- 182 to - 37 base pairs"", ""start_span"": 166, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha gene"", ""start_span"": 250, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
IL - 10 inhibition of IFN - gamma - induced ICAM - 1 expression was apparent as early as 3 hours and was blocked by an anti - IL - 10 antibody but not by an isotype - matched control antibody.	IL - 10,0,7,Gene/Protein	IFN - gamma,22,33,Gene/Protein	ICAM - 1,44,52,Gene/Protein	anti - IL - 10 antibody,119,142,Gene/Protein	isotype - matched control antibody,157,191,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 22, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""anti - IL - 10 antibody"", ""start_span"": 119, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""isotype - matched control antibody"", ""start_span"": 157, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
While the activation of JAK2, Shc, Erk, and STAT5 proteins correlated with hGM - CSF - mediated cell growth, cellular differentiation occurred in the absence of activation of these signal transduction pathways.	JAK2,24,28,Gene/Protein	Shc,30,33,Gene/Protein	Erk,35,38,Gene/Protein	STAT5 proteins,44,58,Gene/Protein	hGM - CSF,75,84,Gene/Protein	"[{""token"": ""JAK2"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""Shc"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""Erk"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""STAT5 proteins"", ""start_span"": 44, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""hGM - CSF"", ""start_span"": 75, ""end_span"": 84, ""type"": ""Gene/Protein""}]"	train
Molecular cloning and characterization of a cDNA, CHEMR1, encoding a chemokine receptor with a homology to the human C - C chemokine receptor, CCR - 4.	cDNA,44,48,Gene/Protein	CHEMR1,50,56,Gene/Protein	chemokine receptor,69,87,Gene/Protein	human C - C chemokine receptor,111,141,Gene/Protein	CCR - 4,143,150,Gene/Protein	"[{""token"": ""cDNA"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""CHEMR1"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""chemokine receptor"", ""start_span"": 69, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""human C - C chemokine receptor"", ""start_span"": 111, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""CCR - 4"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
Human immunodeficiency virus type 1 ( HIV - 1) Tat, an early regulatory protein that is critical for viral gene expression and replication, transactivates the HIV - 1 long terminal repeat ( LTR) via its binding to the transactivation response element ( TAR) and, along with other cellular factors, increases viral transcription initiation and elongation.	regulatory protein,61,79,Gene/Protein	HIV - 1 long terminal repeat,159,187,Gene/Protein	LTR,190,193,Gene/Protein	transactivation response element,218,250,Gene/Protein	TAR,253,256,Gene/Protein	"[{""token"": ""regulatory protein"", ""start_span"": 61, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat"", ""start_span"": 159, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 190, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""transactivation response element"", ""start_span"": 218, ""end_span"": 250, ""type"": ""Gene/Protein""}, {""token"": ""TAR"", ""start_span"": 253, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
In this study, a combined pharmacologic and genetic strategy using two PKC ( NF - kappa B) inhibitors, pentoxifylline ( PTX) and Go - 6976, and a stably expressed anti - Tat single - chain intracellular antibody ( sFv intrabody) was employed to obtain cooperative inhibition of both HIV - 1 LTR - driven gene expression and HIV - 1 replication.	PKC,71,74,Gene/Protein	NF - kappa B,77,89,Gene/Protein	anti - Tat single - chain intracellular antibody,163,211,Gene/Protein	sFv intrabody,214,227,Gene/Protein	LTR,291,294,Gene/Protein	"[{""token"": ""PKC"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""anti - Tat single - chain intracellular antibody"", ""start_span"": 163, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""sFv intrabody"", ""start_span"": 214, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 291, ""end_span"": 294, ""type"": ""Gene/Protein""}]"	train
We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an impaired nuclear translocation of the Rel proteins c - Rel, RelA / p65 and NF - kappa B1 / p50, whereas the nuclear appearance of RelB remains unaffected.	Rel proteins,180,192,Gene/Protein	c - Rel,193,200,Gene/Protein	RelA / p65,202,212,Gene/Protein	NF - kappa B1 / p50,217,236,Gene/Protein	RelB,272,276,Gene/Protein	"[{""token"": ""Rel proteins"", ""start_span"": 180, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 193, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""RelA / p65"", ""start_span"": 202, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B1 / p50"", ""start_span"": 217, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 272, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	train
Accordingly, immunoblot experiments showed that amongst NF - kappa B / Rel proteins, RelA and p50 are mobilized to the nucleus following microglial cell stimulation with A beta ( 25 - 35) plus IFN gamma.	NF - kappa B,56,68,Gene/Protein	/ Rel proteins,69,83,Gene/Protein	RelA,85,89,Gene/Protein	p50,94,97,Gene/Protein	IFN gamma,193,202,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 56, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""/ Rel proteins"", ""start_span"": 69, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""IFN gamma"", ""start_span"": 193, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
EMS analyses utilizing a series of mutated pp repeat elements demonstrate that the nucleotide sequence requirements for U1 ( U1A / U1B) and U2 formation are separable from those required for C1 - C3 formation.	mutated pp repeat elements,35,61,Gene/Protein	U1,120,122,Gene/Protein	U1A / U1B,125,134,Gene/Protein	U2,140,142,Gene/Protein	C1 - C3,191,198,Gene/Protein	"[{""token"": ""mutated pp repeat elements"", ""start_span"": 35, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""U1"", ""start_span"": 120, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""U1A / U1B"", ""start_span"": 125, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""U2"", ""start_span"": 140, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""C1 - C3"", ""start_span"": 191, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
Induction of STAT3 is inhibited by both the serine / threonine protein kinase inhibitor H - 7 and the immunosuppressive drug rapamycin and requires de novo protein synthesis, demonstrating novel coupling between sIg and STAT proteins that differs from the classical paradigm for STAT induction by cytokine receptors.	STAT3,13,18,Gene/Protein	sIg,212,215,Gene/Protein	STAT proteins,220,233,Gene/Protein	STAT,279,283,Gene/Protein	cytokine receptors,297,315,Gene/Protein	"[{""token"": ""STAT3"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""sIg"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""STAT proteins"", ""start_span"": 220, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""STAT"", ""start_span"": 279, ""end_span"": 283, ""type"": ""Gene/Protein""}, {""token"": ""cytokine receptors"", ""start_span"": 297, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
The human TF promoter contains binding sites for the transcription factors AP - 1, c - Rel / p65, Egr - 1, and Sp1.	human TF promoter,4,21,Gene/Protein	AP - 1,75,81,Gene/Protein	c - Rel / p65,83,96,Gene/Protein	Egr - 1,98,105,Gene/Protein	Sp1,111,114,Gene/Protein	"[{""token"": ""human TF promoter"", ""start_span"": 4, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel / p65"", ""start_span"": 83, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}]"	train
Using the yeast two - hybrid system to screen for proteins which interact with Tax1, we isolated the B subunit of the CCAAT binding protein NF - Y from a HeLa cDNA library.	Tax1,79,83,Gene/Protein	B subunit,101,110,Gene/Protein	CCAAT binding protein,118,139,Gene/Protein	NF - Y,140,146,Gene/Protein	HeLa cDNA library,154,171,Gene/Protein	"[{""token"": ""Tax1"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""B subunit"", ""start_span"": 101, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""CCAAT binding protein"", ""start_span"": 118, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""NF - Y"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""HeLa cDNA library"", ""start_span"": 154, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
Using a mitogenically incompetent human G - CSFR mutant in which Pro639 and Pro641 were substituted by alanine, the box 1 PDP motif was found to be required for activation of Jak kinases, tyrosine phosphorylation of the G - CSFR, and recruitment of Stat proteins.	mitogenically incompetent human G - CSFR mutant,8,55,Gene/Protein	box 1 PDP motif,116,131,Gene/Protein	Jak kinases,175,186,Gene/Protein	G - CSFR,220,228,Gene/Protein	Stat proteins,249,262,Gene/Protein	"[{""token"": ""mitogenically incompetent human G - CSFR mutant"", ""start_span"": 8, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""box 1 PDP motif"", ""start_span"": 116, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""Jak kinases"", ""start_span"": 175, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""G - CSFR"", ""start_span"": 220, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""Stat proteins"", ""start_span"": 249, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	train
Activation of the Jak - Stat pathway correlates with proliferative signaling by the G - CSFR and requires the membrane - proximal box 1 PXP motif, which is conserved in members of the cytokine receptor superfamily.	Jak,18,21,Gene/Protein	- Stat,22,28,Gene/Protein	G - CSFR,84,92,Gene/Protein	membrane - proximal box 1 PXP motif,110,145,Gene/Protein	cytokine receptor superfamily,184,213,Gene/Protein	"[{""token"": ""Jak"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""- Stat"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""G - CSFR"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""membrane - proximal box 1 PXP motif"", ""start_span"": 110, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""cytokine receptor superfamily"", ""start_span"": 184, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
GC efficiently suppressed IL - 5 synthesis of T - cell clones activated via either T - cell receptor ( TCR) or IL - 2 receptor ( IL - 2R).	IL - 5,26,32,Gene/Protein	T - cell receptor,83,100,Gene/Protein	TCR,103,106,Gene/Protein	IL - 2 receptor,111,126,Gene/Protein	IL - 2R,129,136,Gene/Protein	"[{""token"": ""IL - 5"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""T - cell receptor"", ""start_span"": 83, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor"", ""start_span"": 111, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R"", ""start_span"": 129, ""end_span"": 136, ""type"": ""Gene/Protein""}]"	train
In addition, RFX1 can bind simultaneously, most likely as a heterodimer, with the transcription factor MIBP1 to NRE gamma.	RFX1,13,17,Gene/Protein	heterodimer,60,71,Gene/Protein	transcription factor,82,102,Gene/Protein	MIBP1,103,108,Gene/Protein	NRE gamma,112,121,Gene/Protein	"[{""token"": ""RFX1"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""heterodimer"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 82, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""MIBP1"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""NRE gamma"", ""start_span"": 112, ""end_span"": 121, ""type"": ""Gene/Protein""}]"	train
We found that NFATx1 DNA binding activity and interaction with AP - 1 polypeptides were dependent on its central Rel similarity region and that transcriptional activation was reduced by deletions of either its N - terminal domain or its C - terminal domain, suggesting the presence of intrinsic transcriptional activation motifs in both regions.	NFATx1,14,20,Gene/Protein	central Rel similarity region,105,134,Gene/Protein	N - terminal domain,210,229,Gene/Protein	C - terminal domain,237,256,Gene/Protein	intrinsic transcriptional activation motifs,285,328,Gene/Protein	"[{""token"": ""NFATx1"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""central Rel similarity region"", ""start_span"": 105, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal domain"", ""start_span"": 210, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal domain"", ""start_span"": 237, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""intrinsic transcriptional activation motifs"", ""start_span"": 285, ""end_span"": 328, ""type"": ""Gene/Protein""}]"	train
NO is produced from at least three different NO synthase ( NOS) isoforms: neuronal NOS ( nNOS), endothelial NOS, and immunologic NOS ( iNOS).	neuronal NOS,74,86,Gene/Protein	nNOS,89,93,Gene/Protein	endothelial NOS,96,111,Gene/Protein	immunologic NOS,117,132,Gene/Protein	iNOS,135,139,Gene/Protein	"[{""token"": ""neuronal NOS"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""nNOS"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""endothelial NOS"", ""start_span"": 96, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""immunologic NOS"", ""start_span"": 117, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""iNOS"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
The transcriptional regulatory elements of many inducible T - cell genes contain adjacent or overlapping binding sites for the Ets and NF - kappaB / NFAT families of transcription factors.	transcriptional regulatory elements,4,39,Gene/Protein	inducible T - cell genes,48,72,Gene/Protein	overlapping binding sites,93,118,Gene/Protein	Ets and NF - kappaB / NFAT families,127,162,Gene/Protein	transcription factors,166,187,Gene/Protein	"[{""token"": ""transcriptional regulatory elements"", ""start_span"": 4, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""inducible T - cell genes"", ""start_span"": 48, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""overlapping binding sites"", ""start_span"": 93, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""Ets and NF - kappaB / NFAT families"", ""start_span"": 127, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 166, ""end_span"": 187, ""type"": ""Gene/Protein""}]"	train
Nuclear factor of activated T cells and AP - 1 are insufficient for IL - 2 promoter activation: requirement for CD28 up - regulation of RE / AP.	Nuclear factor of activated T cells,0,35,Gene/Protein	AP - 1,40,46,Gene/Protein	IL - 2 promoter,68,83,Gene/Protein	CD28,112,116,Gene/Protein	RE / AP,136,143,Gene/Protein	"[{""token"": ""Nuclear factor of activated T cells"", ""start_span"": 0, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 68, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""RE / AP"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	train
Under these conditions HUVEC adhesion molecules, E - selectin, VCAM - 1 and ICAM - 1, were increased at 3 h with only ICAM - 1 remaining overexpressed at 24 h.	HUVEC adhesion molecules,23,47,Gene/Protein	E - selectin,49,61,Gene/Protein	VCAM - 1,63,71,Gene/Protein	ICAM - 1,76,84,Gene/Protein	ICAM - 1,118,126,Gene/Protein	"[{""token"": ""HUVEC adhesion molecules"", ""start_span"": 23, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 49, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 63, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	train
These data indicate specific modulation of the CREB / ATF - 1 family of transcription factors by the CD2 signalling pathway and suggest CD2 receptor modulation of CRE - mediated transcription following ligand engagement ( e. g. cell - to - cell contact).	CREB / ATF - 1 family,47,68,Gene/Protein	transcription factors,72,93,Gene/Protein	CD2,101,104,Gene/Protein	CD2,136,139,Gene/Protein	CRE,163,166,Gene/Protein	"[{""token"": ""CREB / ATF - 1 family"", ""start_span"": 47, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 72, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""CRE"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
Interleukin - 10 ( IL - 10) and transforming growth factor beta ( TGF - beta) are inhibitory for B and T cells, IgE production, and mast cell proliferation, and they induce apoptosis in eosinophils.	Interleukin - 10,0,16,Gene/Protein	IL - 10,19,26,Gene/Protein	transforming growth factor beta,32,63,Gene/Protein	TGF - beta,66,76,Gene/Protein	IgE,112,115,Gene/Protein	"[{""token"": ""Interleukin - 10"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""transforming growth factor beta"", ""start_span"": 32, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene/Protein""}]"	train
The IL - 10 gene polymorphism was a C - to - A exchange 571 base pairs upstream from the translation start site and was present between consensus binding sequences for Sp1 and elevated total serum.	IL - 10,4,11,Gene/Protein	571 base pairs upstream,56,79,Gene/Protein	translation start site,89,111,Gene/Protein	consensus binding sequences,136,163,Gene/Protein	Sp1,168,171,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""571 base pairs upstream"", ""start_span"": 56, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""translation start site"", ""start_span"": 89, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""consensus binding sequences"", ""start_span"": 136, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 168, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
We investigated the function of the evolutionary conserved X2 box in the promoter of the HLA - DRA gene from the human major histocompatibility complex ( MHC) in resting and activated B cells.	X2 box,59,65,Gene/Protein	promoter,73,81,Gene/Protein	HLA - DRA gene,89,103,Gene/Protein	human major histocompatibility complex,113,151,Gene/Protein	MHC,154,157,Gene/Protein	"[{""token"": ""X2 box"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DRA gene"", ""start_span"": 89, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""human major histocompatibility complex"", ""start_span"": 113, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""MHC"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
Cross - linking of FcR, on the THP - 1 monocytic cell line, by immune complexes resulted in both activation of the transcription factor NF - kappaB and interleukin 1 production.	FcR,19,22,Gene/Protein	immune complexes,63,79,Gene/Protein	transcription factor,115,135,Gene/Protein	NF - kappaB,136,147,Gene/Protein	interleukin 1,152,165,Gene/Protein	"[{""token"": ""FcR"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""immune complexes"", ""start_span"": 63, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 115, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 1"", ""start_span"": 152, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
Neither the E12 nor the E47 product of the E2A gene nor the wild - type HLF protein was able to protect the cells from apoptosis induced by IL - 3 deprivation.	E12,12,15,Gene/Protein	E47,24,27,Gene/Protein	E2A gene,43,51,Gene/Protein	wild - type HLF protein,60,83,Gene/Protein	IL - 3,140,146,Gene/Protein	"[{""token"": ""E12"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""E47"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""E2A gene"", ""start_span"": 43, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""wild - type HLF protein"", ""start_span"": 60, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
Progesterone effectively blocked a broad spectrum of K + channels, reducing both Kv1. 3 and charybdotoxin - resistant components of KV current and KCa current in T cells, as well as blocking several cloned KV channels expressed in cell lines.	K + channels,53,65,Gene/Protein	charybdotoxin - resistant components,92,128,Gene/Protein	KV,132,134,Gene/Protein	KCa,147,150,Gene/Protein	cloned KV channels,199,217,Gene/Protein	"[{""token"": ""K + channels"", ""start_span"": 53, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""charybdotoxin - resistant components"", ""start_span"": 92, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""KV"", ""start_span"": 132, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""KCa"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""cloned KV channels"", ""start_span"": 199, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	train
It was proposed that the mechanism of antiviral action of S9a was on the host cell, by blocking TNF - alpha transcription via a Tat - induced tar - independent loop, which decreases downstream NF - kappaB activation of HIV - 1 long terminal repeat ( LTR).	TNF - alpha,96,107,Gene/Protein	Tat,128,131,Gene/Protein	NF - kappaB,193,204,Gene/Protein	HIV - 1 long terminal repeat,219,247,Gene/Protein	LTR,250,253,Gene/Protein	"[{""token"": ""TNF - alpha"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""Tat"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 193, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat"", ""start_span"": 219, ""end_span"": 247, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 250, ""end_span"": 253, ""type"": ""Gene/Protein""}]"	train
PDBu + iono induced equally high IL - 2 levels in both groups and, when stimulated with plate - bound anti - CD3 monoclonal antibody ( mAb), the IL - 2 secretion by neonatal cells was undetectable and adult cells produced low amounts of IL - 2 ( mean 331 + / - 86 pg / ml).	IL - 2,33,39,Gene/Protein	anti - CD3 monoclonal antibody,102,132,Gene/Protein	mAb,135,138,Gene/Protein	IL - 2,145,151,Gene/Protein	IL - 2,237,243,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3 monoclonal antibody"", ""start_span"": 102, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""mAb"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 237, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
Our results suggest that reduced IL - 2 production by neonatal T cells is specific for anti - CD3 and anti - CD3 + anti - CD28 - mediated stimulation and that these activators can not effectively activate the ROI - NF - kappa B signalling pathway in neonatal T cells.	IL - 2,33,39,Gene/Protein	anti - CD3,87,97,Gene/Protein	anti - CD3,102,112,Gene/Protein	anti - CD28,115,126,Gene/Protein	- NF - kappa B,213,227,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 87, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 102, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD28"", ""start_span"": 115, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""- NF - kappa B"", ""start_span"": 213, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
The Duffy protein is a receptor for the Plasmodium vivax erythrocyte - binding protein and is also a receptor for various chemokines ( thus renamed Duffy Antigen Receptor for Chemokines [ DARC]).	Duffy protein,4,17,Gene/Protein	Plasmodium vivax erythrocyte - binding protein,40,86,Gene/Protein	chemokines,122,132,Gene/Protein	Duffy Antigen Receptor for Chemokines,148,185,Gene/Protein	DARC,188,192,Gene/Protein	"[{""token"": ""Duffy protein"", ""start_span"": 4, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""Plasmodium vivax erythrocyte - binding protein"", ""start_span"": 40, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""chemokines"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""Duffy Antigen Receptor for Chemokines"", ""start_span"": 148, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""DARC"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
The transcription factors active at the IL - 2 promoter were differentially influenced: upon down - modulation of okadaic acid - sensitive phosphatases, transactivation by octamer, NF - kappa B, and NF of activated T cells proteins was abrogated, while transactivation by AP - 1 proteins was even enhanced.	transcription factors,4,25,Gene/Protein	IL - 2 promoter,40,55,Gene/Protein	okadaic acid - sensitive phosphatases,114,151,Gene/Protein	NF - kappa B,181,193,Gene/Protein	NF of activated T cells proteins,199,231,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 4, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 40, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""okadaic acid - sensitive phosphatases"", ""start_span"": 114, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 181, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""NF of activated T cells proteins"", ""start_span"": 199, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
However, the change in p130 phosphorylation in response to alpha - IFN occurs before dephosphorylation of pRb is complete because loss of p130 Form 3 occurs throughout the cell cycle prior to complete arrest in G1, whereas pRb is dephosphorylated only in G1.	p130,23,27,Gene/Protein	alpha - IFN,59,70,Gene/Protein	pRb,106,109,Gene/Protein	p130 Form 3,138,149,Gene/Protein	pRb,223,226,Gene/Protein	"[{""token"": ""p130"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""alpha - IFN"", ""start_span"": 59, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""pRb"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""p130 Form 3"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""pRb"", ""start_span"": 223, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	train
This pathway resulted in the induction of the transcription factors NF - kappa B, NF - AT, and proteins binding to the CD28 response element of the IL - 2 promoter.	transcription factors,46,67,Gene/Protein	NF - kappa B,68,80,Gene/Protein	NF - AT,82,89,Gene/Protein	CD28,119,123,Gene/Protein	IL - 2 promoter,148,163,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 46, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 148, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
We first demonstrate, in human and mouse intraspecies hybrids, the coordinate suppression of MHC class II, Ii ( invariant chain) and HLA - DM gene transcription, and the release of the silencing by the addition of interferon gamma.	MHC class II,93,105,Gene/Protein	Ii,107,109,Gene/Protein	invariant chain,112,127,Gene/Protein	HLA - DM gene,133,146,Gene/Protein	interferon gamma,214,230,Gene/Protein	"[{""token"": ""MHC class II"", ""start_span"": 93, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Ii"", ""start_span"": 107, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""invariant chain"", ""start_span"": 112, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DM gene"", ""start_span"": 133, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""interferon gamma"", ""start_span"": 214, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
In contrast, a mutant of Tax termed M22, which does not induce NF - kappaB, fails to activate either IKKalpha or IKKbeta.	Tax,25,28,Gene/Protein	M22,36,39,Gene/Protein	NF - kappaB,63,74,Gene/Protein	IKKalpha,101,109,Gene/Protein	IKKbeta,113,120,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""M22"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""IKKalpha"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene/Protein""}]"	train
IL - 7 did not maintain v - Abl - mediated differentiation arrest of the pre - B cells, as activation of NF - kappaB and RAG gene transcription was unaffected by IL - 7.	IL - 7,0,6,Gene/Protein	v - Abl,24,31,Gene/Protein	NF - kappaB,105,116,Gene/Protein	RAG gene,121,129,Gene/Protein	IL - 7,162,168,Gene/Protein	"[{""token"": ""IL - 7"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""v - Abl"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""RAG gene"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
Functional analysis of the promoter by transient transfection assays indicated that synergistic action between an SP - 1 - like element at - 21 / - 12, a GATA site at - 59 / - 54, and a novel regulatory element, CPRE ( - GGACTACAG -) at - 49 / - 41, is essential for the promoter activity in murine erythroleukemia ( MEL) cells.	SP - 1 - like element,114,135,Gene/Protein	GATA site,154,163,Gene/Protein	novel regulatory element,186,210,Gene/Protein	CPRE,212,216,Gene/Protein	GGACTACAG,221,230,Gene/Protein	"[{""token"": ""SP - 1 - like element"", ""start_span"": 114, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""GATA site"", ""start_span"": 154, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""novel regulatory element"", ""start_span"": 186, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""CPRE"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""GGACTACAG"", ""start_span"": 221, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
Here we investigated the impact of retinoid X receptor ( RXR), retinoic acid receptor ( RAR), and of the c - erbA / thyroid hormone ( T3) receptor ( c - erbA / TR) on growth and differentiation of erythroid cells using an in vitro culture system of stem cell factor - dependent erythroid progenitors.	retinoid X receptor,35,54,Gene/Protein	RXR,57,60,Gene/Protein	retinoic acid receptor,63,85,Gene/Protein	RAR,88,91,Gene/Protein	c - erbA / TR,149,162,Gene/Protein	"[{""token"": ""retinoid X receptor"", ""start_span"": 35, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""RXR"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""retinoic acid receptor"", ""start_span"": 63, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""RAR"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""c - erbA / TR"", ""start_span"": 149, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
The activation of NF - kappaB has been recognized to regulate a number of genes necessary for normal T cell responses including IL - 2, IL - 6, IL - 8, and several T cell surface receptors.	NF - kappaB,18,29,Gene/Protein	IL - 2,128,134,Gene/Protein	IL - 6,136,142,Gene/Protein	IL - 8,144,150,Gene/Protein	T cell surface receptors,164,188,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""T cell surface receptors"", ""start_span"": 164, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
SLP - 76 was not required for TCR - induced tyrosine phosphorylation of most proteins, but was required for optimal tyrosine phosphorylation and activation of phospholipase C - gamma1 ( PLC - gamma1), as well as Ras pathway activation.	SLP - 76,0,8,Gene/Protein	TCR,30,33,Gene/Protein	phospholipase C - gamma1,159,183,Gene/Protein	PLC - gamma1,186,198,Gene/Protein	Ras,212,215,Gene/Protein	"[{""token"": ""SLP - 76"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""phospholipase C - gamma1"", ""start_span"": 159, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""PLC - gamma1"", ""start_span"": 186, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
Dominant negative forms of Stat1alpha or Stat3 promoted the EPO - induced erythroid differentiation of UT - 7 / GM cells, even in the presence of granulocyte - macrophage colony - stimulating factor, although this cytokine never induced erythroid differentiation of the parent UT - 7 / GM cells with or without EPO.	Stat1alpha,27,37,Gene/Protein	Stat3,41,46,Gene/Protein	EPO,60,63,Gene/Protein	granulocyte - macrophage colony - stimulating factor,146,198,Gene/Protein	EPO,311,314,Gene/Protein	"[{""token"": ""Stat1alpha"", ""start_span"": 27, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 146, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 311, ""end_span"": 314, ""type"": ""Gene/Protein""}]"	train
Data obtained by electrophoretic mobility shift assay suggested that the activated Stat - 3 protein associates with the human serum - inducible element ( hSIE) DNA - probe derived from the interferon - gamma activated site ( GAS) in the c - fos promoter, a common DNA sequence for Stat protein binding.	activated Stat - 3 protein,73,99,Gene/Protein	interferon - gamma activated site,189,222,Gene/Protein	GAS,225,228,Gene/Protein	c - fos promoter,237,253,Gene/Protein	Stat protein,281,293,Gene/Protein	"[{""token"": ""activated Stat - 3 protein"", ""start_span"": 73, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""interferon - gamma activated site"", ""start_span"": 189, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""GAS"", ""start_span"": 225, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""c - fos promoter"", ""start_span"": 237, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""Stat protein"", ""start_span"": 281, ""end_span"": 293, ""type"": ""Gene/Protein""}]"	train
BACKGROUND: The class II transactivator ( CIITA) is a bi - or multifunctional domain protein that acts as a transcriptional activator and plays a critical role in the expression of MHC class II genes.	class II transactivator,16,39,Gene/Protein	CIITA,42,47,Gene/Protein	bi - or multifunctional domain protein,54,92,Gene/Protein	transcriptional activator,108,133,Gene/Protein	MHC class II genes,181,199,Gene/Protein	"[{""token"": ""class II transactivator"", ""start_span"": 16, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""bi - or multifunctional domain protein"", ""start_span"": 54, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activator"", ""start_span"": 108, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""MHC class II genes"", ""start_span"": 181, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
Macrophages in human atheroma contain PPARgamma: differentiation - dependent peroxisomal proliferator - activated receptor gamma ( PPARgamma) expression and reduction of MMP - 9 activity through PPARgamma activation in mononuclear phagocytes in vitro.	PPARgamma,38,47,Gene/Protein	differentiation - dependent peroxisomal proliferator - activated receptor gamma,49,128,Gene/Protein	PPARgamma,131,140,Gene/Protein	MMP - 9,170,177,Gene/Protein	PPARgamma,195,204,Gene/Protein	"[{""token"": ""PPARgamma"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""differentiation - dependent peroxisomal proliferator - activated receptor gamma"", ""start_span"": 49, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""PPARgamma"", ""start_span"": 131, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 170, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""PPARgamma"", ""start_span"": 195, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	train
The observation that IL - 4 can differentially regulate the expression of TGF - alpha and TGF - beta1 suggests that IL - 4 may serve as a physiologic molecular switch of TGF expression by the infiltrating eosinophils in wound healing and carcinogenesis.	IL - 4,21,27,Gene/Protein	TGF - alpha,74,85,Gene/Protein	TGF - beta1,90,101,Gene/Protein	IL - 4,116,122,Gene/Protein	TGF,170,173,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""TGF - alpha"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 90, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""TGF"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
These findings show that IL - 13 and IL - 4 have the ability to regulate NK and T cell activation and that IL - 13 is a potent regulator of STAT6 and JAK3 in these cell types.	IL - 13,25,32,Gene/Protein	IL - 4,37,43,Gene/Protein	IL - 13,107,114,Gene/Protein	STAT6,140,145,Gene/Protein	JAK3,150,154,Gene/Protein	"[{""token"": ""IL - 13"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
Activation of the HIV - 1 provirus correlated with the activation of binding of 55 - and 85 - kDa proteins to the kappa B enhancer and binding of the 50 - kDa HLP - 1 protein to the LBP - 1 sequences of the HIV - 1 long terminal repeat.	55 - and 85 - kDa proteins,80,106,Gene/Protein	kappa B enhancer,114,130,Gene/Protein	50 - kDa HLP - 1 protein,150,174,Gene/Protein	LBP - 1 sequences,182,199,Gene/Protein	HIV - 1 long terminal repeat,207,235,Gene/Protein	"[{""token"": ""55 - and 85 - kDa proteins"", ""start_span"": 80, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""kappa B enhancer"", ""start_span"": 114, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""50 - kDa HLP - 1 protein"", ""start_span"": 150, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""LBP - 1 sequences"", ""start_span"": 182, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat"", ""start_span"": 207, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
Transcriptional activation of the macrophage colony - stimulating factor gene by IL - 2 is associated with secretion of bioactive macrophage colony - stimulating factor protein by monocytes and involves activation of the transcription factor NF - kappa B.	macrophage colony - stimulating factor gene,34,77,Gene/Protein	IL - 2,81,87,Gene/Protein	macrophage colony - stimulating factor protein,130,176,Gene/Protein	transcription factor,221,241,Gene/Protein	NF - kappa B,242,254,Gene/Protein	"[{""token"": ""macrophage colony - stimulating factor gene"", ""start_span"": 34, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""macrophage colony - stimulating factor protein"", ""start_span"": 130, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 221, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 242, ""end_span"": 254, ""type"": ""Gene/Protein""}]"	train
Transcriptional activation of the M - CSF gene by IL - 2 is preceded by enhanced binding activity of the transcription factor NF - kappa B to its recognition sequence in the 5 ' regulatory enhancer region of the M - CSF gene.	M - CSF gene,34,46,Gene/Protein	IL - 2,50,56,Gene/Protein	transcription factor,105,125,Gene/Protein	NF - kappa B,126,138,Gene/Protein	M - CSF gene,212,224,Gene/Protein	"[{""token"": ""M - CSF gene"", ""start_span"": 34, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 105, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF gene"", ""start_span"": 212, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
Northern analysis demonstrated coordinate downregulation of alpha globin and gamma globin in addition to the two lineage - restricted transcription factors, SCL and GATA - 1.	alpha globin,60,72,Gene/Protein	gamma globin,77,89,Gene/Protein	transcription factors,134,155,Gene/Protein	SCL,157,160,Gene/Protein	GATA - 1,165,173,Gene/Protein	"[{""token"": ""alpha globin"", ""start_span"": 60, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""gamma globin"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 134, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""SCL"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
To determine whether the defect in the patient ' s T lymphocytes involved a trans - acting factor common to the affected lymphokine genes, we examined the ability of nuclear factors from the patient ' s T lymphocytes to bind response elements present in the regulatory region of IL2.	trans - acting factor,76,97,Gene/Protein	lymphokine genes,121,137,Gene/Protein	nuclear factors,166,181,Gene/Protein	regulatory region,258,275,Gene/Protein	IL2,279,282,Gene/Protein	"[{""token"": ""trans - acting factor"", ""start_span"": 76, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""lymphokine genes"", ""start_span"": 121, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factors"", ""start_span"": 166, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""regulatory region"", ""start_span"": 258, ""end_span"": 275, ""type"": ""Gene/Protein""}, {""token"": ""IL2"", ""start_span"": 279, ""end_span"": 282, ""type"": ""Gene/Protein""}]"	train
In contrast, the binding of the nuclear factor of activated T cells ( NF - AT) to its response element in the IL2 enhancer and to an NF - AT - like response element present in the IL4 enhancer was abnormal.	nuclear factor of activated T cells,32,67,Gene/Protein	NF - AT,70,77,Gene/Protein	IL2 enhancer,110,122,Gene/Protein	NF - AT - like response element,133,164,Gene/Protein	IL4 enhancer,180,192,Gene/Protein	"[{""token"": ""nuclear factor of activated T cells"", ""start_span"": 32, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IL2 enhancer"", ""start_span"": 110, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT - like response element"", ""start_span"": 133, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""IL4 enhancer"", ""start_span"": 180, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
Few known genes ( IL - 2, members of the IL - 8 family, interferon - gamma) are induced in T cells only through the combined effect of phorbol myristic acetate ( PMA) and a Ca ( 2 +) - ionophore, and expression of only these genes can be fully suppressed by Cyclosporin A ( CyA).	genes,10,15,Gene/Protein	IL - 2,18,24,Gene/Protein	IL - 8 family,41,54,Gene/Protein	interferon - gamma,56,74,Gene/Protein	genes,225,230,Gene/Protein	"[{""token"": ""genes"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8 family"", ""start_span"": 41, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""interferon - gamma"", ""start_span"": 56, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""genes"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
Competition with an AP - 1 motif or with anti - Jun and anti - Fos antibodies abolished binding to the NFAT motif in both T and B cells, indicating that Jun and Fos are critical for NFAT complex formation in both cell types.	AP - 1 motif,20,32,Gene/Protein	anti - Jun,41,51,Gene/Protein	anti - Fos antibodies,56,77,Gene/Protein	NFAT motif,103,113,Gene/Protein	NFAT complex,182,194,Gene/Protein	"[{""token"": ""AP - 1 motif"", ""start_span"": 20, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""anti - Jun"", ""start_span"": 41, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""anti - Fos antibodies"", ""start_span"": 56, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""NFAT motif"", ""start_span"": 103, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""NFAT complex"", ""start_span"": 182, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
IFN - MCP was not inhibited by infection with dl343, despite the production of large amounts of both early ( E1B, p55) and late ( hexon) Ad proteins.	IFN,0,3,Gene/Protein	E1B,109,112,Gene/Protein	p55,114,117,Gene/Protein	hexon,130,135,Gene/Protein	Ad proteins,137,148,Gene/Protein	"[{""token"": ""IFN"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""E1B"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""p55"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""hexon"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""Ad proteins"", ""start_span"": 137, ""end_span"": 148, ""type"": ""Gene/Protein""}]"	train
Globin chains ( alpha, beta and gamma) were clearly detectable by affinity chromatography in UT - 7 Epo but not in UT - 7 cells.	Globin chains,0,13,Gene/Protein	alpha,16,21,Gene/Protein	beta,23,27,Gene/Protein	gamma,32,37,Gene/Protein	UT - 7 Epo,93,103,Gene/Protein	"[{""token"": ""Globin chains"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""alpha"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""beta"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""gamma"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""UT - 7 Epo"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Gene/Protein""}]"	train
This paper describes how the expression of the monocyte - macrophage Ag, CD14, and the low affinity Fc receptor for IgE, CD23, were inversely regulated during VitD3 - and RA - induced monocytic differentiation of human U - 937 monoblasts.	monocyte - macrophage Ag,47,71,Gene/Protein	CD14,73,77,Gene/Protein	affinity Fc receptor,91,111,Gene/Protein	IgE,116,119,Gene/Protein	CD23,121,125,Gene/Protein	"[{""token"": ""monocyte - macrophage Ag"", ""start_span"": 47, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""affinity Fc receptor"", ""start_span"": 91, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	train
Increased c - jun, jun - B, and jun - D expression above basal levels and increased transcriptional activity of AP - 1 / TPA responsive elements fused to chloramphenicol acetyl - transferase vectors were observed in T cells treated with TPA alone or in combination with dexamethasone.	c - jun,10,17,Gene/Protein	jun - B,19,26,Gene/Protein	jun - D,32,39,Gene/Protein	AP - 1 / TPA responsive elements,112,144,Gene/Protein	chloramphenicol acetyl - transferase vectors,154,198,Gene/Protein	"[{""token"": ""c - jun"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""jun - B"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""jun - D"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 / TPA responsive elements"", ""start_span"": 112, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyl - transferase vectors"", ""start_span"": 154, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
A novel T cell - specific negative regulatory element ( NRE) composed of two protein - binding sites were mapped in the 5 ' flanking region of the IL - 4 gene: - 311CTCCCTTCT - 303 ( NRE - I) and - 288CTTTTTGCTT - TGC - 300 ( NRE - II).	novel T cell - specific negative regulatory element,2,53,Gene/Protein	NRE,56,59,Gene/Protein	IL - 4 gene,147,158,Gene/Protein	NRE - I,183,190,Gene/Protein	NRE - II,226,234,Gene/Protein	"[{""token"": ""novel T cell - specific negative regulatory element"", ""start_span"": 2, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""NRE"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 gene"", ""start_span"": 147, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""NRE - I"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""NRE - II"", ""start_span"": 226, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
Blockade of the DNA - binding complexes with an anti - Fos mAb demonstrated a direct participation of c - Fos in the AP - 1 complexes induced by anti - AIM mAb.	DNA - binding complexes,16,39,Gene/Protein	anti - Fos mAb,48,62,Gene/Protein	c - Fos,102,109,Gene/Protein	AP - 1 complexes,117,133,Gene/Protein	anti - AIM mAb,145,159,Gene/Protein	"[{""token"": ""DNA - binding complexes"", ""start_span"": 16, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""anti - Fos mAb"", ""start_span"": 48, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 complexes"", ""start_span"": 117, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""anti - AIM mAb"", ""start_span"": 145, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
The endothelium plays a critical role in inflammation by directing circulating leukocytes into extravascular tissues by expressing adhesive molecules for leukocytes [ e. g., endothelial - leukocyte adhesion molecule 1 ( ELAM - 1) and intercellular adhesion molecule 1 ( ICAM - 1)].	adhesive molecules,131,149,Gene/Protein	endothelial - leukocyte adhesion molecule 1,174,217,Gene/Protein	ELAM - 1,220,228,Gene/Protein	intercellular adhesion molecule 1,234,267,Gene/Protein	ICAM - 1,270,278,Gene/Protein	"[{""token"": ""adhesive molecules"", ""start_span"": 131, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""endothelial - leukocyte adhesion molecule 1"", ""start_span"": 174, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""ELAM - 1"", ""start_span"": 220, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule 1"", ""start_span"": 234, ""end_span"": 267, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 270, ""end_span"": 278, ""type"": ""Gene/Protein""}]"	train
The conversion of the TCEd to a ' perfect ' NF - kB binding site leads to a tighter binding of NF - kB to TCEd DNA and, as a functional consequence, to the activity of the ' converted ' TCEd motifs in HeLa cells.	TCEd,22,26,Gene/Protein	' perfect ' NF - kB binding site,32,64,Gene/Protein	NF - kB,95,102,Gene/Protein	TCEd DNA,106,114,Gene/Protein	' converted ' TCEd motifs,172,197,Gene/Protein	"[{""token"": ""TCEd"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""' perfect ' NF - kB binding site"", ""start_span"": 32, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""TCEd DNA"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""' converted ' TCEd motifs"", ""start_span"": 172, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
In lymphocytes activated either by PHA or OKT3 ( but not in resting cells), a 50 - kDa species cross - reacting with a monoclonal antibody against the intestinal vitamin D receptor was detected.	PHA,35,38,Gene/Protein	OKT3,42,46,Gene/Protein	50 - kDa species,78,94,Gene/Protein	monoclonal antibody,119,138,Gene/Protein	intestinal vitamin D receptor,151,180,Gene/Protein	"[{""token"": ""PHA"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""OKT3"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""50 - kDa species"", ""start_span"": 78, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""monoclonal antibody"", ""start_span"": 119, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""intestinal vitamin D receptor"", ""start_span"": 151, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
Previously, a nuclear factor, IRF - 1 ( interferon regulatory factor 1), which binds to type I IFN and some IFN - inducible gene promoters, was identified and cloned.	nuclear factor,14,28,Gene/Protein	IRF - 1,30,37,Gene/Protein	interferon regulatory factor 1,40,70,Gene/Protein	type I IFN,88,98,Gene/Protein	IFN - inducible gene promoters,108,138,Gene/Protein	"[{""token"": ""nuclear factor"", ""start_span"": 14, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""interferon regulatory factor 1"", ""start_span"": 40, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""type I IFN"", ""start_span"": 88, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IFN - inducible gene promoters"", ""start_span"": 108, ""end_span"": 138, ""type"": ""Gene/Protein""}]"	train
Transforming growth factor - beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA.	Transforming growth factor - beta,0,33,Gene/Protein	human B lymphocyte Ig,45,66,Gene/Protein	membrane form,126,139,Gene/Protein	secreted form,147,160,Gene/Protein	Ig mRNA,164,171,Gene/Protein	"[{""token"": ""Transforming growth factor - beta"", ""start_span"": 0, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""human B lymphocyte Ig"", ""start_span"": 45, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""membrane form"", ""start_span"": 126, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""secreted form"", ""start_span"": 147, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""Ig mRNA"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
We have isolated a human cDNA clone encoding a zinc finger protein ( NF - E1) that binds to the negative - acting segment of the kappa E3 ' enhancer.	human cDNA clone,19,35,Gene/Protein	zinc finger protein,47,66,Gene/Protein	NF - E1,69,76,Gene/Protein	negative - acting segment,96,121,Gene/Protein	kappa E3 ' enhancer,129,148,Gene/Protein	"[{""token"": ""human cDNA clone"", ""start_span"": 19, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger protein"", ""start_span"": 47, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""NF - E1"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""negative - acting segment"", ""start_span"": 96, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""kappa E3 ' enhancer"", ""start_span"": 129, ""end_span"": 148, ""type"": ""Gene/Protein""}]"	train
TCF - 1 alpha is currently unique among the newly emerging family of DNA - binding regulatory proteins that share the HMG motif in that it is a highly tissue - specific RNA polymerase II transcription factor.	TCF - 1 alpha,0,13,Gene/Protein	DNA - binding regulatory proteins,69,102,Gene/Protein	HMG motif,118,127,Gene/Protein	highly tissue - specific RNA polymerase II,144,186,Gene/Protein	transcription factor,187,207,Gene/Protein	"[{""token"": ""TCF - 1 alpha"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding regulatory proteins"", ""start_span"": 69, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""HMG motif"", ""start_span"": 118, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""highly tissue - specific RNA polymerase II"", ""start_span"": 144, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 187, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
Moreover, M - CSF - induced expression of the fos - related gene, fra - 1, was delayed compared to that for both c - fos and fos - B.	M - CSF,10,17,Gene/Protein	fos - related gene,46,64,Gene/Protein	fra - 1,66,73,Gene/Protein	c - fos,113,120,Gene/Protein	fos - B,125,132,Gene/Protein	"[{""token"": ""M - CSF"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""fos - related gene"", ""start_span"": 46, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""fra - 1"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""fos - B"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Gene/Protein""}]"	train
In contrast, mild oxidation with glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.	glucose oxidase,33,48,Gene/Protein	p75,70,73,Gene/Protein	p85,78,81,Gene/Protein	p50,109,112,Gene/Protein	p55,117,120,Gene/Protein	"[{""token"": ""glucose oxidase"", ""start_span"": 33, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""p75"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""p85"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""p55"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}]"	train
A transcription factor, NF - AT, which is essential for early T - cell gene activation, seems to be a specific target of cyclosporin A and FK506 action because transcription directed by this protein is blocked in T cells treated with these drugs, with little or no effect on other transcription factors such as AP - 1 and NF - kappa B.	transcription factor,2,22,Gene/Protein	NF - AT,24,31,Gene/Protein	transcription factors,281,302,Gene/Protein	AP - 1,311,317,Gene/Protein	NF - kappa B,322,334,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 2, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 281, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 311, ""end_span"": 317, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 322, ""end_span"": 334, ""type"": ""Gene/Protein""}]"	train
From information available in the literature on the substrate specificity of the three enzymes, it is clear that a cysteine is not accepted in any of the S2, S1, S1 ', and S2 ' subsites of cathepsin B and L, and not in the S1 and S1 ' subsites of cathepsin D.	enzymes,87,94,Gene/Protein	cathepsin B and L,189,206,Gene/Protein	S1,223,225,Gene/Protein	S1 ',230,234,Gene/Protein	cathepsin D,247,258,Gene/Protein	"[{""token"": ""enzymes"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""cathepsin B and L"", ""start_span"": 189, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""S1"", ""start_span"": 223, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""S1 '"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""cathepsin D"", ""start_span"": 247, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	train
Starting with a replication - incompetent molecular clone of human immunodeficiency virus type 1, lacking all the NF - kappa B and Sp1 binding sites present in the native long terminal repeat ( LTR), proviruses containing reconstructed LTRs with individual or combinations of NF - kappa B and Sp1 elements were generated and evaluated for their capacity to produce virus progeny following transfection - cocultivation.	NF - kappa B and Sp1 binding sites,114,148,Gene/Protein	native long terminal repeat,164,191,Gene/Protein	LTR,194,197,Gene/Protein	reconstructed LTRs,222,240,Gene/Protein	NF - kappa B and Sp1 elements,276,305,Gene/Protein	"[{""token"": ""NF - kappa B and Sp1 binding sites"", ""start_span"": 114, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""native long terminal repeat"", ""start_span"": 164, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""reconstructed LTRs"", ""start_span"": 222, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B and Sp1 elements"", ""start_span"": 276, ""end_span"": 305, ""type"": ""Gene/Protein""}]"	train
The defensin sensitivities of Salmonella typhimurium strains with mutations in the phoP / phoQ two - component virulence regulon were tested by using purified defensins NP - 1 and NP - 2.	defensin,4,12,Gene/Protein	phoP / phoQ two - component virulence regulon,83,128,Gene/Protein	purified defensins,150,168,Gene/Protein	NP - 1,169,175,Gene/Protein	NP - 2,180,186,Gene/Protein	"[{""token"": ""defensin"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""phoP / phoQ two - component virulence regulon"", ""start_span"": 83, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""purified defensins"", ""start_span"": 150, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""NP - 1"", ""start_span"": 169, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""NP - 2"", ""start_span"": 180, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
Competition experiments did not reveal any high - affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility ( MHC) genes, suggesting that BSAP is a regulator of a different set of B - lymphoid - specific genes.	high - affinity binding site,43,71,Gene/Protein	BSAP,76,80,Gene/Protein	regulatory regions,90,108,Gene/Protein	BSAP,195,199,Gene/Protein	B - lymphoid - specific genes,237,266,Gene/Protein	"[{""token"": ""high - affinity binding site"", ""start_span"": 43, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""regulatory regions"", ""start_span"": 90, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 195, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""B - lymphoid - specific genes"", ""start_span"": 237, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
The same agents induce transcription from the interleukin - 2 receptor alpha - chain and interleukin - 2 genes, depending on promoter elements that bind the inducible transcription factor NF - kappa B ( or an NF - kappa B - like factor).	interleukin - 2 receptor alpha - chain and interleukin - 2 genes,46,110,Gene/Protein	promoter elements,125,142,Gene/Protein	inducible transcription factor,157,187,Gene/Protein	NF - kappa B,188,200,Gene/Protein	NF - kappa B - like factor,209,235,Gene/Protein	"[{""token"": ""interleukin - 2 receptor alpha - chain and interleukin - 2 genes"", ""start_span"": 46, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""promoter elements"", ""start_span"": 125, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""inducible transcription factor"", ""start_span"": 157, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 188, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B - like factor"", ""start_span"": 209, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
Transcription factor IID ( TFIID) binds to the TATA box promoter element and regulates the expression of most eukaryotic genes transcribed by RNA polymerase II.	Transcription factor IID,0,24,Gene/Protein	TFIID,27,32,Gene/Protein	TATA box promoter element,47,72,Gene/Protein	eukaryotic genes,110,126,Gene/Protein	RNA polymerase II,142,159,Gene/Protein	"[{""token"": ""Transcription factor IID"", ""start_span"": 0, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""TFIID"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""TATA box promoter element"", ""start_span"": 47, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""eukaryotic genes"", ""start_span"": 110, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""RNA polymerase II"", ""start_span"": 142, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
Human T - cell leukemia virus types I ( HTLV - I) and II ( HTLV - II) have two nonstructural trans - acting regulatory genes, tax and rex, located in the 3 ' region of the viral genome.	nonstructural trans - acting regulatory genes,79,124,Gene/Protein	tax,126,129,Gene/Protein	rex,134,137,Gene/Protein	3 ' region,154,164,Gene/Protein	viral genome,172,184,Gene/Protein	"[{""token"": ""nonstructural trans - acting regulatory genes"", ""start_span"": 79, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""tax"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""rex"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""3 ' region"", ""start_span"": 154, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""viral genome"", ""start_span"": 172, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
This similarity in expression and the fact that NFAT - 1 has been shown to bind functional sequences in HIV - LTR suggest a role for NFAT - 1 in dermal activation of the HIV - LTR.	NFAT - 1,48,56,Gene/Protein	functional sequences,80,100,Gene/Protein	HIV - LTR,104,113,Gene/Protein	NFAT - 1,133,141,Gene/Protein	HIV - LTR,170,179,Gene/Protein	"[{""token"": ""NFAT - 1"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""functional sequences"", ""start_span"": 80, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""HIV - LTR"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""NFAT - 1"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""HIV - LTR"", ""start_span"": 170, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
Treatment of immunoprecipitated NFATp from untreated HT - 2 cells with calcineurin resulted in the dephosphorylation of NFATp, demonstrating that NFATp is an in vitro substrate for calcineurin.	NFATp,32,37,Gene/Protein	calcineurin,71,82,Gene/Protein	NFATp,120,125,Gene/Protein	NFATp,146,151,Gene/Protein	calcineurin,181,192,Gene/Protein	"[{""token"": ""NFATp"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 71, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 181, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
Since many cytokines that activate Jak kinases also lead to the tyrosine phosphorylation and activation of members of the Stat family of transcription factors, the ability of IL - 2 to trigger Stat phosphorylation was examined.	cytokines,11,20,Gene/Protein	Jak kinases,35,46,Gene/Protein	Stat family,122,133,Gene/Protein	transcription factors,137,158,Gene/Protein	IL - 2,175,181,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 11, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""Jak kinases"", ""start_span"": 35, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""Stat family"", ""start_span"": 122, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 137, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 175, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
To identify osteoblast - specific cis - acting elements and trans - acting factors, we initiated an analysis of the promoter of a mouse osteocalcin gene, an osteoblast - specific gene.	osteoblast - specific cis - acting elements,12,55,Gene/Protein	trans - acting factors,60,82,Gene/Protein	promoter,116,124,Gene/Protein	mouse osteocalcin gene,130,152,Gene/Protein	osteoblast - specific gene,157,183,Gene/Protein	"[{""token"": ""osteoblast - specific cis - acting elements"", ""start_span"": 12, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""trans - acting factors"", ""start_span"": 60, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""mouse osteocalcin gene"", ""start_span"": 130, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""osteoblast - specific gene"", ""start_span"": 157, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
These studies are the first to determine the structure and organization of the 5 ' end of the thromboxane receptor gene and demonstrate that thromboxane receptor gene expression can be regulated by activation of protein kinase C via induction of an AP - 2 - like nuclear factor binding to upstream promoter elements.	thromboxane receptor gene,94,119,Gene/Protein	thromboxane receptor gene,141,166,Gene/Protein	protein kinase C,212,228,Gene/Protein	AP - 2 - like nuclear factor,249,277,Gene/Protein	upstream promoter elements,289,315,Gene/Protein	"[{""token"": ""thromboxane receptor gene"", ""start_span"": 94, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""thromboxane receptor gene"", ""start_span"": 141, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 212, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2 - like nuclear factor"", ""start_span"": 249, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""upstream promoter elements"", ""start_span"": 289, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
Inhibition of endogenous C / EBP proteins, using either an excess of C / EBP binding sites or a trans - dominant negative inhibitor, demonstrated that C / EBP proteins are required for basal and activated levels of HIV - 1 LTR transcription in the promonocytic cell line U937.	endogenous C / EBP proteins,14,41,Gene/Protein	C / EBP binding sites,69,90,Gene/Protein	trans - dominant negative inhibitor,96,131,Gene/Protein	C / EBP proteins,151,167,Gene/Protein	HIV - 1 LTR,215,226,Gene/Protein	"[{""token"": ""endogenous C / EBP proteins"", ""start_span"": 14, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP binding sites"", ""start_span"": 69, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""trans - dominant negative inhibitor"", ""start_span"": 96, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP proteins"", ""start_span"": 151, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 215, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	train
Since expression of the viruses is in large part regulated by the sequence elements in their long terminal repeats ( LTRs), this study was directed to an analysis of the regulatory elements in the HIV - 2 LTR.	sequence elements,66,83,Gene/Protein	long terminal repeats,93,114,Gene/Protein	LTRs,117,121,Gene/Protein	regulatory elements,170,189,Gene/Protein	HIV - 2 LTR,197,208,Gene/Protein	"[{""token"": ""sequence elements"", ""start_span"": 66, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""long terminal repeats"", ""start_span"": 93, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""LTRs"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""regulatory elements"", ""start_span"": 170, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 2 LTR"", ""start_span"": 197, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	train
Protein phosphorylation has an important role in the regulation of these two factors: ( 1) it induces the transactivating capacity of the AP - 1 protein c - Jun; and ( 2) it is involved in the release of the cytoplasmic inhibitor, I kappa B, from NF - kappa B, allowing translocation of the latter into the nucleus.	AP - 1 protein,138,152,Gene/Protein	c - Jun,153,160,Gene/Protein	cytoplasmic inhibitor,208,229,Gene/Protein	I kappa B,231,240,Gene/Protein	NF - kappa B,247,259,Gene/Protein	"[{""token"": ""AP - 1 protein"", ""start_span"": 138, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic inhibitor"", ""start_span"": 208, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 231, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 247, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	train
In all cell lines investigated, the NF - kappa B complexes induced following CD30 engagement were shown to contain p50 NF - kappa B1, p65 RelA, and possibly other transcription factors.	NF - kappa B complexes,36,58,Gene/Protein	CD30,77,81,Gene/Protein	p50 NF - kappa B1,115,132,Gene/Protein	p65 RelA,134,142,Gene/Protein	transcription factors,163,184,Gene/Protein	"[{""token"": ""NF - kappa B complexes"", ""start_span"": 36, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""CD30"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""p50 NF - kappa B1"", ""start_span"": 115, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""p65 RelA"", ""start_span"": 134, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 163, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
The present study demonstrates that triggering of complement receptors CR1 ( CD35) and CR3 ( CD11b / CD18) enhances viral replication in HIV - infected human monocytic cells.	complement receptors,50,70,Gene/Protein	CR1,71,74,Gene/Protein	CD35,77,81,Gene/Protein	CR3,87,90,Gene/Protein	CD11b / CD18,93,105,Gene/Protein	"[{""token"": ""complement receptors"", ""start_span"": 50, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CR1"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""CD35"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""CR3"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""CD11b / CD18"", ""start_span"": 93, ""end_span"": 105, ""type"": ""Gene/Protein""}]"	train
Immunoprecipitation of the gp 160 - induced nuclear extracts with polyclonal antibodies to Fos and Jun proteins indicates that AP - 1 complex is comprised of members of these family of proteins.	gp 160,27,33,Gene/Protein	polyclonal antibodies,66,87,Gene/Protein	Fos,91,94,Gene/Protein	Jun proteins,99,111,Gene/Protein	AP - 1 complex,127,141,Gene/Protein	"[{""token"": ""gp 160"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""polyclonal antibodies"", ""start_span"": 66, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""Fos"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""Jun proteins"", ""start_span"": 99, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 complex"", ""start_span"": 127, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	train
